<SEC-DOCUMENT>0001035267-21-000178.txt : 20211020
<SEC-HEADER>0001035267-21-000178.hdr.sgml : 20211020
<ACCEPTANCE-DATETIME>20211020170106
ACCESSION NUMBER:		0001035267-21-000178
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		78
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211020
DATE AS OF CHANGE:		20211020

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTUITIVE SURGICAL INC
		CENTRAL INDEX KEY:			0001035267
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				770416458
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30713
		FILM NUMBER:		211334784

	BUSINESS ADDRESS:	
		STREET 1:		1020 KIFER ROAD
		CITY:			SUNNYVALE
		STATE:			CA
		ZIP:			94086
		BUSINESS PHONE:		4085232100

	MAIL ADDRESS:	
		STREET 1:		1020 KIFER ROAD
		CITY:			SUNNYVALE
		STATE:			CA
		ZIP:			94086
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>isrg-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:4f3ead07-f4ad-4d18-aec5-70406fe3497c,g:13f40b2a-7689-41e3-982f-2ccf6cf675cb,d:944f300b8c29463aa56139ed7eaca296--><html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:isrg="http://www.intuitivesurgical.com/20210930" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>isrg-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80L2ZyYWc6Mjk5OTE3ZjA2ZWFjNGQ0Mjg3MzgyMTM4ODBkY2JlNmYvdGFibGU6YmVhNzY0OWMxZTgzNGI4NzliNTZkMmYwNDcwNTdjNDIvdGFibGVyYW5nZTpiZWE3NjQ5YzFlODM0Yjg3OWI1NmQyZjA0NzA1N2M0Ml8zLTEtMS0xLTA_793a97fe-e490-44f6-a649-f243def71a70">0001035267</ix:nonNumeric><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80L2ZyYWc6Mjk5OTE3ZjA2ZWFjNGQ0Mjg3MzgyMTM4ODBkY2JlNmYvdGFibGU6YmVhNzY0OWMxZTgzNGI4NzliNTZkMmYwNDcwNTdjNDIvdGFibGVyYW5nZTpiZWE3NjQ5YzFlODM0Yjg3OWI1NmQyZjA0NzA1N2M0Ml81LTEtMS0xLTA_a78f62da-3267-4055-b7b5-494634eb1395">2021</ix:nonNumeric><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80L2ZyYWc6Mjk5OTE3ZjA2ZWFjNGQ0Mjg3MzgyMTM4ODBkY2JlNmYvdGFibGU6YmVhNzY0OWMxZTgzNGI4NzliNTZkMmYwNDcwNTdjNDIvdGFibGVyYW5nZTpiZWE3NjQ5YzFlODM0Yjg3OWI1NmQyZjA0NzA1N2M0Ml82LTEtMS0xLTA_c77ea574-3dcc-4841-af29-800a5f792b12">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" format="ixt:fixed-false" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80L2ZyYWc6Mjk5OTE3ZjA2ZWFjNGQ0Mjg3MzgyMTM4ODBkY2JlNmYvdGFibGU6YmVhNzY0OWMxZTgzNGI4NzliNTZkMmYwNDcwNTdjNDIvdGFibGVyYW5nZTpiZWE3NjQ5YzFlODM0Yjg3OWI1NmQyZjA0NzA1N2M0Ml83LTEtMS0xLTA_09f9d006-eb28-4317-a37a-b771eeda6951">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80L2ZyYWc6Mjk5OTE3ZjA2ZWFjNGQ0Mjg3MzgyMTM4ODBkY2JlNmYvdGV4dHJlZ2lvbjoyOTk5MTdmMDZlYWM0ZDQyODczODIxMzg4MGRjYmU2Zl83_6dac07de-439b-4be9-97f4-f82cf7c0f9e7">--12-31</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="isrg-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i24def724605546e8b248a658364e4bd2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ib71d87d145ef41b297a97754a430484b_I20211014"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i75cbfe3d586a465494dffae57715ee91_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b5caccf7f8842848177872d08d31bd3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00ffc107447849539c91c165ecee4fa0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2533132d0f44dacbeb417a8b14afee9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80bf05acda8e4d86bc05c11853836a6d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i332e55c2a8f94b45933b5aef35f08ce1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0a77442ddf0494f9388b80f7fee300e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8872118a076840b18b642c05bc7c8fdd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a2ef2720e5d48859c0e54b81ae7ab52_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic452fc69ad0b4328b92b435105261628_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id79ce19a534e4d139e67bf0750158934_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac4be23e732e4f789fec20c9fc25381a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4319e4b98dd145c2a90852e2abd3b90d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie068099537924951abe627974208afa6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7cff1e3b70b4d59942f780200c132ae_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea68361551fa4459a3df45292aa07f09_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id420ed12c599434ea400964616900e95_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fb374215fd24fceb8e6353f18d88ae5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfc8dbc3d6fb4425a9ff2241572e2cf1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i051ac4e837b3485fb8a292b1fcaf07ec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06308a83da3a4180bee5bf62322c5e37_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06c58807713747e68d9de8c22f9c0180_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4894873227d4ea89ae1cd010bac1f63_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d720541eae04f0fb8a83fef4019ced8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11db865dc86840629acd13c8a709c2d3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50b6e061ae8c4457ae5cc241cd439143_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84eb653b91034599a7ec24d50e0fad92_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib87bb311713b42d2a296729d6a21259a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae28aecb5f7a4c7bacd3c8ecb4f9026a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">isrg:IntangibleAndOtherAssetsNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe9058395d09478a81e0df11992f7575_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12b57348d47e45dbbc469e0cd82180c2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46504ffcecdd46ce81248e08922c68cb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">isrg:IntangibleAndOtherAssetsNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i319aeb288bcf4439b7aa385bd35027af_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77c4e5ac2bfa409fbf298841deccc21d_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12b53adfc2da450d83928c0d59c0cf9b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8b8d9c0c6b447738c87b3b7e16f0a5e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i229a1c443d19443798c91258bb8d018d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e2c2a67bae840698c4ce5e39a92dddc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1d4b29a68414fe6b3b2e75caa359a5d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">isrg:CollarContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0fa4f45ec164a5ebc9a515e1b8f57b3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24d4644b1a994c0f8abaeee9b5dcdb06_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63493d444f724a8296203ce9004defce_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i194cea79cb2847038852265b56fab10c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied0febbfd3184ec78820350f31b1a206_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i673322c7553b44c88a98e44d90b50183_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50d502c033d34a2bb8803baed7932450_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6b35b549a824fe8a766f46dd9432198_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56683a8f54f2401e93b699a3ebeca829_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23484c1a1c1f47c7a08373f58c84bc7a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2143a91feda349708ea3355e40ad18d5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f223d39fb294552a8bcfb3bc81d4ebd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecb4ff6e5fe5459f9bc00395116a38fb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf31bd19117d49ad9339442660f985f1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife0812e0ddbd443b89d9604955851763_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2604357eba845b084dd3bf73b2757e5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41d6f85820774298aee1036152f3f737_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25dca51a46e14c27ba59a12aad400497_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id89c6d81b52d4816b2252aef11227497_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c75d5f4a15f44ca9ac400c2f1889d82_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i406fb20eeca84b7d92fe357463e85f6c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad16e7fe313c4489a4b36c3fbd634251_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3925b0e265e6407ba522b052f71f3c41_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7caf933d32a44a348550d2fe3f894b90_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f847939b19c491f9f7d865b8bed8ca5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4aecb14552b54937b40537850614044e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88e4709c5bac4f04a4f648b34d11dcfc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dda0f930e68405ab3bc179a126443d9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f77153a86ef4445b2643323afa75e0d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6decb5bae0bb4ac8a4dd1cb95e052fb1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e03e6e08b894f258a0ae7e5baf29d4d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i577d8ffa87da4e9f87387883bec6f02b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77bac0e4769042e483f91c8ebb08ee8e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice87d9c6353945688b8d23575204c383_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9db5f294e20446a485b225b9c62bd623_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4dcb119f285471db2ed01f635d0158b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e116d872911487b964787a5ad7b829e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b8fa49940cf4659848e727c825f73c9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bbf79c7461d494abe77f32ab6fa2494_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbabbfafefa044f6b3ce8e02746f0a49_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i412f99609e454649a82b61eed8aa58ac_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i996abb0f87034c4f91f7b2f0ad4eda06_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i672905085bc3459a9d00cbc325e97bb4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f0a990e6c394d8c8008639d37935b0a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b1f121a531948669a508b4480804ca0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ae8d93de5f54b1ab269fde30dd6b190_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idab02e2b14ea4d82817b4d902d15adc7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i620c79857bce477992bc9f8b37092c6c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if10e966d0d6b4c70a5fb900ee48bfb44_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1901af46aeed45319e6c22a2482f0527_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2075d28d68b94983bd02ac4a20ff18d2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i977db1115aba4294ab954fafbee1ba05_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica0e2ab5444c405588f03410c79beb75_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37656fec38db4901b77f277074155cce_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1022821765b944a7a6645ef3d885d0d8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89a0602b4836416f90adbc080a012a8e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie286ee6f7f574339b7040c18df117a53_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40ae7c3cefde401583c8e526051dd07b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb5a865f78164fc18aef9ad29f31e8ff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4d7cc4e81e94501bcf79b671e5df53c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49470d81e3c048edbcda45a279c28a74_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77ba4e1aaa0a40daa59040ab5003d99d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib82660af9cff4336adca1f99b02c09c4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief72904a51c44045bc02018f15b8f0ed_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">isrg:HighMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b5e071604dd4ac48f9826527375a58a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">isrg:ModerateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfeb8a45a0084daf9e15f7fde113be1c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">isrg:LowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibccf075334db4130accdd0e847125918_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0040668084154bd5bbaa4b3954aa2f3b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id153e77c855a4d55ae7589981388d8e2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6019979522c14652baffb83a0302dc78_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad348be44e784609b63102d7bd423e75_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a10116d504946cbab544899d14169f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1d61c223bb747ee95152c8eee22b13c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice3d62c192824cc4b074c71a8ae80571_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66e41b3c2e834c119d0176db2e8af060_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17c6dd038d1e4e839081d843139db4ba_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18955016352d4c2f9c1114363b8cf2d5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91f3018ef47c4b5fa0e52396465d7744_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecbbf0bac773402585e5625778664eaf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d4217ee5ed9439ca27f0168c8e3920a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a616a50f9f54a62a3dff6cc537b74d5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f10f7a841b9428193c67c65a7651180_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b4dddac366f478ba48b52ac99d622cd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0939772d62d942b796188dfdf7fcc61e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f38a035988a4b04bc207db50d81f2e6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7722e2881b60414b88d5e47e4ff0c212_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12b4985e5aab46088463bd2ea8c718c3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i494c07d22f024c88948a992d708aea7e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4acd3901acf4471db1cf795db1c4a248_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib32048ff4ad6455287e4c2b2f78d13a1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia693b8c7b00c4855b184870531142247_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i278f38b19568472ebae990bee1c0db33_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a1f00bb40df4d9597f66832f85ab8ef_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7ef2803613641c69436d6aa1c5b43d6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16ae1d800ab0420085daf458dee535a2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6975f86655b24c28bb3402aa5c5ca96b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29efc4bde4c9438ab296aa4811b7ca13_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib780080ab3a8424fbe082969241fa1f5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49309f63539141078a0b3ba243955ca1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbbd8d73ef944adc832fbdfb193e657e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacea1d90eb614cbba03fd2b9f5332772_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91590958a4e84c3fba1738213a5cff5e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08eb4b64387b42b3aac663f9c29cced9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie46138cc218c44bdab5454b674d97eb7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53f8ced32a444ff4b52e4928b94175dd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i879d429e085f447493c82a85ba62c318_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i818cc058723f4fab9e6730e25fd2ff75_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4abb28eb95f4310a27bcff42b173ed8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73ec9b1829e641dda129e28b2a310e58_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22d1823a37a8412087b1432940f4c878_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42eb9966ff944cf086ee492f9ee5720c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i298e438389654f6da638e3e8d14778e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ecdb391c0e74585907d8294c4b4d69e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac9eea68e98844389ba6177116b318aa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if74d89ff156145239e2267161cac4cd1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f0850dbce3d4403ad215d9950255074_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfef3e14f8544cecabe32b0486e9b751_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f2fc119452d4229a0c5865465b20e5c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3578980607fc4e1dbb9e534383697716_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20ecaa1bd9224b37ba51ddb3346bde9b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida4fee943cff4029b9a8507c4a72da04_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23d7cb9591264bbe8dc96ff49f2da4c2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6da3e57aeb6d40558803471b05c62423_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifebe86d96c974e9995f2ab3c8bee539a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia41fc6f9fdbc465a9ff6c912c6a47cc8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if153039c790149ae84e26285a922687c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabc57ded48384f2291a996748a5d75e9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bb77f1efb29470393902b43dc1a6d3b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b9791a8b20a4038bdc81c09768ee380_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1f58decd61f48438b11935b7b7b714b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb71bb2eb1d2412590a4afbcb608ddd3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc1061d70ad5423599fbd327cc33d223_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c546426be6a4e028b9617594f0b1719_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a2243e61faf45dab6768e7f1d20f6ca_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a19e6703be642579f343e142e25ceb2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd3fcfe8635544479553199fd6d5870b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbc28f1ab9984d34933140b676cdeda5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb62ec09022f420caf06b91fbe4483c6_I20190131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45ed2df55a904b73a9495b2d3967029c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dc58ace2562461ab1b5006b2f252b53_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i553f65ed4f294d7bbb0fb4e0b36c4669_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id90bdf528ea1473fb22ba73a9cf8fec7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ec0403c801644f7b94ced14e5abe91e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">isrg:A2010IncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ba50cc2545940ee9b0e537bcee9fecb_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">isrg:A2010IncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90d117c8ce8b4a12a61bca2bc0d175ea_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a351862876548c3806015af800a7f8b_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i120ec0e7f5d74c85a3c972e2814bae13_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">isrg:A2010IncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24b8332d62be4e67924e1b675742a795_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">isrg:A2010IncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i027fee4566074a4f9475d1aa2d3fbb42_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4414a789bd34fbebcd0395bb363b24f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ac96970f42e4066a4c840390044d4b5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92cbadc1b4dc43c78d9b42fe98dc9359_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97592680c7ea4d0c98add45dc8ac42d6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3dc8c8c90db4f51afb0d492dbb4b82e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53ae1d88875d4f12a62bc03a44e1b07f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie24d4b4f022c47c9803198a89abebb1c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i553935c5696341248be4dde6c6466dc1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i636e52596b904d9aabe71c6e5c662679_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fcd59b1068d47cba389bdf071fe2a4a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f6cbcbf701a42bf9968bf5dc8e400e2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5299dae533374f869f3916eb74f78a0d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23ec5af0dc794a8b819199e06c9c7e0e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0e0073a5326490ca14b42218c217b9a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic17eef63e1f745a382c154accc3d123e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec5a6bdd4379479bbf40a5d7ea2ea843_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief8e8ca8a5314cf29b3f0cd00926ccf6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5991df12b084f31a3209fb60aac8919_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bdc2cf5e4434be7a2c05799c2f073a0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie98c2152fa284185b7a3eec1e86e9308_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida259e2fffb84c6daef0d3ae72179664_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17cd59475f274e609d82992c047d3bef_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf5c832845ad43ffaae3030609897c12_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1fc23134d92414983b8c9ffd7172fcc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i39d2400983df44e786e5f043ff29f072_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86ee9cb414864a739611fb6aa952b4b5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19f02cddebeb45688a3df400d1f96f9f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26618f20dcf34488b46dc5d1ad566328_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ee2fa93adb64b729a028c991c27406a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69e0aa09b22945fe8e76dfb3e9ac826e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8e60490c05d45a5903e47f96d9854af_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86f7d62644344bb5b63935be28a53d36_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i944f300b8c29463aa56139ed7eaca296_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-top:3pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV84Ng_378b347a-b40d-4434-b7f4-376fa9c06e9e">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Mark One)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6ZmRlODYyOTIwN2QxNGY0Yzk3OGEwZDI4NmNhYzg3NWUvdGFibGVyYW5nZTpmZGU4NjI5MjA3ZDE0ZjRjOTc4YTBkMjg2Y2FjODc1ZV8wLTAtMS0xLTA_603ed1fb-b331-45d3-b9e5-d3642118f72a">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8xMzQ_20ffcded-1cf0-4a18-9521-8b07c9e15a37">September 30, 2021</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6MmQ0YmJiNTlhYTcxNDY5ZGE0OTUxMWUyY2Q1MTA5ZmUvdGFibGVyYW5nZToyZDRiYmI1OWFhNzE0NjlkYTQ5NTExZTJjZDUxMDlmZV8wLTAtMS0xLTA_d9fafea6-efe4-47cb-b18c-2064b1f7556b">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8yMjQ_2c41d2c3-23fa-4d7b-b728-e5bde6e54ae9">000-30713</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8yMjk_e4c24e77-21b1-4e3f-a4be-ad98fe9f96c0">Intuitive Surgical, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of Registrant as specified in its Charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6NjhjODNmYjhmMWIyNGYyOWE4OGJjMDNhNzdhN2ExMDYvdGFibGVyYW5nZTo2OGM4M2ZiOGYxYjI0ZjI5YTg4YmMwM2E3N2E3YTEwNl8wLTAtMS0xLTA_c2e86b3b-0dc1-40db-9c67-b4566eb378db">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6NjhjODNmYjhmMWIyNGYyOWE4OGJjMDNhNzdhN2ExMDYvdGFibGVyYW5nZTo2OGM4M2ZiOGYxYjI0ZjI5YTg4YmMwM2E3N2E3YTEwNl8wLTItMS0xLTA_e00ad5a7-57b9-450d-b6c0-cb0aeeb8300f">77-0416458</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or Other Jurisdiction of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8yOTE_e947cfc3-c49c-4db3-8192-6023f06b42e5">1020 Kifer Road</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8yOTU_a36e97f1-a137-45b8-8005-eaefc52a9742">Sunnyvale</ix:nonNumeric>, <ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8yOTk_ac8ed101-82d8-429a-85b7-ca0c5d61e02e">California</ix:nonNumeric> <ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8zMDI_b4522d1b-0eb3-4869-b9fd-6fb4d65e38bc">94086</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8zNTk_b6fe1a67-b75d-4755-b809-20e545cf9da9">408</ix:nonNumeric>) <ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8zNjM_7411c8e2-6552-4cb9-a3ae-2d287134bb5e">523-2100</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:39.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.113%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6NDdkZmJkODM2NzE1NGJlNzkyNDRmZDgzYThlNDBhZDUvdGFibGVyYW5nZTo0N2RmYmQ4MzY3MTU0YmU3OTI0NGZkODNhOGU0MGFkNV8xLTAtMS0xLTA_36437900-48cb-40d6-84a0-5f13320519c9">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6NDdkZmJkODM2NzE1NGJlNzkyNDRmZDgzYThlNDBhZDUvdGFibGVyYW5nZTo0N2RmYmQ4MzY3MTU0YmU3OTI0NGZkODNhOGU0MGFkNV8xLTEtMS0xLTA_b53e11af-bf40-4ad0-bca7-01234dd9909f">ISRG</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6NDdkZmJkODM2NzE1NGJlNzkyNDRmZDgzYThlNDBhZDUvdGFibGVyYW5nZTo0N2RmYmQ4MzY3MTU0YmU3OTI0NGZkODNhOGU0MGFkNV8xLTItMS0xLTA_e8c25494-7ebe-49e3-b3bd-a95830261b5a">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV84MzI_659b936f-d6fb-47ab-8030-4c1c9f4d177e">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8xMTU5_7fe10420-b090-4bda-94ac-5e7e5cdc51db">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6NWNlNWE5MTU1NGU3NDA1ZDkwYWFhZDU5NmMxN2IxZTQvdGFibGVyYW5nZTo1Y2U1YTkxNTU0ZTc0MDVkOTBhYWFkNTk2YzE3YjFlNF8wLTAtMS0xLTA_1a8e9f5a-9196-444c-9356-03e645f8c157">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#168;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#168;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6NWNlNWE5MTU1NGU3NDA1ZDkwYWFhZDU5NmMxN2IxZTQvdGFibGVyYW5nZTo1Y2U1YTkxNTU0ZTc0MDVkOTBhYWFkNTk2YzE3YjFlNF8xLTQtMS0xLTA_b9c55b1b-e85f-4498-adf2-1a7093b5ae22">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6NWNlNWE5MTU1NGU3NDA1ZDkwYWFhZDU5NmMxN2IxZTQvdGFibGVyYW5nZTo1Y2U1YTkxNTU0ZTc0MDVkOTBhYWFkNTk2YzE3YjFlNF8yLTQtMS0xLTA_60e8a116-47c3-455a-817e-d2e73b3783be">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.             &#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8xOTA4_a5f27da3-ca14-4d40-ba1b-6a1034eb1f37">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Registrant had <ix:nonFraction unitRef="shares" contextRef="ib71d87d145ef41b297a97754a430484b_I20211014" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8xOTM5_35c502c7-d936-46c7-a385-a45f315fdeaa">357,236,861</ix:nonFraction> shares of Common Stock, $0.001 par value per share, outstanding as of October&#160;14, 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:center;text-indent:24.75pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_7"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTUITIVE SURGICAL, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.942%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page&#160;No.</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I. FINANCIAL INFORMATION</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_13">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_13">Financial Statements (unaudited):</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_16">Condensed consolidated balance sheets as of September 30, 2021, and September 30, 20</a>20</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_16">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_22">Condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2021, and 20</a>20</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_22">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_25">Condensed consolidated statements of cash flows for the nine months ended September 30, 2021, and 20</a>20</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_25">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_28">Notes to condensed consolidated financial statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_28">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_70">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_70">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_70">23</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_163">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_163">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_163">44</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_166">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_166">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_166">44</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II. OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_172">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_172">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_172">45</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_175">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_175">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_175">45</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_178">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_178">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_178">46</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_181">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_181">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_181">47</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_184">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_184">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_184">47</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_187">Item&#160;5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_187">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_187">47</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_190">Item&#160;6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_190">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_190">48</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_193">Signature</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_193">49</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="i944f300b8c29463aa56139ed7eaca296_13"></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1.         FINANCIAL STATEMENTS</span></div><div id="i944f300b8c29463aa56139ed7eaca296_16"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTUITIVE SURGICAL, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">in millions (except par values)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMy0xLTEtMS0w_18675f62-0d03-4aeb-8f27-a8ea3412acc0">1,346.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMy0zLTEtMS0w_efa6af0d-1373-4650-b7d1-de23ef4707be">1,622.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfNC0xLTEtMS0w_911d36d4-eca7-4467-b2e5-21c060c50e85">2,741.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfNC0zLTEtMS0w_51566405-7af2-4779-a9fd-25d56242fcbd">3,488.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfNS0xLTEtMS0w_02c3636b-cdad-46ff-a6d8-f931b2241bb9">695.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfNS0zLTEtMS0w_b15db41b-b350-43fd-a085-29ca6a732325">645.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfNi0xLTEtMS0w_fb4f1102-bc38-48d4-b11b-3d741230bd07">584.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfNi0zLTEtMS0w_f2b8b5ee-15a3-4567-bcee-52a941db8078">601.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfNy0xLTEtMS0w_cda19872-c9e0-41a6-a8ff-37ccb0288e22">359.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfNy0zLTEtMS0w_4aaa04ac-f2fa-4220-98fb-f12721841993">267.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfOC0xLTEtMS0w_fc5b2358-a42a-4c9b-8700-f4cbb203b693">5,728.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfOC0zLTEtMS0w_9c06b66f-919b-46ea-83d4-75041c0d0539">6,625.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfOS0xLTEtMS0w_44bf1033-db2e-4169-a684-9b9050516a91">1,737.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfOS0zLTEtMS0w_52dcace6-631f-4270-9e04-7de7e2c3ba64">1,577.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTAtMS0xLTEtMA_5675d0e2-adae-4e5e-83b4-96fb6c253c2b">4,131.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTAtMy0xLTEtMA_a070da05-3fb9-4af8-96c8-ed556b0bc496">1,757.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTEtMS0xLTEtMA_45f34a76-cc88-42cc-98e6-0794fcaae673">411.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTEtMy0xLTEtMA_0bb496ce-c98a-40a6-8ac9-e0e01eab3970">367.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible and other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="isrg:IntangibleAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTItMS0xLTEtMA_9d89056d-fc4b-4874-806a-d8977aa8ec68">581.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="isrg:IntangibleAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTItMy0xLTEtMA_59a7c9d1-26b3-4dff-8490-ec1007cb4ee7">503.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTMtMS0xLTEtMA_10bff0a0-7d7a-4ef1-b019-5c0b9cb1f6e8">344.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTMtMy0xLTEtMA_60d6d808-c9d0-452e-879a-6896a912416a">336.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTQtMS0xLTEtMA_9e7fafa8-5912-4f89-adea-7956e6959393">12,934.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTQtMy0xLTEtMA_3b2d60f8-c738-4367-93a9-e1e1618ff2ef">11,168.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTctMS0xLTEtMA_b7b5aeba-852c-45a4-9540-11d4ba5e915f">120.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTctMy0xLTEtMA_c2c87cb6-f57c-474e-917f-a5431e4ab0f0">81.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTgtMS0xLTEtMA_94f992ec-0101-4da3-bc77-cc296fc4d898">265.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTgtMy0xLTEtMA_87bbf4da-d3ff-4986-b8ff-ebc9a75ae197">235.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTktMS0xLTEtMA_71224ac7-15bb-42e8-b46f-53f33b007c06">348.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTktMy0xLTEtMA_affec25f-4ee7-40ca-b942-ce5225213da1">350.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjAtMS0xLTEtMA_ce41b3cc-60ec-475f-9cb2-739f96894c66">293.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjAtMy0xLTEtMA_4b3fcb98-b30d-4cfa-977c-fd8b0dac064a">298.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjEtMS0xLTEtMA_edf31c11-90e4-4f91-a219-45db281ae21a">1,027.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjEtMy0xLTEtMA_552a93c7-02ca-4169-876f-d4ae4d72a962">965.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjItMS0xLTEtMA_8d9be2df-8d61-42ba-9360-83a81c8cd491">447.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjItMy0xLTEtMA_a42fa21e-5b49-4a01-82b5-34d587c614b9">444.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjMtMS0xLTEtMA_380c9df2-7f75-4ae8-b699-ae50f8ed9bf6">1,475.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjMtMy0xLTEtMA_242f8483-3073-4652-a1bc-a4c8c2e1b6c0">1,409.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingencies (Note 8)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjQtMS0xLTEtMA_d56e6f33-1741-4444-ba75-5e4928d6afc9"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjQtMy0xLTEtMA_b037e46f-15bc-48bd-9626-3bdd17819e9a"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, <ix:nonFraction unitRef="shares" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjdmYzNiN2Y3MzIxZDQ4NTViYmZiMzI1MThhZDYwMmEyXzIx_5240120e-5fc2-4f2a-886c-d9cb5bb65dd1"><ix:nonFraction unitRef="shares" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjdmYzNiN2Y3MzIxZDQ4NTViYmZiMzI1MThhZDYwMmEyXzIx_68076e44-37fc-425a-9ac7-0164da65057d">2.5</ix:nonFraction></ix:nonFraction> shares authorized, $<ix:nonFraction unitRef="usdPerShare" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjdmYzNiN2Y3MzIxZDQ4NTViYmZiMzI1MThhZDYwMmEyXzQz_01639275-038a-436a-a079-6f905b0e0bb2"><ix:nonFraction unitRef="usdPerShare" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjdmYzNiN2Y3MzIxZDQ4NTViYmZiMzI1MThhZDYwMmEyXzQz_60e6c82f-f51b-4ada-8084-497379c1475a">0.001</ix:nonFraction></ix:nonFraction> par value, issuable in series; <ix:nonFraction unitRef="shares" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjdmYzNiN2Y3MzIxZDQ4NTViYmZiMzI1MThhZDYwMmEyXzc3_43f0813e-b8b2-41dd-8b78-e589d9ab2e73"><ix:nonFraction unitRef="shares" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjdmYzNiN2Y3MzIxZDQ4NTViYmZiMzI1MThhZDYwMmEyXzc3_804443f9-92a5-40b4-a9c1-ef6013fe510f"><ix:nonFraction unitRef="shares" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjdmYzNiN2Y3MzIxZDQ4NTViYmZiMzI1MThhZDYwMmEyXzc3_aeb9fd7a-bd87-4945-b55c-759c0b90f484"><ix:nonFraction unitRef="shares" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjdmYzNiN2Y3MzIxZDQ4NTViYmZiMzI1MThhZDYwMmEyXzc3_ce656903-5e57-4198-aab2-76f46a634c9b">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of September&#160;30, 2021, and December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMS0xLTEtMA_ecc3e677-f53c-47b3-9365-84c2b03ba39d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMy0xLTEtMA_18006b3e-875a-42ba-a76f-34803cfa9b9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, <ix:nonFraction unitRef="shares" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmNlYWFkOTdmY2JkMzRkOTA5NWE1MTRhMTkwM2RhYTgxXzE5_07dc35f4-4246-4c8a-b58e-3dbd48554b1b"><ix:nonFraction unitRef="shares" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmNlYWFkOTdmY2JkMzRkOTA5NWE1MTRhMTkwM2RhYTgxXzE5_3579d956-4a4f-4b8e-b197-9165740fb0c1">600.0</ix:nonFraction></ix:nonFraction> shares authorized, $<ix:nonFraction unitRef="usdPerShare" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmNlYWFkOTdmY2JkMzRkOTA5NWE1MTRhMTkwM2RhYTgxXzQx_75fd4867-63bd-47d5-88db-869dde66b977"><ix:nonFraction unitRef="usdPerShare" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmNlYWFkOTdmY2JkMzRkOTA5NWE1MTRhMTkwM2RhYTgxXzQx_f275fa7e-fabc-41d8-9786-d03e15f7ee51">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmNlYWFkOTdmY2JkMzRkOTA5NWE1MTRhMTkwM2RhYTgxXzU1_3319278b-1322-4a36-8a8b-da26c6802646"><ix:nonFraction unitRef="shares" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmNlYWFkOTdmY2JkMzRkOTA5NWE1MTRhMTkwM2RhYTgxXzU1_d410427d-c3bb-423b-ba0b-a693fd59c5da">357.2</ix:nonFraction></ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmNlYWFkOTdmY2JkMzRkOTA5NWE1MTRhMTkwM2RhYTgxXzY5_3e4a542c-fce9-4dee-a06e-01730eb5eeb0"><ix:nonFraction unitRef="shares" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-3" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmNlYWFkOTdmY2JkMzRkOTA5NWE1MTRhMTkwM2RhYTgxXzY5_f7d63ef8-61df-49cb-804b-14826d85b70d">353.1</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of September&#160;30, 2021, and December&#160;31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMS0xLTEtMA_5fbebe53-b131-47c2-8174-ab9c6011d81c">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMy0xLTEtMA_9cedd792-bcb3-4840-8268-7e4c641fc564">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjgtMS0xLTEtMA_af95f205-a694-4666-8f5c-37de0ab5e80c">7,015.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjgtMy0xLTEtMA_9c809cce-6a53-47aa-b0f8-e2435f25efa2">6,444.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjktMS0xLTEtMA_a80a6356-f238-4124-bcb1-59e51c34cc93">4,390.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjktMy0xLTEtMA_4c45c385-ca48-493c-828c-5a602e901662">3,261.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzAtMS0xLTEtMA_23c033b1-577f-4067-a2c2-33e770baccb2">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzAtMy0xLTEtMA_5ce0049c-a0ff-4ba8-bcea-9df162348c26">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Intuitive Surgical, Inc. stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzEtMS0xLTEtMA_3bc75915-f124-49a0-9eb7-0cbc0b92226a">11,410.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzEtMy0xLTEtMA_d0d5aecd-7fba-407b-9b6c-5b80661cdb55">9,731.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest in joint venture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzItMS0xLTEtMA_14eba46f-578e-4a1b-a026-205e6b069a4f">48.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzItMy0xLTEtMA_742a1e66-ee44-4851-8480-3179a7793c6c">27.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzMtMS0xLTEtMA_d0c1d052-df27-43ce-bd2e-bff201b4733b">11,459.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzMtMy0xLTEtMA_0e38b685-8451-48ac-bcaf-61c55a353660">9,759.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzQtMS0xLTEtMA_52603799-4263-466b-8871-c54287937053">12,934.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzQtMy0xLTEtMA_513a9ce0-785e-4e07-a1b4-6315b7aac3fa">11,168.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_22"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTUITIVE SURGICAL, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">in millions (except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75cbfe3d586a465494dffae57715ee91_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMy0xLTEtMS0w_88f81b7f-7867-4ce2-869c-2c61e89ccd58">1,170.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5caccf7f8842848177872d08d31bd3_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMy0zLTEtMS0w_14a7de36-f2bd-47d1-bc88-0fe6aa8984c8">898.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00ffc107447849539c91c165ecee4fa0_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMy01LTEtMS0w_ef6c129b-06ff-488d-8c33-b755bfc1ac1d">3,481.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2533132d0f44dacbeb417a8b14afee9_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMy03LTEtMS0w_e7b7ee5f-8ae0-4844-a4a9-8d39b694b9de">2,521.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80bf05acda8e4d86bc05c11853836a6d_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNC0xLTEtMS0w_47839547-af8f-4d93-a79e-41bb433b6b5b">232.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i332e55c2a8f94b45933b5aef35f08ce1_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNC0zLTEtMS0w_a7f2dcbd-aeca-4f3f-a566-2650ba8d1c1a">179.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a77442ddf0494f9388b80f7fee300e_D20210101-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNC01LTEtMS0w_c3a66345-9ec7-4ed5-8050-cded15242ae7">678.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8872118a076840b18b642c05bc7c8fdd_D20200101-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNC03LTEtMS0w_d9bf1a78-f8f0-4414-97b0-dc3b12ec120b">508.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNS0xLTEtMS0w_59a81bed-eacf-4e40-972f-22182ea4c63f">1,403.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNS0zLTEtMS0w_c3da3afc-411b-4419-b422-e85a1ca33310">1,077.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNS01LTEtMS0w_58c3bf6a-abe2-4b94-9857-56b6704d2b93">4,159.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNS03LTEtMS0w_363f2c2e-80c2-49d7-b263-a2b174bbdeb7">3,029.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75cbfe3d586a465494dffae57715ee91_D20210701-20210930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNy0xLTEtMS0w_f98a6099-3329-409b-9ba2-f67944235af4">355.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5caccf7f8842848177872d08d31bd3_D20200701-20200930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNy0zLTEtMS0w_80bea0d0-3c3b-4e11-ac71-fd4a7ffbbf1b">287.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00ffc107447849539c91c165ecee4fa0_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNy01LTEtMS0w_8840684c-c7e7-4543-9690-fcc8a96c79f0">1,049.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2533132d0f44dacbeb417a8b14afee9_D20200101-20200930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNy03LTEtMS0w_51c2f397-efca-41e7-b7e7-143c8aadd1fd">868.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80bf05acda8e4d86bc05c11853836a6d_D20210701-20210930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfOC0xLTEtMS0w_06be2dbc-d06c-421d-a2c4-6c3061aa39bd">76.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i332e55c2a8f94b45933b5aef35f08ce1_D20200701-20200930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfOC0zLTEtMS0w_03b455d1-935c-4c8e-8b97-53f855dc4245">65.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a77442ddf0494f9388b80f7fee300e_D20210101-20210930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfOC01LTEtMS0w_4fcc6767-8342-467b-80a6-2d32467f0c12">212.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8872118a076840b18b642c05bc7c8fdd_D20200101-20200930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfOC03LTEtMS0w_9647e303-86fd-4d02-951f-4fbfd47b99aa">195.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfOS0xLTEtMS0w_fd7a5787-e03b-4f29-ba00-bbad8116cb61">431.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfOS0zLTEtMS0w_b7103f8a-0615-409a-b784-32830d362130">353.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfOS01LTEtMS0w_1067e3aa-4ce9-46a2-8b88-db98be6d9bb0">1,261.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfOS03LTEtMS0w_c7f1c354-d070-46d7-850b-133aaad7f1f2">1,063.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTAtMS0xLTEtMA_b52dff63-55de-495d-9ef4-04e6dd14e59d">971.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTAtMy0xLTEtMA_261fde57-1834-4e35-9440-f4bb1999575b">724.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTAtNS0xLTEtMA_4a822dce-9403-47ca-8413-3d209042902c">2,897.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTAtNy0xLTEtMA_9dda2606-c23b-4547-9078-97700d0c1ecb">1,965.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTItMS0xLTEtMA_2e39218e-e3f0-411b-aa27-2b0ff9283c5a">363.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTItMy0xLTEtMA_dcab27ce-918d-4494-bd6c-6bf172fd3d94">298.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTItNS0xLTEtMA_fb4201c4-e0bb-4cb0-9141-74bd7c328efa">1,039.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTItNy0xLTEtMA_2502ed00-77e0-42ac-9340-3d2d3fa1d0ba">886.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTMtMS0xLTEtMA_9f70c5fc-4586-4fdb-9128-5f13c208ce33">165.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTMtMy0xLTEtMA_b9b1afa2-4f41-478b-b768-07f65acf76e5">155.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTMtNS0xLTEtMA_d08d0577-dab7-48e4-b782-6b1c635b9aa9">487.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTMtNy0xLTEtMA_e5134cea-0463-490a-ba62-de826bdf83f4">445.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTQtMS0xLTEtMA_e0d0fe32-52da-491c-a60a-d034e101c03d">528.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTQtMy0xLTEtMA_f87c937a-112d-4e0e-9ed8-778d21eebac0">453.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTQtNS0xLTEtMA_35bcf136-c68c-4ca3-bc85-a6695b0e4c95">1,527.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTQtNy0xLTEtMA_66445a0e-59ca-4a93-8b90-093173351a61">1,331.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTUtMS0xLTEtMA_6e0f2211-360c-43c9-ad93-4af7f12e47a5">442.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTUtMy0xLTEtMA_08df85b7-ab1f-4875-a9f7-3119dbc05d24">270.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTUtNS0xLTEtMA_fe0df8f0-a1c6-4387-a936-d5da3738ff7e">1,370.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTUtNy0xLTEtMA_2762eb66-042e-43d9-a69b-e28d7f00e64b">634.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTYtMS0xLTEtMA_56a8b8d4-93af-48dd-a213-a286bf5e6da8">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTYtMy0xLTEtMA_055373de-9907-4dfb-b3e7-6d324a838f25">84.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTYtNS0xLTEtMA_1c30869a-509e-48b9-9faa-925cc35d7b62">65.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTYtNy0xLTEtMA_fa66f065-f447-4bf4-b50b-228cb784738d">136.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTctMS0xLTEtMA_8f1c3838-980e-4918-aa34-de002cfad828">461.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTctMy0xLTEtMA_13815d10-bc4f-46f6-bfb5-a739c4fdc02f">355.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTctNS0xLTEtMA_75535156-fb00-4d67-9228-53ae2d515f9f">1,436.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTctNy0xLTEtMA_ab0a66ba-6bf8-4f52-adec-217a437c67ca">770.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTgtMS0xLTEtMA_e6d87965-0726-4618-9013-976163b3de4c">73.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTgtMy0xLTEtMA_e632731e-ea5d-40d6-86e4-ff0a42bb2c96">38.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTgtNS0xLTEtMA_b7f07f9f-35ff-456a-a9f5-3d7793ac96eb">90.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTgtNy0xLTEtMA_3dd14e4c-018b-4251-8414-cdaf066bf218">67.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTktMS0xLTEtMA_b239e934-ff20-442e-82d4-b63a4b9def48">387.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTktMy0xLTEtMA_4a1e275a-5a96-4a33-90ba-a1b4f2a0b0ca">316.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTktNS0xLTEtMA_6d695512-cea7-4423-ae74-08f38e4de042">1,345.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTktNy0xLTEtMA_160bbf5a-06eb-4a8c-b992-ece5631ac442">703.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net income attributable to noncontrolling interest in joint venture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjAtMS0xLTEtMA_7d323cd1-3011-4d67-9962-59cd89a97a4a">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjAtMy0xLTEtMA_29d18ca9-d404-4a33-8c91-bab852bf3108">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a2ef2720e5d48859c0e54b81ae7ab52_D20210101-20210930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjAtNS0xLTEtMA_476c481c-b754-474d-ad52-cf9e9e0073c3">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjAtNy0xLTEtMA_6f6f129c-8ecc-4995-9ffa-2e8e64159d52">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjEtMS0xLTEtMA_a80b7283-c39f-414c-9312-0d32e65f535a">380.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjEtMy0xLTEtMA_0671fc68-1627-4cc7-a6ec-fe4eaba4d3df">313.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjEtNS0xLTEtMA_b980e96f-ab1a-4df5-beee-1c47a0bfd1c8">1,324.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjEtNy0xLTEtMA_7e694472-005c-4e7d-85ca-c09c485f3391">695.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to Intuitive Surgical, Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjMtMS0xLTEtMA_bc1e847d-b854-4032-bdb9-6689765f93ed">1.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjMtMy0xLTEtMA_11f4ef8c-9fdf-4aaf-82fd-5963edb9e010">0.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjMtNS0xLTEtMA_7d5ebdef-805b-419f-bcaa-c79cb0f7d633">3.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjMtNy0xLTEtMA_0abd2e6b-6d30-4519-b16d-dcf1ced83954">1.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjQtMS0xLTEtMA_a6dd19e4-33eb-4c91-bc3f-a218a9253e2f">1.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjQtMy0xLTEtMA_2f2604e7-8135-4cb4-ba7a-9c064d793612">0.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjQtNS0xLTEtMA_d13063a4-4ca5-4309-afff-aecc537fcbbc">3.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjQtNy0xLTEtMA_2e879cc0-c01b-4505-9653-a9778d7d35df">1.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing net income per share attributable to Intuitive Surgical, Inc.:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjYtMS0xLTEtMA_71dd695a-2c41-4293-90a1-46493fc8db90">356.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjYtMy0xLTEtMA_c2bdba54-a599-4308-953f-f380d6ee4176">352.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjYtNS0xLTEtMA_e7133081-6505-4c54-9403-dc780299dcea">355.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjYtNy0xLTEtMA_2b54ec47-abd3-4dcc-a928-828859e33d85">350.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjctMS0xLTEtMA_469336a5-2ff1-4f87-a969-914ed5483610">366.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjctMy0xLTEtMA_d86b9978-d89c-48d5-9215-5644c9d81f01">361.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjctNS0xLTEtMA_b0de7944-eca7-4b50-b9f9-64eed6e8ba6d">365.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjctNy0xLTEtMA_7f60607b-ca28-4a63-9d43-5b5b72a50558">360.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjktMS0xLTEtMA_081bfa30-523d-4311-95d8-ab78b3c78c1e">382.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjktMy0xLTEtMA_5d149244-e894-4235-920c-39fc2d9d5fb9">310.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjktNS0xLTEtMA_f577f667-efeb-4185-9b72-633b7b3d17bd">1,325.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjktNy0xLTEtMA_60c0f899-4328-4fe0-9138-393d52a0cb32">707.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: comprehensive income attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMzAtMS0xLTEtMA_0558a2ce-067c-4279-8d26-3d2e78612581">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMzAtMy0xLTEtMA_3c693113-62e7-4414-921b-7ea39a122729">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMzAtNS0xLTEtMA_c59851ac-f493-41b3-9e47-d63b086777f5">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMzAtNy0xLTEtMA_a300af4a-9b2a-4ba3-b3ae-d2361c9c81ba">8.0</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income attributable to Intuitive Surgical, Inc.</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMzEtMS0xLTEtMA_4c250470-3133-4d64-9cb6-13b1d3eed4ec">375.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMzEtMy0xLTEtMA_30f930a2-13ee-4784-932a-e2c75811e7db">307.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMzEtNS0xLTEtMA_617f7754-19f1-4d87-8771-14429f9d0d76">1,304.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMzEtNy0xLTEtMA_43dff025-50b2-4749-bde2-a21381fcc95d">699.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_25"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTUITIVE SURGICAL, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">in millions&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMy0xLTEtMS0w_bd77c14a-c670-4e38-9599-4d7f2f6c1eb7">1,345.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMy0zLTEtMS0w_9500c96b-cd56-429b-8f39-7b73b4591e47">703.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and loss on disposal of property, plant, and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfNS0xLTEtMS0w_269e9431-d68e-4fb1-a372-036093b15f74">208.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfNS0zLTEtMS0w_c2ec334c-66d3-4180-9a3b-7898b5707295">159.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfNi0xLTEtMS0w_44ebb482-259e-4db6-ae13-292d799466cb">20.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfNi0zLTEtMS0w_151c91ce-7a62-4303-880f-d92efe5e2346">37.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on investments, accretion, and amortization, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfNy0xLTEtMS0w_f48485ed-4087-4741-90e5-27f6fbd059e5">2.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfNy0zLTEtMS0w_7abb1e3f-e962-4a03-bdff-a389d8df2e5b">64.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfOC0xLTEtMS0w_72af2386-0950-44fd-8d98-cb1edf747979">40.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfOC0zLTEtMS0w_c7585406-9f01-4fd0-b71c-847eb77003cc">71.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTAtMS0xLTEtMA_e03363bc-3248-4cc0-bfed-ec2ff8cea1be">331.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTAtMy0xLTEtMA_74856346-e247-40ca-9f56-020c6dfcd744">292.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of contract acquisition assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTEtMS0xLTEtMA_b2aa74ad-8a56-4d87-9312-f83cbeda8dbe">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTEtMy0xLTEtMA_c803e42e-d4fc-4c3d-8191-8f4228b84727">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of effects of acquisitions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTMtMS0xLTEtMA_5967127a-9e25-46ee-93c7-e3ab121387b3">54.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTMtMy0xLTEtMA_81677936-b777-49a8-b700-3138f543195b">57.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTQtMS0xLTEtMA_7a7a2569-9505-44df-8a65-44d6994ca1f3">189.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTQtMy0xLTEtMA_20272ac1-2236-4751-9342-e7bdc4ce0683">177.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTUtMS0xLTEtMA_180b9eb8-4d22-49a2-9c4b-046c23b7dfbf">216.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTUtMy0xLTEtMA_de140c70-fce4-4221-b4c2-c3ddd53e7fd1">118.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTctMS0xLTEtMA_c52bf87e-1611-4cb0-b8d4-14b189942d44">35.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTctMy0xLTEtMA_107121fd-5992-4247-b0ea-cb6ca5ab5efd">3.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and employee benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTgtMS0xLTEtMA_7af7511a-8f50-4971-92b2-c918908631b8">30.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTgtMy0xLTEtMA_86855450-bb9e-4913-87ed-f78152d07b93">76.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTktMS0xLTEtMA_960337be-48af-4fa8-9442-310d7497fdcc">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTktMy0xLTEtMA_b14ea5e5-61c0-43c0-beeb-82e54ba2f4f1">9.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjAtMS0xLTEtMA_5c26cbcc-6daa-4854-a1be-a1e856612294">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjAtMy0xLTEtMA_3517f588-c027-4796-b2f3-f06152c384ec">26.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjEtMS0xLTEtMA_58365b7c-422c-4c5a-b6f2-b3a1764113c2">1,521.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjEtMy0xLTEtMA_7f17ccd5-754b-4e8d-8efc-acd00ecec27f">857.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjMtMS0xLTEtMA_fa3fc3dc-292a-4248-9f70-aa4e41bf1eca">5,213.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjMtMy0xLTEtMA_bf1df7ec-ef7a-42f9-826c-bacf60e50ff1">3,023.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjQtMS0xLTEtMA_1af2687d-89d1-454e-8270-8615a845a0f7">72.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjQtMy0xLTEtMA_17022749-d87d-4c8d-a41e-ab4ab20b05a8">800.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from maturities of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjUtMS0xLTEtMA_49a35061-82fe-45cd-836d-fd69de745ab2">3,532.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjUtMy0xLTEtMA_60a7aa09-ed46-46f3-aaeb-a77855ec1bc4">1,933.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant, and equipment and intellectual property</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjYtMS0xLTEtMA_5f01bd45-6eed-434b-9bca-cf934b3aea0f">202.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjYtMy0xLTEtMA_c0cd24b6-9525-4e48-b326-d8d0dd001d3d">279.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of businesses, net of cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjctMS0xLTEtMA_d01c65e1-a252-4dbf-8bba-8cc6640431f3">8.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjctMy0xLTEtMA_ea5a88e4-53bf-4c83-b78d-3301787a4ca2">37.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjktMS0xLTEtMA_b3336ec9-c975-4743-b297-39554aae904e">1,820.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjktMy0xLTEtMA_b98e23ce-c433-474d-8bab-8e6f86f70d61">606.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock relating to employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzEtMS0xLTEtMA_43962c07-49a7-44da-b7ca-ad414a278e55">244.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzEtMy0xLTEtMA_8bda10d8-677a-42ca-b147-b399a0028ab8">267.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzItMS0xLTEtMA_3cc2e9ed-594c-450e-a5c8-c9f4e62b163c">201.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzItMy0xLTEtMA_941a39b3-9c1a-43dd-b268-156b4acdf909">165.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzMtMS0xLTEtMA_4c16554f-37d5-49ba-af3d-572d0a08186f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzMtMy0xLTEtMA_73da5ea6-88fd-46ca-a315-4dddebfbfac7">100.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of deferred purchase consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzUtMS0xLTEtMA_48fa8169-48e2-4dc4-b67e-3cf4364540d1">19.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzUtMy0xLTEtMA_4f77c052-7709-49f7-a5d5-cd0440bfcebc">48.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzYtMS0xLTEtMA_bec3d0e3-f92b-4ea7-abeb-e7fbd4f24aa3">24.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzYtMy0xLTEtMA_335c5f47-3328-4b6c-94aa-5c0242380250">45.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzctMS0xLTEtMA_df35772f-4b6c-45e3-b394-f2c3d0538a4d">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzctMy0xLTEtMA_d10f0896-f946-4d94-8c1c-704b514a36a6">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzgtMS0xLTEtMA_5875cdc3-2839-4d2e-ba96-12f011f347cc">276.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzgtMy0xLTEtMA_a643c5c2-b922-4518-b80a-0aab69187bf9">203.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzktMS0xLTEtMA_5a94da3c-b973-4f8a-9f98-b1eb70e8bbb2">1,638.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452fc69ad0b4328b92b435105261628_I20191231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzktMy0xLTEtMA_ccbe089d-77c2-4e0f-b2a0-e6334558bb97">1,182.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfNDAtMS0xLTEtMA_838fc387-6091-4459-988d-0dcc70120385">1,361.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id79ce19a534e4d139e67bf0750158934_I20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfNDAtMy0xLTEtMA_4dcbfb02-052b-4516-99a2-0a2ec614ddc5">1,385.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited).</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTUITIVE SURGICAL, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this report, &#8220;Intuitive Surgical,&#8221; &#8220;Intuitive,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Intuitive Surgical, Inc. and its wholly and majority-owned subsidiaries.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_31"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zMS9mcmFnOjU5Y2I1ZGUxMDZkZjQ0YWQ5Y2EzNjM0MGRkZWE2ZDU2L3RleHRyZWdpb246NTljYjVkZTEwNmRmNDRhZDljYTM2MzQwZGRlYTZkNTZfNjY5_9213e1c0-5616-4f03-aef0-1be8bcf83a23" continuedAt="ib3ae855811d3419e8958b94953a33513" escape="true">DESCRIPTION OF THE BUSINESS</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><ix:continuation id="ib3ae855811d3419e8958b94953a33513"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intuitive Surgical, Inc. (&#8220;Intuitive&#8221; or the &#8220;Company&#8221;) develops, manufactures, and markets the da Vinci</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Surgical System and the Ion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> endoluminal system.&#160;The Company&#8217;s products and related services enable physicians and healthcare providers to improve the quality of and access to minimally invasive care. The da Vinci Surgical System consists of a surgeon console or consoles, a patient-side cart, a high-performance vision system, and proprietary instruments and accessories. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform that utilizes instruments and accessories for lung biopsies.</span></ix:continuation></div><div id="i944f300b8c29463aa56139ed7eaca296_34"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNC9mcmFnOjNjMjVhMTkyMWE0MzRmYjdiODMyZjk2Yzg5NjNlNTM4L3RleHRyZWdpb246M2MyNWExOTIxYTQzNGZiN2I4MzJmOTZjODk2M2U1MzhfNDc3Mw_0adc9eae-6497-44ee-9638-cbbb305ce428" continuedAt="i6636fe2028644dcf8c91bc125b52f31c" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i6636fe2028644dcf8c91bc125b52f31c" continuedAt="i78842419f8bd47e2b25c4465af908a52"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNC9mcmFnOjNjMjVhMTkyMWE0MzRmYjdiODMyZjk2Yzg5NjNlNTM4L3RleHRyZWdpb246M2MyNWExOTIxYTQzNGZiN2I4MzJmOTZjODk2M2U1MzhfNDc1Mg_61b1d78b-59c4-4417-a387-6bbc2c8220e0" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements (&#8220;Financial Statements&#8221;) of Intuitive Surgical, Inc. and its wholly and majority-owned subsidiaries have been prepared on a consistent basis with the audited Consolidated Financial Statements for the fiscal year ended December&#160;31, 2020, and include all adjustments, consisting of only normal, recurring adjustments, necessary to fairly state the information set forth herein. The Financial Statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and, therefore, omit certain information and footnote disclosure necessary to present the Financial Statements in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). These Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, which was filed with the SEC on February&#160;10, 2021. The results of operations for the first nine months of fiscal year 2021 are not necessarily indicative of the results to be expected for the entire fiscal year or any future periods.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNC9mcmFnOjNjMjVhMTkyMWE0MzRmYjdiODMyZjk2Yzg5NjNlNTM4L3RleHRyZWdpb246M2MyNWExOTIxYTQzNGZiN2I4MzJmOTZjODk2M2U1MzhfNDc2OA_135555d9-51a9-44c1-a7a7-3caeb9215626" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Financial Statements include the results and the balances of the Company&#8217;s majority-owned joint venture (referred to herein as the &#8220;Joint Venture&#8221;) with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (&#8220;Fosun Pharma&#8221;). The Company holds a controlling financial interest in the Joint Venture, and the noncontrolling interest is reflected as a separate component of consolidated stockholders&#8217; equity. The noncontrolling interest&#8217;s share of the earnings in the Joint Venture is presented separately in the condensed consolidated statements of comprehensive income.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Split</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares issued pursuant to the three-for-one stock split (the "Stock Split") of the Company's issued and outstanding common stock, par value $0.001 per share, were distributed on October 4, 2021, to stockholders of record as of September 27, 2021. All share and per-share information presented in the Financial Statements have been retroactively adjusted to reflect the Stock Split.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to additional risks and uncertainties due to the COVID-19 pandemic. The extent of the impact on the Company&#8217;s business is highly uncertain and difficult to predict. In certain regions, the Company&#8217;s customers continue to divert resources to treat COVID-19 patients and defer some elective surgical procedures, both of which may impact the Company&#8217;s customers&#8217; ability to meet their obligations, including to the Company. Furthermore, economies worldwide have been negatively impacted by the COVID-19 pandemic, and it is possible that the impact could cause an extended local and/or global economic recession. Such economic disruption could have a material adverse effect on our business as hospitals curtail and reduce capital and overall spending. Policymakers around the globe have responded with fiscal policy actions to support the healthcare industry and their economies. However, the magnitude and overall effectiveness of these actions remains uncertain.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The severity of the impact of the COVID-19 pandemic on the Company&#8217;s business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on the Company&#8217;s customers, all of which are uncertain and cannot be predicted. The Company&#8217;s future results of operations and liquidity could be materially adversely affected by delays in payments of outstanding receivables, supply chain disruptions, including shortages and inflationary pressure, uncertain or reduced demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operational challenges faced by its customers.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, we have experienced increased difficulties in obtaining a sufficient amount of component materials used in our products, including those in the semiconductor market, as global supply has become significantly constrained due to increased demand in semiconductors and other materials. Additionally, prices of such materials have increased due to the increased demand and supply shortage. The Company is engaged in activities to seek to mitigate supply disruptions by, for example, increasing our communications with our suppliers and modifying our purchase order coverage and inventory levels. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><ix:continuation id="i78842419f8bd47e2b25c4465af908a52" continuedAt="i91d0a024d2224512912bfb64fe1962af"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, the global semiconductor supply shortage is likely to remain a challenge for the foreseeable future. We have also experienced challenges in logistics, as certain shipping routes have been impacted by port closures. Such global shortages in important components and logistics challenges have resulted in, and will continue to cause, inflationary cost pressure in our supply chain. To date, these challenges have not materially impacted our ability to deliver product and services to our customers. However, if shortages in important supply chain materials in the semiconductor or other markets continue, we could fail to meet product demand, which would adversely impact our business, financial condition, results of operations, or cash flows.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased labor shortages globally, including staff burnout and attrition, could also impact our ability to hire and retain personnel critical to our manufacturing, logistics, and commercial operations. We are also highly dependent on the principal members of our management and scientific staff. Attracting and retaining qualified personnel is critical to our success, and competition for them has become more intense. The loss of critical members of our team, or our inability to attract and retain qualified personnel, could significantly harm our operations, business, and ability to compete. In addition, hospitals are also experiencing staffing shortages and supply chain issues that could impact their ability to provide patient care. As of the date of issuance of these Financial Statements, the extent to which the COVID-19 pandemic may materially adversely affect the Company&#8217;s financial condition, liquidity, or results of operations is uncertain.</span></div><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNC9mcmFnOjNjMjVhMTkyMWE0MzRmYjdiODMyZjk2Yzg5NjNlNTM4L3RleHRyZWdpb246M2MyNWExOTIxYTQzNGZiN2I4MzJmOTZjODk2M2U1MzhfNDc3NQ_20c44883-4d77-446f-931d-295005f19118" continuedAt="i8d1b7f329dcc4b55be1321b15621b4eb" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Leases with Variable Lease Payments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2021-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessors - Certain Leases with Variable Lease Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which amends the lessor lease classification guidance in ASC 842 for leases that include any amount of variable lease payments that are not based on an index or rate. The Company has early adopted this ASU as of July 1, 2021, on a prospective basis. The standard had no impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i91d0a024d2224512912bfb64fe1962af"><ix:continuation id="i8d1b7f329dcc4b55be1321b15621b4eb">There have been no new or material changes to the significant accounting policies discussed in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020</ix:continuation></ix:continuation>.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_37"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNTcwNQ_58ffff5b-e778-4dc8-8ef4-746d5b85abf3" continuedAt="i9203812b3d7c48be93b3670e4e60c5e6" escape="true">FINANCIAL INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="i9203812b3d7c48be93b3670e4e60c5e6" continuedAt="ibaab38379f684417a9403b9bc50de2a2"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Investments</span></div><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:AvailableForSaleSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNTY3OQ_2a4a67e3-412c-4972-af24-afc4c356d590" continuedAt="i56c2c8b938dd44b3a71605829ffcfc6f" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s cash and available-for-sale marketable securities&#8217; amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant investment category reported as cash and cash equivalents, short-term investments, or long-term investments as of September&#160;30, 2021, and December&#160;31, 2020 (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and<br/>Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-<br/>term<br/>Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-<br/>term<br/>Investments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac4be23e732e4f789fec20c9fc25381a_I20210930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMy0xLTEtMS0w_7d2ba184-09ca-4bcf-a355-513077300574">534.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac4be23e732e4f789fec20c9fc25381a_I20210930" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMy05LTEtMS0w_68f593ad-e9ac-468b-a2a4-58eaca136f97">534.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac4be23e732e4f789fec20c9fc25381a_I20210930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMy0xMS0xLTEtMA_fc4d7851-fa66-48ad-ac29-650a5fa3eb5c">534.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4319e4b98dd145c2a90852e2abd3b90d_I20210930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNS0xLTEtMS0w_8a7c847c-af31-4c87-86cc-0a5eab9758e2">812.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4319e4b98dd145c2a90852e2abd3b90d_I20210930" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNS05LTEtMS0w_84a19451-e22e-445f-a2a2-c7f22d838d0e">812.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4319e4b98dd145c2a90852e2abd3b90d_I20210930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNS0xMS0xLTEtMA_c196e5a6-747c-4954-8cd6-2587f27f9656">812.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4319e4b98dd145c2a90852e2abd3b90d_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNS0xMy0xLTEtMA_70121fdb-4dd7-4968-8795-7938e1b88df1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4319e4b98dd145c2a90852e2abd3b90d_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNS0xNS0xLTEtMA_b299bc54-73e4-419c-b836-f7eaa650a786">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie068099537924951abe627974208afa6_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNi0xLTEtMS0w_bcb27574-7642-4d2f-8f0d-434e042aaaf3">3,250.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie068099537924951abe627974208afa6_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNi0zLTEtMS0w_0a0c06f7-d9b0-44bb-b9ff-948305e95978">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie068099537924951abe627974208afa6_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNi01LTEtMS0w_24df1363-4a01-4a9b-9d07-7bd5771b7938">2.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie068099537924951abe627974208afa6_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNi03LTEtMS0w_a7dd30a1-492f-41e7-b336-db5b0dc89306">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie068099537924951abe627974208afa6_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNi05LTEtMS0w_e6f0c1e5-63d7-44d5-bfd1-8ecfaa71f2cf">3,258.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie068099537924951abe627974208afa6_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNi0xMS0xLTEtMA_a4f1551f-315e-4364-99be-51e5cd514b2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie068099537924951abe627974208afa6_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNi0xMy0xLTEtMA_f8f4b8d5-89f8-4249-beae-f93c41f001e8">1,104.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie068099537924951abe627974208afa6_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNi0xNS0xLTEtMA_b3439613-5d24-4076-a5b6-347134c3f957">2,153.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNy0xLTEtMS0w_ebe5fc33-ce45-4de1-8b51-bd849ca4765e">4,062.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNy0zLTEtMS0w_ab40b247-6504-4cb7-b93a-f83f36317281">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNy01LTEtMS0w_89cc2075-7d51-4239-9bd0-f1810e7bb5be">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNy03LTEtMS0w_9456b839-aa53-4e0b-9e62-99ed9c69051e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNy05LTEtMS0w_7aebd9dd-8f66-4a7f-ab85-41cc70b36384">4,070.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNy0xMS0xLTEtMA_d45f9b22-c5c4-49ce-9277-579fb87d5405">812.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNy0xMy0xLTEtMA_965f8b93-089d-4e42-8e67-f117ef3bfe83">1,104.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNy0xNS0xLTEtMA_5f14486d-5cd2-4567-853a-43fba5fdb8cb">2,153.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfOS0xLTEtMS0w_84336a0f-7b0b-4b78-8e0f-2333c928a413">632.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfOS0zLTEtMS0w_29b360af-1190-425e-bebb-0af6a318f876">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfOS01LTEtMS0w_a3cea990-8212-4ff1-a820-f0c3e0a59873">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfOS03LTEtMS0w_1d7af006-0b13-44b3-9aa8-a12f18000c5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfOS05LTEtMS0w_13de1e02-f390-4b8e-a988-7037205373bf">632.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfOS0xMS0xLTEtMA_e992419e-ddea-4b43-89c9-9045cafb5839">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfOS0xMy0xLTEtMA_4f13d5cb-433c-4c5c-8ac2-176c1c91d73e">632.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfOS0xNS0xLTEtMA_0e49c7ca-105d-47c1-82bd-c5e4710bbd4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea68361551fa4459a3df45292aa07f09_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTAtMS0xLTEtMA_793bae47-8a6c-4fa7-8396-1b7e8ed90607">2,262.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea68361551fa4459a3df45292aa07f09_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTAtMy0xLTEtMA_44a0711a-5757-4374-a41c-a505c4bed559">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea68361551fa4459a3df45292aa07f09_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTAtNS0xLTEtMA_fe430204-b50d-4c8e-b5bf-47123898d3e1">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea68361551fa4459a3df45292aa07f09_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTAtNy0xLTEtMA_921c757c-1b21-4fd8-9d84-6cf55a3c6d4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea68361551fa4459a3df45292aa07f09_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTAtOS0xLTEtMA_391f5375-fdfe-4b3b-b2fc-d954321e1c87">2,265.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea68361551fa4459a3df45292aa07f09_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTAtMTEtMS0xLTA_929f9094-d980-4b44-b135-16b85d6067fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea68361551fa4459a3df45292aa07f09_I20210930" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTAtMTMtMS0xLTA_7c0da49a-30b2-462d-b6bb-bdb53065f2e3">794.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea68361551fa4459a3df45292aa07f09_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTAtMTUtMS0xLTA_a6519817-3e3d-4ac0-9435-82b56b632c9d">1,471.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id420ed12c599434ea400964616900e95_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTEtMS0xLTEtMA_bf6329bf-938c-46f6-9df6-31674b199538">538.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id420ed12c599434ea400964616900e95_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTEtMy0xLTEtMA_c397f715-fc97-4d5c-b1f0-4ba2bd1a13b1">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id420ed12c599434ea400964616900e95_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTEtNS0xLTEtMA_cd07f917-0f27-4ae9-9a17-4c34f95b273d">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id420ed12c599434ea400964616900e95_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTEtNy0xLTEtMA_28149999-5753-4828-8862-381920138298">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id420ed12c599434ea400964616900e95_I20210930" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTEtOS0xLTEtMA_b6beda16-56e5-48a2-8fec-c5bbac7ddc0e">538.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id420ed12c599434ea400964616900e95_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTEtMTEtMS0xLTA_84c4c30e-ed8e-4975-9347-64a6c62395f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id420ed12c599434ea400964616900e95_I20210930" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTEtMTMtMS0xLTA_b059bfdd-f7ab-4bfd-aa03-1905b498af77">150.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id420ed12c599434ea400964616900e95_I20210930" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTEtMTUtMS0xLTA_786ee1b4-16e4-4cab-a675-cb40af92b61c">387.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb374215fd24fceb8e6353f18d88ae5_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTMtMS0xLTEtMA_615c48a5-006e-4756-9045-15cd67cca1d2">176.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb374215fd24fceb8e6353f18d88ae5_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTMtMy0xLTEtMA_88aafc78-5d4f-4eb2-a89a-c8ccc818a716">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fb374215fd24fceb8e6353f18d88ae5_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTMtNS0xLTEtMA_462672b1-eee1-48fa-b483-4610bda0e04d">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb374215fd24fceb8e6353f18d88ae5_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTMtNy0xLTEtMA_9e3ffea3-ed63-46a6-9ddb-ce7972157182">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb374215fd24fceb8e6353f18d88ae5_I20210930" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTMtOS0xLTEtMA_548bf0ad-73fd-4441-b038-3b459ccef56b">177.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb374215fd24fceb8e6353f18d88ae5_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTMtMTEtMS0xLTA_9c649c58-8442-49b1-b19c-a275206fdbcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb374215fd24fceb8e6353f18d88ae5_I20210930" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTMtMTMtMS0xLTA_c2eb7f58-c048-47ab-8741-fd3cfeffd5f6">59.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb374215fd24fceb8e6353f18d88ae5_I20210930" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTMtMTUtMS0xLTA_6afb25c0-3eb2-49a1-b829-36dbe3083eb0">118.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTQtMS0xLTEtMA_d437e89f-7e83-40c6-b095-f9d960b862ad">3,610.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTQtMy0xLTEtMA_01c5e6cf-9b1f-45e2-8057-c82299317fd0">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTQtNS0xLTEtMA_e0001f1a-5b8f-4a69-97df-29a5dbef0182">2.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTQtNy0xLTEtMA_cc0b71b9-7394-4e1c-844c-fcf7dffafc58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTQtOS0xLTEtMA_33c7226f-e8e9-43e4-940c-ee50726874d2">3,614.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTQtMTEtMS0xLTA_cd6c7f20-d6d9-4ef6-b182-a6692497a520">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTQtMTMtMS0xLTA_2900d815-a645-49c3-8be5-6ef35a63e3a3">1,636.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTQtMTUtMS0xLTA_9f0c5ea7-9e76-4bba-8a11-55ed8c978bd7">1,977.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTgtMS0xLTEtMA_88d4ca21-b397-45ed-975c-aac7aee26664">8,207.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTgtMy0xLTEtMA_330426a9-03d8-4323-b272-4e5a4fff64b1">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTgtNS0xLTEtMA_abd14a8c-6c0a-4227-a28f-e07324af5802">5.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTgtNy0xLTEtMA_cef4b054-fdfb-45b0-8c55-88365453479a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTgtOS0xLTEtMA_29b44c3d-9bc4-4306-9132-a3decd683756">8,219.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTgtMTEtMS0xLTA_87e0cddd-07d7-4107-b13d-ddcb7fb7b00a">1,346.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTgtMTMtMS0xLTA_c281f984-4d99-4c9b-a6e5-cf69beaf758a">2,741.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTgtMTUtMS0xLTA_97e7d6dc-8697-4950-b4e8-230db6a641c4">4,131.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><ix:continuation id="ibaab38379f684417a9403b9bc50de2a2" continuedAt="i3153f0f38ae94d3c99453e41c2d89ac7"><div style="margin-bottom:6pt;text-align:center"><ix:continuation id="i56c2c8b938dd44b3a71605829ffcfc6f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and<br/>Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-<br/>term<br/>Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-<br/>term<br/>Investments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfc8dbc3d6fb4425a9ff2241572e2cf1_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMy0xLTEtMS0w_691a579e-feaa-40c3-b598-ec79e80d1624">644.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfc8dbc3d6fb4425a9ff2241572e2cf1_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMy05LTEtMS0w_d15120b1-3223-4286-be00-1e4d6f0f8533">644.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfc8dbc3d6fb4425a9ff2241572e2cf1_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMy0xMS0xLTEtMA_3acd0262-6b6d-41dc-be88-a92ff7f30880">644.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i051ac4e837b3485fb8a292b1fcaf07ec_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNS0xLTEtMS0w_c8556992-2c37-4c01-906c-a873ea41aa43">625.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i051ac4e837b3485fb8a292b1fcaf07ec_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNS05LTEtMS0w_c1f07b1e-ac1e-40ff-a51b-c428d67efc16">625.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i051ac4e837b3485fb8a292b1fcaf07ec_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNS0xMS0xLTEtMA_4249b518-d3b5-4cb7-840a-683785d876dc">625.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i051ac4e837b3485fb8a292b1fcaf07ec_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNS0xMy0xLTEtMA_7d2b4b68-e1d3-4bb5-a956-0c5334bcc982">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i051ac4e837b3485fb8a292b1fcaf07ec_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNS0xNS0xLTEtMA_587e8ca2-927d-4904-960b-6edd1e58226d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06308a83da3a4180bee5bf62322c5e37_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNi0xLTEtMS0w_abd80397-24d5-424a-b695-6636996cd584">2,626.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06308a83da3a4180bee5bf62322c5e37_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNi0zLTEtMS0w_33f8efc9-1893-42ea-8a43-04596d7a7c60">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06308a83da3a4180bee5bf62322c5e37_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNi01LTEtMS0w_67236e0e-45a8-44c1-a618-7bdcaf1d74f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06308a83da3a4180bee5bf62322c5e37_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNi03LTEtMS0w_e0e72ca8-2938-4a8d-b242-053233b00f12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06308a83da3a4180bee5bf62322c5e37_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNi05LTEtMS0w_d2054f78-ba5c-49c9-955d-f262e8f8a406">2,649.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06308a83da3a4180bee5bf62322c5e37_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNi0xMS0xLTEtMA_4220daa1-0e64-40a0-b013-e423daf0e19e">212.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06308a83da3a4180bee5bf62322c5e37_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNi0xMy0xLTEtMA_51ae09ca-5302-4a1d-9cc7-58d76663e12e">1,567.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06308a83da3a4180bee5bf62322c5e37_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNi0xNS0xLTEtMA_8fed59c4-91ee-43a9-9714-1c474a745c70">869.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNy0xLTEtMS0w_849b5e16-ab4d-42f9-a7e0-0be7fcec08b7">3,252.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNy0zLTEtMS0w_5d7213cd-0101-40a0-abd1-5b0b8c5c825b">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNy01LTEtMS0w_81c5c0d6-8357-45b4-b4e3-efa2121e19dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNy03LTEtMS0w_b7a49c10-bc94-423c-8741-a13255d7d3de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNy05LTEtMS0w_91fde960-ced3-47a7-bcdc-82e6165d4937">3,275.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNy0xMS0xLTEtMA_699b5f6a-2ed5-4355-a80a-2c65cd3eb40c">838.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNy0xMy0xLTEtMA_a0bc888a-bfc1-4f34-b951-d80978bd2c24">1,567.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNy0xNS0xLTEtMA_0769da7c-795d-4381-afdf-68a6a6915126">869.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4894873227d4ea89ae1cd010bac1f63_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfOS0xLTEtMS0w_5fee9ac0-79f0-4ede-a48e-052fde1cab32">671.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4894873227d4ea89ae1cd010bac1f63_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfOS0zLTEtMS0w_0bffbbc6-03db-4cae-9b4c-68feec4aea09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4894873227d4ea89ae1cd010bac1f63_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfOS01LTEtMS0w_d0a1a8fd-6b2b-46d1-9934-22bdcd654b36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4894873227d4ea89ae1cd010bac1f63_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfOS03LTEtMS0w_11b98dff-db46-4baa-b544-1b42a641dc84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4894873227d4ea89ae1cd010bac1f63_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfOS05LTEtMS0w_b8c92f75-3be6-47ab-9444-3d36d8657584">671.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4894873227d4ea89ae1cd010bac1f63_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfOS0xMS0xLTEtMA_52eccb96-1c39-46b6-b9ca-70e269ed0bbe">64.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4894873227d4ea89ae1cd010bac1f63_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfOS0xMy0xLTEtMA_7a115a27-a8bc-48ad-bb8e-ccc42538b4a3">607.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4894873227d4ea89ae1cd010bac1f63_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfOS0xNS0xLTEtMA_bfac2ad7-1812-4356-be51-15203299a628">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d720541eae04f0fb8a83fef4019ced8_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTAtMS0xLTEtMA_de557b7a-1a44-452d-920c-8ef67defb689">1,425.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d720541eae04f0fb8a83fef4019ced8_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTAtMy0xLTEtMA_7f62f34f-00c1-4250-8d48-5ee2e56b2511">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d720541eae04f0fb8a83fef4019ced8_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTAtNS0xLTEtMA_5ed4c375-caa5-43f3-a279-4186b3621633">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d720541eae04f0fb8a83fef4019ced8_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTAtNy0xLTEtMA_02792e50-6a9a-4b70-81b2-c76b862eebc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d720541eae04f0fb8a83fef4019ced8_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTAtOS0xLTEtMA_ddc0ec9f-48c1-436d-aa6e-598ec6477954">1,437.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d720541eae04f0fb8a83fef4019ced8_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTAtMTEtMS0xLTA_2061c8e2-8c45-49ac-bf6d-df898e8177a9">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d720541eae04f0fb8a83fef4019ced8_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTAtMTMtMS0xLTA_be017f0d-dc32-477e-9dad-cf7201312e85">1,036.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d720541eae04f0fb8a83fef4019ced8_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTAtMTUtMS0xLTA_18f7d7c3-560d-455c-bff1-d6a0018083b6">397.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11db865dc86840629acd13c8a709c2d3_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTEtMS0xLTEtMA_5902d3fa-17b4-4d42-9f17-335513b97141">716.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11db865dc86840629acd13c8a709c2d3_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTEtMy0xLTEtMA_9bdb0145-ebab-476b-8fd7-7ba20b8035c5">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11db865dc86840629acd13c8a709c2d3_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTEtNS0xLTEtMA_8c0931c1-7cd2-4ae2-975c-80a3dd0c7409">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11db865dc86840629acd13c8a709c2d3_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTEtNy0xLTEtMA_a3f5153d-68bd-4e9f-87b1-64fc0c5a6f26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11db865dc86840629acd13c8a709c2d3_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTEtOS0xLTEtMA_238d2e3c-a5ae-4144-883b-491059eebbb8">719.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11db865dc86840629acd13c8a709c2d3_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTEtMTEtMS0xLTA_2416d174-55b0-4f1e-9a9d-e1736529723c">72.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11db865dc86840629acd13c8a709c2d3_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTEtMTMtMS0xLTA_86fd8e56-faf4-4c76-9213-04688cf1e7b2">233.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11db865dc86840629acd13c8a709c2d3_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTEtMTUtMS0xLTA_dbcabd99-2225-4580-8559-3a5784843b9a">412.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTMtMS0xLTEtMA_b23ddf7a-3025-4b8d-8edf-6ebbd8b8e7b5">119.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTMtMy0xLTEtMA_57178079-f065-49a1-9e91-405a937f0461">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTMtNS0xLTEtMA_4de009e4-3d1f-40cd-819c-83f87145e448">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTMtNy0xLTEtMA_8b764b21-c991-4973-a665-512e919470d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTMtOS0xLTEtMA_11f1a622-3e5f-4600-bae0-8d8fa6fba7b5">121.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTMtMTEtMS0xLTA_d2fc677b-ea44-4311-950c-9c3371fc03be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTMtMTMtMS0xLTA_53ad9390-5454-4edf-944f-aac5cfb25eef">43.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTMtMTUtMS0xLTA_99d68272-0259-44e4-9841-6da9a2dea555">78.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTQtMS0xLTEtMA_0f20e542-58be-4f06-a673-4f83d7db6b50">2,933.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTQtMy0xLTEtMA_909efc5b-17b0-473b-a000-93a2fa03b73d">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTQtNS0xLTEtMA_ccbf851e-b422-4779-8837-53d13651956a">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTQtNy0xLTEtMA_7e161f9f-452f-4e61-86b3-f91eececb4c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTQtOS0xLTEtMA_6a7a794f-150d-4cbd-ad8e-789490111f97">2,949.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTQtMTEtMS0xLTA_183af93a-c84d-4ee3-b4c2-8e216408ac84">140.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTQtMTMtMS0xLTA_53359bb2-d409-4d22-a9fd-13d19d841cf6">1,920.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTQtMTUtMS0xLTA_eda3a9bb-d53c-45a2-a1b5-04a54136933a">888.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTgtMS0xLTEtMA_4e183010-91e3-4243-abeb-97f1f7cf3fb0">6,829.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTgtMy0xLTEtMA_2cced3c2-3d8a-4818-92b2-56520d969990">39.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTgtNS0xLTEtMA_49797936-425b-4696-9795-9bc450543419">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTgtNy0xLTEtMA_033204d6-7e3c-4969-8aad-f4b2731e762c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTgtOS0xLTEtMA_6efdc42c-f804-4432-9483-a351559089c4">6,869.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTgtMTEtMS0xLTA_76b37349-5459-42b5-b901-978de056ab41">1,622.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTgtMTMtMS0xLTA_c1f17677-5982-42cc-95c2-70bf8e7ec48a">3,488.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTgtMTUtMS0xLTA_586ea1a0-1d59-40b6-9f0b-d6a961e933a4">1,757.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNTY5MQ_523af4b8-4328-4a3e-a63a-d9ac1ac9afd6" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the contractual maturities of the Company&#8217;s cash equivalents and available-for-sale investments (excluding cash and money market funds), as of September&#160;30, 2021 (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in less than one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiOGE5N2I5NTZiNzRjYTk5ZTM0YWIxOWMzNWQ1YWVlL3RhYmxlcmFuZ2U6MWI4YTk3Yjk1NmI3NGNhOTllMzRhYjE5YzM1ZDVhZWVfMS0xLTEtMS0w_b1ba9a37-827e-4216-be8b-3fc8a2c4353c">2,735.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiOGE5N2I5NTZiNzRjYTk5ZTM0YWIxOWMzNWQ1YWVlL3RhYmxlcmFuZ2U6MWI4YTk3Yjk1NmI3NGNhOTllMzRhYjE5YzM1ZDVhZWVfMS0zLTEtMS0w_3886d8df-7c73-41f3-9e24-17996083b50f">2,741.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in one to five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiOGE5N2I5NTZiNzRjYTk5ZTM0YWIxOWMzNWQ1YWVlL3RhYmxlcmFuZ2U6MWI4YTk3Yjk1NmI3NGNhOTllMzRhYjE5YzM1ZDVhZWVfMi0xLTEtMS0w_4fc53ca4-70e5-4c5f-9e0e-e4ce625406bc">4,125.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiOGE5N2I5NTZiNzRjYTk5ZTM0YWIxOWMzNWQ1YWVlL3RhYmxlcmFuZ2U6MWI4YTk3Yjk1NmI3NGNhOTllMzRhYjE5YzM1ZDVhZWVfMi0zLTEtMS0w_e86899f2-674b-433d-abcf-338828c12619">4,131.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiOGE5N2I5NTZiNzRjYTk5ZTM0YWIxOWMzNWQ1YWVlL3RhYmxlcmFuZ2U6MWI4YTk3Yjk1NmI3NGNhOTllMzRhYjE5YzM1ZDVhZWVfNC0xLTEtMS0w_df424305-d831-48dc-ac39-be48c1ca2da2">6,860.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="isrg:AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiOGE5N2I5NTZiNzRjYTk5ZTM0YWIxOWMzNWQ1YWVlL3RhYmxlcmFuZ2U6MWI4YTk3Yjk1NmI3NGNhOTllMzRhYjE5YzM1ZDVhZWVfNC0zLTEtMS0w_3961ffd2-6dcc-4924-bb38-1b5318c58063">6,873.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from contractual maturities, because certain borrowers have the right to call or prepay certain obligations. Gross realized gains recognized on the sale of investments were not material for the three and nine months ended September&#160;30, 2021, and not significant and $<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfODgx_02d4bda0-f77d-49ff-b3ec-0caa8f9b924d">8.3</ix:nonFraction>&#160;million for the three and nine months ended September&#160;30, 2020, respectively. Gross realized losses recognized on the sale of investments were not material for any of the periods presented.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment portfolio at any point in time contains available-for-sale debt securities including investments in U.S. treasury and U.S. government agency securities, taxable and tax-exempt municipal notes, corporate notes and bonds, commercial paper, non-U.S. government agency securities, cash deposits, and money market funds. The Company segments its portfolio based on the underlying risk profiles of the securities and have a zero-loss expectation for U.S. treasury and U.S. government agency securities. The Company regularly reviews the securities in an unrealized loss position and evaluates the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, and current economic conditions. For the nine months ended September&#160;30, 2021, the credit losses related to available-for-sales debt securities were not significant.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Investments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds equity investments with readily determinable fair values and equity investments without readily determinable fair values. The Company generally recognizes equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><ix:continuation id="i3153f0f38ae94d3c99453e41c2d89ac7" continuedAt="if0f7fe3734d84c149ee42702500d49a0"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNTY5Mw_084e8042-b21c-4eea-a021-8fde4c3a7ddf" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the activity related to equity investments (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:24.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.687%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020<br/>Carrying Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Changes in Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sales/Purchases/Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September&#160;30, 2021</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prepaids and other current assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible and other assets, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity investments with readily determinable value (Level 1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMi0xLTEtMS0w_d055400b-83c9-44ee-a91c-895bbd34ee54">60.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84eb653b91034599a7ec24d50e0fad92_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMi0zLTEtMS0w_69eb3b85-44f3-4a08-ada1-c48b2ec8e720">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84eb653b91034599a7ec24d50e0fad92_D20210101-20210930" decimals="-5" sign="-" name="isrg:EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMi01LTEtMS0w_f0cefe72-6c78-4753-85db-155344445d16">15.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMi03LTEtMS0w_686dd984-de71-43c7-94d3-669c4fc456b0">43.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib87bb311713b42d2a296729d6a21259a_I20210930" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMi05LTEtMS0w_dc6c0f73-ce3d-4ebe-b185-1459fafc1296">43.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae28aecb5f7a4c7bacd3c8ecb4f9026a_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMi0xMS0xLTEtMA_305477d6-4ea3-48dd-a1ce-f00f42080c25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity investments without readily determinable value (Level 2)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMy0xLTEtMS0w_5e424598-b040-4988-bc34-8b725f402e9c">30.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe9058395d09478a81e0df11992f7575_D20210101-20210930" decimals="-5" name="isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMy0zLTEtMS0w_d9c50eb3-10c0-4e37-91c2-01061d815c6a">34.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe9058395d09478a81e0df11992f7575_D20210101-20210930" decimals="-5" sign="-" name="isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMy01LTEtMS0w_be6b0f0a-2c33-4ef8-9e37-0c75400340ea">52.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMy03LTEtMS0w_fc8e3160-7fbb-4450-834d-5127425097d6">12.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b57348d47e45dbbc469e0cd82180c2_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMy05LTEtMS0w_b2bd6e22-41e8-422b-96ee-250fbc5dd3b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46504ffcecdd46ce81248e08922c68cb_I20210930" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMy0xMS0xLTEtMA_95cf2a5c-b2d1-46eb-ada7-168c10d7cf81">12.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Recorded in Interest and other income, net.</span></div></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Other includes conversion of certain equity investments without readily determinable value to equity investments with readily determinable value.</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized a $<ix:nonFraction unitRef="usd" contextRef="ibe9058395d09478a81e0df11992f7575_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfMjUwOQ_ddc5cf52-21e1-40c1-90be-a853188909c8">34.5</ix:nonFraction>&#160;million increase in fair value, which was reflected in Interest and other income, net, due to changes in observable prices for certain equity investments that had been held at cost, because they lacked readily determinable market values (Level 2). A total of $<ix:nonFraction unitRef="usd" contextRef="ibe9058395d09478a81e0df11992f7575_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfMTA5OTUxMTYzNTc4Ng_bbdaf934-0447-4dd9-88cd-d59f599818e8">34.2</ix:nonFraction>&#160;million of this increase in fair value was related to an equity investment in preferred shares of Broncus Medical, Inc. (&#8220;Broncus&#8221;). There were no decreases in fair value reflected in net income due to impairments.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, Broncus completed its initial public offering (&#8220;IPO&#8221;). Upon completion of its IPO, the Company&#8217;s preferred shares were converted to common shares, which have a readily determinable value (Level 1). The Company is restricted from selling these shares for a period of six months. Subsequent to the IPO, the Company recognized a $<ix:nonFraction unitRef="usd" contextRef="i319aeb288bcf4439b7aa385bd35027af_D20210901-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfMTY0OTI2NzQ1MDE2Ng_e379b865-90ef-4278-ba86-e7801c271713">12.3</ix:nonFraction>&#160;million decrease in fair value from this investment. As such, for the nine months ended September&#160;30, 2021, the Company has recognized a net gain of $<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNDM5ODA0NjUyMTAwNw_8d4d12e7-5f6f-42bb-ab56-d3004d4de179">21.9</ix:nonFraction> million related to Broncus, comprised of the $<ix:nonFraction unitRef="usd" contextRef="ibe9058395d09478a81e0df11992f7575_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNDM5ODA0NjUyMTQ3OQ_bbdaf934-0447-4dd9-88cd-d59f599818e8">34.2</ix:nonFraction>&#160;million gain reflected in changes in fair value for Level 2 equity investments, offset by the $<ix:nonFraction unitRef="usd" contextRef="i319aeb288bcf4439b7aa385bd35027af_D20210901-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNDM5ODA0NjUyMTMyOQ_e379b865-90ef-4278-ba86-e7801c271713">12.3</ix:nonFraction>&#160;million loss reflected in changes in fair value for Level 1 equity investments, both of which were reflected in Interest and other income, net.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company sold all of its shares of Teladoc Health, Inc. (&#8220;Teladoc&#8221;), a publicly traded company, for $<ix:nonFraction unitRef="usd" contextRef="i77c4e5ac2bfa409fbf298841deccc21d_D20210101-20210131" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfMjg3Ng_b48b92d2-20c8-4dea-9b61-29e61b820233">71.5</ix:nonFraction>&#160;million and recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="i77c4e5ac2bfa409fbf298841deccc21d_D20210101-20210131" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSaleOfEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfMjkwNA_473d1170-c893-441d-82ba-972307600601">11.4</ix:nonFraction>&#160;million, which was reflected in Interest and other income, net. This gain was offset by a $<ix:nonFraction unitRef="usd" contextRef="i77c4e5ac2bfa409fbf298841deccc21d_D20210101-20210131" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSaleOfDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfMjk4OQ_0d20041f-a3bf-4023-8de5-dc18dd3fe081">7.5</ix:nonFraction>&#160;million loss recognized upon the settlement of a corresponding derivative collar contract.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Derivatives</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The objective of the Company&#8217;s hedging program is to mitigate the impact of changes in currency exchange rates on net cash flow from foreign currency-denominated sales, expenses, intercompany balances, and other monetary assets or liabilities denominated in currencies other than the U.S. dollar (&#8220;USD&#8221;). The terms of the Company&#8217;s derivative contracts are generally twelve months or shorter. The derivative assets and liabilities are measured using Level 2 fair value inputs.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into currency forward contracts as cash flow hedges to hedge certain forecasted revenue transactions denominated in currencies other than the USD, primarily the Euro (&#8220;EUR&#8221;), the British Pound (&#8220;GBP&#8221;), the Japanese Yen (&#8220;JPY&#8221;),&#160;and the Korean Won (&#8220;KRW&#8221;). The Company also enters into currency forward contracts as cash flow hedges to hedge certain forecasted expense transactions denominated in EUR and the Swiss Franc (&#8220;CHF&#8221;).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For these derivatives, the Company reports the unrealized after-tax gain or loss from the hedge as a component of accumulated other comprehensive income/(loss) in stockholders&#8217; equity and reclassifies the amount into earnings in the same period in which the hedged transaction affects earnings. The amounts reclassified to revenue and expenses related to the hedged transactions and the ineffective portions of cash flow hedges were not material for the periods presented.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Derivatives Not Designated as Hedging Instruments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other derivatives not designated as hedging instruments consist primarily of forward contracts that the Company uses to hedge intercompany balances and other monetary assets or liabilities denominated in currencies other than the USD, primarily the EUR, GBP, JPY, KRW, CHF, Indian Rupee ("INR"), Mexican Peso ("MXN"), Chinese Yuan ("CNY"), and New Taiwan Dollar ("TWD").</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><ix:continuation id="if0f7fe3734d84c149ee42702500d49a0"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNTcxMQ_60515b84-484f-4285-b254-76d51bfb0378" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These derivative instruments are used to hedge against balance sheet foreign currency exposures. The related gains and losses were as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized gains/(losses) in Interest and other income, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b53adfc2da450d83928c0d59c0cf9b_D20210701-20210930" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjE2NWZiNWFhZGEzMjRmYzJiMDJlNTc0OTVhMzExNTcxL3RhYmxlcmFuZ2U6MTY1ZmI1YWFkYTMyNGZjMmIwMmU1NzQ5NWEzMTE1NzFfMi0xLTEtMS0w_70733698-0fa3-4f0f-ab01-5e48133b58d1">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8b8d9c0c6b447738c87b3b7e16f0a5e_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjE2NWZiNWFhZGEzMjRmYzJiMDJlNTc0OTVhMzExNTcxL3RhYmxlcmFuZ2U6MTY1ZmI1YWFkYTMyNGZjMmIwMmU1NzQ5NWEzMTE1NzFfMi0zLTEtMS0w_ac960f81-8e84-46f5-8e9d-5abf2ed0438e">5.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i229a1c443d19443798c91258bb8d018d_D20210101-20210930" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjE2NWZiNWFhZGEzMjRmYzJiMDJlNTc0OTVhMzExNTcxL3RhYmxlcmFuZ2U6MTY1ZmI1YWFkYTMyNGZjMmIwMmU1NzQ5NWEzMTE1NzFfMi01LTEtMS0w_55ab2781-5658-4fe1-8d07-5e8cc302acc3">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e2c2a67bae840698c4ce5e39a92dddc_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjE2NWZiNWFhZGEzMjRmYzJiMDJlNTc0OTVhMzExNTcxL3RhYmxlcmFuZ2U6MTY1ZmI1YWFkYTMyNGZjMmIwMmU1NzQ5NWEzMTE1NzFfMi03LTEtMS0w_a1216766-d7b1-4271-a62c-51b46d03e1e6">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gains/(losses) related to balance sheet re-measurement</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjE2NWZiNWFhZGEzMjRmYzJiMDJlNTc0OTVhMzExNTcxL3RhYmxlcmFuZ2U6MTY1ZmI1YWFkYTMyNGZjMmIwMmU1NzQ5NWEzMTE1NzFfMy0xLTEtMS0w_f6d23f2b-e2ad-43c1-8ae7-9611d7a19039">6.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjE2NWZiNWFhZGEzMjRmYzJiMDJlNTc0OTVhMzExNTcxL3RhYmxlcmFuZ2U6MTY1ZmI1YWFkYTMyNGZjMmIwMmU1NzQ5NWEzMTE1NzFfMy0zLTEtMS0w_04c6e81b-6084-4069-88a7-aa52d7b76750">5.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjE2NWZiNWFhZGEzMjRmYzJiMDJlNTc0OTVhMzExNTcxL3RhYmxlcmFuZ2U6MTY1ZmI1YWFkYTMyNGZjMmIwMmU1NzQ5NWEzMTE1NzFfMy01LTEtMS0w_b1d13102-05ce-490b-ac94-20a80ccfb307">12.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjE2NWZiNWFhZGEzMjRmYzJiMDJlNTc0OTVhMzExNTcxL3RhYmxlcmFuZ2U6MTY1ZmI1YWFkYTMyNGZjMmIwMmU1NzQ5NWEzMTE1NzFfMy03LTEtMS0w_153f9f25-dfb1-4e70-a743-df942d5989ee">1.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in January 2021, the Company settled a collar contract previously entered into to hedge its equity investment in Teladoc Health, Inc. For the nine months ended September&#160;30, 2021, a loss of $<ix:nonFraction unitRef="usd" contextRef="ic1d4b29a68414fe6b3b2e75caa359a5d_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNTM3Mw_d28bc0e9-75b2-4631-b694-8ee68efedf1f">7.5</ix:nonFraction>&#160;million was recognized in Interest and other income, net.</span></div><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNTY4MQ_bf9998a7-93e1-4793-8808-bea0e255506f" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts for derivative instruments provide one measure of the transaction volume. Total gross notional amounts (in USD) for outstanding derivatives and the aggregate gross fair value at the end of each period were as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:47.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.257%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notional amounts:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0fa4f45ec164a5ebc9a515e1b8f57b3_I20210930" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfMy0xLTEtMS0w_fd8dbfb1-64f6-4054-9673-984dd4aa42e3">203.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24d4644b1a994c0f8abaeee9b5dcdb06_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfMy0zLTEtMS0w_0514d5ff-8a68-46ea-9d24-c71a101ca253">154.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63493d444f724a8296203ce9004defce_I20210930" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfMy01LTEtMS0w_3593b7bb-e3fb-4a33-8190-057676ef2c5e">285.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i194cea79cb2847038852265b56fab10c_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfMy03LTEtMS0w_c39c7d4d-b97e-4d3e-a5ba-850038f23cbb">309.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross fair value recorded in:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied0febbfd3184ec78820350f31b1a206_I20210930" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfNS0xLTEtMS0w_8237d2d4-7ed8-49e2-af6e-ef42c386c84d">6.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673322c7553b44c88a98e44d90b50183_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfNS0zLTEtMS0w_8bb38b60-9d04-49e3-bdf4-a2447d6c3d9c">0.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50d502c033d34a2bb8803baed7932450_I20210930" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfNS01LTEtMS0w_aa31128c-ab48-449e-8aa2-02c343b51d9f">5.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b35b549a824fe8a766f46dd9432198_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfNS03LTEtMS0w_e9798f72-cc2d-46f7-b0d0-ab681e0f46aa">0.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56683a8f54f2401e93b699a3ebeca829_I20210930" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfNi0xLTEtMS0w_9b961a8a-cf3c-4fba-a7c2-ebfca010debc">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23484c1a1c1f47c7a08373f58c84bc7a_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfNi0zLTEtMS0w_6ba27f05-e0c7-4479-8a35-aa002de16d31">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2143a91feda349708ea3355e40ad18d5_I20210930" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfNi01LTEtMS0w_b063ca65-fef3-40c0-a064-26ab68ef5f2f">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f223d39fb294552a8bcfb3bc81d4ebd_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfNi03LTEtMS0w_cc3c8114-a039-4125-b3eb-ef6022293ff7">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i944f300b8c29463aa56139ed7eaca296_40"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RleHRyZWdpb246YWVkMmJhMDJlOTE0NGFiNGEzYjk0ZWFkMTVhNzk0ODJfMzI0_e132c604-55da-45ed-91e2-ace3c77f8cf4" continuedAt="ia76b675686854fd3958a685b4e930407" escape="true">BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION</ix:nonNumeric></span></div><ix:continuation id="ia76b675686854fd3958a685b4e930407" continuedAt="i3020ea16a4694931beb83826376bb112"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Balance Sheet Details</span></div><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RleHRyZWdpb246YWVkMmJhMDJlOTE0NGFiNGEzYjk0ZWFkMTVhNzk0ODJfMzQy_ff79a513-b5a2-40d5-8155-44654d12645a" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide details of selected balance sheet line items (in millions):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Inventory</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmYxODVkYzRmZjI4MTQ1MmFiMWFiMzhlYTQ4ZWNmNmVmL3RhYmxlcmFuZ2U6ZjE4NWRjNGZmMjgxNDUyYWIxYWIzOGVhNDhlY2Y2ZWZfMi0xLTEtMS0w_7e296034-d205-4733-9f4c-b0f536053b70">181.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmYxODVkYzRmZjI4MTQ1MmFiMWFiMzhlYTQ4ZWNmNmVmL3RhYmxlcmFuZ2U6ZjE4NWRjNGZmMjgxNDUyYWIxYWIzOGVhNDhlY2Y2ZWZfMi0zLTEtMS0w_20f20e72-c7de-4819-8da5-7863da92ee4f">184.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmYxODVkYzRmZjI4MTQ1MmFiMWFiMzhlYTQ4ZWNmNmVmL3RhYmxlcmFuZ2U6ZjE4NWRjNGZmMjgxNDUyYWIxYWIzOGVhNDhlY2Y2ZWZfMy0xLTEtMS0w_103d4240-84d5-49e0-b4c0-d819b59cc8c3">85.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmYxODVkYzRmZjI4MTQ1MmFiMWFiMzhlYTQ4ZWNmNmVmL3RhYmxlcmFuZ2U6ZjE4NWRjNGZmMjgxNDUyYWIxYWIzOGVhNDhlY2Y2ZWZfMy0zLTEtMS0w_f1841fe1-eeaa-409f-ad9d-99c65268ff2d">75.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmYxODVkYzRmZjI4MTQ1MmFiMWFiMzhlYTQ4ZWNmNmVmL3RhYmxlcmFuZ2U6ZjE4NWRjNGZmMjgxNDUyYWIxYWIzOGVhNDhlY2Y2ZWZfNC0xLTEtMS0w_5d46d4e9-1470-42bf-9773-f1e92410e7d4">317.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmYxODVkYzRmZjI4MTQ1MmFiMWFiMzhlYTQ4ZWNmNmVmL3RhYmxlcmFuZ2U6ZjE4NWRjNGZmMjgxNDUyYWIxYWIzOGVhNDhlY2Y2ZWZfNC0zLTEtMS0w_2d6e3763-5761-40b0-a7f9-f0ed02566c56">341.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmYxODVkYzRmZjI4MTQ1MmFiMWFiMzhlYTQ4ZWNmNmVmL3RhYmxlcmFuZ2U6ZjE4NWRjNGZmMjgxNDUyYWIxYWIzOGVhNDhlY2Y2ZWZfNS0xLTEtMS0w_06c92d83-66fa-4686-bef0-4db8fdf2cfcd">584.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmYxODVkYzRmZjI4MTQ1MmFiMWFiMzhlYTQ4ZWNmNmVmL3RhYmxlcmFuZ2U6ZjE4NWRjNGZmMjgxNDUyYWIxYWIzOGVhNDhlY2Y2ZWZfNS0zLTEtMS0w_24050411-6674-4f83-8e70-eeed22bd2750">601.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RleHRyZWdpb246YWVkMmJhMDJlOTE0NGFiNGEzYjk0ZWFkMTVhNzk0ODJfMzQ1_9958959e-e401-4bc9-ab8e-194c531648b0" escape="true"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RleHRyZWdpb246YWVkMmJhMDJlOTE0NGFiNGEzYjk0ZWFkMTVhNzk0ODJfMzQ5_f89ace20-f1c3-4abb-965e-7606b244c1ca" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Prepaids and other current assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfMi0xLTEtMS0w_bd26ed9b-2a9e-4a85-ae9f-59a3c6951e58">78.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfMi0zLTEtMS0w_a93fdd7e-98d3-4d18-a807-81d379c47238">28.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfMy0xLTEtMS0w_64b021ad-556d-403a-8e50-79a70de8868e">43.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfMy0zLTEtMS0w_768166b5-efab-4d44-a1df-2599e909b9bb">60.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases &#8211; short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="isrg:SalesTypeLeaseNetInvestmentInLeaseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfNC0xLTEtMS0w_4b5fbfa5-4e7f-4546-b078-4dca9f48a9f8">98.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="isrg:SalesTypeLeaseNetInvestmentInLeaseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfNC0zLTEtMS0w_4b9c3ea6-b9fc-4b30-afc3-4dc300383508">81.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaids and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:OtherPrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfNS0xLTEtMS0w_be3295b9-95f6-4ddc-bf7f-6c22446dd0d9">139.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:OtherPrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfNS0zLTEtMS0w_319419d7-bc00-41b6-abb7-cc900c1c7592">97.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaids and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfNi0xLTEtMS0w_58160aaf-09d3-4411-8f83-c088fc683364">359.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfNi0zLTEtMS0w_362ff627-0480-46fe-bb1d-cba67d5fc2fc">267.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><ix:continuation id="i3020ea16a4694931beb83826376bb112"><div style="margin-bottom:12pt;text-align:center"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RleHRyZWdpb246YWVkMmJhMDJlOTE0NGFiNGEzYjk0ZWFkMTVhNzk0ODJfMzQw_e660b37e-5b41-46b4-92ab-b116cd5872d8" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other accrued liabilities&#8211;short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfMi0xLTEtMS0w_3f49d0c2-0e8a-43f2-b29f-363b8dba9fef">65.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfMi0zLTEtMS0w_9dd95a5a-35c2-4a20-8724-e496e34c2fc3">47.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of deferred purchase consideration payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="isrg:DeferredPurchaseConsiderationPaymentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfNC0xLTEtMS0w_0f4d42dc-8a2c-48f8-a76c-c3359bd6e1ce">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="isrg:DeferredPurchaseConsiderationPaymentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfNC0zLTEtMS0w_02882963-af11-4a2b-afa5-f08e820849f2">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfNS0xLTEtMS0w_94fdc2d9-5e21-440a-89f7-3cf65d08336b">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfNS0zLTEtMS0w_bc8ec5c7-bbc9-43bd-a0ca-729a8e41a834">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfNi0xLTEtMS0w_00191968-bed9-4eb4-92d6-8b1df1e258a7">214.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfNi0zLTEtMS0w_3dc62cdf-57f2-49b5-ac1c-d5c56d6a5112">225.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other accrued liabilities&#8211;short-term</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfNy0xLTEtMS0w_91319625-42bf-440e-a8ac-2ed2717b0e21">293.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfNy0zLTEtMS0w_8b30e1fb-e577-4c02-a28a-cae859ee1099">298.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:center"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RleHRyZWdpb246YWVkMmJhMDJlOTE0NGFiNGEzYjk0ZWFkMTVhNzk0ODJfMzU2_5dbc33ea-8316-4cb8-87bc-b4af8226df7a" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other long-term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes&#8211;long-term</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmY5NmZlYTZlOWNmYzQ0Mjg4NzU1NWNlOTBkZjcyMzBhL3RhYmxlcmFuZ2U6Zjk2ZmVhNmU5Y2ZjNDQyODg3NTU1Y2U5MGRmNzIzMGFfMi0xLTEtMS0w_aef26862-faf8-44aa-9af5-36efaa217b74">309.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmY5NmZlYTZlOWNmYzQ0Mjg4NzU1NWNlOTBkZjcyMzBhL3RhYmxlcmFuZ2U6Zjk2ZmVhNmU5Y2ZjNDQyODg3NTU1Y2U5MGRmNzIzMGFfMi0zLTEtMS0w_c293ab17-a419-402b-b621-462105d2f28a">305.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue&#8211;long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmY5NmZlYTZlOWNmYzQ0Mjg4NzU1NWNlOTBkZjcyMzBhL3RhYmxlcmFuZ2U6Zjk2ZmVhNmU5Y2ZjNDQyODg3NTU1Y2U5MGRmNzIzMGFfMy0xLTEtMS0w_b942e620-96a7-42d6-895f-178ef20e9d23">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmY5NmZlYTZlOWNmYzQ0Mjg4NzU1NWNlOTBkZjcyMzBhL3RhYmxlcmFuZ2U6Zjk2ZmVhNmU5Y2ZjNDQyODg3NTU1Y2U5MGRmNzIzMGFfMy0zLTEtMS0w_0590d4fa-c1f7-409b-9e71-16f7ce87e4bf">32.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmY5NmZlYTZlOWNmYzQ0Mjg4NzU1NWNlOTBkZjcyMzBhL3RhYmxlcmFuZ2U6Zjk2ZmVhNmU5Y2ZjNDQyODg3NTU1Y2U5MGRmNzIzMGFfNC0xLTEtMS0w_d8e0368d-9e7d-475b-bae9-7b16f4db8ca9">103.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmY5NmZlYTZlOWNmYzQ0Mjg4NzU1NWNlOTBkZjcyMzBhL3RhYmxlcmFuZ2U6Zjk2ZmVhNmU5Y2ZjNDQyODg3NTU1Y2U5MGRmNzIzMGFfNC0zLTEtMS0w_f7891364-2bb5-4d42-8950-bd718e6c1e0b">106.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmY5NmZlYTZlOWNmYzQ0Mjg4NzU1NWNlOTBkZjcyMzBhL3RhYmxlcmFuZ2U6Zjk2ZmVhNmU5Y2ZjNDQyODg3NTU1Y2U5MGRmNzIzMGFfNS0xLTEtMS0w_ba5e2565-0115-4095-a60b-c1d55a00599c">447.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmY5NmZlYTZlOWNmYzQ0Mjg4NzU1NWNlOTBkZjcyMzBhL3RhYmxlcmFuZ2U6Zjk2ZmVhNmU5Y2ZjNDQyODg3NTU1Y2U5MGRmNzIzMGFfNS0zLTEtMS0w_c8e498e8-6206-43c7-a2e2-c7997de4b62a">444.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="margin-bottom:6pt;text-indent:18pt"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RleHRyZWdpb246YWVkMmJhMDJlOTE0NGFiNGEzYjk0ZWFkMTVhNzk0ODJfMzQ2_db307501-d4dd-497d-abc8-23bcad5781bc" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides supplemental non-cash investing and financing activities (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentTransfersAndChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjNjYjk3YTg1YWJjNTQ1YTc5OWNhNTQzODQ5MDM2YTBhL3RhYmxlcmFuZ2U6M2NiOTdhODVhYmM1NDVhNzk5Y2E1NDM4NDkwMzZhMGFfMi00LTEtMS0w_0f969493-105a-4595-a1de-e9d283da532e">229.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentTransfersAndChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjNjYjk3YTg1YWJjNTQ1YTc5OWNhNTQzODQ5MDM2YTBhL3RhYmxlcmFuZ2U6M2NiOTdhODVhYmM1NDVhNzk5Y2E1NDM4NDkwMzZhMGFfMi02LTEtMS0w_b0b4549f-e99e-48c4-8051-73a9bbc88f1d">123.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of property, plant, and equipment in accounts payable and accrued liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjNjYjk3YTg1YWJjNTQ1YTc5OWNhNTQzODQ5MDM2YTBhL3RhYmxlcmFuZ2U6M2NiOTdhODVhYmM1NDVhNzk5Y2E1NDM4NDkwMzZhMGFfMy00LTEtMS0w_e1f17577-6847-424a-880e-5ef133f73db9">29.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjNjYjk3YTg1YWJjNTQ1YTc5OWNhNTQzODQ5MDM2YTBhL3RhYmxlcmFuZ2U6M2NiOTdhODVhYmM1NDVhNzk5Y2E1NDM4NDkwMzZhMGFfMy02LTEtMS0w_342db21d-0dad-465e-9afa-9bea0dc04022">44.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred payments and contingent consideration related to business combinations and asset acquisitions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="isrg:BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjNjYjk3YTg1YWJjNTQ1YTc5OWNhNTQzODQ5MDM2YTBhL3RhYmxlcmFuZ2U6M2NiOTdhODVhYmM1NDVhNzk5Y2E1NDM4NDkwMzZhMGFfNC00LTEtMS0w_2b25eac3-6fd7-46c1-a64d-7d9badd0abf9">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="isrg:BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjNjYjk3YTg1YWJjNTQ1YTc5OWNhNTQzODQ5MDM2YTBhL3RhYmxlcmFuZ2U6M2NiOTdhODVhYmM1NDVhNzk5Y2E1NDM4NDkwMzZhMGFfNC02LTEtMS0w_c1fce476-b96d-4f95-8ab3-76cd8e91508b">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i944f300b8c29463aa56139ed7eaca296_43"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfOTg5NTYwNDY1NDkyNg_35658d20-4c0b-4353-9081-713c3a0bd021" continuedAt="i9a76cf89d4c646eaa2a0a04ba68ac780" escape="true">REVENUE AND CONTRACT ACQUISITION COSTS</ix:nonNumeric></span></div><ix:continuation id="i9a76cf89d4c646eaa2a0a04ba68ac780" continuedAt="i88da2cc11709413d9ebca82b6e5e5375"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMzg2MA_6e7b7287-2827-44cc-b96d-b06846dd10a7" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue disaggregated by types and geography (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb4ff6e5fe5459f9bc00395116a38fb_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMi0xLTEtMS0w_72bc5e38-308b-4e16-9b9f-2475a690ad48">535.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf31bd19117d49ad9339442660f985f1_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMi0zLTEtMS0w_de8efd83-eee2-4565-a195-1832c1a888bc">467.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife0812e0ddbd443b89d9604955851763_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMi01LTEtMS0w_824d2359-ffb1-4ab6-96ae-d99e421a0d2a">1,614.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2604357eba845b084dd3bf73b2757e5_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMi03LTEtMS0w_52bdf9b0-765d-461b-84e9-d1198745699b">1,227.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41d6f85820774298aee1036152f3f737_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMy0xLTEtMS0w_d8e1ae5b-54dc-467d-bced-593050f9603f">263.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25dca51a46e14c27ba59a12aad400497_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMy0zLTEtMS0w_1c97bea5-2827-4f60-a491-766b375c9853">157.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id89c6d81b52d4816b2252aef11227497_D20210101-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMy01LTEtMS0w_69c84525-4837-40b3-ab09-5718b1824805">743.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c75d5f4a15f44ca9ac400c2f1889d82_D20200101-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMy03LTEtMS0w_d203d611-f28d-46cf-a492-395f3c9c1d60">495.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i406fb20eeca84b7d92fe357463e85f6c_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfNC0xLTEtMS0w_f940126f-dbc0-4868-a3c3-add34ac1fdfe">153.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad16e7fe313c4489a4b36c3fbd634251_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfNC0zLTEtMS0w_3e030188-6960-40c4-8138-4540f10e2bc4">118.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3925b0e265e6407ba522b052f71f3c41_D20210101-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfNC01LTEtMS0w_c879b03e-00a6-4302-9df0-552e767d4206">447.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7caf933d32a44a348550d2fe3f894b90_D20200101-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfNC03LTEtMS0w_bc9401ba-fde3-4d8e-91a9-c4c77003af00">337.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. revenue</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f847939b19c491f9f7d865b8bed8ca5_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfNS0xLTEtMS0w_60254c43-eb4e-4d2e-9322-757bfc615cf5">952.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aecb14552b54937b40537850614044e_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfNS0zLTEtMS0w_077b9323-d1aa-46e2-a3fb-f6c5dca5b85c">743.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88e4709c5bac4f04a4f648b34d11dcfc_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfNS01LTEtMS0w_905144c6-cd73-48ef-9c22-516b6d9d4da4">2,805.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dda0f930e68405ab3bc179a126443d9_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfNS03LTEtMS0w_1b665d8a-a185-4ebb-b4c1-c6e43ee44583">2,060.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Outside of U.S. (&#8220;OUS&#8221;)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f77153a86ef4445b2643323afa75e0d_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfOC0xLTEtMS0w_7d79a181-c4b1-4e41-ad29-1f674d373d2c">219.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6decb5bae0bb4ac8a4dd1cb95e052fb1_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfOC0zLTEtMS0w_60579da4-209b-4f79-824c-b9e729f1fee4">163.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e03e6e08b894f258a0ae7e5baf29d4d_D20210101-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfOC01LTEtMS0w_0976e3ba-7b5c-4730-bee1-36c6e8370638">643.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577d8ffa87da4e9f87387883bec6f02b_D20200101-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfOC03LTEtMS0w_589e34ee-35bc-4050-b7b6-d9b5121a8b02">481.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77bac0e4769042e483f91c8ebb08ee8e_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfOS0xLTEtMS0w_d91e6375-555a-413a-9d98-2792c7d53a9b">151.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice87d9c6353945688b8d23575204c383_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfOS0zLTEtMS0w_699a5157-b2a8-4eb9-86bb-369ac9438b8e">110.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db5f294e20446a485b225b9c62bd623_D20210101-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfOS01LTEtMS0w_dd719c2a-ee58-40b8-9a9d-ab0f5d09f99e">479.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4dcb119f285471db2ed01f635d0158b_D20200101-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfOS03LTEtMS0w_88ba1f7c-034c-4af7-975e-9f76cea543a7">316.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e116d872911487b964787a5ad7b829e_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTAtMS0xLTEtMA_eba7b16c-96ed-4d61-9934-974f5eff0e70">79.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b8fa49940cf4659848e727c825f73c9_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTAtMy0xLTEtMA_00e18b15-ca70-4003-817b-a126964045e0">60.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bbf79c7461d494abe77f32ab6fa2494_D20210101-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTAtNS0xLTEtMA_efe4232b-d183-4134-abe7-a8fd41782e29">230.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbabbfafefa044f6b3ce8e02746f0a49_D20200101-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTAtNy0xLTEtMA_5fade72d-4853-4367-ade3-99bb5b29e905">170.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total OUS revenue</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i412f99609e454649a82b61eed8aa58ac_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTEtMS0xLTEtMA_8143e169-ba99-4e51-ae5e-e393478255ba">451.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996abb0f87034c4f91f7b2f0ad4eda06_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTEtMy0xLTEtMA_960cdb96-e2c0-4baa-8d7c-0f16d9d326f3">333.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i672905085bc3459a9d00cbc325e97bb4_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTEtNS0xLTEtMA_cbeaab61-d167-447f-9185-bd298ddbe393">1,353.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f0a990e6c394d8c8008639d37935b0a_D20200101-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTEtNy0xLTEtMA_ede9db59-0b0f-4b13-a8b2-c6f8bd8d0e7b">968.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Total </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1f121a531948669a508b4480804ca0_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTQtMS0xLTEtMA_60dd92e8-c9b4-4f9c-afd3-204b7586f0d1">755.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ae8d93de5f54b1ab269fde30dd6b190_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTQtMy0xLTEtMA_9d5de290-7a6a-400b-bd26-9ad9138d4df2">630.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idab02e2b14ea4d82817b4d902d15adc7_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTQtNS0xLTEtMA_d21195e2-1ab1-4b90-ac1e-75cbac9ddf73">2,257.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i620c79857bce477992bc9f8b37092c6c_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTQtNy0xLTEtMA_403b6fea-2ce2-4a5e-8a0f-4a7679d85d1a">1,708.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if10e966d0d6b4c70a5fb900ee48bfb44_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTUtMS0xLTEtMA_b1bccbec-48db-48f1-bd0b-98a2611661ee">415.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1901af46aeed45319e6c22a2482f0527_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTUtMy0xLTEtMA_5d382aec-f35e-4b6c-866f-c92c31aff8ea">267.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2075d28d68b94983bd02ac4a20ff18d2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTUtNS0xLTEtMA_f39880e6-6782-4444-a5b9-eef5e609cc73">1,223.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977db1115aba4294ab954fafbee1ba05_D20200101-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTUtNy0xLTEtMA_378c7d70-fe65-45c5-ae5b-1b6457085ec2">812.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica0e2ab5444c405588f03410c79beb75_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTYtMS0xLTEtMA_2a38559e-87b5-4bf3-825f-62d1518e4c35">232.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37656fec38db4901b77f277074155cce_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTYtMy0xLTEtMA_eac3e661-8259-4883-bd58-ea92925570d3">179.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1022821765b944a7a6645ef3d885d0d8_D20210101-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTYtNS0xLTEtMA_f104b445-18cb-44ff-9367-983a05b9c6d8">678.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89a0602b4836416f90adbc080a012a8e_D20200101-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTYtNy0xLTEtMA_ac48b056-e136-4862-99cc-094449f0e2cd">508.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTctMS0xLTEtMA_7d41351e-1d5b-48c6-83c5-8cc320e86987">1,403.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTctMy0xLTEtMA_1ccc796f-6d32-43e1-ad92-11e9d3294c3a">1,077.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTctNS0xLTEtMA_ce387a61-4372-4828-8ff0-d8225b4b2122">4,159.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTctNy0xLTEtMA_c8cbd6e5-f993-4146-a564-c74085a3f2d8">3,029.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><ix:continuation id="i88da2cc11709413d9ebca82b6e5e5375"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which revenue has not yet been recognized. A significant portion of these performance obligations relate to service obligations in the Company's system sale and lease arrangements that will be satisfied and recognized as revenue in future periods. The transaction price allocated to the remaining performance obligations was $<ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfODU1_76403e39-0957-41e4-8eab-c3cbd1cf32b7">1,723</ix:nonFraction> million as of September&#160;30, 2021. The remaining performance obligations are expected to be satisfied over the term of the system sale and lease arrangements, which generally are up to <ix:nonNumeric contextRef="ie286ee6f7f574339b7040c18df117a53_I20210930" format="ixt-sec:duryear" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMTAwNw_4294839f-8fc1-4440-9440-eb1ade4d475d">5</ix:nonNumeric> years. Service revenue associated with the lease arrangements will be recognized over the service period.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMzg1NQ_040a7dfd-c11b-46f2-ae2b-2aaef0f51329" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information summarizes the Company&#8217;s contract assets and liabilities (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmU1MDY3NDNjNWYyMzRmNjFhNGRhNjJmNjkyYTk3YzJiL3RhYmxlcmFuZ2U6ZTUwNjc0M2M1ZjIzNGY2MWE0ZGE2MmY2OTJhOTdjMmJfMy0xLTEtMS0w_a1445658-f9b5-4f10-978a-57aa6f40d231">44.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmU1MDY3NDNjNWYyMzRmNjFhNGRhNjJmNjkyYTk3YzJiL3RhYmxlcmFuZ2U6ZTUwNjc0M2M1ZjIzNGY2MWE0ZGE2MmY2OTJhOTdjMmJfMy0zLTEtMS0w_cc2c6caa-a342-4363-b79e-e5bb627e0f45">34.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmU1MDY3NDNjNWYyMzRmNjFhNGRhNjJmNjkyYTk3YzJiL3RhYmxlcmFuZ2U6ZTUwNjc0M2M1ZjIzNGY2MWE0ZGE2MmY2OTJhOTdjMmJfNC0xLTEtMS0w_353e8336-85f5-4d90-ba13-efbaf9cd7537">383.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmU1MDY3NDNjNWYyMzRmNjFhNGRhNjJmNjkyYTk3YzJiL3RhYmxlcmFuZ2U6ZTUwNjc0M2M1ZjIzNGY2MWE0ZGE2MmY2OTJhOTdjMmJfNC0zLTEtMS0w_4e04e6ab-137b-449a-ae05-556d9539491b">382.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invoices its customers based on the billing schedules in its sales arrangements. Payments are generally due 30 to 60 days from date of invoice. Contract assets for the periods presented primarily represent the difference between the revenue that was recognized based on the relative standalone selling price of the related performance obligations satisfied and the contractual billing terms in the arrangements. Deferred revenue for the periods presented primarily relates to service contracts where the service fees are billed up-front, generally quarterly or annually, prior to those services having been performed. The associated deferred revenue is generally recognized over the term of the service period. The Company did not have any significant impairment losses on its contract assets for the periods presented.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2021, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMjE3OQ_033ffae9-ba2b-4698-a8d8-b62c5ef3082d">66.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMjE4Ng_d61a338c-26f5-46aa-be2c-98f667872e9f">319.3</ix:nonFraction>&#160;million of revenue, respectively, that was included in the deferred revenue balance as of December&#160;31, 2020. During the three and nine months ended September&#160;30, 2020, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMjMyOQ_85b1dff1-f65b-4ca4-851b-bade4531638c">58.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMjMzNg_fbc62c81-97c8-48b7-b270-1eee722d6dca">249.7</ix:nonFraction>&#160;million of revenue, respectively, net of the impact of the Customer Relief Program, that was included in the deferred revenue balance as of December&#160;31, 2019.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intuitive System Leasing</span></div><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:OperatingLeaseLeaseIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMzg1Nw_d0fc623a-4f49-4736-b65b-dcc351436a88" escape="true"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:SalesTypeLeaseLeaseIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMzg1OA_5939fbe1-053d-4ae0-899a-af2c6602d20e" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue from Intuitive System Leasing arrangements (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmEwZDFhMzI3YWYyZTQyMTk5OWYwNWQ2Y2Y2M2YwOTVkL3RhYmxlcmFuZ2U6YTBkMWEzMjdhZjJlNDIxOTk5ZjA1ZDZjZjYzZjA5NWRfMi0xLTEtMS0w_ac66dbea-6d25-4edb-8c4f-a0a5d736d1c5">39.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmEwZDFhMzI3YWYyZTQyMTk5OWYwNWQ2Y2Y2M2YwOTVkL3RhYmxlcmFuZ2U6YTBkMWEzMjdhZjJlNDIxOTk5ZjA1ZDZjZjYzZjA5NWRfMi0zLTEtMS0w_e09e347a-a0ac-41d8-afc1-1ed9065bc40d">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmEwZDFhMzI3YWYyZTQyMTk5OWYwNWQ2Y2Y2M2YwOTVkL3RhYmxlcmFuZ2U6YTBkMWEzMjdhZjJlNDIxOTk5ZjA1ZDZjZjYzZjA5NWRfMi01LTEtMS0w_f6a80365-c32d-4739-84c3-b1920860d019">140.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmEwZDFhMzI3YWYyZTQyMTk5OWYwNWQ2Y2Y2M2YwOTVkL3RhYmxlcmFuZ2U6YTBkMWEzMjdhZjJlNDIxOTk5ZjA1ZDZjZjYzZjA5NWRfMi03LTEtMS0w_f37c54c2-7d51-474f-8524-bb1dd5addcb4">96.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmEwZDFhMzI3YWYyZTQyMTk5OWYwNWQ2Y2Y2M2YwOTVkL3RhYmxlcmFuZ2U6YTBkMWEzMjdhZjJlNDIxOTk5ZjA1ZDZjZjYzZjA5NWRfMy0xLTEtMS0w_20c0f46f-9f1c-4328-b317-9ec65657e157">72.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmEwZDFhMzI3YWYyZTQyMTk5OWYwNWQ2Y2Y2M2YwOTVkL3RhYmxlcmFuZ2U6YTBkMWEzMjdhZjJlNDIxOTk5ZjA1ZDZjZjYzZjA5NWRfMy0zLTEtMS0w_67fa5e6d-1b37-463a-ab26-a4c47e12be39">45.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmEwZDFhMzI3YWYyZTQyMTk5OWYwNWQ2Y2Y2M2YwOTVkL3RhYmxlcmFuZ2U6YTBkMWEzMjdhZjJlNDIxOTk5ZjA1ZDZjZjYzZjA5NWRfMy01LTEtMS0w_151dddb7-bc20-40d0-be9a-35c4aa9d4907">198.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmEwZDFhMzI3YWYyZTQyMTk5OWYwNWQ2Y2Y2M2YwOTVkL3RhYmxlcmFuZ2U6YTBkMWEzMjdhZjJlNDIxOTk5ZjA1ZDZjZjYzZjA5NWRfMy03LTEtMS0w_f56046c3-1ce5-4f49-9ef9-be38f1a9f834">127.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2021, and 2020, variable lease revenue relating to usage-based arrangements was not material.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Accounts Receivable</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for doubtful accounts is based on the Company&#8217;s assessment of the collectibility of customer accounts. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, the age of the accounts receivable balances, and current economic conditions that may affect a customer&#8217;s ability to pay. For the three and nine months ended September&#160;30, 2021, and 2020, bad debt expense was not material.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. Although the Company has historically not experienced significant credit losses, it is possible that there could be a material adverse impact from potential adjustments of the carrying amount of lease and trade receivables as hospital cash flows are impacted by their response to the COVID-19 pandemic and deferral of elective surgical procedures.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:LessorSalesTypeLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RleHRyZWdpb246NWQzOTE5ZDFlYmU3NDNhMTgwOTFiZTQ2YTM3ZDQ1ZGNfMTcxNA_bec8e3a8-6faf-4c4b-a34c-a1f08b4ff544" continuedAt="i0f3efda6dace4dd080ee2d678f22fba8" escape="true">LEASES</ix:nonNumeric></span></div><ix:continuation id="i0f3efda6dace4dd080ee2d678f22fba8"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessor Information</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales-type Leases. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RleHRyZWdpb246NWQzOTE5ZDFlYmU3NDNhMTgwOTFiZTQ2YTM3ZDQ1ZGNfMTczNQ_e56c5c28-1fe3-49d8-bd3f-1ca81e61e687" continuedAt="i40f2e354355b492ca1acba8cfad1741f" escape="true"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RleHRyZWdpb246NWQzOTE5ZDFlYmU3NDNhMTgwOTFiZTQ2YTM3ZDQ1ZGNfMTc0Mg_92207806-1b2b-4f86-8a53-c79dea42b16a" continuedAt="i49bb42d1c54241d6a4ce02456e479acf" escape="true">Lease receivables relating to sales-type lease arrangements are presented on the Condensed Consolidated Balance Sheets as follows (in millions):</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="i40f2e354355b492ca1acba8cfad1741f"><ix:continuation id="i49bb42d1c54241d6a4ce02456e479acf"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross lease receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="isrg:SalesTypeLeaseGrossInvestmentInLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfMi0xLTEtMS0w_ec3431a1-b912-4d50-81f4-fe6181b850c5">356.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="isrg:SalesTypeLeaseGrossInvestmentInLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfMi0zLTEtMS0w_49592245-3545-49e9-bec0-736fb18dd65d">286.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="isrg:SalestypeLeaseDeferredSellingProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfMy0xLTEtMS0w_f4c6f862-f93b-4588-b404-2aead567f124">11.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="isrg:SalestypeLeaseDeferredSellingProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfMy0zLTEtMS0w_97e65076-b367-4230-812a-89f2ca8c1a4f">11.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfNC0xLTEtMS0w_cea8963a-517e-44a2-99f4-abf9e80eed2d">344.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfNC0zLTEtMS0w_61add7ec-d578-48bd-8854-e98f6eb97d33">275.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfNS0xLTEtMS0w_082f4ccc-87ee-44bd-90b0-4386c460700c">3.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfNS0zLTEtMS0w_6ab6f57a-b1b7-423b-bb44-ea780f9af5db">4.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfNi0xLTEtMS0w_41fa65e8-ff7a-4faf-aec8-e1805487d170">340.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfNi0zLTEtMS0w_a50c1ed9-8d60-4f13-817c-aa9efbd5faf7">270.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40ae7c3cefde401583c8e526051dd07b_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfOC0xLTEtMS0w_c05c16bc-99d7-4318-b304-ff700a90b255">98.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb5a865f78164fc18aef9ad29f31e8ff_I20201231" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfOC0zLTEtMS0w_557d7783-18d8-41d2-8406-2b62ffcbd9c6">81.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible and other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4d7cc4e81e94501bcf79b671e5df53c_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfOS0xLTEtMS0w_57e2b13b-0148-46e9-8022-2175c4dc301f">242.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49470d81e3c048edbcda45a279c28a74_I20201231" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfOS0zLTEtMS0w_3b89627d-ba69-4df5-92a1-3c760af90770">189.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfMTAtMS0xLTEtMA_9e5bdc5f-6ea3-4357-bda3-15979c6e88be">340.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfMTAtMy0xLTEtMA_668cd5d4-4aea-4f90-9bb0-606ffc877e1b">270.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-bottom:6pt;text-indent:18pt"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RleHRyZWdpb246NWQzOTE5ZDFlYmU3NDNhMTgwOTFiZTQ2YTM3ZDQ1ZGNfMTcyMQ_0a5b0846-ee73-436b-bef9-8a2a8b66c714" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of gross lease receivables at September&#160;30, 2021, are as follows (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjE1OTk1MDU1ODY1ODRkNmQ5OTNjZDIzNWE1ODBkMzMyL3RhYmxlcmFuZ2U6MTU5OTUwNTU4NjU4NGQ2ZDk5M2NkMjM1YTU4MGQzMzJfMS0xLTEtMS0w_d3f72235-b080-41ac-a8d7-5f06220c4f0b">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjE1OTk1MDU1ODY1ODRkNmQ5OTNjZDIzNWE1ODBkMzMyL3RhYmxlcmFuZ2U6MTU5OTUwNTU4NjU4NGQ2ZDk5M2NkMjM1YTU4MGQzMzJfMi0xLTEtMS0w_7ac4b6b8-2e7a-46c6-935c-9d00fcf5e7f1">101.4</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjE1OTk1MDU1ODY1ODRkNmQ5OTNjZDIzNWE1ODBkMzMyL3RhYmxlcmFuZ2U6MTU5OTUwNTU4NjU4NGQ2ZDk5M2NkMjM1YTU4MGQzMzJfMy0xLTEtMS0w_6cf16ed6-bcda-4908-8c12-5b2182bf0052">86.5</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjE1OTk1MDU1ODY1ODRkNmQ5OTNjZDIzNWE1ODBkMzMyL3RhYmxlcmFuZ2U6MTU5OTUwNTU4NjU4NGQ2ZDk5M2NkMjM1YTU4MGQzMzJfNC0xLTEtMS0w_f83b0af8-1669-4c52-9bb8-a0c56990d161">74.2</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjE1OTk1MDU1ODY1ODRkNmQ5OTNjZDIzNWE1ODBkMzMyL3RhYmxlcmFuZ2U6MTU5OTUwNTU4NjU4NGQ2ZDk5M2NkMjM1YTU4MGQzMzJfNS0xLTEtMS0w_77f5288a-b5bf-4f17-8d34-646b9a1142f6">49.4</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="isrg:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjE1OTk1MDU1ODY1ODRkNmQ5OTNjZDIzNWE1ODBkMzMyL3RhYmxlcmFuZ2U6MTU5OTUwNTU4NjU4NGQ2ZDk5M2NkMjM1YTU4MGQzMzJfNi0xLTEtMS0w_85da27ce-9716-443d-bc6c-b7eccced82ba">19.0</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjE1OTk1MDU1ODY1ODRkNmQ5OTNjZDIzNWE1ODBkMzMyL3RhYmxlcmFuZ2U6MTU5OTUwNTU4NjU4NGQ2ZDk5M2NkMjM1YTU4MGQzMzJfNy0xLTEtMS0w_9dedcb1c-cdd0-4ed3-b7a3-6b7f968e1068">356.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into sales-type leases with certain qualified customers to purchase its systems. Sales-type leases have terms that generally range from <ix:nonNumeric contextRef="i77ba4e1aaa0a40daa59040ab5003d99d_I20210930" format="ixt-sec:durmonth" name="us-gaap:LessorSalesTypeLeaseTermOfContract1" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RleHRyZWdpb246NWQzOTE5ZDFlYmU3NDNhMTgwOTFiZTQ2YTM3ZDQ1ZGNfNDQ4_998911ba-91b5-46dd-98d6-5167bf165560">24</ix:nonNumeric> to <ix:nonNumeric contextRef="ib82660af9cff4336adca1f99b02c09c4_I20210930" format="ixt-sec:durmonth" name="us-gaap:LessorSalesTypeLeaseTermOfContract1" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RleHRyZWdpb246NWQzOTE5ZDFlYmU3NDNhMTgwOTFiZTQ2YTM3ZDQ1ZGNfNDU0_288c9b47-6c0f-4ffd-be73-96264f3e3ec2">84</ix:nonNumeric> months and are usually collateralized by a security interest in the underlying assets. The allowance for loan loss is based on the Company&#8217;s assessment of current expected lifetime loss on lease receivables. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, the age of the lease receivable balances, and current economic conditions that may affect a customer&#8217;s ability to pay. Lease receivables are considered past due 90 days after invoice.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages the credit risk in net investment in sales-type leases using a number of factors, including, but not limited to the following: size of operations; profitability, liquidity, and debt ratios; payment history; and past due amounts. The Company also uses credit scores obtained from external providers as a key credit quality indicator for the purposes of determining credit quality. The following table presents credit quality by class of net investment in sales-type leases as of September&#160;30, 2021. <ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RleHRyZWdpb246NWQzOTE5ZDFlYmU3NDNhMTgwOTFiZTQ2YTM3ZDQ1ZGNfMTcxOQ_23196dbf-0fc6-4e07-83a7-470ba150f53a" continuedAt="i0d76f914d27a4742b10c7368741d2993" escape="true">The following table summarizes the amortized cost basis by year of origination and credit quality indicator as of September&#160;30, 2021 (in millions):</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="i0d76f914d27a4742b10c7368741d2993"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Credit Rating:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief72904a51c44045bc02018f15b8f0ed_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMi0xLTEtMS0w_f57b19e6-b7ce-4732-9630-24faf9a63728">76.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief72904a51c44045bc02018f15b8f0ed_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMi0zLTEtMS0w_9bb2082b-3305-4517-b775-036f37309083">56.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief72904a51c44045bc02018f15b8f0ed_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMi01LTEtMS0w_aaaa91ae-0f7d-49ee-b259-988fe7353d37">25.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief72904a51c44045bc02018f15b8f0ed_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMi03LTEtMS0w_7276381f-346c-4eff-9ea2-1bb9f82c1fdb">5.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief72904a51c44045bc02018f15b8f0ed_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMi05LTEtMS0w_bfd34e51-41c5-498c-83f6-cc6fdfb20b92">3.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief72904a51c44045bc02018f15b8f0ed_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMi0xMS0xLTEtMA_dfbc7bc9-6193-452e-9747-66b6857ef709">0.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief72904a51c44045bc02018f15b8f0ed_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMi0xMy0xLTEtMA_58295b77-cf94-4ef2-bf62-a13c32b1d5af">167.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moderate</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5e071604dd4ac48f9826527375a58a_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMy0xLTEtMS0w_5b2d79ff-af21-4da5-a99c-e30a25c36a26">70.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5e071604dd4ac48f9826527375a58a_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMy0zLTEtMS0w_c42542c1-8c73-4493-9039-755e1ca027d8">67.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5e071604dd4ac48f9826527375a58a_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMy01LTEtMS0w_708f7af4-dc88-44e4-9d4c-1722164ee875">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5e071604dd4ac48f9826527375a58a_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMy03LTEtMS0w_c16933b2-8013-4d4a-9bd5-76341fadac2a">11.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5e071604dd4ac48f9826527375a58a_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMy05LTEtMS0w_cfd670ee-4111-4c91-96d4-354eac9adc0d">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5e071604dd4ac48f9826527375a58a_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMy0xMS0xLTEtMA_18a96cc4-ee6a-478c-b911-def0e127a873">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5e071604dd4ac48f9826527375a58a_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMy0xMy0xLTEtMA_0a79744d-8720-4be6-9bb6-2ccd1f4da0a2">171.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Low</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfeb8a45a0084daf9e15f7fde113be1c_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNC0xLTEtMS0w_c0cc9bd9-fa34-4c71-8447-f55e0eb86b30">0.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfeb8a45a0084daf9e15f7fde113be1c_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNC0zLTEtMS0w_53c90b78-10ec-4692-88a9-2cd3cfb9dd5f">4.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfeb8a45a0084daf9e15f7fde113be1c_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNC01LTEtMS0w_1682acc0-52fa-431c-8955-6c8c6b676b9b">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfeb8a45a0084daf9e15f7fde113be1c_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNC03LTEtMS0w_84faf1fb-ff66-42ec-8b87-55ab98f9d4fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfeb8a45a0084daf9e15f7fde113be1c_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNC05LTEtMS0w_d8282b94-3fea-49fc-a558-3c2619c1a5d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfeb8a45a0084daf9e15f7fde113be1c_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNC0xMS0xLTEtMA_0fa394f4-4e68-4dd8-a5eb-f5906e40ced6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfeb8a45a0084daf9e15f7fde113be1c_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNC0xMy0xLTEtMA_c1b24db3-3336-470c-a265-3db36aa02055">5.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNS0xLTEtMS0w_5b92b722-2a81-4610-b56b-06cb3485ace7">147.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNS0zLTEtMS0w_6de23e27-503b-48bc-b2ef-0cd60f099fe6">128.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNS01LTEtMS0w_b8f3ef63-e028-474b-8c0c-41f1d86f5d75">44.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNS03LTEtMS0w_f18291c2-7481-4d87-b88f-8203e563fa54">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNS05LTEtMS0w_f910b581-2df5-4d4b-8884-0583b4d12705">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNS0xMS0xLTEtMA_caa311b7-cfdc-448a-955b-3eebdfada1b9">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNS0xMy0xLTEtMA_ed2bf3da-f43b-46e1-a466-4140b683e2aa">344.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2021, and 2020, credit losses related to net investment in sales-type leases were not significant.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RleHRyZWdpb246NDk4ZTM2NmI2Y2Y3NDljZGFiZjUxODBmODI1NTA5NjhfMTY0OQ_50649a1a-3b18-49c2-ae76-b15d1ccdfd5e" continuedAt="if60675776da646389df5be8af49e811b" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="if60675776da646389df5be8af49e811b"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions in 2021</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material acquisitions for the three and nine months ended September&#160;30, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions in 2020</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Orpheus Medical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company acquired Orpheus Medical Ltd. and its wholly owned subsidiaries (&#8220;Orpheus Medical&#8221;) to deepen and expand our integrated informatics platform (the &#8220;Orpheus Medical Acquisition&#8221;). Orpheus Medical provides hospitals with information technology connectivity, as well as expertise in capturing, processing, and archiving clinical videos across the hospital. The Orpheus Medical Acquisition did not have a material impact on the financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RleHRyZWdpb246NDk4ZTM2NmI2Y2Y3NDljZGFiZjUxODBmODI1NTA5NjhfMTY1MA_747f656e-61e3-4be8-ae20-cf352a0c7873" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOmU3NTQwNjFjYjhlZDQ0NDBhZWMxZWI1NWJmOWNhNjBjL3RhYmxlcmFuZ2U6ZTc1NDA2MWNiOGVkNDQ0MGFlYzFlYjU1YmY5Y2E2MGNfMS0xLTEtMS0w_99ae2110-c4c6-4c62-b410-7851c4e73849">336.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition activity</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOmU3NTQwNjFjYjhlZDQ0NDBhZWMxZWI1NWJmOWNhNjBjL3RhYmxlcmFuZ2U6ZTc1NDA2MWNiOGVkNDQ0MGFlYzFlYjU1YmY5Y2E2MGNfMi0xLTEtMS0w_05aee826-8b84-4916-ba93-f9dd72dbde4b">8.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOmU3NTQwNjFjYjhlZDQ0NDBhZWMxZWI1NWJmOWNhNjBjL3RhYmxlcmFuZ2U6ZTc1NDA2MWNiOGVkNDQ0MGFlYzFlYjU1YmY5Y2E2MGNfMy0xLTEtMS0w_265ee145-d264-4622-9484-0b68a61b605e">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOmU3NTQwNjFjYjhlZDQ0NDBhZWMxZWI1NWJmOWNhNjBjL3RhYmxlcmFuZ2U6ZTc1NDA2MWNiOGVkNDQ0MGFlYzFlYjU1YmY5Y2E2MGNfNC0xLTEtMS0w_043147ae-21bf-4614-8701-e7e81a88f9c7">344.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RleHRyZWdpb246NDk4ZTM2NmI2Y2Y3NDljZGFiZjUxODBmODI1NTA5NjhfMTY1MQ_3b9c5eb4-b6ef-460a-bc94-92853d4daa15" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of gross intangible assets, accumulated amortization, and net intangible asset balances as of September&#160;30, 2021, and December&#160;31, 2020 (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:29.207%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibccf075334db4130accdd0e847125918_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMi0yLTEtMS0w_85467d66-2336-4fdf-9012-c6e9d0a4ad3e">219.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibccf075334db4130accdd0e847125918_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMi00LTEtMS0w_7a3d0e20-baaf-44fa-9c7c-75a8b94505fd">169.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibccf075334db4130accdd0e847125918_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMi02LTEtMS0w_d3f21513-3382-4a45-bd66-51e8913beac7">50.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0040668084154bd5bbaa4b3954aa2f3b_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMi04LTEtMS0w_747ab423-3305-45f1-9f76-b35904caf941">198.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0040668084154bd5bbaa4b3954aa2f3b_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMi0xMC0xLTEtMA_a55f14f9-e9bf-471e-819d-a2c46d64c490">158.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0040668084154bd5bbaa4b3954aa2f3b_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMi0xMi0xLTEtMA_d63031c8-1ee1-4e6c-9ee6-8776c922e70d">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution rights and others</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id153e77c855a4d55ae7589981388d8e2_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMy0yLTEtMS0w_f5c983d7-30c5-42eb-aa98-7a31be183837">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id153e77c855a4d55ae7589981388d8e2_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMy00LTEtMS0w_52865a6c-cf45-474d-853f-4f220db39e9d">17.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id153e77c855a4d55ae7589981388d8e2_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMy02LTEtMS0w_f9baa51f-7fe9-456f-9301-e6be3d5cf4e8">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6019979522c14652baffb83a0302dc78_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMy04LTEtMS0w_9b8eade5-e0d8-4bcf-a5f9-f71c29b383ad">91.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6019979522c14652baffb83a0302dc78_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMy0xMC0xLTEtMA_d6697428-e204-4fc2-923e-ec5c09dfc3b8">77.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6019979522c14652baffb83a0302dc78_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMy0xMi0xLTEtMA_3e67bd31-aafd-4620-8ed9-fd81b868f7ea">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad348be44e784609b63102d7bd423e75_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNC0yLTEtMS0w_9ef597e8-11ec-4153-8576-df4638134470">31.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad348be44e784609b63102d7bd423e75_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNC00LTEtMS0w_2bf2bddb-9650-4cf3-8b48-4c3a50ec0ab2">13.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad348be44e784609b63102d7bd423e75_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNC02LTEtMS0w_0b037b6c-18ab-41bf-88eb-41e0f061f945">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a10116d504946cbab544899d14169f4_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNC04LTEtMS0w_19cd74ac-69ce-4529-a4ca-4bb68b1c3f62">59.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a10116d504946cbab544899d14169f4_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNC0xMC0xLTEtMA_da5684a6-477a-44dd-8d40-59119aebbe99">35.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a10116d504946cbab544899d14169f4_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNC0xMi0xLTEtMA_b6b53483-fdf0-420d-b7c9-1ad7a18787e8">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNS0yLTEtMS0w_3736a174-0d4c-4c3f-873b-4fde4944ee94">277.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNS00LTEtMS0w_90b475ed-86aa-4693-9909-25d1d4312455">200.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNS02LTEtMS0w_2072732a-5baf-43cc-88d0-dafe96ec1518">77.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNS04LTEtMS0w_c61fe2d3-f877-434e-9968-a49c475502d1">349.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNS0xMC0xLTEtMA_3ae78d29-74d6-41d3-b692-2d79ace3bda9">271.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNS0xMi0xLTEtMA_52aacae2-a14b-4199-b308-98edf86dedc9">77.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RleHRyZWdpb246NDk4ZTM2NmI2Y2Y3NDljZGFiZjUxODBmODI1NTA5NjhfOTg2_1e7c6dbc-5e4a-4aed-b720-84be12afb1ec">6.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RleHRyZWdpb246NDk4ZTM2NmI2Y2Y3NDljZGFiZjUxODBmODI1NTA5NjhfOTkz_da712581-ffee-4f6b-8f55-815ed617e57d">12.6</ix:nonFraction> million for the three months ended September&#160;30, 2021, and 2020, respectively. Amortization expense related to intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RleHRyZWdpb246NDk4ZTM2NmI2Y2Y3NDljZGFiZjUxODBmODI1NTA5NjhfMTEwMA_44ebb482-259e-4db6-ae13-292d799466cb">20.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RleHRyZWdpb246NDk4ZTM2NmI2Y2Y3NDljZGFiZjUxODBmODI1NTA5NjhfMTEwNw_151c91ce-7a62-4303-880f-d92efe5e2346">37.3</ix:nonFraction> million for the nine months ended September&#160;30, 2021, and 2020, respectively.</span></div><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RleHRyZWdpb246NDk4ZTM2NmI2Y2Y3NDljZGFiZjUxODBmODI1NTA5NjhfMTY0OA_e7595410-0d2d-47eb-9273-6ec4b576d08a" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future amortization expense related to intangible assets as of September&#160;30, 2021, is as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjYxMzNhZWEyYzc1MzRmMWI5NDUzNTAyZjFjNzI2OGRlL3RhYmxlcmFuZ2U6NjEzM2FlYTJjNzUzNGYxYjk0NTM1MDJmMWM3MjY4ZGVfMS0xLTEtMS0w_7d426d7a-459a-48ce-bf8a-253f2723d2d2">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjYxMzNhZWEyYzc1MzRmMWI5NDUzNTAyZjFjNzI2OGRlL3RhYmxlcmFuZ2U6NjEzM2FlYTJjNzUzNGYxYjk0NTM1MDJmMWM3MjY4ZGVfMi0xLTEtMS0w_e8042e25-d9ee-4ad1-a769-149e590f7df4">23.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjYxMzNhZWEyYzc1MzRmMWI5NDUzNTAyZjFjNzI2OGRlL3RhYmxlcmFuZ2U6NjEzM2FlYTJjNzUzNGYxYjk0NTM1MDJmMWM3MjY4ZGVfMy0xLTEtMS0w_8652cb66-3f47-428e-bc08-e48018ec938f">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjYxMzNhZWEyYzc1MzRmMWI5NDUzNTAyZjFjNzI2OGRlL3RhYmxlcmFuZ2U6NjEzM2FlYTJjNzUzNGYxYjk0NTM1MDJmMWM3MjY4ZGVfNC0xLTEtMS0w_ac107911-fa89-49d7-97bf-1128fe20986f">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjYxMzNhZWEyYzc1MzRmMWI5NDUzNTAyZjFjNzI2OGRlL3RhYmxlcmFuZ2U6NjEzM2FlYTJjNzUzNGYxYjk0NTM1MDJmMWM3MjY4ZGVfNS0xLTEtMS0w_18af67d4-e666-477c-be0d-6f7800420085">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="isrg:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjYxMzNhZWEyYzc1MzRmMWI5NDUzNTAyZjFjNzI2OGRlL3RhYmxlcmFuZ2U6NjEzM2FlYTJjNzUzNGYxYjk0NTM1MDJmMWM3MjY4ZGVfNi0xLTEtMS0w_7eac49a5-1fa4-4b52-b20d-ce5ea88e15dc">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjYxMzNhZWEyYzc1MzRmMWI5NDUzNTAyZjFjNzI2OGRlL3RhYmxlcmFuZ2U6NjEzM2FlYTJjNzUzNGYxYjk0NTM1MDJmMWM3MjY4ZGVfNy0xLTEtMS0w_ea168112-1399-463d-a226-4d200ae1adf1">77.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preceding expected amortization expense is an estimate. Actual amounts of amortization expense may differ from estimated amounts due to additional intangible asset acquisitions, measurement-period adjustments to intangible assets, changes in foreign currency exchange rates, impairments of intangible assets, accelerated amortization of intangible assets, and other events.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81Mi9mcmFnOjg5N2NlMWIyMTRiNTQ0YTc5NDdkZDE2MWZjYjNjOWU1L3RleHRyZWdpb246ODk3Y2UxYjIxNGI1NDRhNzk0N2RkMTYxZmNiM2M5ZTVfMTEyNjc_4cdf7f7c-8e4a-4f5c-8e88-01d04526b9f2" continuedAt="i756a8ac26c494714bf0505c8e6e830d7" escape="true">CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i756a8ac26c494714bf0505c8e6e830d7" continuedAt="ie547a44db6ea4450bf3523f9b56ca6bf"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is involved in a variety of claims, lawsuits, investigations, and proceedings relating to securities laws, product liability, intellectual property, insurance, contract disputes, employment, and other matters. Certain of these lawsuits and claims are described in further detail below. It is not possible to predict what the outcome of these matters will be, and the Company cannot guarantee that any resolution will be reached on commercially reasonable terms, if at all.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A liability and related charge to earnings are recorded in the Financial Statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to each case. Nevertheless, it is possible that additional future legal costs (including settlements, judgments, legal fees, and other related defense costs) could have a material adverse effect on the Company&#8217;s business, financial position, and future results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently named as a defendant in a number of individual product liability lawsuits filed in various state and federal courts. The plaintiffs generally allege that they or a family member underwent surgical procedures that utilized the da Vinci Surgical System and sustained a variety of personal injuries and, in some cases, death as a result of such surgery. Several of the filed cases have trial dates in the next 12 months.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cases raise a variety of allegations including, to varying degrees, that plaintiffs&#8217; injuries resulted from purported defects in the da Vinci Surgical System and/or failure on the Company&#8217;s part to provide adequate training resources to the healthcare professionals who performed plaintiffs&#8217; surgeries. The cases further allege that the Company failed to adequately disclose and/or misrepresented the potential risks and/or benefits of the da Vinci Surgical System. Plaintiffs also assert a variety of causes of action, including, for example, strict liability based on purported design defects, negligence, fraud, breach of express and implied warranties, unjust enrichment, and loss of consortium. Plaintiffs seek recovery for alleged personal injuries and, in many cases, punitive damages. The Company disputes these allegations and is defending against these claims.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimate of the anticipated cost of resolving the pending cases is based on negotiations with attorneys for the claimants. The final outcome of the pending lawsuits and claims, and others that might arise, is dependent on many variables that are difficult to predict, and the ultimate cost associated with these product liability lawsuits and claims may be materially different than the amount of the current estimate and accruals and could have a material adverse effect on the Company&#8217;s business, financial position, and future results of operations. Although there is a reasonable possibility that a loss in excess of the amount recognized exists, the Company is unable to estimate the possible loss or range of loss in excess of the amount recognized at this time.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Litigation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2017, Ethicon LLC, Ethicon Endo-Surgery, Inc., and Ethicon US LLC (collectively, &#8220;Ethicon&#8221;) filed a complaint for patent infringement against the Company in the U.S. District Court for the District of Delaware. The complaint, which was served on the Company on July 12, 2017, alleges that the Company&#8217;s EndoWrist</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stapler instruments infringe several of Ethicon&#8217;s patents. Ethicon asserts infringement of U.S. Patent Nos. 9,585,658, 8,479,969, 9,113,874, 8,998,058, 8,991,677, 9,084,601, and 8,616,431. A claim construction hearing occurred on October 1, 2018, and the court issued a scheduling order on December 28, 2018. On March 20, 2019, the court granted the Company&#8217;s Motion to Stay pending an Inter Partes Review to be held at the Patent Trademark and Appeals Board to review patentability of six of the seven patents noted above and vacated the trial date. On August 1, 2019, the court granted the parties&#8217; joint stipulation to modify the stay in light of Ethicon&#8217;s U.S. International Trade Commission (&#8220;USITC&#8221;) complaint against Intuitive involving U.S. Patent Nos. 8,479,969 and 9,113,874, discussed below.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 27, 2018, Ethicon filed a second complaint for patent infringement against the Company in the U.S. District Court for the District of Delaware. The complaint alleges that the Company&#8217;s SureForm 60 Staplers infringe five of Ethicon&#8217;s patents. Ethicon asserts infringement of U.S. Patent Nos. 9,884,369, 7,490,749, 8,602,288, 8,602,287, and 9,326,770. The Company filed an answer denying all claims. On March 19, 2019, Ethicon filed a Motion for Leave to File a First Amended Complaint, removing allegations related to U.S. Patent No. 9,326,770 and adding allegations related to U.S. Patent Nos. 9,844,379 and 8,479,969. On July 17, 2019, the court entered an order denying the amendment, without prejudice, and granting the parties&#8217; joint stipulation to stay the case in its entirety in light of the USITC investigation involving U.S. Patent Nos. 9,844,369 and 7,490,749, discussed below.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from these matters.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><ix:continuation id="ie547a44db6ea4450bf3523f9b56ca6bf"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 30, 2019, Ethicon filed a complaint with the USITC, asserting infringement of U.S. Patent Nos. 9,884,369 (&#8220;&#8217;369&#8221;), 7,490,749 (&#8220;&#8217;749&#8221;), 9,844,379 (&#8220;&#8217;379&#8221;), 9,113,874 (&#8220;&#8217;874&#8221;), and 8,479,969 (&#8220;&#8217;969&#8221;). On June 28, 2019, the USITC voted to institute an investigation (No. 337-TA-1167) with respect to the claims in this complaint. The accused products include the Company&#8217;s EndoWrist 30, EndoWrist 45, SureForm 45, and SureForm 60 Staplers, as well as the stapler reload cartridges. In March 2020, Ethicon dismissed its claims concerning the &#8217;749 patent. The evidentiary hearing took place in February 2021. On June 8, 2021, the Chief Administrative Law Judge issued an Initial Determination concluding that (1) the accused products do not infringe the asserted claims in the &#8217;874 or &#8217;969 patents; (2) the asserted claims in the &#8217;874 and &#8217;969 patents are invalid; (3) the accused SureForm staplers and associated reload cartridges infringe two claims of the &#8217;369 patent; (4) the accused SureForm staplers and associated reload cartridges infringe two claims of the &#8217;379 patent; and (5) the Company was estopped from contending that the asserted claims in the &#8217;379 patent are invalid. Ethicon has not challenged the Initial Determination with regard to the findings that absolve Intuitive of any liability regarding the accused EndoWrist staplers and associated reload cartridges. On October 14, 2021, the USITC issued its Opinion in which it made the following rulings: (1) the USITC absolved Intuitive from any liability regarding the &#8217;874, &#8217;969, and &#8217;369 patents; and (2) the USITC found that, while the SureForm staplers and their associated reload cartridges infringe the asserted claims in the &#8217;379 patent, it has suspended the imposition of any remedial order pending an opinion from the Federal Circuit Court of Appeal of whether the Patent and Trademark Office correctly found the asserted claims in this patent to be invalid. A lifting of the suspension of any remedial order by the USITC could result in a prohibition on importing the accused SureForm products into the U.S. or necessitating workarounds. Based on currently available information, the Company does not believe that any losses arising from this matter would be material.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Litigation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2019, Restore Robotics LLC and Restore Repair LLC (&#8220;Restore&#8221;) filed a complaint alleging anti-trust claims against the Company. On May 13, 2019, Restore filed an amended complaint alleging anti-trust claims relating to the da Vinci Surgical System and EndoWrist service, maintenance, and repair processes. On September 16, 2019, the Court partially granted and partially denied the Company&#8217;s Motion to Dismiss the amended complaint.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, the Company filed an answer denying the anti-trust allegations and filed a counterclaim against Restore. The Company filed amended counterclaims after the Court partially granted and partially denied Restore&#8217;s Motion to Dismiss the counterclaim. The amended counterclaims allege that Restore violated the Federal Lanham Act, the Federal Computer Fraud and Abuse Act, and Florida&#8217;s Deceptive and Unfair Trade Practices Act and that Restore is also liable to the Company for Unfair Competition and Tortious Interference with Contract. On January 7, 2020, the Court denied Restore&#8217;s Motion to Dismiss the amended counterclaims.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its initial scheduling order, the Court stated that it anticipated trial in this case to occur in or before February 2022. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from these matters.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, Rebotix Repair Inc. (&#8220;Rebotix&#8221;) filed a complaint alleging anti-trust claims against the Company relating to EndoWrist service, maintenance, and repair processes. The complaint was formally served on the Company on October 6, 2020. On March 8, 2021, the Court partially granted and partially denied the Company&#8217;s Motion to Dismiss the complaint. The Company filed an answer denying the anti-trust allegations and filed counterclaims against Rebotix. The counterclaims allege that Rebotix violated the Federal Lanham Act and Florida&#8217;s Deceptive and Unfair Trade Practices Act and that Rebotix is also liable to the Company for Tortious Interference with Contract.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Court stated that it anticipated trial in this case to occur in or around April 2022. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from this matter.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar to the claims asserted in the Restore case, on May 10, 2021, Surgical Instrument Service Company, Inc. (&#8220;SIS&#8221;) filed a complaint in the Northern District of California Court alleging anti-trust claims against the Company relating to EndoWrist service, maintenance, and repair processes. The Company filed a Motion to Dismiss on which a hearing was held on October 7, 2021. The Court has not yet issued an Order on this Motion to Dismiss. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from this matter.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three class action complaints were filed against the Company in the Northern District of California Court alleging anti-trust allegations relating to the service and repair of certain instruments manufactured by the Company. A complaint by Larkin Community Hospital was filed on May 20, 2021, a complaint by Franciscan Alliance, Inc. and King County Public Hospital District No. 1 was filed on July 6, 2021, and a complaint by Kaleida Health was filed on July 8, 2021. The Court has consolidated the Franciscan Alliance, Inc. and King County Public Hospital District No. 1 and Kaleida Health cases with the Larkin Community Hospital case, which is now captioned on the Larkin docket as &#8220;In Re: da Vinci Surgical Robot Antitrust Litigation.&#8221; A Consolidated Amended Class Action Complaint has been filed on behalf of each plaintiff named in the earlier-filed cases. The Company filed a Motion to Dismiss this Consolidated Amended Class Action Complaint on October 11, 2021. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from these matters.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RleHRyZWdpb246NDI0MWEzZGI3OTEzNDI1YmFhZjAxMDc0YjYzNDY1ODJfOTM2_590d6b53-1f7a-4380-a8ed-c0561a30a964" continuedAt="ifadb535a7ebc4619a7aab8564e7f761c" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="ifadb535a7ebc4619a7aab8564e7f761c" continuedAt="i63ad9e9a207742bdae2c4fecaf38cd81"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stockholders&#8217; Equity</span></div><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RleHRyZWdpb246NDI0MWEzZGI3OTEzNDI1YmFhZjAxMDc0YjYzNDY1ODJfOTMy_d57c8025-a018-4a98-88bf-3133ea9436de" continuedAt="if8f3ba40cfca423eb99194884e5f133e" escape="true"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the changes in stockholders&#8217; equity (in millions):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1d61c223bb747ee95152c8eee22b13c_I20210630" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMy0xLTEtMS0w_521cfd42-d94b-4359-8b2c-6ab941ad8464">356.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1d61c223bb747ee95152c8eee22b13c_I20210630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMy0zLTEtMS0w_259f3151-9eed-47ce-a06d-a9556bb13947">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice3d62c192824cc4b074c71a8ae80571_I20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMy01LTEtMS0w_5b71e6f4-52a7-466d-a057-7941107debf8">6,804.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e41b3c2e834c119d0176db2e8af060_I20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMy03LTEtMS0w_b9c79e45-295c-4bc8-b1b7-10b51b7bb92b">4,022.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17c6dd038d1e4e839081d843139db4ba_I20210630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMy05LTEtMS0w_5a993c22-20bb-42ff-a440-8637c9e52789">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18955016352d4c2f9c1114363b8cf2d5_I20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMy0xMS0xLTEtMA_b9beee9e-71f2-4dae-90e5-b386f450c5f4">10,837.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91f3018ef47c4b5fa0e52396465d7744_I20210630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMy0xMy0xLTEtMA_9572b0bb-ce0e-403b-b01c-de88dbd28a14">42.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecbbf0bac773402585e5625778664eaf_I20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMy0xNS0xLTEtMA_bee9607f-e663-4718-b950-490363f9d654">10,879.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d4217ee5ed9439ca27f0168c8e3920a_D20210701-20210930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNS0xLTEtMS0w_04ca6bd2-3752-48b2-bd58-e94fd600b05c">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a616a50f9f54a62a3dff6cc537b74d5_D20210701-20210930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNS01LTEtMS0w_5127c41e-3a52-480c-8c0a-86e52604576b">91.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f10f7a841b9428193c67c65a7651180_D20210701-20210930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNS0xMS0xLTEtMA_c9b1bb5d-0ff7-4e44-9f26-f9e4b1d5c0d3">91.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNS0xNS0xLTEtMA_1731deff-39ea-4033-8392-3e77ad66caff">91.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9d4217ee5ed9439ca27f0168c8e3920a_D20210701-20210930" decimals="-5" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNi0xLTEtMS0w_17afb613-8cdb-4959-899d-d5724f3c8166">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a616a50f9f54a62a3dff6cc537b74d5_D20210701-20210930" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNi01LTEtMS0w_9a5d704e-0238-48c0-be18-dac658f41061">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b4dddac366f478ba48b52ac99d622cd_D20210701-20210930" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNi03LTEtMS0w_e06b91fb-eaf4-4afb-bdf2-3569c4dfe926">13.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f10f7a841b9428193c67c65a7651180_D20210701-20210930" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNi0xMS0xLTEtMA_5c88230b-9863-44bc-9903-3a5708319865">13.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNi0xNS0xLTEtMA_07bd862d-bdc3-4606-b9b3-38ba7d9a692d">13.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a616a50f9f54a62a3dff6cc537b74d5_D20210701-20210930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNy01LTEtMS0w_82d9ae17-de70-4ba8-b6cc-242d3b931e85">120.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f10f7a841b9428193c67c65a7651180_D20210701-20210930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNy0xMS0xLTEtMA_a7579920-9b96-4c48-b1ab-55bec52724e7">120.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNy0xNS0xLTEtMA_1d7aca7c-a588-4b05-9cb8-f3c7f2ee1022">120.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b4dddac366f478ba48b52ac99d622cd_D20210701-20210930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfOS03LTEtMS0w_7fbd8345-194f-4d78-91c6-027deac09141">380.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f10f7a841b9428193c67c65a7651180_D20210701-20210930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfOS0xMS0xLTEtMA_533477eb-4954-4526-9d3b-3b894cd40461">380.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfOS0xNS0xLTEtMA_d841fb57-07d4-4b34-be6c-0f120d6f41e5">380.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0939772d62d942b796188dfdf7fcc61e_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTAtOS0xLTEtMA_d7540b13-d3de-48aa-b911-508ec106cec0">5.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f10f7a841b9428193c67c65a7651180_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTAtMTEtMS0xLTA_47d49fea-0e7c-44db-9e51-cf230ae094f9">5.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f38a035988a4b04bc207db50d81f2e6_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTAtMTMtMS0xLTA_fa1db570-f3a6-403e-a6dc-05f5ffb80203">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTAtMTUtMS0xLTA_33732aa9-3951-47c5-a1b2-b58a264627f3">5.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f38a035988a4b04bc207db50d81f2e6_D20210701-20210930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTItMTMtMS0xLTA_3b2c6bae-ff3b-45ed-a5d8-c1e3d1b262fe">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTItMTUtMS0xLTA_33b70a34-ec15-43c6-9e6b-b7355724b157">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7722e2881b60414b88d5e47e4ff0c212_I20210930" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTMtMS0xLTEtMA_ccfecffc-ea13-4bdc-bd52-a8aae4a4a8e5">357.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7722e2881b60414b88d5e47e4ff0c212_I20210930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTMtMy0xLTEtMA_45eba0c5-b202-4f2a-9586-d3ad89553e19">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b4985e5aab46088463bd2ea8c718c3_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTMtNS0xLTEtMA_16a3c1f6-c1e6-4cc9-b52b-232442fd7a4e">7,015.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i494c07d22f024c88948a992d708aea7e_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTMtNy0xLTEtMA_93cd05fa-ba0c-489e-93ee-ca51fae412cd">4,390.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4acd3901acf4471db1cf795db1c4a248_I20210930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTMtOS0xLTEtMA_23f6cdc5-2795-425b-a9aa-0f058aa68662">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib32048ff4ad6455287e4c2b2f78d13a1_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTMtMTEtMS0xLTA_8210fbb1-48a9-4978-a86f-3bb181d79d2e">11,410.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia693b8c7b00c4855b184870531142247_I20210930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTMtMTMtMS0xLTA_5890a6e8-79f9-44d3-b36f-f8c596523f69">48.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTMtMTUtMS0xLTA_7767e40d-a8bc-4c73-8303-fc3a3e0b4201">11,459.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:25.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i278f38b19568472ebae990bee1c0db33_I20200630" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMTgtMS0xLTEtMA_e60d3d01-805e-43c2-9c5c-d54bb9ef002f">351.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i278f38b19568472ebae990bee1c0db33_I20200630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMTgtMy0xLTEtMA_5eeb2235-789a-4adb-b260-ac7138456f48">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a1f00bb40df4d9597f66832f85ab8ef_I20200630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMTgtNS0xLTEtMA_cdcf4f38-7933-4efe-b71a-ee38e27bffa6">6,084.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7ef2803613641c69436d6aa1c5b43d6_I20200630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMTgtNy0xLTEtMA_15fa1439-5fbf-4c20-be3a-fe753e7bd7bc">2,633.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16ae1d800ab0420085daf458dee535a2_I20200630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMTgtOS0xLTEtMA_f623cd02-01ea-40d8-aad7-13a5ebb4744a">22.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6975f86655b24c28bb3402aa5c5ca96b_I20200630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMTgtMTEtMS0xLTA_e6993c3b-1036-45d8-8dc9-c67823da96e5">8,740.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29efc4bde4c9438ab296aa4811b7ca13_I20200630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMTgtMTMtMS0xLTA_ff11f655-f8b1-4bd8-9461-0e3f57ad8f12">25.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib780080ab3a8424fbe082969241fa1f5_I20200630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMTgtMTUtMS0xLTA_a83bc3c2-8cac-4c5c-ab12-b8f002622759">8,766.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i49309f63539141078a0b3ba243955ca1_D20200701-20200930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjAtMS0xLTEtMA_a13d6105-b21a-440d-afe3-4d44c69cae32">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbbd8d73ef944adc832fbdfb193e657e_D20200701-20200930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjAtNS0xLTEtMA_e3c28665-d429-4748-91fb-78ba7e534889">113.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacea1d90eb614cbba03fd2b9f5332772_D20200701-20200930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjAtMTEtMS0xLTA_d8714757-2be3-4762-acb2-ae12f4c70e0e">113.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjAtMTUtMS0xLTA_e85bad1a-2101-48bc-b5fe-ae6cd8ca74c8">113.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i49309f63539141078a0b3ba243955ca1_D20200701-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjEtMS0xLTEtMA_8a465b8d-aa12-46d1-9266-c5286d834558">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbbd8d73ef944adc832fbdfb193e657e_D20200701-20200930" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjEtNS0xLTEtMA_eaca6a10-2568-4ec5-b179-c9dd3cc97502">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91590958a4e84c3fba1738213a5cff5e_D20200701-20200930" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjEtNy0xLTEtMA_313dd7b1-abee-4fe6-a8bb-b7c913ad1578">9.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacea1d90eb614cbba03fd2b9f5332772_D20200701-20200930" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjEtMTEtMS0xLTA_ee526ac5-d252-4400-9286-db4fc6a45132">10.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjEtMTUtMS0xLTA_24a1e2ba-2035-4473-99de-c64f1bbb7eb4">10.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbbd8d73ef944adc832fbdfb193e657e_D20200701-20200930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjItNS0xLTEtMA_a6cc9658-845a-4627-be6e-96e8d23b8ce7">105.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacea1d90eb614cbba03fd2b9f5332772_D20200701-20200930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjItMTEtMS0xLTA_06b27646-1686-462c-af17-52df956fd7e5">105.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjItMTUtMS0xLTA_26c0e3ad-a449-41e8-bdba-58953b48af20">105.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91590958a4e84c3fba1738213a5cff5e_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjQtNy0xLTEtMA_5f6f0470-ffd2-4130-9e52-cfe7fe8d25b2">313.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacea1d90eb614cbba03fd2b9f5332772_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjQtMTEtMS0xLTA_934ea68f-87f2-4bcc-aca8-22d1ef485d31">313.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjQtMTUtMS0xLTA_e6f57f71-72cc-4623-bf54-74a141a44eb3">313.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08eb4b64387b42b3aac663f9c29cced9_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjUtOS0xLTEtMA_b5dff5bd-9748-47ad-8258-f18c6a72f30f">6.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacea1d90eb614cbba03fd2b9f5332772_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjUtMTEtMS0xLTA_2bc9a522-4995-41cb-8dc2-f2847df299d6">6.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie46138cc218c44bdab5454b674d97eb7_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjUtMTMtMS0xLTA_aadc967c-8074-4195-a874-39bc6957b99b">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjUtMTUtMS0xLTA_91b1302d-5354-4148-84c0-994f6187d65a">6.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie46138cc218c44bdab5454b674d97eb7_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjYtMTMtMS0xLTA_485011f8-f3bf-41c8-b346-8e2e0f961bb0">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjYtMTUtMS0xLTA_5ebfd6c1-c589-4cdb-b3e6-cb282993e7bb">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53f8ced32a444ff4b52e4928b94175dd_I20200930" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjctMS0xLTEtMA_4c9decf3-2be5-4b81-8b08-552b8fc0849f">352.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f8ced32a444ff4b52e4928b94175dd_I20200930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjctMy0xLTEtMA_7a47a836-2d03-480b-9437-ef3df3fc546f">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i879d429e085f447493c82a85ba62c318_I20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjctNS0xLTEtMA_bebc327c-6787-4756-8d8f-588fd39cab42">6,304.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i818cc058723f4fab9e6730e25fd2ff75_I20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjctNy0xLTEtMA_2833d51e-c429-413b-a249-f1e1593c23b8">2,937.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4abb28eb95f4310a27bcff42b173ed8_I20200930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjctOS0xLTEtMA_fd033ce5-1153-43bd-9921-9361eb652f12">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73ec9b1829e641dda129e28b2a310e58_I20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjctMTEtMS0xLTA_f8bfdf39-1214-4057-8f98-6bee3e9bc3dc">9,257.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22d1823a37a8412087b1432940f4c878_I20200930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjctMTMtMS0xLTA_cdac5620-32f8-4546-a091-fc2a3b24ae26">28.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id79ce19a534e4d139e67bf0750158934_I20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjctMTUtMS0xLTA_98c43d81-cf6f-4e64-bfb2-20ad29553092">9,286.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><ix:continuation id="i63ad9e9a207742bdae2c4fecaf38cd81" continuedAt="ic690f84b8fe941188add0dbec4b9faec"><ix:continuation id="if8f3ba40cfca423eb99194884e5f133e"><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:25.184%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.507%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.507%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.157%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42eb9966ff944cf086ee492f9ee5720c_I20201231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMy0xLTEtMS0w_e33bc23c-ad66-44b7-b668-5267080cd106">353.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42eb9966ff944cf086ee492f9ee5720c_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMy0zLTEtMS0w_9857717e-638e-4a25-80aa-802722f0903b">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298e438389654f6da638e3e8d14778e7_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMy01LTEtMS0w_590d60b2-29db-43ad-9ef1-3f85fa8eb56a">6,444.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ecdb391c0e74585907d8294c4b4d69e_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMy03LTEtMS0w_0e22671e-bb91-4e56-922c-b2fbda17bbd0">3,261.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac9eea68e98844389ba6177116b318aa_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMy05LTEtMS0w_0d5de4d2-2db1-4a51-98c4-0759a5da9483">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if74d89ff156145239e2267161cac4cd1_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMy0xMS0xLTEtMA_0009d5a9-f2e5-47c4-8486-01f86f27558a">9,731.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f0850dbce3d4403ad215d9950255074_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMy0xMy0xLTEtMA_97595645-b707-441b-a23e-df1fb3435328">27.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMy0xNS0xLTEtMA_7c140454-a389-4603-b0aa-56e4222b06a0">9,759.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icfef3e14f8544cecabe32b0486e9b751_D20210101-20210930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNS0xLTEtMS0w_6904e57e-a9e6-474f-ad22-bf1216f954b7">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f2fc119452d4229a0c5865465b20e5c_D20210101-20210930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNS01LTEtMS0w_cfd8db5a-c845-4695-a1a5-9cec28702fe8">244.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3578980607fc4e1dbb9e534383697716_D20210101-20210930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNS0xMS0xLTEtMA_43c50ddf-4d94-40bf-9068-4eb8e1c56863">244.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNS0xNS0xLTEtMA_9f3d098b-bd81-4a90-97a2-b8e0343b71f7">244.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="icfef3e14f8544cecabe32b0486e9b751_D20210101-20210930" decimals="-5" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNi0xLTEtMS0w_370ed213-8877-4f10-8156-698ef4861bff">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f2fc119452d4229a0c5865465b20e5c_D20210101-20210930" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNi01LTEtMS0w_06b5c847-1b5e-4a3d-962b-63354ca34854">6.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20ecaa1bd9224b37ba51ddb3346bde9b_D20210101-20210930" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNi03LTEtMS0w_e130939e-58d6-4f35-9321-f92624cb1a04">195.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3578980607fc4e1dbb9e534383697716_D20210101-20210930" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNi0xMS0xLTEtMA_2bccd5c4-a8de-439c-ad8d-97f16ae22239">201.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNi0xNS0xLTEtMA_f0d30b3a-ce79-4911-9f06-8cd196e006eb">201.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f2fc119452d4229a0c5865465b20e5c_D20210101-20210930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNy01LTEtMS0w_60b0100d-3c7a-43a0-8909-71d1d9a10d34">331.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3578980607fc4e1dbb9e534383697716_D20210101-20210930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNy0xMS0xLTEtMA_f3cdd27b-f3d8-4473-9de7-dfcc52851a41">331.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNy0xNS0xLTEtMA_99c317cc-62c3-4a15-a8ff-ed203ff35005">331.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20ecaa1bd9224b37ba51ddb3346bde9b_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfOS03LTEtMS0w_b158f6c6-f880-4177-8c2d-1cf4d55639e1">1,324.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3578980607fc4e1dbb9e534383697716_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfOS0xMS0xLTEtMA_d63220e1-74af-4ee0-9cdc-69575b766680">1,324.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfOS0xNS0xLTEtMA_13fb0b81-9c1f-4065-af9e-b7bc2ef07943">1,324.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida4fee943cff4029b9a8507c4a72da04_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTAtOS0xLTEtMA_4267d5bc-c45a-4ee4-b9e6-963fac96d748">19.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3578980607fc4e1dbb9e534383697716_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTAtMTEtMS0xLTA_e822a49d-1f96-4b95-a307-569cc30235bd">19.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a2ef2720e5d48859c0e54b81ae7ab52_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTAtMTMtMS0xLTA_1d385007-8929-466c-97ea-219cd5a23367">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTAtMTUtMS0xLTA_6b197f7a-262d-4e46-a220-c6dd19485380">20.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a2ef2720e5d48859c0e54b81ae7ab52_D20210101-20210930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTItMTMtMS0xLTA_b4328b4e-2b2e-40bc-a11c-838eecf9cb6e">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTItMTUtMS0xLTA_7d5031bd-bc31-42cb-bd52-9333987c4189">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7722e2881b60414b88d5e47e4ff0c212_I20210930" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTMtMS0xLTEtMA_dda48bad-da6b-462a-9a58-ab4f6e31a6ee">357.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7722e2881b60414b88d5e47e4ff0c212_I20210930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTMtMy0xLTEtMA_eb919975-054d-4516-9ada-9b6e15b9b4da">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b4985e5aab46088463bd2ea8c718c3_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTMtNS0xLTEtMA_7432f540-bb92-42db-8fd9-984156e687c5">7,015.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i494c07d22f024c88948a992d708aea7e_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTMtNy0xLTEtMA_a4bca302-12c7-45af-a139-6ce237c863e4">4,390.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4acd3901acf4471db1cf795db1c4a248_I20210930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTMtOS0xLTEtMA_d7d65681-e6e5-45f0-872a-b2f1a3b9e14e">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib32048ff4ad6455287e4c2b2f78d13a1_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTMtMTEtMS0xLTA_628314d5-11d3-4e19-b549-c923de653fda">11,410.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia693b8c7b00c4855b184870531142247_I20210930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTMtMTMtMS0xLTA_222a71e3-021b-4c5b-adfb-3237b34f8a0d">48.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTMtMTUtMS0xLTA_8e0c9044-1928-4e76-8c49-72ab11c1a458">11,459.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:25.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i23d7cb9591264bbe8dc96ff49f2da4c2_I20191231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTgtMS0xLTEtMA_2cf1a42b-3eb7-4ff6-a910-9ed0faf8ea98">347.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23d7cb9591264bbe8dc96ff49f2da4c2_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTgtMy0xLTEtMA_cc433c9d-1ee3-4dee-ae3b-386623c6cd48">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6da3e57aeb6d40558803471b05c62423_I20191231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTgtNS0xLTEtMA_3cf515d1-7075-44c9-b914-00429741a11b">5,756.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebe86d96c974e9995f2ab3c8bee539a_I20191231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTgtNy0xLTEtMA_11ae961f-f000-4167-aa62-de60c8103d9d">2,494.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia41fc6f9fdbc465a9ff6c912c6a47cc8_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTgtOS0xLTEtMA_d0ae223d-00e9-40d3-8920-a73f49f1973c">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if153039c790149ae84e26285a922687c_I20191231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTgtMTEtMS0xLTA_d690b740-f7f1-4649-8678-cefcb049e43d">8,263.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabc57ded48384f2291a996748a5d75e9_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTgtMTMtMS0xLTA_e3ad7dda-6a0a-4909-b9bc-76f217364fda">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452fc69ad0b4328b92b435105261628_I20191231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTgtMTUtMS0xLTA_97c2a132-7231-4e6a-85a7-ab39a2a301cf">8,284.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adoption of new accounting standard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bb77f1efb29470393902b43dc1a6d3b_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTktNy0xLTEtMA_4b752fe2-6c9f-4838-b062-b89b743e1dcc">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b9791a8b20a4038bdc81c09768ee380_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTktMTEtMS0xLTA_5ec23ba0-6cd1-42fc-9f41-3d1758c1c56e">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1f58decd61f48438b11935b7b7b714b_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTktMTUtMS0xLTA_32f6ba59-2a93-431f-b408-1ffa85fd5297">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb71bb2eb1d2412590a4afbcb608ddd3_D20200101-20200930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjAtMS0xLTEtMA_ce8b595f-142c-4537-a1cc-63c2f6098c32">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc1061d70ad5423599fbd327cc33d223_D20200101-20200930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjAtNS0xLTEtMA_38438af7-0300-42c0-af4c-95ab081b9f88">267.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c546426be6a4e028b9617594f0b1719_D20200101-20200930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjAtMTEtMS0xLTA_dddea9da-3fe2-43bd-9446-2b179130e6cf">267.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjAtMTUtMS0xLTA_4b9d66eb-a050-4996-b14c-04030d3247b1">267.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ieb71bb2eb1d2412590a4afbcb608ddd3_D20200101-20200930" decimals="-5" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjEtMS0xLTEtMA_a292e984-a331-4478-b7f7-789f22902371">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc1061d70ad5423599fbd327cc33d223_D20200101-20200930" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjEtNS0xLTEtMA_6408383e-1bf8-4b2a-a531-ba37e92e2b94">7.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a2243e61faf45dab6768e7f1d20f6ca_D20200101-20200930" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjEtNy0xLTEtMA_34de7a5e-1d96-419c-8f37-616cf81338eb">157.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c546426be6a4e028b9617594f0b1719_D20200101-20200930" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjEtMTEtMS0xLTA_3a0b23c0-9bc5-4d3a-ba6f-993ef0aca561">165.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjEtMTUtMS0xLTA_bf5a8dc9-ae00-4c6b-93c0-aab046eca066">165.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc1061d70ad5423599fbd327cc33d223_D20200101-20200930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjItNS0xLTEtMA_79d95c68-2f1e-4261-ad6a-297afc11d1bb">292.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c546426be6a4e028b9617594f0b1719_D20200101-20200930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjItMTEtMS0xLTA_87acb8ed-d6f8-457f-96a5-b86f1d44fb92">292.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjItMTUtMS0xLTA_c0a072b3-b227-4761-99c3-82d722f4b7cf">292.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ieb71bb2eb1d2412590a4afbcb608ddd3_D20200101-20200930" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjMtMS0xLTEtMA_0af93d4d-82bb-470d-8c38-e53e07e996ca">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb71bb2eb1d2412590a4afbcb608ddd3_D20200101-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjMtMy0xLTEtMA_5668d6c8-f9a0-4d53-825b-ec04a42c7316">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc1061d70ad5423599fbd327cc33d223_D20200101-20200930" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjMtNS0xLTEtMA_ee1d0a2e-2e23-4f50-9d31-f7f5d433e9aa">5.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a2243e61faf45dab6768e7f1d20f6ca_D20200101-20200930" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjMtNy0xLTEtMA_5e75b8a6-db0e-4e6a-9953-64e7e5a1fc5a">94.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c546426be6a4e028b9617594f0b1719_D20200101-20200930" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjMtMTEtMS0xLTA_ec9d66c3-7315-45c7-8fb1-83f8e6ce262c">100.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjMtMTUtMS0xLTA_9ff8f0c6-46d9-49d5-9e2a-a1e1b61aeafa">100.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a2243e61faf45dab6768e7f1d20f6ca_D20200101-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjQtNy0xLTEtMA_fdb9c809-9e25-4014-8f03-5571f8ff889a">695.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c546426be6a4e028b9617594f0b1719_D20200101-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjQtMTEtMS0xLTA_e7255aba-e244-4db1-9af9-f173ef0b62c6">695.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjQtMTUtMS0xLTA_7a3b0324-1743-45a0-8b15-7a555fe61626">695.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a19e6703be642579f343e142e25ceb2_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjUtOS0xLTEtMA_2cefdd24-b0a4-48ac-b09d-6840c8f374ee">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c546426be6a4e028b9617594f0b1719_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjUtMTEtMS0xLTA_ba9fe4bc-b421-4c1c-81dc-e674e3e145fe">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd3fcfe8635544479553199fd6d5870b_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjUtMTMtMS0xLTA_197dab37-75a8-4bcc-b0e0-85ad78c2643a">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjUtMTUtMS0xLTA_f688bb62-bd9d-4d50-823d-3b0c3c36cabe">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd3fcfe8635544479553199fd6d5870b_D20200101-20200930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjYtMTMtMS0xLTA_4717dac8-2749-44de-89ea-23ee96f4cf17">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjYtMTUtMS0xLTA_094a1274-9667-43c7-a39c-2964e15ded1b">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53f8ced32a444ff4b52e4928b94175dd_I20200930" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjctMS0xLTEtMA_22c479a9-6af0-41a1-b05a-52e292d79b14">352.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f8ced32a444ff4b52e4928b94175dd_I20200930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjctMy0xLTEtMA_553fff36-8b44-4bec-a18f-3d0ffbf48765">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i879d429e085f447493c82a85ba62c318_I20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjctNS0xLTEtMA_7de03433-fac5-4a20-98cd-99138e69b519">6,304.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i818cc058723f4fab9e6730e25fd2ff75_I20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjctNy0xLTEtMA_bcd60036-efe4-4c04-a422-2566207982b1">2,937.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4abb28eb95f4310a27bcff42b173ed8_I20200930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjctOS0xLTEtMA_f32372c6-ecbc-4c92-8fa4-ba688a73dfd1">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73ec9b1829e641dda129e28b2a310e58_I20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjctMTEtMS0xLTA_878d356f-3c4c-44e7-8cc7-c9c0505d9190">9,257.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22d1823a37a8412087b1432940f4c878_I20200930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjctMTMtMS0xLTA_80c4234e-7f37-4206-bfc2-29637f381d71">28.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id79ce19a534e4d139e67bf0750158934_I20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjctMTUtMS0xLTA_d5654c2f-9a60-45fc-9cf0-55febdf617ef">9,286.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Board of Directors (the &#8220;Board&#8221;) has authorized an aggregate of&#160;$<ix:nonFraction unitRef="usd" contextRef="ibbc28f1ab9984d34933140b676cdeda5_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RleHRyZWdpb246NDI0MWEzZGI3OTEzNDI1YmFhZjAxMDc0YjYzNDY1ODJfMjQ2_b2817742-9e53-4239-aff3-c5126b4f7797">7.5</ix:nonFraction> billion of funding for the Company&#8217;s common stock repurchase program (the &#8220;Repurchase Program&#8221;) since its establishment in March 2009. The most recent authorization occurred in January 2019 when the Board increased the authorized amount available under the Repurchase Program to&#160;$<ix:nonFraction unitRef="usd" contextRef="ibb62ec09022f420caf06b91fbe4483c6_I20190131" decimals="INF" format="ixt:num-dot-decimal" name="isrg:StockRepurchaseProgramincreasedtoauthorizedamount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RleHRyZWdpb246NDI0MWEzZGI3OTEzNDI1YmFhZjAxMDc0YjYzNDY1ODJfNTIw_aa468f03-2824-45ff-ba93-eba5e20def0e">2.0</ix:nonFraction> billion. As of September&#160;30, 2021, the remaining amount of share repurchases authorized by the Board was $<ix:nonFraction unitRef="usd" contextRef="ibbc28f1ab9984d34933140b676cdeda5_I20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RleHRyZWdpb246NDI0MWEzZGI3OTEzNDI1YmFhZjAxMDc0YjYzNDY1ODJfNjA0_c9bfc8c9-1228-4655-b543-6c1bc8cee2aa">1.6</ix:nonFraction> billion.</span></div><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RleHRyZWdpb246NDI0MWEzZGI3OTEzNDI1YmFhZjAxMDc0YjYzNDY1ODJfOTQ3_2541cde8-b6e6-4d51-ab99-39fed54292b9" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides share repurchase activities (in millions, except per share amounts):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i45ed2df55a904b73a9495b2d3967029c_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfMi0xLTEtMS0w_758247b7-fba4-45cb-af5b-64ef75cfe4f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4dc58ace2562461ab1b5006b2f252b53_D20200701-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfMi0zLTEtMS0w_99d7654b-101e-4d19-8562-ab959efa2d22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i553f65ed4f294d7bbb0fb4e0b36c4669_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfMi01LTEtMS0w_c75bc6a1-306d-405c-af2b-05e3f5df2c93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id90bdf528ea1473fb22ba73a9cf8fec7_D20200101-20200930" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfMi03LTEtMS0w_39e3ec30-7643-40b3-be5c-e5b2484be373">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i45ed2df55a904b73a9495b2d3967029c_D20210701-20210930" decimals="2" format="ixt:fixed-zero" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfMy0xLTEtMS0w_5a233a87-1035-4520-9e78-b1d8218aa776">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4dc58ace2562461ab1b5006b2f252b53_D20200701-20200930" decimals="2" format="ixt:fixed-zero" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfMy0zLTEtMS0w_d3082747-8a48-459a-ad9d-25e247fc3770">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i553f65ed4f294d7bbb0fb4e0b36c4669_D20210101-20210930" decimals="2" format="ixt:fixed-zero" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfMy01LTEtMS0w_932d9d16-5862-4905-b45c-668927477c4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id90bdf528ea1473fb22ba73a9cf8fec7_D20200101-20200930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfMy03LTEtMS0w_9d7f98b5-65ef-4d94-8a7b-688c9cc81510">173.94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45ed2df55a904b73a9495b2d3967029c_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfNC0xLTEtMS0w_800e54c0-abb4-4890-83f2-4f6acc56d496">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dc58ace2562461ab1b5006b2f252b53_D20200701-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfNC0zLTEtMS0w_69214de3-f20b-4742-ba2a-5a933b3de241">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553f65ed4f294d7bbb0fb4e0b36c4669_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfNC01LTEtMS0w_ec3bd792-b6da-4bfe-9b5f-19a68db48154">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id90bdf528ea1473fb22ba73a9cf8fec7_D20200101-20200930" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfNC03LTEtMS0w_e4792a93-6d8c-4506-957f-a27c060ff9f1">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><ix:continuation id="ic690f84b8fe941188add0dbec4b9faec" continuedAt="i9a59b81d40cb4ee3b4b8cc206686a227"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss), Net of Tax, Attributable to Intuitive</span></div><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RleHRyZWdpb246NDI0MWEzZGI3OTEzNDI1YmFhZjAxMDc0YjYzNDY1ODJfOTM1_4b88d478-36b8-469c-929e-9c1d416b147a" continuedAt="i3d0ea60d1e8945a9a4e9b1955ca23222" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive income (loss), net of tax, attributable to Intuitive are as follows (in millions):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:41.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecbbf0bac773402585e5625778664eaf_I20210630" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMi0xLTEtMS0w_8fc46793-7e48-4cb1-a61b-ea8176e7b9a7">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecbbf0bac773402585e5625778664eaf_I20210630" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMi0zLTEtMS0w_a1519d38-2f8d-4b41-836d-e548546a7adf">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecbbf0bac773402585e5625778664eaf_I20210630" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMi01LTEtMS0w_ea3e93a9-a597-4377-a99a-728ec4461384">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecbbf0bac773402585e5625778664eaf_I20210630" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMi03LTEtMS0w_e803e38a-2f8f-49e7-b1da-6f79d0622d8d">6.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecbbf0bac773402585e5625778664eaf_I20210630" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMi05LTEtMS0w_b30500e4-e627-4dd6-b041-6b33f6e43f95">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMy0xLTEtMS0w_cbb8e529-830d-4705-94bb-f3ed437cd945">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMy0zLTEtMS0w_013e351d-a5cc-4dad-a58e-d7d59533cc78">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMy01LTEtMS0w_a6e37453-b72e-41ed-9c70-9ac7b5676324">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMy03LTEtMS0w_bfa13d4b-b651-4b83-b9ac-de8e810285ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" sign="-" name="isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMy05LTEtMS0w_a172977f-b1a4-4edc-b40f-5e5f7758382e">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNC0xLTEtMS0w_4931ec5d-d2a3-4199-8cd9-b6278257114a">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNC0zLTEtMS0w_e959eda0-8d55-4177-9274-50107b18852d">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNC01LTEtMS0w_7f9061c5-ac20-4a48-9f22-b783abe876d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNC03LTEtMS0w_b7ecaa3f-a686-4676-8fb7-2a223cdd9abb">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNC05LTEtMS0w_e06c7328-2b83-4cd2-903c-2522c421a5ef">3.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNS0xLTEtMS0w_bb6e375b-1154-4f70-98e9-2a391c528ee2">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNS0zLTEtMS0w_e621bf12-a2ce-4f3e-a427-2ac7af8c063b">4.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNS01LTEtMS0w_5ac1d26f-8db4-4f20-bbbf-15e1ac2a0d85">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNS03LTEtMS0w_fee334ad-dc5c-4ff1-a0d5-ad4d3fd40dce">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNS05LTEtMS0w_fdc46e77-f8a2-4549-8781-73d2fc27cfea">5.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNi0xLTEtMS0w_ebb6d59f-26c9-485b-8330-424873c2ebd5">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNi0zLTEtMS0w_bee0fffe-2e38-44f9-bf9e-47ee38026d4c">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNi01LTEtMS0w_b65b6083-3d36-4914-b40c-ac5bce819e16">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNi03LTEtMS0w_30ad3090-853a-48d4-8569-414300acef37">6.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNi05LTEtMS0w_aecfa2ab-008d-438a-93ce-1c5207c3c1cc">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:41.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib780080ab3a8424fbe082969241fa1f5_I20200630" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMi0xLTEtMS0w_9154af80-d7cc-4958-b586-4f9c5610409f">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib780080ab3a8424fbe082969241fa1f5_I20200630" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMi0zLTEtMS0w_2bbc170c-17c1-4b86-9f1c-12e30d80fc62">44.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib780080ab3a8424fbe082969241fa1f5_I20200630" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMi01LTEtMS0w_3148c7d2-b3a1-46ee-939a-3c5c4d01664a">13.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib780080ab3a8424fbe082969241fa1f5_I20200630" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMi03LTEtMS0w_14196076-a69b-4b30-bff1-f04c70beb790">8.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib780080ab3a8424fbe082969241fa1f5_I20200630" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMi05LTEtMS0w_ee72ba17-1c35-44bb-abb6-9c643ccf9a21">22.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMy0xLTEtMS0w_0396c641-ee4b-434d-b1ad-516a03473e67">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMy0zLTEtMS0w_01c3bd60-9aec-404a-b34b-72f2912329c4">7.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMy01LTEtMS0w_c3cb7e87-4513-47f4-9be9-8e7ba374899d">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMy03LTEtMS0w_7bbeded0-0f82-4a18-8f42-116c2ec72712">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" sign="-" name="isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMy05LTEtMS0w_8cfe1a29-e66a-467a-a7b2-74c78677b29a">5.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNC0xLTEtMS0w_f495eaee-9cd0-4b90-9690-5a7b4c52219e">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNC0zLTEtMS0w_2893cb6b-96cc-471f-809d-f8f8846c6ff1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNC01LTEtMS0w_5ab60dc7-63f1-48a2-9244-5ddaad6b02a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNC03LTEtMS0w_9aff0843-57f3-48ea-9dfc-b25ac8f57572">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNC05LTEtMS0w_71a21289-47cc-44cb-8309-2e77a72e8872">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNS0xLTEtMS0w_8306a080-bffe-4a9a-8515-5ae9680816b9">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNS0zLTEtMS0w_3be31afc-dd95-4dbc-8772-b13855a8f9a8">7.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNS01LTEtMS0w_3d3eaa89-7848-4708-b591-079d49aed159">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNS03LTEtMS0w_f91021a8-17a6-44d5-942f-114d1e32934e">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNS05LTEtMS0w_1303ab7b-a980-412a-b82c-22cb6d9b060d">6.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id79ce19a534e4d139e67bf0750158934_I20200930" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNi0xLTEtMS0w_c2ffde01-73ca-4456-a237-313fccf5c1a8">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id79ce19a534e4d139e67bf0750158934_I20200930" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNi0zLTEtMS0w_2ca62957-a04e-4980-8937-3597ec9f009a">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id79ce19a534e4d139e67bf0750158934_I20200930" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNi01LTEtMS0w_6dbafb5b-8291-44e3-8e32-9bcc6201ea5f">11.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id79ce19a534e4d139e67bf0750158934_I20200930" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNi03LTEtMS0w_d806f3d4-c4ee-4628-990b-82508019e6d7">8.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id79ce19a534e4d139e67bf0750158934_I20200930" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNi05LTEtMS0w_04557101-d9c7-42ce-8918-2ce70273f9c8">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:41.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMi0xLTEtMS0w_16ecab9d-7cd7-4699-a62e-f75917040a10">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMi0zLTEtMS0w_366aa76f-eeb8-4930-bf44-b339375f1385">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMi01LTEtMS0w_9d479a35-53a5-485a-814a-45ce70f29791">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMi03LTEtMS0w_24733c9a-8b75-47e3-8ec8-3d925e8af6f2">6.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMi05LTEtMS0w_4d24c182-8087-4231-b324-02c1134b04fa">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMy0xLTEtMS0w_c5ae492e-199a-47a5-9a6a-fd340a436010">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMy0zLTEtMS0w_5fdac6a9-77d5-426b-b9ed-4520b5cba905">19.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMy01LTEtMS0w_842ab3cd-bb6c-427e-a67e-0abe21dac0d7">7.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMy03LTEtMS0w_ada22512-0a5e-453b-a326-e534c38e22f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" sign="-" name="isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMy05LTEtMS0w_7e341f9b-692c-48fc-90e2-936967e21c3b">17.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNC0xLTEtMS0w_bb783325-7bb8-470c-aaf1-2ffb9fd402fc">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNC0zLTEtMS0w_d23daaf9-9e2d-4836-b545-aae059839f4d">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNC01LTEtMS0w_91b4f8fe-768c-4f0c-b2d8-09ebd3dd1fee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNC03LTEtMS0w_bfb3f346-9d22-4aae-a9c5-9b53bee0f700">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNC05LTEtMS0w_c93e3e91-a5e2-4477-832f-aed462c7765d">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNS0xLTEtMS0w_34fafe2f-43d1-4c96-bfbe-43949eb2b3f6">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNS0zLTEtMS0w_56929605-7a27-4c0e-8d69-3f49c4cef1cc">20.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNS01LTEtMS0w_8f6152e9-eaff-4363-b2d4-18aa95717718">7.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNS03LTEtMS0w_b2303cea-788c-4f4b-936d-8a202529cf9e">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNS05LTEtMS0w_251ac0c3-03a1-4ec9-9c86-ef34b2e63822">19.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNi0xLTEtMS0w_e760a8f1-029a-4c4a-ac22-e898ec0c2798">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNi0zLTEtMS0w_e31f9240-2e1a-4523-b189-296c20d9662a">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNi01LTEtMS0w_078703ab-3275-41c7-b31f-86900f2ad8a1">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNi03LTEtMS0w_d31ab049-9abc-4f60-98dd-d81f0aa171de">6.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNi05LTEtMS0w_40a57ce7-f354-4f95-b251-8a3f1cdd8555">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="i9a59b81d40cb4ee3b4b8cc206686a227"><ix:continuation id="i3d0ea60d1e8945a9a4e9b1955ca23222"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:41.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452fc69ad0b4328b92b435105261628_I20191231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMi0xLTEtMS0w_9e9c5046-1bb5-452e-b9ea-7e057ed486cd">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452fc69ad0b4328b92b435105261628_I20191231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMi0zLTEtMS0w_aa183819-66ff-4e58-8d0b-3eb64bd777b7">20.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452fc69ad0b4328b92b435105261628_I20191231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMi01LTEtMS0w_51b9208f-a447-4899-b33c-6844df7ea938">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452fc69ad0b4328b92b435105261628_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMi03LTEtMS0w_3d865b18-3cc1-42a8-aa98-4b11c5340ccc">8.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452fc69ad0b4328b92b435105261628_I20191231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMi05LTEtMS0w_a76d6e7c-0d90-488a-baaf-11695cd38980">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMy0xLTEtMS0w_4a8a2d56-3ee9-474b-ae9f-5c91625fbadc">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMy0zLTEtMS0w_f1b95946-595e-4caa-9a87-2a19cd97411c">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMy01LTEtMS0w_80f74221-1246-45b9-bd67-9193749f6794">11.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMy03LTEtMS0w_84fd2817-4c72-4167-87f7-860dc848619c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMy05LTEtMS0w_7bbe4804-7b48-4ceb-b3c8-2153010704e6">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNC0xLTEtMS0w_c9c30745-f4de-43a9-9aed-66493cf2101c">3.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNC0zLTEtMS0w_acc0585b-1c3f-4b06-b86a-521ba85f50aa">4.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNC01LTEtMS0w_3f44fdc6-4e45-4683-8384-7b540111478f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNC03LTEtMS0w_b331576e-f58c-4744-b49f-6b734c69f986">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNC05LTEtMS0w_71d7b037-8534-4aa3-9da1-1545c85a1607">7.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNS0xLTEtMS0w_7b24c4d0-446a-44a5-8c3b-cc4ca181c123">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNS0zLTEtMS0w_21f0824f-3c24-4965-8435-4c95fe666037">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNS01LTEtMS0w_a4621318-99a6-4293-93d4-a257992e92ba">11.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNS03LTEtMS0w_81dfb4e5-8ec9-4dfb-a368-5ae8adb7a8ab">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNS05LTEtMS0w_bcb8c1d1-f803-46ff-8792-2c92dd655543">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id79ce19a534e4d139e67bf0750158934_I20200930" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNi0xLTEtMS0w_de6ecb6f-aa82-430a-a3bf-3d952fe16456">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id79ce19a534e4d139e67bf0750158934_I20200930" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNi0zLTEtMS0w_d44e5c02-5386-4fad-8606-784373856bf5">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id79ce19a534e4d139e67bf0750158934_I20200930" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNi01LTEtMS0w_3bcb4e17-e48f-46cb-a752-f3988083a4d5">11.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id79ce19a534e4d139e67bf0750158934_I20200930" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNi03LTEtMS0w_1ca142a1-4b51-49a6-af8a-0f39bbc0ccd7">8.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id79ce19a534e4d139e67bf0750158934_I20200930" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNi05LTEtMS0w_9fd4f303-83ca-41a7-a2cd-c5dfccb779e0">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div id="i944f300b8c29463aa56139ed7eaca296_58"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTg0Nw_c66ca445-e8e5-45a6-b4b6-310223be3b55" continuedAt="ibdc8cefbbb1c4c24b62dd21002fecce9" escape="true">SHARE-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="ibdc8cefbbb1c4c24b62dd21002fecce9" continuedAt="i7118fdb0f6494897b1bd486382cd8c4b"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company&#8217;s shareholders approved an amended and restated 2010 Incentive Award Plan to provide for an increase in the number of shares of common stock reserved for issuance thereunder from <ix:nonFraction unitRef="shares" contextRef="i2ec0403c801644f7b94ced14e5abe91e_I20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMjQ1_066a770d-8853-497d-8e27-082d1a954531">32,450,000</ix:nonFraction> to <ix:nonFraction unitRef="shares" contextRef="i3ba50cc2545940ee9b0e537bcee9fecb_I20210430" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMjUx_012c1c97-6d6f-4481-bb9c-896e4292ac27">34,450,000</ix:nonFraction> (or, after giving effect to the Stock Split, <ix:nonFraction unitRef="shares" contextRef="i90d117c8ce8b4a12a61bca2bc0d175ea_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="isrg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTA5OTUxMTYyOTgwMA_a8a49296-5014-4ebf-ba95-1dea7889f98d">97,350,000</ix:nonFraction> to <ix:nonFraction unitRef="shares" contextRef="i3a351862876548c3806015af800a7f8b_I20210430" decimals="-3" format="ixt:num-dot-decimal" name="isrg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTA5OTUxMTYyOTc4Nw_c3ad517b-f069-4e52-8b44-f7e248e2761c">103,350,000</ix:nonFraction>). As of&#160;September&#160;30, 2021, approximately&#160;<ix:nonFraction unitRef="shares" contextRef="i120ec0e7f5d74c85a3c972e2814bae13_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMjc5_84e164f0-1e30-4a48-9580-7fd5142b5b98">25.5</ix:nonFraction> million&#160;shares were reserved for future issuance under the Company&#8217;s stock plans. A maximum of approximately&#160;<ix:nonFraction unitRef="shares" contextRef="i24b8332d62be4e67924e1b675742a795_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMzgz_655515bb-fea4-49c1-97e7-fdc161b1f3cf">11.1</ix:nonFraction> million&#160;of these shares can be awarded as restricted stock units (&#8220;RSUs&#8221;).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Option Information</span></div><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTg1OA_d8cb0e42-2633-4f0d-8423-4bcd4cadab98" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity under all stock plans for the nine months ended September&#160;30, 2021, is presented as follows (in millions, except per share amounts):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:70.118%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options Outstanding</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Exercise&#160;Price Per<br/>Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfMi0yLTEtMS0w_acb7db50-ce21-47f9-9518-3390db250bc7">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfMi00LTEtMS0w_a9b5ed28-632c-4d9e-a331-4c9b7514bf01">101.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfNC0yLTEtMS0w_c84cfff8-ce21-45f8-b62c-de3b5e2b22cd">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfNC00LTEtMS0w_79f7fde3-e979-4366-89d9-33a4b3fb752a">294.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfNS0yLTEtMS0w_a937113e-9544-4695-b987-c6b4de0a2f12">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfNS00LTEtMS0w_5813f6bc-e288-4a51-8ce1-c4c2383ecbbe">74.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited/expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfNi0yLTEtMS0w_9e740a9e-9365-417f-a369-264d0bce0206">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfNi00LTEtMS0w_5893ab18-a6fa-4229-bad7-82bca99458c0">194.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfNy0yLTEtMS0w_9571cc6f-1bf6-4bf8-acb8-faf3569db966">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfNy00LTEtMS0w_56f99769-4339-4b3c-b607-c9aeabad0cc0">123.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, options to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfNjc2_5495ac56-e993-41f5-9a00-6d20ceeaab6f">9.5</ix:nonFraction> million shares of common stock were exercisable at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfNzUw_803ae584-a1e8-4375-88dc-c32fc34a0850">94.76</ix:nonFraction> per share.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units Information</span></div><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTg0NQ_a8db68bc-b6a4-468e-aa89-3291b0cf5607" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSUs activity under all stock plans for the nine months ended September&#160;30, 2021, is presented as follows (in millions, except per share amounts):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i027fee4566074a4f9475d1aa2d3fbb42_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfMS0xLTEtMS0w_d58af212-67c3-4679-b510-af592fc82354">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i027fee4566074a4f9475d1aa2d3fbb42_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfMS0zLTEtMS0w_9c1b3c76-777e-4946-b62a-321f423ddd3b">163.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4414a789bd34fbebcd0395bb363b24f_D20210101-20210930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfMi0xLTEtMS0w_9fac5c42-77cd-493c-9572-57aa80e529c5">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if4414a789bd34fbebcd0395bb363b24f_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfMi0zLTEtMS0w_50f117b3-02dd-42ae-8771-9f66278d82ba">252.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if4414a789bd34fbebcd0395bb363b24f_D20210101-20210930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfMy0xLTEtMS0w_a238291b-e8cb-489f-845c-e9af70480ee3">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if4414a789bd34fbebcd0395bb363b24f_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfMy0zLTEtMS0w_42ab9e00-8e7a-40ab-a7a3-84c62a231fb6">144.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if4414a789bd34fbebcd0395bb363b24f_D20210101-20210930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfNC0xLTEtMS0w_ff8c1659-a3bf-4f8a-a7b7-701a2eaf23f1">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if4414a789bd34fbebcd0395bb363b24f_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfNC0zLTEtMS0w_307949cd-e92f-4e2e-a408-4a0667a118da">191.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4ac96970f42e4066a4c840390044d4b5_I20210930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfNS0xLTEtMS0w_4280d6a0-3b29-4605-93a7-ca0d84486436">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4ac96970f42e4066a4c840390044d4b5_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfNS0zLTEtMS0w_44199b24-5f7d-4c12-96ad-7d47ec32eb3b">204.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Employee Stock Purchase Plan (&#8220;ESPP&#8221;), employees purchased approximately <ix:nonFraction unitRef="shares" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTA1NQ_3dc6ec0a-0469-47f1-a9f5-abfe92e914fc">0.5</ix:nonFraction> million shares for $<ix:nonFraction unitRef="usd" contextRef="i92cbadc1b4dc43c78d9b42fe98dc9359_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTA2OQ_fcabf121-cbfd-4eff-a323-b68ac81d8a21">75.9</ix:nonFraction> million and approximately <ix:nonFraction unitRef="shares" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTA5MA_645912af-4129-4c94-8e76-e6a5630ca56d">0.5</ix:nonFraction> million shares for $<ix:nonFraction unitRef="usd" contextRef="i97592680c7ea4d0c98add45dc8ac42d6_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTEwNA_6c25c166-365a-460e-9571-9dc8ff5675d9">71.2</ix:nonFraction> million during the nine months ended September&#160;30, 2021, and 2020, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><ix:continuation id="i7118fdb0f6494897b1bd486382cd8c4b"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation Expense</span></div><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTg3OQ_8380cbfc-e28f-48d6-8505-33060add365e" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes share-based compensation expense for the three and nine months ended September&#160;30, 2021, and 2020 (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.771%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales &#8211; products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3dc8c8c90db4f51afb0d492dbb4b82e_D20210701-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfMi0xLTEtMS0w_88057c93-102f-4ccf-9393-9056fd0ecc94">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53ae1d88875d4f12a62bc03a44e1b07f_D20200701-20200930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfMi0zLTEtMS0w_1386eaa9-f204-40b9-bd68-e5a2d593bc5c">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie24d4b4f022c47c9803198a89abebb1c_D20210101-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfMi01LTEtMS0w_7c0dc14a-1245-4c0d-8984-7b2f7ec85304">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553935c5696341248be4dde6c6466dc1_D20200101-20200930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfMi03LTEtMS0w_77a8fd94-f1a8-4160-8281-cfdfdc63564d">43.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales &#8211; services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i636e52596b904d9aabe71c6e5c662679_D20210701-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfMy0xLTEtMS0w_6c33818b-d828-4080-ba1d-319993bbfee7">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fcd59b1068d47cba389bdf071fe2a4a_D20200701-20200930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfMy0zLTEtMS0w_c267e045-7667-487d-a62d-9f6a11615b33">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f6cbcbf701a42bf9968bf5dc8e400e2_D20210101-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfMy01LTEtMS0w_ebfb55f1-c178-43f6-8358-51a930f3de75">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5299dae533374f869f3916eb74f78a0d_D20200101-20200930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfMy03LTEtMS0w_fcba0c86-97b9-4b39-ad2f-278825abee6f">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ec5af0dc794a8b819199e06c9c7e0e_D20210701-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNC0xLTEtMS0w_2c191661-2bd3-4ebf-b5ff-2ad18f16358d">25.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0e0073a5326490ca14b42218c217b9a_D20200701-20200930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNC0zLTEtMS0w_071923c9-4ec6-4196-a0af-4e8698d90cbd">23.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic17eef63e1f745a382c154accc3d123e_D20210101-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNC01LTEtMS0w_6de8679f-4e54-4e37-9aa3-c6e0a2708a36">67.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec5a6bdd4379479bbf40a5d7ea2ea843_D20200101-20200930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNC03LTEtMS0w_7615e901-32ee-417c-9609-3f9b1bb3dd54">60.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8e8ca8a5314cf29b3f0cd00926ccf6_D20210701-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNS0xLTEtMS0w_d6109182-f16c-484e-b643-31e4d40a050e">62.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5991df12b084f31a3209fb60aac8919_D20200701-20200930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNS0zLTEtMS0w_32693881-852a-470f-8fd8-98ae9dfc4281">54.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bdc2cf5e4434be7a2c05799c2f073a0_D20210101-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNS01LTEtMS0w_71337bfb-721e-48ef-bcd9-195b1ece1ce6">171.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98c2152fa284185b7a3eec1e86e9308_D20200101-20200930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNS03LTEtMS0w_1105571e-e791-4ea6-a85d-89832dccd5c1">149.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida259e2fffb84c6daef0d3ae72179664_D20210701-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNi0xLTEtMS0w_79682929-a639-486e-aaec-573ffacb3c71">35.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17cd59475f274e609d82992c047d3bef_D20200701-20200930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNi0zLTEtMS0w_23dceb9c-bb2a-480c-9f48-51554346d213">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf5c832845ad43ffaae3030609897c12_D20210101-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNi01LTEtMS0w_d80ad783-0879-439d-a21b-5dcfd89d4f0a">98.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fc23134d92414983b8c9ffd7172fcc_D20200101-20200930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNi03LTEtMS0w_81e42d04-43ca-478c-b681-3aa42abf9abc">84.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNy0xLTEtMS0w_03d64587-365b-4fef-9751-c3974635f2ae">122.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNy0zLTEtMS0w_3e476ffe-0d67-483b-b0f5-64dd48fbea95">107.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNy01LTEtMS0w_e230c2fa-4366-477c-925e-460bc9c2e30e">337.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNy03LTEtMS0w_ce27fd1a-1948-422b-a094-36292070aa97">294.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfOC0xLTEtMS0w_64c9d875-8fbf-40e1-9454-9000364d7f97">24.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfOC0zLTEtMS0w_7e276510-7430-40a2-9d40-341f0cec457f">22.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfOC01LTEtMS0w_2513616c-ec55-416a-be31-62d10b5c2f39">67.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfOC03LTEtMS0w_f3434256-a4f4-4aee-a051-e25ca7b549ef">61.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense after income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfOS0xLTEtMS0w_c337ebdb-8fe3-45af-b154-45d3fae3e2ec">98.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfOS0zLTEtMS0w_b289cc4b-c30e-4ecf-8e33-bbf7af7b4a4b">84.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfOS01LTEtMS0w_1217407c-44b0-4e57-8aed-de5b26eda6cc">269.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfOS03LTEtMS0w_ee571775-6b0e-40e2-9754-4f3401ad168d">233.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTg4MQ_ae589ba1-1ee7-47f9-b622-4d7d3079d403" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options granted under the Company&#8217;s share-based compensation plans and rights to acquire stock granted under the ESPP. The weighted average estimated fair values of stock options and the rights to acquire stock under the ESPP, as well as the weighted average assumptions used in calculating the fair values of stock options and the rights to acquire stock under the ESPP that were granted during the three and nine months ended September&#160;30, 2021, and 2020, were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.771%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39d2400983df44e786e5f043ff29f072_D20210701-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMy0xLTEtMS0w_2ee7a102-5d4c-451d-ae9e-26ad18ddf0df">0.8</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86ee9cb414864a739611fb6aa952b4b5_D20200701-20200930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMy0zLTEtMS0w_cc99f5dd-c761-46c7-b013-7696a86c3b18">0.2</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i19f02cddebeb45688a3df400d1f96f9f_D20210101-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMy01LTEtMS0w_bf0308ec-2c4f-41e8-b48b-42fb4d4f962b">0.8</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26618f20dcf34488b46dc5d1ad566328_D20200101-20200930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMy03LTEtMS0w_a0bf6369-13d7-4d5b-bef2-464a2e61558b">0.6</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i39d2400983df44e786e5f043ff29f072_D20210701-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNC0xLTEtMS0w_c6540ebc-e509-44d4-ae2f-f62e0172e9ff">3.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i86ee9cb414864a739611fb6aa952b4b5_D20200701-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNC0zLTEtMS0w_dec91cec-adc3-4276-b84d-dbd8f74be995">3.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i19f02cddebeb45688a3df400d1f96f9f_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNC01LTEtMS0w_451541a9-eb2d-4820-84f1-9037968a285c">4.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i26618f20dcf34488b46dc5d1ad566328_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNC03LTEtMS0w_b5cd947f-b9a3-44a3-9ac0-da6eb4c3b29b">4.1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39d2400983df44e786e5f043ff29f072_D20210701-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNS0xLTEtMS0w_2ad3b239-445b-49e6-864e-c28be576100d">31</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86ee9cb414864a739611fb6aa952b4b5_D20200701-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNS0zLTEtMS0w_be63b632-9a85-4fc6-9a4e-2c3edbe78d76">34</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i19f02cddebeb45688a3df400d1f96f9f_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNS01LTEtMS0w_fe158b16-aa84-4778-bd79-1131067f5b4a">32</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26618f20dcf34488b46dc5d1ad566328_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNS03LTEtMS0w_cd20f4a6-f9d6-485b-8f2a-f958f498ccae">32</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i39d2400983df44e786e5f043ff29f072_D20210701-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNi0xLTEtMS0w_c209a0a0-bf87-4946-b845-06ae44a0696f">87.35</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i86ee9cb414864a739611fb6aa952b4b5_D20200701-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNi0zLTEtMS0w_4fca772b-a769-4629-8987-55bfcabed375">62.65</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i19f02cddebeb45688a3df400d1f96f9f_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNi01LTEtMS0w_c98c6f5d-06df-4d96-b125-55e2ac7f366d">78.17</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i26618f20dcf34488b46dc5d1ad566328_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNi03LTEtMS0w_5c6b43ef-597d-4a78-80c9-0527151219eb">53.57</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ee2fa93adb64b729a028c991c27406a_D20210701-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfOC0xLTEtMS0w_708cdaf0-afb3-4fcc-8db3-ccd500a6a0ef">0.1</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69e0aa09b22945fe8e76dfb3e9ac826e_D20200701-20200930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfOC0zLTEtMS0w_cf0c0761-ebc3-4877-b78e-18a1e8951b0e">0.1</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i92cbadc1b4dc43c78d9b42fe98dc9359_D20210101-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfOC01LTEtMS0w_c2863ebe-de55-45b2-b37c-2453581ab79c">0.1</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97592680c7ea4d0c98add45dc8ac42d6_D20200101-20200930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfOC03LTEtMS0w_eb608e53-2165-4764-b9a7-22422b94aa48">0.9</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3ee2fa93adb64b729a028c991c27406a_D20210701-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfOS0xLTEtMS0w_adf4103a-57e4-4271-809f-a00d7fcd45b3">1.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i69e0aa09b22945fe8e76dfb3e9ac826e_D20200701-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfOS0zLTEtMS0w_ce68f0a5-74c4-448c-ba68-58fef84e9d8c">1.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i92cbadc1b4dc43c78d9b42fe98dc9359_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfOS01LTEtMS0w_917204a0-2e13-42c7-b0a3-4b911d27456b">1.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97592680c7ea4d0c98add45dc8ac42d6_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfOS03LTEtMS0w_613210c4-2468-4c5f-b606-4ebee60fdcce">1.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ee2fa93adb64b729a028c991c27406a_D20210701-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMTAtMS0xLTEtMA_76efb359-0642-4147-b6a7-0f5b7d025d66">29</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69e0aa09b22945fe8e76dfb3e9ac826e_D20200701-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMTAtMy0xLTEtMA_76365435-7309-474e-8abf-f0b5ecba5dc8">34</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i92cbadc1b4dc43c78d9b42fe98dc9359_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMTAtNS0xLTEtMA_11be14dd-ac96-43f6-804b-ea7c4d2b36e3">29</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97592680c7ea4d0c98add45dc8ac42d6_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMTAtNy0xLTEtMA_a35d56d7-e062-446d-9f21-d9a830bb3720">30</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i3ee2fa93adb64b729a028c991c27406a_D20210701-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMTEtMS0xLTEtMA_572a53e1-d6b5-4a26-bc03-e8f09de56ed0">91.07</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i69e0aa09b22945fe8e76dfb3e9ac826e_D20200701-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMTEtMy0xLTEtMA_ac5f1ee3-46bb-4443-a630-633b1f289787">67.85</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i92cbadc1b4dc43c78d9b42fe98dc9359_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMTEtNS0xLTEtMA_7e48c62b-71c5-4b7a-8491-e9e06be88c2c">89.98</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i97592680c7ea4d0c98add45dc8ac42d6_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMTEtNy0xLTEtMA_d6235139-0d04-4b04-b36d-abed7133762b">57.29</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div id="i944f300b8c29463aa56139ed7eaca296_61"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMzM2Ng_4e712029-a896-44b3-a2ac-f83fbf952893" continuedAt="i04c828c59bae4b15aefefba8b258103a" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i04c828c59bae4b15aefefba8b258103a" continuedAt="if07d0ce73fbc46179352e126e4c37c35"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense for the three months ended September&#160;30, 2021, was $<ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfNzg_c39b9507-a9f1-4c3a-88aa-8b64be3d2f89">73.9</ix:nonFraction>&#160;million, or <ix:nonFraction unitRef="number" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfODU_5a4ed1b7-8193-4508-bdbc-bffb145456c7">16.0</ix:nonFraction>% of income before taxes, compared to $<ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTI0_b0eb475d-f4e2-46d9-b4a1-93008e0790d1">38.4</ix:nonFraction>&#160;million, or <ix:nonFraction unitRef="number" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTMx_ddcfe40e-5ed1-4cb7-b3e0-6713ac571a8b">10.8</ix:nonFraction>% of income before taxes, for the three months ended September&#160;30, 2020. Income tax expense for the nine months ended September&#160;30, 2021, was $<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMjM3_614c2f1d-5169-492c-b1c7-c2379aec4399">90.7</ix:nonFraction> million, or <ix:nonFraction unitRef="number" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMjQ0_53590e57-2842-4f95-bec8-681584247504">6.3</ix:nonFraction>% of income before taxes, compared to $<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMjgz_9541cf1d-5014-4841-ba0b-3c75a108bbab">67.3</ix:nonFraction>&#160;million, or <ix:nonFraction unitRef="number" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMjkw_f591717d-98f8-4ddc-bdbb-968ca1f63296">8.7</ix:nonFraction>% of income before taxes, for the nine months ended September&#160;30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three and nine months ended September&#160;30, 2021, and 2020, differs from the U.S. federal statutory rate of 21% mainly due to excess tax benefits associated with employee equity plans, the effect of income earned by certain overseas entities being taxed at rates lower than the federal statutory rate, and the federal research and development (&#8220;R&amp;D&#8221;) credit benefit, partially offset by U.S. tax on foreign earnings and state income taxes (net of federal benefit).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the nine months ended September&#160;30, 2021, included a one-time benefit of $<ix:nonFraction unitRef="usd" contextRef="ic8e60490c05d45a5903e47f96d9854af_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfODkw_7e3d4ed2-707a-4279-a659-1f6780c124f0"><ix:nonFraction unitRef="usd" contextRef="i86f7d62644344bb5b63935be28a53d36_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfODkw_8ac1b60e-02e2-4776-b735-99d967631c3c">66.4</ix:nonFraction></ix:nonFraction>&#160;million from re-measurement of the Company&#8217;s Swiss deferred tax assets resulting from the extension of the economic useful life of certain intangible assets. The effective tax rate for the nine months ended September&#160;30, 2020, reflected a one-time increase of $<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTEyNw_867a7976-79f3-48dd-aff0-906229bd2960"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTEyNw_d0f0b7a4-48e4-42d7-8d13-eb9e4928235a">36.8</ix:nonFraction></ix:nonFraction>&#160;million in unrecognized tax benefits with a corresponding increase to income tax expense. This increase was related to intercompany charges for share-based compensation for relevant periods prior to 2020, triggered by the finalization of a Ninth Circuit Court of Appeals opinion (the &#8220;Ninth Circuit Opinion&#8221;) involving an independent third party. An additional charge of $<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfODI0NjMzNzIxMjUxNw_8b1852f2-7708-4f10-9a5e-8c400cf2e663"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfODI0NjMzNzIxMjUxNw_da76fa52-c6ff-45fc-b045-b450905307ee">11.1</ix:nonFraction></ix:nonFraction>&#160;million related to this matter was recorded to income tax expense for the three and nine months ended September&#160;30, 2021, as a result of additional IRS guidance issued in July 2021.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><ix:continuation id="if07d0ce73fbc46179352e126e4c37c35"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes for the three and nine months ended September&#160;30, 2021, included excess tax benefits associated with employee equity plans of $<ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTcxOA_503fef1f-8cc1-4da4-bcdf-d238d00e4217">41.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTcyNQ_be2674d5-103f-4a30-9f05-e0b6fc5babc0">158.9</ix:nonFraction>&#160;million, which reduced our effective tax rate by <ix:nonFraction unitRef="number" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTc2OQ_0e7eb9df-4d5b-4f6f-8cfb-ac8f2b72aa58">9.1</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTc3Ng_3e413184-0ae6-4dd5-8b38-ea6fe5b87951">11.1</ix:nonFraction> percentage points, respectively. The provision for income taxes for the three and nine months ended September&#160;30, 2020, included excess tax benefits associated with employee equity plans of $<ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTk0MQ_cb107216-86c2-4d55-b1a1-d5801992b6e0">47.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTk0OA_c0ea66e2-7822-4e1c-ac9e-e12365f9f087">144.8</ix:nonFraction>&#160;million, which reduced our effective tax rate by <ix:nonFraction unitRef="number" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTk5Mg_7352f307-09df-422c-afd8-24fb93b11d24">13.5</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTk5OQ_af1c0cd1-8e1c-49fa-a264-f52a210e26ef">18.8</ix:nonFraction> percentage points, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files federal, state, and foreign income tax returns in many U.S. and OUS jurisdictions. Years before 2016 are closed for the significant jurisdictions. Certain of the Company&#8217;s unrecognized tax benefits could change due to activities of various tax authorities, including potential assessment of additional tax, possible settlement of audits, or through normal expiration of various statutes of limitations, which could affect the Company&#8217;s effective tax rate in the period in which they change. Due to the uncertainty related to the timing and potential outcome of audits, the Company cannot estimate the range of reasonably possible change in unrecognized tax benefits that may occur in the next 12 months.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to the examination of its income tax returns by the Internal Revenue Service and other tax authorities. The outcome of these audits cannot be predicted with certainty. The Company&#8217;s management regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#8217;s provision for income taxes. If any issues addressed in the Company&#8217;s tax audits are resolved in a manner not consistent with management&#8217;s expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs.</span></div></ix:continuation><div id="i944f300b8c29463aa56139ed7eaca296_64"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RleHRyZWdpb246ZmU0OTRmYmQ0YzM5NDJhODk4NTgzZWMzZjg1YjU3MDBfNjcy_9063dd0d-11d9-4184-9198-c4c94ccb0e7f" continuedAt="ida5eba6d93ce460c95ebc0d3d5df00ae" escape="true">NET INCOME PER SHARE</ix:nonNumeric></span></div><ix:continuation id="ida5eba6d93ce460c95ebc0d3d5df00ae"><ix:nonNumeric contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RleHRyZWdpb246ZmU0OTRmYmQ0YzM5NDJhODk4NTgzZWMzZjg1YjU3MDBfNjY0_25ebf740-8bf9-48e9-a806-9d562218028b" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the computation of basic and diluted net income per share attributable to Intuitive Surgical, Inc. (in millions, except per share amounts):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.771%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfMy0xLTEtMS0w_68942a9e-9837-4d89-b814-7cacb41b7a74">380.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfMy0zLTEtMS0w_caf90ee9-b7ac-4697-85d2-a84705589f78">313.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfMy01LTEtMS0w_a7c610dc-ca50-4736-8d08-5f3f185a0f4a">1,324.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfMy03LTEtMS0w_309003a8-4eca-431b-9641-d3b99e7b5405">695.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding used in basic calculation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNS0xLTEtMS0w_053b2954-9552-445b-abd8-b8786474c1a9">356.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNS0zLTEtMS0w_2ad0d4a3-1607-4432-b720-a51b68fc9bd3">352.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNS01LTEtMS0w_b453a38a-2ab8-48b9-96cf-c0a2b339bacb">355.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNS03LTEtMS0w_4c00a0ae-4366-4a45-a6bd-62e67e823702">350.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: dilutive effect of potential common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNi0xLTEtMS0w_91b0cd70-01f3-406f-af82-664e90bb6e21">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNi0zLTEtMS0w_9b85d7f1-7990-4f5e-aecc-400a29d632e7">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNi01LTEtMS0w_c36ce3fd-c549-44c7-8bd0-4f54a72d4472">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNi03LTEtMS0w_e944fdeb-3972-4983-bbc0-3f40318e31d1">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding used in diluted calculation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNy0xLTEtMS0w_e56e9c2d-88d6-4f47-8346-23b5e45cdda8">366.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNy0zLTEtMS0w_0da0d785-fb9f-45b6-a688-c22f7a1082dc">361.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNy01LTEtMS0w_63f9da8b-d241-45ff-bbf2-a1b91c2450ec">365.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNy03LTEtMS0w_3cf468cb-9aab-430d-95a0-9bf02ee6e48c">360.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to Intuitive Surgical, Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfOS0xLTEtMS0w_61d68460-667d-4093-a239-3517144560d2">1.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfOS0zLTEtMS0w_c3407ea3-10bd-4917-82d4-61c77398434d">0.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfOS01LTEtMS0w_8a36d776-e25a-492f-a9f9-fce7cc7492f3">3.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfOS03LTEtMS0w_d3fcd758-1622-4420-b7d1-f934b091b22d">1.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfMTAtMS0xLTEtMA_f97baa05-c885-428d-9814-ea484fe65dfc">1.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfMTAtMy0xLTEtMA_534102fa-e22f-4e70-a07f-72a224049850">0.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfMTAtNS0xLTEtMA_80163d1f-0175-4860-9cd4-739c36ebcd79">3.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfMTAtNy0xLTEtMA_d37bf89c-f1af-4eb2-ac3b-2df79b0e3818">1.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation awards of approximately <ix:nonFraction unitRef="shares" contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RleHRyZWdpb246ZmU0OTRmYmQ0YzM5NDJhODk4NTgzZWMzZjg1YjU3MDBfMjU1_42631ca1-3a39-466c-b939-61a2686eec14">0.2</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RleHRyZWdpb246ZmU0OTRmYmQ0YzM5NDJhODk4NTgzZWMzZjg1YjU3MDBfMjYy_c6499a1f-4338-4167-aea8-c28baa430a6a">0.6</ix:nonFraction>&#160;million shares for the three months ended September&#160;30, 2021, and 2020, respectively, and approximately <ix:nonFraction unitRef="shares" contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RleHRyZWdpb246ZmU0OTRmYmQ0YzM5NDJhODk4NTgzZWMzZjg1YjU3MDBfMzQw_3979b20f-6a13-44dd-b2f9-991e8226e0ba">0.7</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RleHRyZWdpb246ZmU0OTRmYmQ0YzM5NDJhODk4NTgzZWMzZjg1YjU3MDBfMzQ3_7186e07a-a53a-4955-91d9-2e58496f2759">2.6</ix:nonFraction>&#160;million shares for the nine months ended September&#160;30, 2021, and 2020, respectively, were outstanding but were not included in the computation of diluted net income per share attributable to Intuitive Surgical, Inc. common stockholders, because the effect of including such shares would have been anti-dilutive in the periods presented.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;2.&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this report, &#8220;Intuitive Surgical,&#8221; &#8220;Intuitive,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Intuitive Surgical, Inc. and its wholly and majority-owned subsidiaries.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This management&#8217;s discussion and analysis of financial condition as of September&#160;30, 2021, and results of operations for the three and nine months ended September&#160;30, 2021, and 2020, should be read in conjunction with management&#8217;s discussion and analysis of financial condition and results of operations included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report contains &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Forward-looking statements relate to expectations concerning matters that are not historical facts. Words such as &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;plans,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;targeted,&#8221; and similar words and expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements related to the expected impacts of the COVID-19 pandemic on our business, financial condition, and results of operations, the potential impact on our procedure volume, our acquisitions, our expected business, our expected new product introductions, the impacts of Extended Use Instruments, procedures and procedure adoption, future results of operations, future financial position, our ability to increase our revenues, the anticipated mix of our revenues between product and service revenues, our financing plans and future capital requirements, anticipated costs of revenue, anticipated expenses, our potential tax assets or liabilities, the effect of recent accounting pronouncements, our investments, anticipated cash flows, our ability to finance operations from cash flows and similar matters, and statements based on current expectations, estimates, forecasts, and projections about the economies and markets in which we operate and our beliefs and assumptions regarding these economies and markets. These forward-looking statements should be considered in light of various important factors, including, but not limited to, the following: our ability to obtain accurate procedure volume and mix in the midst of the COVID-19 pandemic; the risk that the COVID-19 pandemic could lead to further material delays and cancellations of, or reduced demand for, procedures; curtailed or delayed capital spending by hospitals; disruption to our supply chain, including increased difficulties in obtaining a sufficient amount of materials in the semiconductor and other markets; closures of our facilities; delays in surgeon training; delays in gathering clinical evidence; delays in obtaining new product approvals or clearances from the U.S. Food and Drug Administration due to the effects of the COVID-19 pandemic; the evaluation of the risks of robotic-assisted surgery in the presence of infectious diseases; diversion of management and other resources to respond to COVID-19 outbreaks; the impact of global and regional economic and credit market conditions on healthcare spending; the risk that the COVID-19 virus disrupts local economies and causes economies in our key markets to enter prolonged recessions; healthcare reform legislation in the U.S. and its impact on hospital spending, reimbursement, and fees levied on certain medical device revenues; changes in hospital admissions and actions by payers to limit or manage surgical procedures; the timing and success of product development and market acceptance of developed products; the results of any collaborations, in-licensing arrangements, joint ventures, strategic alliances, or partnerships, including the joint venture with Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; our completion of and ability to successfully integrate acquisitions, including Sch&#246;lly Fiberoptic&#8217;s robotic endoscope business and Orpheus Medical; procedure counts; regulatory approvals, clearances, and restrictions or any dispute that may occur with any regulatory body; guidelines and recommendations in the healthcare and patient communities; intellectual property positions and litigation; competition in the medical device industry and in the specific markets of surgery in which we operate; risks associated with our operations outside of the United States; unanticipated manufacturing disruptions or the inability to meet demand for products; our reliance on sole and single source suppliers; the results of legal proceedings to which we are or may become a party; product liability and other litigation claims; adverse publicity regarding us and the safety of our products and adequacy of training; our ability to expand into foreign markets; the impact of changes to tax legislation, guidance, and interpretations; changes in tariffs, trade barriers, and regulatory requirements; and other risk factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which are based on current expectations and are subject to risks, uncertainties, and assumptions that are difficult to predict, including those risk factors described throughout this filing and in the Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, and other periodic filings with the Securities and Exchange Commission. Our actual results may differ materially and adversely from those expressed in any forward-looking statement. We undertake no obligation to publicly update or release any revisions to these forward-looking statements, except as required by law.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intuitive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Intuitive Surgical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci S HD Surgical System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci Si</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci Si HD Surgical System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci Xi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci SP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, EndoWrist</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Firefly</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, InSite</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Intuitive Surgical EcoSystem</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci X</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, SureForm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Iris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and SynchroSeal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are our trademarks or registered trademarks.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intuitive is committed to advancing patient care in surgery and other acute medical interventions. We are focused on innovating to enable physicians and healthcare providers to improve the quality of and access to minimally invasive care. Our mission reflects that we believe that minimally invasive care is life-enhancing care. Intuitive brings more than two decades of leadership in robotic-assisted surgical technology and solutions to its offerings. While surgery and acute interventions have improved significantly in the past decades, there remains a significant need for better outcomes and decreased variability of these outcomes across care teams. The current healthcare environment continues to stress critical resources, including the professionals who staff care teams: surgeons, anesthesiologists, nurses, and other staff. At the same time, governments strain to cover the healthcare needs of their populations and demand lower total cost per patient to treat disease. In the face of these challenges, we believe scientific, process, and technological advances in biology, computing, imaging, algorithms, and robotics offer new methods to solve continued and difficult problems.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address these needs by focusing on the quadruple aim. First, we focus on products and services that can improve outcomes and decrease variability in the hands of care teams. Second, we seek to improve the patient experience by minimizing disruption to lives and creating greater predictability for the treatment experience. Third, we seek to improve care team satisfaction by creating products and services that are dependable, smart, and optimized for the care environment in which they are used. Finally, we seek to lower the total cost to treat per patient episode when compared with existing treatment alternatives, providing a return on investment for hospitals and healthcare systems and value for payers.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Open surgery remains the predominant form of surgery and is used in almost every area of the body. However, the large incisions required for open surgery create trauma to patients, typically resulting in longer hospitalization and recovery times, increased hospitalization costs, and additional pain and suffering relative to minimally invasive surgery (&#8220;MIS&#8221;), where MIS is available. For over three decades, MIS has reduced trauma to patients by allowing selected surgeries to be performed through small ports rather than large incisions. MIS has been widely adopted for certain surgical procedures.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Da Vinci Surgical Systems enable surgeons to extend the benefits of MIS to many patients who would otherwise undergo a more invasive surgery by using computational, robotic, and imaging technologies to overcome many of the limitations of traditional open surgery or conventional MIS. Surgeons using a da Vinci Surgical System operate while seated comfortably at a console viewing a 3D, high-definition image of the surgical field. This immersive console connects surgeons to the surgical field and their instruments. While seated at the console, the surgeon manipulates instrument controls in a natural manner, similar to open surgical technique. Our technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon&#8217;s hand. In designing our products, we focus on making our technology easy and safe to use.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our da Vinci products fall into five broad categories: da Vinci Surgical Systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems (&#8220;Firefly&#8221;) and da Vinci endoscopes. We also provide a comprehensive suite of services, training, and education programs. Within our integrated ecosystem, our hardware, software, and digital solutions are designed to decrease variability in surgery by offering dependable, consistent functionality and user experiences for surgeons seeking better outcomes. We take a holistic approach, offering intelligent technology and systems designed to work together to make MIS intervention more available and applicable.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have commercialized the following da Vinci Surgical Systems: the da Vinci standard Surgical System in 1999, the da Vinci S Surgical System in 2006, the da Vinci Si Surgical System in 2009, and the fourth generation da Vinci Xi Surgical System in 2014. We have extended our fourth generation platform by adding the da Vinci X Surgical System, commercialized in the second quarter of 2017, and the da Vinci SP Surgical System, commercialized in the third quarter of 2018. The da Vinci SP Surgical System accesses the body through a single incision while the other da Vinci Surgical Systems access the body through multiple incisions. We are still in a measured launch of our da Vinci SP Surgical System, and we have an installed base of 89 da Vinci SP Surgical Systems as of September&#160;30, 2021. Our plans for the rollout of the da Vinci SP Surgical System include putting systems in the hands of experienced da Vinci users first while we optimize training pathways and our supply chain. We received U.S. Food and Drug Administration (&#8220;FDA&#8221;) clearances for the da Vinci SP Surgical System for urological and certain transoral procedures. We also received clearance in South Korea where the da Vinci SP Surgical System may be used for a broad set of procedures. We plan to seek FDA clearances for additional indications for da Vinci SP over time. We also plan to seek clearances in other OUS markets over time. The success of the da Vinci SP Surgical System is dependent on positive experiences and improved clinical outcomes for the procedures for which it has been cleared as well as securing additional clinical clearances. All da Vinci systems include a surgeon&#8217;s console (or consoles), imaging electronics, a patient-side cart, and computational hardware and software.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer approximately 70 different multi-port da Vinci instruments to provide surgeons with flexibility in choosing the types of tools needed to perform a particular surgery. These multi-port instruments are generally robotically controlled and provide end effectors (tips) that are similar to those used in either open or laparoscopic surgery. We offer advanced instrumentation for the da Vinci Xi and da Vinci X platforms, including da Vinci Energy and da Vinci Stapler products, to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provide surgeons with sophisticated, computer-aided tools to precisely and efficiently interact with tissue. Da Vinci X and da Vinci Xi Surgical Systems share the same instruments whereas the da Vinci Si Surgical System uses instruments that are not compatible with da Vinci X or da Vinci Xi systems. We currently offer nine core instruments on our da Vinci SP Surgical System. We plan to expand the SP instrument offering over time.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Training technologies include our Intuitive Simulation products, our Intuitive Telepresence remote case observation and telementoring tools, and our dual console for use in surgeon proctoring and collaborative surgery.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2019, the FDA cleared our Ion endoluminal system to enable minimally invasive biopsies in the lung. Our Ion system extends our commercial offering beyond surgery into diagnostic procedures with this first application. Our rollout of the Ion system in the U.S. is progressing well, and we are continuing to gather additional clinical evidence. We have placed 98 Ion systems as of September&#160;30, 2021. Ion systems are not included in our da Vinci Surgical System installed base. We plan to seek clearances for Ion in OUS markets over time.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of new product introductions depends on a number of factors including, but not limited to, pricing, competition, market and consumer acceptance, the effective forecasting and management of product demand, inventory levels, the management of manufacturing and supply costs, and the risk that new products may have quality or other defects in the early stages of introduction.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Procedures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2020, prior to the spread of COVID-19, we experienced procedure growth trends consistent with those experienced in the fourth quarter of 2019, including strength in general surgery, growth in mature procedures in the U.S., and growth in OUS urology. Beginning in January 2020, we saw a substantial reduction in da Vinci procedures in China and, by early February 2020, procedures per week in China had declined by approximately 90% compared to the weekly procedure rates experienced in early January 2020. As the COVID-19 pandemic subsided in China in March 2020, da Vinci procedure volume began to recover and, by the end of the first quarter of 2020, China procedures per week were approximately 70% of the early January 2020 weekly procedure rate. As the COVID-19 pandemic spread to Western Europe and the U.S., we experienced a significant decline in da Vinci procedures in the last half of March 2020 to approximately 65% of the weekly procedure rate experienced earlier in the first quarter of 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, procedures per week in the U.S. continued to decline in April, reaching approximately 30% of pre-COVID-19 levels, followed by steady recovery in May and June, as COVID-19 cases dropped and elective procedures were permitted. However, with the resurgence of COVID-19 cases in the last two weeks of June, we experienced a corresponding decline in da Vinci procedures. The impact of COVID-19 in Europe during the second quarter of 2020 varied by country with procedures in Italy, France, and the UK declining more steeply, while Germany experienced a year-over-year increase in procedures. In China, procedures per week continued to increase to a level consistent with the early January 2020 weekly procedure rate. We experienced little impact on the procedure volume in Korea and Japan in the second quarter of 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2020, in the U.S., procedures recovered slowly, leveling off to near pre-COVID-19 levels towards the end of the quarter. Outside of the U.S., da Vinci procedures varied depending on the spread and/or resurgence of COVID-19. For example, COVID-19 had a less significant impact in Germany where da Vinci procedures grew at mid-single digits relative to the third quarter of 2019, while it had a more significant impact in the U.K. where da Vinci procedures declined year over year. Procedures in China grew significantly year over year, while COVID-19 outbreaks resulted in year-over-year procedure growth rates in Japan slowing somewhat relative to the second quarter. The COVID-19 pandemic has also affected the volumes of certain procedure types differently. For example, patient concerns over exposure to COVID-19 and the fact that prostate cancer can be slow growing, combined with lower prostate diagnoses and treatments, have caused the number of da Vinci prostatectomy procedures to decline in the third quarter of 2020 relative to the third quarter of 2019. Notwithstanding the impacts of COVID-19, da Vinci bariatric procedures grew significantly year over year due to our optimized instrument set and focus by our sales organization and may also have benefited from certain patients prioritizing weight loss as obesity is a significant COVID-19 risk factor. However, the diagnoses and treatment pathways for bariatric patients are long, and many of the patients in the third quarter may have begun their treatment pathway prior to the spread of COVID-19.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, in the U.S., the COVID-19 resurgence that affected procedures later in the fourth quarter of 2020 continued well into January 2021. Then, as COVID-19 cases subsided beginning in February 2021, da Vinci procedures experienced a steady improvement throughout February and March. In Europe, the spread of COVID-19 varied regionally, and procedure growth rates were mixed with strength in France and a year-over-year decline in the U.K. While there have been COVID-19 hot spots within some of our Asia Pacific markets, they tended to be isolated and, in general, procedures performed well. China growth was significantly higher than other regions, reflecting the severity of the COVID-19 impact on China during the first quarter of the prior year and the additional system installations during 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, as the U.S. continued its broad rollout of vaccinations, COVID-19 cases and hospitalizations decreased, and procedure volumes recovered, partially attributed to the performance of a number of procedures that were deferred during the pandemic. In Europe, the rollout of vaccinations and spread of COVID-19 varied regionally, and procedure growth rates were mixed with notable recovery in the U.K. We continued to see the impacts of regional resurgences of COVID-19 cases within the Asia Pacific markets with growth in India, Taiwan, and Japan lagging behind that of other markets. China growth continued to be strong year over year, primarily reflecting the growth in the system installed base.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2021, COVID-19 infections resurged as the quarter progressed, and we saw a corresponding impact to our da Vinci procedures. In the U.S., we saw decreasing procedure volumes in August and September compared to June as COVID-19 cases and hospitalizations increased. Late in the quarter, as COVID-19 cases began to slow, procedures began to recover. We continue to see certain regions of the U.S. particularly impacted. Outside of the U.S., in Europe, the impact of COVID-19 in the third quarter of 2021 varied regionally with slower growth in Italy and France. We continue to see the impacts of regional resurgences of COVID-19 cases within the Asia Pacific markets, particularly in Japan and Taiwan. China growth in the third quarter continued to be stronger than other Asia Pacific markets, primarily reflecting nearly 40% growth in the system installed base year over year.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depth and extent to which the COVID-19 pandemic will impact individual markets will vary based on the availability of vaccinations, personal protective equipment, intensive care units and operating rooms, and medical staff, as well as government interventions. The impact of COVID-19 on our procedure volumes varies widely by country, region, and type. When COVID-19 infection rates spike in a particular region, procedure volumes have been negatively impacted and the diagnoses of new conditions and their related treatments have been deferred. While there is a backlog of patients, it is unpredictable when those patients will ultimately seek diagnosis and treatment and whether they will be treated through surgery. Based on our experience during 2020, we do not expect all markets, regions, and procedure types to recover at the same time or at the same pace.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">System Demand</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first three quarters of 2020, customers in regions impacted by COVID-19 deferred decisions to purchase or lease systems into future quarters and, in some cases, indefinitely. However, in the first three quarters of 2021, we experienced strong system demand. In general, we believe that the COVID-19 pandemic had less of an impact on hospital spending capacity and that customers recognize that da Vinci surgery meets their quadruple aim objectives better than other surgical approaches. More specifically, during the first three quarters of 2021, system demand reflected procedure growth, hospitals purchasing systems in preparation for a post-COVID-19 pandemic environment, and hospitals upgrading their system portfolio to access and/or standardize on fourth generation capabilities.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General Increase in Risks</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Worldwide economies have been significantly impacted by the COVID-19 pandemic, and it is possible that factors related to the COVID-19 pandemic could cause a prolonged recession in local and/or global economies. Such an economic recession could have a material adverse effect on our long-term business as hospitals curtail and reduce capital and overall spending. The COVID-19 pandemic and local actions, such as &#8220;shelter-in-place&#8221; orders and restrictions on our ability to travel and access our customers or temporary closures of our facilities, including our training and manufacturing operations, or the facilities of our suppliers and their contract manufacturers, could further significantly impact our sales and our ability to produce and ship our products and supply our customers.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, we have experienced increased difficulties in obtaining a sufficient amount of component materials used in our products, including those in the semiconductor market, as global supply has become significantly constrained due to increased demand in semiconductors and other materials. Additionally, prices of such materials have increased due to the increased demand and supply shortage. The global semiconductor and other materials supply shortage is likely to remain a challenge for the foreseeable future. We have also experienced challenges in logistics, as certain shipping routes have been impacted by port closures. Such global shortages in important components and logistics challenges have resulted in, and will continue to cause, inflationary cost pressure in our supply chain. To date, these challenges have not materially impacted our ability to deliver product and services to our customers. However, if shortages in important supply chain materials in the semiconductor or other markets continue, we could fail to meet product demand, which would adversely impact our business, financial condition, results of operations, or cash flows.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased labor shortages globally, including staff burnout and attrition, could also impact our ability to hire and retain personnel critical to our manufacturing, logistics, and commercial operations. We are also highly dependent on the principal members of our management and scientific staff. Attracting and retaining qualified personnel is critical to our success, and competition for them has become more intense. The loss of critical members of our team, or our inability to attract and retain qualified personnel, could significantly harm our operations, business, and ability to compete. In addition, hospitals are also experiencing staffing shortages and supply chain issues that could impact their ability to provide patient care. Any of these </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">events could negatively impact the number of da Vinci procedures performed or the number of system placements and have a material adverse effect on our business, financial condition, results of operations, or cash flows.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Response</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our priorities and actions during the COVID-19 pandemic have been and remain as follows. First, we are focused on the health and safety of all those we serve &#8211; patients, customers, our communities, and our employees &#8211; implementing continuous updates to our health and safety policies and processes. Second, we are supporting our customers according to their priorities &#8211; clinical, operational, and economic &#8211; and ensuring continuity of supply by working with our suppliers and our distributors. Third, we are securing our workforce economically. We have built a valuable team over the years, and we believe they will be important in a recovery that follows the pandemic. Finally, we will continue to invest in our priority development programs while eliminating avoidable spend.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As COVID-19 vaccination rates increase and cases decline, we have enhanced our focus on evaluating and implementing our return-to-office strategy. We intend to remain flexible, allowing many of our employees to work remotely on at least a partial basis, while maintaining productivity and our culture. Our top priority in this process continues to be the health and safety of our employees.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_76"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Model</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue from the placements of da Vinci Surgical Systems, in sales or sales-type lease arrangements where revenue is recognized up-front or in operating lease transactions and usage-based models where revenue is recognized over time. We earn recurring revenue from the sales of instruments, accessories, and services, as well as the revenue from operating leases. The da Vinci Surgical System generally sells for between $0.5 million and $2.5 million, depending upon the model, configuration, and geography, and represents a significant capital equipment investment for our customers when purchased. Our instruments and accessories have limited lives and will either expire or wear out as they are used in surgery, at which point they need to be replaced. We generally earn between $600 and $3,500 of instruments and accessories revenue per surgical procedure performed, depending on the type and complexity of the specific procedures performed and the number and type of instruments used. Further, in late 2020, we launched our Extended Use Program (refer to further discussion immediately below) in the U.S. and Europe, with the intention to reduce the cost for customers to treat patients, which in turn will reduce the overall instruments and accessories revenue per procedure. We typically enter into service contracts at the time systems are sold or leased at an annual fee between $80,000 and $190,000, depending upon the configuration of the underlying system and composition of the services offered under the contract. These service contracts have generally been renewed at the end of the initial contractual service periods.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with the da Vinci Surgical System model described above, we generate revenue from the placements of the Ion endoluminal system at the time of sale in or sales-type lease arrangements or over time in operating lease transactions and usage-based models. We generate revenue from the placements of the Ion system, and we earn recurring revenue from the sales of instruments and accessories used in biopsies and ongoing system service. Ion systems are presented separately from our da Vinci Surgical Systems installed base. For the three and nine months ended September&#160;30, 2021, Ion&#8217;s contribution to revenue and gross margin was not significant.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Extended Use Program</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we announced our "Extended Use Program," which consists of select da Vinci Xi and da Vinci X instruments possessing 12 to 18 uses ("Extended Use Instruments") compared to the current 10 use instruments. These Extended Use Instruments represent some of our higher volume instruments but exclude stapling, monopolar, and advanced energy instruments. Instruments included in the program are used across a number of da Vinci surgeries. Their increased uses are the result of continuous, significant investments in the design and production capabilities of our instruments, resulting in improved quality and durability. Extended Use Instruments have been introduced in the U.S. and Europe in the fourth quarter of 2020 and have launched in most other countries around the world in the first half of 2021, except China due to regulatory timelines. They will continue to be introduced at various times throughout the remainder of 2021 and 2022 in other geographies, depending on regulatory processes. In addition, simultaneous with the regional launches of Extended Use Instruments, we will lower the price of certain instruments that are most commonly used in lower acuity procedures and/or lower reimbursed procedures within the region. These actions will reduce the cost for customers to treat patients, which in turn will reduce our revenue per procedure. Based on 2019 volume and mix of procedures, our Extended Use Program and the reduced pricing on certain other instruments would have reduced 2019 annual instruments and accessories revenue by approximately $150 to $170&#160;million. In the U.S. and Europe, during the first three quarters of 2021, we saw customers adjust their instrument buying patterns to reduce their inventory levels to reflect the additional uses per instrument. Additionally, we believe that, as of the end of Q3 2021, in the U.S. and Europe, full cutover to Extended Use Instruments has occurred, as customers have utilized substantially all of their </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">remaining 10 use instruments. The precise impact of these actions on future revenue will be dependent on the future volume and mix of procedures and whether cost elasticity will enable greater penetration into available markets.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recurring Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recurring revenue consists of instruments and accessories revenue, service revenue, and operating lease revenue. Recurring revenue increased to $3.4 billion, or 77% of total revenue in 2020, compared to $3.2&#160;billion, or 72% of total revenue in 2019, and $2.6&#160;billion, or 71% of total revenue in 2018.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instruments and accessories revenue has grown at a faster rate than systems revenue over time. Instruments and accessories revenue increased to $2.46&#160;billion in 2020, compared to $2.41&#160;billion in 2019 and $1.96&#160;billion in 2018. The growth of instruments and accessories revenue largely reflects continued procedure adoption.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue was $724&#160;million in 2020, compared to $724&#160;million in 2019 and $635&#160;million in 2018. Service revenue remained unchanged, driven by growth of the installed base of da Vinci Surgical Systems, offset by an $80&#160;million decrease due to service fee credits provided to customers as part of the Customer Relief Program that was implemented as a result of the COVID-19 pandemic in the second quarter of 2020. The installed base of da Vinci Surgical Systems grew 7% to approximately 5,989 at December&#160;31, 2020; 12% to approximately 5,582 at December&#160;31, 2019; and 13% to approximately 4,986 at December&#160;31, 2018.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the installed base, number of shipments, and utilization of da Vinci Surgical Systems as metrics for financial and operational decision-making and as a means to evaluate period-to-period comparisons. Management believes that the installed base, number of shipments, and utilization of da Vinci Surgical Systems provide meaningful supplemental information regarding our performance, as management believes that the installed base, number of shipments, and utilization of da Vinci Surgical Systems are an indicator of the rate of adoption of robotic-assisted surgery as well as an indicator of future recurring revenue (particularly service revenue). Management believes that both it and investors benefit from referring to the installed base, number of shipments, and utilization of da Vinci Surgical Systems in assessing our performance and when planning, forecasting, and analyzing future periods. The installed base, number of shipments, and utilization of da Vinci Surgical Systems also facilitate management&#8217;s internal comparisons of our historical performance. We believe that the installed base, number of shipments, and utilization of da Vinci Surgical Systems are useful to investors as metrics, because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making, and (2) they are used by institutional investors and the analyst community to help them analyze the performance of our business. The vast majority of da Vinci Surgical Systems installed are connected via the internet. System logs can also be accessed by field engineers for systems that are not connected to the internet. We utilize this information as well as other information from agreements and discussions with our customers that involve estimates and judgments, which are, by their nature, subject to substantial uncertainties and assumptions. Estimates and judgments for determining the installed base, number of shipments, and utilization of da Vinci Surgical Systems may be impacted over time by various factors, including system internet connectivity, hospital and distributor reporting behavior, and inherent complexities in new agreements. Such estimates and judgments are also susceptible to technical errors. In addition, the relationship between the installed base, number of shipments, and utilization of da Vinci Surgical Systems and our revenues may fluctuate from period to period, and growth in the installed base, number of shipments, and utilization of da Vinci Surgical Systems may not correspond to an increase in revenue. The installed base, number of shipments, and utilization of da Vinci Surgical Systems are not intended to be considered in isolation or as a substitute for, or superior to, revenue or other financial information prepared and presented in accordance with GAAP.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intuitive System Leasing</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2013, we have entered into sales-type and operating lease arrangements directly with certain qualified customers as a way to offer customers flexibility in how they acquire systems and expand their robotic-assisted surgery programs while leveraging our balance sheet. These leases generally have commercially competitive terms as compared to other third-party entities that offer equipment leasing. We have also entered into usage-based arrangements with qualified customers that have committed da Vinci programs where we charge for the system and service as the systems are utilized. We believe that these alternative financing structures have been effective and well-received, and we are willing to expand the proportion of these structures based on customer demand. We include operating and sales-type leases, and systems placed under usage-based arrangements, in our system shipment and installed base disclosures. We exclude operating lease-related revenue, usage-based revenue, and Ion system revenue from our da Vinci Surgical System average selling price (&#8220;ASP&#8221;) computations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the years ended December 31, 2020, 2019, and 2018, we shipped 432, 425, and 272 da Vinci Surgical Systems, respectively, under lease and usage-based arrangements, of which 317, 384, and 229 systems, respectively, were operating lease and usage-based arrangements. Revenue from operating lease arrangements is generally recognized on a straight-line basis over the lease term or, in the case of usage-based arrangements, as the systems are used. We generally set operating lease and usage-based pricing at a modest premium relative to purchased systems reflecting the time value of money and, in the case of usage-based arrangements, the risk that system utilization may fall short of anticipated levels. The proportion of revenue recognized from usage-based arrangements has not been significant and has been included in our operating lease metrics herein. Operating </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lease revenue has grown at a faster rate than overall systems revenue and was $177&#160;million, $107&#160;million, and $51&#160;million for the years ended December 31, 2020, 2019, and 2018, respectively. As revenue from operating lease and usage-based arrangements is recognized over time, total systems revenue growth is reduced in a period when the number of operating lease and usage-based placements increases as a proportion of total system placements. Generally, lease transactions generate similar gross margins as our sale transactions. As of December&#160;31, 2020, a total of 901 da Vinci Surgical Systems were installed at customers under operating lease or usage-based arrangements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our exposure to the credit risks relating to our lease financing arrangements may increase if our customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty or other customer-specific factors. In addition, as customers continue to divert resources to the treatment of or the preparation to treat patients with COVID-19, we may be exposed to defaults under our lease financing arrangements. Moreover, usage-based arrangements generally contain no minimum payments; therefore, customers may exit such arrangements without paying a financial penalty to us. As a result of the COVID-19 pandemic, we anticipate that some customers will exit such arrangements or seek to amend the terms of our operating lease and usage-based arrangements with them.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For some operating lease arrangements, our customers are provided with the right to purchase the leased system at certain points during and/or at the end of the lease term. Revenue generated from customer purchases of systems under operating lease arrangements (&#8220;Lease Buyouts&#8221;) was $52.2 million, $92.8&#160;million, and $48.8&#160;million for the years ended December 31, 2020, 2019, and 2018, respectively. We expect that revenue recognized from customer exercises of the buyout options will fluctuate based on the timing of when, and if, customers choose to exercise their buyout options.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Systems Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">System placements are driven by procedure growth in most markets. In some markets, systems placements are constrained by regulation. In geographies where da Vinci procedure adoption is in an early stage, system sales will precede procedure growth. System placements also vary due to seasonality largely aligned with hospital budgeting cycles. We typically place a higher proportion of annual system placements in the fourth quarter and a lower proportion in the first quarter as customer budgets are reset. Systems revenue is also affected by the proportion of system placements under operating lease and usage-based arrangements, recurring operating lease and usage-based revenue, operating lease buyouts, product mix, ASPs, trade-in activities, and customer mix. Systems revenue declined 12% to $1.18&#160;billion in 2020. Systems revenue grew 19% to $1.35&#160;billion in 2019 and 21% to $1.13&#160;billion in 2018. Based on the factors outlined in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above, we believe that historical system shipment trends may not be a good indicator of future system shipments.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Procedure Mix / Products</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our da Vinci Surgical Systems are generally used for soft tissue surgery for areas of the body between the pelvis and the neck, primarily in general surgery, gynecologic surgery, urologic surgery, cardiothoracic surgery, and head and neck surgery. Within these categories, procedures range in complexity from cancer and other highly complex procedures to less complex procedures for benign conditions. Cancer and other highly complex procedures tend to be reimbursed at higher rates than less complex procedures for benign conditions. Thus, hospitals are more sensitive to the costs associated with treating less complex, benign conditions. Our strategy is to provide hospitals with attractive clinical and economic solutions across the spectrum of procedure complexity. Our fully featured&#160;da Vinci Xi&#160;Surgical System with advanced instruments (including da Vinci Energy and EndoWrist and&#160;SureForm&#160;Stapler products) and our Integrated Table Motion product targets the more complex procedure segment. Our da Vinci X Surgical System is targeted towards price sensitive markets and procedures. Our da Vinci SP Surgical System complements the da Vinci Xi and X Surgical Systems by enabling surgeons to access narrow workspaces.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Procedure Seasonality</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More than half of da Vinci procedures performed are for benign conditions, most notably hernia repairs, hysterectomies, and cholecystectomies. These benign procedures and other short-term elective procedures tend to be more seasonal than cancer operations and surgeries for other life-threatening conditions. Seasonality in the U.S. for procedures for benign conditions typically results in higher fourth quarter procedure volume when more patients have met annual deductibles and lower first quarter procedure volume when deductibles are reset. Seasonality outside the U.S. varies and is more pronounced around local holidays and vacation periods. As a result of the factors outlined in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above, including past and potentially future recommendations of authorities to defer elective procedures, historical procedure patterns may be disrupted.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distribution Channels</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide our products through direct sales organizations in the U.S., Europe (excluding Spain, Portugal, Italy, Greece, and most Eastern European countries), China, Japan, South Korea, India, and Taiwan. In 2018, we began direct operations in India and Taiwan. In January 2019, our Intuitive-Fosun joint venture began direct sales for da Vinci products and services in China. In the remainder of our OUS markets, we provide our products through distributors.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Activities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products must meet the requirements of a large and growing body of international standards that govern the product safety, efficacy, advertising, labeling, safety reporting design, manufacture, materials content and sourcing, testing, certification, packaging, installation, use, and disposal of our products. Examples of such standards include electrical safety standards, such as those of the International Electrotechnical Commission, and composition standards, such as the Reduction of Hazardous Substances and the Waste Electrical and Electronic Equipment Directives. Failure to meet these standards could limit our ability to market our products in those regions that require compliance to such standards.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products and operations are also subject to increasingly stringent medical device, privacy, and other regulations by regional, federal, state, and local authorities. We anticipate that timelines for the introduction of new products and/or indications may be extended relative to past experience as a result of these regulations. For example, we have seen elongated regulatory approval timelines in the U.S. and the EU.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clearances and Approvals</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have generally obtained the clearances required to market our products associated with our da Vinci Surgical Multiport Systems (Standard, S, Si, Xi, and X systems) for our targeted surgical specialties within the U.S., South Korea, Japan, and the European markets in which we operate. Since 2019, we obtained regulatory clearances for the following products:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In late 2020 and early 2021, we obtained FDA clearance, CE mark clearance, and regulatory clearances in most of our significant markets to market our Extended Use Instruments.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In November 2019, we obtained FDA clearance for our SynchroSeal instrument and E-100 generator. Following the FDA clearance, in February 2020, we received CE mark clearance for both products. In March 2020, we received regulatory clearance in Japan to market both our SynchroSeal instrument and E-100 generator. We received regulatory clearance in South Korea to market our SynchroSeal instrument and E-100 generator in January 2020 and August 2020, respectively.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July 2019, we obtained FDA clearance for our SureForm 45 Curved-Tip stapler and SureForm 45 Gray reload, which round out our SureForm 45 portfolio. We have also received CE mark clearance for our SureForm 45 Curved-Tip stapler and SureForm 45 Gray reload. In September 2019, we received regulatory clearance in Japan to market both our SureForm 45 Curved-Tip stapler and SureForm 45 Gray reload. We received regulatory clearance in South Korea to market our SureForm 45 Curved-Tip stapler and SureForm 45 Gray reload in June 2021 and July 2021, respectively.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In June 2019, we received CE mark clearance for our da Vinci Endoscope Plus for the da Vinci Xi and da Vinci X Surgical Systems in Europe. Following the CE mark, in July 2019, we obtained FDA clearance for our da Vinci Endoscope Plus. We have also received regulatory clearances in South Korea and Japan to market our da Vinci Endoscope Plus in December 2019 and May 2020, respectively.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In June 2019, we obtained FDA clearance for our da Vinci Handheld Camera and, in February 2020, we received CE mark clearance.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In February 2019, we obtained FDA clearance for our Ion endoluminal system, our new flexible, robotic-assisted, catheter-based platform, designed to navigate through very small lung airways to reach peripheral nodules for biopsies. Our rollout of the Ion system in the U.S. is progressing well, and we are continuing to gather additional clinical evidence. We have placed 98 Ion systems as of September&#160;30, 2021.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In February 2019, we obtained FDA clearance for our Iris augmented reality product. Iris is a service that delivers a 3D image of the patient anatomy (initially targeting kidneys) to aid surgeons in both pre- and intra-operative settings. We are currently conducting a pilot study of our Iris product and service in the field at a number of U.S. hospitals to gain initial product experience and insights.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In December 2018, we received product registration for our da Vinci Xi Surgical System in China. The registration approval does not include advanced energy or stapling products that attach to the da Vinci Xi system. Separate product registrations are required for each of these products with the China National Medical Products Administration (&#8220;NMPA&#8221;).</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In October 2018, the China National Health Commission published on its official website the quota for major medical equipment to be imported and sold in China through 2020. After an adjustment notice was published in the third quarter of 2020, the government will now allow for the total sale of 225 new surgical robots into China, which could include da Vinci Surgical Systems as well as surgical systems introduced by others. As of September&#160;30, 2021, we have sold 153 da Vinci Surgical Systems under this quota. Future sales of da Vinci Surgical Systems under the quota are uncertain, as they are dependent on hospitals completing a tender process and receiving associated approvals.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the descriptions of our products that received regulatory clearances in 2021, 2020, and 2019 in the New Product Introductions section below.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Japanese Ministry of Health, Labor, and Welfare (&#8220;MHLW&#8221;) considers reimbursement for procedures in April of even-numbered years. The process for obtaining reimbursement requires Japanese university hospitals and surgical societies, with our support, to seek reimbursement. There are multiple pathways to obtain reimbursement for procedures, including those that require in-country clinical data/economic data. In April 2012 and April 2016, the MHLW granted reimbursement status for robotic-assisted prostatectomy and partial nephrectomy, respectively. Most prostatectomies and partial nephrectomies were open procedures prior to da Vinci reimbursement. Da Vinci procedure reimbursement for robotic-assisted prostatectomy and partial nephrectomy procedures are higher than open and conventional laparoscopic procedure reimbursements. An additional 12 da Vinci procedures were granted reimbursement effective April 1, 2018, including gastrectomy, low anterior resection, lobectomy, and hysterectomy, for both malignant and benign conditions. An additional 7 da Vinci procedures were granted reimbursement effective April 1, 2020. These additional 19 reimbursed procedures have varying levels of conventional laparoscopic penetration and will be reimbursed at rates equal to the conventional laparoscopic procedures. Given the reimbursement level and laparoscopic penetration for these 19 procedures, there can be no assurance that the adoption pace for these procedures will be similar to robotic-assisted prostatectomy or partial nephrectomy, given their higher reimbursement, or any other da Vinci procedure.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recalls and Corrections</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical device companies have regulatory obligations to correct or remove medical devices in the field that could pose a risk to health. The definition of &#8220;recalls and corrections&#8221; is expansive and includes repair, replacement, inspections, relabeling, and issuance of new or additional instructions for use or reinforcement of existing instructions for use and training when such actions are taken for specific reasons of safety or compliance. These field actions require stringent documentation, reporting, and monitoring worldwide. There are other actions that a medical device manufacturer may take in the field without reporting including, but not limited to, routine servicing and stock rotations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we determine whether a field action is reportable in any regulatory jurisdiction, we prepare and submit notifications to the appropriate regulatory agency for the particular jurisdiction. Regulators can require the expansion, reclassification, or change in scope and language of the field action. In general, upon submitting required notifications to regulators regarding a field action that is a recall or correction, we will notify customers regarding the field action, provide any additional documentation required in their national language, and arrange, as required, return or replacement of the affected product or a field service visit to perform the correction.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Field actions as well as certain outcomes from regulatory activities can result in adverse effects on our business, including damage to our reputation, delays by customers of purchase decisions, reduction or stoppage of the use of installed systems, and reduced revenue as well as increased expenses.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_82"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Procedures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We model patient value as equal to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">procedure efficacy / invasiveness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In this equation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">procedure efficacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is defined as a measure of the success of the surgery in resolving the underlying disease, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">invasiveness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is defined as a measure of patient pain and disruption of regular activities. When the patient value of a da Vinci procedure is greater than that of alternative treatment options, patients may benefit from seeking out surgeons and hospitals that offer da Vinci Surgery, which could potentially result in a local market share shift. Adoption of da Vinci procedures occurs procedure by procedure and market by market and is driven by the relative patient value and total treatment costs of da Vinci procedures as compared to alternative treatment options for the same disease state or condition.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the number and type of da Vinci procedures as metrics for financial and operational decision-making and as a means to evaluate period-to-period comparisons. Management believes that the number and type of da Vinci procedures provide meaningful supplemental information regarding our performance, as management believes procedure volume is an indicator of the rate of adoption of robotic-assisted surgery as well as an indicator of future revenue (including revenue from usage-based arrangements). Management believes that both it and investors benefit from referring to the number and type of da Vinci procedures in assessing our performance and when planning, forecasting, and analyzing future periods. The number and type of da Vinci procedures also facilitate management&#8217;s internal comparisons of our historical performance. We believe that the number and type of da Vinci procedures are useful to investors as metrics, because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making, and (2) they are used by institutional investors and the analyst community to help them analyze the performance of our business. The vast majority of da Vinci Surgical Systems installed are connected via the internet. System logs can also be accessed by field engineers for systems that are not connected to the internet. We utilize certain methods that rely on information collected from the systems installed for determining the number and type of da Vinci procedures performed that involve estimates and judgments, which are, by their nature, subject to substantial uncertainties and assumptions. Estimates and judgments for determining the number and type </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of da Vinci procedures may be impacted over time by various factors, including changes in treatment modalities, hospital and distributor reporting behavior, and system internet connectivity. Such estimates and judgments are also susceptible to algorithmic or other technical errors. In addition, the relationship between the number and type of da Vinci procedures and our revenues may fluctuate from period to period, and da Vinci procedure volume growth may not correspond to an increase in revenue. The number and type of da Vinci procedures are not intended to be considered in isolation or as a substitute for, or superior to, revenue or other financial information prepared and presented in accordance with GAAP.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Worldwide Procedures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our da Vinci systems and instruments are regulated independently in various countries and regions of the world. The discussion of indications for use and representative or target procedures is intended solely to provide an understanding of the market for da Vinci products and is not intended to promote for sale or use of any Intuitive product outside of its licensed or cleared labeling and indications for use.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of robotic-assisted surgery using the da Vinci Surgical System has the potential to grow for those procedures that offer greater patient value than to non-da Vinci alternatives and competitive total economics for healthcare providers. Our da Vinci Surgical Systems are used primarily in general surgery, gynecologic surgery, urologic surgery, cardiothoracic surgery, and head and neck surgery. We focus our organization and investments on developing, marketing, and training products and services for procedures in which da Vinci can bring patient value relative to alternative treatment options and/or economic benefit to healthcare providers. Target procedures in general surgery include hernia repair (both ventral and inguinal), colorectal procedures, bariatrics, and cholecystostomies. Target procedures in gynecology include hysterectomy for both cancer and benign conditions. Target procedures in urology include prostatectomy and partial nephrectomy. In cardiothoracic surgery, target procedures include lobectomy. In head and neck surgery, target procedures include certain procedures resecting benign and malignant tumors classified as T1 and T2. Not all of the indications, procedures, or products described may be available in a given country or region or on all generations of da Vinci surgical systems. Surgeons and their patients need to consult the product labeling in their specific country and for each product in order to determine the cleared uses, as well as important limitations, restrictions, or contraindications.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, approximately 1,243,000 surgical procedures were performed with da Vinci Surgical Systems, compared to approximately 1,229,000 and 1,038,000 surgical procedures performed with da Vinci Surgical Systems in 2019 and 2018, respectively. The reduced growth in our overall procedure volume in 2020 reflects significant disruption caused by the COVID-19 pandemic, as noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above, and was driven by growth in U.S. general surgery procedures and worldwide urology procedures.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Procedures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall U.S. procedure volume with da Vinci Surgical Systems declined to approximately 876,000 in 2020, compared to approximately 883,000 in 2019 and approximately 753,000 in 2018. General surgery was our largest and fastest growing U.S. specialty in 2020 with procedure volume that grew to approximately 434,000 in 2020, compared to approximately 421,000 in 2019 and approximately 325,000 in 2018. Gynecology was our second largest U.S. surgical specialty in 2020 with procedure volume that declined to approximately 267,000 in 2020, compared to approximately 282,000 in 2019 and approximately 265,000 in 2018. Urology was our third largest U.S. surgical specialty in 2020 with procedure volume that declined to approximately 134,000 in 2020, compared to approximately 138,000 in 2019 and approximately 128,000 in 2018.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Procedures Outside of the U.S.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall OUS procedure volume with da Vinci Surgical Systems grew to approximately 367,000 in 2020, compared to approximately 346,000 in 2019 and approximately 285,000 in 2018. Procedure growth in most OUS markets was driven largely by urology procedure volume, which grew to approximately 214,000 in 2020, compared to approximately 206,000 in 2019 and approximately 175,000 in 2018. General surgery and thoracic procedures also contributed to OUS procedure growth with higher growth rates than urology procedures.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_85"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Business Events and Trends</span></div><div id="i944f300b8c29463aa56139ed7eaca296_88"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Procedures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overall. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total da Vinci procedures performed by our customers grew approximately 20% for the three months ended September&#160;30, 2021, compared to approximately 7% for the three months ended September&#160;30, 2020. Total da Vinci procedures performed by our customers grew approximately 32% for the nine months ended September&#160;30, 2021, as compared with the same period in the prior year. Total da Vinci procedures declined approximately 1% for the nine months ended September&#160;30, 2020. The third quarter and year-to-date procedure results for both periods reflect impacts from the COVID-19 pandemic, as noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above. Growth in the third quarter of 2021 was impacted by a resurgence of COVID-19. We saw growth in most of the major procedure categories in the third quarter of 2021, most notably in general surgery procedures (particularly bariatrics, cholecystectomies, and hernia repair) and, to a lesser extent, urology and gynecology procedures. The rates of recovery in urology procedures continue to be impacted by the COVID-19 pandemic due to delays in both the diagnosis of and procedures in patient populations that are considered to be at higher risk from COVID-19 infections as well as for conditions that may progress more slowly.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Procedures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;U.S. da Vinci procedures grew approximately 16% for the three months ended September&#160;30, 2021, compared to approximately 7% for the three months ended September&#160;30, 2020. U.S. da Vinci procedures grew approximately 31% for the nine months ended September&#160;30, 2021, as compared with the same period in the prior year. U.S. da Vinci procedures declined approximately 3% for the nine months ended September&#160;30, 2020. As noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above, the U.S. procedure results for the three and nine months ended September&#160;30, 2020, reflected significant disruption caused by the COVID-19 pandemic. Growth in the third quarter of 2021 was impacted by a resurgence of COVID-19 as cases and hospitalizations once again increased. During the third quarter of 2021, U.S. procedure growth was largely attributable to general surgery procedures, most notably bariatric, cholecystectomy, and hernia repair procedures and, to a lesser extent, urology and gynecology procedures.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OUS Procedures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> OUS da Vinci procedures grew approximately 30% for the three months ended September&#160;30, 2021, compared to approximately 9% for the three months ended September&#160;30, 2020. OUS da Vinci procedures grew approximately 34% for the nine months ended September&#160;30, 2021, compared to approximately 5% for the nine months ended September&#160;30, 2020. As noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above, the OUS procedure results for the three and nine months ended September&#160;30, 2020, reflected significant disruption caused by the COVID-19 pandemic. Similar to U.S. procedures above, during the third quarter of 2021, OUS da Vinci procedure volumes were impacted as COVID-19 cases and hospitalizations increased in a number of countries. By procedure category, OUS procedure growth was driven by continued growth in urology procedures, most notably prostatectomy and partial nephrectomy procedures, as well as earlier stage growth in general surgery (particularly colorectal), gynecology, and thoracic procedures. The OUS procedure growth rate also reflects continued da Vinci adoption in European and Asian markets. We saw strong procedure growth in China, the UK, South Korea, Germany, and Japan during the third quarter of 2021.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_91"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">System Demand</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We placed 336 da Vinci Surgical Systems in the third quarter of 2021, compared to 195 systems in the third quarter of 2020. The increase in systems placed reflects the significant disruption experienced as a result of the COVID-19 pandemic in the third quarter of 2020, as well as procedure growth, more customers trading in da Vinci Si Surgical Systems for fourth generation da Vinci systems in order to access fourth generation instruments and capabilities as well as to standardize their system portfolio, and further customer validation that da Vinci surgery addresses their quadruple aim objectives.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While third quarter 2021 placements grew 72% compared with 2020, future placements of da Vinci Surgical Systems will be impacted by a number of factors: supply chain risks; economic and geopolitical factors; the impact of the current COVID-19 pandemic, as noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above; hospital response to the evolving healthcare environment; procedure growth rates; hospital consolidation trends; evolving system utilization and point of care dynamics; capital replacement trends; additional reimbursements in various global markets, including Japan: the timing around governmental tenders and authorizations, including China; the timing of when we receive regulatory clearance in our other OUS markets for our da Vinci Xi Surgical System, da Vinci X Surgical System, and da Vinci SP Surgical System, and related instruments; and market response. Market acceptance of our recently launched da Vinci SP Surgical System and the nature and timing of additional da Vinci SP regulatory indications may also impact future system placements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Demand may also be impacted by robotic-assisted surgery competition, including from companies that have introduced products in the field of robotic-assisted surgery or have made explicit statements about their efforts to enter the field. A few of these companies include, but are not limited to, Asensus Surgical, Inc.; avateramedical GmbH; CMR Surgical Ltd.; Johnson &amp; Johnson (including their wholly owned subsidiaries Auris Health, Inc. and Verb Surgical Inc.); Medicaroid Corporation; Medrobotics Corporation; Medtronic plc; meerecompany Inc.; MicroPort Scientific Corporation; Olympus Corporation; Samsung Group; Shandong Weigao Group Medical Polymer Company Ltd.; and Titan Medical Inc.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the above factors will also impact future demand for our Ion system, as we extend our commercial offering into diagnostics, along with additional factors associated with a new product introduction, including, but not limited to, our ability to optimize manufacturing and our supply chain, competition, clinical data to demonstrate value, and market acceptance.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_97"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Product Introductions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SynchroSeal and E-100 Generator.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we obtained FDA clearance for our SynchroSeal instrument and E-100 generator. Following the FDA clearance, in February 2020, we received CE mark clearance for both products. In March 2020, we received regulatory clearance in Japan to market both our SynchroSeal instrument and E-100 generator. We received regulatory clearance in South Korea to market our SynchroSeal instrument and E-100 generator in January 2020 and August 2020, respectively. SynchroSeal is a single-use, bipolar, electrosurgical instrument intended for grasping, dissection, sealing, and transection of tissue. With its wristed articulation, rapid sealing cycle, and refined curved jaw, SynchroSeal offers enhanced versatility to the da Vinci Energy portfolio. The E-100 generator is an electrosurgical generator developed to power two key instruments &#8211; Vessel Sealer Extend and SynchroSeal &#8211; on the da Vinci X and da Vinci Xi Surgical Systems. The generator delivers high frequency energy for cutting, coagulation, and vessel sealing of tissues.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SureForm 45 Curved-Tip and Gray Reload.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In July 2019, we obtained FDA clearance for the SureForm 45 Curved-Tip stapler and SureForm 45 Gray reload. We have also received CE mark clearance for our SureForm 45 Curved-Tip stapler and SureForm 45 Gray reload. SureForm 45 Curved-Tip is a single-use, fully wristed stapling instrument with a curved tip intended for resection, transection, and/or creation of anastomoses. SureForm 45 Gray reload is a new, single-use cartridge that contains multiple staggered rows of implantable staples and a stainless steel knife. The SureForm 45 Curved-Tip stapler and Gray reload have particular utility in thoracic procedures and round out our SureForm 45 portfolio. In September 2019, we received regulatory clearance in Japan to market both our SureForm 45 Curved-Tip stapler and SureForm 45 Gray reload. We received regulatory clearance in South Korea to market our SureForm 45 Curved-Tip stapler and SureForm 45 Gray reload in June 2021 and July 2021, respectively. Not all reloads or staplers are available for use on all systems or in all countries.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Da Vinci Endoscope Plus.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, we received CE mark clearance for our da Vinci Endoscope Plus, an enhanced 3D endoscope for use with our da Vinci X and Xi Surgical Systems. Following the CE mark, in July 2019, we obtained FDA clearance for our da Vinci Endoscope Plus. We have also received regulatory clearances in South Korea and Japan to market our da Vinci Endoscope Plus in December 2019 and May 2020, respectively. The da Vinci Endoscope Plus leverages new sensor technology to allow for increased sharpness and color accuracy.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Da Vinci Handheld Camera.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In June 2019, we obtained FDA clearance for our da Vinci Handheld Camera, a lightweight, 2D camera head, which can be connected to third-party laparoscopes. This allows the laparoscopic image to be displayed on the da Vinci X/Xi vision cart to address aspects of da Vinci procedures that may require use of a laparoscope, thus eliminating the need for redundant equipment in the operating room and increasing procedure efficiency. In February 2020, we received CE mark clearance for our da Vinci Handheld Camera. We broadly launched the da Vinci Handheld Camera in our European direct markets as well as in the U.S. in May 2020 and June 2020, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ion endoluminal system. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, we obtained FDA clearance for the Ion endoluminal system, our new flexible, robotic-assisted, catheter-based platform designed to navigate through very small lung airways to reach peripheral nodules for biopsies. The Ion system uses an ultra-thin articulating robotic catheter that can articulate 180 degrees in all directions. The outer diameter of the catheter is 3.5mm, which allows physicians to navigate through small and tortuous airways to reach nodules in most airway segments within the lung. The Ion system&#8217;s flexible biopsy needle can also pass through very tight bends via Ion&#8217;s catheter to collect tissue in the peripheral lung. The catheter&#8217;s 2mm working channel can also accommodate other biopsy tools, such as biopsy forceps or cytology brushes, if necessary. Our rollout of the Ion system in the U.S. is progressing well, and we are continuing to gather additional clinical evidence. We have placed 98 Ion systems as of September&#160;30, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Iris.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In February 2019, we obtained FDA clearance for our Iris augmented reality product. Iris is a service that delivers a 3D image of the patient anatomy (initially targeting kidneys) to aid surgeons in both the pre- and intra-operative settings. We are now in the early stages of an Iris pilot study in the field at a number of U.S. hospitals to gain initial product experience and insights.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Third Quarter 2021 Operational and Financial Highlights</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenue increased by 30% to $1.40 billion for the three months ended September&#160;30, 2021, compared to $1.08&#160;billion for the three months ended September&#160;30, 2020. The compound annual growth rate between the third quarter of 2019 and the third quarter of 2021 was 12%.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Approximately 395,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">da Vinci procedures were performed during the three months ended September&#160;30, 2021, an increase of 20% compared to approximately 329,000 for the three months ended September&#160;30, 2020. The compound annual growth rate between the third quarter of 2019 and the third quarter of 2021 was 13%.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Instruments and accessories revenue increased by 20% to $755 million for the three months ended September&#160;30, 2021, compared to $631&#160;million for the three months ended September&#160;30, 2020.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Systems revenue increased by 55% to $415 million for the three months ended September&#160;30, 2021, compared to $268&#160;million during the three months ended September&#160;30, 2020.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A total of 336 da Vinci Surgical Systems were shipped during the three months ended September&#160;30, 2021, an increase of 72% compared to 195 systems during the three months ended September&#160;30, 2020.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As of September&#160;30, 2021, we had a da Vinci Surgical System installed base of approximately 6,525 systems, an increase of approximately 11% compared to the installed base of approximately 5,865 systems as of September&#160;30, 2020.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Utilization of da Vinci systems, measured in terms of procedures per system per year, increased 9% relative to the third quarter of 2020. The compound annual growth rate between the third quarter of 2019 and the third quarter of 2021 was 3%.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the three months ended September&#160;30, 2021, we placed 28 Ion systems, compared to 11 systems during the three months ended September&#160;30, 2020.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gross profit as a percentage of revenue was 69.2% for the three months ended September&#160;30, 2021, compared to 67.2% for the three months ended September&#160;30, 2020.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income increased by 64% to $443 million for the three months ended September&#160;30, 2021, compared to $270&#160;million during the three months ended September&#160;30, 2020. Operating income included charges for share-based compensation of $123 million and $107 million related to employee stock plans and $6.4 million and $21.7 million of intangible asset-related charges for the three months ended September&#160;30, 2021, and 2020, respectively.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As of September&#160;30, 2021, we had $8.22&#160;billion in cash, cash equivalents, and investments. Cash, cash equivalents, and investments increased by $1.35&#160;billion, compared to December&#160;31, 2020, primarily as a result of cash provided by our operations and proceeds from stock option exercises and employee stock purchases, partially offset by capital expenditures and taxes paid related to net share settlements of equity awards.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, for the periods indicated, certain unaudited Condensed Consolidated Statements of Income information (in millions, except percentages):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;total<br/>revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;total<br/>revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;total<br/>revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;total<br/>revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,481.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,521.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,159.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,029.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,063.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,432.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,652.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,897.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,527.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,331.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,436.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net income attributable to noncontrolling interest in joint venture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div id="i944f300b8c29463aa56139ed7eaca296_112"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue increased by 30% to $1.4&#160;billion for the three months ended September&#160;30, 2021, compared to $1.1&#160;billion for the three months ended September&#160;30, 2020, resulting from 55% higher systems revenue, driven by 72% higher system placements, 20% higher instruments and accessories revenue, driven by approximately 20% higher procedure volume, and 30% higher service revenue. Total revenue increased by 37% to $4.2&#160;billion for the nine months ended September&#160;30, 2021, compared to $3.0&#160;billion for the nine months ended September&#160;30, 2020, resulting from 51% higher systems revenue, driven by 58% higher system placements, 32% higher instruments and accessories revenue, driven by approximately 32% higher procedure volume, and 33% higher service revenue. In conjunction with our 2020 COVID-19 Customer Relief Program implemented in the second quarter of 2020, service revenue was reduced by $23&#160;million and $82&#160;million for the three and nine months ended September 30, 2020, respectively, for service fee credits provided to customers.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue denominated in foreign currencies as a percentage of total revenue was approximately 23% and 22% for the three and nine months ended September&#160;30, 2021, respectively, and 22% and 23% for the three and nine months ended September&#160;30, 2020, respectively. We generally sell our products and services in local currencies where we have direct distribution channels. Foreign currency rate fluctuations did not have a material impact on total revenue for the three and nine months ended September&#160;30, 2021, nor for the three and nine months ended and September&#160;30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated in the U.S. accounted for 68% and 67%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> total revenue for the three and nine months ended September&#160;30, 2021, and 69%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 68% for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the three and nine months ended September&#160;30, 2020, respectively. We believe that </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. revenue has accounted for the large majority of total revenue due to U.S. patients&#8217; ability to choose their provider and method of treatment, reimbursement structures supportive of innovation and MIS, and our initial investments focused on U.S. infrastructure. We have been investing in our business in the OUS markets, and our OUS procedures have grown faster in proportion to U.S. procedures. We expect that our OUS procedures and revenue will make up a greater portion of our business in the long term.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the COVID-19 pandemic is expected to continue to cause a strain on hospital resources, as outlined in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above, we cannot reliably estimate the extent total revenue will be impacted in the fourth quarter of 2021 and beyond.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our revenue and system unit shipments for the three and nine months ended September&#160;30, 2021, and 2020, respectively (in millions, except percentages and unit shipments):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,708.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,481.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,521.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,159.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,029.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OUS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,159.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,029.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Revenue &#8211; U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Revenue &#8211; OUS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,708.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recurring revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,134.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,344.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Total revenue </span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Da Vinci Surgical Systems Shipments by Region:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. unit shipments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OUS unit shipments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unit shipments*</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*Systems shipped under operating leases (included in total unit shipments)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Da Vinci Surgical Systems Shipments involving System Trade-ins:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unit shipments involving trade-ins</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unit shipments not involving trade-ins</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ion Systems Shipments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2021</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenue increased by 30% to $1.17 billion for the three months ended September&#160;30, 2021, compared to $0.90 billion for the three months ended September&#160;30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instruments and accessories revenue increased by 20% to $755&#160;million for the three months ended September&#160;30, 2021, compared to $631 million for the three months ended September&#160;30, 2020. The increase in instruments and accessories revenue was driven primarily by procedure growth of approximately 20%. The third quarter 2021 U.S. procedure growth was approximately 16%, driven by growth in general surgery procedures, most notably bariatric, cholecystectomy, and hernia repair procedures and, to a lesser extent, urology and gynecology procedures. The third quarter 2021 OUS procedure growth was approximately 30%, driven by continued growth in urology procedures, most notably prostatectomy and partial nephrectomy procedures, as well as earlier stage growth in general surgery (particularly colorectal), gynecology, and thoracic procedures. Both growth rates were impacted by the disruption caused by the COVID-19 pandemic, as noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above. Geographically, the third quarter 2021 OUS procedure growth was driven by procedure expansion in China, the UK, South Korea, Germany, and Japan.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems revenue increased by 55% to $415 million for the three months ended September&#160;30, 2021, compared to $268 million for the three months ended September&#160;30, 2020. The higher third quarter 2021 systems revenue was primarily driven by higher system shipments, higher operating lease revenue, higher lease buyouts, and higher third quarter 2021 ASPs, partially offset by a higher proportion of system shipments under operating leases.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, a total o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f 336 da Vinci Surgical Systems were shipped compared to 195 systems during the third quarter of 2020. By geography, 227 systems were shipped into the U.S., 47 into Europe, 47 into Asia, and 15 into other markets during the third quarter of 2021, compared to 116 systems shipped into the U.S., 39 into Europe, 34 into Asia, and 6 into other markets during the third quarter of 2020. The increase in systems shipments was primarily driven by decisions in the third quarter of 2020 by customers to defer purchases or leases of systems into future quarters as a result of the COVID-19 pandemic, as well as procedure growth, more customers trading in da Vinci Si Surgical Systems for fourth generation da Vinci Xi and da Vinci X systems in order to access fourth generation instruments and capabilities as well as to standardize their system portfolio, and further customer validation that da Vinci surgery addresses their quadruple aim objectives.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We shipped 166 and 83 da Vinci Surgical Systems under lease arrangements, of which 139 and 68 systems were classified as operating leases, for the three months ended September&#160;30, 2021, and 2020, respectively. Operating lease revenue was $72.5 million for the three months ended September&#160;30, 2021, compared to $45.7 million for the three months ended September&#160;30, 2020. Systems placed as operating leases represented 41% of total shipments during the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">third quarter of 2021, compared to 35% during the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> third quarter of 2020. A total of 1,179 da Vinci</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical Systems were installed at customers under operating lease or usage-based arrangements as of September&#160;30, 2021, compared to 806 as of September&#160;30, 2020. Revenue from Lease Buyouts was $24.7 million for the three months ended September&#160;30, 2021, compared to $16.9 million for the three months ended September&#160;30, 2020. We expect revenue from Lease Buyouts to fluctuate period to period depending on the timing of when, and if, customers choose to exercise the buyout options embedded in their leases.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The da Vinci Surgical System ASP, excluding the impact of systems shipped under operating lease or usage-based arrangements and Ion systems, was approximately $1.57 million for the three months ended September&#160;30, 2021, compared to approximately $1.55 million for the three months ended September&#160;30, 2020. ASP fluctuates from period to period based on geographic and product mix, product pricing, systems shipped involving trade-ins, and changes in foreign exchange rates.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended September 30, 2021</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenue increased by 38% to $3.5 billion for the nine months ended September&#160;30, 2021, compared to $2.5&#160;billion for the nine months ended September&#160;30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instruments and accessories revenue increased by 32% to $2.26 billion for the nine months ended September&#160;30, 2021, compared to $1.71&#160;billion for the nine months ended September&#160;30, 2020. The increase in instruments and accessories revenue was driven primarily by procedure growth of approximately 32%. The year-to-date 2021 U.S. procedure growth was approximately 31%, driven by growth in general surgery procedures, most notably bariatric, cholecystectomy, and hernia repair procedures, as well as moderate growth in the more mature gynecologic and urologic procedures categories. The year-to-date 2021 OUS procedure growth was approximately 34%, driven by continued growth in urology procedures, most notably prostatectomy and partial nephrectomy procedures, as well as earlier stage growth in general surgery (particularly colorectal), gynecology, and thoracic procedures. Both growth rates were positively impacted by the disruption caused by the COVID-19 pandemic in 2020, as noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above. Geographically, the year-to-date 2021 OUS procedure growth was driven by procedure expansion in China, Germany, Japan, the UK, and South Korea.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems revenue increased by 51% to $1,223 million for the nine months ended September&#160;30, 2021, compared to $812&#160;million for the nine months ended September&#160;30, 2020. The higher year-to-date 2021 systems revenue was primarily driven by higher system shipments, higher operating lease revenue, higher year-to-date 2021 ASPs, and higher lease buyouts, partially offset by a higher proportion of system shipments under operating leases.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a total o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f 962 da Vinci Surgical Systems were shipped compared to 610 systems during the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2020. By geography, 630 systems were shipped into the U.S., 169 into Europe, 132 into Asia, and 31 into other markets during the nine</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021, compared to 404 systems shipped into the U.S., 82 into Europe, 109 into Asia, and 15 into other markets during the nine</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2020. The increase in systems shipments was primarily driven by decisions in the second and third quarters of 2020 by customers to defer purchases or leases of systems into future quarters as a result of the COVID-19 pandemic, as well as procedure growth, more customers trading in da Vinci Si Surgical Systems for fourth generation da Vinci Xi and da Vinci X systems in order to access fourth generation instruments and capabilities as well as to standardize their system portfolio, and further customer validation that da Vinci surgery addresses their quadruple aim objectives.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We shipped 471 and 265 da Vinci Surgical Systems under lease arrangements, of which 374 and 197 systems were classified as operating leases, for the nine months ended September&#160;30, 2021, and 2020, respectively. Operating lease revenue was $198.8 million for the nine months ended September&#160;30, 2021, compared to $127.0 million for the nine months ended September&#160;30, 2020. Systems placed as operating leases represented 39% of total shipments during the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, compared to 32% during the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> nine</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2020. Revenue from Lease Buyouts was $69.9 million for the nine months ended September&#160;30, 2021, compared to $38.5 million for the nine months ended September&#160;30, 2020. We expect revenue from Lease Buyouts to fluctuate period to period depending on the timing of when, and if, customers choose to exercise the buyout options embedded in their leases.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The da Vinci Surgical System ASP, excluding the impact of systems shipped under operating lease or usage-based arrangements and Ion systems, was approximately $1.59 million for the nine months ended September&#160;30, 2021, compared to approximately $1.54 million for the nine months ended September&#160;30, 2020. ASP fluctuates from period to period based on geographic and product mix, product pricing, systems shipped involving trade-ins, and changes in foreign exchange rates.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_118"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue increased by 30% to $233&#160;million for the three months ended September&#160;30, 2021, compared to $179 million for the three months ended September&#160;30, 2020. The increase in service revenue was primarily driven by a larger installed base of da Vinci Surgical Systems producing service revenue, as well as the effects of the Customer Relief Program in the prior year, which resulted in a $23 million decrease in service revenue in the three months ended September&#160;30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue increased by 33% to $678&#160;million for the nine months ended September&#160;30, 2021, compared to $508&#160;million for the nine months ended September&#160;30, 2020. The increase in service revenue was primarily driven by a larger installed base of da Vinci Surgical Systems producing service revenue, as well as the effects of the Customer Relief Program in the prior year, which resulted in an $82 million decrease in service revenue in the nine months ended September&#160;30, 2020.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_121"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product gross profit for the three months ended September&#160;30, 2021, increased 33% to $815 million, representing 69.6% of product revenue, compared to $611 million, representing 68.0% of product revenue, for the three months ended September&#160;30, 2020. The higher product gross profit for the three months ended September&#160;30, 2021, was primarily driven by higher product revenue and higher product gross profit margin. The higher product gross profit margin for the three months ended September&#160;30, 2021, was primarily driven by higher third quarter 2021 ASPs and lower year-over-year excess and obsolete inventory costs, partially offset by higher freight costs. In addition, we incurred period costs associated with abnormally low production in the third quarter of 2020, which did not recur in the third quarter of 2021 as a result of increased production volumes.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product gross profit for the nine months ended September&#160;30, 2021, increased 47% to $2.4&#160;billion, representing 69.9% of product revenue, compared to $1.7&#160;billion, representing 65.6% of product revenue, for the nine months ended September&#160;30, 2020. The higher product gross profit for the nine months ended September&#160;30, 2021, was primarily driven by higher product revenue and higher product gross profit margin. The higher product gross profit margin for the nine months ended September&#160;30, 2021, was primarily driven by higher year-to-date 2021 ASPs, lower year-over-year excess and obsolete inventory costs, lower year-over-year intangible assets amortization expense, and lower year-over-year costs associated with da Vinci Si product transitions, partially offset by higher share-based compensation expense. In addition, we incurred period costs in the second and third quarters of 2020 associated with abnormally low production, which did not recur in the second and third quarters of 2021 as a result of increased production volumes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product gross profit for the three and nine months ended September&#160;30, 2021, included share-based compensation expense of $19.0 million and $50.9 million, respectively, compared with $16.2&#160;million and $43.0 million, for the three and nine months ended September&#160;30, 2020, respectively. Product gross profit for the three and nine months ended September&#160;30, 2021, included intangible assets amortization expense of $3.8 million and $12.7 million, respectively, compared with $9.0 million and $26.7 million, for the three and nine months ended September&#160;30, 2020, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service gross profit for the three months ended September&#160;30, 2021, increased 38% to $157 million, representing 67.3% of service revenue, compared to $114 million, representing 63.4% of service revenue, for the three months ended September&#160;30, 2020. The higher service gross profit for the three months ended September&#160;30, 2021, was primarily driven by higher service revenue, reflecting a larger installed base of da Vinci Surgical Systems, and higher service gross profit margin. The lower service gross profit margin for the three months ended September&#160;30, 2020, was primarily driven by the decrease in service revenue as a result of the Customer Relief Program.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service gross profit for the nine months ended September&#160;30, 2021, increased 49% to $466&#160;million, representing 68.7% of service revenue, compared to $313&#160;million, representing 61.5% of service revenue, for the nine months ended September&#160;30, 2020. The higher service gross profit for the nine months ended September&#160;30, 2021, was primarily driven by higher service revenue, reflecting a larger installed base of da Vinci Surgical Systems, and higher service gross profit margin. The lower service gross profit margin for the nine months ended September&#160;30, 2020, was primarily driven by the decrease in service revenue as a result of the Customer Relief Program.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service gross profit for the three and nine months ended September&#160;30, 2021, included share-based compensation expense of $6.0 million and $16.9 million, respectively, compared with $7.1&#160;million and $17.8 million, for the three and nine months ended September&#160;30, 2020, respectively. Service gross profit for the three and nine months ended September&#160;30, 2021, included intangible asset charges of $0.2 million and $1.9 million, respectively, compared with $0.9 million and $2.7 million, for the three and nine months ended September&#160;30, 2020, respectively.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_124"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses include costs for sales, marketing, and administrative personnel, sales and marketing activities, tradeshow expenses, legal expenses, regulatory fees, and general corporate expenses.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the three months ended September&#160;30, 2021, increased by 22% to $363 million, compared to $299 million for the three months ended September&#160;30, 2020. Selling, general and administrative expenses for the nine months ended September&#160;30, 2021, increased by 17% to $1,040 million, compared to $886&#160;million for the nine months ended September&#160;30, 2020. The increase in selling, general and administrative expenses for the three and nine months ended September&#160;30, 2021, was primarily driven by higher headcount, resulting in increased fixed and share-based compensation expense, higher variable compensation, and increased infrastructure to support our growth. In addition, there were higher marketing, travel, and training expenses for the three and nine months ended September&#160;30, 2021, as compared with the prior year.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the three and nine months ended September&#160;30, 2021, included share-based compensation expense of $62.5 million and $171.3 million, respectively, compared with $54.2&#160;million and $149.5 million, for the three and nine months ended September&#160;30, 2020, respectively. Selling, general and administrative expenses for the three and nine months ended September&#160;30, 2021, included intangible assets amortization expense of $1.8 million and $5.4 million, respectively, compared with $1.8 million and $5.2 million, for the three and nine months ended September&#160;30, 2020, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses were 26% and 25% for the three and nine months ended September&#160;30, 2021, as a percentage of revenue, compared to 28% and 29% for the three and nine months ended September&#160;30, 2020, and 25% and 26% for the three and nine months ended September 30, 2019. Our spending in the third quarter of 2021 reflected a continued but less pronounced curtailment of certain costs as a result of the COVID-19 pandemic, including travel, marketing events, clinical trials, and other related expenses. We expect that these costs will continue to increase to the extent that the impact of COVID-19 decreases and decline to the extent that the impact of COVID-19 increases. In addition, we expect spending to increase overall and as a percentage of sales as we continue to support our customers, invest in innovation focused on the quadruple aim, and invest in manufacturing and our supply chain to ensure supply for our customers.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_127"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. Research and development expenses include costs associated with the design, development, testing, and significant enhancement of our products.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the three months ended September&#160;30, 2021, increased by 7% to $166 million, compared to $155 million for the three months ended September&#160;30, 2020. Research and development expenses for the nine months ended September&#160;30, 2021, increased by 9% to $488 million, compared to $445&#160;million for the nine months ended </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2020. The increases in research and development expenses for the three and nine months ended September&#160;30, 2021, were primarily driven by higher personnel-related expenses and other project costs incurred to support a broader set of product development initiatives, including Ion and SP platform investments, informatics, advanced instrumentation, advanced imaging, and future generations of robotics.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the three and nine months ended September&#160;30, 2021, included share-based compensation expense of $35.4&#160;million and $98.1 million, respectively, compared with $29.5&#160;million and $84.1 million for the three and nine months ended September&#160;30, 2020, respectively. Research and development expenses for the three and nine months ended September&#160;30, 2021, included intangible asset-related charges of $0.6 million and $5.3 million, respectively, compared with $10.0 million and $15.0 million for the three and nine months ended September&#160;30, 2020, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses fluctuate with project timing. Based upon our broader set of product development initiatives and the stage of the underlying projects, we expect to continue to make substantial investments in research and development and anticipate that research and development expenses will continue to increase in the future.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_130"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest and Other Income, Net</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income, net, for the three and nine months ended September&#160;30, 2021, was $18.5 million, and $65.5&#160;million, respectively, compared with $84.8&#160;million, and $136.5&#160;million, for the three and nine months ended September&#160;30, 2020, respectively. The decrease in interest and other income, net, for the three and nine months ended September&#160;30, 2021, was primarily driven by lower unrealized gains on investments resulting from strategic arrangements, lower interest income earned, despite higher cash and investment balances, due to the decline in average interest rates, and gains on the sale of certain securities in the second quarter of 2020, partially offset by higher foreign exchange losses realized in the second quarter of 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We held an equity investment in preferred shares of Broncus, which was reflected in our financial statements on a cost basis. In September 2021, Broncus completed an IPO. Upon completion of the IPO, the preferred shares were converted to common shares in Broncus, and we recognized a net gain on this investment in the third quarter of 2021 of approximately $8&#160;million. We are restricted from selling these shares for a period of six months. Additionally, during the first quarter of 2021, we recorded an unrealized gain on our investment in Broncus of approximately $14&#160;million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We held an equity investment in preferred shares of InTouch, which was reflected in our financial statements on a cost basis. On July 1, 2020, Teladoc completed its acquisition of InTouch. Based on the terms of the agreement, we received Teladoc shares on the date of closing and recognized a gain on its investment in the third quarter of 2020 of approximately $45&#160;million.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_133"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Tax Expense</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense for the three months ended September&#160;30, 2021, was $73.9 million, or 16.0% of income before taxes, compared to $38.4 million, or 10.8% of income before taxes, for the three months ended September&#160;30, 2020. Income tax expense for the nine months ended September&#160;30, 2021, was $90.7 million, or 6.3% of income before taxes, compared to $67.3&#160;million, or 8.7% of income before taxes, for the nine months ended September&#160;30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for the three and nine months ended September&#160;30, 2021, and 2020, differs from the U.S. federal statutory rate of 21% primarily due to excess tax benefits associated with employee equity plans, the effect of income earned by certain overseas entities being taxed at rates lower than the federal statutory rate, and federal R&amp;D credit benefit, partially offset by U.S. tax on foreign earnings and state income taxes (net of federal benefit).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for the nine months ended September&#160;30, 2021, included a one-time benefit of $66.4&#160;million from re-measurement of our Swiss deferred tax assets resulting from the extension of the economic useful life of certain intangible assets. Our effective tax rate for the nine months ended September&#160;30, 2020, reflected a one-time increase of $36.8&#160;million in unrecognized tax benefits with a corresponding increase to income tax expense. This increase was related to intercompany charges for share-based compensation for relevant periods prior to 2020, triggered by the finalization of a Ninth Circuit Court of Appeals opinion involving an independent third party. An additional charge of $11.1 million related to this matter was recorded to income tax expense for the three and nine months ended September&#160;30, 2021, as a result of additional IRS guidance issued in July 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for income taxes for the three and nine months ended September&#160;30, 2021, included excess tax benefits associated with employee equity plans of $41.9&#160;million and $158.9&#160;million, which reduced our effective tax rate by 9.1 and 11.1 percentage points, respectively. Our provision for income taxes for the three and nine months ended September&#160;30, 2020, included excess tax benefits associated with employee equity plans of $47.9&#160;million and $144.8&#160;million, which reduced our effective tax rate by 13.5 and 18.8 percentage points, respectively. The amount of excess tax benefits or deficiencies will fluctuate from period to period based on the price of our stock, the volume of share-based instruments settled or vested, and the value assigned to employee equity awards under U.S. GAAP, which results in increased income tax expense volatility.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file federal, state, and foreign income tax returns in many U.S. and OUS jurisdictions. Years before 2016 are closed for the significant jurisdictions. Certain of our unrecognized tax benefits could change due to activities of various tax authorities, including evolving interpretations of existing tax laws in the jurisdictions we operate, potential assessment of additional tax, possible settlement of audits, or through normal expiration of various statutes of limitations, which could affect our effective tax rate in the period in which they change. Due to the uncertainty related to the timing and potential outcome of audits, we cannot estimate the range of reasonably possible change in unrecognized tax benefits that may occur in the next 12 months.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the examination of our income tax returns by the IRS and other tax authorities. The outcome of these audits cannot be predicted with certainty. Management regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. If any issues addressed in our tax audits are resolved in a manner not consistent with management&#8217;s expectations, we could be required to adjust our provision for income taxes in the period such resolution occurs.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_136"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Income Attributable to Noncontrolling Interest in Joint Venture</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to noncontrolling interest in Joint Venture for the three and nine months ended September&#160;30, 2021, was $6.7 million and $21.4 million, respectively. Net income attributable to noncontrolling interest in Joint Venture for the three and nine months ended September&#160;30, 2020, was $2.9 million and $7.8&#160;million, respectively. The increase in net income attributable to noncontrolling interest in Joint Venture was primarily due to increased sales in China during the three and nine months ended September&#160;30, 2021, as well as re-measurement losses related to contingent consideration during the three and nine months ended September&#160;30, 2020, which did not recur in the same periods of 2021 as the contingent consideration has been finalized and paid.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_139"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div id="i944f300b8c29463aa56139ed7eaca296_142"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources and Uses of Cash</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal source of liquidity is cash provided by operations and by the issuance of common stock through the exercise of stock options and our employee stock purchase program. Cash and cash equivalents plus short- and long-term investments increased by $1.35&#160;billion to $8.22&#160;billion as of September&#160;30, 2021, from $6.87&#160;billion as of December&#160;31, 2020, primarily from cash provided by our operations and proceeds from stock option exercises and employee stock purchases, partially offset by capital expenditures and taxes paid related to net share settlements of equity awards.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash requirements depend on numerous factors, including market acceptance of our products, the resources we devote to developing and supporting our products, and other factors. We expect to continue to devote substantial resources to expand procedure adoption and acceptance of our products. We have made substantial investments in our commercial operations, product development activities, facilities, and intellectual property. Based upon our business model, we anticipate that we will continue to be able to fund future growth through cash provided by our operations. We believe that our current cash, cash equivalents, and investment balances, together with income to be derived from the sale of our products, will be sufficient to meet our liquidity requirements for the foreseeable future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Item&#160;7A. Quantitative and Qualitative Disclosures About Market Risk&#8221; in our Form 10-K for the fiscal year ended December&#160;31, 2020, for discussion on the impact of interest rate risk and market risk on our investment portfolio.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_145"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Condensed Consolidated Cash Flow Data</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows for the nine months ended September&#160;30, 2021, and 2020 (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,820.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(606.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rates on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2021, net cash provided by operating activities of $1,522 million exceeded our net income of $1,345 million, primarily due to the following reasons:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Our net income included non-cash charges of $534 million, consisting primarily of the following significant items: share-based compensation of $331 million; depreciation expense and losses on the disposal of property, plant, and equipment of $209 million; changes in deferred income taxes of $(41) million; and amortization of intangible assets of $21 million.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The non-cash charges outlined above were partially offset by changes in operating assets and liabilities that resulted in $357 million of cash used by operating activities during the nine months ended September&#160;30, 2021. Prepaid expenses and other assets increased by $217 million, primarily due to an increase in prepaid taxes, driven by the timing of tax payments, and an increase in leasing. Inventory, including the effect of systems inventory built and transferred to property, plant, and equipment as a result of systems placed under operating lease and usage-based arrangements, increased by $189 million, primarily to address the growth in the business as well as to mitigate risks of disruption that could arise from trade, supply, or other matters. Refer to further details in the supplemental cash flow information in Note 4 to the Condensed Consolidated Financial Statements (Unaudited) included in Item&#160;1, Part I. Accounts receivable increased by $55 million, primarily due to the timing of collections. The unfavorable impact of these items on cash provided by operating activities was partially offset by a $36 million increase in accounts payable, primarily due to the timing of payments and vendor billings, a $35 million increase in other liabilities, primarily due to the timing of payments, and a $30 million increase in accrued compensation and employee benefits, primarily due to higher headcount and variable compensation.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_151"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities for the nine months ended September&#160;30, 2021, consisted primarily of purchases of investments (net of proceeds from sales and maturities of investments) of $1,609 million, the acquisition of property and equipment of $203 million, and the acquisition of a business, net of cash acquired, of $9 million. We invest predominantly in high quality, fixed income securities. Our investment portfolio may, at any time, contain investments in U.S. treasury and U.S. government agency securities, taxable and tax-exempt municipal notes, corporate notes and bonds, commercial paper, non-U.S. government agency securities, cash deposits, and money market funds.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_154"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities during the nine months ended September&#160;30, 2021, consisted primarily of proceeds from stock options and exercises and employee stock purchases of $245 million, partially offset by taxes paid on behalf of employees related to net share settlements of vested employee stock purchases of&#160;$201 million and the payment of deferred purchase consideration from prior acquisitions of $19 million.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_157"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Expenditures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is not capital equipment intensive. However, with the growth of our business and our investments in property and facilities and in manufacturing automation, capital investments in these areas have increased. We expect these capital investments to exceed $300&#160;million in 2021 and increase further in 2022. We intend to fund these needs with cash generated from operations.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_160"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion and analysis of our financial condition and results of operations are based upon our Financial Statements, which have been prepared in accordance with U.S. GAAP. The preparation of these Financial Statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses. On an ongoing basis, we evaluate our critical accounting estimates. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. There have been no new or material changes to the critical accounting estimates discussed in our Annual Report on Form 10-K for the fiscal year ended&#160;December&#160;31, 2020, that are of significance, or potential significance, to us.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;3.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in our market risk during the nine months ended September&#160;30, 2021, compared to the disclosures in Part II, Item&#160;7A of our Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_166"></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by SEC Rule 13a-15(b), we carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been no change in our internal control over financial reporting that occurred during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div id="i944f300b8c29463aa56139ed7eaca296_172"></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information included in Note 8 to the Condensed Consolidated Financial Statements (Unaudited) included in Part I, Item 1 of this quarterly report is incorporated herein by reference.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_175"></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider the factors discussed in Part I, &#8220;Item 1A. Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, which could materially affect our business, financial position, or future results of operations. The risks described in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial position, or future results of operations. The risk factors set forth below update, and should be read together with, the risk factors described in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RISKS RELATING TO OUR BUSINESS</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUR RELIANCE ON SOLE AND SINGLE SOURCE SUPPLIERS AND OUR ABILITY TO PURCHASE AT ACCEPTABLE PRICES A SUFFICIENT AMOUNT OF MATERIALS, PARTS, AND COMPONENTS COULD HARM OUR ABILITY TO MEET DEMAND FOR OUR PRODUCTS IN A TIMELY MANNER OR WITHIN BUDGET.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the components necessary for the assembly of our products are currently provided to us by sole-sourced suppliers or single-sourced suppliers. We generally purchase components through purchase orders rather than long-term supply agreements and generally do not maintain large volumes of inventory. While alternative suppliers exist and could be identified for single-sourced components, the disruption or termination of the supply of components, or inflationary pressure in our supply chain, could cause a significant increase in the costs of these components, which could affect our operating results. A disruption or termination in the supply of components could also result in our inability to meet demand for our products, which could harm our ability to generate revenues, lead to customer dissatisfaction, and damage our reputation and our brand. Furthermore, if we are required to change the manufacturer of a key component of our products, we may be required to verify that the new manufacturer maintains facilities and procedures that comply with quality standards and with all applicable regulations and guidelines. The time and processes associated with the verification of a new manufacturer could delay our ability to manufacture our products on schedule or within budget, which may have a material adverse impact on our business, financial condition, results of operations, or cash flows.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our ability to meet customers&#8217; demands depends, in part, on our ability to timely obtain an adequate delivery of quality materials, parts, and components from our suppliers. An information technology systems interruption, including cybersecurity attacks, could adversely affect the ordering, distribution, and manufacturing processes of our suppliers. Difficulties in obtaining a sufficient amount of semiconductor and other component materials continue to increase, and we expect such difficulties to persist in the foreseeable future. Prices of such materials have also increased, and global supply has become significantly constrained due to the increased demand for materials, including semiconductors, to support expansion of server and cloud networks as a greater proportion of the global population worked remotely, the introduction of 5G, and the continued electrification of vehicles. We engage in activities to seek to mitigate such supply disruptions by, for example, increasing our communications with our suppliers and modifying our purchase order coverage and inventory levels. However, notwithstanding these activities, the global semiconductor and materials supply shortage is likely to remain a challenge for the foreseeable future. Such global shortages in important components have resulted in, and will continue to cause, inflationary pressure in our supply chain, which would impact our profits and profit margin. If shortages and price increases in important supply-chain materials in the semiconductor or other markets continue, we could also fail to meet product demand, which would adversely impact our business, financial condition, results of operations, or cash flows.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DISRUPTION OF CRITICAL INFORMATION SYSTEMS OR MATERIAL BREACHES IN THE SECURITY OF OUR SYSTEMS COULD HARM OUR BUSINESS, CUSTOMER RELATIONS, AND FINANCIAL CONDITION.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information technology helps us serve and interface with customers, maintain our supply chain and manufacturing operations, operate effectively and efficiently, maintain financial accuracy and efficiency, and accurately produce our financial statements. If we do not allocate and effectively manage the resources necessary to build and sustain the proper technology infrastructure, we could be subject to transaction errors, processing inefficiencies, the loss of customers, business disruptions or the unauthorized access to, loss of, or damage to intellectual property, confidential information, or personally identifiable information (&#8220;PII&#8221;). If our data management systems do not effectively collect, store, process, and report relevant data for the operation of our business, whether due to equipment malfunction or constraints, software deficiencies, security incidents, or human error, our ability to effectively plan, forecast, and execute our business plan and comply with applicable laws and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulations would be impaired, perhaps materially. Any such impairment could materially and adversely affect our financial condition, results of operations, cash flows, and the timeliness with which we report our internal and external operating results.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business requires us to use and store customer, employee, and business partner PII. This may include names, addresses, phone numbers, email addresses, contact preferences, tax identification numbers, and payment account information. We require user names and passwords in order to access our information technology systems. We also use encryption and authentication technologies to secure the transmission and storage of data. These security measures may be compromised as a result of security breaches by unauthorized persons, employee error, malfeasance, faulty password management, or other irregularity and result in persons obtaining unauthorized access to our data or accounts. Third parties may attempt to fraudulently induce employees or customers into disclosing user names, passwords, or other sensitive information, which may in turn be used to access our information technology systems. For example, our employees have received &#8220;phishing&#8221; emails and phone calls attempting to induce them to divulge passwords and other sensitive information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, unauthorized persons may attempt to hack into our products or systems to obtain personal data relating to patients or employees, our confidential or proprietary information, or confidential information we hold on behalf of third parties. If the unauthorized persons successfully hack into or interfere with our connected products or services, they may create issues with product functionality that could pose a risk of loss of data, a risk to patient safety, and a risk of product recall or field activity, which could adversely impact our business and reputation. We have programs in place to detect, contain, and respond to data security incidents, and we make ongoing improvements to our information-sharing products in order to minimize vulnerabilities, in accordance with industry and regulatory standards. However, because the techniques used to obtain unauthorized access to or steal PII or intellectual property, or sabotage systems containing PII or intellectual property, change frequently and may be difficult to detect, we may not be able to anticipate and prevent these intrusions or mitigate them when and if they occur.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely on external vendors to supply and/or support certain aspects of our information technology systems. The systems of these external vendors may contain defects in design or manufacture or other problems that could unexpectedly compromise information security of our own systems, and we are dependent on these third parties to deploy appropriate security programs to protect their systems. In addition to potential exposure to data breaches, security incidents, or other actions that may compromise the security of or interfere with the function of our systems, defects or vulnerabilities in the software or systems of our external vendors may expose failures in our internal controls and risk management processes, which may adversely impact our business, financial condition, results of operations, or cash flows and may also harm our reputation, brand, and customer relationships.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we devote significant resources to network security, data encryption, and other security measures to protect our systems and data, these security measures cannot provide absolute security. We may experience a breach of our systems and may be unable to protect PII, confidential, or sensitive data. It is possible for such vulnerabilities to remain undetected for an extended period, including several years or longer. The costs to us to eliminate or alleviate network security problems, bugs, viruses, worms, ransomware and other malicious software programs, and security vulnerabilities could be significant. Our efforts to address these problems may not be successful and could result in unexpected interruptions, delays, cessation of service, and harm to our business operations. Moreover, if a computer security breach affects our systems or results in the unauthorized release of PII, our reputation and brand could be materially damaged, and use of our products and services could decrease. We would also be exposed to a risk of loss, litigation and potential liability, and regulatory scrutiny, which could have a material adverse impact on our business, financial condition, results of operations, or cash flows.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_178"></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no unregistered sales of equity securities during the period covered by this report.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c) Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes our stock repurchase activity for the quarter ended September&#160;30, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:38.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.887%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares<br/>Repurchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>Price&#160;Paid<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of<br/>Shares&#160;Purchased&#160;As<br/>Part of a Publicly<br/>Announced Program</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Dollar<br/>Amount&#160;of&#160;Shares&#160;That<br/>May Yet be Purchased<br/>Under the Program (1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1 to July 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;billion</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1 to August 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;billion</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1 to September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;billion</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total during quarter ended September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Since March 2009, we have had a stock repurchase program in place. As of&#160;September&#160;30, 2021, our Board of Directors (the &#8220;Board&#8221;) had authorized an aggregate amount of up to&#160;$7.5&#160;billion&#160;for stock repurchases, of which the most recent authorization occurred in January 2019, when the Board increased the authorized amount available under our share repurchase program to&#160;$2.0&#160;billion. The remaining $1.6&#160;billion&#160;represents the amount available to repurchase shares under the authorized repurchase program as of&#160;September&#160;30, 2021. The authorized stock repurchase program does not have an expiration date.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_181"></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_184"></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i944f300b8c29463aa56139ed7eaca296_187"></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_190"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;&#160;&#160;EXHIBITS</span></div><div style="margin-bottom:6pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit31-arcertificateofi.htm">Amended and Restated Certificate of Incorporation of Intuitive Surgical, Inc., as amended</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1035267/000103526721000021/exhibit31-amendedandrestat.htm">Amended and Restated Bylaws of Intuitive Surgical, Inc. (incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed with the Securities and Exchange Commission on&#160;February&#160;1, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-311q321.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-312q321.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-321q321.htm">Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-322q321.htm">Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from Intuitive Surgical, Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2021, formatted in Inline XBRL (Extensible Business Reporting Language): (i) the unaudited Condensed Consolidated Balance Sheets, (ii) the unaudited Condensed Consolidated Statements of Comprehensive Income, (iii) the unaudited Condensed Consolidated Statements of Cash Flows, and (iv) Notes to Condensed Consolidated Financial Statements (unaudited), tagged at Level I through IV.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, formatted in Inline XBRL and contained in Exhibit 101.</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i944f300b8c29463aa56139ed7eaca296_193"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i944f300b8c29463aa56139ed7eaca296_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:right;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.263%"><tr><td style="width:1.0%"></td><td style="width:7.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.996%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INTUITIVE SURGICAL, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ MARSHALL L. MOHR</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marshall L. Mohr</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and duly authorized signatory)</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: October&#160;20, 2021</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>exhibit31-arcertificateofi.htm
<DESCRIPTION>EX-3.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i58e93ba35bdd4953b7c13a0e3d3a1044_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 3.1</font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATE OF AMENDMENT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDED AND RESTATED CERTIFICATE OF INCORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTUITIVE SURGICAL, INC.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intuitive Surgical, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify that&#58; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FIRST</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; Paragraph (A) of Article IV of the Amended and Restated Certificate of Incorporation is hereby amended to read in its entirety as follows&#58; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;A. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Classes of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This corporation is authorized to issue two classes of stock to be designated, respectively, &#8220;Common Stock&#8221; and &#8220;Preferred Stock.&#8221; The total number of shares which the corporation is authorized to issue is six hundred two million five hundred thousand (602,500,000) shares, of which six hundred million (600,000,000) shares shall be Common Stock, par value $0.001 per share, and two million five hundred thousand (2,500,000) shares shall be Preferred stock, par value $0.001 per share. At the effective time of this Certificate of Amendment, each issued and outstanding share of the corporation&#8217;s Common Stock shall be divided into three (3) validly issued, fully paid and non-assessable shares of Common Stock reflecting a three (3) for one (1) stock split (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Split</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The Stock Split shall occur without any further action on the part of the corporation or the holders of shares of Common Stock and whether or not certificates representing such holders&#8217; shares prior to the Stock Split are surrendered for cancellation.&#8221;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECOND</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; The said amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Corporation has caused this Certificate of Amendment to be signed and made effective as of this 27th day of September 2021.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.981%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Siang Chin</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Vice President, Assistant General Counsel, and Corporate Secretary</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>ex-311q321.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iae5baa53b6404d4bb2fb20b8d229a2e0_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">EXHIBIT 31.1</font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Certification of Chief Executive Officer</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, Gary S. Guthart, certify that&#58;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Intuitive Surgical, Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;  October&#160;20, 2021 </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.243%"><tr><td style="width:1.0%"></td><td style="width:17.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.189%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47; G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">ARY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%"> S. G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">UTHART</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:144%">Gary S. Guthart, Ph.D.</font></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:144%">President and Chief Executive Officer</font></div></td></tr></table></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>ex-312q321.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i5c578a93e1c5461597f2b1f3e87a8479_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">EXHIBIT 31.2</font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Certification of Chief Financial Officer</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, Marshall L. Mohr, certify that&#58;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Intuitive Surgical, Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;  October&#160;20, 2021 </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.243%"><tr><td style="width:1.0%"></td><td style="width:17.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.189%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47; M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">ARSHALL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%"> L. M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">OHR</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:144%">Marshall L. Mohr</font></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:144%">Executive Vice President and Chief Financial Officer</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>ex-321q321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="idc87fb57b1374b1690c67ec6b61c97f0_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">EXHIBIT 32.1</font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Certification of Chief Executive Officer</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Intuitive Surgical, Inc. (the &#8220;Company&#8221;) hereby certifies, to such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:8.57pt">the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended September&#160;30, 2021 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:5.8pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;  October&#160;20, 2021 </font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.243%"><tr><td style="width:1.0%"></td><td style="width:17.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.189%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47; G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">ARY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%"> S. G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">UTHART</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:144%">Gary S. Guthart, Ph.D.</font></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:144%">President and Chief Executive Officer</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>ex-322q321.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i24cf8f35706b49b1a88ba207fb5c61a3_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">EXHIBIT 32.2</font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Certification of Chief Financial Officer</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Intuitive Surgical, Inc. (the &#8220;Company&#8221;) hereby certifies, to such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:8.57pt">the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended September&#160;30, 2021 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:5.8pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;  October&#160;20, 2021 </font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.243%"><tr><td style="width:1.0%"></td><td style="width:17.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.189%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47; M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">ARSHALL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%"> L. M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">OHR</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:144%">Marshall L. Mohr</font></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:144%">Executive Vice President and Chief Financial Officer</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>isrg-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4f3ead07-f4ad-4d18-aec5-70406fe3497c,g:13f40b2a-7689-41e3-982f-2ccf6cf675cb-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:isrg="http://www.intuitivesurgical.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.intuitivesurgical.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="isrg-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="isrg-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="isrg-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="isrg-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.intuitivesurgical.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFTHEBUSINESS" roleURI="http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS">
        <link:definition>2101101 - Disclosure - DESCRIPTION OF THE BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTS" roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS">
        <link:definition>2104103 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSTables" roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables">
        <link:definition>2305301 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails" roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails">
        <link:definition>2406401 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Cash and Available-For-Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1" roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1">
        <link:definition>2406401 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Cash and Available-For-Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails" roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails">
        <link:definition>2407402 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails" roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails">
        <link:definition>2408403 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Equity Investment Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails" roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails">
        <link:definition>2409404 - Disclosure - FINANCIAL INSTRUMENTS - Derivative Instruments Used to Hedge against Balance Sheet Foreign Currency Exposures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails" roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails">
        <link:definition>2410405 - Disclosure - FINANCIAL INSTRUMENTS - Gross Notional Amounts for Outstanding Derivatives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION" roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION">
        <link:definition>2111104 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables" roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables">
        <link:definition>2312302 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails" roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails">
        <link:definition>2413406 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails" roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails">
        <link:definition>2414407 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Prepaids and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails" roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails">
        <link:definition>2415408 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Accrued Liabilities - Short-term (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails" roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails">
        <link:definition>2416409 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Long-term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails" roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails">
        <link:definition>2417410 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDCONTRACTACQUISITIONCOSTS" roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS">
        <link:definition>2118105 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDCONTRACTACQUISITIONCOSTSTables" roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables">
        <link:definition>2319303 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails" roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails">
        <link:definition>2420411 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Revenue Disaggregated by Types and Geography (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails" roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails">
        <link:definition>2421412 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1" roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1">
        <link:definition>2421412 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails" roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails">
        <link:definition>2422413 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Summary of Contract Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails" roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails">
        <link:definition>2423414 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Sales-type and Operating Lease Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.intuitivesurgical.com/role/LEASES">
        <link:definition>2124106 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.intuitivesurgical.com/role/LEASESTables">
        <link:definition>2325304 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESLeaseReceivablesDetails" roleURI="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails">
        <link:definition>2426415 - Disclosure - LEASES - Lease Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESLeaseReceivablesDetails_1" roleURI="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1">
        <link:definition>2426415 - Disclosure - LEASES - Lease Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails" roleURI="http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails">
        <link:definition>2427416 - Disclosure - LEASES - Schedule of Contractual Maturities of Gross Lease Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESCreditQualityIndicatorDetails" roleURI="http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails">
        <link:definition>2428417 - Disclosure - LEASES - Credit Quality Indicator (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESAdditionalInformationDetails" roleURI="http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails">
        <link:definition>2429418 - Disclosure - LEASES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>2130107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>2331305 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails" roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails">
        <link:definition>2432419 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Summary of Changes in Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails" roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails">
        <link:definition>2433420 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails" roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails">
        <link:definition>2434421 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule Of Estimated Future Amortization Expense Of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONTINGENCIES" roleURI="http://www.intuitivesurgical.com/role/CONTINGENCIES">
        <link:definition>2135108 - Disclosure - CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY">
        <link:definition>2136109 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>2337306 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails" roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails">
        <link:definition>2438422 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Stockholders Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails" roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails">
        <link:definition>2439423 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Share Repurchase Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails">
        <link:definition>2440424 - Disclosure - STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails" roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails">
        <link:definition>2441425 - Disclosure - STOCKHOLDERS' EQUITY - Components of Accumulated Other Comprehensive Income, Net of Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATION" roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION">
        <link:definition>2142110 - Disclosure - SHARE-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONTables" roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables">
        <link:definition>2343307 - Disclosure - SHARE-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONAdditionalInformationDetails" roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails">
        <link:definition>2444426 - Disclosure - SHARE-BASED COMPENSATION - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails" roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails">
        <link:definition>2445427 - Disclosure - SHARE-BASED COMPENSATION - Summary of Stock Option Activity Under All Stock Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails" roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails">
        <link:definition>2446428 - Disclosure - SHARE-BASED COMPENSATION - Summary of RSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails">
        <link:definition>2447429 - Disclosure - SHARE-BASED COMPENSATION - Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails" roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails">
        <link:definition>2448430 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Estimated Fair Value of Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.intuitivesurgical.com/role/INCOMETAXES">
        <link:definition>2149111 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESAdditionalInformationDetails" roleURI="http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails">
        <link:definition>2450431 - Disclosure - INCOME TAXES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARE" roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE">
        <link:definition>2151112 - Disclosure - NET INCOME PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARETables" roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables">
        <link:definition>2352308 - Disclosure - NET INCOME PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails" roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails">
        <link:definition>2453432 - Disclosure - NET INCOME PER SHARE - Computation of Basic and Diluted Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHAREAdditionalInformationDetails" roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails">
        <link:definition>2454433 - Disclosure - NET INCOME PER SHARE - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="isrg_ConsolidatingReportingDomain" abstract="true" name="ConsolidatingReportingDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock" abstract="false" name="LessorSalesTypeLeaseLeaseIncomeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="isrg_ResearchAndDevelopmentMember" abstract="true" name="ResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="isrg_IntangibleAndOtherAssetsNetMember" abstract="true" name="IntangibleAndOtherAssetsNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="isrg_DeferredPurchaseConsiderationPaymentsCurrent" abstract="false" name="DeferredPurchaseConsiderationPaymentsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="isrg_SalesTypeLeaseGrossInvestmentInLease" abstract="false" name="SalesTypeLeaseGrossInvestmentInLease" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_IntangibleAndOtherAssets" abstract="false" name="IntangibleAndOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract" abstract="true" name="AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" abstract="false" name="OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_ServicesMember" abstract="true" name="ServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" abstract="false" name="AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_ModerateMember" abstract="true" name="ModerateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" abstract="false" name="CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent" abstract="false" name="SalesTypeLeaseNetInvestmentInLeaseCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_SellingGeneralAndAdministrativeMember" abstract="true" name="SellingGeneralAndAdministrativeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="isrg_HighMember" abstract="true" name="HighMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="isrg_CommonStockRepurchaseProgramMember" abstract="true" name="CommonStockRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="isrg_SystemsMember" abstract="true" name="SystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="isrg_InstrumentsandAccessoriesMember" abstract="true" name="InstrumentsandAccessoriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="isrg_ConsolidatingReportingAxis" abstract="true" name="ConsolidatingReportingAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" abstract="false" name="CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract" abstract="true" name="AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" abstract="false" name="BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_CostOfSalesServiceMember" abstract="true" name="CostOfSalesServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="isrg_AccumulatedOtherComprehensiveIncomeRollForward" abstract="true" name="AccumulatedOtherComprehensiveIncomeRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="isrg_SalestypeLeaseDeferredSellingProfit" abstract="false" name="SalestypeLeaseDeferredSellingProfit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" abstract="false" name="EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_CostOfSalesProductMember" abstract="true" name="CostOfSalesProductMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="isrg_A2010IncentiveAwardPlanMember" abstract="true" name="A2010IncentiveAwardPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="isrg_StockRepurchaseProgramincreasedtoauthorizedamount" abstract="false" name="StockRepurchaseProgramincreasedtoauthorizedamount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" abstract="false" name="SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_CollarContractMember" abstract="true" name="CollarContractMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="isrg_LowMember" abstract="true" name="LowMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>isrg-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4f3ead07-f4ad-4d18-aec5-70406fe3497c,g:13f40b2a-7689-41e3-982f-2ccf6cf675cb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="isrg-20210930.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ecf1a1c7-12b7-4cd7-aa49-54f989040636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_51303593-7bf3-472e-b6b9-dab0f69413ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ecf1a1c7-12b7-4cd7-aa49-54f989040636" xlink:to="loc_us-gaap_PreferredStockValue_51303593-7bf3-472e-b6b9-dab0f69413ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_038a04db-1778-4a92-af48-5cff627f8ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ecf1a1c7-12b7-4cd7-aa49-54f989040636" xlink:to="loc_us-gaap_CommonStockValue_038a04db-1778-4a92-af48-5cff627f8ee7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_08575a0d-2ae7-4862-b482-b1e2d394a07e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ecf1a1c7-12b7-4cd7-aa49-54f989040636" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_08575a0d-2ae7-4862-b482-b1e2d394a07e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2a87138c-184c-49a7-8f69-5a173a1c9da6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ecf1a1c7-12b7-4cd7-aa49-54f989040636" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2a87138c-184c-49a7-8f69-5a173a1c9da6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_137c82fc-2147-42fa-ad3b-d0a824df4327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ecf1a1c7-12b7-4cd7-aa49-54f989040636" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_137c82fc-2147-42fa-ad3b-d0a824df4327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1530f9a5-62fe-4440-a91f-fea1ef9b614b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_676bf8e2-8f46-42f1-a885-f205df2203eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1530f9a5-62fe-4440-a91f-fea1ef9b614b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_676bf8e2-8f46-42f1-a885-f205df2203eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_74ebb9f6-3a40-4c24-bf50-8bc691e8f4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1530f9a5-62fe-4440-a91f-fea1ef9b614b" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_74ebb9f6-3a40-4c24-bf50-8bc691e8f4d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7953200e-a0ca-4417-a8fb-ae5ae81b9876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1530f9a5-62fe-4440-a91f-fea1ef9b614b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7953200e-a0ca-4417-a8fb-ae5ae81b9876" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_712e1d9a-6be1-4d32-a8ed-49e4eba2ca4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1530f9a5-62fe-4440-a91f-fea1ef9b614b" xlink:to="loc_us-gaap_InventoryNet_712e1d9a-6be1-4d32-a8ed-49e4eba2ca4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5a426ce2-26d6-499a-b71a-5504422aca94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1530f9a5-62fe-4440-a91f-fea1ef9b614b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5a426ce2-26d6-499a-b71a-5504422aca94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2a41ac75-469b-4bed-a3d0-ce065e216990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1012c84a-b13c-4f25-a554-faddc4948f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2a41ac75-469b-4bed-a3d0-ce065e216990" xlink:to="loc_us-gaap_Liabilities_1012c84a-b13c-4f25-a554-faddc4948f52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b26f4234-345e-4b93-b302-544b76b00f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2a41ac75-469b-4bed-a3d0-ce065e216990" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b26f4234-345e-4b93-b302-544b76b00f44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3d7e0dc9-a159-42b9-b010-afa451b5462f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2a41ac75-469b-4bed-a3d0-ce065e216990" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3d7e0dc9-a159-42b9-b010-afa451b5462f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_cf270c80-a6cc-42b3-b352-067340bae4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2133fdea-fb28-4d8b-bfe0-0b178d13849b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_cf270c80-a6cc-42b3-b352-067340bae4bf" xlink:to="loc_us-gaap_LiabilitiesCurrent_2133fdea-fb28-4d8b-bfe0-0b178d13849b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_e9120d29-3c96-4fa4-848d-16a1aa6700b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_cf270c80-a6cc-42b3-b352-067340bae4bf" xlink:to="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_e9120d29-3c96-4fa4-848d-16a1aa6700b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f5107be9-135d-4e7c-93dc-b5ed2f01c183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_45293fcd-538c-4023-a463-4bc25055df61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f5107be9-135d-4e7c-93dc-b5ed2f01c183" xlink:to="loc_us-gaap_AccountsPayableCurrent_45293fcd-538c-4023-a463-4bc25055df61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_afdb0e22-8b2a-4a25-9200-f6f6c1e0e56a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f5107be9-135d-4e7c-93dc-b5ed2f01c183" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_afdb0e22-8b2a-4a25-9200-f6f6c1e0e56a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_e46d27fd-72cc-49de-be03-19681232eb7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f5107be9-135d-4e7c-93dc-b5ed2f01c183" xlink:to="loc_us-gaap_DeferredRevenueCurrent_e46d27fd-72cc-49de-be03-19681232eb7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_12239fac-aff7-42bb-a340-7a981a984597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f5107be9-135d-4e7c-93dc-b5ed2f01c183" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_12239fac-aff7-42bb-a340-7a981a984597" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2a895e4c-4d07-435d-97ab-9582653d4584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8b15a813-b1f2-46fa-b828-6bc908fcacf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2a895e4c-4d07-435d-97ab-9582653d4584" xlink:to="loc_us-gaap_AssetsCurrent_8b15a813-b1f2-46fa-b828-6bc908fcacf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d76f2358-59b1-4150-b054-59d2d47caee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2a895e4c-4d07-435d-97ab-9582653d4584" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d76f2358-59b1-4150-b054-59d2d47caee9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_0a5ef835-bc50-4576-92db-fc9a3fafb133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2a895e4c-4d07-435d-97ab-9582653d4584" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_0a5ef835-bc50-4576-92db-fc9a3fafb133" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_011ce881-fa27-4bd6-ab84-3f60c26c6601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2a895e4c-4d07-435d-97ab-9582653d4584" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_011ce881-fa27-4bd6-ab84-3f60c26c6601" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_IntangibleAndOtherAssets_2b2ffb42-2ec9-4ac0-88c3-bf965a014465" xlink:href="isrg-20210930.xsd#isrg_IntangibleAndOtherAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2a895e4c-4d07-435d-97ab-9582653d4584" xlink:to="loc_isrg_IntangibleAndOtherAssets_2b2ffb42-2ec9-4ac0-88c3-bf965a014465" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_09ad1dac-85da-4bf4-9a8c-6d1f0cb8f6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2a895e4c-4d07-435d-97ab-9582653d4584" xlink:to="loc_us-gaap_Goodwill_09ad1dac-85da-4bf4-9a8c-6d1f0cb8f6b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_646c9556-5e61-4740-adcf-81c2aa412871" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ca5ed0c2-c48f-41a8-8b6a-9e2857617345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_646c9556-5e61-4740-adcf-81c2aa412871" xlink:to="loc_us-gaap_StockholdersEquity_ca5ed0c2-c48f-41a8-8b6a-9e2857617345" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_a9165559-4641-4da2-90ec-19f87eb0948a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_646c9556-5e61-4740-adcf-81c2aa412871" xlink:to="loc_us-gaap_MinorityInterest_a9165559-4641-4da2-90ec-19f87eb0948a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="isrg-20210930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6ff7666a-1aee-429f-8585-c7a04ffff08c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_485fc047-81c2-4537-8d9c-0081469b7129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6ff7666a-1aee-429f-8585-c7a04ffff08c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_485fc047-81c2-4537-8d9c-0081469b7129" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7892ba74-7823-4370-b0a3-1098c412e465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6ff7666a-1aee-429f-8585-c7a04ffff08c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7892ba74-7823-4370-b0a3-1098c412e465" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2b775170-2c72-417a-b975-547815cd3e57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8a2323fb-0492-44aa-9618-2065817bba73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2b775170-2c72-417a-b975-547815cd3e57" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8a2323fb-0492-44aa-9618-2065817bba73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_26e0ea13-7e36-4ebc-bd3d-5a306c2c2ead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2b775170-2c72-417a-b975-547815cd3e57" xlink:to="loc_us-gaap_ProfitLoss_26e0ea13-7e36-4ebc-bd3d-5a306c2c2ead" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3d5c0a95-4358-464f-8ee7-0adb3995642c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6259641b-adeb-4463-a980-d534bad3d8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_3d5c0a95-4358-464f-8ee7-0adb3995642c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6259641b-adeb-4463-a980-d534bad3d8cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ece1ccba-db81-4ec0-a596-6e486d45108a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_3d5c0a95-4358-464f-8ee7-0adb3995642c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ece1ccba-db81-4ec0-a596-6e486d45108a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_286f94b3-8c4b-463c-8e68-afb611d1266d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4f65a495-50b8-48e2-8cc2-d694a9b3df11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_286f94b3-8c4b-463c-8e68-afb611d1266d" xlink:to="loc_us-gaap_OperatingIncomeLoss_4f65a495-50b8-48e2-8cc2-d694a9b3df11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_6a6f1220-8e17-4cb0-8a83-ba58ce3e4e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_286f94b3-8c4b-463c-8e68-afb611d1266d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_6a6f1220-8e17-4cb0-8a83-ba58ce3e4e7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_8a588c35-824b-4605-92ce-55a3ed77b6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_38fe03ed-ead3-460a-97a0-0b728edd98b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_8a588c35-824b-4605-92ce-55a3ed77b6ff" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_38fe03ed-ead3-460a-97a0-0b728edd98b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_95a67739-c81e-4c06-911d-06da16d371f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_8a588c35-824b-4605-92ce-55a3ed77b6ff" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_95a67739-c81e-4c06-911d-06da16d371f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e7023f20-a96c-452c-a122-6737c7667f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c911aa0d-bece-4a5a-9d84-07b1eaa2274f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e7023f20-a96c-452c-a122-6737c7667f3f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c911aa0d-bece-4a5a-9d84-07b1eaa2274f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_667010a7-c27c-43ef-813c-be4da8d7e5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e7023f20-a96c-452c-a122-6737c7667f3f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_667010a7-c27c-43ef-813c-be4da8d7e5c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fd72f11d-23ca-40d2-b250-7b14686aa989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_6e4a2b49-296a-4f0d-b356-71cbafe49375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_fd72f11d-23ca-40d2-b250-7b14686aa989" xlink:to="loc_us-gaap_GrossProfit_6e4a2b49-296a-4f0d-b356-71cbafe49375" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6e6104ce-4002-4a1b-8d3b-899b0017102d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_fd72f11d-23ca-40d2-b250-7b14686aa989" xlink:to="loc_us-gaap_OperatingExpenses_6e6104ce-4002-4a1b-8d3b-899b0017102d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="isrg-20210930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2ab69bbf-cfab-43f2-bffb-2b04a1951364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a626860e-64b9-4ff5-82a4-284b37bc0dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2ab69bbf-cfab-43f2-bffb-2b04a1951364" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a626860e-64b9-4ff5-82a4-284b37bc0dfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_96b014c8-e3c3-4558-b99b-12569474968a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2ab69bbf-cfab-43f2-bffb-2b04a1951364" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_96b014c8-e3c3-4558-b99b-12569474968a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8f4d55e5-f433-447e-b02a-f5330b14a6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2ab69bbf-cfab-43f2-bffb-2b04a1951364" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8f4d55e5-f433-447e-b02a-f5330b14a6ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_006aaabd-1155-4306-9c11-fcb96106965d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2ab69bbf-cfab-43f2-bffb-2b04a1951364" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_006aaabd-1155-4306-9c11-fcb96106965d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0fb61051-b784-4cfa-bbcb-7358fcc350ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_2f364ab5-d64e-4de6-b34d-1c789e0f0da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0fb61051-b784-4cfa-bbcb-7358fcc350ea" xlink:to="loc_us-gaap_ProceedsFromStockPlans_2f364ab5-d64e-4de6-b34d-1c789e0f0da2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c5d48988-d4de-499e-bb03-a4e12f1947c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0fb61051-b784-4cfa-bbcb-7358fcc350ea" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c5d48988-d4de-499e-bb03-a4e12f1947c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d3f44e17-1a14-45f0-b5b5-a599c0bc46e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0fb61051-b784-4cfa-bbcb-7358fcc350ea" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d3f44e17-1a14-45f0-b5b5-a599c0bc46e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_258eee42-830e-491d-beda-42bf19cbd265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0fb61051-b784-4cfa-bbcb-7358fcc350ea" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_258eee42-830e-491d-beda-42bf19cbd265" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e2c005-e1e7-4646-a7ce-53b80409c73c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b32db769-cf5c-4aee-8640-969279f6577d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e2c005-e1e7-4646-a7ce-53b80409c73c" xlink:to="loc_us-gaap_ProfitLoss_b32db769-cf5c-4aee-8640-969279f6577d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_4565869a-307c-4a74-a1e5-9dbd49f12752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e2c005-e1e7-4646-a7ce-53b80409c73c" xlink:to="loc_us-gaap_Depreciation_4565869a-307c-4a74-a1e5-9dbd49f12752" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_cc17852b-6bd5-4dc0-8f18-4be5846e9247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e2c005-e1e7-4646-a7ce-53b80409c73c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_cc17852b-6bd5-4dc0-8f18-4be5846e9247" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_865aba6d-a5d0-4b63-b3c5-7fe103a54aee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e2c005-e1e7-4646-a7ce-53b80409c73c" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_865aba6d-a5d0-4b63-b3c5-7fe103a54aee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d615a602-7bdf-4fa0-b51a-8047fa39c6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e2c005-e1e7-4646-a7ce-53b80409c73c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d615a602-7bdf-4fa0-b51a-8047fa39c6c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8d0ec79b-2c72-4b3d-b1b8-5933b94bbf05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e2c005-e1e7-4646-a7ce-53b80409c73c" xlink:to="loc_us-gaap_ShareBasedCompensation_8d0ec79b-2c72-4b3d-b1b8-5933b94bbf05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_b75572f9-9b51-4d36-b1c9-8fdfe2e6b389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e2c005-e1e7-4646-a7ce-53b80409c73c" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_b75572f9-9b51-4d36-b1c9-8fdfe2e6b389" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e337a68d-8949-4e1c-a34f-439539cad2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e2c005-e1e7-4646-a7ce-53b80409c73c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e337a68d-8949-4e1c-a34f-439539cad2f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_32ffaa34-05fd-490f-8303-0cf0347008ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e2c005-e1e7-4646-a7ce-53b80409c73c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_32ffaa34-05fd-490f-8303-0cf0347008ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6723c7b5-3bf4-496f-990a-3204c0eb6ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e2c005-e1e7-4646-a7ce-53b80409c73c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6723c7b5-3bf4-496f-990a-3204c0eb6ad9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_cc790086-3931-49a5-b822-f2631de5d1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e2c005-e1e7-4646-a7ce-53b80409c73c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_cc790086-3931-49a5-b822-f2631de5d1c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_b3460317-15c4-4499-b446-7035a3dd2aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e2c005-e1e7-4646-a7ce-53b80409c73c" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_b3460317-15c4-4499-b446-7035a3dd2aaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_1268c383-7b93-4ecf-b139-548c62098cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e2c005-e1e7-4646-a7ce-53b80409c73c" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_1268c383-7b93-4ecf-b139-548c62098cc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_a64254bb-775d-46ad-9f61-13015217881a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e2c005-e1e7-4646-a7ce-53b80409c73c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_a64254bb-775d-46ad-9f61-13015217881a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_22568b2c-e88b-4517-b939-f2f0c50e776b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_6a15dba5-b1fc-410a-962f-2649639be41c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_22568b2c-e88b-4517-b939-f2f0c50e776b" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_6a15dba5-b1fc-410a-962f-2649639be41c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_13141f02-e9bf-4837-9864-4d2bc8e6f158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_22568b2c-e88b-4517-b939-f2f0c50e776b" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_13141f02-e9bf-4837-9864-4d2bc8e6f158" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_4208f3b8-f67f-4612-9a26-203ce41d8e20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_22568b2c-e88b-4517-b939-f2f0c50e776b" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_4208f3b8-f67f-4612-9a26-203ce41d8e20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_79fa608a-3833-4a23-8bf1-d63a0b3169a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_22568b2c-e88b-4517-b939-f2f0c50e776b" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_79fa608a-3833-4a23-8bf1-d63a0b3169a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_efd604ff-ee67-4656-b59c-839acfca3f22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_22568b2c-e88b-4517-b939-f2f0c50e776b" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_efd604ff-ee67-4656-b59c-839acfca3f22" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_fccf732f-89ad-4abf-a5f1-4e044af9fd87" xlink:href="isrg-20210930.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b4a053f3-c180-4e54-ac2c-1111205276bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_fccf732f-89ad-4abf-a5f1-4e044af9fd87" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b4a053f3-c180-4e54-ac2c-1111205276bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_73a921bd-561d-4576-905b-c76e79652684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_fccf732f-89ad-4abf-a5f1-4e044af9fd87" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_73a921bd-561d-4576-905b-c76e79652684" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_4d9ce11f-c386-4ddd-a021-294e05f74b96" xlink:href="isrg-20210930.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4fef9b80-6b09-4117-afbe-d8f9d8e1fd92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_4d9ce11f-c386-4ddd-a021-294e05f74b96" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4fef9b80-6b09-4117-afbe-d8f9d8e1fd92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5266d942-30ff-4dca-83c5-bc06be1a402f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6d099b19-e76c-4f08-923a-ea773a946cab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5266d942-30ff-4dca-83c5-bc06be1a402f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6d099b19-e76c-4f08-923a-ea773a946cab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9edcb598-7880-4707-b95d-a3ac45235c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5266d942-30ff-4dca-83c5-bc06be1a402f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9edcb598-7880-4707-b95d-a3ac45235c90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_581017c4-c582-41f5-aa8a-33d3ed658827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5266d942-30ff-4dca-83c5-bc06be1a402f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_581017c4-c582-41f5-aa8a-33d3ed658827" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1" xlink:type="simple" xlink:href="isrg-20210930.xsd#FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_8a01809f-6593-4e28-9c2e-93c6cb28a39d" xlink:href="isrg-20210930.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b1de727f-7a32-4369-a26f-2dfb58358eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_8a01809f-6593-4e28-9c2e-93c6cb28a39d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b1de727f-7a32-4369-a26f-2dfb58358eb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a69194ac-3c64-4a1c-b87a-088067374c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_8a01809f-6593-4e28-9c2e-93c6cb28a39d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a69194ac-3c64-4a1c-b87a-088067374c9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_e2b7d268-1dd5-4237-865d-a32bdc3ac26f" xlink:href="isrg-20210930.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_8a01809f-6593-4e28-9c2e-93c6cb28a39d" xlink:to="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_e2b7d268-1dd5-4237-865d-a32bdc3ac26f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal_78706187-1c77-4d21-bc96-23c842929d3b" xlink:href="isrg-20210930.xsd#isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_9dab9cbb-cd12-4604-94d9-93a00117d9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal_78706187-1c77-4d21-bc96-23c842929d3b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_9dab9cbb-cd12-4604-94d9-93a00117d9d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_b4191122-009d-4fc5-8138-28b21d13c18f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal_78706187-1c77-4d21-bc96-23c842929d3b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_b4191122-009d-4fc5-8138-28b21d13c18f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6ffc3f54-0672-4540-80dd-2ee80b330de5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_32f45946-5dcb-4a09-9f43-3b54caefa6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6ffc3f54-0672-4540-80dd-2ee80b330de5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_32f45946-5dcb-4a09-9f43-3b54caefa6e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_d5eba52c-1d9b-4a16-9e1d-912d2773a615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6ffc3f54-0672-4540-80dd-2ee80b330de5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_d5eba52c-1d9b-4a16-9e1d-912d2773a615" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f8141791-f1b3-4cd5-b968-606f881141d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_4f164a58-1ddc-4dd6-aeac-9db287eedb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f8141791-f1b3-4cd5-b968-606f881141d7" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_4f164a58-1ddc-4dd6-aeac-9db287eedb4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_a9cbf766-3dbb-450b-8981-c411e24993a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f8141791-f1b3-4cd5-b968-606f881141d7" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_a9cbf766-3dbb-450b-8981-c411e24993a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_12423957-815c-4bb3-91b1-d9373a79826e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f8141791-f1b3-4cd5-b968-606f881141d7" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_12423957-815c-4bb3-91b1-d9373a79826e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5b90c2fd-0c18-4e81-a8fd-f4c18173ab11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_2f2540a0-3d30-46dd-ac1a-3c119a8c0dde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5b90c2fd-0c18-4e81-a8fd-f4c18173ab11" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_2f2540a0-3d30-46dd-ac1a-3c119a8c0dde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_b980f827-a275-4f8c-a9b8-566f71f7361c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5b90c2fd-0c18-4e81-a8fd-f4c18173ab11" xlink:to="loc_us-gaap_PrepaidTaxes_b980f827-a275-4f8c-a9b8-566f71f7361c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent_014c993f-9c79-4b0c-8112-a685d5bc924c" xlink:href="isrg-20210930.xsd#isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5b90c2fd-0c18-4e81-a8fd-f4c18173ab11" xlink:to="loc_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent_014c993f-9c79-4b0c-8112-a685d5bc924c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_4503aee2-fb01-4148-a781-01a2b52e51c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5b90c2fd-0c18-4e81-a8fd-f4c18173ab11" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_4503aee2-fb01-4148-a781-01a2b52e51c6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_c1b7cf37-1be2-4393-b2f6-702d9f38d2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_DeferredPurchaseConsiderationPaymentsCurrent_a114fc47-1956-4532-8bd1-b8c572f16c4f" xlink:href="isrg-20210930.xsd#isrg_DeferredPurchaseConsiderationPaymentsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_c1b7cf37-1be2-4393-b2f6-702d9f38d2ee" xlink:to="loc_isrg_DeferredPurchaseConsiderationPaymentsCurrent_a114fc47-1956-4532-8bd1-b8c572f16c4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_aefcc4d5-1424-4da0-a174-24ce0b2b36db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_c1b7cf37-1be2-4393-b2f6-702d9f38d2ee" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_aefcc4d5-1424-4da0-a174-24ce0b2b36db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_13cff50f-f871-4679-8ae2-ed797a95c051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_c1b7cf37-1be2-4393-b2f6-702d9f38d2ee" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_13cff50f-f871-4679-8ae2-ed797a95c051" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_c346bb5e-2432-41d9-adc9-a6e4298ccee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_c1b7cf37-1be2-4393-b2f6-702d9f38d2ee" xlink:to="loc_us-gaap_TaxesPayableCurrent_c346bb5e-2432-41d9-adc9-a6e4298ccee5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_831912f7-7b5f-4bcb-abfe-f580d7f9e6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_063ad22c-96a2-4e24-abc3-60688567be32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_831912f7-7b5f-4bcb-abfe-f580d7f9e6c4" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_063ad22c-96a2-4e24-abc3-60688567be32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_01043c35-032b-4e8c-abf8-c824aff09fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_831912f7-7b5f-4bcb-abfe-f580d7f9e6c4" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_01043c35-032b-4e8c-abf8-c824aff09fe7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_444b6e4d-f583-4892-8aef-a4202b2cb70c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_831912f7-7b5f-4bcb-abfe-f580d7f9e6c4" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_444b6e4d-f583-4892-8aef-a4202b2cb70c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#LEASESLeaseReceivablesDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_6d33bf7d-a03a-4d80-b8f8-11871f833bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalestypeLeaseDeferredSellingProfit_be8322c6-2629-4a9f-afc3-5661b1ec1679" xlink:href="isrg-20210930.xsd#isrg_SalestypeLeaseDeferredSellingProfit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_6d33bf7d-a03a-4d80-b8f8-11871f833bc7" xlink:to="loc_isrg_SalestypeLeaseDeferredSellingProfit_be8322c6-2629-4a9f-afc3-5661b1ec1679" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeLeaseGrossInvestmentInLease_688e93e0-17d3-44c5-a7bf-b29b08d4882e" xlink:href="isrg-20210930.xsd#isrg_SalesTypeLeaseGrossInvestmentInLease"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_6d33bf7d-a03a-4d80-b8f8-11871f833bc7" xlink:to="loc_isrg_SalesTypeLeaseGrossInvestmentInLease_688e93e0-17d3-44c5-a7bf-b29b08d4882e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1" xlink:type="simple" xlink:href="isrg-20210930.xsd#LEASESLeaseReceivablesDetails_1"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_1f2cbe70-2e3c-43b6-a539-628a7537b9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseReceivable_0ac4d78a-2305-4974-82ef-805d78ab44b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseLeaseReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_1f2cbe70-2e3c-43b6-a539-628a7537b9fc" xlink:to="loc_us-gaap_SalesTypeLeaseLeaseReceivable_0ac4d78a-2305-4974-82ef-805d78ab44b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss_41bb43e5-47ce-4c68-929d-a0c4c1ff157b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_1f2cbe70-2e3c-43b6-a539-628a7537b9fc" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss_41bb43e5-47ce-4c68-929d-a0c4c1ff157b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_d0df2067-aed9-4378-b1a2-350475947127" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear_bf820da9-873a-4ad6-bd70-7a413adb9d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_d0df2067-aed9-4378-b1a2-350475947127" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear_bf820da9-873a-4ad6-bd70-7a413adb9d1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths_d4bf4cef-81d7-4121-a1c4-6361f5640851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_d0df2067-aed9-4378-b1a2-350475947127" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths_d4bf4cef-81d7-4121-a1c4-6361f5640851" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears_cc7dae35-6335-44e1-bbf5-c00ddbc9e7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_d0df2067-aed9-4378-b1a2-350475947127" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears_cc7dae35-6335-44e1-bbf5-c00ddbc9e7d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears_0dcbcbfe-a27e-430a-a3aa-7884aee27e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_d0df2067-aed9-4378-b1a2-350475947127" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears_0dcbcbfe-a27e-430a-a3aa-7884aee27e6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears_9e6ab066-d80e-4fff-b1f1-99d66d904732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_d0df2067-aed9-4378-b1a2-350475947127" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears_9e6ab066-d80e-4fff-b1f1-99d66d904732" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter_96b2cccf-f586-4e2a-89d2-6422406df386" xlink:href="isrg-20210930.xsd#isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_d0df2067-aed9-4378-b1a2-350475947127" xlink:to="loc_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter_96b2cccf-f586-4e2a-89d2-6422406df386" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#LEASESCreditQualityIndicatorDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_1756a593-b9dd-4133-8dc1-3362fb2e4dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear_fca96608-c9c0-4722-9e6e-f9f64702502d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_1756a593-b9dd-4133-8dc1-3362fb2e4dc0" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear_fca96608-c9c0-4722-9e6e-f9f64702502d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear_d2c97e6c-c036-4010-80f9-aea159aa5dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_1756a593-b9dd-4133-8dc1-3362fb2e4dc0" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear_d2c97e6c-c036-4010-80f9-aea159aa5dfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear_4d94d0ac-04bd-4d77-8394-3834d46e015b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_1756a593-b9dd-4133-8dc1-3362fb2e4dc0" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear_4d94d0ac-04bd-4d77-8394-3834d46e015b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear_99c21c42-6a57-4b3c-9e93-a95b9ee09351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_1756a593-b9dd-4133-8dc1-3362fb2e4dc0" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear_99c21c42-6a57-4b3c-9e93-a95b9ee09351" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear_f4041733-32e4-49aa-b106-3305e70ecda1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_1756a593-b9dd-4133-8dc1-3362fb2e4dc0" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear_f4041733-32e4-49aa-b106-3305e70ecda1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear_da7829a2-671b-419b-bda9-b8df3755b5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_1756a593-b9dd-4133-8dc1-3362fb2e4dc0" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear_da7829a2-671b-419b-bda9-b8df3755b5a5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_68687d67-4601-4fa2-b2e1-979c94c7514e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0197a3c0-08ec-4738-801d-91fa4ed0353f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_68687d67-4601-4fa2-b2e1-979c94c7514e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0197a3c0-08ec-4738-801d-91fa4ed0353f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6e9db74b-4cf6-4060-98f4-7a8857b8348a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_68687d67-4601-4fa2-b2e1-979c94c7514e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6e9db74b-4cf6-4060-98f4-7a8857b8348a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b4ec8c59-fb4c-4efd-ad06-e890bdbac595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_83dbee4f-990b-4a50-b331-243fb182f6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b4ec8c59-fb4c-4efd-ad06-e890bdbac595" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_83dbee4f-990b-4a50-b331-243fb182f6d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_40e882c8-ed25-4477-817d-726da2fa06b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b4ec8c59-fb4c-4efd-ad06-e890bdbac595" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_40e882c8-ed25-4477-817d-726da2fa06b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_35bb3b8f-acb5-4157-9a2a-18ec4da33caf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b4ec8c59-fb4c-4efd-ad06-e890bdbac595" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_35bb3b8f-acb5-4157-9a2a-18ec4da33caf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a06f4652-4c23-4b8b-8809-0df3d1683964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b4ec8c59-fb4c-4efd-ad06-e890bdbac595" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a06f4652-4c23-4b8b-8809-0df3d1683964" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_39d0b970-fc3d-4ece-96e2-10676c9f037f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b4ec8c59-fb4c-4efd-ad06-e890bdbac595" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_39d0b970-fc3d-4ece-96e2-10676c9f037f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_5996bba9-f6e8-432d-9b73-dc0eac1ee68b" xlink:href="isrg-20210930.xsd#isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b4ec8c59-fb4c-4efd-ad06-e890bdbac595" xlink:to="loc_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_5996bba9-f6e8-432d-9b73-dc0eac1ee68b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_1a69f90c-1bcc-401e-a8de-ae76cad62fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_e837358f-e6f2-4153-8f01-72c1116ccfaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_1a69f90c-1bcc-401e-a8de-ae76cad62fc8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_e837358f-e6f2-4153-8f01-72c1116ccfaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_1ca69030-40d0-45e1-9e25-107b11270c52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_1a69f90c-1bcc-401e-a8de-ae76cad62fc8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_1ca69030-40d0-45e1-9e25-107b11270c52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_28967143-2364-43d8-9725-26e0bdec406f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_e53cbea6-b820-4cfb-942e-dd7db9690f59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_28967143-2364-43d8-9725-26e0bdec406f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_e53cbea6-b820-4cfb-942e-dd7db9690f59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_f234d117-6a89-4fab-9a3e-fc18b097b27e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_28967143-2364-43d8-9725-26e0bdec406f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_f234d117-6a89-4fab-9a3e-fc18b097b27e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a8a598cc-65a7-4be2-8f22-aedd21c93cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_682ed304-432b-4032-8324-1c31821b3c66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a8a598cc-65a7-4be2-8f22-aedd21c93cbf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_682ed304-432b-4032-8324-1c31821b3c66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_e84433a2-def7-4128-a260-a17cfd66b55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a8a598cc-65a7-4be2-8f22-aedd21c93cbf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_e84433a2-def7-4128-a260-a17cfd66b55a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_247d8193-5ac6-48b9-8a76-ea2958a42345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax_f12fb712-d0f4-4f52-964c-35c3250a78bb" xlink:href="isrg-20210930.xsd#isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_247d8193-5ac6-48b9-8a76-ea2958a42345" xlink:to="loc_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax_f12fb712-d0f4-4f52-964c-35c3250a78bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_52bb1031-1ee5-449c-aebc-f59ff69829fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_247d8193-5ac6-48b9-8a76-ea2958a42345" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_52bb1031-1ee5-449c-aebc-f59ff69829fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_8288a9e7-95ee-4bc4-89b7-bb9a81c781aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_f66a8231-7818-401f-9b09-e313e75bb072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_8288a9e7-95ee-4bc4-89b7-bb9a81c781aa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_f66a8231-7818-401f-9b09-e313e75bb072" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_11ab3d64-e687-473c-96d1-042f8e2135f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_8288a9e7-95ee-4bc4-89b7-bb9a81c781aa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_11ab3d64-e687-473c-96d1-042f8e2135f1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_cc83afba-c28f-4387-b489-4f2486e0af32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_eb21bcb1-c42a-44e4-bfc6-436cf1e5e335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_cc83afba-c28f-4387-b489-4f2486e0af32" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_eb21bcb1-c42a-44e4-bfc6-436cf1e5e335" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_11e3c25e-00de-4f6f-b58a-ecb9af5d39f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_cc83afba-c28f-4387-b489-4f2486e0af32" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_11e3c25e-00de-4f6f-b58a-ecb9af5d39f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cc88097b-2c8e-4209-bb1d-ad80fcf32293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fe74635e-56de-4f4a-830c-e30a0e76725f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cc88097b-2c8e-4209-bb1d-ad80fcf32293" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fe74635e-56de-4f4a-830c-e30a0e76725f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_0a86783e-fddc-48d1-a232-ce289c423b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cc88097b-2c8e-4209-bb1d-ad80fcf32293" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_0a86783e-fddc-48d1-a232-ce289c423b7a" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>isrg-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4f3ead07-f4ad-4d18-aec5-70406fe3497c,g:13f40b2a-7689-41e3-982f-2ccf6cf675cb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="isrg-20210930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended" id="ib608dfad9207406899c9da8141fc5eef_CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_3c4efb3d-3f2a-4eed-8c81-a6260082cc53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_RevenuesAbstract_3c4efb3d-3f2a-4eed-8c81-a6260082cc53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6d42b114-eab3-4694-8556-ca8f20ba0afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_3c4efb3d-3f2a-4eed-8c81-a6260082cc53" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6d42b114-eab3-4694-8556-ca8f20ba0afa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_4f768e59-d260-4540-82fd-0ad0fa9b1443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_CostOfRevenueAbstract_4f768e59-d260-4540-82fd-0ad0fa9b1443" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_64b7e790-ebf7-4098-8701-8ba93fdc3d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_4f768e59-d260-4540-82fd-0ad0fa9b1443" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_64b7e790-ebf7-4098-8701-8ba93fdc3d3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_db63d15f-4993-4fc3-9506-87417f8ca65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_GrossProfit_db63d15f-4993-4fc3-9506-87417f8ca65a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_76430e4c-1f70-4a1e-92c5-594bf8a86703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_OperatingExpensesAbstract_76430e4c-1f70-4a1e-92c5-594bf8a86703" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_55c0d7ef-a2bb-401a-8727-eaf456d19814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_76430e4c-1f70-4a1e-92c5-594bf8a86703" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_55c0d7ef-a2bb-401a-8727-eaf456d19814" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ffb5cd8f-7441-49f9-84fa-af5193bc664d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_76430e4c-1f70-4a1e-92c5-594bf8a86703" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ffb5cd8f-7441-49f9-84fa-af5193bc664d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_86785be6-313f-4239-81f1-b7fb0ac664eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_76430e4c-1f70-4a1e-92c5-594bf8a86703" xlink:to="loc_us-gaap_OperatingExpenses_86785be6-313f-4239-81f1-b7fb0ac664eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_39dd1fdf-423b-44ea-8e96-343c5f321a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_OperatingIncomeLoss_39dd1fdf-423b-44ea-8e96-343c5f321a45" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c8818051-a2fc-47f3-b9de-4cbc6a18b1af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_c8818051-a2fc-47f3-b9de-4cbc6a18b1af" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c4402969-97ef-4c20-96be-21692d4a59f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c4402969-97ef-4c20-96be-21692d4a59f3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_de8ef65e-9b14-4543-bba4-d5c9eae9adef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_de8ef65e-9b14-4543-bba4-d5c9eae9adef" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a469209f-9101-4a89-9288-89d5a78962f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_ProfitLoss_a469209f-9101-4a89-9288-89d5a78962f3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_22b84cd2-1711-403c-8458-c581c60a152d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_22b84cd2-1711-403c-8458-c581c60a152d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d668c9d4-f425-4f29-9f83-b27ed290770c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_NetIncomeLoss_d668c9d4-f425-4f29-9f83-b27ed290770c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b6f3376b-7a6f-4f4e-9e8e-24dd47d9a78c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_EarningsPerShareAbstract_b6f3376b-7a6f-4f4e-9e8e-24dd47d9a78c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_57ca35c2-5c7a-4974-8d01-7857c1d200f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b6f3376b-7a6f-4f4e-9e8e-24dd47d9a78c" xlink:to="loc_us-gaap_EarningsPerShareBasic_57ca35c2-5c7a-4974-8d01-7857c1d200f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7067cc39-df16-4a83-8e28-ba56f6909ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b6f3376b-7a6f-4f4e-9e8e-24dd47d9a78c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7067cc39-df16-4a83-8e28-ba56f6909ef4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a458aa54-4318-44d0-94e2-190d6b962102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a458aa54-4318-44d0-94e2-190d6b962102" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_202b9aec-18e8-4ca5-bab2-8fec267701a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a458aa54-4318-44d0-94e2-190d6b962102" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_202b9aec-18e8-4ca5-bab2-8fec267701a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_14613d40-01f9-4491-84df-17a3256396c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a458aa54-4318-44d0-94e2-190d6b962102" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_14613d40-01f9-4491-84df-17a3256396c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_dca33120-92ee-44a4-92c2-2906d1f85449" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_dca33120-92ee-44a4-92c2-2906d1f85449" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_633c6635-b706-4fc1-b98e-8edd8b5a6872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_633c6635-b706-4fc1-b98e-8edd8b5a6872" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e5224c5a-bbf6-4c1e-b262-bf2dabd11c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e5224c5a-bbf6-4c1e-b262-bf2dabd11c4c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_38723afa-5220-428c-9725-3228f8712425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_StatementTable_38723afa-5220-428c-9725-3228f8712425" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_162fc1cb-5db5-4de0-9054-fd5181b2a20a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_38723afa-5220-428c-9725-3228f8712425" xlink:to="loc_srt_ProductOrServiceAxis_162fc1cb-5db5-4de0-9054-fd5181b2a20a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_162fc1cb-5db5-4de0-9054-fd5181b2a20a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_162fc1cb-5db5-4de0-9054-fd5181b2a20a" xlink:to="loc_srt_ProductsAndServicesDomain_162fc1cb-5db5-4de0-9054-fd5181b2a20a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5b8fb402-fffa-4c02-9297-304574d9bca8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_162fc1cb-5db5-4de0-9054-fd5181b2a20a" xlink:to="loc_srt_ProductsAndServicesDomain_5b8fb402-fffa-4c02-9297-304574d9bca8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_6b3b78d3-54d7-4281-91f1-528a742be5ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5b8fb402-fffa-4c02-9297-304574d9bca8" xlink:to="loc_us-gaap_ProductMember_6b3b78d3-54d7-4281-91f1-528a742be5ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_8cec4393-346a-463f-bcc6-050f007bbddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5b8fb402-fffa-4c02-9297-304574d9bca8" xlink:to="loc_us-gaap_ServiceMember_8cec4393-346a-463f-bcc6-050f007bbddf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails" xlink:type="extended" id="ide9f98f00ccf44cd939ba533c1dd7c0c_FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5c23190e-82b6-4d4a-a382-0b84f7267787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5c23190e-82b6-4d4a-a382-0b84f7267787" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_19540bdb-3357-4d8d-95ed-bf933ee50aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_19540bdb-3357-4d8d-95ed-bf933ee50aaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6d18183b-b508-44c3-8b5d-3949640f6610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6d18183b-b508-44c3-8b5d-3949640f6610" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_802f3555-113d-4163-850d-dc51b41ae857" xlink:href="isrg-20210930.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_802f3555-113d-4163-850d-dc51b41ae857" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_22cae44a-6594-4976-a714-cf70ed1f744a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_22cae44a-6594-4976-a714-cf70ed1f744a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d43a21ff-b3b2-4027-915f-9c5e5f0aad83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d43a21ff-b3b2-4027-915f-9c5e5f0aad83" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_595192fe-f4da-4b25-8d69-2cb417bed25e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_595192fe-f4da-4b25-8d69-2cb417bed25e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8d837e85-9d7a-4a09-a3b0-483f7e4cab9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8d837e85-9d7a-4a09-a3b0-483f7e4cab9b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_c58e0d56-39d5-4d13-9493-79eb1642e4bd" xlink:href="isrg-20210930.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_c58e0d56-39d5-4d13-9493-79eb1642e4bd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_7540beef-926d-45d6-b490-6f4a60d0e442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_7540beef-926d-45d6-b490-6f4a60d0e442" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_4379d23b-f31b-480c-a3d9-e0aeadd588ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_4379d23b-f31b-480c-a3d9-e0aeadd588ad" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_cc1f0ba8-66b6-4457-a1f8-1cef6cd1eded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_cc1f0ba8-66b6-4457-a1f8-1cef6cd1eded" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9ddb04a3-f8db-48f3-874f-603899dfc42a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_cc1f0ba8-66b6-4457-a1f8-1cef6cd1eded" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9ddb04a3-f8db-48f3-874f-603899dfc42a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ddb04a3-f8db-48f3-874f-603899dfc42a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9ddb04a3-f8db-48f3-874f-603899dfc42a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ddb04a3-f8db-48f3-874f-603899dfc42a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f76e8f78-8b43-48b8-86ac-1edd1d8625b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9ddb04a3-f8db-48f3-874f-603899dfc42a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f76e8f78-8b43-48b8-86ac-1edd1d8625b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3585ff44-2d8c-4bac-8e7b-894eaac09a32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f76e8f78-8b43-48b8-86ac-1edd1d8625b4" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3585ff44-2d8c-4bac-8e7b-894eaac09a32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a92bbc8d-7a2f-4e56-b62b-d1bdb6158f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f76e8f78-8b43-48b8-86ac-1edd1d8625b4" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a92bbc8d-7a2f-4e56-b62b-d1bdb6158f48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_758c0843-d304-4c1c-a967-5e5e05cd600d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_cc1f0ba8-66b6-4457-a1f8-1cef6cd1eded" xlink:to="loc_us-gaap_FinancialInstrumentAxis_758c0843-d304-4c1c-a967-5e5e05cd600d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_758c0843-d304-4c1c-a967-5e5e05cd600d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_758c0843-d304-4c1c-a967-5e5e05cd600d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_758c0843-d304-4c1c-a967-5e5e05cd600d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_758c0843-d304-4c1c-a967-5e5e05cd600d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_19e9c7ee-4c93-4a5a-876e-4077bbb782cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:to="loc_us-gaap_CashMember_19e9c7ee-4c93-4a5a-876e-4077bbb782cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_9ede4a20-e973-48aa-a269-3fda68964161" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:to="loc_us-gaap_MoneyMarketFundsMember_9ede4a20-e973-48aa-a269-3fda68964161" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_51d58ce5-21e0-4c44-9852-da97b8832144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_51d58ce5-21e0-4c44-9852-da97b8832144" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_0fd0c06d-03f2-41ae-8b5f-a275fcbdf859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:to="loc_us-gaap_CommercialPaperMember_0fd0c06d-03f2-41ae-8b5f-a275fcbdf859" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_79ec8bcb-f609-459f-9166-2f016ab2b625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_79ec8bcb-f609-459f-9166-2f016ab2b625" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c09de6d9-f595-4802-9ce2-61b1c2a672bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c09de6d9-f595-4802-9ce2-61b1c2a672bf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalNotesMember_a49c9739-3c71-4190-9b18-f87a11d2a999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MunicipalNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:to="loc_us-gaap_MunicipalNotesMember_a49c9739-3c71-4190-9b18-f87a11d2a999" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails" xlink:type="extended" id="if12a8cf1c04a4f53a68cba98db0b9a00_FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_12722890-173a-42e9-904e-502ccc0c198d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_12722890-173a-42e9-904e-502ccc0c198d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_a85606ee-03aa-493e-a6e2-c0ed9a47c2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_12722890-173a-42e9-904e-502ccc0c198d" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_a85606ee-03aa-493e-a6e2-c0ed9a47c2ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_f29c22fc-6c90-4b09-b145-f89fc4f5389d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_12722890-173a-42e9-904e-502ccc0c198d" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_f29c22fc-6c90-4b09-b145-f89fc4f5389d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments_4c81af91-5888-47b7-94bf-49e4e381ec70" xlink:href="isrg-20210930.xsd#isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_12722890-173a-42e9-904e-502ccc0c198d" xlink:to="loc_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments_4c81af91-5888-47b7-94bf-49e4e381ec70" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c6414569-5619-4688-bbd5-d1bcec041e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_12722890-173a-42e9-904e-502ccc0c198d" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c6414569-5619-4688-bbd5-d1bcec041e30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss_db7d41f4-c1ee-4518-8d23-723119eac65d" xlink:href="isrg-20210930.xsd#isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_12722890-173a-42e9-904e-502ccc0c198d" xlink:to="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss_db7d41f4-c1ee-4518-8d23-723119eac65d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments_7b41c5a6-63c9-4c7a-aee4-bd022afdacde" xlink:href="isrg-20210930.xsd#isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_12722890-173a-42e9-904e-502ccc0c198d" xlink:to="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments_7b41c5a6-63c9-4c7a-aee4-bd022afdacde" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares_fe897e43-f706-4697-8d5a-2fd5a6de2366" xlink:href="isrg-20210930.xsd#isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:to="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares_fe897e43-f706-4697-8d5a-2fd5a6de2366" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_231ccf34-8466-4b07-b35a-8906168ed337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_231ccf34-8466-4b07-b35a-8906168ed337" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_885fd611-e7fe-4a73-84c0-625569cc83b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_885fd611-e7fe-4a73-84c0-625569cc83b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfEquityInvestments_f120da61-8aa1-4822-bd16-6bb88107c0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfEquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:to="loc_us-gaap_GainLossOnSaleOfEquityInvestments_f120da61-8aa1-4822-bd16-6bb88107c0dd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives_a43c9d88-794f-487a-81b1-2b3d28203677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:to="loc_us-gaap_GainLossOnSaleOfDerivatives_a43c9d88-794f-487a-81b1-2b3d28203677" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_18e2939b-de24-485f-8087-e379479cc075" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_18e2939b-de24-485f-8087-e379479cc075" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_5d3c092a-f169-418b-845e-010ece4ab634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_5d3c092a-f169-418b-845e-010ece4ab634" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_94a14c88-00cc-45ee-a7e3-976f23436b48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_5d3c092a-f169-418b-845e-010ece4ab634" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_94a14c88-00cc-45ee-a7e3-976f23436b48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_94a14c88-00cc-45ee-a7e3-976f23436b48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_94a14c88-00cc-45ee-a7e3-976f23436b48" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_94a14c88-00cc-45ee-a7e3-976f23436b48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c72b8c40-06ea-4194-a651-538bd0391242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_94a14c88-00cc-45ee-a7e3-976f23436b48" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c72b8c40-06ea-4194-a651-538bd0391242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_351f1afe-fcc8-4808-a203-433fcb31a60d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c72b8c40-06ea-4194-a651-538bd0391242" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_351f1afe-fcc8-4808-a203-433fcb31a60d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_IntangibleAndOtherAssetsNetMember_6ff0a45c-0bd8-4cd8-9d20-54c0ec27bcf0" xlink:href="isrg-20210930.xsd#isrg_IntangibleAndOtherAssetsNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c72b8c40-06ea-4194-a651-538bd0391242" xlink:to="loc_isrg_IntangibleAndOtherAssetsNetMember_6ff0a45c-0bd8-4cd8-9d20-54c0ec27bcf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_012ddb8a-fa58-45f4-b2a7-a43b7de4cae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_5d3c092a-f169-418b-845e-010ece4ab634" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_012ddb8a-fa58-45f4-b2a7-a43b7de4cae3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_012ddb8a-fa58-45f4-b2a7-a43b7de4cae3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_012ddb8a-fa58-45f4-b2a7-a43b7de4cae3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_012ddb8a-fa58-45f4-b2a7-a43b7de4cae3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3366b65-dccd-4888-b572-75b7c12e9dff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_012ddb8a-fa58-45f4-b2a7-a43b7de4cae3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3366b65-dccd-4888-b572-75b7c12e9dff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_63b2ed89-2ac3-4d4a-815b-ed42ca0a5811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3366b65-dccd-4888-b572-75b7c12e9dff" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_63b2ed89-2ac3-4d4a-815b-ed42ca0a5811" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d3210787-779d-4f41-923c-e6b82a9d1354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3366b65-dccd-4888-b572-75b7c12e9dff" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d3210787-779d-4f41-923c-e6b82a9d1354" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails" xlink:type="extended" id="i6de6405836164d038c2854097864fee3_FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46a7a0a0-332f-4bd8-890b-cf88322f489e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_8692c984-6665-4813-9c39-046d884d28c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46a7a0a0-332f-4bd8-890b-cf88322f489e" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_8692c984-6665-4813-9c39-046d884d28c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_223f94cb-ae16-4b18-a487-47758cbca0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46a7a0a0-332f-4bd8-890b-cf88322f489e" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_223f94cb-ae16-4b18-a487-47758cbca0b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9b3c6d88-acd6-49b1-8d99-82401eb1bd94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46a7a0a0-332f-4bd8-890b-cf88322f489e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9b3c6d88-acd6-49b1-8d99-82401eb1bd94" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a919031d-443d-4097-a3a9-956dc6985626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9b3c6d88-acd6-49b1-8d99-82401eb1bd94" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a919031d-443d-4097-a3a9-956dc6985626" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a919031d-443d-4097-a3a9-956dc6985626_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a919031d-443d-4097-a3a9-956dc6985626" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a919031d-443d-4097-a3a9-956dc6985626_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c53a52b8-a2a8-4b28-94df-67ee88308990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a919031d-443d-4097-a3a9-956dc6985626" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c53a52b8-a2a8-4b28-94df-67ee88308990" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_80a2fc9e-df52-4545-a8d3-0c940e43f324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c53a52b8-a2a8-4b28-94df-67ee88308990" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_80a2fc9e-df52-4545-a8d3-0c940e43f324" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CollarContractMember_01267c4d-a823-4060-8c5b-fbf504bf7051" xlink:href="isrg-20210930.xsd#isrg_CollarContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c53a52b8-a2a8-4b28-94df-67ee88308990" xlink:to="loc_isrg_CollarContractMember_01267c4d-a823-4060-8c5b-fbf504bf7051" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e155fa68-9dba-429f-a545-ca603ab0a76d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9b3c6d88-acd6-49b1-8d99-82401eb1bd94" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e155fa68-9dba-429f-a545-ca603ab0a76d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e155fa68-9dba-429f-a545-ca603ab0a76d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e155fa68-9dba-429f-a545-ca603ab0a76d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e155fa68-9dba-429f-a545-ca603ab0a76d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_50407498-f3e7-4d98-8925-1b7d5f90c01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e155fa68-9dba-429f-a545-ca603ab0a76d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_50407498-f3e7-4d98-8925-1b7d5f90c01b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_8034242d-f5d5-4e4f-9053-bfd322d8d67e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_50407498-f3e7-4d98-8925-1b7d5f90c01b" xlink:to="loc_us-gaap_OtherIncomeMember_8034242d-f5d5-4e4f-9053-bfd322d8d67e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f50526c8-8e8f-4767-bf01-9772949457b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9b3c6d88-acd6-49b1-8d99-82401eb1bd94" xlink:to="loc_us-gaap_HedgingDesignationAxis_f50526c8-8e8f-4767-bf01-9772949457b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f50526c8-8e8f-4767-bf01-9772949457b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_f50526c8-8e8f-4767-bf01-9772949457b1" xlink:to="loc_us-gaap_HedgingDesignationDomain_f50526c8-8e8f-4767-bf01-9772949457b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_55429a45-267e-436e-9fec-e0ef079a5f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_f50526c8-8e8f-4767-bf01-9772949457b1" xlink:to="loc_us-gaap_HedgingDesignationDomain_55429a45-267e-436e-9fec-e0ef079a5f68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_16bdaf83-ca31-42a0-9bb9-38129f3849b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_55429a45-267e-436e-9fec-e0ef079a5f68" xlink:to="loc_us-gaap_NondesignatedMember_16bdaf83-ca31-42a0-9bb9-38129f3849b1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails" xlink:type="extended" id="ifbaf697b16524d5792fbf306b7530c9e_FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_878d3305-8afd-4cf1-b1e9-2f89bcd2f558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_d0be885f-15ad-4b73-89c3-bfd3701f2cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_878d3305-8afd-4cf1-b1e9-2f89bcd2f558" xlink:to="loc_us-gaap_DerivativeNotionalAmount_d0be885f-15ad-4b73-89c3-bfd3701f2cc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a28289-dea6-412e-b292-4076736e967a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_878d3305-8afd-4cf1-b1e9-2f89bcd2f558" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a28289-dea6-412e-b292-4076736e967a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7958798f-236b-4c79-b2c9-f6ca8ce2bf2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a28289-dea6-412e-b292-4076736e967a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7958798f-236b-4c79-b2c9-f6ca8ce2bf2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7958798f-236b-4c79-b2c9-f6ca8ce2bf2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7958798f-236b-4c79-b2c9-f6ca8ce2bf2e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7958798f-236b-4c79-b2c9-f6ca8ce2bf2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_63939eb9-a373-420a-bdc5-ff0e748fe8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7958798f-236b-4c79-b2c9-f6ca8ce2bf2e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_63939eb9-a373-420a-bdc5-ff0e748fe8f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_45f2b85a-340c-451c-a1a3-59de30e829d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_63939eb9-a373-420a-bdc5-ff0e748fe8f9" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_45f2b85a-340c-451c-a1a3-59de30e829d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_514b93ec-d020-4a65-b631-06c50b39e0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a28289-dea6-412e-b292-4076736e967a" xlink:to="loc_us-gaap_HedgingDesignationAxis_514b93ec-d020-4a65-b631-06c50b39e0b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_514b93ec-d020-4a65-b631-06c50b39e0b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_514b93ec-d020-4a65-b631-06c50b39e0b4" xlink:to="loc_us-gaap_HedgingDesignationDomain_514b93ec-d020-4a65-b631-06c50b39e0b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_457b090c-29de-48f0-907f-56ff79492f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_514b93ec-d020-4a65-b631-06c50b39e0b4" xlink:to="loc_us-gaap_HedgingDesignationDomain_457b090c-29de-48f0-907f-56ff79492f2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9a5852f8-4d03-40ea-a5a6-c268e8bce855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_457b090c-29de-48f0-907f-56ff79492f2a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9a5852f8-4d03-40ea-a5a6-c268e8bce855" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_41dc84a4-074d-4afd-a621-b546c2473e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_457b090c-29de-48f0-907f-56ff79492f2a" xlink:to="loc_us-gaap_NondesignatedMember_41dc84a4-074d-4afd-a621-b546c2473e9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_be6d9fde-325b-432d-b2c1-e60625ae56b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a28289-dea6-412e-b292-4076736e967a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_be6d9fde-325b-432d-b2c1-e60625ae56b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_be6d9fde-325b-432d-b2c1-e60625ae56b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_be6d9fde-325b-432d-b2c1-e60625ae56b1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_be6d9fde-325b-432d-b2c1-e60625ae56b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_550f1ce0-1e6a-438c-82ec-1e04b7ffb5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_be6d9fde-325b-432d-b2c1-e60625ae56b1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_550f1ce0-1e6a-438c-82ec-1e04b7ffb5d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_223d5578-8ccb-4a45-b3c4-01deb3e505b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_550f1ce0-1e6a-438c-82ec-1e04b7ffb5d5" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_223d5578-8ccb-4a45-b3c4-01deb3e505b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_2daf2baa-c8fd-46c1-b53b-d78350e9d739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_550f1ce0-1e6a-438c-82ec-1e04b7ffb5d5" xlink:to="loc_us-gaap_OtherLiabilitiesMember_2daf2baa-c8fd-46c1-b53b-d78350e9d739" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails" xlink:type="extended" id="i239e44d566e9431abd0c4a433e506367_REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_4ea2ce69-3b28-40ed-a6b1-a0e3ea0beeae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5c9ec616-78f6-42c8-bfaa-652aeb19588f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_4ea2ce69-3b28-40ed-a6b1-a0e3ea0beeae" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5c9ec616-78f6-42c8-bfaa-652aeb19588f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_3e85d8ad-eda9-45b8-9d92-9e9cf1c50276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_4ea2ce69-3b28-40ed-a6b1-a0e3ea0beeae" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_3e85d8ad-eda9-45b8-9d92-9e9cf1c50276" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_99ab6c45-7ad2-4b49-b11e-d009d9c34c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3e85d8ad-eda9-45b8-9d92-9e9cf1c50276" xlink:to="loc_us-gaap_GeographicDistributionAxis_99ab6c45-7ad2-4b49-b11e-d009d9c34c5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_99ab6c45-7ad2-4b49-b11e-d009d9c34c5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GeographicDistributionAxis_99ab6c45-7ad2-4b49-b11e-d009d9c34c5d" xlink:to="loc_us-gaap_GeographicDistributionDomain_99ab6c45-7ad2-4b49-b11e-d009d9c34c5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_cfa38d61-a3de-49d1-aca9-8224325b9666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GeographicDistributionAxis_99ab6c45-7ad2-4b49-b11e-d009d9c34c5d" xlink:to="loc_us-gaap_GeographicDistributionDomain_cfa38d61-a3de-49d1-aca9-8224325b9666" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_a0dfe9b4-19d0-4aab-95e0-819b299180b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_cfa38d61-a3de-49d1-aca9-8224325b9666" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_a0dfe9b4-19d0-4aab-95e0-819b299180b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember_9068118a-8c45-482f-8bfb-90dab74f1baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_cfa38d61-a3de-49d1-aca9-8224325b9666" xlink:to="loc_us-gaap_GeographicDistributionForeignMember_9068118a-8c45-482f-8bfb-90dab74f1baf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e5e883eb-2b47-48ab-8d9c-c2d49f3d6c3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3e85d8ad-eda9-45b8-9d92-9e9cf1c50276" xlink:to="loc_srt_ProductOrServiceAxis_e5e883eb-2b47-48ab-8d9c-c2d49f3d6c3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e5e883eb-2b47-48ab-8d9c-c2d49f3d6c3e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e5e883eb-2b47-48ab-8d9c-c2d49f3d6c3e" xlink:to="loc_srt_ProductsAndServicesDomain_e5e883eb-2b47-48ab-8d9c-c2d49f3d6c3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0ffdc2f3-a392-4517-8fc9-c217b4c8c803" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e5e883eb-2b47-48ab-8d9c-c2d49f3d6c3e" xlink:to="loc_srt_ProductsAndServicesDomain_0ffdc2f3-a392-4517-8fc9-c217b4c8c803" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_InstrumentsandAccessoriesMember_2fc6331e-a913-4197-a134-34670c17bd6e" xlink:href="isrg-20210930.xsd#isrg_InstrumentsandAccessoriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0ffdc2f3-a392-4517-8fc9-c217b4c8c803" xlink:to="loc_isrg_InstrumentsandAccessoriesMember_2fc6331e-a913-4197-a134-34670c17bd6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SystemsMember_faba09d6-7afe-44ba-aa76-7a321e237e35" xlink:href="isrg-20210930.xsd#isrg_SystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0ffdc2f3-a392-4517-8fc9-c217b4c8c803" xlink:to="loc_isrg_SystemsMember_faba09d6-7afe-44ba-aa76-7a321e237e35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ServicesMember_470f8b3f-a688-42f2-8311-f63dbfb8b3f9" xlink:href="isrg-20210930.xsd#isrg_ServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0ffdc2f3-a392-4517-8fc9-c217b4c8c803" xlink:to="loc_isrg_ServicesMember_470f8b3f-a688-42f2-8311-f63dbfb8b3f9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails" xlink:type="extended" id="i079f8f3afde44b258a2c6e1fd4ae75d9_REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0c11ae8b-ad7a-441b-b2a7-befafd396d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_9870acd3-e9f0-4870-9408-1ddec190d7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0c11ae8b-ad7a-441b-b2a7-befafd396d1f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_9870acd3-e9f0-4870-9408-1ddec190d7d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1_4f09ecf2-9a86-4bcf-94c2-1c5c29c60fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorSalesTypeLeaseTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0c11ae8b-ad7a-441b-b2a7-befafd396d1f" xlink:to="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1_4f09ecf2-9a86-4bcf-94c2-1c5c29c60fd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_59496f6c-1a20-4c21-aa70-c36b0877732c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0c11ae8b-ad7a-441b-b2a7-befafd396d1f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_59496f6c-1a20-4c21-aa70-c36b0877732c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_dfdf3556-8211-4e2b-bdb9-9a8155d637ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_59496f6c-1a20-4c21-aa70-c36b0877732c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_dfdf3556-8211-4e2b-bdb9-9a8155d637ca" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1" xlink:type="simple" xlink:href="isrg-20210930.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1" xlink:type="extended" id="id30bf8ac4ceb4e36a911937a02740e73_REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0c11ae8b-ad7a-441b-b2a7-befafd396d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_9870acd3-e9f0-4870-9408-1ddec190d7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0c11ae8b-ad7a-441b-b2a7-befafd396d1f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_9870acd3-e9f0-4870-9408-1ddec190d7d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1_4f09ecf2-9a86-4bcf-94c2-1c5c29c60fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorSalesTypeLeaseTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0c11ae8b-ad7a-441b-b2a7-befafd396d1f" xlink:to="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1_4f09ecf2-9a86-4bcf-94c2-1c5c29c60fd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_59496f6c-1a20-4c21-aa70-c36b0877732c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0c11ae8b-ad7a-441b-b2a7-befafd396d1f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_59496f6c-1a20-4c21-aa70-c36b0877732c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#LEASESLeaseReceivablesDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails" xlink:type="extended" id="ia960ef0e1c7c45ed88d95e4a981620e4_LEASESLeaseReceivablesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasedAssetsLineItems_87815d59-1e14-4a17-a9cb-20b675bc7ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeLeaseGrossInvestmentInLease_25724578-1339-42f4-9a02-2937145984e5" xlink:href="isrg-20210930.xsd#isrg_SalesTypeLeaseGrossInvestmentInLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_87815d59-1e14-4a17-a9cb-20b675bc7ccf" xlink:to="loc_isrg_SalesTypeLeaseGrossInvestmentInLease_25724578-1339-42f4-9a02-2937145984e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalestypeLeaseDeferredSellingProfit_4ee0fdd2-08b6-4da0-a53a-623cbc92f3d5" xlink:href="isrg-20210930.xsd#isrg_SalestypeLeaseDeferredSellingProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_87815d59-1e14-4a17-a9cb-20b675bc7ccf" xlink:to="loc_isrg_SalestypeLeaseDeferredSellingProfit_4ee0fdd2-08b6-4da0-a53a-623cbc92f3d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_63584966-0753-4287-a4da-99b13db11f50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_87815d59-1e14-4a17-a9cb-20b675bc7ccf" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_63584966-0753-4287-a4da-99b13db11f50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss_7a4cf2b0-eefb-4350-b0cc-e802796f5af8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_87815d59-1e14-4a17-a9cb-20b675bc7ccf" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss_7a4cf2b0-eefb-4350-b0cc-e802796f5af8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseReceivable_0f448eec-e4b8-43f1-ac5c-5ce5c4ff108b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseLeaseReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_87815d59-1e14-4a17-a9cb-20b675bc7ccf" xlink:to="loc_us-gaap_SalesTypeLeaseLeaseReceivable_0f448eec-e4b8-43f1-ac5c-5ce5c4ff108b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_cc0039d7-2d9f-4cae-9a5c-225d7b4129c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCapitalLeasedAsssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_87815d59-1e14-4a17-a9cb-20b675bc7ccf" xlink:to="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_cc0039d7-2d9f-4cae-9a5c-225d7b4129c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a2e3aa74-b92f-4ec6-adf3-a2a41b3d8255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_cc0039d7-2d9f-4cae-9a5c-225d7b4129c3" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a2e3aa74-b92f-4ec6-adf3-a2a41b3d8255" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a2e3aa74-b92f-4ec6-adf3-a2a41b3d8255_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a2e3aa74-b92f-4ec6-adf3-a2a41b3d8255" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a2e3aa74-b92f-4ec6-adf3-a2a41b3d8255_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d2ce56f6-8785-4d02-a531-bef338ee9cce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a2e3aa74-b92f-4ec6-adf3-a2a41b3d8255" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d2ce56f6-8785-4d02-a531-bef338ee9cce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_cc8c37f0-7edd-41dd-9144-8624e68f907a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d2ce56f6-8785-4d02-a531-bef338ee9cce" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_cc8c37f0-7edd-41dd-9144-8624e68f907a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_49df747c-a946-428a-8f9f-30ae3f769d41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d2ce56f6-8785-4d02-a531-bef338ee9cce" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_49df747c-a946-428a-8f9f-30ae3f769d41" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#LEASESCreditQualityIndicatorDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails" xlink:type="extended" id="ib5b2c175d7ec49d2a54339ab21ce2c67_LEASESCreditQualityIndicatorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear_4ba4bdd6-0687-45fe-b836-f1a4fbcb1a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear_4ba4bdd6-0687-45fe-b836-f1a4fbcb1a1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear_0302c508-d97e-4ee0-a079-52657f2f0817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear_0302c508-d97e-4ee0-a079-52657f2f0817" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear_25564d70-e69f-4009-9085-69d3b1679c75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear_25564d70-e69f-4009-9085-69d3b1679c75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear_97e241f9-4336-4176-b971-bca3f18e2092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear_97e241f9-4336-4176-b971-bca3f18e2092" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear_e29e68ab-a06d-4127-bfe3-e70941409cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear_e29e68ab-a06d-4127-bfe3-e70941409cdf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear_f66e003d-4ecc-4539-9035-feeeecfe4d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear_f66e003d-4ecc-4539-9035-feeeecfe4d2f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_1847d07a-329f-4ddf-9dc4-a5f5bc745777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_1847d07a-329f-4ddf-9dc4-a5f5bc745777" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_c8ff9ebc-5675-41c5-bd04-471129a4d4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_c8ff9ebc-5675-41c5-bd04-471129a4d4d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentAxis_34a75665-eba2-4bf3-8fb8-f8ef2da1a817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalCreditAssessmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_c8ff9ebc-5675-41c5-bd04-471129a4d4d1" xlink:to="loc_us-gaap_InternalCreditAssessmentAxis_34a75665-eba2-4bf3-8fb8-f8ef2da1a817" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain_34a75665-eba2-4bf3-8fb8-f8ef2da1a817_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis_34a75665-eba2-4bf3-8fb8-f8ef2da1a817" xlink:to="loc_us-gaap_InternalCreditAssessmentDomain_34a75665-eba2-4bf3-8fb8-f8ef2da1a817_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain_5de6399f-98e8-4b6e-ac44-9e3a5af30b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis_34a75665-eba2-4bf3-8fb8-f8ef2da1a817" xlink:to="loc_us-gaap_InternalCreditAssessmentDomain_5de6399f-98e8-4b6e-ac44-9e3a5af30b2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_HighMember_634cb53b-051c-4f57-ab09-88d277ffce9b" xlink:href="isrg-20210930.xsd#isrg_HighMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_5de6399f-98e8-4b6e-ac44-9e3a5af30b2b" xlink:to="loc_isrg_HighMember_634cb53b-051c-4f57-ab09-88d277ffce9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ModerateMember_41b9c0a3-c89b-40a5-bc5d-5a8861277e1d" xlink:href="isrg-20210930.xsd#isrg_ModerateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_5de6399f-98e8-4b6e-ac44-9e3a5af30b2b" xlink:to="loc_isrg_ModerateMember_41b9c0a3-c89b-40a5-bc5d-5a8861277e1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_LowMember_5397baf2-cf8a-46b3-b13d-1380609d10d3" xlink:href="isrg-20210930.xsd#isrg_LowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_5de6399f-98e8-4b6e-ac44-9e3a5af30b2b" xlink:to="loc_isrg_LowMember_5397baf2-cf8a-46b3-b13d-1380609d10d3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#LEASESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails" xlink:type="extended" id="ice2c180f7c37443ba51117a908871eb2_LEASESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_aec9faa3-547a-4898-b2b9-443067ae75eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1_730a4592-f377-43fe-9192-e1671d03a1db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorSalesTypeLeaseTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_aec9faa3-547a-4898-b2b9-443067ae75eb" xlink:to="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1_730a4592-f377-43fe-9192-e1671d03a1db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d7e68d81-e0dd-4ba0-8630-1287040d4452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_aec9faa3-547a-4898-b2b9-443067ae75eb" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d7e68d81-e0dd-4ba0-8630-1287040d4452" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_beb13735-9eb8-4dd9-af7c-4845055697ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d7e68d81-e0dd-4ba0-8630-1287040d4452" xlink:to="loc_srt_RangeAxis_beb13735-9eb8-4dd9-af7c-4845055697ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_beb13735-9eb8-4dd9-af7c-4845055697ba_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_beb13735-9eb8-4dd9-af7c-4845055697ba" xlink:to="loc_srt_RangeMember_beb13735-9eb8-4dd9-af7c-4845055697ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_81fea08a-0b70-4aa2-ac33-7904466ccf69" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_beb13735-9eb8-4dd9-af7c-4845055697ba" xlink:to="loc_srt_RangeMember_81fea08a-0b70-4aa2-ac33-7904466ccf69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_792492cc-3508-402f-bed8-78568c3d400a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_81fea08a-0b70-4aa2-ac33-7904466ccf69" xlink:to="loc_srt_MinimumMember_792492cc-3508-402f-bed8-78568c3d400a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_185b1077-0c52-4583-a943-8969b04bae4c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_81fea08a-0b70-4aa2-ac33-7904466ccf69" xlink:to="loc_srt_MaximumMember_185b1077-0c52-4583-a943-8969b04bae4c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails" xlink:type="extended" id="i739742bf13f34b02852d9a791426c332_GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac5908b8-c756-4160-9ee3-bf7292cba0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_084e4246-4028-4f17-898b-316dc3a94229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac5908b8-c756-4160-9ee3-bf7292cba0ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_084e4246-4028-4f17-898b-316dc3a94229" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c4fb4ef5-95c8-496e-be66-84a14bb2eed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac5908b8-c756-4160-9ee3-bf7292cba0ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c4fb4ef5-95c8-496e-be66-84a14bb2eed0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bcbab5e5-2a12-4e55-b462-1e6331e254e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac5908b8-c756-4160-9ee3-bf7292cba0ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bcbab5e5-2a12-4e55-b462-1e6331e254e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3f8f6276-be59-466f-9992-735040d7cc48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac5908b8-c756-4160-9ee3-bf7292cba0ca" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3f8f6276-be59-466f-9992-735040d7cc48" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9550c5ef-fea9-47a3-8fff-81aebe03a62c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3f8f6276-be59-466f-9992-735040d7cc48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9550c5ef-fea9-47a3-8fff-81aebe03a62c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9550c5ef-fea9-47a3-8fff-81aebe03a62c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9550c5ef-fea9-47a3-8fff-81aebe03a62c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9550c5ef-fea9-47a3-8fff-81aebe03a62c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3eb2d3bb-3ad1-45a1-9eae-d5398fbc6ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9550c5ef-fea9-47a3-8fff-81aebe03a62c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3eb2d3bb-3ad1-45a1-9eae-d5398fbc6ed2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_5d5a27b3-5f01-46d3-84d3-d254c71a3e48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3eb2d3bb-3ad1-45a1-9eae-d5398fbc6ed2" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_5d5a27b3-5f01-46d3-84d3-d254c71a3e48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionRightsMember_c0b72ae3-f065-4587-80de-ad57125cab16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3eb2d3bb-3ad1-45a1-9eae-d5398fbc6ed2" xlink:to="loc_us-gaap_DistributionRightsMember_c0b72ae3-f065-4587-80de-ad57125cab16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_263cc9ef-68c1-400c-9a65-3b945dc05c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3eb2d3bb-3ad1-45a1-9eae-d5398fbc6ed2" xlink:to="loc_us-gaap_CustomerRelationshipsMember_263cc9ef-68c1-400c-9a65-3b945dc05c45" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails" xlink:type="extended" id="i42d05c3bf1f74875a58a1153a17732e6_STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_54e2f8f4-e4c8-451b-ac25-fa878420f17f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_54e2f8f4-e4c8-451b-ac25-fa878420f17f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_74582af7-408b-4b71-bc3f-bddf9dfdc7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_74582af7-408b-4b71-bc3f-bddf9dfdc7ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8fb48a95-3564-41fa-9742-5beb7d066856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8fb48a95-3564-41fa-9742-5beb7d066856" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_cf8521d3-60c9-4317-932a-abdb0882052c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_cf8521d3-60c9-4317-932a-abdb0882052c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5ffd25ee-b93c-4330-b19b-af32a81fb493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5ffd25ee-b93c-4330-b19b-af32a81fb493" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_d04d5dfd-5176-45ba-9447-2e63d7a54d43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_d04d5dfd-5176-45ba-9447-2e63d7a54d43" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_f205a6c1-827c-423b-b586-286d2e219d84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_f205a6c1-827c-423b-b586-286d2e219d84" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_85700986-e15a-438c-9402-f8168e015fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_85700986-e15a-438c-9402-f8168e015fe5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_505ead8f-80f7-4072-af0c-14eb42416312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_505ead8f-80f7-4072-af0c-14eb42416312" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_6021a9cd-7cd6-4580-8e34-d818ea3cfde0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_6021a9cd-7cd6-4580-8e34-d818ea3cfde0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_af6edec3-5a83-421e-b076-dafdd7f9afb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_NetIncomeLoss_af6edec3-5a83-421e-b076-dafdd7f9afb3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_359dd7ff-0bbc-4d95-8cde-a794a6bbc6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_359dd7ff-0bbc-4d95-8cde-a794a6bbc6fc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a7c3d440-b67f-406b-8411-ed9b343d2117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a7c3d440-b67f-406b-8411-ed9b343d2117" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_175a4d9b-3bb2-4f37-9708-fbde2ee713b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f04d76d3-aa46-4e0d-bdc8-d342690c8367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d0c76633-988f-4a6c-b160-3f91668e13ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_54e2f8f4-e4c8-451b-ac25-fa878420f17f" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d0c76633-988f-4a6c-b160-3f91668e13ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_63608310-e84e-49aa-a1b3-4fddb6dccce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d0c76633-988f-4a6c-b160-3f91668e13ac" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_63608310-e84e-49aa-a1b3-4fddb6dccce7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_63608310-e84e-49aa-a1b3-4fddb6dccce7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_63608310-e84e-49aa-a1b3-4fddb6dccce7" xlink:to="loc_us-gaap_EquityComponentDomain_63608310-e84e-49aa-a1b3-4fddb6dccce7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_258bcace-33a0-4e38-942c-12fb490874ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_63608310-e84e-49aa-a1b3-4fddb6dccce7" xlink:to="loc_us-gaap_EquityComponentDomain_258bcace-33a0-4e38-942c-12fb490874ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5480fa9c-cdcd-4948-8889-8eab3cf55d28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_258bcace-33a0-4e38-942c-12fb490874ff" xlink:to="loc_us-gaap_CommonStockMember_5480fa9c-cdcd-4948-8889-8eab3cf55d28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9aa3f03d-10d3-4d4f-a554-7753c8ca1ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_258bcace-33a0-4e38-942c-12fb490874ff" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9aa3f03d-10d3-4d4f-a554-7753c8ca1ab1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_4412a527-d2ef-4b53-99c8-4a22259517a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_258bcace-33a0-4e38-942c-12fb490874ff" xlink:to="loc_us-gaap_RetainedEarningsMember_4412a527-d2ef-4b53-99c8-4a22259517a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0ab74850-6d15-4107-b080-1dbc4ecd90cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_258bcace-33a0-4e38-942c-12fb490874ff" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0ab74850-6d15-4107-b080-1dbc4ecd90cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_7ddac4b4-d976-40e3-aa58-4282b7479008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_258bcace-33a0-4e38-942c-12fb490874ff" xlink:to="loc_us-gaap_ParentMember_7ddac4b4-d976-40e3-aa58-4282b7479008" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_463fc5dd-0b24-492f-b9a8-26692c2d8e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_258bcace-33a0-4e38-942c-12fb490874ff" xlink:to="loc_us-gaap_NoncontrollingInterestMember_463fc5dd-0b24-492f-b9a8-26692c2d8e58" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a785ea7e-d648-4b57-8a25-d1f138ddb4b4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d0c76633-988f-4a6c-b160-3f91668e13ac" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a785ea7e-d648-4b57-8a25-d1f138ddb4b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a785ea7e-d648-4b57-8a25-d1f138ddb4b4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a785ea7e-d648-4b57-8a25-d1f138ddb4b4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a785ea7e-d648-4b57-8a25-d1f138ddb4b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1703b01-7ad2-48dc-adad-d9e5db55ff91" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a785ea7e-d648-4b57-8a25-d1f138ddb4b4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1703b01-7ad2-48dc-adad-d9e5db55ff91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f907186a-0801-44e2-906d-3be340ec99f9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1703b01-7ad2-48dc-adad-d9e5db55ff91" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f907186a-0801-44e2-906d-3be340ec99f9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails" xlink:type="extended" id="i3d0b87ca07ec4c7f824c881bfd1558bb_STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ce4f00bb-ebf0-44ce-8b64-8f6adc2b5a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_495fd0f1-c0ee-4ce4-98a0-260b47d69fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ce4f00bb-ebf0-44ce-8b64-8f6adc2b5a7d" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_495fd0f1-c0ee-4ce4-98a0-260b47d69fa8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_bbbd4950-bbd8-400d-b18a-34afebd7839d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ce4f00bb-ebf0-44ce-8b64-8f6adc2b5a7d" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_bbbd4950-bbd8-400d-b18a-34afebd7839d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_be4a54fd-0df5-45fe-9f1f-0bea5dde1200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ce4f00bb-ebf0-44ce-8b64-8f6adc2b5a7d" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_be4a54fd-0df5-45fe-9f1f-0bea5dde1200" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_44412b6e-ab0a-4475-a70c-c65804b6113a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ce4f00bb-ebf0-44ce-8b64-8f6adc2b5a7d" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_44412b6e-ab0a-4475-a70c-c65804b6113a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d5d6f55e-413c-4b26-80a2-be9b06136f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_44412b6e-ab0a-4475-a70c-c65804b6113a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d5d6f55e-413c-4b26-80a2-be9b06136f9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d5d6f55e-413c-4b26-80a2-be9b06136f9c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d5d6f55e-413c-4b26-80a2-be9b06136f9c" xlink:to="loc_us-gaap_EquityComponentDomain_d5d6f55e-413c-4b26-80a2-be9b06136f9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_63cf029d-17df-40af-a3ba-20a91faed713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d5d6f55e-413c-4b26-80a2-be9b06136f9c" xlink:to="loc_us-gaap_EquityComponentDomain_63cf029d-17df-40af-a3ba-20a91faed713" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6235e734-23a0-4077-9e8f-33f3fa92d349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_63cf029d-17df-40af-a3ba-20a91faed713" xlink:to="loc_us-gaap_CommonStockMember_6235e734-23a0-4077-9e8f-33f3fa92d349" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_a1b740c4-0f4e-49fb-814c-b95dc6300aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_44412b6e-ab0a-4475-a70c-c65804b6113a" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_a1b740c4-0f4e-49fb-814c-b95dc6300aa5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_a1b740c4-0f4e-49fb-814c-b95dc6300aa5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_a1b740c4-0f4e-49fb-814c-b95dc6300aa5" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_a1b740c4-0f4e-49fb-814c-b95dc6300aa5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_c37d2b94-6f13-4b71-8799-e3ff93327a76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_a1b740c4-0f4e-49fb-814c-b95dc6300aa5" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_c37d2b94-6f13-4b71-8799-e3ff93327a76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CommonStockRepurchaseProgramMember_cc613e26-9ec0-41f0-ac7f-8ea595b0f0ed" xlink:href="isrg-20210930.xsd#isrg_CommonStockRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_c37d2b94-6f13-4b71-8799-e3ff93327a76" xlink:to="loc_isrg_CommonStockRepurchaseProgramMember_cc613e26-9ec0-41f0-ac7f-8ea595b0f0ed" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="extended" id="i57f4d9c988044d5a948282aa1a2c62fe_STOCKHOLDERSEQUITYStockRepurchaseProgramDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_30c1ba3b-046d-4fe5-beb8-9344d691cb29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_d3e6fb18-221d-4886-a759-cf258e8b36bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_30c1ba3b-046d-4fe5-beb8-9344d691cb29" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_d3e6fb18-221d-4886-a759-cf258e8b36bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_StockRepurchaseProgramincreasedtoauthorizedamount_13600bd8-a8fe-4ce6-b6ae-6f36481d9ba1" xlink:href="isrg-20210930.xsd#isrg_StockRepurchaseProgramincreasedtoauthorizedamount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_30c1ba3b-046d-4fe5-beb8-9344d691cb29" xlink:to="loc_isrg_StockRepurchaseProgramincreasedtoauthorizedamount_13600bd8-a8fe-4ce6-b6ae-6f36481d9ba1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_57853091-c4a3-4573-a0bc-c99164498a09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_30c1ba3b-046d-4fe5-beb8-9344d691cb29" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_57853091-c4a3-4573-a0bc-c99164498a09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_fe5fc020-059d-4c92-9441-6e572864f7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_30c1ba3b-046d-4fe5-beb8-9344d691cb29" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_fe5fc020-059d-4c92-9441-6e572864f7ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_427b7537-60bd-47ca-802e-dd182fd3649c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_fe5fc020-059d-4c92-9441-6e572864f7ef" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_427b7537-60bd-47ca-802e-dd182fd3649c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_427b7537-60bd-47ca-802e-dd182fd3649c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_427b7537-60bd-47ca-802e-dd182fd3649c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_427b7537-60bd-47ca-802e-dd182fd3649c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_1204f0cc-63dc-4c14-8254-dd39fa0d9a89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_427b7537-60bd-47ca-802e-dd182fd3649c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_1204f0cc-63dc-4c14-8254-dd39fa0d9a89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CommonStockRepurchaseProgramMember_d53280e7-ae27-4248-bde2-cf2346e06e19" xlink:href="isrg-20210930.xsd#isrg_CommonStockRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_1204f0cc-63dc-4c14-8254-dd39fa0d9a89" xlink:to="loc_isrg_CommonStockRepurchaseProgramMember_d53280e7-ae27-4248-bde2-cf2346e06e19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_dc383f7d-382e-4f70-9850-4947460c56a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_fe5fc020-059d-4c92-9441-6e572864f7ef" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_dc383f7d-382e-4f70-9850-4947460c56a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dc383f7d-382e-4f70-9850-4947460c56a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dc383f7d-382e-4f70-9850-4947460c56a0" xlink:to="loc_us-gaap_EquityComponentDomain_dc383f7d-382e-4f70-9850-4947460c56a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f583fc9e-a9bc-469a-b344-98d1c090341f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dc383f7d-382e-4f70-9850-4947460c56a0" xlink:to="loc_us-gaap_EquityComponentDomain_f583fc9e-a9bc-469a-b344-98d1c090341f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c4fbc8ab-c97e-48cb-ba87-b3b85a4ad52a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f583fc9e-a9bc-469a-b344-98d1c090341f" xlink:to="loc_us-gaap_CommonStockMember_c4fbc8ab-c97e-48cb-ba87-b3b85a4ad52a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#SHAREBASEDCOMPENSATIONAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="extended" id="ie84f0f2d990f44268ca19f127ea8828d_SHAREBASEDCOMPENSATIONAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b8b4d03d-a3b4-4581-9bec-50e82386b88c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b8b4d03d-a3b4-4581-9bec-50e82386b88c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit_15214feb-ef30-417b-9c22-10931731f657" xlink:href="isrg-20210930.xsd#isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit_15214feb-ef30-417b-9c22-10931731f657" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f46230df-3c2f-4954-9a0c-d59b4130706e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f46230df-3c2f-4954-9a0c-d59b4130706e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_68fb1aba-08a9-439d-8f92-cc29a19fb84f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_68fb1aba-08a9-439d-8f92-cc29a19fb84f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4c58f327-52ac-4fc3-a120-fbf3d91f8857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4c58f327-52ac-4fc3-a120-fbf3d91f8857" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2e99251f-95bd-4787-bbcc-15e7c768afdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2e99251f-95bd-4787-bbcc-15e7c768afdc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_10996b23-95c5-43f3-8463-5630a22e381a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_10996b23-95c5-43f3-8463-5630a22e381a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_7d6f4568-eef4-4e0a-a345-f77a012c9235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_7d6f4568-eef4-4e0a-a345-f77a012c9235" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad04022e-f7b1-4ae2-95ec-4315a723feb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad04022e-f7b1-4ae2-95ec-4315a723feb8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ef0a8d53-ce6b-47ce-85c0-e808f1f3ee9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad04022e-f7b1-4ae2-95ec-4315a723feb8" xlink:to="loc_us-gaap_AwardTypeAxis_ef0a8d53-ce6b-47ce-85c0-e808f1f3ee9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef0a8d53-ce6b-47ce-85c0-e808f1f3ee9e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ef0a8d53-ce6b-47ce-85c0-e808f1f3ee9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef0a8d53-ce6b-47ce-85c0-e808f1f3ee9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e130bcc-8609-4118-b4c0-6818304e97fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ef0a8d53-ce6b-47ce-85c0-e808f1f3ee9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e130bcc-8609-4118-b4c0-6818304e97fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f0cf6ade-d460-4a76-bc0c-60b779d78e70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e130bcc-8609-4118-b4c0-6818304e97fe" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f0cf6ade-d460-4a76-bc0c-60b779d78e70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_5563be24-1f68-4b55-b093-eba748ee2cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e130bcc-8609-4118-b4c0-6818304e97fe" xlink:to="loc_us-gaap_EmployeeStockMember_5563be24-1f68-4b55-b093-eba748ee2cb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ee9ef2d2-3fe5-4b3e-b320-629f30dc6402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad04022e-f7b1-4ae2-95ec-4315a723feb8" xlink:to="loc_us-gaap_PlanNameAxis_ee9ef2d2-3fe5-4b3e-b320-629f30dc6402" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ee9ef2d2-3fe5-4b3e-b320-629f30dc6402_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_ee9ef2d2-3fe5-4b3e-b320-629f30dc6402" xlink:to="loc_us-gaap_PlanNameDomain_ee9ef2d2-3fe5-4b3e-b320-629f30dc6402_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1d448b12-56f8-4fe8-9a9a-21d18bbf2000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_ee9ef2d2-3fe5-4b3e-b320-629f30dc6402" xlink:to="loc_us-gaap_PlanNameDomain_1d448b12-56f8-4fe8-9a9a-21d18bbf2000" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_A2010IncentiveAwardPlanMember_567e31c5-8fec-4e46-af39-918bf3309263" xlink:href="isrg-20210930.xsd#isrg_A2010IncentiveAwardPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1d448b12-56f8-4fe8-9a9a-21d18bbf2000" xlink:to="loc_isrg_A2010IncentiveAwardPlanMember_567e31c5-8fec-4e46-af39-918bf3309263" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails" xlink:type="extended" id="i8c558e6182e741709d612b34c352be73_SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a0092020-3310-46b1-bedd-e6b6c1d6b0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4fc4a63e-0dea-4485-bec1-901ffa288447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a0092020-3310-46b1-bedd-e6b6c1d6b0fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4fc4a63e-0dea-4485-bec1-901ffa288447" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_94cff074-1359-4c6d-8b77-9755ad49fd94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4fc4a63e-0dea-4485-bec1-901ffa288447" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_94cff074-1359-4c6d-8b77-9755ad49fd94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dc18b4c7-8038-4109-a589-93cd295b061c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4fc4a63e-0dea-4485-bec1-901ffa288447" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dc18b4c7-8038-4109-a589-93cd295b061c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8e3100d4-db27-4c7a-b9ba-d076f5093dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4fc4a63e-0dea-4485-bec1-901ffa288447" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8e3100d4-db27-4c7a-b9ba-d076f5093dd5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a80693ff-905d-4346-9498-d6682bfbd3db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4fc4a63e-0dea-4485-bec1-901ffa288447" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a80693ff-905d-4346-9498-d6682bfbd3db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_948d4f97-4b8d-49ea-8dad-9ef32aaf40d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2e946616-e477-494d-8c53-a43d50099b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a0092020-3310-46b1-bedd-e6b6c1d6b0fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2e946616-e477-494d-8c53-a43d50099b5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8fa6f9e5-0b5b-475e-bc43-6c814aa96ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2e946616-e477-494d-8c53-a43d50099b5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8fa6f9e5-0b5b-475e-bc43-6c814aa96ba0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_316d4d10-ec5d-43b8-a1f4-3166bc1df301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2e946616-e477-494d-8c53-a43d50099b5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_316d4d10-ec5d-43b8-a1f4-3166bc1df301" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d8716f2d-e2a9-40d7-a7d6-ec379368d336" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2e946616-e477-494d-8c53-a43d50099b5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d8716f2d-e2a9-40d7-a7d6-ec379368d336" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_caf043de-1b2c-4be7-aa40-f4bea9544018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2e946616-e477-494d-8c53-a43d50099b5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_caf043de-1b2c-4be7-aa40-f4bea9544018" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c6e6ca85-997c-4899-98d6-3b5edba6e926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2fdc50-82f4-44ff-b879-c22baf14c2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a0092020-3310-46b1-bedd-e6b6c1d6b0fe" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2fdc50-82f4-44ff-b879-c22baf14c2e8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_34efffdc-0ef3-4347-b239-fdc3919e68ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2fdc50-82f4-44ff-b879-c22baf14c2e8" xlink:to="loc_us-gaap_AwardTypeAxis_34efffdc-0ef3-4347-b239-fdc3919e68ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_34efffdc-0ef3-4347-b239-fdc3919e68ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_34efffdc-0ef3-4347-b239-fdc3919e68ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_34efffdc-0ef3-4347-b239-fdc3919e68ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff50853-cb7d-4308-a07b-e779a669c9b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_34efffdc-0ef3-4347-b239-fdc3919e68ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff50853-cb7d-4308-a07b-e779a669c9b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d5ab9664-5b24-402f-a337-37db1eec672f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff50853-cb7d-4308-a07b-e779a669c9b1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d5ab9664-5b24-402f-a337-37db1eec672f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" xlink:type="extended" id="idc1248d149744601b68df88a3c708a33_SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3e7edf9d-ce3f-44c8-9565-a191b1acecab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1f863b7b-baa7-4ba1-a0bd-6d80f952251e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3e7edf9d-ce3f-44c8-9565-a191b1acecab" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1f863b7b-baa7-4ba1-a0bd-6d80f952251e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_379c7ea7-0383-43ad-a0d8-08e074dee0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3e7edf9d-ce3f-44c8-9565-a191b1acecab" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_379c7ea7-0383-43ad-a0d8-08e074dee0a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_a47a774a-fddc-4577-a970-fed2d0c1c034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3e7edf9d-ce3f-44c8-9565-a191b1acecab" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_a47a774a-fddc-4577-a970-fed2d0c1c034" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_ea453b1e-9d15-4885-af32-2638c3ed4811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3e7edf9d-ce3f-44c8-9565-a191b1acecab" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_ea453b1e-9d15-4885-af32-2638c3ed4811" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6abce462-ad07-4f1d-91f2-ccf964dad85a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_ea453b1e-9d15-4885-af32-2638c3ed4811" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6abce462-ad07-4f1d-91f2-ccf964dad85a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6abce462-ad07-4f1d-91f2-ccf964dad85a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6abce462-ad07-4f1d-91f2-ccf964dad85a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6abce462-ad07-4f1d-91f2-ccf964dad85a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_406bf9fe-80d8-416d-a264-e3d8f815af10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6abce462-ad07-4f1d-91f2-ccf964dad85a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_406bf9fe-80d8-416d-a264-e3d8f815af10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_2b3bc2aa-6989-4095-b75f-d786a1296577" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_406bf9fe-80d8-416d-a264-e3d8f815af10" xlink:to="loc_us-gaap_CostOfSalesMember_2b3bc2aa-6989-4095-b75f-d786a1296577" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SellingGeneralAndAdministrativeMember_87648683-8331-4b0f-9765-d8f98999c855" xlink:href="isrg-20210930.xsd#isrg_SellingGeneralAndAdministrativeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_406bf9fe-80d8-416d-a264-e3d8f815af10" xlink:to="loc_isrg_SellingGeneralAndAdministrativeMember_87648683-8331-4b0f-9765-d8f98999c855" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ResearchAndDevelopmentMember_e53beba0-3b97-4b9a-992b-bd2387c30d85" xlink:href="isrg-20210930.xsd#isrg_ResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_406bf9fe-80d8-416d-a264-e3d8f815af10" xlink:to="loc_isrg_ResearchAndDevelopmentMember_e53beba0-3b97-4b9a-992b-bd2387c30d85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ConsolidatingReportingAxis_fc6e2031-b7e3-4912-b869-4aa8227cf8f6" xlink:href="isrg-20210930.xsd#isrg_ConsolidatingReportingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_ea453b1e-9d15-4885-af32-2638c3ed4811" xlink:to="loc_isrg_ConsolidatingReportingAxis_fc6e2031-b7e3-4912-b869-4aa8227cf8f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ConsolidatingReportingDomain_fc6e2031-b7e3-4912-b869-4aa8227cf8f6_default" xlink:href="isrg-20210930.xsd#isrg_ConsolidatingReportingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_isrg_ConsolidatingReportingAxis_fc6e2031-b7e3-4912-b869-4aa8227cf8f6" xlink:to="loc_isrg_ConsolidatingReportingDomain_fc6e2031-b7e3-4912-b869-4aa8227cf8f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ConsolidatingReportingDomain_f8055ebc-eab2-4d21-b714-93ec7269e644" xlink:href="isrg-20210930.xsd#isrg_ConsolidatingReportingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_isrg_ConsolidatingReportingAxis_fc6e2031-b7e3-4912-b869-4aa8227cf8f6" xlink:to="loc_isrg_ConsolidatingReportingDomain_f8055ebc-eab2-4d21-b714-93ec7269e644" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CostOfSalesProductMember_377b73b3-3513-40df-aec0-d6d502e28da5" xlink:href="isrg-20210930.xsd#isrg_CostOfSalesProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_isrg_ConsolidatingReportingDomain_f8055ebc-eab2-4d21-b714-93ec7269e644" xlink:to="loc_isrg_CostOfSalesProductMember_377b73b3-3513-40df-aec0-d6d502e28da5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CostOfSalesServiceMember_60d7a336-795b-49a0-9fea-f60df610ec9d" xlink:href="isrg-20210930.xsd#isrg_CostOfSalesServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_isrg_ConsolidatingReportingDomain_f8055ebc-eab2-4d21-b714-93ec7269e644" xlink:to="loc_isrg_CostOfSalesServiceMember_60d7a336-795b-49a0-9fea-f60df610ec9d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails" xlink:type="extended" id="i38f01a03e90d48cdb40949e8eb127be1_SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e39f3e66-ffcb-47d6-9bd6-d38e840fb61c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5539c432-7dfd-4fe5-ac1d-130bcc84d0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e39f3e66-ffcb-47d6-9bd6-d38e840fb61c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5539c432-7dfd-4fe5-ac1d-130bcc84d0d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_450a6a8b-ecb5-4643-b04c-030e7eb25252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e39f3e66-ffcb-47d6-9bd6-d38e840fb61c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_450a6a8b-ecb5-4643-b04c-030e7eb25252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2f22ad81-3400-41f2-b482-19988952fbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e39f3e66-ffcb-47d6-9bd6-d38e840fb61c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2f22ad81-3400-41f2-b482-19988952fbc9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a9157d7d-1e73-4035-8cc2-6c2b77ec72d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e39f3e66-ffcb-47d6-9bd6-d38e840fb61c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a9157d7d-1e73-4035-8cc2-6c2b77ec72d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2a5f12d-3ab8-4909-8553-f2436ef1f776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e39f3e66-ffcb-47d6-9bd6-d38e840fb61c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2a5f12d-3ab8-4909-8553-f2436ef1f776" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1222c3c8-e096-4c51-8a3b-4732e3949267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2a5f12d-3ab8-4909-8553-f2436ef1f776" xlink:to="loc_us-gaap_AwardTypeAxis_1222c3c8-e096-4c51-8a3b-4732e3949267" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1222c3c8-e096-4c51-8a3b-4732e3949267_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1222c3c8-e096-4c51-8a3b-4732e3949267" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1222c3c8-e096-4c51-8a3b-4732e3949267_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f3f180d-bca8-4e40-b505-179ba319354b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1222c3c8-e096-4c51-8a3b-4732e3949267" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f3f180d-bca8-4e40-b505-179ba319354b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_7c9516b0-0da4-47a5-905c-e9cb5b0aeb57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f3f180d-bca8-4e40-b505-179ba319354b" xlink:to="loc_us-gaap_StockOptionMember_7c9516b0-0da4-47a5-905c-e9cb5b0aeb57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_cc263a56-a539-4ccb-ad8c-5ca3f1813691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f3f180d-bca8-4e40-b505-179ba319354b" xlink:to="loc_us-gaap_EmployeeStockMember_cc263a56-a539-4ccb-ad8c-5ca3f1813691" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#INCOMETAXESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="extended" id="id11efc8dcd14434997d240a1aa92a430_INCOMETAXESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_7af5ad03-5e57-4ed8-a172-1434f506d282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_962bbfee-e9ac-4b1c-ab3d-31760c5e0e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7af5ad03-5e57-4ed8-a172-1434f506d282" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_962bbfee-e9ac-4b1c-ab3d-31760c5e0e3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_01ff1eaa-7efe-4996-a3cf-9fa94ef106e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7af5ad03-5e57-4ed8-a172-1434f506d282" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_01ff1eaa-7efe-4996-a3cf-9fa94ef106e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c8b68be5-bdf8-416f-87dd-4109f4f2e043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7af5ad03-5e57-4ed8-a172-1434f506d282" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c8b68be5-bdf8-416f-87dd-4109f4f2e043" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_d57d80d5-1226-41af-86a9-f2e4da38d273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7af5ad03-5e57-4ed8-a172-1434f506d282" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_d57d80d5-1226-41af-86a9-f2e4da38d273" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_1dea9ca2-9b1c-4524-9d0f-d1de9a1b2854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7af5ad03-5e57-4ed8-a172-1434f506d282" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_1dea9ca2-9b1c-4524-9d0f-d1de9a1b2854" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_20c77ff8-5ed8-42af-9c7b-c555d0309439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7af5ad03-5e57-4ed8-a172-1434f506d282" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_20c77ff8-5ed8-42af-9c7b-c555d0309439" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_cf2f0120-0d39-4599-ab91-4a02c9c97f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7af5ad03-5e57-4ed8-a172-1434f506d282" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_cf2f0120-0d39-4599-ab91-4a02c9c97f9f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_b5714fc2-5975-41df-8320-038930add0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_cf2f0120-0d39-4599-ab91-4a02c9c97f9f" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_b5714fc2-5975-41df-8320-038930add0bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b5714fc2-5975-41df-8320-038930add0bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b5714fc2-5975-41df-8320-038930add0bb" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b5714fc2-5975-41df-8320-038930add0bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_7bca3bb1-5a43-4056-bcb4-dc10071aee99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b5714fc2-5975-41df-8320-038930add0bb" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_7bca3bb1-5a43-4056-bcb4-dc10071aee99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_771ee038-1c38-44d7-a7ad-a0669238c1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_7bca3bb1-5a43-4056-bcb4-dc10071aee99" xlink:to="loc_us-gaap_ForeignCountryMember_771ee038-1c38-44d7-a7ad-a0669238c1ae" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>isrg-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4f3ead07-f4ad-4d18-aec5-70406fe3497c,g:13f40b2a-7689-41e3-982f-2ccf6cf675cb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_0e761806-0272-49ff-8701-921d1bc0a220_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of share repurchases authorized</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_13be77f3-cf1c-4cde-8f72-88c5a7e9b23f_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_77f6c977-8d4b-4a78-9e5b-9a75863ddfec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share Repurchase Activities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_065d7d85-6a7d-410d-a226-ad01b6a2764b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_feafa097-f74b-4db8-9f81-5b576380611d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_71457e64-338a-4d9c-98fa-354757eb3bc0_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Intuitive Surgical, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_55e31841-fb57-4d9e-b186-4cac783e8315_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Intuitive Surgical, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_042e99f6-6b2f-4d13-b5de-742bc5318546_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorSalesTypeLeaseTermOfContract1_bf42b390-06d8-4887-8925-c347af3ba810_terseLabel_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type leases terms</link:label>
    <link:label id="lab_us-gaap_LessorSalesTypeLeaseTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorSalesTypeLeaseTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1" xlink:to="lab_us-gaap_LessorSalesTypeLeaseTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_f19e0f01-591b-4bb9-9552-33040951a0b9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_955d89fb-ca52-4ddb-b717-4517fd0c7a71_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and employee benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_e1627f2b-e8a6-4ce8-aa83-272f8ca88c1e_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_18c451f0-c90a-48a3-80f9-eabd94b150e5_terseLabel_en-US" xlink:label="lab_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 and thereafter</link:label>
    <link:label id="lab_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_label_en-US" xlink:label="lab_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, after Year Four</link:label>
    <link:label id="lab_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_documentation_en-US" xlink:label="lab_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:href="isrg-20210930.xsd#isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:to="lab_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_a3d09b5e-2ed3-4283-914e-0d3e8c2fd65f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_94a6293e-de18-4566-b9a2-0f237a9862d9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_e70f4958-01f8-4c74-9a73-ecc105ae243d_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_4db2bf84-a09c-4140-a293-b278a1292d96_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments_9992f1cd-2383-420b-ac0f-5da8de26507e_terseLabel_en-US" xlink:label="lab_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred payments and contingent consideration related to business combinations and asset acquisitions</link:label>
    <link:label id="lab_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments_label_en-US" xlink:label="lab_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Present Value of Future Cash Payments</link:label>
    <link:label id="lab_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments_documentation_en-US" xlink:label="lab_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Present Value of Future Cash Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" xlink:href="isrg-20210930.xsd#isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" xlink:to="lab_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeasedAssetsLineItems_9b623b6c-164b-4dff-aa87-2a3735d5f989_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_CapitalLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_CapitalLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems" xlink:to="lab_us-gaap_CapitalLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_f8dcd178-20f2-403b-bdb0-2b4516ee96da_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current-period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_89388c43-70cd-4a4e-a943-9a1a9da7a95d_periodStartLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments with readily determinable value beginning balance, Carrying Value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_0b0aef67-243a-4232-9e9a-dd28b8f12fc9_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2cae6923-c365-42f7-89b1-c913d14936ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_b2994c51-66b2-4acd-b015-c45cf47a6717_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_ea8480de-cfb5-464f-a9b1-30dec0843ccf_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current-period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_1b82cf7c-145e-4fde-a4b2-ac509cf8fc56_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Contract Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_02baf2ab-0b11-4362-868b-bc8a47ddda27_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_7ec68584-d319-43cd-9089-0f7b9b3b2f33_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c66f45a9-c652-49c3-a20d-58eeced1e87c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_6730c997-f01a-4899-86f4-51831c827074_totalLabel_en-US" xlink:label="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value, Fair Value</link:label>
    <link:label id="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_label_en-US" xlink:label="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents and Debt Securities, Available-for-sale, Fair Value</link:label>
    <link:label id="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_documentation_en-US" xlink:label="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents and Debt Securities, Available-for-sale, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" xlink:href="isrg-20210930.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" xlink:to="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_902cc581-c9d9-460c-8e97-917289b871c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock reserved for issuance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5701c341-5dc4-47b0-9767-24836d37f255_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_87987e82-0326-40c0-9fbb-84fff71121a5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease revenue</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_37e1c203-9041-4fc9-a6cf-bf89715f5878_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense related to employee stock plans</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_2f7c6e42-1393-459c-8964-6e40d46a87ae_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Revenue</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_db9ee483-eb91-4897-829c-813de9ea8dca_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_b0423bbb-dbc5-4e81-8c35-0353f6ad8813_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_7cb31ebe-d217-49c8-ba8f-21433ef7cd05_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_07ab4789-2647-46b4-8ebc-4d8a03f2009a_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_4c2e23b0-a898-41f9-b819-6b958e4f6231_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8376a5eb-baf0-4f8a-900a-93f00f888416_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining amount of share repurchases authorized</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_623264dd-60d6-4c4e-96f3-bc3f474b25bb_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock options excluded from computation of diluted net income per share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_206dc372-28ad-492a-831c-7b9825d901fd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Details</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_ea1d7be7-8583-41bb-9082-6ce30d64f7d1_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear_73250602-3913-481b-b7ea-ed615d40d15b_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Year One, Originated, Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_17b7795c-cc62-4fda-895a-c84c43e2553e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1ada5cab-37ac-4678-baf9-62262535d799_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_6ac57a82-e4ed-435a-bf6d-f0483999c04a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b8815a9-aa84-4479-8819-af58f59646ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_edc51322-da39-44bd-9b81-16b7f9f6e04a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_070fa984-6476-4841-91da-4ee645018622_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_96b375ba-c47f-4629-a222-dfa2def4dea4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_ede58eef-f6a0-43a5-8568-fcb5a915dead_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable, number of shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_719f722c-b7af-4c29-963a-22dd0b54b65a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_f9a1bda3-d460-4e52-9591-2bb3bf828dba_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cf4a6890-68e7-4200-af06-96f10ea219e9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5b6ef11c-3972-4a3a-a395-693963afed23_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_17309d62-ee21-4b43-9367-eef190d0e5ed_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of September&#160;30, 2021, and December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e3c65e70-e344-4fcf-9ed5-4bd4b8fe1e9e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, Number Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4a6a8487-4bf4-4677-be1f-a9cf3e7aa341_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, Number Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3afc5c8b-37b4-4a3d-872a-0f41ac27b4ac_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_41aa4d52-d569-42cb-a273-79c3821e1672_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_88f34f93-10be-4786-9d43-125707442e99_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of available-for-sale securities, equity</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Available-for-sale Securities, Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9ab156d6-eefc-4a99-b84f-09944cab1ee7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_ConsolidatingReportingDomain_ac2726b3-faec-4c3c-8327-f4255f493ac3_terseLabel_en-US" xlink:label="lab_isrg_ConsolidatingReportingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidating Reporting [Domain]</link:label>
    <link:label id="lab_isrg_ConsolidatingReportingDomain_label_en-US" xlink:label="lab_isrg_ConsolidatingReportingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidating Reporting [Domain]</link:label>
    <link:label id="lab_isrg_ConsolidatingReportingDomain_documentation_en-US" xlink:label="lab_isrg_ConsolidatingReportingDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidating Reporting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ConsolidatingReportingDomain" xlink:href="isrg-20210930.xsd#isrg_ConsolidatingReportingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_ConsolidatingReportingDomain" xlink:to="lab_isrg_ConsolidatingReportingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_72cca590-315d-482e-b17b-e8bea9e79f52_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_29f788e2-2a3f-4a12-89f4-a70cc65f2d20_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and retirement of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_3730e5a7-4620-4094-ad47-1cc698a8620d_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_fc6d669e-0aa1-4c9b-b058-a0e4380ebb2e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_e586a31c-d428-48cf-89e2-39794c749e57_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears_83c3c7c1-ef1c-44f8-8658-2b6fcb37ec21_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1d05c31c-6cb2-4265-bee6-2d9c62d211e3_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of property, plant, and equipment in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_IntangibleAndOtherAssets_55a5b2ea-f38a-4828-9f7b-18b8545ae9d1_terseLabel_en-US" xlink:label="lab_isrg_IntangibleAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible and other assets, net</link:label>
    <link:label id="lab_isrg_IntangibleAndOtherAssets_label_en-US" xlink:label="lab_isrg_IntangibleAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible And Other Assets</link:label>
    <link:label id="lab_isrg_IntangibleAndOtherAssets_documentation_en-US" xlink:label="lab_isrg_IntangibleAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sum of carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges and other non-current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_IntangibleAndOtherAssets" xlink:href="isrg-20210930.xsd#isrg_IntangibleAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_IntangibleAndOtherAssets" xlink:to="lab_isrg_IntangibleAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_52e75e23-42c5-4a1f-9c35-324691204825_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental non-cash investing activities:</link:label>
    <link:label id="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_14489d56-15da-4aba-a283-9397632fb108_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld related to net share settlement of equity awards (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_9a4d04cd-01e1-423d-b811-4bb2c47d7691_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e6c7f436-fd3e-4b21-a54b-cd65de015089_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalCreditAssessmentDomain_6d024f28-def7-4dd7-b7b0-a1b78c0f0a42_terseLabel_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Domain]</link:label>
    <link:label id="lab_us-gaap_InternalCreditAssessmentDomain_label_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain" xlink:to="lab_us-gaap_InternalCreditAssessmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a1c6c231-f94d-487d-9ce7-d93e7c98cbbf_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_ec2c6685-5f59-4a86-89f0-f5c01ee33048_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_7a250699-4b07-413a-9b9a-f797db2de085_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_b4ba433e-aa33-4d24-bf64-76e76c01fff4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear_f3bad294-08a6-42fa-aa78-3fa5752b5c25_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Year Four, Originated, Three Years before Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_48c92a83-e242-4e63-8c51-858555e2fd91_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_8e5e29d5-692c-4912-a0f8-335dc7964711_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_91682bbd-e1be-46ce-b46e-9ed44d618cbd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_fb7869a6-16c0-4d38-8ef0-3ebc1b295ca5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE AND CONTRACT ACQUISITION COSTS</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments_7a3111ab-2da3-4a52-bba6-e9b6bf166512_terseLabel_en-US" xlink:label="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales/Purchases/Others, Level 2</link:label>
    <link:label id="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments_label_en-US" xlink:label="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Sales, Purchases and Other Adjustments</link:label>
    <link:label id="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments_documentation_en-US" xlink:label="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Sales, Purchases and Other Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" xlink:href="isrg-20210930.xsd#isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" xlink:to="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f28d8573-4064-4c9e-b772-2031dcd7a2a9_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_65e601ac-721e-474b-bed4-8e81e28e5437_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_99eb47b5-2817-414e-9f20-bc18fb7a021e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_076a2b04-319c-4499-9dfb-58650c1e852b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature in one to five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_6ebde24f-c2df-465e-96c6-c68da5997f6e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Disaggregated by Types and Geography</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_873975c3-2ef8-4618-8c56-12a235bc71f0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_09db9774-f872-4017-9f66-cd6765e80682_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_DeferredPurchaseConsiderationPaymentsCurrent_a22e99b4-bcf7-4935-8ca5-3d4193595521_terseLabel_en-US" xlink:label="lab_isrg_DeferredPurchaseConsiderationPaymentsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of deferred purchase consideration payments</link:label>
    <link:label id="lab_isrg_DeferredPurchaseConsiderationPaymentsCurrent_label_en-US" xlink:label="lab_isrg_DeferredPurchaseConsiderationPaymentsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Purchase Consideration Payments, Current</link:label>
    <link:label id="lab_isrg_DeferredPurchaseConsiderationPaymentsCurrent_documentation_en-US" xlink:label="lab_isrg_DeferredPurchaseConsiderationPaymentsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Purchase Consideration Payments, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_DeferredPurchaseConsiderationPaymentsCurrent" xlink:href="isrg-20210930.xsd#isrg_DeferredPurchaseConsiderationPaymentsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_DeferredPurchaseConsiderationPaymentsCurrent" xlink:to="lab_isrg_DeferredPurchaseConsiderationPaymentsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ce018a6f-169b-46a9-8502-debf5ccdd0b9_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption of new accounting standard</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_cfca11e2-4cc7-4fc6-8def-538031870ba7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_cd8d6267-1e25-4186-9209-be37929124fc_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_c186355e-215e-4d68-8b59-068ee191087a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits associated with employee equity plans (in percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_a18643b9-efc7-44bd-a9da-d4092794bce6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_bc067144-9095-4907-b928-693208842e18_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_53a1a0a9-169e-4ea0-bc98-763d16f9797b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfEquityInvestments_dbc512dd-4c80-4d2b-aafb-b4b7d8070919_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on sale of equity investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfEquityInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Equity Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfEquityInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfEquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfEquityInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfEquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear_3a2c7a48-e1a2-4269-a287-3ed54b95fa41_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2021</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_3c824f18-ae97-4613-9331-7a847219aebb_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_31118756-7641-4e0f-a36a-8522d07f4342_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_128e6f88-dc51-496b-a572-4dfc4d3d620c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Other than Long-term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_5ef43267-5ddc-44a9-9f2b-96d259209db2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7e9dbdf-ae56-4194-b999-f94d0ba92173_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_397ba3a6-5d1d-47b7-a43b-bd200179bcbf_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_102fb474-9e1d-4038-9684-0a4625a79bcd_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_397b43dd-0883-40d5-838a-19801b6b64f8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_0750a3c9-6335-4378-90e6-89bc8ce8277f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_305e65b9-3956-4fb2-bb6b-73a3373c2582_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_c4482170-18b5-4ead-95e3-a7af3562efdd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_f959d6f0-352a-411a-92b9-3378464ca912_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation and Joint Ventures</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_d0b8624b-8ddd-4466-8281-82c1838849c8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits associated with employee equity plans</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_f4d5a696-7b37-42db-a25b-46c51c39b8d7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised, Weighted Average Exercise Price Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock_6c94cb2b-0cc6-4e13-93f9-d2963de2ec5c_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease Revenue</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Lease Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock" xlink:to="lab_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_c811093d-ba57-4ca7-b54a-d3e534c3d378_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_52ef9897-b63e-4a26-8c2b-33bc084823a1_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government agencies</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_260dab0a-6983-4b6c-a7aa-172a45d0e48f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7c7d944-7510-4c82-a6c6-f1d2d64957b5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears_6ce7893b-628d-4383-83c3-e899b9691e2e_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_7a5334c1-71ea-465b-9d75-cc5af80eaf82_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_7cbad9b4-3c3a-4c08-8ae0-8cda8198998e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_855e36da-0565-4a92-987a-5d0bfadbf55e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_82af2885-7c3b-4ce8-a85e-72b5713915c9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_93493fe0-6405-4bb4-b973-22caa7dc23bd_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7c00a21c-8d9d-420c-ade0-5e482f097c39_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_3d59f016-5166-4e79-924d-70034941027e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_e19ef963-809e-4829-a807-9ff486c6f59b_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit_9d605aba-a7b9-4813-9e5e-071151d3e3ba_terseLabel_en-US" xlink:label="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant, Giving Effect to Future Stock Split</link:label>
    <link:label id="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit_label_en-US" xlink:label="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant, Giving Effect to Future Stock Split</link:label>
    <link:label id="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit_documentation_en-US" xlink:label="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant, Giving Effect to Future Stock Split</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit" xlink:href="isrg-20210930.xsd#isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit" xlink:to="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_4c27db78-a3ad-4c9e-a5ce-bd4fce191e63_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_674bdacc-d722-488a-bfc1-202dedfc69de_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short- term Investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear_13143133-f05a-4fd8-8b06-de576a8e4796_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Year Three, Originated, Two Years before Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_54fd784d-9e1d-482b-ad21-5daeecd78a17_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_c9ae9dee-3b0a-44e8-8b28-47e4fca8eccf_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1df644b5-77db-4345-ba21-6effba04187e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_65f88443-11b3-49ea-b91d-9a01b3da24c2_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_15762128-4acf-423f-9ed1-afa5febdd9b5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_ad27af9d-0d36-455a-85de-5540bd68846f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_2114a93d-3bdf-44b7-bece-cfbbddb92a62_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_20016b92-de42-486f-ba6a-e28caf9aba8a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_f53f7ab8-2585-45ba-84d5-ea4a24aa1991_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_531de7a3-0c64-4dae-bcc7-d98c8701087a_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_70919483-60a2-4317-a8ac-1af7ae8092c1_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol(s)</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_939ffcfe-cda1-4dee-8187-aa33e5ad4146_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_30ddaf2d-75f2-410a-a3d5-6412f0644a58_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7c798db1-3bcc-45f9-a2cf-7854327b1ddc_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of businesses, net of cash</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d758ed1d-4771-4fd0-8ebd-f942aed79993_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable, weighted-average exercise price (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_052717dd-161f-4cd1-9b1a-5cbb6e8dd849_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHARE-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_ConsolidatingReportingAxis_f690e51a-afec-45f2-a24d-3f363a363161_terseLabel_en-US" xlink:label="lab_isrg_ConsolidatingReportingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidating Reporting [Axis]</link:label>
    <link:label id="lab_isrg_ConsolidatingReportingAxis_label_en-US" xlink:label="lab_isrg_ConsolidatingReportingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidating Reporting [Axis]</link:label>
    <link:label id="lab_isrg_ConsolidatingReportingAxis_documentation_en-US" xlink:label="lab_isrg_ConsolidatingReportingAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidating Reporting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ConsolidatingReportingAxis" xlink:href="isrg-20210930.xsd#isrg_ConsolidatingReportingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_ConsolidatingReportingAxis" xlink:to="lab_isrg_ConsolidatingReportingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_c9818524-9b81-40b5-ac49-edcfdb7c604f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_946433af-22a4-4acb-9648-d78b3ddec0a4_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_019b771f-043b-42c2-b78c-1c687ecbeff4_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_f2bdff47-f130-4c35-8953-9163a60e12c6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_80138276-3e35-42be-be14-84e24373c19f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_efcfc6e8-096b-40d8-91f4-80bc2720c4d7_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent_1c0783b4-65e1-4c22-99dc-159183d24d4d_verboseLabel_en-US" xlink:label="lab_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment in sales-type leases &#8211; short-term</link:label>
    <link:label id="lab_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent_label_en-US" xlink:label="lab_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Current</link:label>
    <link:label id="lab_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent_documentation_en-US" xlink:label="lab_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent" xlink:href="isrg-20210930.xsd#isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent" xlink:to="lab_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_103c3d18-b647-4f58-8855-6ea6f5e91fd3_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange gains/(losses) related to balance sheet re-measurement</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_eb30bdeb-4402-48c9-b11d-2c9355e3317f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, 600.0 shares authorized, $0.001 par value, 357.2 shares and 353.1 shares issued and outstanding as of September&#160;30, 2021, and December&#160;31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_a79cb86c-92b8-4cf5-9486-95052880f46f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_77435630-9b40-4786-bd87-054bb17ab6d4_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesTextBlock_9929fe58-01bc-4b6f-96d7-371967462850_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Cash and Available-For-Sale Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_04887ea4-ffb8-4f92-a01e-41de6837ff1f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested beginning balance (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_282f80b5-f146-4585-afed-677b5d5774dd_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested ending balance (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_35b44e81-36d0-4fc1-8d09-b6b8534427e5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition activity</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_897dcb22-7ada-4f3c-bea4-129647ee3d89_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_7575549f-87a6-466b-96b1-692166750ffb_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies (Note 8)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_58092675-8b3d-4db7-a0a3-0815cabbf9f8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3ca2cae0-e487-498e-b45e-dc7a1c9583c7_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5b26e862-6487-4a62-b435-7bb1e24b2006_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_98972ef8-5c07-4e05-bf42-a1b059866668_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_9206289e-e4b4-4e31-a56c-5ede9f43f7a3_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes&#8211;long-term</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_02fe58c7-e4f2-481f-8189-f7c87f360bac_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_f5557b6a-d5ce-4f37-949a-9a01571275ab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_8b0bbc2e-89d9-41ad-8812-079995584233_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e818eb8d-4bab-4a3f-b3c4-c1ae1f715ad3_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_afc9230d-0de2-4eda-9f01-b7a49d1098db_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities - Short-term</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_6401bb99-40f7-47e0-ba34-0d6fbb5b7bc4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_1d5909fb-a36a-40e2-8ac6-73122807996b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_c50dbace-4297-442d-a018-2973200e76f5_terseLabel_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains&#160;(Losses) on&#160;Hedge Instruments</link:label>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_label_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax [Abstract]</link:label>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_documentation_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract" xlink:href="isrg-20210930.xsd#isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract" xlink:to="lab_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_1662cbed-3c23-4bf3-a9db-c58b17bde251_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomesticMember_bb2eb0b7-2f43-4d47-b008-9554112efb58_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomesticMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomesticMember_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomesticMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Domestic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomesticMember" xlink:to="lab_us-gaap_GeographicDistributionDomesticMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_afd575f4-2290-4e27-8c11-cb022d32a429_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant, and equipment and intellectual property</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7b30e3ea-ff48-4a68-b231-8a748423febc_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e1451758-e5e9-4df4-b108-8ee68d301df3_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_6f50dd90-3413-4055-9e93-342ee9bbd169_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eb9fd34e-0dac-4a05-8980-11bb0807a20a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_606a647f-368a-40a7-89dc-ed627bcb780d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b2edb38c-569e-430e-b4dd-db583d057674_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_250e92f8-d749-4133-8da3-5573ece44c4c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_505ac4df-9ca9-4285-8819-9de80d2d80f1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_6a1add87-5f41-41ca-9f20-87b181388dd7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_0a4443cd-c864-431d-b879-b45d2763d94f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_47241c3e-302a-4cf1-9ae3-28a28ef16a2f_totalLabel_en-US" xlink:label="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value, Amortized Cost</link:label>
    <link:label id="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_label_en-US" xlink:label="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents and Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:label id="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_documentation_en-US" xlink:label="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents and Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" xlink:href="isrg-20210930.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" xlink:to="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear_6f364c85-a871-49a4-be2b-c532f44b2c77_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Year Two, Originated, Fiscal Year before Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfDerivatives_43004a1b-de7a-46dc-81c5-9a5c3fff235a_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on sale of derivatives</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfDerivatives_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfDerivatives" xlink:to="lab_us-gaap_GainLossOnSaleOfDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_e18c66f9-0d47-4ef7-a1c3-cd0615b9d373_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7f8d67b7-68ba-4054-b123-b33ac5e529a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_SalesTypeLeaseGrossInvestmentInLease_0741a170-7982-4924-907b-d89ed92295d7_terseLabel_en-US" xlink:label="lab_isrg_SalesTypeLeaseGrossInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross lease receivables</link:label>
    <link:label id="lab_isrg_SalesTypeLeaseGrossInvestmentInLease_label_en-US" xlink:label="lab_isrg_SalesTypeLeaseGrossInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Gross Investment in Lease</link:label>
    <link:label id="lab_isrg_SalesTypeLeaseGrossInvestmentInLease_documentation_en-US" xlink:label="lab_isrg_SalesTypeLeaseGrossInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Gross Investment in Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeLeaseGrossInvestmentInLease" xlink:href="isrg-20210930.xsd#isrg_SalesTypeLeaseGrossInvestmentInLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_SalesTypeLeaseGrossInvestmentInLease" xlink:to="lab_isrg_SalesTypeLeaseGrossInvestmentInLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_e37cb134-e66d-4731-b190-04f99905d042_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature in one to five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e6ab6f79-e471-4b04-835c-2ce2a3f8008c_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_3aabd1e5-cc10-42ba-aefe-d60fd9790e91_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: comprehensive income attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_49374a15-0857-463f-983f-51f69ca34e41_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_192d1184-9cf0-47ac-94b2-680f11a57dea_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_3f3430ca-fc58-4d34-8ea0-fbb8e400f071_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_50e06ed6-c86c-44a8-9063-833367b367d3_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_faa04106-f94d-4aae-bd3d-f0a0d6ffbe00_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_aa98aea9-ec41-45f5-8ef3-378ee0cfa783_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_fd3a5337-323a-4236-b506-1b5ba3f134ed_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_cb3dd210-3e7f-4ef5-9796-99e776e0bbd4_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Table]</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_ccf97909-dc2c-424c-b585-59860f7ff10b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_04fa0219-92e5-4d13-aec8-4af1939fbfae_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and loss on disposal of property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_aeae4c18-5877-4f68-83c4-5d085000779c_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_81b6acd5-b71c-4d7e-ab1b-4c4eb9fac803_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_23b9582e-cfa0-4945-bc8c-1951544236b4_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and developed technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear_da95d64e-1739-42a8-8a41-cbd917e75b5b_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Year Five, Originated, Four Years before Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionForeignMember_0c616fcf-ff79-4c9f-892c-35f55fae4140_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionForeignMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside of U.S. (&#8220;OUS&#8221;)</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionForeignMember_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionForeignMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Foreign [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionForeignMember" xlink:to="lab_us-gaap_GeographicDistributionForeignMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b4b8b652-2aed-46fe-ab31-ba87b64f20b2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_6e32c9f4-3ff7-41b7-bd20-93a653149d40_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of RSU Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_3fda59af-5e7f-4b1a-8544-37aa72f4c73e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts of outstanding currency forward contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_34ad3d6a-10a0-48fa-ba5e-1ea7ad0b6865_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_bf37cc91-0bc2-44c7-a4ff-3154340f5345_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and retirement of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_b081f0d4-467f-4990-a9c2-d28d1285aaac_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_3ba9cd1b-baca-41d9-91c2-034b4aa7d8ba_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_e864a381-6c49-4d11-9e12-61fc1fce5312_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other accrued liabilities&#8211;short-term</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_ffa79615-a125-41c7-87ae-0b6dafec9db5_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6554db16-5a31-485a-9e21-0c3bcdc9c51f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_4396ee63-bce5-4b8f-b2bc-43b53ca723ac_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_664faa20-07bb-4916-a240-ccff2db66f90_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalCreditAssessmentAxis_3515ed7e-b2d8-476d-8c92-45579d43de64_terseLabel_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Axis]</link:label>
    <link:label id="lab_us-gaap_InternalCreditAssessmentAxis_label_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalCreditAssessmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis" xlink:to="lab_us-gaap_InternalCreditAssessmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_e5993d27-d0f2-4289-9e41-bb22b4c3510f_verboseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_94963d8f-2017-4bd0-8335-884a67c54719_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c7323782-8806-43ac-b236-7830ce2fee59_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a5153040-86ef-4971-ba06-1bc33842e919_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted, Weighted Average Exercise Price Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23c1df1a-9709-4113-8f28-9da669d437c2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_cefdb6f3-c312-4f88-bc7c-a057ecf1fe4e_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options forfeited/expired, Number Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_a7067c91-3cbc-4cb9-b9a6-3286dfb276f7_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Intuitive Surgical, Inc. stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_94ecfabf-4f4e-4cc0-81aa-4c49e76814c5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_7235f26d-41df-4520-9bea-f4178084ed40_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Equity Investment Activity</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:to="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_a6e4304e-79b6-47fa-acbf-44ff2bc86638_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_7613f5ed-f6e8-460b-8d31-7c24ce533cd1_terseLabel_en-US" xlink:label="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Exercise&#160;Price Per Share</link:label>
    <link:label id="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_label_en-US" xlink:label="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Exercise Price [Abstract]</link:label>
    <link:label id="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_documentation_en-US" xlink:label="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:href="isrg-20210930.xsd#isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:to="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_ee6f73c1-38aa-4203-8596-0210ee4b1874_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_316cbb5a-2165-4b4a-a211-f337e7e7bb95_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0a4ff659-5ac1-4201-b97a-800b4cc793f2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_ef769d64-984e-4d31-8987-c0b5fee51dd8_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_4481053c-b03c-4f2a-b254-18a9b26b39de_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Accumulated Other Comprehensive Income, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeRollForward_5f2352d6-9221-4d08-bf05-59bb9397be29_terseLabel_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeRollForward_label_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeRollForward_documentation_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward" xlink:href="isrg-20210930.xsd#isrg_AccumulatedOtherComprehensiveIncomeRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward" xlink:to="lab_isrg_AccumulatedOtherComprehensiveIncomeRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_63f96f54-8b74-4fe3-91cb-9499da986453_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_4ddfcfe0-9f88-4738-903e-14655dab4aa8_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths_824804ca-daba-484f-99ef-bd561b2507d9_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_d729d2ef-391b-45e9-b6b4-ba1b176c3be5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and employee benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_f904ec4a-f524-4abf-86ac-d15a8945eeac_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c5f92088-403d-4d41-8c8b-9248cc0146bf_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_c45c6914-fd40-47f5-acf1-69a1fb970c56_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_0345f5a3-efe3-4410-8c22-0c383411e02c_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of contract acquisition assets</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortization" xlink:to="lab_us-gaap_CapitalizedContractCostAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_fff6021e-0b8f-4b63-88b6-87a4446039f0_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_17b44ec1-f654-4e66-aa22-f8f3e9508ccc_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_IntangibleAndOtherAssetsNetMember_d6b47c44-c442-400c-8758-01b7821238d5_terseLabel_en-US" xlink:label="lab_isrg_IntangibleAndOtherAssetsNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible and other assets, net</link:label>
    <link:label id="lab_isrg_IntangibleAndOtherAssetsNetMember_label_en-US" xlink:label="lab_isrg_IntangibleAndOtherAssetsNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible and Other Assets, Net [Member]</link:label>
    <link:label id="lab_isrg_IntangibleAndOtherAssetsNetMember_documentation_en-US" xlink:label="lab_isrg_IntangibleAndOtherAssetsNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible and Other Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_IntangibleAndOtherAssetsNetMember" xlink:href="isrg-20210930.xsd#isrg_IntangibleAndOtherAssetsNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_IntangibleAndOtherAssetsNetMember" xlink:to="lab_isrg_IntangibleAndOtherAssetsNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_912c8482-0d8a-4e34-a62e-b6ca7b2c52ff_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a224a500-e546-4fae-a461-bf0ff7107530_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan, number of shares purchased by employees</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_64462a3e-c1a2-4956-9d5a-0cb120cb9242_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_ee296fbc-8eac-424f-9e88-c02c30cd9e3e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_d40a9a86-b256-4a18-8f67-c410d3f48fdb_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. treasuries</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_e0b7ecd7-ff13-4aad-bb90-286b116c6845_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_c922ce50-b928-47cd-bfcc-7f0a23571e46_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_666a356d-1ea5-4648-9962-8f3411f32879_terseLabel_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses)&#160;on Available-for-Sale Securities</link:label>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_label_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax [Abstract]</link:label>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_documentation_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Available-For-Sale Securities Adjustment, Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract" xlink:href="isrg-20210930.xsd#isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract" xlink:to="lab_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_17c15af8-ca8a-430d-a51c-24acb57cb81f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible and other assets, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_ba6d9bb8-6232-4208-ae1f-d94f15d18400_terseLabel_en-US" xlink:label="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Gains&#160;(Losses)</link:label>
    <link:label id="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_label_en-US" xlink:label="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Translation Adjustment Summary [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CumulativeTranslationAdjustmentSummaryRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:to="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bdaf9dd6-b8ff-4b38-a151-d107e044c87a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_17c8f673-4175-4033-ae33-98de508d8812_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_4102c5f8-8e41-4766-9164-f7c7b5e2b629_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_375dd019-d2b7-47bf-acdf-6e6dda18a35a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8fd5799b-dc8c-443a-b1e9-956b60acd7b6_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ca05f673-eee0-48c4-bcaf-f8e428343717_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_b2dc8294-348c-4707-9ee9-c002478551f9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_5c8ef80b-5daf-48f5-8f9d-3f3ba0275455_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_401f4517-ecf5-4cd8-9fcd-58316d9b25b2_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_62ebaacb-4df7-4c15-bed9-6273482134a5_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_06258a8f-d383-4aa1-ae6f-e207cb082428_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8e88684d-e36d-439b-aacc-185a14fda8f4_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_fd209417-5c4d-407d-af32-065e5d9cc68e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_c1922885-5c6b-4e22-bd75-9b6f0d72ba2e_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_004ecc4b-ac13-4a5f-b7f0-97f217fe79aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Re-measurement of deferred tax assets</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_91e7cd24-ba74-4073-ac39-2577b3ef907f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted, Number Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_b354ec7d-8b53-4252-996c-6b2749960117_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_6b965249-7eb3-400f-b134-531099405048_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_cf9c83c1-020a-4531-b806-d37bf99599bd_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_307bcfa7-c876-47cb-99c7-18e7d788639b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e9f500a3-e3f7-4f26-a064-ec7f4e7f2c77_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_834ddb51-0713-4585-b084-4abcfc3006fa_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_940af119-d702-4ecc-b3a9-20a8e90d0ca3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c844c3bb-a557-4000-9595-b08260215e1c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options forfeited/expired, Weighted Average Exercise Price Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_f853b0d3-e4c1-4f70-9ccf-2dffd21eddc5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_9609db2e-5a98-47db-bd4a-b92ce79a1f49_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a0fade10-4717-4706-a55a-aacf49b9066e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State or Other Jurisdiction of Incorporation or Organization</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_CostOfSalesProductMember_909e2e27-8aa6-4a76-8d19-7424ddf8bbe9_terseLabel_en-US" xlink:label="lab_isrg_CostOfSalesProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales - products</link:label>
    <link:label id="lab_isrg_CostOfSalesProductMember_label_en-US" xlink:label="lab_isrg_CostOfSalesProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Sales Product [Member]</link:label>
    <link:label id="lab_isrg_CostOfSalesProductMember_documentation_en-US" xlink:label="lab_isrg_CostOfSalesProductMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Sales Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CostOfSalesProductMember" xlink:href="isrg-20210930.xsd#isrg_CostOfSalesProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_CostOfSalesProductMember" xlink:to="lab_isrg_CostOfSalesProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_8e960bf1-a44e-4513-97f8-14b0a8afc01f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_fe97e8ea-5cbb-4af4-af8a-d12b106ead41_periodStartLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments without readily determinable value, Carrying Value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_1489f395-d110-4129-955b-41518d4fe0a1_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_83b97036-8361-486d-a26d-b3e672f42d04_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value at grant date (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_df781ddf-e75a-463b-9628-f86642dc520b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_4b75ec1a-a25e-4c9b-a314-7dc9a24cdb8a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock through employee stock plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_cb398cbd-e12e-4864-a3ae-c63b3d97d0a5_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current-period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_920da4ce-6a7f-47c3-ad1a-e1223714227d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Transfers and Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTransfersAndChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_CommonStockRepurchaseProgramMember_219432ac-3bfc-40f1-90ad-25a5be5ae61c_terseLabel_en-US" xlink:label="lab_isrg_CommonStockRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase Program</link:label>
    <link:label id="lab_isrg_CommonStockRepurchaseProgramMember_label_en-US" xlink:label="lab_isrg_CommonStockRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Repurchase Program [Member]</link:label>
    <link:label id="lab_isrg_CommonStockRepurchaseProgramMember_documentation_en-US" xlink:label="lab_isrg_CommonStockRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CommonStockRepurchaseProgramMember" xlink:href="isrg-20210930.xsd#isrg_CommonStockRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_CommonStockRepurchaseProgramMember" xlink:to="lab_isrg_CommonStockRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_b3bc13a3-b900-4e1c-9619-1a4ee3056c62_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_cc67bb9c-44ca-443f-9eb9-2f959d96a989_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long- term Investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_0b64e6f5-c4da-484d-a2b5-5776b1fd9505_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_e39cb3a9-927e-4ed5-9464-15c5eb4ac523_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost Basis by Year of Origination and Credit Quality Indicator</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable Credit Quality Indicators [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:to="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears_f1b334ea-b328-47e6-bdda-0227832e9876_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_3c79b82f-8386-4ca6-a73a-e480200636a7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price allocated to remaining performance obligations</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_b1738d09-f7bf-4b1f-ba48-3bd56b01b7b4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock through employee stock plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_28747d60-e06f-4db8-adc5-4b2536fe3196_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Share-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71716c72-2c47-4702-95ef-a0c3bad3c541_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_f0965e97-ab37-4851-9368-7c5bb0412362_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_5a480986-4173-4df4-a8c0-b919f8798c2d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_32912974-95bc-4d64-b3b1-1b4259384326_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_44ab6ccb-318c-48a6-b1e1-ae9ab291eda8_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomain" xlink:to="lab_us-gaap_GeographicDistributionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_34fe6e1b-4c9c-4728-bf00-1e93cad203d6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized gains/(losses) in Interest and other income, net</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_ResearchAndDevelopmentMember_aa1c2a50-aac7-4931-aeaa-bce87d88aeca_terseLabel_en-US" xlink:label="lab_isrg_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_isrg_ResearchAndDevelopmentMember_label_en-US" xlink:label="lab_isrg_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development [Member]</link:label>
    <link:label id="lab_isrg_ResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_isrg_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ResearchAndDevelopmentMember" xlink:href="isrg-20210930.xsd#isrg_ResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_ResearchAndDevelopmentMember" xlink:to="lab_isrg_ResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d2a4fa4a-0e67-46f0-aad7-bf4ffc6f7dcd_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_2caa2c51-4312-4ab1-86aa-5f086bb42ac8_totalLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_370a151a-384c-464a-8cca-9b688b998cb6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Basic and Diluted Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_3bce2eec-ed8c-4e86-a723-75ae5e88efe0_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_42dd2657-67ce-41a5-95f6-125a6eb9d6a0_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_32e26bbb-a8c3-47b9-aed6-e24aa834518d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current-period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_595209c1-b78b-425c-a898-90527ee37764_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue&#8211;long-term</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_c54ef617-27b6-4321-b42a-74358628c362_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation and other</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_29114632-74be-4301-bb32-16819e4c581b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_f6805036-8a23-4091-aab6-f6cae324b549_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_aca03518-e2a6-48a5-b630-b1415ece39d1_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_label_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:to="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_d9815d79-03e3-44a6-98d5-548ae6aca7af_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_96b117cd-3d3f-4759-b0a9-8ebb3ea35e50_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_9fcd72eb-3c8c-459f-b3dd-bb365f4c56ab_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Joint Venture</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_51f784f9-e70b-48a4-8ee7-1750107fcc4c_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_0c74c1ac-5280-42b6-b591-c6091355baf3_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_eb0de7f0-c4eb-48b8-af2f-51b876d2e27c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_fdc997ad-6e80-41d6-bf97-cd553ecb04f0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0f7348fe-5b77-43d0-83d7-df109078f03d_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: net income attributable to noncontrolling interest in joint venture</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_98f448fe-50fd-4d38-a2b1-4b07b1cd227e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interest in joint venture</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_848a46bd-205c-4147-8fe5-cf4b5a09bbf6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_79660d6b-03d4-452f-a46e-c9418629f676_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_bd11ffbe-e247-4a33-8bec-d5d657b650a9_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_cd69baf9-5956-48c3-90f0-22b87a3f4963_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_46b849a9-ea5e-423c-b90e-bd1f2654e77b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligations</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_3c8b0a11-8b49-4f34-9efe-15e9018e0c0e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_de518113-c09b-430e-8c3e-6abbb48ae44b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8f3daf89-8ace-4971-a98e-c6bec2323bb3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_fef9ffdb-a7dc-48e7-9ab8-3ee0f5715c81_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I.R.S. Employer Identification No.</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_A2010IncentiveAwardPlanMember_1dc45c0a-4783-46d9-8760-47e279f77013_terseLabel_en-US" xlink:label="lab_isrg_A2010IncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Incentive Award Plan</link:label>
    <link:label id="lab_isrg_A2010IncentiveAwardPlanMember_label_en-US" xlink:label="lab_isrg_A2010IncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Incentive Award Plan [Member]</link:label>
    <link:label id="lab_isrg_A2010IncentiveAwardPlanMember_documentation_en-US" xlink:label="lab_isrg_A2010IncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Incentive Award Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_A2010IncentiveAwardPlanMember" xlink:href="isrg-20210930.xsd#isrg_A2010IncentiveAwardPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_A2010IncentiveAwardPlanMember" xlink:to="lab_isrg_A2010IncentiveAwardPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_4855eed5-2bbe-4645-8782-a0713c4d1bc1_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments_2b8105b1-7c00-451b-be7d-e259cbd7df8a_terseLabel_en-US" xlink:label="lab_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales/Purchases/Others, Level 1</link:label>
    <link:label id="lab_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments_label_en-US" xlink:label="lab_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Sales, Purchases and Other Adjustments</link:label>
    <link:label id="lab_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments_documentation_en-US" xlink:label="lab_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Sales, Purchases and Other Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" xlink:href="isrg-20210930.xsd#isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" xlink:to="lab_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8a673e84-2b27-4c50-9a39-6f2e6b934897_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e2095379-4415-41ff-8b95-81ba9129d8c8_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding used in basic calculation</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_8005479a-a52a-4002-8565-94809f1b5289_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_4e7ac5b8-dd70-45a0-a1f1-3d6c11662082_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: dilutive effect of potential common shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_d66ab13c-48ac-4781-8fba-8e67fd9faa73_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_HighMember_1f828ffe-09c1-453c-a389-2a1aceaad5ad_terseLabel_en-US" xlink:label="lab_isrg_HighMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High</link:label>
    <link:label id="lab_isrg_HighMember_label_en-US" xlink:label="lab_isrg_HighMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High [Member]</link:label>
    <link:label id="lab_isrg_HighMember_documentation_en-US" xlink:label="lab_isrg_HighMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_HighMember" xlink:href="isrg-20210930.xsd#isrg_HighMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_HighMember" xlink:to="lab_isrg_HighMember" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_SellingGeneralAndAdministrativeMember_f62589b3-dc85-46d0-b230-aca75ec464d1_terseLabel_en-US" xlink:label="lab_isrg_SellingGeneralAndAdministrativeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_isrg_SellingGeneralAndAdministrativeMember_label_en-US" xlink:label="lab_isrg_SellingGeneralAndAdministrativeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling General And Administrative [Member]</link:label>
    <link:label id="lab_isrg_SellingGeneralAndAdministrativeMember_documentation_en-US" xlink:label="lab_isrg_SellingGeneralAndAdministrativeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs related to selling, general and administrative activities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SellingGeneralAndAdministrativeMember" xlink:href="isrg-20210930.xsd#isrg_SellingGeneralAndAdministrativeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_SellingGeneralAndAdministrativeMember" xlink:to="lab_isrg_SellingGeneralAndAdministrativeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_a35fab52-93da-4fcf-ba7d-1d533adec478_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income attributable to Intuitive Surgical, Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_d57fb559-c929-4aad-921f-391023ce9a2f_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_17616e44-c755-4066-9b61-71f59b723094_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gains/(losses) on investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_225d6fed-d9f8-4dc2-a9ce-9407b333bad1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8bcb5af2-de2a-4b94-a54c-e405b24a45bb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in computing net income per share attributable to Intuitive Surgical, Inc.:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_af17f75d-4493-4c13-93d5-bcc3aac17029_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_LowMember_3a06fe86-f057-450d-8cc0-35068f7ee7d1_terseLabel_en-US" xlink:label="lab_isrg_LowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Low</link:label>
    <link:label id="lab_isrg_LowMember_label_en-US" xlink:label="lab_isrg_LowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Low [Member]</link:label>
    <link:label id="lab_isrg_LowMember_documentation_en-US" xlink:label="lab_isrg_LowMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Low</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_LowMember" xlink:href="isrg-20210930.xsd#isrg_LowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_LowMember" xlink:to="lab_isrg_LowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_94ea72ac-760c-4c69-80c8-0b202ab37412_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DistributionRightsMember_ab03cd28-01e3-451b-8633-111fe7c0cb35_terseLabel_en-US" xlink:label="lab_us-gaap_DistributionRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution rights and others</link:label>
    <link:label id="lab_us-gaap_DistributionRightsMember_label_en-US" xlink:label="lab_us-gaap_DistributionRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DistributionRightsMember" xlink:to="lab_us-gaap_DistributionRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_7f0f2cda-a2a6-4b65-9f76-8c7ca6b5da77_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_05134d2b-17c1-423c-a90c-487cbd95dfc8_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b9b42acd-245d-4d1f-9c47-8e7a1aeb901e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_389d13d6-9d00-468a-9cb9-df9aceb9828f_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense after income taxes</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_9e6cbe35-6df8-4f34-ba49-bbc175f1953c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swiss</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal_f29ce262-a158-4400-b9f1-22640b446cc6_totalLabel_en-US" xlink:label="lab_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal_label_en-US" xlink:label="lab_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Maturities Fair Value Total</link:label>
    <link:label id="lab_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal_documentation_en-US" xlink:label="lab_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Maturities Fair Value Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" xlink:href="isrg-20210930.xsd#isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" xlink:to="lab_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c896df4f-e6be-4452-b2a8-d6cc8a888533_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_474f9082-cfa4-4eb5-961d-9b040934f38e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseLeaseReceivable_8079dbb1-8f4b-408c-a71d-8a6cc760f350_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease receivables</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseLeaseReceivable_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Lease Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseLeaseReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseLeaseReceivable" xlink:to="lab_us-gaap_SalesTypeLeaseLeaseReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_21fdb138-1be5-4203-b736-09e972482acf_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_5f7b31b7-5cca-4f92-b065-73530e25adc3_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_01b0dd04-0599-4e9c-8eae-5f7d3d0b9ae9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefit Plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ff927ac0-cfef-4d06-bc03-d61b29d33ca5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_99e521ea-2d73-4318-9193-1d86116d0fed_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a4a8d81a-6b36-447b-90f6-2926467b757f_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c63d4e68-a1ee-4438-b101-00ec170effe5_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_4f86230a-530e-4b65-af8a-7713004f0c86_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_db3d2b6f-d322-43e8-b2f7-8529ec5518d9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_158f5531-6c98-45ad-82b4-ea0ab00ab764_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current-period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_caf5ee21-7cea-4933-94de-23b49b61637a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares_13789910-8a52-4ef1-9bab-d09863188203_terseLabel_en-US" xlink:label="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments without readily determinable value, portion attributable to investment in preferred shares</link:label>
    <link:label id="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares_label_en-US" xlink:label="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss), Portion Attributable to Investment in Preferred Shares</link:label>
    <link:label id="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares_documentation_en-US" xlink:label="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss), Portion Attributable to Investment in Preferred Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares" xlink:href="isrg-20210930.xsd#isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares" xlink:to="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_a239735c-ae6a-4bc8-8b2c-0e76c659b8c0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_bb51ae3b-3159-4c14-a74a-b84c934b8497_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_e3aa4609-ee87-4629-b5c9-67f948549b73_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature in less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_0995fcd0-b66b-4244-b652-c2ee36e844c9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_022e4552-ff56-4c74-9fe8-9f09716fcd81_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other prepaids and other current assets</link:label>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:to="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_3212c47f-51fb-465a-b636-3349c9ea52b1_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_CostOfSalesServiceMember_a4860fe9-a946-4cfc-93a0-fb100426491e_terseLabel_en-US" xlink:label="lab_isrg_CostOfSalesServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales - services</link:label>
    <link:label id="lab_isrg_CostOfSalesServiceMember_label_en-US" xlink:label="lab_isrg_CostOfSalesServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Sales Service [Member]</link:label>
    <link:label id="lab_isrg_CostOfSalesServiceMember_documentation_en-US" xlink:label="lab_isrg_CostOfSalesServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Sales Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CostOfSalesServiceMember" xlink:href="isrg-20210930.xsd#isrg_CostOfSalesServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_CostOfSalesServiceMember" xlink:to="lab_isrg_CostOfSalesServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeMember_1d272717-2761-47c6-8549-6054fda7fa69_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeMember" xlink:to="lab_us-gaap_OtherIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3f9d8b41-7f8d-4dda-8fe2-c948fff8b37e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Estimated Future Amortization Expense Of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_15554b77-5fdf-4a9a-8240-e38a2e4a4010_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_0645428c-25d3-45b7-984f-2bff097c3102_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to Intuitive Surgical, Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_465ca313-a830-4404-a260-67fd5acff0a4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Available-for-sale Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_feaba152-26c4-4158-b9c8-4c21ed725ebb_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in fair value, Level 1</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_SalestypeLeaseDeferredSellingProfit_7eb7fd83-9c4e-4b67-93d3-b8bc50494cf3_negatedLabel_en-US" xlink:label="lab_isrg_SalestypeLeaseDeferredSellingProfit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned income</link:label>
    <link:label id="lab_isrg_SalestypeLeaseDeferredSellingProfit_label_en-US" xlink:label="lab_isrg_SalestypeLeaseDeferredSellingProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Deferred Selling Profit</link:label>
    <link:label id="lab_isrg_SalestypeLeaseDeferredSellingProfit_documentation_en-US" xlink:label="lab_isrg_SalestypeLeaseDeferredSellingProfit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Deferred Selling Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalestypeLeaseDeferredSellingProfit" xlink:href="isrg-20210930.xsd#isrg_SalestypeLeaseDeferredSellingProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_SalestypeLeaseDeferredSellingProfit" xlink:to="lab_isrg_SalestypeLeaseDeferredSellingProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_4e578d06-5336-4e06-8d5c-fab9d5ed4fe2_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_44c61a90-db54-4905-aaf6-7d0ffc3a4475_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_aae5628e-8bfc-489d-bcc1-d61d28b41bc0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Fair Value of the Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_ModerateMember_aac76092-8300-4849-8de8-daf4d391edc7_terseLabel_en-US" xlink:label="lab_isrg_ModerateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Moderate</link:label>
    <link:label id="lab_isrg_ModerateMember_label_en-US" xlink:label="lab_isrg_ModerateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Moderate [Member]</link:label>
    <link:label id="lab_isrg_ModerateMember_documentation_en-US" xlink:label="lab_isrg_ModerateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Moderate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ModerateMember" xlink:href="isrg-20210930.xsd#isrg_ModerateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_ModerateMember" xlink:to="lab_isrg_ModerateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax_9b9f5715-9cb3-4a8c-b138-d0a36d403838_terseLabel_en-US" xlink:label="lab_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Loss Before Reclassification Adjustments Net Of Tax</link:label>
    <link:label id="lab_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax_documentation_en-US" xlink:label="lab_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Before Reclassification Adjustments, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" xlink:href="isrg-20210930.xsd#isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1e61df04-7e33-4eab-ba1d-1ad0c131da40_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, Weighted Average Exercise Price Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_89d7e799-2628-4a17-8f33-a8d815cca652_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, Weighted Average Exercise Price Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ef84ed67-b5d5-4d02-8e87-f57ed0cc4145_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_be235d9e-3975-450f-9480-b42af5b8ae98_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense before income taxes</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_746e9159-a17d-4cd5-ad94-be2f875149f5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_771bb5d1-7616-446d-a4ea-b21565deef46_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to Intuitive Surgical, Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_134472fd-aee6-4210-8109-62f9f9e12651_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_f1fa8088-0738-40f5-a8c1-d8331a2e18c4_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseLeaseIncome_d2d45822-0b59-4d5a-bf3c-ea809e0951bc_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type lease revenue</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseLeaseIncome" xlink:to="lab_us-gaap_SalesTypeLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_835b4e88-eea8-4837-b439-8632d9443ff4_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense, percentage of pre-tax income</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_879e9f2e-f799-426b-8c7c-e4191768bb6a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalLeasedAsssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capital Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalLeasedAsssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capital Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCapitalLeasedAsssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable" xlink:to="lab_us-gaap_ScheduleOfCapitalLeasedAsssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease_d7d26913-41e7-492a-b6b4-7a917b4a3fc6_totalLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-Type Lease, Net Investment in Lease, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_e1a70817-c09f-4cae-9c1e-915318e168a4_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_4856c588-703c-4790-840b-640715479d2b_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_760bdcdc-3db2-43f5-868e-205328f5d620_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on investments, accretion, and amortization, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a92a95b7-d64e-4338-8fcc-479eb98e636f_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2cb6ba42-77f6-4bf1-9265-6d8885eaeded_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_1105f698-ba83-400b-928e-91e951e9d533_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Notional Amounts for Derivatives and Aggregate Gross Fair Value Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_CollarContractMember_2be0c546-5673-40d8-a5fd-6c37b309d06c_terseLabel_en-US" xlink:label="lab_isrg_CollarContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collar Contract</link:label>
    <link:label id="lab_isrg_CollarContractMember_label_en-US" xlink:label="lab_isrg_CollarContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collar Contract [Member]</link:label>
    <link:label id="lab_isrg_CollarContractMember_documentation_en-US" xlink:label="lab_isrg_CollarContractMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collar Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CollarContractMember" xlink:href="isrg-20210930.xsd#isrg_CollarContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_CollarContractMember" xlink:to="lab_isrg_CollarContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_50bb7eee-131a-4ca5-9ce5-56c81f940d20_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_2ac15f01-d8ce-49a7-ba4b-2b2334d1886f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_11938c67-235a-411c-9b5e-123213071d27_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_b5519107-76c1-46e5-929a-d22dc66c42ab_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_76d0be0e-f54b-40a1-8460-260ee8d5c92f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of deferred purchase consideration</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_4941f6c6-f02e-4417-8bed-3100804bcc08_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_75f5871f-05ec-4110-84ce-72fb372de4a1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares reserved for future issuance</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_2d2acf94-4b2a-4113-84ed-e461c5f8592c_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_StockRepurchaseProgramincreasedtoauthorizedamount_4fd3a96e-5b5e-48a5-8050-8a5bf902c355_terseLabel_en-US" xlink:label="lab_isrg_StockRepurchaseProgramincreasedtoauthorizedamount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, increased to authorized amount</link:label>
    <link:label id="lab_isrg_StockRepurchaseProgramincreasedtoauthorizedamount_label_en-US" xlink:label="lab_isrg_StockRepurchaseProgramincreasedtoauthorizedamount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, increased to authorized amount</link:label>
    <link:label id="lab_isrg_StockRepurchaseProgramincreasedtoauthorizedamount_documentation_en-US" xlink:label="lab_isrg_StockRepurchaseProgramincreasedtoauthorizedamount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increased to authorized shares repurchase amount for Stock Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_StockRepurchaseProgramincreasedtoauthorizedamount" xlink:href="isrg-20210930.xsd#isrg_StockRepurchaseProgramincreasedtoauthorizedamount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_StockRepurchaseProgramincreasedtoauthorizedamount" xlink:to="lab_isrg_StockRepurchaseProgramincreasedtoauthorizedamount" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_InstrumentsandAccessoriesMember_63cbdb71-cb8e-44fe-b42b-7037e983d43c_terseLabel_en-US" xlink:label="lab_isrg_InstrumentsandAccessoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments and accessories</link:label>
    <link:label id="lab_isrg_InstrumentsandAccessoriesMember_label_en-US" xlink:label="lab_isrg_InstrumentsandAccessoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments and Accessories [Member]</link:label>
    <link:label id="lab_isrg_InstrumentsandAccessoriesMember_documentation_en-US" xlink:label="lab_isrg_InstrumentsandAccessoriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments and Accessories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_InstrumentsandAccessoriesMember" xlink:href="isrg-20210930.xsd#isrg_InstrumentsandAccessoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_InstrumentsandAccessoriesMember" xlink:to="lab_isrg_InstrumentsandAccessoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_607ace05-e741-4f27-8575-caf89fd13bfe_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3c089e98-1ee7-4313-b171-9d04a5738fdc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_b39df656-04c9-4e69-ac30-7f36a481fc1e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f32ce8c8-920c-4db3-88ec-063494a2e0fb_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5cf0b392-5da8-4981-82e9-9ca04fbcf420_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3017ab1e-8999-4190-bef8-879d8e4e0d28_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised, Number Outstanding</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter_cc6cae8d-f872-45c1-acb0-35582135f99a_terseLabel_en-US" xlink:label="lab_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 and thereafter</link:label>
    <link:label id="lab_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter_label_en-US" xlink:label="lab_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Year Five and Thereafter</link:label>
    <link:label id="lab_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter_documentation_en-US" xlink:label="lab_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Year Five and Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" xlink:href="isrg-20210930.xsd#isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" xlink:to="lab_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d2ef8380-bed6-42f3-83e3-3898d563ebbf_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_55a9a5d0-cf4c-44c7-a615-c441412f19a2_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding used in diluted calculation</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_030ed369-1007-48f8-ac35-f1532723008c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_50264511-90c8-43d5-b62d-82d062d2acdd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorSalesTypeLeasesTextBlock_a58f1c9a-25b7-4b5f-ae5b-bc56520b0bc0_terseLabel_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LessorSalesTypeLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorSalesTypeLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:to="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_46f83250-50ae-428f-a531-2bbe11ddd22a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_a06d4a9a-b081-4bcc-a3fb-4ad0af1e3922_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock Option Activity Under All Stock Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1ac1fe33-7b85-4778-a95a-835d4bf18fe8_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_ServicesMember_1ebc0708-1342-4bc3-bf01-7dc012e0bcad_terseLabel_en-US" xlink:label="lab_isrg_ServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_isrg_ServicesMember_label_en-US" xlink:label="lab_isrg_ServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services [Member]</link:label>
    <link:label id="lab_isrg_ServicesMember_documentation_en-US" xlink:label="lab_isrg_ServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ServicesMember" xlink:href="isrg-20210930.xsd#isrg_ServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_ServicesMember" xlink:to="lab_isrg_ServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_9f3f9eb0-697f-46b3-a8e3-7ba7754a486d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_e88f2691-d5ad-4cf8-b560-e5e2a22892f7_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_160996dd-aae5-404b-8cd3-5aabb8209077_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and developed technology</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock_bfc784af-cca4-4b58-bbbf-63e63537267b_terseLabel_en-US" xlink:label="lab_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Receivables</link:label>
    <link:label id="lab_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock_label_en-US" xlink:label="lab_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type Lease, Lease Income [Table Text Block]</link:label>
    <link:label id="lab_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock_documentation_en-US" xlink:label="lab_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock" xlink:href="isrg-20210930.xsd#isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock" xlink:to="lab_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_27ef52e1-f08d-40bb-be0e-f95c4f84ad75_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a69f27d4-5faf-41d2-8054-100af7b5141e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_adadb72a-1508-4de6-a1fe-e13ad492c9e5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of effects of acquisition:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_7d7bcb1b-bfc2-4c48-8f29-f0c79f6993a6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan, value of shares purchased by employees</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_163c5efd-6ded-496a-9aa0-562ce475795d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dd2b3847-636d-4e8b-9aea-bac635b48a10_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_43865cf8-cec0-4d55-bf4d-019180769584_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ab85ceb2-e2a8-4cd5-89a0-897bd85095f6_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_cb2c3965-26b9-4f70-a6d1-0478267cc3ae_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_97d30d23-0250-48ee-bc57-533b6ea5ccb2_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e08e8881-d655-4a00-9829-2acdb78a84f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_8907f4ce-5872-41f7-b30d-da27c17623a7_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contractual Maturities of Gross Lease Receivables</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_741b03de-607e-4363-ab3d-fc765f6eec59_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_32fd0376-e619-484b-a005-fcab3bfa5371_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MunicipalNotesMember_84a380c9-6e24-4342-8a83-0b50144d8348_terseLabel_en-US" xlink:label="lab_us-gaap_MunicipalNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal securities</link:label>
    <link:label id="lab_us-gaap_MunicipalNotesMember_label_en-US" xlink:label="lab_us-gaap_MunicipalNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MunicipalNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MunicipalNotesMember" xlink:to="lab_us-gaap_MunicipalNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_a84948cd-8fb0-4541-abcc-5915284585ff_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_41cd69e6-3c52-4e4b-884a-eed6ba743fb4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_56ac1c84-44f0-48eb-a9a2-fcd628dbe81e_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_c3587451-2974-4dda-9d81-f748258b75ec_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of each class</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss_bf0e19ab-5223-43fb-babe-cb4e443d0fc7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_0c139e10-98be-4b7f-9439-18fcf0db610e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock relating to employee stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_8137514a-4be7-46eb-8dab-c146d586e31c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e9450369-16c9-43c1-98df-f52843c7887e_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_60ac8fbe-70f3-41eb-a1b0-b512c97d9ca6_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss_488cf880-df85-465b-8388-1d68bc948fd3_terseLabel_en-US" xlink:label="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in fair value, Level 2</link:label>
    <link:label id="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss_label_en-US" xlink:label="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss)</link:label>
    <link:label id="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss_documentation_en-US" xlink:label="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" xlink:href="isrg-20210930.xsd#isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" xlink:to="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_738435e9-8441-43fa-a6ed-bac21e130b14_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_9388f22b-a258-4d74-abeb-fb35d48c52fe_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_1386e7c5-d082-4129-8ab9-1ba43c683dc2_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_f9913e70-ec4e-41dc-b2c7-0ed4abecc830_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_927d865f-86df-4a91-b334-af0cf67fb28a_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_3df79159-3d54-4877-9c21-0fcd50132432_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_1dd797de-179f-4f98-9e04-e1e5590cafbc_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Ending Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_f8fa4040-e24c-4f48-94a0-09c755208fc7_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest in joint venture</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_SystemsMember_4b37b618-9738-4568-9062-ad923d0d0dba_terseLabel_en-US" xlink:label="lab_isrg_SystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Systems</link:label>
    <link:label id="lab_isrg_SystemsMember_label_en-US" xlink:label="lab_isrg_SystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Systems [Member]</link:label>
    <link:label id="lab_isrg_SystemsMember_documentation_en-US" xlink:label="lab_isrg_SystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SystemsMember" xlink:href="isrg-20210930.xsd#isrg_SystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_SystemsMember" xlink:to="lab_isrg_SystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_341ced37-af17-49e7-8c9e-efd7f7a0bc87_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_a80c85f7-6397-47e6-b35b-5e6b2134a609_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_5ca5281a-fdfa-48e8-bdd0-cd19ef27027d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_ea4c5387-1292-4e80-b4d3-4f2b23afcb01_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Summary of Changes in Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_1c046393-d963-436a-a229-29119a9e6280_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DESCRIPTION OF THE BUSINESS</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01e59af0-93bf-4d5e-b3e0-2f95af4ff665_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear_e5e77df8-bcbc-431a-948e-bcf5a5aeb659_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Originated, More than Five Years before Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_accb1fb1-c909-48a6-8dd8-a2ade5e4e7dd_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature in less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_9fa3af93-c4ce-4cda-ae99-294a232196b3_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionAxis" xlink:to="lab_us-gaap_GeographicDistributionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ec4d83d0-440d-4902-a18e-e61af2ec898a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_e2478369-e145-477b-9024-78fd5631309f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>isrg-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4f3ead07-f4ad-4d18-aec5-70406fe3497c,g:13f40b2a-7689-41e3-982f-2ccf6cf675cb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CoverPage" xlink:type="simple" xlink:href="isrg-20210930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f34714aa-a028-42f6-9869-09a4f62fd293" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_DocumentType_f34714aa-a028-42f6-9869-09a4f62fd293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_18b955ea-93b6-4a35-af04-06fec5239b4a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_DocumentQuarterlyReport_18b955ea-93b6-4a35-af04-06fec5239b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f534b7e0-6aae-48ef-9cd8-6a1d42b20021" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_DocumentPeriodEndDate_f534b7e0-6aae-48ef-9cd8-6a1d42b20021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_d8376d28-c067-4bc0-90ee-a3c076a80170" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_DocumentTransitionReport_d8376d28-c067-4bc0-90ee-a3c076a80170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_bdb2645b-c290-4b49-bb6b-ea3b300e7142" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_EntityFileNumber_bdb2645b-c290-4b49-bb6b-ea3b300e7142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_fb2cdac6-f4c6-4f58-8230-70ff6853929b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_EntityRegistrantName_fb2cdac6-f4c6-4f58-8230-70ff6853929b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b45ea979-8e3b-4a8c-b6ae-4bffde303b6b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b45ea979-8e3b-4a8c-b6ae-4bffde303b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_cc0481b3-ad53-4988-adc1-1f5caec2d19a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_EntityTaxIdentificationNumber_cc0481b3-ad53-4988-adc1-1f5caec2d19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7f0693b3-970a-4d75-954e-cfa302eab13e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_EntityAddressAddressLine1_7f0693b3-970a-4d75-954e-cfa302eab13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_dda802fd-d6ee-4b66-bb3c-71436fd03ad5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_EntityAddressCityOrTown_dda802fd-d6ee-4b66-bb3c-71436fd03ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6b46fa41-b799-437e-8839-b4e0d3504d60" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_EntityAddressStateOrProvince_6b46fa41-b799-437e-8839-b4e0d3504d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4a2bf1df-c5e1-4b10-956e-eeb825240bdf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_EntityAddressPostalZipCode_4a2bf1df-c5e1-4b10-956e-eeb825240bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e894f651-2558-467f-b171-f8439d7051f7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_CityAreaCode_e894f651-2558-467f-b171-f8439d7051f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_06a1ed8b-aff0-4bf7-8a67-8df74b53b509" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_LocalPhoneNumber_06a1ed8b-aff0-4bf7-8a67-8df74b53b509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_553e88d7-7e36-47d4-8199-eee3fc983ef2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_Security12bTitle_553e88d7-7e36-47d4-8199-eee3fc983ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a29a8fe1-a642-4a08-824b-b5c0cc69f410" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_TradingSymbol_a29a8fe1-a642-4a08-824b-b5c0cc69f410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_05eff7df-986c-4e39-aea1-6a4eb053af03" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_SecurityExchangeName_05eff7df-986c-4e39-aea1-6a4eb053af03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_8b73b795-362e-4d46-a9db-bc19d867acdb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_EntityCurrentReportingStatus_8b73b795-362e-4d46-a9db-bc19d867acdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_8d571d9c-8742-4581-a5ee-c6aa2cc9e0c1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_EntityInteractiveDataCurrent_8d571d9c-8742-4581-a5ee-c6aa2cc9e0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_24e0f020-c728-41c3-b3a9-009723c3d9c7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_EntityFilerCategory_24e0f020-c728-41c3-b3a9-009723c3d9c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_1094c826-9857-481a-b307-e9bb835778a7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_EntitySmallBusiness_1094c826-9857-481a-b307-e9bb835778a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1cb81da9-09c5-4c64-b00b-8eae664cca2f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_EntityEmergingGrowthCompany_1cb81da9-09c5-4c64-b00b-8eae664cca2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_cac029a8-532c-444b-a5c8-c3d3e74d74a5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_EntityShellCompany_cac029a8-532c-444b-a5c8-c3d3e74d74a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_c0b6b5b6-ef0d-47b0-8797-09305079c5f5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_c0b6b5b6-ef0d-47b0-8797-09305079c5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5c3bfe6a-0c6e-4580-9556-871186b32d33" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_EntityCentralIndexKey_5c3bfe6a-0c6e-4580-9556-871186b32d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_b5ed252b-0e6d-43e9-8314-f4189130fb86" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_CurrentFiscalYearEndDate_b5ed252b-0e6d-43e9-8314-f4189130fb86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e18b37dc-f2f4-4b6b-86ea-996dea9fa9b5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_DocumentFiscalYearFocus_e18b37dc-f2f4-4b6b-86ea-996dea9fa9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_a539d799-5dee-4bf0-8700-e4149dbb472e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_a539d799-5dee-4bf0-8700-e4149dbb472e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_0a1685b8-c600-4b99-b323-d2fa5be4e7fa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2aea0083-bf62-4f71-a3ce-2fe4527fb21e" xlink:to="loc_dei_AmendmentFlag_0a1685b8-c600-4b99-b323-d2fa5be4e7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="isrg-20210930.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_156a2600-7ffc-4f18-b968-0282e3938ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_20ef52c2-28a0-4a14-ba00-175704fbf987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_156a2600-7ffc-4f18-b968-0282e3938ac3" xlink:to="loc_us-gaap_AssetsAbstract_20ef52c2-28a0-4a14-ba00-175704fbf987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_0dcaf7bb-32cc-445e-a038-e401c554e2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_20ef52c2-28a0-4a14-ba00-175704fbf987" xlink:to="loc_us-gaap_AssetsCurrentAbstract_0dcaf7bb-32cc-445e-a038-e401c554e2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_05481ec5-ea6e-4f23-b27b-9c798a11530a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0dcaf7bb-32cc-445e-a038-e401c554e2ca" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_05481ec5-ea6e-4f23-b27b-9c798a11530a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_d908e3b1-fbf1-4c03-b698-e89c96c38d75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0dcaf7bb-32cc-445e-a038-e401c554e2ca" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_d908e3b1-fbf1-4c03-b698-e89c96c38d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_503c8ed6-3c38-4dab-aa68-3f980b57a343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0dcaf7bb-32cc-445e-a038-e401c554e2ca" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_503c8ed6-3c38-4dab-aa68-3f980b57a343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4838a7ae-4ade-4bff-baa3-a371a96eec49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0dcaf7bb-32cc-445e-a038-e401c554e2ca" xlink:to="loc_us-gaap_InventoryNet_4838a7ae-4ade-4bff-baa3-a371a96eec49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cc974113-8254-4f72-bf0b-b46ab9655063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0dcaf7bb-32cc-445e-a038-e401c554e2ca" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cc974113-8254-4f72-bf0b-b46ab9655063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7b6608b6-3e86-4ac7-96f4-64fc00cdb361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0dcaf7bb-32cc-445e-a038-e401c554e2ca" xlink:to="loc_us-gaap_AssetsCurrent_7b6608b6-3e86-4ac7-96f4-64fc00cdb361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e25a6522-a220-40d3-bf88-390ba8779939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_20ef52c2-28a0-4a14-ba00-175704fbf987" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e25a6522-a220-40d3-bf88-390ba8779939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_d9dceb3a-ba56-4d12-a13e-a215f20bb034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_20ef52c2-28a0-4a14-ba00-175704fbf987" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_d9dceb3a-ba56-4d12-a13e-a215f20bb034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_97780023-60f3-41f1-97ff-d848444ce6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_20ef52c2-28a0-4a14-ba00-175704fbf987" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_97780023-60f3-41f1-97ff-d848444ce6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_IntangibleAndOtherAssets_88ddeb36-9dad-4ddf-9dd2-29f7a3334ec6" xlink:href="isrg-20210930.xsd#isrg_IntangibleAndOtherAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_20ef52c2-28a0-4a14-ba00-175704fbf987" xlink:to="loc_isrg_IntangibleAndOtherAssets_88ddeb36-9dad-4ddf-9dd2-29f7a3334ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6752dc83-ccfa-4dbc-b870-b3cf8c423e01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_20ef52c2-28a0-4a14-ba00-175704fbf987" xlink:to="loc_us-gaap_Goodwill_6752dc83-ccfa-4dbc-b870-b3cf8c423e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_fa4932dc-f26d-4bd8-af37-f30fd8f80532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_20ef52c2-28a0-4a14-ba00-175704fbf987" xlink:to="loc_us-gaap_Assets_fa4932dc-f26d-4bd8-af37-f30fd8f80532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb916fcb-f3bc-4fe4-8e82-0eb4d52aad59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_156a2600-7ffc-4f18-b968-0282e3938ac3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb916fcb-f3bc-4fe4-8e82-0eb4d52aad59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_7fa54e96-0826-4e2f-8df2-20d08e77bffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb916fcb-f3bc-4fe4-8e82-0eb4d52aad59" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_7fa54e96-0826-4e2f-8df2-20d08e77bffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_14165d12-717f-4cbc-b489-84c31413e986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7fa54e96-0826-4e2f-8df2-20d08e77bffb" xlink:to="loc_us-gaap_AccountsPayableCurrent_14165d12-717f-4cbc-b489-84c31413e986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_3a2aa017-86f9-4fea-961b-cebbd7f16972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7fa54e96-0826-4e2f-8df2-20d08e77bffb" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_3a2aa017-86f9-4fea-961b-cebbd7f16972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_4620332b-041d-4ed5-a085-51ccfcf1c353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7fa54e96-0826-4e2f-8df2-20d08e77bffb" xlink:to="loc_us-gaap_DeferredRevenueCurrent_4620332b-041d-4ed5-a085-51ccfcf1c353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e9417a0a-b0eb-4037-a605-b8a9f7128cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7fa54e96-0826-4e2f-8df2-20d08e77bffb" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_e9417a0a-b0eb-4037-a605-b8a9f7128cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ef829ba3-5fb6-4dd1-9a75-300711edd244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7fa54e96-0826-4e2f-8df2-20d08e77bffb" xlink:to="loc_us-gaap_LiabilitiesCurrent_ef829ba3-5fb6-4dd1-9a75-300711edd244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_4a3fdb47-b36d-4b0f-9384-f6d06b2aaaa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb916fcb-f3bc-4fe4-8e82-0eb4d52aad59" xlink:to="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_4a3fdb47-b36d-4b0f-9384-f6d06b2aaaa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_48452e22-2c44-489e-abb2-bb2c8d7bf14c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb916fcb-f3bc-4fe4-8e82-0eb4d52aad59" xlink:to="loc_us-gaap_Liabilities_48452e22-2c44-489e-abb2-bb2c8d7bf14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_998a59fa-b96c-4a1d-9b29-3b3d918d8240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb916fcb-f3bc-4fe4-8e82-0eb4d52aad59" xlink:to="loc_us-gaap_CommitmentsAndContingencies_998a59fa-b96c-4a1d-9b29-3b3d918d8240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_af35185e-c400-421c-ab7d-ef9d105e34a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb916fcb-f3bc-4fe4-8e82-0eb4d52aad59" xlink:to="loc_us-gaap_StockholdersEquityAbstract_af35185e-c400-421c-ab7d-ef9d105e34a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_e416350c-464f-4632-a53b-dfb7514e15be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_af35185e-c400-421c-ab7d-ef9d105e34a5" xlink:to="loc_us-gaap_PreferredStockValue_e416350c-464f-4632-a53b-dfb7514e15be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5243652e-0de8-4137-9b6f-bfdfc7d106c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_af35185e-c400-421c-ab7d-ef9d105e34a5" xlink:to="loc_us-gaap_CommonStockValue_5243652e-0de8-4137-9b6f-bfdfc7d106c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_88549531-eba8-4d56-b966-ebae8d07d9b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_af35185e-c400-421c-ab7d-ef9d105e34a5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_88549531-eba8-4d56-b966-ebae8d07d9b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3371d8c6-134d-421c-8924-24cae7011e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_af35185e-c400-421c-ab7d-ef9d105e34a5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3371d8c6-134d-421c-8924-24cae7011e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_90d248b6-9c33-44c8-9d43-9e41fd3bb48d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_af35185e-c400-421c-ab7d-ef9d105e34a5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_90d248b6-9c33-44c8-9d43-9e41fd3bb48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f3bcd909-1f31-40d6-9281-bec2e0a09cff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_af35185e-c400-421c-ab7d-ef9d105e34a5" xlink:to="loc_us-gaap_StockholdersEquity_f3bcd909-1f31-40d6-9281-bec2e0a09cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_25144eec-c90e-43b6-8d5d-48d931ccbee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb916fcb-f3bc-4fe4-8e82-0eb4d52aad59" xlink:to="loc_us-gaap_MinorityInterest_25144eec-c90e-43b6-8d5d-48d931ccbee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f32800f2-3ad8-496b-a1fc-f18783b416af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb916fcb-f3bc-4fe4-8e82-0eb4d52aad59" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f32800f2-3ad8-496b-a1fc-f18783b416af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3fc814dc-b566-408e-870b-993fa7afb2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb916fcb-f3bc-4fe4-8e82-0eb4d52aad59" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_3fc814dc-b566-408e-870b-993fa7afb2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="isrg-20210930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_45bb416f-200e-465d-83a9-808e41f4c7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_6a7f6524-3f69-4eae-97ca-a0e83e701e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_45bb416f-200e-465d-83a9-808e41f4c7d2" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_6a7f6524-3f69-4eae-97ca-a0e83e701e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0a580ca7-4191-4362-84dc-a14818cc8179" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_45bb416f-200e-465d-83a9-808e41f4c7d2" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0a580ca7-4191-4362-84dc-a14818cc8179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_5f0fa2b5-077b-4128-9514-27ef531679e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_45bb416f-200e-465d-83a9-808e41f4c7d2" xlink:to="loc_us-gaap_PreferredStockSharesIssued_5f0fa2b5-077b-4128-9514-27ef531679e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_ede2474b-9e42-4804-b234-c63d2a37266a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_45bb416f-200e-465d-83a9-808e41f4c7d2" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_ede2474b-9e42-4804-b234-c63d2a37266a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_154d2129-96cd-416b-b1d5-e5a951671c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_45bb416f-200e-465d-83a9-808e41f4c7d2" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_154d2129-96cd-416b-b1d5-e5a951671c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8016cad1-1eca-4233-8493-6aa68b6799f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_45bb416f-200e-465d-83a9-808e41f4c7d2" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8016cad1-1eca-4233-8493-6aa68b6799f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_23d58dad-083e-4b1d-a5ec-4305dfce1547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_45bb416f-200e-465d-83a9-808e41f4c7d2" xlink:to="loc_us-gaap_CommonStockSharesIssued_23d58dad-083e-4b1d-a5ec-4305dfce1547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_247fb7c7-0492-4743-ae01-065e087cfe99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_45bb416f-200e-465d-83a9-808e41f4c7d2" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_247fb7c7-0492-4743-ae01-065e087cfe99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="isrg-20210930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_5d9a0a0a-bf46-4b62-a9fc-b5cf7bff37a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_38723afa-5220-428c-9725-3228f8712425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5d9a0a0a-bf46-4b62-a9fc-b5cf7bff37a4" xlink:to="loc_us-gaap_StatementTable_38723afa-5220-428c-9725-3228f8712425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_162fc1cb-5db5-4de0-9054-fd5181b2a20a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_38723afa-5220-428c-9725-3228f8712425" xlink:to="loc_srt_ProductOrServiceAxis_162fc1cb-5db5-4de0-9054-fd5181b2a20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5b8fb402-fffa-4c02-9297-304574d9bca8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_162fc1cb-5db5-4de0-9054-fd5181b2a20a" xlink:to="loc_srt_ProductsAndServicesDomain_5b8fb402-fffa-4c02-9297-304574d9bca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_6b3b78d3-54d7-4281-91f1-528a742be5ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5b8fb402-fffa-4c02-9297-304574d9bca8" xlink:to="loc_us-gaap_ProductMember_6b3b78d3-54d7-4281-91f1-528a742be5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_8cec4393-346a-463f-bcc6-050f007bbddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5b8fb402-fffa-4c02-9297-304574d9bca8" xlink:to="loc_us-gaap_ServiceMember_8cec4393-346a-463f-bcc6-050f007bbddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_38723afa-5220-428c-9725-3228f8712425" xlink:to="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_3c4efb3d-3f2a-4eed-8c81-a6260082cc53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_RevenuesAbstract_3c4efb3d-3f2a-4eed-8c81-a6260082cc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6d42b114-eab3-4694-8556-ca8f20ba0afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_3c4efb3d-3f2a-4eed-8c81-a6260082cc53" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6d42b114-eab3-4694-8556-ca8f20ba0afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_4f768e59-d260-4540-82fd-0ad0fa9b1443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_CostOfRevenueAbstract_4f768e59-d260-4540-82fd-0ad0fa9b1443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_64b7e790-ebf7-4098-8701-8ba93fdc3d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_4f768e59-d260-4540-82fd-0ad0fa9b1443" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_64b7e790-ebf7-4098-8701-8ba93fdc3d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_db63d15f-4993-4fc3-9506-87417f8ca65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_GrossProfit_db63d15f-4993-4fc3-9506-87417f8ca65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_76430e4c-1f70-4a1e-92c5-594bf8a86703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_OperatingExpensesAbstract_76430e4c-1f70-4a1e-92c5-594bf8a86703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_55c0d7ef-a2bb-401a-8727-eaf456d19814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_76430e4c-1f70-4a1e-92c5-594bf8a86703" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_55c0d7ef-a2bb-401a-8727-eaf456d19814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ffb5cd8f-7441-49f9-84fa-af5193bc664d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_76430e4c-1f70-4a1e-92c5-594bf8a86703" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ffb5cd8f-7441-49f9-84fa-af5193bc664d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_86785be6-313f-4239-81f1-b7fb0ac664eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_76430e4c-1f70-4a1e-92c5-594bf8a86703" xlink:to="loc_us-gaap_OperatingExpenses_86785be6-313f-4239-81f1-b7fb0ac664eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_39dd1fdf-423b-44ea-8e96-343c5f321a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_OperatingIncomeLoss_39dd1fdf-423b-44ea-8e96-343c5f321a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c8818051-a2fc-47f3-b9de-4cbc6a18b1af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_c8818051-a2fc-47f3-b9de-4cbc6a18b1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c4402969-97ef-4c20-96be-21692d4a59f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c4402969-97ef-4c20-96be-21692d4a59f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_de8ef65e-9b14-4543-bba4-d5c9eae9adef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_de8ef65e-9b14-4543-bba4-d5c9eae9adef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a469209f-9101-4a89-9288-89d5a78962f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_ProfitLoss_a469209f-9101-4a89-9288-89d5a78962f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_22b84cd2-1711-403c-8458-c581c60a152d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_22b84cd2-1711-403c-8458-c581c60a152d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d668c9d4-f425-4f29-9f83-b27ed290770c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_NetIncomeLoss_d668c9d4-f425-4f29-9f83-b27ed290770c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b6f3376b-7a6f-4f4e-9e8e-24dd47d9a78c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_EarningsPerShareAbstract_b6f3376b-7a6f-4f4e-9e8e-24dd47d9a78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_57ca35c2-5c7a-4974-8d01-7857c1d200f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b6f3376b-7a6f-4f4e-9e8e-24dd47d9a78c" xlink:to="loc_us-gaap_EarningsPerShareBasic_57ca35c2-5c7a-4974-8d01-7857c1d200f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7067cc39-df16-4a83-8e28-ba56f6909ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b6f3376b-7a6f-4f4e-9e8e-24dd47d9a78c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7067cc39-df16-4a83-8e28-ba56f6909ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a458aa54-4318-44d0-94e2-190d6b962102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a458aa54-4318-44d0-94e2-190d6b962102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_202b9aec-18e8-4ca5-bab2-8fec267701a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a458aa54-4318-44d0-94e2-190d6b962102" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_202b9aec-18e8-4ca5-bab2-8fec267701a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_14613d40-01f9-4491-84df-17a3256396c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a458aa54-4318-44d0-94e2-190d6b962102" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_14613d40-01f9-4491-84df-17a3256396c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_dca33120-92ee-44a4-92c2-2906d1f85449" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_dca33120-92ee-44a4-92c2-2906d1f85449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_633c6635-b706-4fc1-b98e-8edd8b5a6872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_633c6635-b706-4fc1-b98e-8edd8b5a6872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e5224c5a-bbf6-4c1e-b262-bf2dabd11c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bab3cbcc-7ce4-46f9-b3b7-8c02c4b9f571" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e5224c5a-bbf6-4c1e-b262-bf2dabd11c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="isrg-20210930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_94caeacd-0a12-483f-87b0-3428d7d69906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6dfdf251-4ca6-4aac-b1dd-1a7ce963ea44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94caeacd-0a12-483f-87b0-3428d7d69906" xlink:to="loc_us-gaap_ProfitLoss_6dfdf251-4ca6-4aac-b1dd-1a7ce963ea44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_be8d10dc-13eb-400f-9f86-548162f41cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94caeacd-0a12-483f-87b0-3428d7d69906" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_be8d10dc-13eb-400f-9f86-548162f41cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40364a9e-37b6-4e26-9dc2-3a0c35419f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_be8d10dc-13eb-400f-9f86-548162f41cec" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40364a9e-37b6-4e26-9dc2-3a0c35419f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_422f2f34-8c03-4b53-8322-df145ca2b890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40364a9e-37b6-4e26-9dc2-3a0c35419f1a" xlink:to="loc_us-gaap_Depreciation_422f2f34-8c03-4b53-8322-df145ca2b890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_52d3af8a-27eb-4222-849a-32a039085b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40364a9e-37b6-4e26-9dc2-3a0c35419f1a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_52d3af8a-27eb-4222-849a-32a039085b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_7c86894b-f918-43f8-9510-4d1a48d87ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40364a9e-37b6-4e26-9dc2-3a0c35419f1a" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_7c86894b-f918-43f8-9510-4d1a48d87ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_460a5ae8-ea56-482f-96de-1d49e6672540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40364a9e-37b6-4e26-9dc2-3a0c35419f1a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_460a5ae8-ea56-482f-96de-1d49e6672540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4f7c24d4-d433-4aae-aa9a-1aca43aa9a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40364a9e-37b6-4e26-9dc2-3a0c35419f1a" xlink:to="loc_us-gaap_ShareBasedCompensation_4f7c24d4-d433-4aae-aa9a-1aca43aa9a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_bc950d2d-5262-4578-82d3-e0da101c1751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40364a9e-37b6-4e26-9dc2-3a0c35419f1a" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_bc950d2d-5262-4578-82d3-e0da101c1751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9243e3ea-9e07-4bbd-85a2-2897b5836b94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40364a9e-37b6-4e26-9dc2-3a0c35419f1a" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9243e3ea-9e07-4bbd-85a2-2897b5836b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_82785bc2-2d0d-4950-b24e-811d8730b36e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9243e3ea-9e07-4bbd-85a2-2897b5836b94" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_82785bc2-2d0d-4950-b24e-811d8730b36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_324660a6-0f05-41a8-a39e-b43a53a10f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9243e3ea-9e07-4bbd-85a2-2897b5836b94" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_324660a6-0f05-41a8-a39e-b43a53a10f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b1c6d3a5-1ca9-4727-a252-4575bcad5bae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9243e3ea-9e07-4bbd-85a2-2897b5836b94" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b1c6d3a5-1ca9-4727-a252-4575bcad5bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_55326ceb-68ac-40fd-9ae3-fbbe2fca3efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9243e3ea-9e07-4bbd-85a2-2897b5836b94" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_55326ceb-68ac-40fd-9ae3-fbbe2fca3efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_d2f81e77-21a6-4310-9a3e-01f4095df77c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9243e3ea-9e07-4bbd-85a2-2897b5836b94" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_d2f81e77-21a6-4310-9a3e-01f4095df77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_df97614f-d442-41d3-82de-da2e666623ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9243e3ea-9e07-4bbd-85a2-2897b5836b94" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_df97614f-d442-41d3-82de-da2e666623ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_4a1c9917-dce1-4b44-829e-4cc0fd1282bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9243e3ea-9e07-4bbd-85a2-2897b5836b94" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_4a1c9917-dce1-4b44-829e-4cc0fd1282bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_04b2609f-4b61-4274-a3c8-eb025dfe02e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9243e3ea-9e07-4bbd-85a2-2897b5836b94" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_04b2609f-4b61-4274-a3c8-eb025dfe02e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7c72f30b-083c-4e7f-a3ad-e2d80ec1ea17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94caeacd-0a12-483f-87b0-3428d7d69906" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7c72f30b-083c-4e7f-a3ad-e2d80ec1ea17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_f69d57d1-fb19-48bb-bbe0-e251c87e8b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7c72f30b-083c-4e7f-a3ad-e2d80ec1ea17" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_f69d57d1-fb19-48bb-bbe0-e251c87e8b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_55f69850-03cf-4c93-87de-64244c7274a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7c72f30b-083c-4e7f-a3ad-e2d80ec1ea17" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_55f69850-03cf-4c93-87de-64244c7274a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_31b6058c-726e-480b-abe1-21bab7078a00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7c72f30b-083c-4e7f-a3ad-e2d80ec1ea17" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_31b6058c-726e-480b-abe1-21bab7078a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_ce5c7518-60fb-4d7a-9238-83939b18af8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7c72f30b-083c-4e7f-a3ad-e2d80ec1ea17" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_ce5c7518-60fb-4d7a-9238-83939b18af8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2df48ad8-e5f0-4c98-b10c-0591d625f8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7c72f30b-083c-4e7f-a3ad-e2d80ec1ea17" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2df48ad8-e5f0-4c98-b10c-0591d625f8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_17b02591-5f1d-4db0-afc7-4663a4a399c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7c72f30b-083c-4e7f-a3ad-e2d80ec1ea17" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_17b02591-5f1d-4db0-afc7-4663a4a399c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8f1c94df-c5d5-4d30-89ce-e635e9c47042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94caeacd-0a12-483f-87b0-3428d7d69906" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8f1c94df-c5d5-4d30-89ce-e635e9c47042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_2734a813-e4ca-4c80-ab3f-b611dfbbe2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8f1c94df-c5d5-4d30-89ce-e635e9c47042" xlink:to="loc_us-gaap_ProceedsFromStockPlans_2734a813-e4ca-4c80-ab3f-b611dfbbe2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_bbc44e24-e89a-411c-876d-a2604f2d0da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8f1c94df-c5d5-4d30-89ce-e635e9c47042" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_bbc44e24-e89a-411c-876d-a2604f2d0da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_030ea941-a6bd-4a49-8ac9-3dc37a6b4e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8f1c94df-c5d5-4d30-89ce-e635e9c47042" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_030ea941-a6bd-4a49-8ac9-3dc37a6b4e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4e74c717-f2b1-4fd5-a40d-8a50352889a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8f1c94df-c5d5-4d30-89ce-e635e9c47042" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4e74c717-f2b1-4fd5-a40d-8a50352889a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_746c227d-baff-41cf-997f-e2ed5b7a8403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8f1c94df-c5d5-4d30-89ce-e635e9c47042" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_746c227d-baff-41cf-997f-e2ed5b7a8403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_26f7d496-df17-4601-bf36-d6df8748795c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94caeacd-0a12-483f-87b0-3428d7d69906" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_26f7d496-df17-4601-bf36-d6df8748795c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6f6ca584-b2a1-4fa0-b5d5-b92b7e52e38b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94caeacd-0a12-483f-87b0-3428d7d69906" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6f6ca584-b2a1-4fa0-b5d5-b92b7e52e38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44ad1e8d-5092-4b05-9996-14506997567d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94caeacd-0a12-483f-87b0-3428d7d69906" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44ad1e8d-5092-4b05-9996-14506997567d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0d115772-13b6-49aa-a113-6dc1a74c9e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94caeacd-0a12-483f-87b0-3428d7d69906" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0d115772-13b6-49aa-a113-6dc1a74c9e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS" xlink:type="simple" xlink:href="isrg-20210930.xsd#DESCRIPTIONOFTHEBUSINESS"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7c58f6f0-5ee4-4360-a69e-2f9f0f0fd358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_3787439f-5780-4bfc-913d-80cb27eec902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7c58f6f0-5ee4-4360-a69e-2f9f0f0fd358" xlink:to="loc_us-gaap_NatureOfOperations_3787439f-5780-4bfc-913d-80cb27eec902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="isrg-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4de22d24-f38e-46ae-bda3-0352074d2723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_8799a7ca-ea0a-4e88-9bed-f32eca2d0d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4de22d24-f38e-46ae-bda3-0352074d2723" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_8799a7ca-ea0a-4e88-9bed-f32eca2d0d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="isrg-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_80c86f74-190e-4328-9a2f-177a0ddeeb4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_9082f95f-5715-40db-a849-b86666a4b2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_80c86f74-190e-4328-9a2f-177a0ddeeb4f" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_9082f95f-5715-40db-a849-b86666a4b2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_90c12405-83b3-46f1-a5f9-c947f0f2ebdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_80c86f74-190e-4328-9a2f-177a0ddeeb4f" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_90c12405-83b3-46f1-a5f9-c947f0f2ebdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b1a30fb2-9415-4e6a-82bd-7ad632e9b0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_80c86f74-190e-4328-9a2f-177a0ddeeb4f" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b1a30fb2-9415-4e6a-82bd-7ad632e9b0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="isrg-20210930.xsd#FINANCIALINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_016d6fec-f3bb-4f6f-b700-552f4beb3b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_8452a47b-f51a-42f9-95e1-6af9f45d9eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_016d6fec-f3bb-4f6f-b700-552f4beb3b21" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_8452a47b-f51a-42f9-95e1-6af9f45d9eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="isrg-20210930.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_0412d238-0579-43b3-ba12-a381a49115ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesTextBlock_77f9dbbc-f4d9-4be9-bb75-30f26ff15d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_0412d238-0579-43b3-ba12-a381a49115ca" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesTextBlock_77f9dbbc-f4d9-4be9-bb75-30f26ff15d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_95705cc6-9fe8-44d4-a4d5-702ac291e7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_0412d238-0579-43b3-ba12-a381a49115ca" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_95705cc6-9fe8-44d4-a4d5-702ac291e7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_9425fc54-b54a-4387-b9b9-cd0da730137c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_0412d238-0579-43b3-ba12-a381a49115ca" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_9425fc54-b54a-4387-b9b9-cd0da730137c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_d294e92f-b003-44c4-8605-6168c4672376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_0412d238-0579-43b3-ba12-a381a49115ca" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_d294e92f-b003-44c4-8605-6168c4672376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_7a59bebf-8b80-405f-81b1-1d1b785b64eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_0412d238-0579-43b3-ba12-a381a49115ca" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_7a59bebf-8b80-405f-81b1-1d1b785b64eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_93cc0835-6044-4597-b6e6-0314280856d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_cc1f0ba8-66b6-4457-a1f8-1cef6cd1eded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_93cc0835-6044-4597-b6e6-0314280856d3" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_cc1f0ba8-66b6-4457-a1f8-1cef6cd1eded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9ddb04a3-f8db-48f3-874f-603899dfc42a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_cc1f0ba8-66b6-4457-a1f8-1cef6cd1eded" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9ddb04a3-f8db-48f3-874f-603899dfc42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f76e8f78-8b43-48b8-86ac-1edd1d8625b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9ddb04a3-f8db-48f3-874f-603899dfc42a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f76e8f78-8b43-48b8-86ac-1edd1d8625b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3585ff44-2d8c-4bac-8e7b-894eaac09a32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f76e8f78-8b43-48b8-86ac-1edd1d8625b4" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3585ff44-2d8c-4bac-8e7b-894eaac09a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a92bbc8d-7a2f-4e56-b62b-d1bdb6158f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f76e8f78-8b43-48b8-86ac-1edd1d8625b4" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a92bbc8d-7a2f-4e56-b62b-d1bdb6158f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_758c0843-d304-4c1c-a967-5e5e05cd600d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_cc1f0ba8-66b6-4457-a1f8-1cef6cd1eded" xlink:to="loc_us-gaap_FinancialInstrumentAxis_758c0843-d304-4c1c-a967-5e5e05cd600d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_758c0843-d304-4c1c-a967-5e5e05cd600d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_19e9c7ee-4c93-4a5a-876e-4077bbb782cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:to="loc_us-gaap_CashMember_19e9c7ee-4c93-4a5a-876e-4077bbb782cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_9ede4a20-e973-48aa-a269-3fda68964161" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:to="loc_us-gaap_MoneyMarketFundsMember_9ede4a20-e973-48aa-a269-3fda68964161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_51d58ce5-21e0-4c44-9852-da97b8832144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_51d58ce5-21e0-4c44-9852-da97b8832144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_0fd0c06d-03f2-41ae-8b5f-a275fcbdf859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:to="loc_us-gaap_CommercialPaperMember_0fd0c06d-03f2-41ae-8b5f-a275fcbdf859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_79ec8bcb-f609-459f-9166-2f016ab2b625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_79ec8bcb-f609-459f-9166-2f016ab2b625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c09de6d9-f595-4802-9ce2-61b1c2a672bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c09de6d9-f595-4802-9ce2-61b1c2a672bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalNotesMember_a49c9739-3c71-4190-9b18-f87a11d2a999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MunicipalNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05501b66-270c-4c01-a53f-58b1baf50b72" xlink:to="loc_us-gaap_MunicipalNotesMember_a49c9739-3c71-4190-9b18-f87a11d2a999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_cc1f0ba8-66b6-4457-a1f8-1cef6cd1eded" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5c23190e-82b6-4d4a-a382-0b84f7267787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5c23190e-82b6-4d4a-a382-0b84f7267787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_19540bdb-3357-4d8d-95ed-bf933ee50aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_19540bdb-3357-4d8d-95ed-bf933ee50aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6d18183b-b508-44c3-8b5d-3949640f6610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6d18183b-b508-44c3-8b5d-3949640f6610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_802f3555-113d-4163-850d-dc51b41ae857" xlink:href="isrg-20210930.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_802f3555-113d-4163-850d-dc51b41ae857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_22cae44a-6594-4976-a714-cf70ed1f744a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_22cae44a-6594-4976-a714-cf70ed1f744a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d43a21ff-b3b2-4027-915f-9c5e5f0aad83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d43a21ff-b3b2-4027-915f-9c5e5f0aad83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_595192fe-f4da-4b25-8d69-2cb417bed25e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_595192fe-f4da-4b25-8d69-2cb417bed25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8d837e85-9d7a-4a09-a3b0-483f7e4cab9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8d837e85-9d7a-4a09-a3b0-483f7e4cab9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_c58e0d56-39d5-4d13-9493-79eb1642e4bd" xlink:href="isrg-20210930.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_c58e0d56-39d5-4d13-9493-79eb1642e4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_7540beef-926d-45d6-b490-6f4a60d0e442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_7540beef-926d-45d6-b490-6f4a60d0e442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_4379d23b-f31b-480c-a3d9-e0aeadd588ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7b5d78-abb9-4226-bf2c-fac94c4d7f5e" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_4379d23b-f31b-480c-a3d9-e0aeadd588ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1" xlink:type="simple" xlink:href="isrg-20210930.xsd#FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_115ddb35-c102-4454-a71f-33f2722bf877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_b8b06149-737a-44ca-90d7-7066ddc86329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_115ddb35-c102-4454-a71f-33f2722bf877" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_b8b06149-737a-44ca-90d7-7066ddc86329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_4e0fb545-2799-46c9-88c7-385b7f2ffe1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_b8b06149-737a-44ca-90d7-7066ddc86329" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_4e0fb545-2799-46c9-88c7-385b7f2ffe1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_1c807d90-32a3-43d9-a47a-b5fce3ce8bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_b8b06149-737a-44ca-90d7-7066ddc86329" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_1c807d90-32a3-43d9-a47a-b5fce3ce8bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_61cf2690-fbe2-4e74-b0ae-003d34b904e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_b8b06149-737a-44ca-90d7-7066ddc86329" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_61cf2690-fbe2-4e74-b0ae-003d34b904e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_1baebd48-f15e-4489-a55d-38d46c5da0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_115ddb35-c102-4454-a71f-33f2722bf877" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_1baebd48-f15e-4489-a55d-38d46c5da0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_abfa3428-9ab9-4337-b4bb-a29b5ef1233e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_1baebd48-f15e-4489-a55d-38d46c5da0b8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_abfa3428-9ab9-4337-b4bb-a29b5ef1233e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_fbdd4050-3a4a-4cd2-95f6-ae29c6b9bf1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_1baebd48-f15e-4489-a55d-38d46c5da0b8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_fbdd4050-3a4a-4cd2-95f6-ae29c6b9bf1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal_08b97dd2-3c9f-4818-a088-5318a6ce17f6" xlink:href="isrg-20210930.xsd#isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_1baebd48-f15e-4489-a55d-38d46c5da0b8" xlink:to="loc_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal_08b97dd2-3c9f-4818-a088-5318a6ce17f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_e11975a0-97d5-4893-90f4-04e5eb7a0f96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_115ddb35-c102-4454-a71f-33f2722bf877" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_e11975a0-97d5-4893-90f4-04e5eb7a0f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_bffd0e99-874d-4ef1-84cb-968429df24a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_5d3c092a-f169-418b-845e-010ece4ab634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bffd0e99-874d-4ef1-84cb-968429df24a4" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_5d3c092a-f169-418b-845e-010ece4ab634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_94a14c88-00cc-45ee-a7e3-976f23436b48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_5d3c092a-f169-418b-845e-010ece4ab634" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_94a14c88-00cc-45ee-a7e3-976f23436b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c72b8c40-06ea-4194-a651-538bd0391242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_94a14c88-00cc-45ee-a7e3-976f23436b48" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c72b8c40-06ea-4194-a651-538bd0391242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_351f1afe-fcc8-4808-a203-433fcb31a60d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c72b8c40-06ea-4194-a651-538bd0391242" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_351f1afe-fcc8-4808-a203-433fcb31a60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_IntangibleAndOtherAssetsNetMember_6ff0a45c-0bd8-4cd8-9d20-54c0ec27bcf0" xlink:href="isrg-20210930.xsd#isrg_IntangibleAndOtherAssetsNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c72b8c40-06ea-4194-a651-538bd0391242" xlink:to="loc_isrg_IntangibleAndOtherAssetsNetMember_6ff0a45c-0bd8-4cd8-9d20-54c0ec27bcf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_012ddb8a-fa58-45f4-b2a7-a43b7de4cae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_5d3c092a-f169-418b-845e-010ece4ab634" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_012ddb8a-fa58-45f4-b2a7-a43b7de4cae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3366b65-dccd-4888-b572-75b7c12e9dff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_012ddb8a-fa58-45f4-b2a7-a43b7de4cae3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3366b65-dccd-4888-b572-75b7c12e9dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_63b2ed89-2ac3-4d4a-815b-ed42ca0a5811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3366b65-dccd-4888-b572-75b7c12e9dff" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_63b2ed89-2ac3-4d4a-815b-ed42ca0a5811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d3210787-779d-4f41-923c-e6b82a9d1354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3366b65-dccd-4888-b572-75b7c12e9dff" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d3210787-779d-4f41-923c-e6b82a9d1354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_5d3c092a-f169-418b-845e-010ece4ab634" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_12722890-173a-42e9-904e-502ccc0c198d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_12722890-173a-42e9-904e-502ccc0c198d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_a85606ee-03aa-493e-a6e2-c0ed9a47c2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_12722890-173a-42e9-904e-502ccc0c198d" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_a85606ee-03aa-493e-a6e2-c0ed9a47c2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_f29c22fc-6c90-4b09-b145-f89fc4f5389d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_12722890-173a-42e9-904e-502ccc0c198d" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_f29c22fc-6c90-4b09-b145-f89fc4f5389d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments_4c81af91-5888-47b7-94bf-49e4e381ec70" xlink:href="isrg-20210930.xsd#isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_12722890-173a-42e9-904e-502ccc0c198d" xlink:to="loc_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments_4c81af91-5888-47b7-94bf-49e4e381ec70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c6414569-5619-4688-bbd5-d1bcec041e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_12722890-173a-42e9-904e-502ccc0c198d" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c6414569-5619-4688-bbd5-d1bcec041e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss_db7d41f4-c1ee-4518-8d23-723119eac65d" xlink:href="isrg-20210930.xsd#isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_12722890-173a-42e9-904e-502ccc0c198d" xlink:to="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss_db7d41f4-c1ee-4518-8d23-723119eac65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments_7b41c5a6-63c9-4c7a-aee4-bd022afdacde" xlink:href="isrg-20210930.xsd#isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_12722890-173a-42e9-904e-502ccc0c198d" xlink:to="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments_7b41c5a6-63c9-4c7a-aee4-bd022afdacde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares_fe897e43-f706-4697-8d5a-2fd5a6de2366" xlink:href="isrg-20210930.xsd#isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:to="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares_fe897e43-f706-4697-8d5a-2fd5a6de2366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_231ccf34-8466-4b07-b35a-8906168ed337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_231ccf34-8466-4b07-b35a-8906168ed337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_885fd611-e7fe-4a73-84c0-625569cc83b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_885fd611-e7fe-4a73-84c0-625569cc83b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfEquityInvestments_f120da61-8aa1-4822-bd16-6bb88107c0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfEquityInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:to="loc_us-gaap_GainLossOnSaleOfEquityInvestments_f120da61-8aa1-4822-bd16-6bb88107c0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives_a43c9d88-794f-487a-81b1-2b3d28203677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:to="loc_us-gaap_GainLossOnSaleOfDerivatives_a43c9d88-794f-487a-81b1-2b3d28203677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_18e2939b-de24-485f-8087-e379479cc075" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_be93d42a-b2bd-485d-8618-c1fc5109fc32" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_18e2939b-de24-485f-8087-e379479cc075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a9abd925-7db1-4ab4-aeb3-f970bce2ae40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9b3c6d88-acd6-49b1-8d99-82401eb1bd94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a9abd925-7db1-4ab4-aeb3-f970bce2ae40" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9b3c6d88-acd6-49b1-8d99-82401eb1bd94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a919031d-443d-4097-a3a9-956dc6985626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9b3c6d88-acd6-49b1-8d99-82401eb1bd94" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a919031d-443d-4097-a3a9-956dc6985626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c53a52b8-a2a8-4b28-94df-67ee88308990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a919031d-443d-4097-a3a9-956dc6985626" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c53a52b8-a2a8-4b28-94df-67ee88308990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_80a2fc9e-df52-4545-a8d3-0c940e43f324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c53a52b8-a2a8-4b28-94df-67ee88308990" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_80a2fc9e-df52-4545-a8d3-0c940e43f324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CollarContractMember_01267c4d-a823-4060-8c5b-fbf504bf7051" xlink:href="isrg-20210930.xsd#isrg_CollarContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c53a52b8-a2a8-4b28-94df-67ee88308990" xlink:to="loc_isrg_CollarContractMember_01267c4d-a823-4060-8c5b-fbf504bf7051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e155fa68-9dba-429f-a545-ca603ab0a76d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9b3c6d88-acd6-49b1-8d99-82401eb1bd94" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e155fa68-9dba-429f-a545-ca603ab0a76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_50407498-f3e7-4d98-8925-1b7d5f90c01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e155fa68-9dba-429f-a545-ca603ab0a76d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_50407498-f3e7-4d98-8925-1b7d5f90c01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_8034242d-f5d5-4e4f-9053-bfd322d8d67e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_50407498-f3e7-4d98-8925-1b7d5f90c01b" xlink:to="loc_us-gaap_OtherIncomeMember_8034242d-f5d5-4e4f-9053-bfd322d8d67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f50526c8-8e8f-4767-bf01-9772949457b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9b3c6d88-acd6-49b1-8d99-82401eb1bd94" xlink:to="loc_us-gaap_HedgingDesignationAxis_f50526c8-8e8f-4767-bf01-9772949457b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_55429a45-267e-436e-9fec-e0ef079a5f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_f50526c8-8e8f-4767-bf01-9772949457b1" xlink:to="loc_us-gaap_HedgingDesignationDomain_55429a45-267e-436e-9fec-e0ef079a5f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_16bdaf83-ca31-42a0-9bb9-38129f3849b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_55429a45-267e-436e-9fec-e0ef079a5f68" xlink:to="loc_us-gaap_NondesignatedMember_16bdaf83-ca31-42a0-9bb9-38129f3849b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46a7a0a0-332f-4bd8-890b-cf88322f489e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9b3c6d88-acd6-49b1-8d99-82401eb1bd94" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46a7a0a0-332f-4bd8-890b-cf88322f489e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_8692c984-6665-4813-9c39-046d884d28c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46a7a0a0-332f-4bd8-890b-cf88322f489e" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_8692c984-6665-4813-9c39-046d884d28c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_223f94cb-ae16-4b18-a487-47758cbca0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_46a7a0a0-332f-4bd8-890b-cf88322f489e" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_223f94cb-ae16-4b18-a487-47758cbca0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_0bdf3b74-b7e0-4bab-97d9-b37713238477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a28289-dea6-412e-b292-4076736e967a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_0bdf3b74-b7e0-4bab-97d9-b37713238477" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a28289-dea6-412e-b292-4076736e967a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7958798f-236b-4c79-b2c9-f6ca8ce2bf2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a28289-dea6-412e-b292-4076736e967a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7958798f-236b-4c79-b2c9-f6ca8ce2bf2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_63939eb9-a373-420a-bdc5-ff0e748fe8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7958798f-236b-4c79-b2c9-f6ca8ce2bf2e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_63939eb9-a373-420a-bdc5-ff0e748fe8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_45f2b85a-340c-451c-a1a3-59de30e829d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_63939eb9-a373-420a-bdc5-ff0e748fe8f9" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_45f2b85a-340c-451c-a1a3-59de30e829d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_514b93ec-d020-4a65-b631-06c50b39e0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a28289-dea6-412e-b292-4076736e967a" xlink:to="loc_us-gaap_HedgingDesignationAxis_514b93ec-d020-4a65-b631-06c50b39e0b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_457b090c-29de-48f0-907f-56ff79492f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_514b93ec-d020-4a65-b631-06c50b39e0b4" xlink:to="loc_us-gaap_HedgingDesignationDomain_457b090c-29de-48f0-907f-56ff79492f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9a5852f8-4d03-40ea-a5a6-c268e8bce855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_457b090c-29de-48f0-907f-56ff79492f2a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9a5852f8-4d03-40ea-a5a6-c268e8bce855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_41dc84a4-074d-4afd-a621-b546c2473e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_457b090c-29de-48f0-907f-56ff79492f2a" xlink:to="loc_us-gaap_NondesignatedMember_41dc84a4-074d-4afd-a621-b546c2473e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_be6d9fde-325b-432d-b2c1-e60625ae56b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a28289-dea6-412e-b292-4076736e967a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_be6d9fde-325b-432d-b2c1-e60625ae56b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_550f1ce0-1e6a-438c-82ec-1e04b7ffb5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_be6d9fde-325b-432d-b2c1-e60625ae56b1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_550f1ce0-1e6a-438c-82ec-1e04b7ffb5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_223d5578-8ccb-4a45-b3c4-01deb3e505b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_550f1ce0-1e6a-438c-82ec-1e04b7ffb5d5" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_223d5578-8ccb-4a45-b3c4-01deb3e505b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_2daf2baa-c8fd-46c1-b53b-d78350e9d739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_550f1ce0-1e6a-438c-82ec-1e04b7ffb5d5" xlink:to="loc_us-gaap_OtherLiabilitiesMember_2daf2baa-c8fd-46c1-b53b-d78350e9d739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_878d3305-8afd-4cf1-b1e9-2f89bcd2f558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a28289-dea6-412e-b292-4076736e967a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_878d3305-8afd-4cf1-b1e9-2f89bcd2f558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_d0be885f-15ad-4b73-89c3-bfd3701f2cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_878d3305-8afd-4cf1-b1e9-2f89bcd2f558" xlink:to="loc_us-gaap_DerivativeNotionalAmount_d0be885f-15ad-4b73-89c3-bfd3701f2cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION" xlink:type="simple" xlink:href="isrg-20210930.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3c7a5e3a-7cfa-4d5a-851d-80a7fdb23ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_678f55ec-216d-48c1-b1b4-dc9e2331c2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3c7a5e3a-7cfa-4d5a-851d-80a7fdb23ca1" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_678f55ec-216d-48c1-b1b4-dc9e2331c2e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables" xlink:type="simple" xlink:href="isrg-20210930.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bbf943c4-622e-4692-8b17-d9f99d6cde8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_661b3852-1e6f-409d-9f5d-544a6353ec65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bbf943c4-622e-4692-8b17-d9f99d6cde8e" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_661b3852-1e6f-409d-9f5d-544a6353ec65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_9d834311-8e4a-49a4-9a43-ba89d94d0944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bbf943c4-622e-4692-8b17-d9f99d6cde8e" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_9d834311-8e4a-49a4-9a43-ba89d94d0944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_5d8c9d1b-4cd1-4a06-8180-d0ac89083fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bbf943c4-622e-4692-8b17-d9f99d6cde8e" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_5d8c9d1b-4cd1-4a06-8180-d0ac89083fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_6abd95de-5d51-48e0-8780-98e6b604efc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bbf943c4-622e-4692-8b17-d9f99d6cde8e" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_6abd95de-5d51-48e0-8780-98e6b604efc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_2e580933-003c-4124-8aa0-f1c49057bc7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bbf943c4-622e-4692-8b17-d9f99d6cde8e" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_2e580933-003c-4124-8aa0-f1c49057bc7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0eb715cd-b067-4d76-af26-1385aea8f388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_2bbe4a3f-9994-4122-98c5-2d1560571601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0eb715cd-b067-4d76-af26-1385aea8f388" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_2bbe4a3f-9994-4122-98c5-2d1560571601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_df68f484-0438-4053-b902-7325819646f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0eb715cd-b067-4d76-af26-1385aea8f388" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_df68f484-0438-4053-b902-7325819646f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5854f8e1-f115-405f-834f-80e76bc7ff21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0eb715cd-b067-4d76-af26-1385aea8f388" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5854f8e1-f115-405f-834f-80e76bc7ff21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_60cb1455-5b26-4b43-b617-1e466045372a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0eb715cd-b067-4d76-af26-1385aea8f388" xlink:to="loc_us-gaap_InventoryNet_60cb1455-5b26-4b43-b617-1e466045372a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_41a083f6-d884-4491-8295-395054351259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_17827939-884f-4d68-a872-817c586a2a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_41a083f6-d884-4491-8295-395054351259" xlink:to="loc_us-gaap_PrepaidTaxes_17827939-884f-4d68-a872-817c586a2a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_565120aa-477c-46a1-b2b5-4f38ba1ed64f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_41a083f6-d884-4491-8295-395054351259" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_565120aa-477c-46a1-b2b5-4f38ba1ed64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent_caf672cd-66a9-49ac-8bdb-39db39252440" xlink:href="isrg-20210930.xsd#isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_41a083f6-d884-4491-8295-395054351259" xlink:to="loc_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent_caf672cd-66a9-49ac-8bdb-39db39252440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_ea9859ab-1ea6-4688-a0d0-d55a0b18fae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_41a083f6-d884-4491-8295-395054351259" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_ea9859ab-1ea6-4688-a0d0-d55a0b18fae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_717c1720-930f-4cb0-93d5-30cc9d78cf66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_41a083f6-d884-4491-8295-395054351259" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_717c1720-930f-4cb0-93d5-30cc9d78cf66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c840d013-b269-41c6-94fa-f36bbb5ffc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_daa9b6ff-2474-4815-92a9-e8dec4786445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c840d013-b269-41c6-94fa-f36bbb5ffc3a" xlink:to="loc_us-gaap_TaxesPayableCurrent_daa9b6ff-2474-4815-92a9-e8dec4786445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_DeferredPurchaseConsiderationPaymentsCurrent_c4d1fe6c-92e5-443e-83a0-ed0aa96b3655" xlink:href="isrg-20210930.xsd#isrg_DeferredPurchaseConsiderationPaymentsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c840d013-b269-41c6-94fa-f36bbb5ffc3a" xlink:to="loc_isrg_DeferredPurchaseConsiderationPaymentsCurrent_c4d1fe6c-92e5-443e-83a0-ed0aa96b3655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_fe055e80-03dd-4958-a84d-ad55e357bc23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c840d013-b269-41c6-94fa-f36bbb5ffc3a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_fe055e80-03dd-4958-a84d-ad55e357bc23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_44acd213-66e4-4097-adf6-5c1a66e5800c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c840d013-b269-41c6-94fa-f36bbb5ffc3a" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_44acd213-66e4-4097-adf6-5c1a66e5800c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_3ac993e1-ee4c-420c-9b07-3a0ada30e3d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c840d013-b269-41c6-94fa-f36bbb5ffc3a" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_3ac993e1-ee4c-420c-9b07-3a0ada30e3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7f3fa0a7-5cb0-4f60-9bae-2b49dc97322a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_495a0de2-ff97-43f3-9fba-e16bfc2a6c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7f3fa0a7-5cb0-4f60-9bae-2b49dc97322a" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_495a0de2-ff97-43f3-9fba-e16bfc2a6c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_071b37bd-cd1e-4d35-a626-e928180d92f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7f3fa0a7-5cb0-4f60-9bae-2b49dc97322a" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_071b37bd-cd1e-4d35-a626-e928180d92f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_c0f6c850-6b2d-4eb2-b721-fb0cc66ee91b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7f3fa0a7-5cb0-4f60-9bae-2b49dc97322a" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_c0f6c850-6b2d-4eb2-b721-fb0cc66ee91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_0dce91e1-dc4f-4132-8b2b-da7360813631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7f3fa0a7-5cb0-4f60-9bae-2b49dc97322a" xlink:to="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_0dce91e1-dc4f-4132-8b2b-da7360813631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_60171ab0-67c1-4da6-a9c9-93f07d465fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_f34f5680-0a26-4725-a84c-4c10dcd25255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_60171ab0-67c1-4da6-a9c9-93f07d465fc2" xlink:to="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_f34f5680-0a26-4725-a84c-4c10dcd25255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_71a0172e-2cbc-490c-9021-027e1567d35e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTransfersAndChanges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_f34f5680-0a26-4725-a84c-4c10dcd25255" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_71a0172e-2cbc-490c-9021-027e1567d35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_c3d28bdd-60d5-4c3b-a892-15d6797f19ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_f34f5680-0a26-4725-a84c-4c10dcd25255" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_c3d28bdd-60d5-4c3b-a892-15d6797f19ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments_41f65d6a-8509-481f-9ebe-4e55d526083a" xlink:href="isrg-20210930.xsd#isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_f34f5680-0a26-4725-a84c-4c10dcd25255" xlink:to="loc_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments_41f65d6a-8509-481f-9ebe-4e55d526083a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS" xlink:type="simple" xlink:href="isrg-20210930.xsd#REVENUEANDCONTRACTACQUISITIONCOSTS"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_14ede01e-f61f-4d2f-9a2e-5a9ce39122dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_1b25a1ac-213d-46a9-8632-384af69ec972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_14ede01e-f61f-4d2f-9a2e-5a9ce39122dc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_1b25a1ac-213d-46a9-8632-384af69ec972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables" xlink:type="simple" xlink:href="isrg-20210930.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSTables"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bb31fe46-4dd9-48d4-a62e-82339077abb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_f7d6ea05-1e5f-4f7c-a0b1-2c87faa9357a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bb31fe46-4dd9-48d4-a62e-82339077abb0" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_f7d6ea05-1e5f-4f7c-a0b1-2c87faa9357a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_06e2bf1b-9077-482a-b8b5-f5a4b9f6a33f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bb31fe46-4dd9-48d4-a62e-82339077abb0" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_06e2bf1b-9077-482a-b8b5-f5a4b9f6a33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock_ff1cf76a-2810-43d7-b244-ae6d37c228f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bb31fe46-4dd9-48d4-a62e-82339077abb0" xlink:to="loc_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock_ff1cf76a-2810-43d7-b244-ae6d37c228f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_26a9ae72-3183-4e7f-93c3-7fe558cc3776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bb31fe46-4dd9-48d4-a62e-82339077abb0" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_26a9ae72-3183-4e7f-93c3-7fe558cc3776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_85f8a3c5-b60a-476a-b373-030fc97994bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_3e85d8ad-eda9-45b8-9d92-9e9cf1c50276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_85f8a3c5-b60a-476a-b373-030fc97994bc" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_3e85d8ad-eda9-45b8-9d92-9e9cf1c50276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_99ab6c45-7ad2-4b49-b11e-d009d9c34c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3e85d8ad-eda9-45b8-9d92-9e9cf1c50276" xlink:to="loc_us-gaap_GeographicDistributionAxis_99ab6c45-7ad2-4b49-b11e-d009d9c34c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_cfa38d61-a3de-49d1-aca9-8224325b9666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionAxis_99ab6c45-7ad2-4b49-b11e-d009d9c34c5d" xlink:to="loc_us-gaap_GeographicDistributionDomain_cfa38d61-a3de-49d1-aca9-8224325b9666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_a0dfe9b4-19d0-4aab-95e0-819b299180b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_cfa38d61-a3de-49d1-aca9-8224325b9666" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_a0dfe9b4-19d0-4aab-95e0-819b299180b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember_9068118a-8c45-482f-8bfb-90dab74f1baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_cfa38d61-a3de-49d1-aca9-8224325b9666" xlink:to="loc_us-gaap_GeographicDistributionForeignMember_9068118a-8c45-482f-8bfb-90dab74f1baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e5e883eb-2b47-48ab-8d9c-c2d49f3d6c3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3e85d8ad-eda9-45b8-9d92-9e9cf1c50276" xlink:to="loc_srt_ProductOrServiceAxis_e5e883eb-2b47-48ab-8d9c-c2d49f3d6c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0ffdc2f3-a392-4517-8fc9-c217b4c8c803" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e5e883eb-2b47-48ab-8d9c-c2d49f3d6c3e" xlink:to="loc_srt_ProductsAndServicesDomain_0ffdc2f3-a392-4517-8fc9-c217b4c8c803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_InstrumentsandAccessoriesMember_2fc6331e-a913-4197-a134-34670c17bd6e" xlink:href="isrg-20210930.xsd#isrg_InstrumentsandAccessoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0ffdc2f3-a392-4517-8fc9-c217b4c8c803" xlink:to="loc_isrg_InstrumentsandAccessoriesMember_2fc6331e-a913-4197-a134-34670c17bd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SystemsMember_faba09d6-7afe-44ba-aa76-7a321e237e35" xlink:href="isrg-20210930.xsd#isrg_SystemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0ffdc2f3-a392-4517-8fc9-c217b4c8c803" xlink:to="loc_isrg_SystemsMember_faba09d6-7afe-44ba-aa76-7a321e237e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ServicesMember_470f8b3f-a688-42f2-8311-f63dbfb8b3f9" xlink:href="isrg-20210930.xsd#isrg_ServicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0ffdc2f3-a392-4517-8fc9-c217b4c8c803" xlink:to="loc_isrg_ServicesMember_470f8b3f-a688-42f2-8311-f63dbfb8b3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_4ea2ce69-3b28-40ed-a6b1-a0e3ea0beeae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3e85d8ad-eda9-45b8-9d92-9e9cf1c50276" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_4ea2ce69-3b28-40ed-a6b1-a0e3ea0beeae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5c9ec616-78f6-42c8-bfaa-652aeb19588f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_4ea2ce69-3b28-40ed-a6b1-a0e3ea0beeae" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5c9ec616-78f6-42c8-bfaa-652aeb19588f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_15a9c13a-5dfa-4c55-9d1c-7ecbcf3e2d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_ed271d71-4e8f-4e2d-8dfd-be6b8c20ab7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_15a9c13a-5dfa-4c55-9d1c-7ecbcf3e2d0a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_ed271d71-4e8f-4e2d-8dfd-be6b8c20ab7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_59496f6c-1a20-4c21-aa70-c36b0877732c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_15a9c13a-5dfa-4c55-9d1c-7ecbcf3e2d0a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_59496f6c-1a20-4c21-aa70-c36b0877732c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_dfdf3556-8211-4e2b-bdb9-9a8155d637ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_59496f6c-1a20-4c21-aa70-c36b0877732c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_dfdf3556-8211-4e2b-bdb9-9a8155d637ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0c11ae8b-ad7a-441b-b2a7-befafd396d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_59496f6c-1a20-4c21-aa70-c36b0877732c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0c11ae8b-ad7a-441b-b2a7-befafd396d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_9870acd3-e9f0-4870-9408-1ddec190d7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0c11ae8b-ad7a-441b-b2a7-befafd396d1f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_9870acd3-e9f0-4870-9408-1ddec190d7d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1_4f09ecf2-9a86-4bcf-94c2-1c5c29c60fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorSalesTypeLeaseTermOfContract1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0c11ae8b-ad7a-441b-b2a7-befafd396d1f" xlink:to="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1_4f09ecf2-9a86-4bcf-94c2-1c5c29c60fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_dc00555c-ac15-4d1d-a15c-495515e5c2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_15a9c13a-5dfa-4c55-9d1c-7ecbcf3e2d0a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_dc00555c-ac15-4d1d-a15c-495515e5c2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1" xlink:type="simple" xlink:href="isrg-20210930.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_00b57cd9-0764-4e99-b82a-8b5406dc0960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_c68dc53f-c053-4842-ba57-c523b0633f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_00b57cd9-0764-4e99-b82a-8b5406dc0960" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_c68dc53f-c053-4842-ba57-c523b0633f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_e8591ac0-55fa-4792-be1b-bcd0333842b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_00b57cd9-0764-4e99-b82a-8b5406dc0960" xlink:to="loc_us-gaap_ContractWithCustomerLiability_e8591ac0-55fa-4792-be1b-bcd0333842b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4b679883-686c-4de0-9e66-80d93340df28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseIncome_bae1cb32-5b7c-43b0-89b1-cb67173d1c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseLeaseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4b679883-686c-4de0-9e66-80d93340df28" xlink:to="loc_us-gaap_SalesTypeLeaseLeaseIncome_bae1cb32-5b7c-43b0-89b1-cb67173d1c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_85199af4-dde2-450b-9fe4-ce3cc5ec20bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4b679883-686c-4de0-9e66-80d93340df28" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_85199af4-dde2-450b-9fe4-ce3cc5ec20bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASES" xlink:type="simple" xlink:href="isrg-20210930.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_498f41e5-b50e-4dba-9e94-1ef98c322e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeasesTextBlock_ed25dbb2-a6de-42ef-8f91-b643fd22d7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorSalesTypeLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_498f41e5-b50e-4dba-9e94-1ef98c322e1e" xlink:to="loc_us-gaap_LessorSalesTypeLeasesTextBlock_ed25dbb2-a6de-42ef-8f91-b643fd22d7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESTables" xlink:type="simple" xlink:href="isrg-20210930.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_323301d2-4280-4c4c-9638-e655bcecd2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock_137c0dfd-c7a3-4e4c-b383-494be37f39b4" xlink:href="isrg-20210930.xsd#isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_323301d2-4280-4c4c-9638-e655bcecd2eb" xlink:to="loc_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock_137c0dfd-c7a3-4e4c-b383-494be37f39b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_ed25dffa-2614-4356-ba78-504293b0d7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_323301d2-4280-4c4c-9638-e655bcecd2eb" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_ed25dffa-2614-4356-ba78-504293b0d7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_85365a9b-380c-47dc-bdd6-a7742098332d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_323301d2-4280-4c4c-9638-e655bcecd2eb" xlink:to="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_85365a9b-380c-47dc-bdd6-a7742098332d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#LEASESLeaseReceivablesDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0dbb8319-59d5-453a-81ab-447e4ab0a1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_cc0039d7-2d9f-4cae-9a5c-225d7b4129c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCapitalLeasedAsssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0dbb8319-59d5-453a-81ab-447e4ab0a1d7" xlink:to="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_cc0039d7-2d9f-4cae-9a5c-225d7b4129c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a2e3aa74-b92f-4ec6-adf3-a2a41b3d8255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_cc0039d7-2d9f-4cae-9a5c-225d7b4129c3" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a2e3aa74-b92f-4ec6-adf3-a2a41b3d8255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d2ce56f6-8785-4d02-a531-bef338ee9cce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a2e3aa74-b92f-4ec6-adf3-a2a41b3d8255" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d2ce56f6-8785-4d02-a531-bef338ee9cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_cc8c37f0-7edd-41dd-9144-8624e68f907a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d2ce56f6-8785-4d02-a531-bef338ee9cce" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_cc8c37f0-7edd-41dd-9144-8624e68f907a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_49df747c-a946-428a-8f9f-30ae3f769d41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d2ce56f6-8785-4d02-a531-bef338ee9cce" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_49df747c-a946-428a-8f9f-30ae3f769d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasedAssetsLineItems_87815d59-1e14-4a17-a9cb-20b675bc7ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_cc0039d7-2d9f-4cae-9a5c-225d7b4129c3" xlink:to="loc_us-gaap_CapitalLeasedAssetsLineItems_87815d59-1e14-4a17-a9cb-20b675bc7ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeLeaseGrossInvestmentInLease_25724578-1339-42f4-9a02-2937145984e5" xlink:href="isrg-20210930.xsd#isrg_SalesTypeLeaseGrossInvestmentInLease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_87815d59-1e14-4a17-a9cb-20b675bc7ccf" xlink:to="loc_isrg_SalesTypeLeaseGrossInvestmentInLease_25724578-1339-42f4-9a02-2937145984e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalestypeLeaseDeferredSellingProfit_4ee0fdd2-08b6-4da0-a53a-623cbc92f3d5" xlink:href="isrg-20210930.xsd#isrg_SalestypeLeaseDeferredSellingProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_87815d59-1e14-4a17-a9cb-20b675bc7ccf" xlink:to="loc_isrg_SalestypeLeaseDeferredSellingProfit_4ee0fdd2-08b6-4da0-a53a-623cbc92f3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_63584966-0753-4287-a4da-99b13db11f50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_87815d59-1e14-4a17-a9cb-20b675bc7ccf" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_63584966-0753-4287-a4da-99b13db11f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss_7a4cf2b0-eefb-4350-b0cc-e802796f5af8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_87815d59-1e14-4a17-a9cb-20b675bc7ccf" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss_7a4cf2b0-eefb-4350-b0cc-e802796f5af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseReceivable_0f448eec-e4b8-43f1-ac5c-5ce5c4ff108b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseLeaseReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_87815d59-1e14-4a17-a9cb-20b675bc7ccf" xlink:to="loc_us-gaap_SalesTypeLeaseLeaseReceivable_0f448eec-e4b8-43f1-ac5c-5ce5c4ff108b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1" xlink:type="simple" xlink:href="isrg-20210930.xsd#LEASESLeaseReceivablesDetails_1"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_00de2a4d-b34e-4898-ac1f-966c6474b1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear_f662da20-0b01-4ccc-b79d-f37e29b7d5df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00de2a4d-b34e-4898-ac1f-966c6474b1cb" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear_f662da20-0b01-4ccc-b79d-f37e29b7d5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths_bfc51b78-d83c-4914-85b6-79104b7e19d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00de2a4d-b34e-4898-ac1f-966c6474b1cb" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths_bfc51b78-d83c-4914-85b6-79104b7e19d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears_86a33bd4-1743-41c1-a3b6-724c64de78f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00de2a4d-b34e-4898-ac1f-966c6474b1cb" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears_86a33bd4-1743-41c1-a3b6-724c64de78f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears_142a75d6-2fb3-453e-ad16-f23293182cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00de2a4d-b34e-4898-ac1f-966c6474b1cb" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears_142a75d6-2fb3-453e-ad16-f23293182cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears_a5f605ae-7f43-4696-aa85-a10b274ad99c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00de2a4d-b34e-4898-ac1f-966c6474b1cb" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears_a5f605ae-7f43-4696-aa85-a10b274ad99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter_217531c5-5081-4e6a-a45a-871abe872b2f" xlink:href="isrg-20210930.xsd#isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00de2a4d-b34e-4898-ac1f-966c6474b1cb" xlink:to="loc_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter_217531c5-5081-4e6a-a45a-871abe872b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_5e51dc86-8cc5-4bd0-b8ef-300c5027d64c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00de2a4d-b34e-4898-ac1f-966c6474b1cb" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_5e51dc86-8cc5-4bd0-b8ef-300c5027d64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#LEASESCreditQualityIndicatorDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fb445368-bd9b-4cb4-815b-d38516285f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_c8ff9ebc-5675-41c5-bd04-471129a4d4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fb445368-bd9b-4cb4-815b-d38516285f6b" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_c8ff9ebc-5675-41c5-bd04-471129a4d4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentAxis_34a75665-eba2-4bf3-8fb8-f8ef2da1a817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalCreditAssessmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_c8ff9ebc-5675-41c5-bd04-471129a4d4d1" xlink:to="loc_us-gaap_InternalCreditAssessmentAxis_34a75665-eba2-4bf3-8fb8-f8ef2da1a817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain_5de6399f-98e8-4b6e-ac44-9e3a5af30b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis_34a75665-eba2-4bf3-8fb8-f8ef2da1a817" xlink:to="loc_us-gaap_InternalCreditAssessmentDomain_5de6399f-98e8-4b6e-ac44-9e3a5af30b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_HighMember_634cb53b-051c-4f57-ab09-88d277ffce9b" xlink:href="isrg-20210930.xsd#isrg_HighMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_5de6399f-98e8-4b6e-ac44-9e3a5af30b2b" xlink:to="loc_isrg_HighMember_634cb53b-051c-4f57-ab09-88d277ffce9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ModerateMember_41b9c0a3-c89b-40a5-bc5d-5a8861277e1d" xlink:href="isrg-20210930.xsd#isrg_ModerateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_5de6399f-98e8-4b6e-ac44-9e3a5af30b2b" xlink:to="loc_isrg_ModerateMember_41b9c0a3-c89b-40a5-bc5d-5a8861277e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_LowMember_5397baf2-cf8a-46b3-b13d-1380609d10d3" xlink:href="isrg-20210930.xsd#isrg_LowMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_5de6399f-98e8-4b6e-ac44-9e3a5af30b2b" xlink:to="loc_isrg_LowMember_5397baf2-cf8a-46b3-b13d-1380609d10d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_c8ff9ebc-5675-41c5-bd04-471129a4d4d1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear_4ba4bdd6-0687-45fe-b836-f1a4fbcb1a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear_4ba4bdd6-0687-45fe-b836-f1a4fbcb1a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear_0302c508-d97e-4ee0-a079-52657f2f0817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear_0302c508-d97e-4ee0-a079-52657f2f0817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear_25564d70-e69f-4009-9085-69d3b1679c75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear_25564d70-e69f-4009-9085-69d3b1679c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear_97e241f9-4336-4176-b971-bca3f18e2092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear_97e241f9-4336-4176-b971-bca3f18e2092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear_e29e68ab-a06d-4127-bfe3-e70941409cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear_e29e68ab-a06d-4127-bfe3-e70941409cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear_f66e003d-4ecc-4539-9035-feeeecfe4d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear_f66e003d-4ecc-4539-9035-feeeecfe4d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_1847d07a-329f-4ddf-9dc4-a5f5bc745777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_5ee53412-1944-480a-b4ae-40cb90fd84c1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_1847d07a-329f-4ddf-9dc4-a5f5bc745777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#LEASESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a00a7275-05f4-4212-8ad6-4aa8790d0d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d7e68d81-e0dd-4ba0-8630-1287040d4452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a00a7275-05f4-4212-8ad6-4aa8790d0d35" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d7e68d81-e0dd-4ba0-8630-1287040d4452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_beb13735-9eb8-4dd9-af7c-4845055697ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d7e68d81-e0dd-4ba0-8630-1287040d4452" xlink:to="loc_srt_RangeAxis_beb13735-9eb8-4dd9-af7c-4845055697ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_81fea08a-0b70-4aa2-ac33-7904466ccf69" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_beb13735-9eb8-4dd9-af7c-4845055697ba" xlink:to="loc_srt_RangeMember_81fea08a-0b70-4aa2-ac33-7904466ccf69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_792492cc-3508-402f-bed8-78568c3d400a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_81fea08a-0b70-4aa2-ac33-7904466ccf69" xlink:to="loc_srt_MinimumMember_792492cc-3508-402f-bed8-78568c3d400a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_185b1077-0c52-4583-a943-8969b04bae4c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_81fea08a-0b70-4aa2-ac33-7904466ccf69" xlink:to="loc_srt_MaximumMember_185b1077-0c52-4583-a943-8969b04bae4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_aec9faa3-547a-4898-b2b9-443067ae75eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d7e68d81-e0dd-4ba0-8630-1287040d4452" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_aec9faa3-547a-4898-b2b9-443067ae75eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1_730a4592-f377-43fe-9192-e1671d03a1db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorSalesTypeLeaseTermOfContract1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_aec9faa3-547a-4898-b2b9-443067ae75eb" xlink:to="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1_730a4592-f377-43fe-9192-e1671d03a1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="isrg-20210930.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_136e3644-0b4e-4703-b6e2-c31bfef4524f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_58ecc590-bac2-47bb-b22b-158688fd8c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_136e3644-0b4e-4703-b6e2-c31bfef4524f" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_58ecc590-bac2-47bb-b22b-158688fd8c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="isrg-20210930.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_63a73d90-a138-4f9b-9c40-dc3760a0d4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_98ff97df-7245-43d7-867b-f0bf1d6c9bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_63a73d90-a138-4f9b-9c40-dc3760a0d4ab" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_98ff97df-7245-43d7-867b-f0bf1d6c9bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_08b1ccc5-de0e-4b17-b7fa-f69e8555a4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_63a73d90-a138-4f9b-9c40-dc3760a0d4ab" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_08b1ccc5-de0e-4b17-b7fa-f69e8555a4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_6f24e30b-e097-4dc8-988f-b954be846ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_63a73d90-a138-4f9b-9c40-dc3760a0d4ab" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_6f24e30b-e097-4dc8-988f-b954be846ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_857f1795-bf6d-4c7d-896c-66ee5d8e6eae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_fdde2cf6-1311-48ea-966e-c8df3dab801d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_857f1795-bf6d-4c7d-896c-66ee5d8e6eae" xlink:to="loc_us-gaap_GoodwillRollForward_fdde2cf6-1311-48ea-966e-c8df3dab801d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5fa0c9e9-a4cd-4951-9f1d-b4b429fff94b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_fdde2cf6-1311-48ea-966e-c8df3dab801d" xlink:to="loc_us-gaap_Goodwill_5fa0c9e9-a4cd-4951-9f1d-b4b429fff94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_ceef4396-668d-47a9-84e7-99edaa23b675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_fdde2cf6-1311-48ea-966e-c8df3dab801d" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_ceef4396-668d-47a9-84e7-99edaa23b675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_1797aad4-3f0b-4b83-8e48-16935c42f31a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_fdde2cf6-1311-48ea-966e-c8df3dab801d" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_1797aad4-3f0b-4b83-8e48-16935c42f31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_39062503-94ea-4bef-9b03-8643034fd49c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_fdde2cf6-1311-48ea-966e-c8df3dab801d" xlink:to="loc_us-gaap_Goodwill_39062503-94ea-4bef-9b03-8643034fd49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_380540b5-e3fd-438b-822e-30e467da1947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3f8f6276-be59-466f-9992-735040d7cc48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_380540b5-e3fd-438b-822e-30e467da1947" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3f8f6276-be59-466f-9992-735040d7cc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9550c5ef-fea9-47a3-8fff-81aebe03a62c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3f8f6276-be59-466f-9992-735040d7cc48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9550c5ef-fea9-47a3-8fff-81aebe03a62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3eb2d3bb-3ad1-45a1-9eae-d5398fbc6ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9550c5ef-fea9-47a3-8fff-81aebe03a62c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3eb2d3bb-3ad1-45a1-9eae-d5398fbc6ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_5d5a27b3-5f01-46d3-84d3-d254c71a3e48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3eb2d3bb-3ad1-45a1-9eae-d5398fbc6ed2" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_5d5a27b3-5f01-46d3-84d3-d254c71a3e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionRightsMember_c0b72ae3-f065-4587-80de-ad57125cab16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3eb2d3bb-3ad1-45a1-9eae-d5398fbc6ed2" xlink:to="loc_us-gaap_DistributionRightsMember_c0b72ae3-f065-4587-80de-ad57125cab16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_263cc9ef-68c1-400c-9a65-3b945dc05c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3eb2d3bb-3ad1-45a1-9eae-d5398fbc6ed2" xlink:to="loc_us-gaap_CustomerRelationshipsMember_263cc9ef-68c1-400c-9a65-3b945dc05c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac5908b8-c756-4160-9ee3-bf7292cba0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3f8f6276-be59-466f-9992-735040d7cc48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac5908b8-c756-4160-9ee3-bf7292cba0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_084e4246-4028-4f17-898b-316dc3a94229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac5908b8-c756-4160-9ee3-bf7292cba0ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_084e4246-4028-4f17-898b-316dc3a94229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c4fb4ef5-95c8-496e-be66-84a14bb2eed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac5908b8-c756-4160-9ee3-bf7292cba0ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c4fb4ef5-95c8-496e-be66-84a14bb2eed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bcbab5e5-2a12-4e55-b462-1e6331e254e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac5908b8-c756-4160-9ee3-bf7292cba0ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bcbab5e5-2a12-4e55-b462-1e6331e254e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1577166a-f421-4309-914a-27861f00fa6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_66fbb1cb-3a81-4dcd-811d-842baae69afd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1577166a-f421-4309-914a-27861f00fa6c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_66fbb1cb-3a81-4dcd-811d-842baae69afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2b650c2a-45ac-4f61-ac71-5322ce6be128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1577166a-f421-4309-914a-27861f00fa6c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2b650c2a-45ac-4f61-ac71-5322ce6be128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fd6593da-2746-46c6-a6f5-ac6b73728934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1577166a-f421-4309-914a-27861f00fa6c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fd6593da-2746-46c6-a6f5-ac6b73728934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2ed0ec12-bd91-4141-9142-632cb3f93d70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1577166a-f421-4309-914a-27861f00fa6c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2ed0ec12-bd91-4141-9142-632cb3f93d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7bb3102c-aa1f-4e42-a0e8-e06d6e88fcdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1577166a-f421-4309-914a-27861f00fa6c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7bb3102c-aa1f-4e42-a0e8-e06d6e88fcdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_2cdbcea3-ddac-4481-b59d-291a708ecd79" xlink:href="isrg-20210930.xsd#isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1577166a-f421-4309-914a-27861f00fa6c" xlink:to="loc_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_2cdbcea3-ddac-4481-b59d-291a708ecd79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_26e31bec-5fdd-4f9b-9bcc-a39f38a9b356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1577166a-f421-4309-914a-27861f00fa6c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_26e31bec-5fdd-4f9b-9bcc-a39f38a9b356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CONTINGENCIES" xlink:type="simple" xlink:href="isrg-20210930.xsd#CONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/CONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3024b590-bd45-4413-8b42-1c9a436c48c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a9c5b59f-373c-4fcc-aeb9-9c86342e96a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3024b590-bd45-4413-8b42-1c9a436c48c8" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a9c5b59f-373c-4fcc-aeb9-9c86342e96a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="isrg-20210930.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_28478d5a-8e12-4866-a7e1-113e050f2a90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6aeba586-c480-4986-9c12-095adb2dee0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_28478d5a-8e12-4866-a7e1-113e050f2a90" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6aeba586-c480-4986-9c12-095adb2dee0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="isrg-20210930.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3ec8ed4f-0428-4668-a3bc-47b22e86ccbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_7c5e1028-5f17-4c1e-901d-84c313ee138c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3ec8ed4f-0428-4668-a3bc-47b22e86ccbd" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_7c5e1028-5f17-4c1e-901d-84c313ee138c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_0143024a-f9b0-43c4-b4da-9f727b3f505e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3ec8ed4f-0428-4668-a3bc-47b22e86ccbd" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_0143024a-f9b0-43c4-b4da-9f727b3f505e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2a90d322-9d07-40a9-bf0a-d97e813221c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3ec8ed4f-0428-4668-a3bc-47b22e86ccbd" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2a90d322-9d07-40a9-bf0a-d97e813221c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_fa87dfc3-e4d1-42e9-b5ce-e0821b3eee48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d0c76633-988f-4a6c-b160-3f91668e13ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fa87dfc3-e4d1-42e9-b5ce-e0821b3eee48" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d0c76633-988f-4a6c-b160-3f91668e13ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_63608310-e84e-49aa-a1b3-4fddb6dccce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d0c76633-988f-4a6c-b160-3f91668e13ac" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_63608310-e84e-49aa-a1b3-4fddb6dccce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_258bcace-33a0-4e38-942c-12fb490874ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_63608310-e84e-49aa-a1b3-4fddb6dccce7" xlink:to="loc_us-gaap_EquityComponentDomain_258bcace-33a0-4e38-942c-12fb490874ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5480fa9c-cdcd-4948-8889-8eab3cf55d28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_258bcace-33a0-4e38-942c-12fb490874ff" xlink:to="loc_us-gaap_CommonStockMember_5480fa9c-cdcd-4948-8889-8eab3cf55d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9aa3f03d-10d3-4d4f-a554-7753c8ca1ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_258bcace-33a0-4e38-942c-12fb490874ff" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9aa3f03d-10d3-4d4f-a554-7753c8ca1ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_4412a527-d2ef-4b53-99c8-4a22259517a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_258bcace-33a0-4e38-942c-12fb490874ff" xlink:to="loc_us-gaap_RetainedEarningsMember_4412a527-d2ef-4b53-99c8-4a22259517a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0ab74850-6d15-4107-b080-1dbc4ecd90cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_258bcace-33a0-4e38-942c-12fb490874ff" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0ab74850-6d15-4107-b080-1dbc4ecd90cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_7ddac4b4-d976-40e3-aa58-4282b7479008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_258bcace-33a0-4e38-942c-12fb490874ff" xlink:to="loc_us-gaap_ParentMember_7ddac4b4-d976-40e3-aa58-4282b7479008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_463fc5dd-0b24-492f-b9a8-26692c2d8e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_258bcace-33a0-4e38-942c-12fb490874ff" xlink:to="loc_us-gaap_NoncontrollingInterestMember_463fc5dd-0b24-492f-b9a8-26692c2d8e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a785ea7e-d648-4b57-8a25-d1f138ddb4b4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d0c76633-988f-4a6c-b160-3f91668e13ac" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a785ea7e-d648-4b57-8a25-d1f138ddb4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1703b01-7ad2-48dc-adad-d9e5db55ff91" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a785ea7e-d648-4b57-8a25-d1f138ddb4b4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1703b01-7ad2-48dc-adad-d9e5db55ff91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f907186a-0801-44e2-906d-3be340ec99f9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1703b01-7ad2-48dc-adad-d9e5db55ff91" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f907186a-0801-44e2-906d-3be340ec99f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_54e2f8f4-e4c8-451b-ac25-fa878420f17f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d0c76633-988f-4a6c-b160-3f91668e13ac" xlink:to="loc_us-gaap_ClassOfStockLineItems_54e2f8f4-e4c8-451b-ac25-fa878420f17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54e2f8f4-e4c8-451b-ac25-fa878420f17f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_74582af7-408b-4b71-bc3f-bddf9dfdc7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_74582af7-408b-4b71-bc3f-bddf9dfdc7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8fb48a95-3564-41fa-9742-5beb7d066856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8fb48a95-3564-41fa-9742-5beb7d066856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_cf8521d3-60c9-4317-932a-abdb0882052c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_cf8521d3-60c9-4317-932a-abdb0882052c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5ffd25ee-b93c-4330-b19b-af32a81fb493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5ffd25ee-b93c-4330-b19b-af32a81fb493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_d04d5dfd-5176-45ba-9447-2e63d7a54d43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_d04d5dfd-5176-45ba-9447-2e63d7a54d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_f205a6c1-827c-423b-b586-286d2e219d84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_f205a6c1-827c-423b-b586-286d2e219d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_85700986-e15a-438c-9402-f8168e015fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_85700986-e15a-438c-9402-f8168e015fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_505ead8f-80f7-4072-af0c-14eb42416312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_505ead8f-80f7-4072-af0c-14eb42416312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_6021a9cd-7cd6-4580-8e34-d818ea3cfde0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_6021a9cd-7cd6-4580-8e34-d818ea3cfde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_af6edec3-5a83-421e-b076-dafdd7f9afb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_NetIncomeLoss_af6edec3-5a83-421e-b076-dafdd7f9afb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_359dd7ff-0bbc-4d95-8cde-a794a6bbc6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_359dd7ff-0bbc-4d95-8cde-a794a6bbc6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a7c3d440-b67f-406b-8411-ed9b343d2117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a7c3d440-b67f-406b-8411-ed9b343d2117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_175a4d9b-3bb2-4f37-9708-fbde2ee713b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_175a4d9b-3bb2-4f37-9708-fbde2ee713b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f04d76d3-aa46-4e0d-bdc8-d342690c8367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca9f0db4-d484-41eb-9cfe-33453bc62cd8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f04d76d3-aa46-4e0d-bdc8-d342690c8367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_75e64c5e-ea32-4321-badc-d370db7a81e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_44412b6e-ab0a-4475-a70c-c65804b6113a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_75e64c5e-ea32-4321-badc-d370db7a81e6" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_44412b6e-ab0a-4475-a70c-c65804b6113a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d5d6f55e-413c-4b26-80a2-be9b06136f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_44412b6e-ab0a-4475-a70c-c65804b6113a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d5d6f55e-413c-4b26-80a2-be9b06136f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_63cf029d-17df-40af-a3ba-20a91faed713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d5d6f55e-413c-4b26-80a2-be9b06136f9c" xlink:to="loc_us-gaap_EquityComponentDomain_63cf029d-17df-40af-a3ba-20a91faed713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6235e734-23a0-4077-9e8f-33f3fa92d349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_63cf029d-17df-40af-a3ba-20a91faed713" xlink:to="loc_us-gaap_CommonStockMember_6235e734-23a0-4077-9e8f-33f3fa92d349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_a1b740c4-0f4e-49fb-814c-b95dc6300aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_44412b6e-ab0a-4475-a70c-c65804b6113a" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_a1b740c4-0f4e-49fb-814c-b95dc6300aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_c37d2b94-6f13-4b71-8799-e3ff93327a76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_a1b740c4-0f4e-49fb-814c-b95dc6300aa5" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_c37d2b94-6f13-4b71-8799-e3ff93327a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CommonStockRepurchaseProgramMember_cc613e26-9ec0-41f0-ac7f-8ea595b0f0ed" xlink:href="isrg-20210930.xsd#isrg_CommonStockRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_c37d2b94-6f13-4b71-8799-e3ff93327a76" xlink:to="loc_isrg_CommonStockRepurchaseProgramMember_cc613e26-9ec0-41f0-ac7f-8ea595b0f0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ce4f00bb-ebf0-44ce-8b64-8f6adc2b5a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_44412b6e-ab0a-4475-a70c-c65804b6113a" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ce4f00bb-ebf0-44ce-8b64-8f6adc2b5a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_495fd0f1-c0ee-4ce4-98a0-260b47d69fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ce4f00bb-ebf0-44ce-8b64-8f6adc2b5a7d" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_495fd0f1-c0ee-4ce4-98a0-260b47d69fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_bbbd4950-bbd8-400d-b18a-34afebd7839d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ce4f00bb-ebf0-44ce-8b64-8f6adc2b5a7d" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_bbbd4950-bbd8-400d-b18a-34afebd7839d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_be4a54fd-0df5-45fe-9f1f-0bea5dde1200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ce4f00bb-ebf0-44ce-8b64-8f6adc2b5a7d" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_be4a54fd-0df5-45fe-9f1f-0bea5dde1200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_17fdfc15-63c8-481e-ad86-adf6241bf3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_fe5fc020-059d-4c92-9441-6e572864f7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_17fdfc15-63c8-481e-ad86-adf6241bf3c0" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_fe5fc020-059d-4c92-9441-6e572864f7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_427b7537-60bd-47ca-802e-dd182fd3649c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_fe5fc020-059d-4c92-9441-6e572864f7ef" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_427b7537-60bd-47ca-802e-dd182fd3649c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_1204f0cc-63dc-4c14-8254-dd39fa0d9a89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_427b7537-60bd-47ca-802e-dd182fd3649c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_1204f0cc-63dc-4c14-8254-dd39fa0d9a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CommonStockRepurchaseProgramMember_d53280e7-ae27-4248-bde2-cf2346e06e19" xlink:href="isrg-20210930.xsd#isrg_CommonStockRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_1204f0cc-63dc-4c14-8254-dd39fa0d9a89" xlink:to="loc_isrg_CommonStockRepurchaseProgramMember_d53280e7-ae27-4248-bde2-cf2346e06e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_dc383f7d-382e-4f70-9850-4947460c56a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_fe5fc020-059d-4c92-9441-6e572864f7ef" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_dc383f7d-382e-4f70-9850-4947460c56a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f583fc9e-a9bc-469a-b344-98d1c090341f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dc383f7d-382e-4f70-9850-4947460c56a0" xlink:to="loc_us-gaap_EquityComponentDomain_f583fc9e-a9bc-469a-b344-98d1c090341f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c4fbc8ab-c97e-48cb-ba87-b3b85a4ad52a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f583fc9e-a9bc-469a-b344-98d1c090341f" xlink:to="loc_us-gaap_CommonStockMember_c4fbc8ab-c97e-48cb-ba87-b3b85a4ad52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_30c1ba3b-046d-4fe5-beb8-9344d691cb29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_fe5fc020-059d-4c92-9441-6e572864f7ef" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_30c1ba3b-046d-4fe5-beb8-9344d691cb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_d3e6fb18-221d-4886-a759-cf258e8b36bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_30c1ba3b-046d-4fe5-beb8-9344d691cb29" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_d3e6fb18-221d-4886-a759-cf258e8b36bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_StockRepurchaseProgramincreasedtoauthorizedamount_13600bd8-a8fe-4ce6-b6ae-6f36481d9ba1" xlink:href="isrg-20210930.xsd#isrg_StockRepurchaseProgramincreasedtoauthorizedamount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_30c1ba3b-046d-4fe5-beb8-9344d691cb29" xlink:to="loc_isrg_StockRepurchaseProgramincreasedtoauthorizedamount_13600bd8-a8fe-4ce6-b6ae-6f36481d9ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_57853091-c4a3-4573-a0bc-c99164498a09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_30c1ba3b-046d-4fe5-beb8-9344d691cb29" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_57853091-c4a3-4573-a0bc-c99164498a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_04f7fbf0-9867-4c8b-9072-fb922b246889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward_0cf9d650-34bc-4f2c-a284-142f24133473" xlink:href="isrg-20210930.xsd#isrg_AccumulatedOtherComprehensiveIncomeRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_04f7fbf0-9867-4c8b-9072-fb922b246889" xlink:to="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward_0cf9d650-34bc-4f2c-a284-142f24133473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_5dff51e5-79e0-455d-a797-16df1e6085bf" xlink:href="isrg-20210930.xsd#isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward_0cf9d650-34bc-4f2c-a284-142f24133473" xlink:to="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_5dff51e5-79e0-455d-a797-16df1e6085bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_d164eed3-dfbf-477e-a15a-1c6abbb9e3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_5dff51e5-79e0-455d-a797-16df1e6085bf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_d164eed3-dfbf-477e-a15a-1c6abbb9e3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_6525cc67-7b6a-4513-b03c-57f933074430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_5dff51e5-79e0-455d-a797-16df1e6085bf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_6525cc67-7b6a-4513-b03c-57f933074430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_82829862-88bb-4d43-97c0-5f8a18fe0ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_5dff51e5-79e0-455d-a797-16df1e6085bf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_82829862-88bb-4d43-97c0-5f8a18fe0ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_14bcba2b-f43b-4c4f-8611-1dfd06abf399" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_5dff51e5-79e0-455d-a797-16df1e6085bf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_14bcba2b-f43b-4c4f-8611-1dfd06abf399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_b0ff7a42-c6e9-47c6-bf82-ef4eb51bcb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_5dff51e5-79e0-455d-a797-16df1e6085bf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_b0ff7a42-c6e9-47c6-bf82-ef4eb51bcb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_0795d0fd-0671-4265-a70e-c57e30fa5ba3" xlink:href="isrg-20210930.xsd#isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward_0cf9d650-34bc-4f2c-a284-142f24133473" xlink:to="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_0795d0fd-0671-4265-a70e-c57e30fa5ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_98523a7c-0a94-4803-8981-57413d234d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_0795d0fd-0671-4265-a70e-c57e30fa5ba3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_98523a7c-0a94-4803-8981-57413d234d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_cdf7fe84-7879-4424-8f56-766a7cc0defc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_0795d0fd-0671-4265-a70e-c57e30fa5ba3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_cdf7fe84-7879-4424-8f56-766a7cc0defc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_d0d87bd4-c9ba-4b42-9309-4f0e09eece95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_0795d0fd-0671-4265-a70e-c57e30fa5ba3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_d0d87bd4-c9ba-4b42-9309-4f0e09eece95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_97676d4c-9155-4207-9d98-0d1f898bfdd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_0795d0fd-0671-4265-a70e-c57e30fa5ba3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_97676d4c-9155-4207-9d98-0d1f898bfdd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_91197dac-6a1d-400d-8655-be0e0c0076b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_0795d0fd-0671-4265-a70e-c57e30fa5ba3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_91197dac-6a1d-400d-8655-be0e0c0076b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_cafe5c02-34a2-461e-ab4d-2ccf13378a07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CumulativeTranslationAdjustmentSummaryRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward_0cf9d650-34bc-4f2c-a284-142f24133473" xlink:to="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_cafe5c02-34a2-461e-ab4d-2ccf13378a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_cebd0507-e7c2-4230-888c-8c2725a96472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_cafe5c02-34a2-461e-ab4d-2ccf13378a07" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_cebd0507-e7c2-4230-888c-8c2725a96472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_b9098ba3-ffd3-4fe7-b338-c1c1af1b46fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_cafe5c02-34a2-461e-ab4d-2ccf13378a07" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_b9098ba3-ffd3-4fe7-b338-c1c1af1b46fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_0474cc6c-f019-413f-b7ac-23ebcf05e97c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_cafe5c02-34a2-461e-ab4d-2ccf13378a07" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_0474cc6c-f019-413f-b7ac-23ebcf05e97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c0615bb0-78fe-40eb-b383-8ee561ce357d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_cafe5c02-34a2-461e-ab4d-2ccf13378a07" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c0615bb0-78fe-40eb-b383-8ee561ce357d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_41761ad2-ca8f-4f3c-8747-48e242ed96d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_cafe5c02-34a2-461e-ab4d-2ccf13378a07" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_41761ad2-ca8f-4f3c-8747-48e242ed96d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_669f2dc9-e7c1-4f19-a3f7-d8f05c3c041f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward_0cf9d650-34bc-4f2c-a284-142f24133473" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_669f2dc9-e7c1-4f19-a3f7-d8f05c3c041f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_417ee766-4b7f-412a-8a3e-951a64cd69e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_669f2dc9-e7c1-4f19-a3f7-d8f05c3c041f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_417ee766-4b7f-412a-8a3e-951a64cd69e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_199980ac-24f9-462c-ba33-2929a510c839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_669f2dc9-e7c1-4f19-a3f7-d8f05c3c041f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_199980ac-24f9-462c-ba33-2929a510c839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_7f77c14c-8d46-4fd5-ac8a-3af380fe9618" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_669f2dc9-e7c1-4f19-a3f7-d8f05c3c041f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_7f77c14c-8d46-4fd5-ac8a-3af380fe9618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_86fb9074-42c0-4cf4-8e13-032dcad2b114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_669f2dc9-e7c1-4f19-a3f7-d8f05c3c041f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_86fb9074-42c0-4cf4-8e13-032dcad2b114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_4e9e2ab8-5da0-4d58-a6f9-ff1654ef2935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_669f2dc9-e7c1-4f19-a3f7-d8f05c3c041f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_4e9e2ab8-5da0-4d58-a6f9-ff1654ef2935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_c55508b4-10d9-4678-8b59-4db58d6d8c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward_0cf9d650-34bc-4f2c-a284-142f24133473" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_c55508b4-10d9-4678-8b59-4db58d6d8c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_59ae7e5b-d14f-45ab-b1f3-c08507923b66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_c55508b4-10d9-4678-8b59-4db58d6d8c4a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_59ae7e5b-d14f-45ab-b1f3-c08507923b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax_34124c4a-6626-4214-9a45-e4a8f4c1e497" xlink:href="isrg-20210930.xsd#isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_c55508b4-10d9-4678-8b59-4db58d6d8c4a" xlink:to="loc_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax_34124c4a-6626-4214-9a45-e4a8f4c1e497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2819f6dc-7fa0-46dc-a692-2e14131c8e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_c55508b4-10d9-4678-8b59-4db58d6d8c4a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2819f6dc-7fa0-46dc-a692-2e14131c8e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7172f5b9-a8ae-4cb4-b9dc-f7820527b917" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_c55508b4-10d9-4678-8b59-4db58d6d8c4a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7172f5b9-a8ae-4cb4-b9dc-f7820527b917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_48022814-07a0-4c9c-882b-f260abe8a697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_c55508b4-10d9-4678-8b59-4db58d6d8c4a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_48022814-07a0-4c9c-882b-f260abe8a697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_fafd4d4a-ad98-423a-b7a4-c491114bb01a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_04f7fbf0-9867-4c8b-9072-fb922b246889" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_fafd4d4a-ad98-423a-b7a4-c491114bb01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION" xlink:type="simple" xlink:href="isrg-20210930.xsd#SHAREBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_999d04cf-8b68-4a4d-a7b1-730ea888b846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_8cb1b226-9d4a-43e4-927a-0c5f0c4c23e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_999d04cf-8b68-4a4d-a7b1-730ea888b846" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_8cb1b226-9d4a-43e4-927a-0c5f0c4c23e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="isrg-20210930.xsd#SHAREBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_28c7bb55-3009-460e-be58-54f7c524e1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_f7f31df1-df5b-4d5c-9289-e8a3e592bb81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_28c7bb55-3009-460e-be58-54f7c524e1d4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_f7f31df1-df5b-4d5c-9289-e8a3e592bb81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_8f99e087-1d85-4793-9117-dd9bc5b99d57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_28c7bb55-3009-460e-be58-54f7c524e1d4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_8f99e087-1d85-4793-9117-dd9bc5b99d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_3ecc2a28-63b4-4a32-978b-a39beafc8f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_28c7bb55-3009-460e-be58-54f7c524e1d4" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_3ecc2a28-63b4-4a32-978b-a39beafc8f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_5d9dc002-b891-4305-9907-cbb659233f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_28c7bb55-3009-460e-be58-54f7c524e1d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_5d9dc002-b891-4305-9907-cbb659233f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#SHAREBASEDCOMPENSATIONAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6e03b915-3228-4179-838f-998e00a69e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad04022e-f7b1-4ae2-95ec-4315a723feb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6e03b915-3228-4179-838f-998e00a69e5c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad04022e-f7b1-4ae2-95ec-4315a723feb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ef0a8d53-ce6b-47ce-85c0-e808f1f3ee9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad04022e-f7b1-4ae2-95ec-4315a723feb8" xlink:to="loc_us-gaap_AwardTypeAxis_ef0a8d53-ce6b-47ce-85c0-e808f1f3ee9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e130bcc-8609-4118-b4c0-6818304e97fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ef0a8d53-ce6b-47ce-85c0-e808f1f3ee9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e130bcc-8609-4118-b4c0-6818304e97fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f0cf6ade-d460-4a76-bc0c-60b779d78e70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e130bcc-8609-4118-b4c0-6818304e97fe" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f0cf6ade-d460-4a76-bc0c-60b779d78e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_5563be24-1f68-4b55-b093-eba748ee2cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e130bcc-8609-4118-b4c0-6818304e97fe" xlink:to="loc_us-gaap_EmployeeStockMember_5563be24-1f68-4b55-b093-eba748ee2cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ee9ef2d2-3fe5-4b3e-b320-629f30dc6402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad04022e-f7b1-4ae2-95ec-4315a723feb8" xlink:to="loc_us-gaap_PlanNameAxis_ee9ef2d2-3fe5-4b3e-b320-629f30dc6402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1d448b12-56f8-4fe8-9a9a-21d18bbf2000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_ee9ef2d2-3fe5-4b3e-b320-629f30dc6402" xlink:to="loc_us-gaap_PlanNameDomain_1d448b12-56f8-4fe8-9a9a-21d18bbf2000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_A2010IncentiveAwardPlanMember_567e31c5-8fec-4e46-af39-918bf3309263" xlink:href="isrg-20210930.xsd#isrg_A2010IncentiveAwardPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1d448b12-56f8-4fe8-9a9a-21d18bbf2000" xlink:to="loc_isrg_A2010IncentiveAwardPlanMember_567e31c5-8fec-4e46-af39-918bf3309263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad04022e-f7b1-4ae2-95ec-4315a723feb8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b8b4d03d-a3b4-4581-9bec-50e82386b88c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b8b4d03d-a3b4-4581-9bec-50e82386b88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit_15214feb-ef30-417b-9c22-10931731f657" xlink:href="isrg-20210930.xsd#isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit_15214feb-ef30-417b-9c22-10931731f657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f46230df-3c2f-4954-9a0c-d59b4130706e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f46230df-3c2f-4954-9a0c-d59b4130706e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_68fb1aba-08a9-439d-8f92-cc29a19fb84f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_68fb1aba-08a9-439d-8f92-cc29a19fb84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4c58f327-52ac-4fc3-a120-fbf3d91f8857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4c58f327-52ac-4fc3-a120-fbf3d91f8857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2e99251f-95bd-4787-bbcc-15e7c768afdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2e99251f-95bd-4787-bbcc-15e7c768afdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_10996b23-95c5-43f3-8463-5630a22e381a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_10996b23-95c5-43f3-8463-5630a22e381a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_7d6f4568-eef4-4e0a-a345-f77a012c9235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7fdf07b-ee3d-41d4-b779-b986efe57b28" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_7d6f4568-eef4-4e0a-a345-f77a012c9235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e988a1ef-abf2-43fe-aa41-4b152bda5d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_83f28573-2a89-4d8f-856d-0660e445f03b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e988a1ef-abf2-43fe-aa41-4b152bda5d93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_83f28573-2a89-4d8f-856d-0660e445f03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f4b61717-1cad-4576-a719-1a6f5ea9fdc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_83f28573-2a89-4d8f-856d-0660e445f03b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f4b61717-1cad-4576-a719-1a6f5ea9fdc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_6622f97d-4be9-4c8b-addd-145d4caea546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_83f28573-2a89-4d8f-856d-0660e445f03b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_6622f97d-4be9-4c8b-addd-145d4caea546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_444445a1-bfa3-4200-b531-099056ccdfe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_83f28573-2a89-4d8f-856d-0660e445f03b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_444445a1-bfa3-4200-b531-099056ccdfe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_9b9d920e-7e24-4435-a80d-737cc2b4c1af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_83f28573-2a89-4d8f-856d-0660e445f03b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_9b9d920e-7e24-4435-a80d-737cc2b4c1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_cf522c5f-7c19-4628-b993-0fc42ebb457b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_83f28573-2a89-4d8f-856d-0660e445f03b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_cf522c5f-7c19-4628-b993-0fc42ebb457b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_1e5a28d5-ca6c-4c90-bbbc-c3ca5bb07de2" xlink:href="isrg-20210930.xsd#isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e988a1ef-abf2-43fe-aa41-4b152bda5d93" xlink:to="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_1e5a28d5-ca6c-4c90-bbbc-c3ca5bb07de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0fd368b3-e21b-4bc4-8d5e-c51d5aa6fa58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_1e5a28d5-ca6c-4c90-bbbc-c3ca5bb07de2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0fd368b3-e21b-4bc4-8d5e-c51d5aa6fa58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_69c2a889-a9f4-4c45-83c5-af3e2823c248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_1e5a28d5-ca6c-4c90-bbbc-c3ca5bb07de2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_69c2a889-a9f4-4c45-83c5-af3e2823c248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_59841659-a4ac-46e4-b6ae-4a88250ce589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_1e5a28d5-ca6c-4c90-bbbc-c3ca5bb07de2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_59841659-a4ac-46e4-b6ae-4a88250ce589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_e1ca152d-c212-425c-aa02-cfbfcb068c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_1e5a28d5-ca6c-4c90-bbbc-c3ca5bb07de2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_e1ca152d-c212-425c-aa02-cfbfcb068c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_84390348-ed43-44d0-95a4-0a918e401999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_1e5a28d5-ca6c-4c90-bbbc-c3ca5bb07de2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_84390348-ed43-44d0-95a4-0a918e401999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_227ae1fc-c19c-4e2e-a07a-1fdb72969ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2fdc50-82f4-44ff-b879-c22baf14c2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_227ae1fc-c19c-4e2e-a07a-1fdb72969ab8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2fdc50-82f4-44ff-b879-c22baf14c2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_34efffdc-0ef3-4347-b239-fdc3919e68ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2fdc50-82f4-44ff-b879-c22baf14c2e8" xlink:to="loc_us-gaap_AwardTypeAxis_34efffdc-0ef3-4347-b239-fdc3919e68ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff50853-cb7d-4308-a07b-e779a669c9b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_34efffdc-0ef3-4347-b239-fdc3919e68ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff50853-cb7d-4308-a07b-e779a669c9b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d5ab9664-5b24-402f-a337-37db1eec672f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff50853-cb7d-4308-a07b-e779a669c9b1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d5ab9664-5b24-402f-a337-37db1eec672f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a0092020-3310-46b1-bedd-e6b6c1d6b0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2fdc50-82f4-44ff-b879-c22baf14c2e8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a0092020-3310-46b1-bedd-e6b6c1d6b0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4fc4a63e-0dea-4485-bec1-901ffa288447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a0092020-3310-46b1-bedd-e6b6c1d6b0fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4fc4a63e-0dea-4485-bec1-901ffa288447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_94cff074-1359-4c6d-8b77-9755ad49fd94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4fc4a63e-0dea-4485-bec1-901ffa288447" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_94cff074-1359-4c6d-8b77-9755ad49fd94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dc18b4c7-8038-4109-a589-93cd295b061c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4fc4a63e-0dea-4485-bec1-901ffa288447" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dc18b4c7-8038-4109-a589-93cd295b061c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8e3100d4-db27-4c7a-b9ba-d076f5093dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4fc4a63e-0dea-4485-bec1-901ffa288447" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8e3100d4-db27-4c7a-b9ba-d076f5093dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a80693ff-905d-4346-9498-d6682bfbd3db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4fc4a63e-0dea-4485-bec1-901ffa288447" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a80693ff-905d-4346-9498-d6682bfbd3db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_948d4f97-4b8d-49ea-8dad-9ef32aaf40d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4fc4a63e-0dea-4485-bec1-901ffa288447" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_948d4f97-4b8d-49ea-8dad-9ef32aaf40d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2e946616-e477-494d-8c53-a43d50099b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a0092020-3310-46b1-bedd-e6b6c1d6b0fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2e946616-e477-494d-8c53-a43d50099b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8fa6f9e5-0b5b-475e-bc43-6c814aa96ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2e946616-e477-494d-8c53-a43d50099b5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8fa6f9e5-0b5b-475e-bc43-6c814aa96ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_316d4d10-ec5d-43b8-a1f4-3166bc1df301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2e946616-e477-494d-8c53-a43d50099b5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_316d4d10-ec5d-43b8-a1f4-3166bc1df301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d8716f2d-e2a9-40d7-a7d6-ec379368d336" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2e946616-e477-494d-8c53-a43d50099b5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d8716f2d-e2a9-40d7-a7d6-ec379368d336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_caf043de-1b2c-4be7-aa40-f4bea9544018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2e946616-e477-494d-8c53-a43d50099b5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_caf043de-1b2c-4be7-aa40-f4bea9544018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c6e6ca85-997c-4899-98d6-3b5edba6e926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2e946616-e477-494d-8c53-a43d50099b5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c6e6ca85-997c-4899-98d6-3b5edba6e926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f57da5fb-d8ca-4139-8162-622d698d7c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_ea453b1e-9d15-4885-af32-2638c3ed4811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f57da5fb-d8ca-4139-8162-622d698d7c7b" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_ea453b1e-9d15-4885-af32-2638c3ed4811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6abce462-ad07-4f1d-91f2-ccf964dad85a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_ea453b1e-9d15-4885-af32-2638c3ed4811" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6abce462-ad07-4f1d-91f2-ccf964dad85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_406bf9fe-80d8-416d-a264-e3d8f815af10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6abce462-ad07-4f1d-91f2-ccf964dad85a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_406bf9fe-80d8-416d-a264-e3d8f815af10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_2b3bc2aa-6989-4095-b75f-d786a1296577" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_406bf9fe-80d8-416d-a264-e3d8f815af10" xlink:to="loc_us-gaap_CostOfSalesMember_2b3bc2aa-6989-4095-b75f-d786a1296577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SellingGeneralAndAdministrativeMember_87648683-8331-4b0f-9765-d8f98999c855" xlink:href="isrg-20210930.xsd#isrg_SellingGeneralAndAdministrativeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_406bf9fe-80d8-416d-a264-e3d8f815af10" xlink:to="loc_isrg_SellingGeneralAndAdministrativeMember_87648683-8331-4b0f-9765-d8f98999c855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ResearchAndDevelopmentMember_e53beba0-3b97-4b9a-992b-bd2387c30d85" xlink:href="isrg-20210930.xsd#isrg_ResearchAndDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_406bf9fe-80d8-416d-a264-e3d8f815af10" xlink:to="loc_isrg_ResearchAndDevelopmentMember_e53beba0-3b97-4b9a-992b-bd2387c30d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ConsolidatingReportingAxis_fc6e2031-b7e3-4912-b869-4aa8227cf8f6" xlink:href="isrg-20210930.xsd#isrg_ConsolidatingReportingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_ea453b1e-9d15-4885-af32-2638c3ed4811" xlink:to="loc_isrg_ConsolidatingReportingAxis_fc6e2031-b7e3-4912-b869-4aa8227cf8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ConsolidatingReportingDomain_f8055ebc-eab2-4d21-b714-93ec7269e644" xlink:href="isrg-20210930.xsd#isrg_ConsolidatingReportingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_ConsolidatingReportingAxis_fc6e2031-b7e3-4912-b869-4aa8227cf8f6" xlink:to="loc_isrg_ConsolidatingReportingDomain_f8055ebc-eab2-4d21-b714-93ec7269e644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CostOfSalesProductMember_377b73b3-3513-40df-aec0-d6d502e28da5" xlink:href="isrg-20210930.xsd#isrg_CostOfSalesProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_ConsolidatingReportingDomain_f8055ebc-eab2-4d21-b714-93ec7269e644" xlink:to="loc_isrg_CostOfSalesProductMember_377b73b3-3513-40df-aec0-d6d502e28da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CostOfSalesServiceMember_60d7a336-795b-49a0-9fea-f60df610ec9d" xlink:href="isrg-20210930.xsd#isrg_CostOfSalesServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_ConsolidatingReportingDomain_f8055ebc-eab2-4d21-b714-93ec7269e644" xlink:to="loc_isrg_CostOfSalesServiceMember_60d7a336-795b-49a0-9fea-f60df610ec9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3e7edf9d-ce3f-44c8-9565-a191b1acecab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_ea453b1e-9d15-4885-af32-2638c3ed4811" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3e7edf9d-ce3f-44c8-9565-a191b1acecab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1f863b7b-baa7-4ba1-a0bd-6d80f952251e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3e7edf9d-ce3f-44c8-9565-a191b1acecab" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1f863b7b-baa7-4ba1-a0bd-6d80f952251e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_379c7ea7-0383-43ad-a0d8-08e074dee0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3e7edf9d-ce3f-44c8-9565-a191b1acecab" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_379c7ea7-0383-43ad-a0d8-08e074dee0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_a47a774a-fddc-4577-a970-fed2d0c1c034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3e7edf9d-ce3f-44c8-9565-a191b1acecab" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_a47a774a-fddc-4577-a970-fed2d0c1c034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_38f5fa74-e750-48c8-8909-ef8b608c2481" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2a5f12d-3ab8-4909-8553-f2436ef1f776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_38f5fa74-e750-48c8-8909-ef8b608c2481" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2a5f12d-3ab8-4909-8553-f2436ef1f776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1222c3c8-e096-4c51-8a3b-4732e3949267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2a5f12d-3ab8-4909-8553-f2436ef1f776" xlink:to="loc_us-gaap_AwardTypeAxis_1222c3c8-e096-4c51-8a3b-4732e3949267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f3f180d-bca8-4e40-b505-179ba319354b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1222c3c8-e096-4c51-8a3b-4732e3949267" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f3f180d-bca8-4e40-b505-179ba319354b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_7c9516b0-0da4-47a5-905c-e9cb5b0aeb57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f3f180d-bca8-4e40-b505-179ba319354b" xlink:to="loc_us-gaap_StockOptionMember_7c9516b0-0da4-47a5-905c-e9cb5b0aeb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_cc263a56-a539-4ccb-ad8c-5ca3f1813691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f3f180d-bca8-4e40-b505-179ba319354b" xlink:to="loc_us-gaap_EmployeeStockMember_cc263a56-a539-4ccb-ad8c-5ca3f1813691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e39f3e66-ffcb-47d6-9bd6-d38e840fb61c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2a5f12d-3ab8-4909-8553-f2436ef1f776" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e39f3e66-ffcb-47d6-9bd6-d38e840fb61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5539c432-7dfd-4fe5-ac1d-130bcc84d0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e39f3e66-ffcb-47d6-9bd6-d38e840fb61c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5539c432-7dfd-4fe5-ac1d-130bcc84d0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_450a6a8b-ecb5-4643-b04c-030e7eb25252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e39f3e66-ffcb-47d6-9bd6-d38e840fb61c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_450a6a8b-ecb5-4643-b04c-030e7eb25252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2f22ad81-3400-41f2-b482-19988952fbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e39f3e66-ffcb-47d6-9bd6-d38e840fb61c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2f22ad81-3400-41f2-b482-19988952fbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a9157d7d-1e73-4035-8cc2-6c2b77ec72d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e39f3e66-ffcb-47d6-9bd6-d38e840fb61c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a9157d7d-1e73-4035-8cc2-6c2b77ec72d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/INCOMETAXES" xlink:type="simple" xlink:href="isrg-20210930.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f752c258-a671-455e-8602-8357dcda3133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_b0401b98-4761-4ddb-9da6-614a71bdf24a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f752c258-a671-455e-8602-8357dcda3133" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_b0401b98-4761-4ddb-9da6-614a71bdf24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#INCOMETAXESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_732df265-9215-4daa-a698-1c080cb0f688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_cf2f0120-0d39-4599-ab91-4a02c9c97f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_732df265-9215-4daa-a698-1c080cb0f688" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_cf2f0120-0d39-4599-ab91-4a02c9c97f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_b5714fc2-5975-41df-8320-038930add0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_cf2f0120-0d39-4599-ab91-4a02c9c97f9f" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_b5714fc2-5975-41df-8320-038930add0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_7bca3bb1-5a43-4056-bcb4-dc10071aee99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b5714fc2-5975-41df-8320-038930add0bb" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_7bca3bb1-5a43-4056-bcb4-dc10071aee99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_771ee038-1c38-44d7-a7ad-a0669238c1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_7bca3bb1-5a43-4056-bcb4-dc10071aee99" xlink:to="loc_us-gaap_ForeignCountryMember_771ee038-1c38-44d7-a7ad-a0669238c1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_7af5ad03-5e57-4ed8-a172-1434f506d282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_cf2f0120-0d39-4599-ab91-4a02c9c97f9f" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_7af5ad03-5e57-4ed8-a172-1434f506d282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_962bbfee-e9ac-4b1c-ab3d-31760c5e0e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7af5ad03-5e57-4ed8-a172-1434f506d282" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_962bbfee-e9ac-4b1c-ab3d-31760c5e0e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_01ff1eaa-7efe-4996-a3cf-9fa94ef106e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7af5ad03-5e57-4ed8-a172-1434f506d282" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_01ff1eaa-7efe-4996-a3cf-9fa94ef106e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c8b68be5-bdf8-416f-87dd-4109f4f2e043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7af5ad03-5e57-4ed8-a172-1434f506d282" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c8b68be5-bdf8-416f-87dd-4109f4f2e043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_d57d80d5-1226-41af-86a9-f2e4da38d273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7af5ad03-5e57-4ed8-a172-1434f506d282" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_d57d80d5-1226-41af-86a9-f2e4da38d273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_1dea9ca2-9b1c-4524-9d0f-d1de9a1b2854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7af5ad03-5e57-4ed8-a172-1434f506d282" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_1dea9ca2-9b1c-4524-9d0f-d1de9a1b2854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_20c77ff8-5ed8-42af-9c7b-c555d0309439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7af5ad03-5e57-4ed8-a172-1434f506d282" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_20c77ff8-5ed8-42af-9c7b-c555d0309439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE" xlink:type="simple" xlink:href="isrg-20210930.xsd#NETINCOMEPERSHARE"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_92a8d48b-4fc6-4029-9434-75acd81d77f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_de83ed06-488e-4090-961d-4563a0476cce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_92a8d48b-4fc6-4029-9434-75acd81d77f8" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_de83ed06-488e-4090-961d-4563a0476cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables" xlink:type="simple" xlink:href="isrg-20210930.xsd#NETINCOMEPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e6904317-f359-44da-b518-d40e679f12c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e4d928ee-c41a-4335-a8a5-67d85b46681d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e6904317-f359-44da-b518-d40e679f12c1" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e4d928ee-c41a-4335-a8a5-67d85b46681d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d0244b63-157d-44af-9834-4f6ef93ac28b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_565400bd-b65e-482c-9e4f-49c62fb687de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d0244b63-157d-44af-9834-4f6ef93ac28b" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_565400bd-b65e-482c-9e4f-49c62fb687de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b2d17661-7f65-4f0f-ba02-29fc2fc56000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_565400bd-b65e-482c-9e4f-49c62fb687de" xlink:to="loc_us-gaap_NetIncomeLoss_b2d17661-7f65-4f0f-ba02-29fc2fc56000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_eebee5dd-e1a1-43f2-ac08-9a88bbf685b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d0244b63-157d-44af-9834-4f6ef93ac28b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_eebee5dd-e1a1-43f2-ac08-9a88bbf685b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9a37dbd6-240d-4c30-938e-97e9f6d67643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_eebee5dd-e1a1-43f2-ac08-9a88bbf685b5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9a37dbd6-240d-4c30-938e-97e9f6d67643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_475f420e-a1ea-4e50-a8e2-a71a275312aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_eebee5dd-e1a1-43f2-ac08-9a88bbf685b5" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_475f420e-a1ea-4e50-a8e2-a71a275312aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0e5e9508-f65d-42ae-8772-df3f72706a56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_eebee5dd-e1a1-43f2-ac08-9a88bbf685b5" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0e5e9508-f65d-42ae-8772-df3f72706a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3a4c7b4c-f233-4756-a0a5-d95c88d3eedf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d0244b63-157d-44af-9834-4f6ef93ac28b" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3a4c7b4c-f233-4756-a0a5-d95c88d3eedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a9f03b4e-8a39-4998-86e5-4ac8d6418305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3a4c7b4c-f233-4756-a0a5-d95c88d3eedf" xlink:to="loc_us-gaap_EarningsPerShareBasic_a9f03b4e-8a39-4998-86e5-4ac8d6418305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0719cc86-a661-45e2-9e1f-4fd2bcbf3fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3a4c7b4c-f233-4756-a0a5-d95c88d3eedf" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0719cc86-a661-45e2-9e1f-4fd2bcbf3fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210930.xsd#NETINCOMEPERSHAREAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f710533c-649a-4be8-9c87-31dc70850d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_11517988-fc42-41d2-8ad0-b2f8b4f69358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f710533c-649a-4be8-9c87-31dc70850d72" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_11517988-fc42-41d2-8ad0-b2f8b4f69358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>isrg-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:isrg="http://www.intuitivesurgical.com/20210930"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="isrg-20210930.xsd" xlink:type="simple"/>
    <context id="i24def724605546e8b248a658364e4bd2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib71d87d145ef41b297a97754a430484b_I20211014">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <instant>2021-10-14</instant>
        </period>
    </context>
    <context id="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75cbfe3d586a465494dffae57715ee91_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1b5caccf7f8842848177872d08d31bd3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i00ffc107447849539c91c165ecee4fa0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie2533132d0f44dacbeb417a8b14afee9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i80bf05acda8e4d86bc05c11853836a6d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i332e55c2a8f94b45933b5aef35f08ce1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib0a77442ddf0494f9388b80f7fee300e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8872118a076840b18b642c05bc7c8fdd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7a2ef2720e5d48859c0e54b81ae7ab52_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic452fc69ad0b4328b92b435105261628_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id79ce19a534e4d139e67bf0750158934_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iac4be23e732e4f789fec20c9fc25381a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4319e4b98dd145c2a90852e2abd3b90d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie068099537924951abe627974208afa6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie7cff1e3b70b4d59942f780200c132ae_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iea68361551fa4459a3df45292aa07f09_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id420ed12c599434ea400964616900e95_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9fb374215fd24fceb8e6353f18d88ae5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibfc8dbc3d6fb4425a9ff2241572e2cf1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i051ac4e837b3485fb8a292b1fcaf07ec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06308a83da3a4180bee5bf62322c5e37_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06c58807713747e68d9de8c22f9c0180_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie4894873227d4ea89ae1cd010bac1f63_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1d720541eae04f0fb8a83fef4019ced8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i11db865dc86840629acd13c8a709c2d3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i50b6e061ae8c4457ae5cc241cd439143_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84eb653b91034599a7ec24d50e0fad92_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib87bb311713b42d2a296729d6a21259a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iae28aecb5f7a4c7bacd3c8ecb4f9026a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">isrg:IntangibleAndOtherAssetsNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibe9058395d09478a81e0df11992f7575_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i12b57348d47e45dbbc469e0cd82180c2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i46504ffcecdd46ce81248e08922c68cb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">isrg:IntangibleAndOtherAssetsNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i319aeb288bcf4439b7aa385bd35027af_D20210901-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i77c4e5ac2bfa409fbf298841deccc21d_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i12b53adfc2da450d83928c0d59c0cf9b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic8b8d9c0c6b447738c87b3b7e16f0a5e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i229a1c443d19443798c91258bb8d018d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5e2c2a67bae840698c4ce5e39a92dddc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic1d4b29a68414fe6b3b2e75caa359a5d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">isrg:CollarContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id0fa4f45ec164a5ebc9a515e1b8f57b3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i24d4644b1a994c0f8abaeee9b5dcdb06_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i63493d444f724a8296203ce9004defce_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i194cea79cb2847038852265b56fab10c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ied0febbfd3184ec78820350f31b1a206_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i673322c7553b44c88a98e44d90b50183_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i50d502c033d34a2bb8803baed7932450_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if6b35b549a824fe8a766f46dd9432198_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i56683a8f54f2401e93b699a3ebeca829_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i23484c1a1c1f47c7a08373f58c84bc7a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2143a91feda349708ea3355e40ad18d5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3f223d39fb294552a8bcfb3bc81d4ebd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iecb4ff6e5fe5459f9bc00395116a38fb_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icf31bd19117d49ad9339442660f985f1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ife0812e0ddbd443b89d9604955851763_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia2604357eba845b084dd3bf73b2757e5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i41d6f85820774298aee1036152f3f737_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i25dca51a46e14c27ba59a12aad400497_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id89c6d81b52d4816b2252aef11227497_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9c75d5f4a15f44ca9ac400c2f1889d82_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i406fb20eeca84b7d92fe357463e85f6c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iad16e7fe313c4489a4b36c3fbd634251_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3925b0e265e6407ba522b052f71f3c41_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7caf933d32a44a348550d2fe3f894b90_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3f847939b19c491f9f7d865b8bed8ca5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4aecb14552b54937b40537850614044e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i88e4709c5bac4f04a4f648b34d11dcfc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7dda0f930e68405ab3bc179a126443d9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4f77153a86ef4445b2643323afa75e0d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6decb5bae0bb4ac8a4dd1cb95e052fb1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5e03e6e08b894f258a0ae7e5baf29d4d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i577d8ffa87da4e9f87387883bec6f02b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i77bac0e4769042e483f91c8ebb08ee8e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ice87d9c6353945688b8d23575204c383_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9db5f294e20446a485b225b9c62bd623_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia4dcb119f285471db2ed01f635d0158b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5e116d872911487b964787a5ad7b829e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2b8fa49940cf4659848e727c825f73c9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5bbf79c7461d494abe77f32ab6fa2494_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibbabbfafefa044f6b3ce8e02746f0a49_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i412f99609e454649a82b61eed8aa58ac_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i996abb0f87034c4f91f7b2f0ad4eda06_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i672905085bc3459a9d00cbc325e97bb4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4f0a990e6c394d8c8008639d37935b0a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1b1f121a531948669a508b4480804ca0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0ae8d93de5f54b1ab269fde30dd6b190_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idab02e2b14ea4d82817b4d902d15adc7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i620c79857bce477992bc9f8b37092c6c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if10e966d0d6b4c70a5fb900ee48bfb44_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1901af46aeed45319e6c22a2482f0527_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2075d28d68b94983bd02ac4a20ff18d2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i977db1115aba4294ab954fafbee1ba05_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ica0e2ab5444c405588f03410c79beb75_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i37656fec38db4901b77f277074155cce_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1022821765b944a7a6645ef3d885d0d8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i89a0602b4836416f90adbc080a012a8e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie286ee6f7f574339b7040c18df117a53_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i40ae7c3cefde401583c8e526051dd07b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifb5a865f78164fc18aef9ad29f31e8ff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id4d7cc4e81e94501bcf79b671e5df53c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i49470d81e3c048edbcda45a279c28a74_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i77ba4e1aaa0a40daa59040ab5003d99d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib82660af9cff4336adca1f99b02c09c4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ief72904a51c44045bc02018f15b8f0ed_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">isrg:HighMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1b5e071604dd4ac48f9826527375a58a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">isrg:ModerateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icfeb8a45a0084daf9e15f7fde113be1c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">isrg:LowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibccf075334db4130accdd0e847125918_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0040668084154bd5bbaa4b3954aa2f3b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id153e77c855a4d55ae7589981388d8e2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6019979522c14652baffb83a0302dc78_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iad348be44e784609b63102d7bd423e75_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3a10116d504946cbab544899d14169f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib1d61c223bb747ee95152c8eee22b13c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ice3d62c192824cc4b074c71a8ae80571_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i66e41b3c2e834c119d0176db2e8af060_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i17c6dd038d1e4e839081d843139db4ba_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i18955016352d4c2f9c1114363b8cf2d5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i91f3018ef47c4b5fa0e52396465d7744_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iecbbf0bac773402585e5625778664eaf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9d4217ee5ed9439ca27f0168c8e3920a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9a616a50f9f54a62a3dff6cc537b74d5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2f10f7a841b9428193c67c65a7651180_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3b4dddac366f478ba48b52ac99d622cd_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0939772d62d942b796188dfdf7fcc61e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8f38a035988a4b04bc207db50d81f2e6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7722e2881b60414b88d5e47e4ff0c212_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i12b4985e5aab46088463bd2ea8c718c3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i494c07d22f024c88948a992d708aea7e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4acd3901acf4471db1cf795db1c4a248_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib32048ff4ad6455287e4c2b2f78d13a1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia693b8c7b00c4855b184870531142247_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i278f38b19568472ebae990bee1c0db33_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9a1f00bb40df4d9597f66832f85ab8ef_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id7ef2803613641c69436d6aa1c5b43d6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i16ae1d800ab0420085daf458dee535a2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6975f86655b24c28bb3402aa5c5ca96b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i29efc4bde4c9438ab296aa4811b7ca13_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib780080ab3a8424fbe082969241fa1f5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i49309f63539141078a0b3ba243955ca1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifbbd8d73ef944adc832fbdfb193e657e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iacea1d90eb614cbba03fd2b9f5332772_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i91590958a4e84c3fba1738213a5cff5e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i08eb4b64387b42b3aac663f9c29cced9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie46138cc218c44bdab5454b674d97eb7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i53f8ced32a444ff4b52e4928b94175dd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i879d429e085f447493c82a85ba62c318_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i818cc058723f4fab9e6730e25fd2ff75_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if4abb28eb95f4310a27bcff42b173ed8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i73ec9b1829e641dda129e28b2a310e58_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i22d1823a37a8412087b1432940f4c878_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i42eb9966ff944cf086ee492f9ee5720c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i298e438389654f6da638e3e8d14778e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1ecdb391c0e74585907d8294c4b4d69e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iac9eea68e98844389ba6177116b318aa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if74d89ff156145239e2267161cac4cd1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f0850dbce3d4403ad215d9950255074_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icfef3e14f8544cecabe32b0486e9b751_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3f2fc119452d4229a0c5865465b20e5c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3578980607fc4e1dbb9e534383697716_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i20ecaa1bd9224b37ba51ddb3346bde9b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ida4fee943cff4029b9a8507c4a72da04_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i23d7cb9591264bbe8dc96ff49f2da4c2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6da3e57aeb6d40558803471b05c62423_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifebe86d96c974e9995f2ab3c8bee539a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia41fc6f9fdbc465a9ff6c912c6a47cc8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if153039c790149ae84e26285a922687c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iabc57ded48384f2291a996748a5d75e9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6bb77f1efb29470393902b43dc1a6d3b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8b9791a8b20a4038bdc81c09768ee380_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie1f58decd61f48438b11935b7b7b714b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieb71bb2eb1d2412590a4afbcb608ddd3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibc1061d70ad5423599fbd327cc33d223_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8c546426be6a4e028b9617594f0b1719_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3a2243e61faf45dab6768e7f1d20f6ca_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7a19e6703be642579f343e142e25ceb2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idd3fcfe8635544479553199fd6d5870b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibbc28f1ab9984d34933140b676cdeda5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibb62ec09022f420caf06b91fbe4483c6_I20190131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-31</instant>
        </period>
    </context>
    <context id="i45ed2df55a904b73a9495b2d3967029c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4dc58ace2562461ab1b5006b2f252b53_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i553f65ed4f294d7bbb0fb4e0b36c4669_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id90bdf528ea1473fb22ba73a9cf8fec7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2ec0403c801644f7b94ced14e5abe91e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">isrg:A2010IncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3ba50cc2545940ee9b0e537bcee9fecb_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">isrg:A2010IncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i90d117c8ce8b4a12a61bca2bc0d175ea_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3a351862876548c3806015af800a7f8b_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i120ec0e7f5d74c85a3c972e2814bae13_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">isrg:A2010IncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i24b8332d62be4e67924e1b675742a795_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">isrg:A2010IncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i027fee4566074a4f9475d1aa2d3fbb42_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if4414a789bd34fbebcd0395bb363b24f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4ac96970f42e4066a4c840390044d4b5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i92cbadc1b4dc43c78d9b42fe98dc9359_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i97592680c7ea4d0c98add45dc8ac42d6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie3dc8c8c90db4f51afb0d492dbb4b82e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i53ae1d88875d4f12a62bc03a44e1b07f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie24d4b4f022c47c9803198a89abebb1c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i553935c5696341248be4dde6c6466dc1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i636e52596b904d9aabe71c6e5c662679_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6fcd59b1068d47cba389bdf071fe2a4a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1f6cbcbf701a42bf9968bf5dc8e400e2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5299dae533374f869f3916eb74f78a0d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i23ec5af0dc794a8b819199e06c9c7e0e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie0e0073a5326490ca14b42218c217b9a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic17eef63e1f745a382c154accc3d123e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iec5a6bdd4379479bbf40a5d7ea2ea843_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ief8e8ca8a5314cf29b3f0cd00926ccf6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic5991df12b084f31a3209fb60aac8919_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6bdc2cf5e4434be7a2c05799c2f073a0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie98c2152fa284185b7a3eec1e86e9308_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ida259e2fffb84c6daef0d3ae72179664_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i17cd59475f274e609d82992c047d3bef_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icf5c832845ad43ffaae3030609897c12_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib1fc23134d92414983b8c9ffd7172fcc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i39d2400983df44e786e5f043ff29f072_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i86ee9cb414864a739611fb6aa952b4b5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i19f02cddebeb45688a3df400d1f96f9f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i26618f20dcf34488b46dc5d1ad566328_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3ee2fa93adb64b729a028c991c27406a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i69e0aa09b22945fe8e76dfb3e9ac826e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic8e60490c05d45a5903e47f96d9854af_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i86f7d62644344bb5b63935be28a53d36_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80L2ZyYWc6Mjk5OTE3ZjA2ZWFjNGQ0Mjg3MzgyMTM4ODBkY2JlNmYvdGFibGU6YmVhNzY0OWMxZTgzNGI4NzliNTZkMmYwNDcwNTdjNDIvdGFibGVyYW5nZTpiZWE3NjQ5YzFlODM0Yjg3OWI1NmQyZjA0NzA1N2M0Ml8zLTEtMS0xLTA_793a97fe-e490-44f6-a649-f243def71a70">0001035267</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80L2ZyYWc6Mjk5OTE3ZjA2ZWFjNGQ0Mjg3MzgyMTM4ODBkY2JlNmYvdGFibGU6YmVhNzY0OWMxZTgzNGI4NzliNTZkMmYwNDcwNTdjNDIvdGFibGVyYW5nZTpiZWE3NjQ5YzFlODM0Yjg3OWI1NmQyZjA0NzA1N2M0Ml81LTEtMS0xLTA_a78f62da-3267-4055-b7b5-494634eb1395">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80L2ZyYWc6Mjk5OTE3ZjA2ZWFjNGQ0Mjg3MzgyMTM4ODBkY2JlNmYvdGFibGU6YmVhNzY0OWMxZTgzNGI4NzliNTZkMmYwNDcwNTdjNDIvdGFibGVyYW5nZTpiZWE3NjQ5YzFlODM0Yjg3OWI1NmQyZjA0NzA1N2M0Ml82LTEtMS0xLTA_c77ea574-3dcc-4841-af29-800a5f792b12">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80L2ZyYWc6Mjk5OTE3ZjA2ZWFjNGQ0Mjg3MzgyMTM4ODBkY2JlNmYvdGFibGU6YmVhNzY0OWMxZTgzNGI4NzliNTZkMmYwNDcwNTdjNDIvdGFibGVyYW5nZTpiZWE3NjQ5YzFlODM0Yjg3OWI1NmQyZjA0NzA1N2M0Ml83LTEtMS0xLTA_09f9d006-eb28-4317-a37a-b771eeda6951">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80L2ZyYWc6Mjk5OTE3ZjA2ZWFjNGQ0Mjg3MzgyMTM4ODBkY2JlNmYvdGV4dHJlZ2lvbjoyOTk5MTdmMDZlYWM0ZDQyODczODIxMzg4MGRjYmU2Zl83_6dac07de-439b-4be9-97f4-f82cf7c0f9e7">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV84Ng_378b347a-b40d-4434-b7f4-376fa9c06e9e">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6ZmRlODYyOTIwN2QxNGY0Yzk3OGEwZDI4NmNhYzg3NWUvdGFibGVyYW5nZTpmZGU4NjI5MjA3ZDE0ZjRjOTc4YTBkMjg2Y2FjODc1ZV8wLTAtMS0xLTA_603ed1fb-b331-45d3-b9e5-d3642118f72a">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8xMzQ_20ffcded-1cf0-4a18-9521-8b07c9e15a37">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6MmQ0YmJiNTlhYTcxNDY5ZGE0OTUxMWUyY2Q1MTA5ZmUvdGFibGVyYW5nZToyZDRiYmI1OWFhNzE0NjlkYTQ5NTExZTJjZDUxMDlmZV8wLTAtMS0xLTA_d9fafea6-efe4-47cb-b18c-2064b1f7556b">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8yMjQ_2c41d2c3-23fa-4d7b-b728-e5bde6e54ae9">000-30713</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8yMjk_e4c24e77-21b1-4e3f-a4be-ad98fe9f96c0">Intuitive Surgical, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6NjhjODNmYjhmMWIyNGYyOWE4OGJjMDNhNzdhN2ExMDYvdGFibGVyYW5nZTo2OGM4M2ZiOGYxYjI0ZjI5YTg4YmMwM2E3N2E3YTEwNl8wLTAtMS0xLTA_c2e86b3b-0dc1-40db-9c67-b4566eb378db">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6NjhjODNmYjhmMWIyNGYyOWE4OGJjMDNhNzdhN2ExMDYvdGFibGVyYW5nZTo2OGM4M2ZiOGYxYjI0ZjI5YTg4YmMwM2E3N2E3YTEwNl8wLTItMS0xLTA_e00ad5a7-57b9-450d-b6c0-cb0aeeb8300f">77-0416458</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8yOTE_e947cfc3-c49c-4db3-8192-6023f06b42e5">1020 Kifer Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8yOTU_a36e97f1-a137-45b8-8005-eaefc52a9742">Sunnyvale</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8yOTk_ac8ed101-82d8-429a-85b7-ca0c5d61e02e">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8zMDI_b4522d1b-0eb3-4869-b9fd-6fb4d65e38bc">94086</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8zNTk_b6fe1a67-b75d-4755-b809-20e545cf9da9">408</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8zNjM_7411c8e2-6552-4cb9-a3ae-2d287134bb5e">523-2100</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6NDdkZmJkODM2NzE1NGJlNzkyNDRmZDgzYThlNDBhZDUvdGFibGVyYW5nZTo0N2RmYmQ4MzY3MTU0YmU3OTI0NGZkODNhOGU0MGFkNV8xLTAtMS0xLTA_36437900-48cb-40d6-84a0-5f13320519c9">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6NDdkZmJkODM2NzE1NGJlNzkyNDRmZDgzYThlNDBhZDUvdGFibGVyYW5nZTo0N2RmYmQ4MzY3MTU0YmU3OTI0NGZkODNhOGU0MGFkNV8xLTEtMS0xLTA_b53e11af-bf40-4ad0-bca7-01234dd9909f">ISRG</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6NDdkZmJkODM2NzE1NGJlNzkyNDRmZDgzYThlNDBhZDUvdGFibGVyYW5nZTo0N2RmYmQ4MzY3MTU0YmU3OTI0NGZkODNhOGU0MGFkNV8xLTItMS0xLTA_e8c25494-7ebe-49e3-b3bd-a95830261b5a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV84MzI_659b936f-d6fb-47ab-8030-4c1c9f4d177e">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8xMTU5_7fe10420-b090-4bda-94ac-5e7e5cdc51db">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6NWNlNWE5MTU1NGU3NDA1ZDkwYWFhZDU5NmMxN2IxZTQvdGFibGVyYW5nZTo1Y2U1YTkxNTU0ZTc0MDVkOTBhYWFkNTk2YzE3YjFlNF8wLTAtMS0xLTA_1a8e9f5a-9196-444c-9356-03e645f8c157">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6NWNlNWE5MTU1NGU3NDA1ZDkwYWFhZDU5NmMxN2IxZTQvdGFibGVyYW5nZTo1Y2U1YTkxNTU0ZTc0MDVkOTBhYWFkNTk2YzE3YjFlNF8xLTQtMS0xLTA_b9c55b1b-e85f-4498-adf2-1a7093b5ae22">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGFibGU6NWNlNWE5MTU1NGU3NDA1ZDkwYWFhZDU5NmMxN2IxZTQvdGFibGVyYW5nZTo1Y2U1YTkxNTU0ZTc0MDVkOTBhYWFkNTk2YzE3YjFlNF8yLTQtMS0xLTA_60e8a116-47c3-455a-817e-d2e73b3783be">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8xOTA4_a5f27da3-ca14-4d40-ba1b-6a1034eb1f37">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ib71d87d145ef41b297a97754a430484b_I20211014"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xL2ZyYWc6Mjk1NzAyMmE0NjgyNDllNWI0ZDEwMmFlMjkwNzhlMWEvdGV4dHJlZ2lvbjoyOTU3MDIyYTQ2ODI0OWU1YjRkMTAyYWUyOTA3OGUxYV8xOTM5_35c502c7-d936-46c7-a385-a45f315fdeaa"
      unitRef="shares">357236861</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMy0xLTEtMS0w_18675f62-0d03-4aeb-8f27-a8ea3412acc0"
      unitRef="usd">1346700000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMy0zLTEtMS0w_efa6af0d-1373-4650-b7d1-de23ef4707be"
      unitRef="usd">1622600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfNC0xLTEtMS0w_911d36d4-eca7-4467-b2e5-21c060c50e85"
      unitRef="usd">2741500000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfNC0zLTEtMS0w_51566405-7af2-4779-a9fd-25d56242fcbd"
      unitRef="usd">3488800000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfNS0xLTEtMS0w_02c3636b-cdad-46ff-a6d8-f931b2241bb9"
      unitRef="usd">695000000.0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfNS0zLTEtMS0w_b15db41b-b350-43fd-a085-29ca6a732325"
      unitRef="usd">645500000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfNi0xLTEtMS0w_fb4f1102-bc38-48d4-b11b-3d741230bd07"
      unitRef="usd">584900000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfNi0zLTEtMS0w_f2b8b5ee-15a3-4567-bcee-52a941db8078"
      unitRef="usd">601500000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfNy0xLTEtMS0w_cda19872-c9e0-41a6-a8ff-37ccb0288e22"
      unitRef="usd">359900000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfNy0zLTEtMS0w_4aaa04ac-f2fa-4220-98fb-f12721841993"
      unitRef="usd">267500000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfOC0xLTEtMS0w_fc5b2358-a42a-4c9b-8700-f4cbb203b693"
      unitRef="usd">5728000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfOC0zLTEtMS0w_9c06b66f-919b-46ea-83d4-75041c0d0539"
      unitRef="usd">6625900000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfOS0xLTEtMS0w_44bf1033-db2e-4169-a684-9b9050516a91"
      unitRef="usd">1737900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfOS0zLTEtMS0w_52dcace6-631f-4270-9e04-7de7e2c3ba64"
      unitRef="usd">1577300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTAtMS0xLTEtMA_5675d0e2-adae-4e5e-83b4-96fb6c253c2b"
      unitRef="usd">4131500000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTAtMy0xLTEtMA_a070da05-3fb9-4af8-96c8-ed556b0bc496"
      unitRef="usd">1757700000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTEtMS0xLTEtMA_45f34a76-cc88-42cc-98e6-0794fcaae673"
      unitRef="usd">411500000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTEtMy0xLTEtMA_0bb496ce-c98a-40a6-8ac9-e0e01eab3970"
      unitRef="usd">367700000</us-gaap:DeferredIncomeTaxAssetsNet>
    <isrg:IntangibleAndOtherAssets
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTItMS0xLTEtMA_9d89056d-fc4b-4874-806a-d8977aa8ec68"
      unitRef="usd">581400000</isrg:IntangibleAndOtherAssets>
    <isrg:IntangibleAndOtherAssets
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTItMy0xLTEtMA_59a7c9d1-26b3-4dff-8490-ec1007cb4ee7"
      unitRef="usd">503600000</isrg:IntangibleAndOtherAssets>
    <us-gaap:Goodwill
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTMtMS0xLTEtMA_10bff0a0-7d7a-4ef1-b019-5c0b9cb1f6e8"
      unitRef="usd">344300000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTMtMy0xLTEtMA_60d6d808-c9d0-452e-879a-6896a912416a"
      unitRef="usd">336700000</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTQtMS0xLTEtMA_9e7fafa8-5912-4f89-adea-7956e6959393"
      unitRef="usd">12934600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTQtMy0xLTEtMA_3b2d60f8-c738-4367-93a9-e1e1618ff2ef"
      unitRef="usd">11168900000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTctMS0xLTEtMA_b7b5aeba-852c-45a4-9540-11d4ba5e915f"
      unitRef="usd">120000000.0</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTctMy0xLTEtMA_c2c87cb6-f57c-474e-917f-a5431e4ab0f0"
      unitRef="usd">81600000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTgtMS0xLTEtMA_94f992ec-0101-4da3-bc77-cc296fc4d898"
      unitRef="usd">265300000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTgtMy0xLTEtMA_87bbf4da-d3ff-4986-b8ff-ebc9a75ae197"
      unitRef="usd">235000000.0</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTktMS0xLTEtMA_71224ac7-15bb-42e8-b46f-53f33b007c06"
      unitRef="usd">348500000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMTktMy0xLTEtMA_affec25f-4ee7-40ca-b942-ce5225213da1"
      unitRef="usd">350300000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjAtMS0xLTEtMA_ce41b3cc-60ec-475f-9cb2-739f96894c66"
      unitRef="usd">293500000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjAtMy0xLTEtMA_4b3fcb98-b30d-4cfa-977c-fd8b0dac064a"
      unitRef="usd">298300000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjEtMS0xLTEtMA_edf31c11-90e4-4f91-a219-45db281ae21a"
      unitRef="usd">1027300000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjEtMy0xLTEtMA_552a93c7-02ca-4169-876f-d4ae4d72a962"
      unitRef="usd">965200000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjItMS0xLTEtMA_8d9be2df-8d61-42ba-9360-83a81c8cd491"
      unitRef="usd">447800000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjItMy0xLTEtMA_a42fa21e-5b49-4a01-82b5-34d587c614b9"
      unitRef="usd">444600000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:Liabilities
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjMtMS0xLTEtMA_380c9df2-7f75-4ae8-b699-ae50f8ed9bf6"
      unitRef="usd">1475100000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjMtMy0xLTEtMA_242f8483-3073-4652-a1bc-a4c8c2e1b6c0"
      unitRef="usd">1409800000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjQtMS0xLTEtMA_d56e6f33-1741-4444-ba75-5e4928d6afc9"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjQtMy0xLTEtMA_b037e46f-15bc-48bd-9626-3bdd17819e9a"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjdmYzNiN2Y3MzIxZDQ4NTViYmZiMzI1MThhZDYwMmEyXzIx_5240120e-5fc2-4f2a-886c-d9cb5bb65dd1"
      unitRef="shares">2500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjdmYzNiN2Y3MzIxZDQ4NTViYmZiMzI1MThhZDYwMmEyXzIx_68076e44-37fc-425a-9ac7-0164da65057d"
      unitRef="shares">2500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjdmYzNiN2Y3MzIxZDQ4NTViYmZiMzI1MThhZDYwMmEyXzQz_01639275-038a-436a-a079-6f905b0e0bb2"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjdmYzNiN2Y3MzIxZDQ4NTViYmZiMzI1MThhZDYwMmEyXzQz_60e6c82f-f51b-4ada-8084-497379c1475a"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjdmYzNiN2Y3MzIxZDQ4NTViYmZiMzI1MThhZDYwMmEyXzc3_43f0813e-b8b2-41dd-8b78-e589d9ab2e73"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjdmYzNiN2Y3MzIxZDQ4NTViYmZiMzI1MThhZDYwMmEyXzc3_804443f9-92a5-40b4-a9c1-ef6013fe510f"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjdmYzNiN2Y3MzIxZDQ4NTViYmZiMzI1MThhZDYwMmEyXzc3_aeb9fd7a-bd87-4945-b55c-759c0b90f484"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjdmYzNiN2Y3MzIxZDQ4NTViYmZiMzI1MThhZDYwMmEyXzc3_ce656903-5e57-4198-aab2-76f46a634c9b"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMS0xLTEtMA_ecc3e677-f53c-47b3-9365-84c2b03ba39d"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjYtMy0xLTEtMA_18006b3e-875a-42ba-a76f-34803cfa9b9c"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmNlYWFkOTdmY2JkMzRkOTA5NWE1MTRhMTkwM2RhYTgxXzE5_07dc35f4-4246-4c8a-b58e-3dbd48554b1b"
      unitRef="shares">600000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmNlYWFkOTdmY2JkMzRkOTA5NWE1MTRhMTkwM2RhYTgxXzE5_3579d956-4a4f-4b8e-b197-9165740fb0c1"
      unitRef="shares">600000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmNlYWFkOTdmY2JkMzRkOTA5NWE1MTRhMTkwM2RhYTgxXzQx_75fd4867-63bd-47d5-88db-869dde66b977"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmNlYWFkOTdmY2JkMzRkOTA5NWE1MTRhMTkwM2RhYTgxXzQx_f275fa7e-fabc-41d8-9786-d03e15f7ee51"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmNlYWFkOTdmY2JkMzRkOTA5NWE1MTRhMTkwM2RhYTgxXzU1_3319278b-1322-4a36-8a8b-da26c6802646"
      unitRef="shares">357200000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmNlYWFkOTdmY2JkMzRkOTA5NWE1MTRhMTkwM2RhYTgxXzU1_d410427d-c3bb-423b-ba0b-a693fd59c5da"
      unitRef="shares">357200000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmNlYWFkOTdmY2JkMzRkOTA5NWE1MTRhMTkwM2RhYTgxXzY5_3e4a542c-fce9-4dee-a06e-01730eb5eeb0"
      unitRef="shares">353100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmNlYWFkOTdmY2JkMzRkOTA5NWE1MTRhMTkwM2RhYTgxXzY5_f7d63ef8-61df-49cb-804b-14826d85b70d"
      unitRef="shares">353100000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMS0xLTEtMA_5fbebe53-b131-47c2-8174-ab9c6011d81c"
      unitRef="usd">400000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjctMy0xLTEtMA_9cedd792-bcb3-4840-8268-7e4c641fc564"
      unitRef="usd">400000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjgtMS0xLTEtMA_af95f205-a694-4666-8f5c-37de0ab5e80c"
      unitRef="usd">7015100000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjgtMy0xLTEtMA_9c809cce-6a53-47aa-b0f8-e2435f25efa2"
      unitRef="usd">6444900000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjktMS0xLTEtMA_a80a6356-f238-4124-bcb1-59e51c34cc93"
      unitRef="usd">4390100000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMjktMy0xLTEtMA_4c45c385-ca48-493c-828c-5a602e901662"
      unitRef="usd">3261300000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzAtMS0xLTEtMA_23c033b1-577f-4067-a2c2-33e770baccb2"
      unitRef="usd">5300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzAtMy0xLTEtMA_5ce0049c-a0ff-4ba8-bcea-9df162348c26"
      unitRef="usd">24900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzEtMS0xLTEtMA_3bc75915-f124-49a0-9eb7-0cbc0b92226a"
      unitRef="usd">11410900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzEtMy0xLTEtMA_d0d5aecd-7fba-407b-9b6c-5b80661cdb55"
      unitRef="usd">9731500000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzItMS0xLTEtMA_14eba46f-578e-4a1b-a026-205e6b069a4f"
      unitRef="usd">48600000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzItMy0xLTEtMA_742a1e66-ee44-4851-8480-3179a7793c6c"
      unitRef="usd">27600000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzMtMS0xLTEtMA_d0c1d052-df27-43ce-bd2e-bff201b4733b"
      unitRef="usd">11459500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzMtMy0xLTEtMA_0e38b685-8451-48ac-bcaf-61c55a353660"
      unitRef="usd">9759100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzQtMS0xLTEtMA_52603799-4263-466b-8871-c54287937053"
      unitRef="usd">12934600000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8xNi9mcmFnOmIwOGZmYjMxYWY0MTRhMTJhYWMyMGFlODFjOTg4MjBjL3RhYmxlOjZiZTExNzg0YTQwMTRiOWM4MTFmMzUxNDg0YzE2YjJiL3RhYmxlcmFuZ2U6NmJlMTE3ODRhNDAxNGI5YzgxMWYzNTE0ODRjMTZiMmJfMzQtMy0xLTEtMA_513a9ce0-785e-4e07-a1b4-6315b7aac3fa"
      unitRef="usd">11168900000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75cbfe3d586a465494dffae57715ee91_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMy0xLTEtMS0w_88f81b7f-7867-4ce2-869c-2c61e89ccd58"
      unitRef="usd">1170600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b5caccf7f8842848177872d08d31bd3_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMy0zLTEtMS0w_14a7de36-f2bd-47d1-bc88-0fe6aa8984c8"
      unitRef="usd">898400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00ffc107447849539c91c165ecee4fa0_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMy01LTEtMS0w_ef6c129b-06ff-488d-8c33-b755bfc1ac1d"
      unitRef="usd">3481100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2533132d0f44dacbeb417a8b14afee9_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMy03LTEtMS0w_e7b7ee5f-8ae0-4844-a4a9-8d39b694b9de"
      unitRef="usd">2521000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80bf05acda8e4d86bc05c11853836a6d_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNC0xLTEtMS0w_47839547-af8f-4d93-a79e-41bb433b6b5b"
      unitRef="usd">232700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i332e55c2a8f94b45933b5aef35f08ce1_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNC0zLTEtMS0w_a7f2dcbd-aeca-4f3f-a566-2650ba8d1c1a"
      unitRef="usd">179300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0a77442ddf0494f9388b80f7fee300e_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNC01LTEtMS0w_c3a66345-9ec7-4ed5-8050-cded15242ae7"
      unitRef="usd">678300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8872118a076840b18b642c05bc7c8fdd_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNC03LTEtMS0w_d9bf1a78-f8f0-4414-97b0-dc3b12ec120b"
      unitRef="usd">508300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNS0xLTEtMS0w_59a81bed-eacf-4e40-972f-22182ea4c63f"
      unitRef="usd">1403300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNS0zLTEtMS0w_c3da3afc-411b-4419-b422-e85a1ca33310"
      unitRef="usd">1077700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNS01LTEtMS0w_58c3bf6a-abe2-4b94-9857-56b6704d2b93"
      unitRef="usd">4159400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNS03LTEtMS0w_363f2c2e-80c2-49d7-b263-a2b174bbdeb7"
      unitRef="usd">3029300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i75cbfe3d586a465494dffae57715ee91_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNy0xLTEtMS0w_f98a6099-3329-409b-9ba2-f67944235af4"
      unitRef="usd">355800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i1b5caccf7f8842848177872d08d31bd3_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNy0zLTEtMS0w_80bea0d0-3c3b-4e11-ac71-fd4a7ffbbf1b"
      unitRef="usd">287700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i00ffc107447849539c91c165ecee4fa0_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNy01LTEtMS0w_8840684c-c7e7-4543-9690-fcc8a96c79f0"
      unitRef="usd">1049100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie2533132d0f44dacbeb417a8b14afee9_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfNy03LTEtMS0w_51c2f397-efca-41e7-b7e7-143c8aadd1fd"
      unitRef="usd">868200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i80bf05acda8e4d86bc05c11853836a6d_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfOC0xLTEtMS0w_06be2dbc-d06c-421d-a2c4-6c3061aa39bd"
      unitRef="usd">76100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i332e55c2a8f94b45933b5aef35f08ce1_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfOC0zLTEtMS0w_03b455d1-935c-4c8e-8b97-53f855dc4245"
      unitRef="usd">65700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib0a77442ddf0494f9388b80f7fee300e_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfOC01LTEtMS0w_4fcc6767-8342-467b-80a6-2d32467f0c12"
      unitRef="usd">212600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i8872118a076840b18b642c05bc7c8fdd_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfOC03LTEtMS0w_9647e303-86fd-4d02-951f-4fbfd47b99aa"
      unitRef="usd">195700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfOS0xLTEtMS0w_fd7a5787-e03b-4f29-ba00-bbad8116cb61"
      unitRef="usd">431900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfOS0zLTEtMS0w_b7103f8a-0615-409a-b784-32830d362130"
      unitRef="usd">353400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfOS01LTEtMS0w_1067e3aa-4ce9-46a2-8b88-db98be6d9bb0"
      unitRef="usd">1261700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfOS03LTEtMS0w_c7f1c354-d070-46d7-850b-133aaad7f1f2"
      unitRef="usd">1063900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTAtMS0xLTEtMA_b52dff63-55de-495d-9ef4-04e6dd14e59d"
      unitRef="usd">971400000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTAtMy0xLTEtMA_261fde57-1834-4e35-9440-f4bb1999575b"
      unitRef="usd">724300000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTAtNS0xLTEtMA_4a822dce-9403-47ca-8413-3d209042902c"
      unitRef="usd">2897700000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTAtNy0xLTEtMA_9dda2606-c23b-4547-9078-97700d0c1ecb"
      unitRef="usd">1965400000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTItMS0xLTEtMA_2e39218e-e3f0-411b-aa27-2b0ff9283c5a"
      unitRef="usd">363300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTItMy0xLTEtMA_dcab27ce-918d-4494-bd6c-6bf172fd3d94"
      unitRef="usd">298900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTItNS0xLTEtMA_fb4201c4-e0bb-4cb0-9141-74bd7c328efa"
      unitRef="usd">1039500000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTItNy0xLTEtMA_2502ed00-77e0-42ac-9340-3d2d3fa1d0ba"
      unitRef="usd">886100000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTMtMS0xLTEtMA_9f70c5fc-4586-4fdb-9128-5f13c208ce33"
      unitRef="usd">165500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTMtMy0xLTEtMA_b9b1afa2-4f41-478b-b768-07f65acf76e5"
      unitRef="usd">155000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTMtNS0xLTEtMA_d08d0577-dab7-48e4-b782-6b1c635b9aa9"
      unitRef="usd">487600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTMtNy0xLTEtMA_e5134cea-0463-490a-ba62-de826bdf83f4"
      unitRef="usd">445300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTQtMS0xLTEtMA_e0d0fe32-52da-491c-a60a-d034e101c03d"
      unitRef="usd">528800000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTQtMy0xLTEtMA_f87c937a-112d-4e0e-9ed8-778d21eebac0"
      unitRef="usd">453900000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTQtNS0xLTEtMA_35bcf136-c68c-4ca3-bc85-a6695b0e4c95"
      unitRef="usd">1527100000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTQtNy0xLTEtMA_66445a0e-59ca-4a93-8b90-093173351a61"
      unitRef="usd">1331400000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTUtMS0xLTEtMA_6e0f2211-360c-43c9-ad93-4af7f12e47a5"
      unitRef="usd">442600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTUtMy0xLTEtMA_08df85b7-ab1f-4875-a9f7-3119dbc05d24"
      unitRef="usd">270400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTUtNS0xLTEtMA_fe0df8f0-a1c6-4387-a936-d5da3738ff7e"
      unitRef="usd">1370600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTUtNy0xLTEtMA_2762eb66-042e-43d9-a69b-e28d7f00e64b"
      unitRef="usd">634000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTYtMS0xLTEtMA_56a8b8d4-93af-48dd-a213-a286bf5e6da8"
      unitRef="usd">18500000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTYtMy0xLTEtMA_055373de-9907-4dfb-b3e7-6d324a838f25"
      unitRef="usd">84800000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTYtNS0xLTEtMA_1c30869a-509e-48b9-9faa-925cc35d7b62"
      unitRef="usd">65500000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTYtNy0xLTEtMA_fa66f065-f447-4bf4-b50b-228cb784738d"
      unitRef="usd">136500000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTctMS0xLTEtMA_8f1c3838-980e-4918-aa34-de002cfad828"
      unitRef="usd">461100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTctMy0xLTEtMA_13815d10-bc4f-46f6-bfb5-a739c4fdc02f"
      unitRef="usd">355200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTctNS0xLTEtMA_75535156-fb00-4d67-9228-53ae2d515f9f"
      unitRef="usd">1436100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTctNy0xLTEtMA_ab0a66ba-6bf8-4f52-adec-217a437c67ca"
      unitRef="usd">770500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTgtMS0xLTEtMA_e6d87965-0726-4618-9013-976163b3de4c"
      unitRef="usd">73900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTgtMy0xLTEtMA_e632731e-ea5d-40d6-86e4-ff0a42bb2c96"
      unitRef="usd">38400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTgtNS0xLTEtMA_b7f07f9f-35ff-456a-a9f5-3d7793ac96eb"
      unitRef="usd">90700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTgtNy0xLTEtMA_3dd14e4c-018b-4251-8414-cdaf066bf218"
      unitRef="usd">67300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTktMS0xLTEtMA_b239e934-ff20-442e-82d4-b63a4b9def48"
      unitRef="usd">387200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTktMy0xLTEtMA_4a1e275a-5a96-4a33-90ba-a1b4f2a0b0ca"
      unitRef="usd">316800000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTktNS0xLTEtMA_6d695512-cea7-4423-ae74-08f38e4de042"
      unitRef="usd">1345400000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMTktNy0xLTEtMA_160bbf5a-06eb-4a8c-b992-ece5631ac442"
      unitRef="usd">703200000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjAtMS0xLTEtMA_7d323cd1-3011-4d67-9962-59cd89a97a4a"
      unitRef="usd">6700000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjAtMy0xLTEtMA_29d18ca9-d404-4a33-8c91-bab852bf3108"
      unitRef="usd">2900000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7a2ef2720e5d48859c0e54b81ae7ab52_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjAtNS0xLTEtMA_476c481c-b754-474d-ad52-cf9e9e0073c3"
      unitRef="usd">21400000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjAtNy0xLTEtMA_6f6f129c-8ecc-4995-9ffa-2e8e64159d52"
      unitRef="usd">7800000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjEtMS0xLTEtMA_a80b7283-c39f-414c-9312-0d32e65f535a"
      unitRef="usd">380500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjEtMy0xLTEtMA_0671fc68-1627-4cc7-a6ec-fe4eaba4d3df"
      unitRef="usd">313900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjEtNS0xLTEtMA_b980e96f-ab1a-4df5-beee-1c47a0bfd1c8"
      unitRef="usd">1324000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjEtNy0xLTEtMA_7e694472-005c-4e7d-85ca-c09c485f3391"
      unitRef="usd">695400000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjMtMS0xLTEtMA_bc1e847d-b854-4032-bdb9-6689765f93ed"
      unitRef="usdPerShare">1.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjMtMy0xLTEtMA_11f4ef8c-9fdf-4aaf-82fd-5963edb9e010"
      unitRef="usdPerShare">0.89</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjMtNS0xLTEtMA_7d5ebdef-805b-419f-bcaa-c79cb0f7d633"
      unitRef="usdPerShare">3.72</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjMtNy0xLTEtMA_0abd2e6b-6d30-4519-b16d-dcf1ced83954"
      unitRef="usdPerShare">1.98</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjQtMS0xLTEtMA_a6dd19e4-33eb-4c91-bc3f-a218a9253e2f"
      unitRef="usdPerShare">1.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjQtMy0xLTEtMA_2f2604e7-8135-4cb4-ba7a-9c064d793612"
      unitRef="usdPerShare">0.87</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjQtNS0xLTEtMA_d13063a4-4ca5-4309-afff-aecc537fcbbc"
      unitRef="usdPerShare">3.63</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjQtNy0xLTEtMA_2e879cc0-c01b-4505-9653-a9778d7d35df"
      unitRef="usdPerShare">1.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjYtMS0xLTEtMA_71dd695a-2c41-4293-90a1-46493fc8db90"
      unitRef="shares">356800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjYtMy0xLTEtMA_c2bdba54-a599-4308-953f-f380d6ee4176"
      unitRef="shares">352000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjYtNS0xLTEtMA_e7133081-6505-4c54-9403-dc780299dcea"
      unitRef="shares">355600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjYtNy0xLTEtMA_2b54ec47-abd3-4dcc-a928-828859e33d85"
      unitRef="shares">350500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjctMS0xLTEtMA_469336a5-2ff1-4f87-a969-914ed5483610"
      unitRef="shares">366800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjctMy0xLTEtMA_d86b9978-d89c-48d5-9215-5644c9d81f01"
      unitRef="shares">361900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjctNS0xLTEtMA_b0de7944-eca7-4b50-b9f9-64eed6e8ba6d"
      unitRef="shares">365100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjctNy0xLTEtMA_7f60607b-ca28-4a63-9d43-5b5b72a50558"
      unitRef="shares">360100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjktMS0xLTEtMA_081bfa30-523d-4311-95d8-ab78b3c78c1e"
      unitRef="usd">382100000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjktMy0xLTEtMA_5d149244-e894-4235-920c-39fc2d9d5fb9"
      unitRef="usd">310800000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjktNS0xLTEtMA_f577f667-efeb-4185-9b72-633b7b3d17bd"
      unitRef="usd">1325400000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMjktNy0xLTEtMA_60c0f899-4328-4fe0-9138-393d52a0cb32"
      unitRef="usd">707200000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMzAtMS0xLTEtMA_0558a2ce-067c-4279-8d26-3d2e78612581"
      unitRef="usd">6600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMzAtMy0xLTEtMA_3c693113-62e7-4414-921b-7ea39a122729"
      unitRef="usd">3000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMzAtNS0xLTEtMA_c59851ac-f493-41b3-9e47-d63b086777f5"
      unitRef="usd">21000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMzAtNy0xLTEtMA_a300af4a-9b2a-4ba3-b3ae-d2361c9c81ba"
      unitRef="usd">8000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMzEtMS0xLTEtMA_4c250470-3133-4d64-9cb6-13b1d3eed4ec"
      unitRef="usd">375500000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMzEtMy0xLTEtMA_30f930a2-13ee-4784-932a-e2c75811e7db"
      unitRef="usd">307800000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMzEtNS0xLTEtMA_617f7754-19f1-4d87-8771-14429f9d0d76"
      unitRef="usd">1304400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yMi9mcmFnOjc4Yzc3OWEzYzljZjRjOWZiZDlmOWE3NDI3ZDg4YWE1L3RhYmxlOmJkNTU4YzBlNzdkMjRmYjdhZDVkOGFjYzRiYjM5YzNkL3RhYmxlcmFuZ2U6YmQ1NThjMGU3N2QyNGZiN2FkNWQ4YWNjNGJiMzljM2RfMzEtNy0xLTEtMA_43dff025-50b2-4749-bde2-a21381fcc95d"
      unitRef="usd">699200000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMy0xLTEtMS0w_bd77c14a-c670-4e38-9599-4d7f2f6c1eb7"
      unitRef="usd">1345400000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMy0zLTEtMS0w_9500c96b-cd56-429b-8f39-7b73b4591e47"
      unitRef="usd">703200000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfNS0xLTEtMS0w_269e9431-d68e-4fb1-a372-036093b15f74"
      unitRef="usd">208500000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfNS0zLTEtMS0w_c2ec334c-66d3-4180-9a3b-7898b5707295"
      unitRef="usd">159100000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfNi0xLTEtMS0w_44ebb482-259e-4db6-ae13-292d799466cb"
      unitRef="usd">20800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfNi0zLTEtMS0w_151c91ce-7a62-4303-880f-d92efe5e2346"
      unitRef="usd">37300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfNy0xLTEtMS0w_f48485ed-4087-4741-90e5-27f6fbd059e5"
      unitRef="usd">2100000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfNy0zLTEtMS0w_7abb1e3f-e962-4a03-bdff-a389d8df2e5b"
      unitRef="usd">64200000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfOC0xLTEtMS0w_72af2386-0950-44fd-8d98-cb1edf747979"
      unitRef="usd">-40600000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfOC0zLTEtMS0w_c7585406-9f01-4fd0-b71c-847eb77003cc"
      unitRef="usd">71900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTAtMS0xLTEtMA_e03363bc-3248-4cc0-bfed-ec2ff8cea1be"
      unitRef="usd">331400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTAtMy0xLTEtMA_74856346-e247-40ca-9f56-020c6dfcd744"
      unitRef="usd">292300000</us-gaap:ShareBasedCompensation>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTEtMS0xLTEtMA_b2aa74ad-8a56-4d87-9312-f83cbeda8dbe"
      unitRef="usd">15500000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTEtMy0xLTEtMA_c803e42e-d4fc-4c3d-8191-8f4228b84727"
      unitRef="usd">12400000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTMtMS0xLTEtMA_5967127a-9e25-46ee-93c7-e3ab121387b3"
      unitRef="usd">54700000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTMtMy0xLTEtMA_81677936-b777-49a8-b700-3138f543195b"
      unitRef="usd">-57200000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTQtMS0xLTEtMA_7a7a2569-9505-44df-8a65-44d6994ca1f3"
      unitRef="usd">189200000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTQtMy0xLTEtMA_20272ac1-2236-4751-9342-e7bdc4ce0683"
      unitRef="usd">177000000.0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTUtMS0xLTEtMA_180b9eb8-4d22-49a2-9c4b-046c23b7dfbf"
      unitRef="usd">216700000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTUtMy0xLTEtMA_de140c70-fce4-4221-b4c2-c3ddd53e7fd1"
      unitRef="usd">118800000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTctMS0xLTEtMA_c52bf87e-1611-4cb0-b8d4-14b189942d44"
      unitRef="usd">35800000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTctMy0xLTEtMA_107121fd-5992-4247-b0ea-cb6ca5ab5efd"
      unitRef="usd">-3900000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTgtMS0xLTEtMA_7af7511a-8f50-4971-92b2-c918908631b8"
      unitRef="usd">30300000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTgtMy0xLTEtMA_86855450-bb9e-4913-87ed-f78152d07b93"
      unitRef="usd">-76400000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTktMS0xLTEtMA_960337be-48af-4fa8-9442-310d7497fdcc"
      unitRef="usd">2300000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMTktMy0xLTEtMA_b14ea5e5-61c0-43c0-beeb-82e54ba2f4f1"
      unitRef="usd">-9200000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjAtMS0xLTEtMA_5c26cbcc-6daa-4854-a1be-a1e856612294"
      unitRef="usd">35000000.0</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjAtMy0xLTEtMA_3517f588-c027-4796-b2f3-f06152c384ec"
      unitRef="usd">-26600000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjEtMS0xLTEtMA_58365b7c-422c-4c5a-b6f2-b3a1764113c2"
      unitRef="usd">1521700000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjEtMy0xLTEtMA_7f17ccd5-754b-4e8d-8efc-acd00ecec27f"
      unitRef="usd">857300000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjMtMS0xLTEtMA_fa3fc3dc-292a-4248-9f70-aa4e41bf1eca"
      unitRef="usd">5213700000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjMtMy0xLTEtMA_bf1df7ec-ef7a-42f9-826c-bacf60e50ff1"
      unitRef="usd">3023200000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjQtMS0xLTEtMA_1af2687d-89d1-454e-8270-8615a845a0f7"
      unitRef="usd">72400000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjQtMy0xLTEtMA_17022749-d87d-4c8d-a41e-ab4ab20b05a8"
      unitRef="usd">800700000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjUtMS0xLTEtMA_49a35061-82fe-45cd-836d-fd69de745ab2"
      unitRef="usd">3532100000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjUtMy0xLTEtMA_60a7aa09-ed46-46f3-aaeb-a77855ec1bc4"
      unitRef="usd">1933500000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjYtMS0xLTEtMA_5f01bd45-6eed-434b-9bca-cf934b3aea0f"
      unitRef="usd">202600000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjYtMy0xLTEtMA_c0cd24b6-9525-4e48-b326-d8d0dd001d3d"
      unitRef="usd">279600000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjctMS0xLTEtMA_d01c65e1-a252-4dbf-8bba-8cc6640431f3"
      unitRef="usd">8700000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjctMy0xLTEtMA_ea5a88e4-53bf-4c83-b78d-3301787a4ca2"
      unitRef="usd">37700000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjktMS0xLTEtMA_b3336ec9-c975-4743-b297-39554aae904e"
      unitRef="usd">-1820500000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMjktMy0xLTEtMA_b98e23ce-c433-474d-8bab-8e6f86f70d61"
      unitRef="usd">-606300000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzEtMS0xLTEtMA_43962c07-49a7-44da-b7ca-ad414a278e55"
      unitRef="usd">244800000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzEtMy0xLTEtMA_8bda10d8-677a-42ca-b147-b399a0028ab8"
      unitRef="usd">267900000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzItMS0xLTEtMA_3cc2e9ed-594c-450e-a5c8-c9f4e62b163c"
      unitRef="usd">201200000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzItMy0xLTEtMA_941a39b3-9c1a-43dd-b268-156b4acdf909"
      unitRef="usd">165300000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzMtMS0xLTEtMA_4c16554f-37d5-49ba-af3d-572d0a08186f"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzMtMy0xLTEtMA_73da5ea6-88fd-46ca-a315-4dddebfbfac7"
      unitRef="usd">100000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzUtMS0xLTEtMA_48fa8169-48e2-4dc4-b67e-3cf4364540d1"
      unitRef="usd">-19200000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzUtMy0xLTEtMA_4f77c052-7709-49f7-a5d5-cd0440bfcebc"
      unitRef="usd">-48500000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzYtMS0xLTEtMA_bec3d0e3-f92b-4ea7-abeb-e7fbd4f24aa3"
      unitRef="usd">24400000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzYtMy0xLTEtMA_335c5f47-3328-4b6c-94aa-5c0242380250"
      unitRef="usd">-45900000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzctMS0xLTEtMA_df35772f-4b6c-45e3-b394-f2c3d0538a4d"
      unitRef="usd">-2300000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzctMy0xLTEtMA_d10f0896-f946-4d94-8c1c-704b514a36a6"
      unitRef="usd">-2000000.0</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzgtMS0xLTEtMA_5875cdc3-2839-4d2e-ba96-12f011f347cc"
      unitRef="usd">-276700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzgtMy0xLTEtMA_a643c5c2-b922-4518-b80a-0aab69187bf9"
      unitRef="usd">203100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzktMS0xLTEtMA_5a94da3c-b973-4f8a-9f98-b1eb70e8bbb2"
      unitRef="usd">1638500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic452fc69ad0b4328b92b435105261628_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfMzktMy0xLTEtMA_ccbe089d-77c2-4e0f-b2a0-e6334558bb97"
      unitRef="usd">1182600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfNDAtMS0xLTEtMA_838fc387-6091-4459-988d-0dcc70120385"
      unitRef="usd">1361800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id79ce19a534e4d139e67bf0750158934_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8yNS9mcmFnOjhjZTcwNmUxOWIyNjQ2Zjk4NTI1Mjk4ODQ1MTZhMGZlL3RhYmxlOjJmMjc5MzdlOWZlZjRjN2Q4MmNlZjA5ZDM3ZmQ0MjA3L3RhYmxlcmFuZ2U6MmYyNzkzN2U5ZmVmNGM3ZDgyY2VmMDlkMzdmZDQyMDdfNDAtMy0xLTEtMA_4dcbfb02-052b-4516-99a2-0a2ec614ddc5"
      unitRef="usd">1385700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NatureOfOperations
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zMS9mcmFnOjU5Y2I1ZGUxMDZkZjQ0YWQ5Y2EzNjM0MGRkZWE2ZDU2L3RleHRyZWdpb246NTljYjVkZTEwNmRmNDRhZDljYTM2MzQwZGRlYTZkNTZfNjY5_9213e1c0-5616-4f03-aef0-1be8bcf83a23">DESCRIPTION OF THE BUSINESS&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intuitive Surgical, Inc. (&#x201c;Intuitive&#x201d; or the &#x201c;Company&#x201d;) develops, manufactures, and markets the da Vinci&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Surgical System and the Ion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; endoluminal system.&#160;The Company&#x2019;s products and related services enable physicians and healthcare providers to improve the quality of and access to minimally invasive care. The da Vinci Surgical System consists of a surgeon console or consoles, a patient-side cart, a high-performance vision system, and proprietary instruments and accessories. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform that utilizes instruments and accessories for lung biopsies.&lt;/span&gt;</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNC9mcmFnOjNjMjVhMTkyMWE0MzRmYjdiODMyZjk2Yzg5NjNlNTM4L3RleHRyZWdpb246M2MyNWExOTIxYTQzNGZiN2I4MzJmOTZjODk2M2U1MzhfNDc3Mw_0adc9eae-6497-44ee-9638-cbbb305ce428">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements (&#x201c;Financial Statements&#x201d;) of Intuitive Surgical, Inc. and its wholly and majority-owned subsidiaries have been prepared on a consistent basis with the audited Consolidated Financial Statements for the fiscal year ended December&#160;31, 2020, and include all adjustments, consisting of only normal, recurring adjustments, necessary to fairly state the information set forth herein. The Financial Statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and, therefore, omit certain information and footnote disclosure necessary to present the Financial Statements in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). These Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, which was filed with the SEC on February&#160;10, 2021. The results of operations for the first nine months of fiscal year 2021 are not necessarily indicative of the results to be expected for the entire fiscal year or any future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Financial Statements include the results and the balances of the Company&#x2019;s majority-owned joint venture (referred to herein as the &#x201c;Joint Venture&#x201d;) with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (&#x201c;Fosun Pharma&#x201d;). The Company holds a controlling financial interest in the Joint Venture, and the noncontrolling interest is reflected as a separate component of consolidated stockholders&#x2019; equity. The noncontrolling interest&#x2019;s share of the earnings in the Joint Venture is presented separately in the condensed consolidated statements of comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock Split&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares issued pursuant to the three-for-one stock split (the "Stock Split") of the Company's issued and outstanding common stock, par value $0.001 per share, were distributed on October 4, 2021, to stockholders of record as of September 27, 2021. All share and per-share information presented in the Financial Statements have been retroactively adjusted to reflect the Stock Split.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to additional risks and uncertainties due to the COVID-19 pandemic. The extent of the impact on the Company&#x2019;s business is highly uncertain and difficult to predict. In certain regions, the Company&#x2019;s customers continue to divert resources to treat COVID-19 patients and defer some elective surgical procedures, both of which may impact the Company&#x2019;s customers&#x2019; ability to meet their obligations, including to the Company. Furthermore, economies worldwide have been negatively impacted by the COVID-19 pandemic, and it is possible that the impact could cause an extended local and/or global economic recession. Such economic disruption could have a material adverse effect on our business as hospitals curtail and reduce capital and overall spending. Policymakers around the globe have responded with fiscal policy actions to support the healthcare industry and their economies. However, the magnitude and overall effectiveness of these actions remains uncertain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The severity of the impact of the COVID-19 pandemic on the Company&#x2019;s business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on the Company&#x2019;s customers, all of which are uncertain and cannot be predicted. The Company&#x2019;s future results of operations and liquidity could be materially adversely affected by delays in payments of outstanding receivables, supply chain disruptions, including shortages and inflationary pressure, uncertain or reduced demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operational challenges faced by its customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In particular, we have experienced increased difficulties in obtaining a sufficient amount of component materials used in our products, including those in the semiconductor market, as global supply has become significantly constrained due to increased demand in semiconductors and other materials. Additionally, prices of such materials have increased due to the increased demand and supply shortage. The Company is engaged in activities to seek to mitigate supply disruptions by, for example, increasing our communications with our suppliers and modifying our purchase order coverage and inventory levels. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;However, the global semiconductor supply shortage is likely to remain a challenge for the foreseeable future. We have also experienced challenges in logistics, as certain shipping routes have been impacted by port closures. Such global shortages in important components and logistics challenges have resulted in, and will continue to cause, inflationary cost pressure in our supply chain. To date, these challenges have not materially impacted our ability to deliver product and services to our customers. However, if shortages in important supply chain materials in the semiconductor or other markets continue, we could fail to meet product demand, which would adversely impact our business, financial condition, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Increased labor shortages globally, including staff burnout and attrition, could also impact our ability to hire and retain personnel critical to our manufacturing, logistics, and commercial operations. We are also highly dependent on the principal members of our management and scientific staff. Attracting and retaining qualified personnel is critical to our success, and competition for them has become more intense. The loss of critical members of our team, or our inability to attract and retain qualified personnel, could significantly harm our operations, business, and ability to compete. In addition, hospitals are also experiencing staffing shortages and supply chain issues that could impact their ability to provide patient care. As of the date of issuance of these Financial Statements, the extent to which the COVID-19 pandemic may materially adversely affect the Company&#x2019;s financial condition, liquidity, or results of operations is uncertain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Certain Leases with Variable Lease Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2021-05, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessors - Certain Leases with Variable Lease Payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which amends the lessor lease classification guidance in ASC 842 for leases that include any amount of variable lease payments that are not based on an index or rate. The Company has early adopted this ASU as of July 1, 2021, on a prospective basis. The standard had no impact on the Company's consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;There have been no new or material changes to the significant accounting policies discussed in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNC9mcmFnOjNjMjVhMTkyMWE0MzRmYjdiODMyZjk2Yzg5NjNlNTM4L3RleHRyZWdpb246M2MyNWExOTIxYTQzNGZiN2I4MzJmOTZjODk2M2U1MzhfNDc1Mg_61b1d78b-59c4-4417-a387-6bbc2c8220e0">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements (&#x201c;Financial Statements&#x201d;) of Intuitive Surgical, Inc. and its wholly and majority-owned subsidiaries have been prepared on a consistent basis with the audited Consolidated Financial Statements for the fiscal year ended December&#160;31, 2020, and include all adjustments, consisting of only normal, recurring adjustments, necessary to fairly state the information set forth herein. The Financial Statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and, therefore, omit certain information and footnote disclosure necessary to present the Financial Statements in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). These Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, which was filed with the SEC on February&#160;10, 2021. The results of operations for the first nine months of fiscal year 2021 are not necessarily indicative of the results to be expected for the entire fiscal year or any future periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNC9mcmFnOjNjMjVhMTkyMWE0MzRmYjdiODMyZjk2Yzg5NjNlNTM4L3RleHRyZWdpb246M2MyNWExOTIxYTQzNGZiN2I4MzJmOTZjODk2M2U1MzhfNDc2OA_135555d9-51a9-44c1-a7a7-3caeb9215626">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Financial Statements include the results and the balances of the Company&#x2019;s majority-owned joint venture (referred to herein as the &#x201c;Joint Venture&#x201d;) with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (&#x201c;Fosun Pharma&#x201d;). The Company holds a controlling financial interest in the Joint Venture, and the noncontrolling interest is reflected as a separate component of consolidated stockholders&#x2019; equity. The noncontrolling interest&#x2019;s share of the earnings in the Joint Venture is presented separately in the condensed consolidated statements of comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock Split&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares issued pursuant to the three-for-one stock split (the "Stock Split") of the Company's issued and outstanding common stock, par value $0.001 per share, were distributed on October 4, 2021, to stockholders of record as of September 27, 2021. All share and per-share information presented in the Financial Statements have been retroactively adjusted to reflect the Stock Split.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNC9mcmFnOjNjMjVhMTkyMWE0MzRmYjdiODMyZjk2Yzg5NjNlNTM4L3RleHRyZWdpb246M2MyNWExOTIxYTQzNGZiN2I4MzJmOTZjODk2M2U1MzhfNDc3NQ_20c44883-4d77-446f-931d-295005f19118">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Certain Leases with Variable Lease Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2021-05, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessors - Certain Leases with Variable Lease Payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which amends the lessor lease classification guidance in ASC 842 for leases that include any amount of variable lease payments that are not based on an index or rate. The Company has early adopted this ASU as of July 1, 2021, on a prospective basis. The standard had no impact on the Company's consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;There have been no new or material changes to the significant accounting policies discussed in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNTcwNQ_58ffff5b-e778-4dc8-8ef4-746d5b85abf3">FINANCIAL INSTRUMENTS&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company&#x2019;s cash and available-for-sale marketable securities&#x2019; amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant investment category reported as cash and cash equivalents, short-term investments, or long-term investments as of September&#160;30, 2021, and December&#160;31, 2020 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allowance for Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and&lt;br/&gt;Cash&lt;br/&gt;Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-&lt;br/&gt;term&lt;br/&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-&lt;br/&gt;term&lt;br/&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,250.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,258.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,153.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,062.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,070.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,153.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,610.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,614.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,636.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,977.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,207.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,219.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,741.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,131.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allowance for Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and&lt;br/&gt;Cash&lt;br/&gt;Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-&lt;br/&gt;term&lt;br/&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-&lt;br/&gt;term&lt;br/&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,626.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,649.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,567.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,252.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,567.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,437.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,036.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,933.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,949.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,829.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,869.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,622.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,488.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,757.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the contractual maturities of the Company&#x2019;s cash equivalents and available-for-sale investments (excluding cash and money market funds), as of September&#160;30, 2021 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature in less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,735.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,741.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature in one to five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,125.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,131.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,860.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Actual maturities may differ from contractual maturities, because certain borrowers have the right to call or prepay certain obligations. Gross realized gains recognized on the sale of investments were not material for the three and nine months ended September&#160;30, 2021, and not significant and $8.3&#160;million for the three and nine months ended September&#160;30, 2020, respectively. Gross realized losses recognized on the sale of investments were not material for any of the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investment portfolio at any point in time contains available-for-sale debt securities including investments in U.S. treasury and U.S. government agency securities, taxable and tax-exempt municipal notes, corporate notes and bonds, commercial paper, non-U.S. government agency securities, cash deposits, and money market funds. The Company segments its portfolio based on the underlying risk profiles of the securities and have a zero-loss expectation for U.S. treasury and U.S. government agency securities. The Company regularly reviews the securities in an unrealized loss position and evaluates the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, and current economic conditions. For the nine months ended September&#160;30, 2021, the credit losses related to available-for-sales debt securities were not significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds equity investments with readily determinable fair values and equity investments without readily determinable fair values. The Company generally recognizes equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the activity related to equity investments (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.687%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;br/&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Changes in Fair Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Sales/Purchases/Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intangible and other assets, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity investments with readily determinable value (Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity investments without readily determinable value (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Recorded in Interest and other income, net.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; Other includes conversion of certain equity investments without readily determinable value to equity investments with readily determinable value.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized a $34.5&#160;million increase in fair value, which was reflected in Interest and other income, net, due to changes in observable prices for certain equity investments that had been held at cost, because they lacked readily determinable market values (Level 2). A total of $34.2&#160;million of this increase in fair value was related to an equity investment in preferred shares of Broncus Medical, Inc. (&#x201c;Broncus&#x201d;). There were no decreases in fair value reflected in net income due to impairments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021, Broncus completed its initial public offering (&#x201c;IPO&#x201d;). Upon completion of its IPO, the Company&#x2019;s preferred shares were converted to common shares, which have a readily determinable value (Level 1). The Company is restricted from selling these shares for a period of six months. Subsequent to the IPO, the Company recognized a $12.3&#160;million decrease in fair value from this investment. As such, for the nine months ended September&#160;30, 2021, the Company has recognized a net gain of $21.9 million related to Broncus, comprised of the $34.2&#160;million gain reflected in changes in fair value for Level 2 equity investments, offset by the $12.3&#160;million loss reflected in changes in fair value for Level 1 equity investments, both of which were reflected in Interest and other income, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the Company sold all of its shares of Teladoc Health, Inc. (&#x201c;Teladoc&#x201d;), a publicly traded company, for $71.5&#160;million and recognized a gain of $11.4&#160;million, which was reflected in Interest and other income, net. This gain was offset by a $7.5&#160;million loss recognized upon the settlement of a corresponding derivative collar contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The objective of the Company&#x2019;s hedging program is to mitigate the impact of changes in currency exchange rates on net cash flow from foreign currency-denominated sales, expenses, intercompany balances, and other monetary assets or liabilities denominated in currencies other than the U.S. dollar (&#x201c;USD&#x201d;). The terms of the Company&#x2019;s derivative contracts are generally twelve months or shorter. The derivative assets and liabilities are measured using Level 2 fair value inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into currency forward contracts as cash flow hedges to hedge certain forecasted revenue transactions denominated in currencies other than the USD, primarily the Euro (&#x201c;EUR&#x201d;), the British Pound (&#x201c;GBP&#x201d;), the Japanese Yen (&#x201c;JPY&#x201d;),&#160;and the Korean Won (&#x201c;KRW&#x201d;). The Company also enters into currency forward contracts as cash flow hedges to hedge certain forecasted expense transactions denominated in EUR and the Swiss Franc (&#x201c;CHF&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For these derivatives, the Company reports the unrealized after-tax gain or loss from the hedge as a component of accumulated other comprehensive income/(loss) in stockholders&#x2019; equity and reclassifies the amount into earnings in the same period in which the hedged transaction affects earnings. The amounts reclassified to revenue and expenses related to the hedged transactions and the ineffective portions of cash flow hedges were not material for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other derivatives not designated as hedging instruments consist primarily of forward contracts that the Company uses to hedge intercompany balances and other monetary assets or liabilities denominated in currencies other than the USD, primarily the EUR, GBP, JPY, KRW, CHF, Indian Rupee ("INR"), Mexican Peso ("MXN"), Chinese Yuan ("CNY"), and New Taiwan Dollar ("TWD").&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These derivative instruments are used to hedge against balance sheet foreign currency exposures. The related gains and losses were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized gains/(losses) in Interest and other income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange gains/(losses) related to balance sheet re-measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, in January 2021, the Company settled a collar contract previously entered into to hedge its equity investment in Teladoc Health, Inc. For the nine months ended September&#160;30, 2021, a loss of $7.5&#160;million was recognized in Interest and other income, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts for derivative instruments provide one measure of the transaction volume. Total gross notional amounts (in USD) for outstanding derivatives and the aggregate gross fair value at the end of each period were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notional amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross fair value recorded in:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:AvailableForSaleSecuritiesTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNTY3OQ_2a4a67e3-412c-4972-af24-afc4c356d590">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company&#x2019;s cash and available-for-sale marketable securities&#x2019; amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant investment category reported as cash and cash equivalents, short-term investments, or long-term investments as of September&#160;30, 2021, and December&#160;31, 2020 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allowance for Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and&lt;br/&gt;Cash&lt;br/&gt;Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-&lt;br/&gt;term&lt;br/&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-&lt;br/&gt;term&lt;br/&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,250.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,258.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,153.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,062.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,070.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,153.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,610.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,614.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,636.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,977.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,207.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,219.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,741.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,131.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allowance for Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and&lt;br/&gt;Cash&lt;br/&gt;Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-&lt;br/&gt;term&lt;br/&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-&lt;br/&gt;term&lt;br/&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,626.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,649.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,567.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,252.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,567.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,437.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,036.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,933.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,949.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,829.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,869.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,622.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,488.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,757.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AvailableForSaleSecuritiesTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iac4be23e732e4f789fec20c9fc25381a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMy0xLTEtMS0w_7d2ba184-09ca-4bcf-a355-513077300574"
      unitRef="usd">534500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iac4be23e732e4f789fec20c9fc25381a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMy05LTEtMS0w_68f593ad-e9ac-468b-a2a4-58eaca136f97"
      unitRef="usd">534500000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iac4be23e732e4f789fec20c9fc25381a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMy0xMS0xLTEtMA_fc4d7851-fa66-48ad-ac29-650a5fa3eb5c"
      unitRef="usd">534500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4319e4b98dd145c2a90852e2abd3b90d_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNS0xLTEtMS0w_8a7c847c-af31-4c87-86cc-0a5eab9758e2"
      unitRef="usd">812200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i4319e4b98dd145c2a90852e2abd3b90d_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNS05LTEtMS0w_84a19451-e22e-445f-a2a2-c7f22d838d0e"
      unitRef="usd">812200000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4319e4b98dd145c2a90852e2abd3b90d_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNS0xMS0xLTEtMA_c196e5a6-747c-4954-8cd6-2587f27f9656"
      unitRef="usd">812200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i4319e4b98dd145c2a90852e2abd3b90d_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNS0xMy0xLTEtMA_70121fdb-4dd7-4968-8795-7938e1b88df1"
      unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i4319e4b98dd145c2a90852e2abd3b90d_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNS0xNS0xLTEtMA_b299bc54-73e4-419c-b836-f7eaa650a786"
      unitRef="usd">0</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie068099537924951abe627974208afa6_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNi0xLTEtMS0w_bcb27574-7642-4d2f-8f0d-434e042aaaf3"
      unitRef="usd">3250700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie068099537924951abe627974208afa6_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNi0zLTEtMS0w_0a0c06f7-d9b0-44bb-b9ff-948305e95978"
      unitRef="usd">10600000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie068099537924951abe627974208afa6_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNi01LTEtMS0w_24df1363-4a01-4a9b-9d07-7bd5771b7938"
      unitRef="usd">2800000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ie068099537924951abe627974208afa6_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNi03LTEtMS0w_a7dd30a1-492f-41e7-b336-db5b0dc89306"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie068099537924951abe627974208afa6_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNi05LTEtMS0w_e6f0c1e5-63d7-44d5-bfd1-8ecfaa71f2cf"
      unitRef="usd">3258500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie068099537924951abe627974208afa6_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNi0xMS0xLTEtMA_a4f1551f-315e-4364-99be-51e5cd514b2d"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ie068099537924951abe627974208afa6_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNi0xMy0xLTEtMA_f8f4b8d5-89f8-4249-beae-f93c41f001e8"
      unitRef="usd">1104600000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="ie068099537924951abe627974208afa6_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNi0xNS0xLTEtMA_b3439613-5d24-4076-a5b6-347134c3f957"
      unitRef="usd">2153900000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNy0xLTEtMS0w_ebe5fc33-ce45-4de1-8b51-bd849ca4765e"
      unitRef="usd">4062900000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNy0zLTEtMS0w_ab40b247-6504-4cb7-b93a-f83f36317281"
      unitRef="usd">10600000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNy01LTEtMS0w_89cc2075-7d51-4239-9bd0-f1810e7bb5be"
      unitRef="usd">2800000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNy03LTEtMS0w_9456b839-aa53-4e0b-9e62-99ed9c69051e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNy05LTEtMS0w_7aebd9dd-8f66-4a7f-ab85-41cc70b36384"
      unitRef="usd">4070700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNy0xMS0xLTEtMA_d45f9b22-c5c4-49ce-9277-579fb87d5405"
      unitRef="usd">812200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNy0xMy0xLTEtMA_965f8b93-089d-4e42-8e67-f117ef3bfe83"
      unitRef="usd">1104600000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfNy0xNS0xLTEtMA_5f14486d-5cd2-4567-853a-43fba5fdb8cb"
      unitRef="usd">2153900000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfOS0xLTEtMS0w_84336a0f-7b0b-4b78-8e0f-2333c928a413"
      unitRef="usd">632700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfOS0zLTEtMS0w_29b360af-1190-425e-bebb-0af6a318f876"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfOS01LTEtMS0w_a3cea990-8212-4ff1-a820-f0c3e0a59873"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfOS03LTEtMS0w_1d7af006-0b13-44b3-9aa8-a12f18000c5d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfOS05LTEtMS0w_13de1e02-f390-4b8e-a988-7037205373bf"
      unitRef="usd">632700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfOS0xMS0xLTEtMA_e992419e-ddea-4b43-89c9-9045cafb5839"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfOS0xMy0xLTEtMA_4f13d5cb-433c-4c5c-8ac2-176c1c91d73e"
      unitRef="usd">632700000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="ie9f4476015ee42bcac63cfbfc1d32ade_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfOS0xNS0xLTEtMA_0e49c7ca-105d-47c1-82bd-c5e4710bbd4a"
      unitRef="usd">0</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iea68361551fa4459a3df45292aa07f09_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTAtMS0xLTEtMA_793bae47-8a6c-4fa7-8396-1b7e8ed90607"
      unitRef="usd">2262400000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iea68361551fa4459a3df45292aa07f09_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTAtMy0xLTEtMA_44a0711a-5757-4374-a41c-a505c4bed559"
      unitRef="usd">5300000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iea68361551fa4459a3df45292aa07f09_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTAtNS0xLTEtMA_fe430204-b50d-4c8e-b5bf-47123898d3e1"
      unitRef="usd">2000000.0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="iea68361551fa4459a3df45292aa07f09_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTAtNy0xLTEtMA_921c757c-1b21-4fd8-9d84-6cf55a3c6d4b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iea68361551fa4459a3df45292aa07f09_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTAtOS0xLTEtMA_391f5375-fdfe-4b3b-b2fc-d954321e1c87"
      unitRef="usd">2265700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iea68361551fa4459a3df45292aa07f09_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTAtMTEtMS0xLTA_929f9094-d980-4b44-b135-16b85d6067fe"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="iea68361551fa4459a3df45292aa07f09_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTAtMTMtMS0xLTA_7c0da49a-30b2-462d-b6bb-bdb53065f2e3"
      unitRef="usd">794400000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="iea68361551fa4459a3df45292aa07f09_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTAtMTUtMS0xLTA_a6519817-3e3d-4ac0-9435-82b56b632c9d"
      unitRef="usd">1471300000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id420ed12c599434ea400964616900e95_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTEtMS0xLTEtMA_bf6329bf-938c-46f6-9df6-31674b199538"
      unitRef="usd">538300000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id420ed12c599434ea400964616900e95_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTEtMy0xLTEtMA_c397f715-fc97-4d5c-b1f0-4ba2bd1a13b1"
      unitRef="usd">500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id420ed12c599434ea400964616900e95_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTEtNS0xLTEtMA_cd07f917-0f27-4ae9-9a17-4c34f95b273d"
      unitRef="usd">500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="id420ed12c599434ea400964616900e95_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTEtNy0xLTEtMA_28149999-5753-4828-8862-381920138298"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id420ed12c599434ea400964616900e95_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTEtOS0xLTEtMA_b6beda16-56e5-48a2-8fec-c5bbac7ddc0e"
      unitRef="usd">538300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id420ed12c599434ea400964616900e95_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTEtMTEtMS0xLTA_84c4c30e-ed8e-4975-9347-64a6c62395f4"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="id420ed12c599434ea400964616900e95_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTEtMTMtMS0xLTA_b059bfdd-f7ab-4bfd-aa03-1905b498af77"
      unitRef="usd">150800000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="id420ed12c599434ea400964616900e95_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTEtMTUtMS0xLTA_786ee1b4-16e4-4cab-a675-cb40af92b61c"
      unitRef="usd">387500000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9fb374215fd24fceb8e6353f18d88ae5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTMtMS0xLTEtMA_615c48a5-006e-4756-9045-15cd67cca1d2"
      unitRef="usd">176800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9fb374215fd24fceb8e6353f18d88ae5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTMtMy0xLTEtMA_88aafc78-5d4f-4eb2-a89a-c8ccc818a716"
      unitRef="usd">1200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9fb374215fd24fceb8e6353f18d88ae5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTMtNS0xLTEtMA_462672b1-eee1-48fa-b483-4610bda0e04d"
      unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i9fb374215fd24fceb8e6353f18d88ae5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTMtNy0xLTEtMA_9e3ffea3-ed63-46a6-9ddb-ce7972157182"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9fb374215fd24fceb8e6353f18d88ae5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTMtOS0xLTEtMA_548bf0ad-73fd-4441-b038-3b459ccef56b"
      unitRef="usd">177800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9fb374215fd24fceb8e6353f18d88ae5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTMtMTEtMS0xLTA_9c649c58-8442-49b1-b19c-a275206fdbcc"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i9fb374215fd24fceb8e6353f18d88ae5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTMtMTMtMS0xLTA_c2eb7f58-c048-47ab-8741-fd3cfeffd5f6"
      unitRef="usd">59000000.0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i9fb374215fd24fceb8e6353f18d88ae5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTMtMTUtMS0xLTA_6afb25c0-3eb2-49a1-b829-36dbe3083eb0"
      unitRef="usd">118800000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTQtMS0xLTEtMA_d437e89f-7e83-40c6-b095-f9d960b862ad"
      unitRef="usd">3610200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTQtMy0xLTEtMA_01c5e6cf-9b1f-45e2-8057-c82299317fd0"
      unitRef="usd">7000000.0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTQtNS0xLTEtMA_e0001f1a-5b8f-4a69-97df-29a5dbef0182"
      unitRef="usd">2700000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTQtNy0xLTEtMA_cc0b71b9-7394-4e1c-844c-fcf7dffafc58"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTQtOS0xLTEtMA_33c7226f-e8e9-43e4-940c-ee50726874d2"
      unitRef="usd">3614500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTQtMTEtMS0xLTA_cd6c7f20-d6d9-4ef6-b182-a6692497a520"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTQtMTMtMS0xLTA_2900d815-a645-49c3-8be5-6ef35a63e3a3"
      unitRef="usd">1636900000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTQtMTUtMS0xLTA_9f0c5ea7-9e76-4bba-8a11-55ed8c978bd7"
      unitRef="usd">1977600000</us-gaap:MarketableSecuritiesNoncurrent>
    <isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTgtMS0xLTEtMA_88d4ca21-b397-45ed-975c-aac7aee26664"
      unitRef="usd">8207600000</isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTgtMy0xLTEtMA_330426a9-03d8-4323-b272-4e5a4fff64b1"
      unitRef="usd">17600000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTgtNS0xLTEtMA_abd14a8c-6c0a-4227-a28f-e07324af5802"
      unitRef="usd">5500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTgtNy0xLTEtMA_cef4b054-fdfb-45b0-8c55-88365453479a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTgtOS0xLTEtMA_29b44c3d-9bc4-4306-9132-a3decd683756"
      unitRef="usd">8219700000</isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTgtMTEtMS0xLTA_87e0cddd-07d7-4107-b13d-ddcb7fb7b00a"
      unitRef="usd">1346700000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTgtMTMtMS0xLTA_c281f984-4d99-4c9b-a6e5-cf69beaf758a"
      unitRef="usd">2741500000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmQwMGY5YzVjNTBmMDQ1OWFhYWRhYjNjZTFjNjY1NmQ1L3RhYmxlcmFuZ2U6ZDAwZjljNWM1MGYwNDU5YWFhZGFiM2NlMWM2NjU2ZDVfMTgtMTUtMS0xLTA_97e7d6dc-8697-4950-b4e8-230db6a641c4"
      unitRef="usd">4131500000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ibfc8dbc3d6fb4425a9ff2241572e2cf1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMy0xLTEtMS0w_691a579e-feaa-40c3-b598-ec79e80d1624"
      unitRef="usd">644300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ibfc8dbc3d6fb4425a9ff2241572e2cf1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMy05LTEtMS0w_d15120b1-3223-4286-be00-1e4d6f0f8533"
      unitRef="usd">644300000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ibfc8dbc3d6fb4425a9ff2241572e2cf1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMy0xMS0xLTEtMA_3acd0262-6b6d-41dc-be88-a92ff7f30880"
      unitRef="usd">644300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i051ac4e837b3485fb8a292b1fcaf07ec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNS0xLTEtMS0w_c8556992-2c37-4c01-906c-a873ea41aa43"
      unitRef="usd">625800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i051ac4e837b3485fb8a292b1fcaf07ec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNS05LTEtMS0w_c1f07b1e-ac1e-40ff-a51b-c428d67efc16"
      unitRef="usd">625800000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i051ac4e837b3485fb8a292b1fcaf07ec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNS0xMS0xLTEtMA_4249b518-d3b5-4cb7-840a-683785d876dc"
      unitRef="usd">625800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i051ac4e837b3485fb8a292b1fcaf07ec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNS0xMy0xLTEtMA_7d2b4b68-e1d3-4bb5-a956-0c5334bcc982"
      unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i051ac4e837b3485fb8a292b1fcaf07ec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNS0xNS0xLTEtMA_587e8ca2-927d-4904-960b-6edd1e58226d"
      unitRef="usd">0</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i06308a83da3a4180bee5bf62322c5e37_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNi0xLTEtMS0w_abd80397-24d5-424a-b695-6636996cd584"
      unitRef="usd">2626800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i06308a83da3a4180bee5bf62322c5e37_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNi0zLTEtMS0w_33f8efc9-1893-42ea-8a43-04596d7a7c60"
      unitRef="usd">23000000.0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i06308a83da3a4180bee5bf62322c5e37_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNi01LTEtMS0w_67236e0e-45a8-44c1-a618-7bdcaf1d74f6"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i06308a83da3a4180bee5bf62322c5e37_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNi03LTEtMS0w_e0e72ca8-2938-4a8d-b242-053233b00f12"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i06308a83da3a4180bee5bf62322c5e37_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNi05LTEtMS0w_d2054f78-ba5c-49c9-955d-f262e8f8a406"
      unitRef="usd">2649800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i06308a83da3a4180bee5bf62322c5e37_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNi0xMS0xLTEtMA_4220daa1-0e64-40a0-b013-e423daf0e19e"
      unitRef="usd">212500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i06308a83da3a4180bee5bf62322c5e37_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNi0xMy0xLTEtMA_51ae09ca-5302-4a1d-9cc7-58d76663e12e"
      unitRef="usd">1567900000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i06308a83da3a4180bee5bf62322c5e37_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNi0xNS0xLTEtMA_8fed59c4-91ee-43a9-9714-1c474a745c70"
      unitRef="usd">869400000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNy0xLTEtMS0w_849b5e16-ab4d-42f9-a7e0-0be7fcec08b7"
      unitRef="usd">3252600000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNy0zLTEtMS0w_5d7213cd-0101-40a0-abd1-5b0b8c5c825b"
      unitRef="usd">23000000.0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNy01LTEtMS0w_81c5c0d6-8357-45b4-b4e3-efa2121e19dd"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNy03LTEtMS0w_b7a49c10-bc94-423c-8741-a13255d7d3de"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNy05LTEtMS0w_91fde960-ced3-47a7-bcdc-82e6165d4937"
      unitRef="usd">3275600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNy0xMS0xLTEtMA_699b5f6a-2ed5-4355-a80a-2c65cd3eb40c"
      unitRef="usd">838300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNy0xMy0xLTEtMA_a0bc888a-bfc1-4f34-b951-d80978bd2c24"
      unitRef="usd">1567900000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfNy0xNS0xLTEtMA_0769da7c-795d-4381-afdf-68a6a6915126"
      unitRef="usd">869400000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie4894873227d4ea89ae1cd010bac1f63_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfOS0xLTEtMS0w_5fee9ac0-79f0-4ede-a48e-052fde1cab32"
      unitRef="usd">671300000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie4894873227d4ea89ae1cd010bac1f63_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfOS0zLTEtMS0w_0bffbbc6-03db-4cae-9b4c-68feec4aea09"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie4894873227d4ea89ae1cd010bac1f63_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfOS01LTEtMS0w_d0a1a8fd-6b2b-46d1-9934-22bdcd654b36"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ie4894873227d4ea89ae1cd010bac1f63_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfOS03LTEtMS0w_11b98dff-db46-4baa-b544-1b42a641dc84"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie4894873227d4ea89ae1cd010bac1f63_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfOS05LTEtMS0w_b8c92f75-3be6-47ab-9444-3d36d8657584"
      unitRef="usd">671300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie4894873227d4ea89ae1cd010bac1f63_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfOS0xMS0xLTEtMA_52eccb96-1c39-46b6-b9ca-70e269ed0bbe"
      unitRef="usd">64100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ie4894873227d4ea89ae1cd010bac1f63_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfOS0xMy0xLTEtMA_7a115a27-a8bc-48ad-bb8e-ccc42538b4a3"
      unitRef="usd">607200000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="ie4894873227d4ea89ae1cd010bac1f63_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfOS0xNS0xLTEtMA_bfac2ad7-1812-4356-be51-15203299a628"
      unitRef="usd">0</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1d720541eae04f0fb8a83fef4019ced8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTAtMS0xLTEtMA_de557b7a-1a44-452d-920c-8ef67defb689"
      unitRef="usd">1425400000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1d720541eae04f0fb8a83fef4019ced8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTAtMy0xLTEtMA_7f62f34f-00c1-4250-8d48-5ee2e56b2511"
      unitRef="usd">11900000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1d720541eae04f0fb8a83fef4019ced8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTAtNS0xLTEtMA_5ed4c375-caa5-43f3-a279-4186b3621633"
      unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i1d720541eae04f0fb8a83fef4019ced8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTAtNy0xLTEtMA_02792e50-6a9a-4b70-81b2-c76b862eebc1"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1d720541eae04f0fb8a83fef4019ced8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTAtOS0xLTEtMA_ddc0ec9f-48c1-436d-aa6e-598ec6477954"
      unitRef="usd">1437100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1d720541eae04f0fb8a83fef4019ced8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTAtMTEtMS0xLTA_2061c8e2-8c45-49ac-bf6d-df898e8177a9"
      unitRef="usd">3400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i1d720541eae04f0fb8a83fef4019ced8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTAtMTMtMS0xLTA_be017f0d-dc32-477e-9dad-cf7201312e85"
      unitRef="usd">1036500000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i1d720541eae04f0fb8a83fef4019ced8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTAtMTUtMS0xLTA_18f7d7c3-560d-455c-bff1-d6a0018083b6"
      unitRef="usd">397200000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i11db865dc86840629acd13c8a709c2d3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTEtMS0xLTEtMA_5902d3fa-17b4-4d42-9f17-335513b97141"
      unitRef="usd">716500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i11db865dc86840629acd13c8a709c2d3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTEtMy0xLTEtMA_9bdb0145-ebab-476b-8fd7-7ba20b8035c5"
      unitRef="usd">2500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i11db865dc86840629acd13c8a709c2d3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTEtNS0xLTEtMA_8c0931c1-7cd2-4ae2-975c-80a3dd0c7409"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i11db865dc86840629acd13c8a709c2d3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTEtNy0xLTEtMA_a3f5153d-68bd-4e9f-87b1-64fc0c5a6f26"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i11db865dc86840629acd13c8a709c2d3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTEtOS0xLTEtMA_238d2e3c-a5ae-4144-883b-491059eebbb8"
      unitRef="usd">719000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i11db865dc86840629acd13c8a709c2d3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTEtMTEtMS0xLTA_2416d174-55b0-4f1e-9a9d-e1736529723c"
      unitRef="usd">72500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i11db865dc86840629acd13c8a709c2d3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTEtMTMtMS0xLTA_86fd8e56-faf4-4c76-9213-04688cf1e7b2"
      unitRef="usd">233600000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i11db865dc86840629acd13c8a709c2d3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTEtMTUtMS0xLTA_dbcabd99-2225-4580-8559-3a5784843b9a"
      unitRef="usd">412900000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTMtMS0xLTEtMA_b23ddf7a-3025-4b8d-8edf-6ebbd8b8e7b5"
      unitRef="usd">119800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTMtMy0xLTEtMA_57178079-f065-49a1-9e91-405a937f0461"
      unitRef="usd">2000000.0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTMtNS0xLTEtMA_4de009e4-3d1f-40cd-819c-83f87145e448"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTMtNy0xLTEtMA_8b764b21-c991-4973-a665-512e919470d1"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTMtOS0xLTEtMA_11f1a622-3e5f-4600-bae0-8d8fa6fba7b5"
      unitRef="usd">121800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTMtMTEtMS0xLTA_d2fc677b-ea44-4311-950c-9c3371fc03be"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTMtMTMtMS0xLTA_53ad9390-5454-4edf-944f-aac5cfb25eef"
      unitRef="usd">43600000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i0cd0a0ad305a476b92b21cf38d1794c1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTMtMTUtMS0xLTA_99d68272-0259-44e4-9841-6da9a2dea555"
      unitRef="usd">78200000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTQtMS0xLTEtMA_0f20e542-58be-4f06-a673-4f83d7db6b50"
      unitRef="usd">2933000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTQtMy0xLTEtMA_909efc5b-17b0-473b-a000-93a2fa03b73d"
      unitRef="usd">16400000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTQtNS0xLTEtMA_ccbf851e-b422-4779-8837-53d13651956a"
      unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTQtNy0xLTEtMA_7e161f9f-452f-4e61-86b3-f91eececb4c3"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTQtOS0xLTEtMA_6a7a794f-150d-4cbd-ad8e-789490111f97"
      unitRef="usd">2949200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTQtMTEtMS0xLTA_183af93a-c84d-4ee3-b4c2-8e216408ac84"
      unitRef="usd">140000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTQtMTMtMS0xLTA_53359bb2-d409-4d22-a9fd-13d19d841cf6"
      unitRef="usd">1920900000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTQtMTUtMS0xLTA_eda3a9bb-d53c-45a2-a1b5-04a54136933a"
      unitRef="usd">888300000</us-gaap:MarketableSecuritiesNoncurrent>
    <isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTgtMS0xLTEtMA_4e183010-91e3-4243-abeb-97f1f7cf3fb0"
      unitRef="usd">6829900000</isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTgtMy0xLTEtMA_2cced3c2-3d8a-4818-92b2-56520d969990"
      unitRef="usd">39400000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTgtNS0xLTEtMA_49797936-425b-4696-9795-9bc450543419"
      unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTgtNy0xLTEtMA_033204d6-7e3c-4969-8aad-f4b2731e762c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTgtOS0xLTEtMA_6efdc42c-f804-4432-9483-a351559089c4"
      unitRef="usd">6869100000</isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTgtMTEtMS0xLTA_76b37349-5459-42b5-b901-978de056ab41"
      unitRef="usd">1622600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTgtMTMtMS0xLTA_c1f17677-5982-42cc-95c2-70bf8e7ec48a"
      unitRef="usd">3488800000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFhNTMzZGNkZDZhYjRlYzU5NTdmMTZmMDkwZGRlNzRlL3RhYmxlcmFuZ2U6MWE1MzNkY2RkNmFiNGVjNTk1N2YxNmYwOTBkZGU3NGVfMTgtMTUtMS0xLTA_586ea1a0-1d59-40b6-9f0b-d6a961e933a4"
      unitRef="usd">1757700000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNTY5MQ_523af4b8-4328-4a3e-a63a-d9ac1ac9afd6">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the contractual maturities of the Company&#x2019;s cash equivalents and available-for-sale investments (excluding cash and money market funds), as of September&#160;30, 2021 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature in less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,735.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,741.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature in one to five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,125.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,131.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,860.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiOGE5N2I5NTZiNzRjYTk5ZTM0YWIxOWMzNWQ1YWVlL3RhYmxlcmFuZ2U6MWI4YTk3Yjk1NmI3NGNhOTllMzRhYjE5YzM1ZDVhZWVfMS0xLTEtMS0w_b1ba9a37-827e-4216-be8b-3fc8a2c4353c"
      unitRef="usd">2735300000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiOGE5N2I5NTZiNzRjYTk5ZTM0YWIxOWMzNWQ1YWVlL3RhYmxlcmFuZ2U6MWI4YTk3Yjk1NmI3NGNhOTllMzRhYjE5YzM1ZDVhZWVfMS0zLTEtMS0w_3886d8df-7c73-41f3-9e24-17996083b50f"
      unitRef="usd">2741500000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiOGE5N2I5NTZiNzRjYTk5ZTM0YWIxOWMzNWQ1YWVlL3RhYmxlcmFuZ2U6MWI4YTk3Yjk1NmI3NGNhOTllMzRhYjE5YzM1ZDVhZWVfMi0xLTEtMS0w_4fc53ca4-70e5-4c5f-9e0e-e4ce625406bc"
      unitRef="usd">4125600000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiOGE5N2I5NTZiNzRjYTk5ZTM0YWIxOWMzNWQ1YWVlL3RhYmxlcmFuZ2U6MWI4YTk3Yjk1NmI3NGNhOTllMzRhYjE5YzM1ZDVhZWVfMi0zLTEtMS0w_e86899f2-674b-433d-abcf-338828c12619"
      unitRef="usd">4131500000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiOGE5N2I5NTZiNzRjYTk5ZTM0YWIxOWMzNWQ1YWVlL3RhYmxlcmFuZ2U6MWI4YTk3Yjk1NmI3NGNhOTllMzRhYjE5YzM1ZDVhZWVfNC0xLTEtMS0w_df424305-d831-48dc-ac39-be48c1ca2da2"
      unitRef="usd">6860900000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <isrg:AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiOGE5N2I5NTZiNzRjYTk5ZTM0YWIxOWMzNWQ1YWVlL3RhYmxlcmFuZ2U6MWI4YTk3Yjk1NmI3NGNhOTllMzRhYjE5YzM1ZDVhZWVfNC0zLTEtMS0w_3961ffd2-6dcc-4924-bb38-1b5318c58063"
      unitRef="usd">6873000000</isrg:AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfODgx_02d4bda0-f77d-49ff-b3ec-0caa8f9b924d"
      unitRef="usd">8300000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNTY5Mw_084e8042-b21c-4eea-a021-8fde4c3a7ddf">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the activity related to equity investments (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.687%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;br/&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Changes in Fair Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Sales/Purchases/Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intangible and other assets, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity investments with readily determinable value (Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity investments without readily determinable value (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Recorded in Interest and other income, net.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; Other includes conversion of certain equity investments without readily determinable value to equity investments with readily determinable value.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i06c58807713747e68d9de8c22f9c0180_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMi0xLTEtMS0w_d055400b-83c9-44ee-a91c-895bbd34ee54"
      unitRef="usd">60100000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i84eb653b91034599a7ec24d50e0fad92_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMi0zLTEtMS0w_69eb3b85-44f3-4a08-ada1-c48b2ec8e720"
      unitRef="usd">-900000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <isrg:EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments
      contextRef="i84eb653b91034599a7ec24d50e0fad92_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMi01LTEtMS0w_f0cefe72-6c78-4753-85db-155344445d16"
      unitRef="usd">-15400000</isrg:EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ie7cff1e3b70b4d59942f780200c132ae_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMi03LTEtMS0w_686dd984-de71-43c7-94d3-669c4fc456b0"
      unitRef="usd">43800000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib87bb311713b42d2a296729d6a21259a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMi05LTEtMS0w_dc6c0f73-ce3d-4ebe-b185-1459fafc1296"
      unitRef="usd">43800000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iae28aecb5f7a4c7bacd3c8ecb4f9026a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMi0xMS0xLTEtMA_305477d6-4ea3-48dd-a1ce-f00f42080c25"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i50b6e061ae8c4457ae5cc241cd439143_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMy0xLTEtMS0w_5e424598-b040-4988-bc34-8b725f402e9c"
      unitRef="usd">30200000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss
      contextRef="ibe9058395d09478a81e0df11992f7575_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMy0zLTEtMS0w_d9c50eb3-10c0-4e37-91c2-01061d815c6a"
      unitRef="usd">34500000</isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss>
    <isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments
      contextRef="ibe9058395d09478a81e0df11992f7575_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMy01LTEtMS0w_be6b0f0a-2c33-4ef8-9e37-0c75400340ea"
      unitRef="usd">-52200000</isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="if18a7befa5ee4b6291d1a42889e3d5e2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMy03LTEtMS0w_fc8e3160-7fbb-4450-834d-5127425097d6"
      unitRef="usd">12500000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i12b57348d47e45dbbc469e0cd82180c2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMy05LTEtMS0w_b2bd6e22-41e8-422b-96ee-250fbc5dd3b3"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i46504ffcecdd46ce81248e08922c68cb_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjFiNTY2OTU1NzAzYjQ0MTE5NTY3MDdmN2U5MDBhOTE4L3RhYmxlcmFuZ2U6MWI1NjY5NTU3MDNiNDQxMTk1NjcwN2Y3ZTkwMGE5MThfMy0xMS0xLTEtMA_95cf2a5c-b2d1-46eb-ada7-168c10d7cf81"
      unitRef="usd">12500000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss
      contextRef="ibe9058395d09478a81e0df11992f7575_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfMjUwOQ_ddc5cf52-21e1-40c1-90be-a853188909c8"
      unitRef="usd">34500000</isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss>
    <isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares
      contextRef="ibe9058395d09478a81e0df11992f7575_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfMTA5OTUxMTYzNTc4Ng_bbdaf934-0447-4dd9-88cd-d59f599818e8"
      unitRef="usd">34200000</isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i319aeb288bcf4439b7aa385bd35027af_D20210901-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfMTY0OTI2NzQ1MDE2Ng_e379b865-90ef-4278-ba86-e7801c271713"
      unitRef="usd">12300000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNDM5ODA0NjUyMTAwNw_8d4d12e7-5f6f-42bb-ab56-d3004d4de179"
      unitRef="usd">21900000</us-gaap:UnrealizedGainLossOnInvestments>
    <isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares
      contextRef="ibe9058395d09478a81e0df11992f7575_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNDM5ODA0NjUyMTQ3OQ_bbdaf934-0447-4dd9-88cd-d59f599818e8"
      unitRef="usd">34200000</isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i319aeb288bcf4439b7aa385bd35027af_D20210901-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNDM5ODA0NjUyMTMyOQ_e379b865-90ef-4278-ba86-e7801c271713"
      unitRef="usd">12300000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity
      contextRef="i77c4e5ac2bfa409fbf298841deccc21d_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfMjg3Ng_b48b92d2-20c8-4dea-9b61-29e61b820233"
      unitRef="usd">71500000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity>
    <us-gaap:GainLossOnSaleOfEquityInvestments
      contextRef="i77c4e5ac2bfa409fbf298841deccc21d_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfMjkwNA_473d1170-c893-441d-82ba-972307600601"
      unitRef="usd">11400000</us-gaap:GainLossOnSaleOfEquityInvestments>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="i77c4e5ac2bfa409fbf298841deccc21d_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfMjk4OQ_0d20041f-a3bf-4023-8de5-dc18dd3fe081"
      unitRef="usd">7500000</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNTcxMQ_60515b84-484f-4285-b254-76d51bfb0378">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These derivative instruments are used to hedge against balance sheet foreign currency exposures. The related gains and losses were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized gains/(losses) in Interest and other income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange gains/(losses) related to balance sheet re-measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i12b53adfc2da450d83928c0d59c0cf9b_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjE2NWZiNWFhZGEzMjRmYzJiMDJlNTc0OTVhMzExNTcxL3RhYmxlcmFuZ2U6MTY1ZmI1YWFkYTMyNGZjMmIwMmU1NzQ5NWEzMTE1NzFfMi0xLTEtMS0w_70733698-0fa3-4f0f-ab01-5e48133b58d1"
      unitRef="usd">4400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ic8b8d9c0c6b447738c87b3b7e16f0a5e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjE2NWZiNWFhZGEzMjRmYzJiMDJlNTc0OTVhMzExNTcxL3RhYmxlcmFuZ2U6MTY1ZmI1YWFkYTMyNGZjMmIwMmU1NzQ5NWEzMTE1NzFfMi0zLTEtMS0w_ac960f81-8e84-46f5-8e9d-5abf2ed0438e"
      unitRef="usd">-5000000.0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i229a1c443d19443798c91258bb8d018d_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjE2NWZiNWFhZGEzMjRmYzJiMDJlNTc0OTVhMzExNTcxL3RhYmxlcmFuZ2U6MTY1ZmI1YWFkYTMyNGZjMmIwMmU1NzQ5NWEzMTE1NzFfMi01LTEtMS0w_55ab2781-5658-4fe1-8d07-5e8cc302acc3"
      unitRef="usd">11800000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i5e2c2a67bae840698c4ce5e39a92dddc_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjE2NWZiNWFhZGEzMjRmYzJiMDJlNTc0OTVhMzExNTcxL3RhYmxlcmFuZ2U6MTY1ZmI1YWFkYTMyNGZjMmIwMmU1NzQ5NWEzMTE1NzFfMi03LTEtMS0w_a1216766-d7b1-4271-a62c-51b46d03e1e6"
      unitRef="usd">-3200000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjE2NWZiNWFhZGEzMjRmYzJiMDJlNTc0OTVhMzExNTcxL3RhYmxlcmFuZ2U6MTY1ZmI1YWFkYTMyNGZjMmIwMmU1NzQ5NWEzMTE1NzFfMy0xLTEtMS0w_f6d23f2b-e2ad-43c1-8ae7-9611d7a19039"
      unitRef="usd">-6400000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjE2NWZiNWFhZGEzMjRmYzJiMDJlNTc0OTVhMzExNTcxL3RhYmxlcmFuZ2U6MTY1ZmI1YWFkYTMyNGZjMmIwMmU1NzQ5NWEzMTE1NzFfMy0zLTEtMS0w_04c6e81b-6084-4069-88a7-aa52d7b76750"
      unitRef="usd">5900000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjE2NWZiNWFhZGEzMjRmYzJiMDJlNTc0OTVhMzExNTcxL3RhYmxlcmFuZ2U6MTY1ZmI1YWFkYTMyNGZjMmIwMmU1NzQ5NWEzMTE1NzFfMy01LTEtMS0w_b1d13102-05ce-490b-ac94-20a80ccfb307"
      unitRef="usd">-12400000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOjE2NWZiNWFhZGEzMjRmYzJiMDJlNTc0OTVhMzExNTcxL3RhYmxlcmFuZ2U6MTY1ZmI1YWFkYTMyNGZjMmIwMmU1NzQ5NWEzMTE1NzFfMy03LTEtMS0w_153f9f25-dfb1-4e70-a743-df942d5989ee"
      unitRef="usd">-1100000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ic1d4b29a68414fe6b3b2e75caa359a5d_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNTM3Mw_d28bc0e9-75b2-4631-b694-8ee68efedf1f"
      unitRef="usd">7500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RleHRyZWdpb246NzQxODRhNzkyYjg2NDBkMDk1MTJhN2Q2YjMzOGViYjBfNTY4MQ_bf9998a7-93e1-4793-8808-bea0e255506f">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts for derivative instruments provide one measure of the transaction volume. Total gross notional amounts (in USD) for outstanding derivatives and the aggregate gross fair value at the end of each period were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notional amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross fair value recorded in:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id0fa4f45ec164a5ebc9a515e1b8f57b3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfMy0xLTEtMS0w_fd8dbfb1-64f6-4054-9673-984dd4aa42e3"
      unitRef="usd">203700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i24d4644b1a994c0f8abaeee9b5dcdb06_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfMy0zLTEtMS0w_0514d5ff-8a68-46ea-9d24-c71a101ca253"
      unitRef="usd">154300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i63493d444f724a8296203ce9004defce_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfMy01LTEtMS0w_3593b7bb-e3fb-4a33-8190-057676ef2c5e"
      unitRef="usd">285800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i194cea79cb2847038852265b56fab10c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfMy03LTEtMS0w_c39c7d4d-b97e-4d3e-a5ba-850038f23cbb"
      unitRef="usd">309800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ied0febbfd3184ec78820350f31b1a206_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfNS0xLTEtMS0w_8237d2d4-7ed8-49e2-af6e-ef42c386c84d"
      unitRef="usd">6800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i673322c7553b44c88a98e44d90b50183_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfNS0zLTEtMS0w_8bb38b60-9d04-49e3-bdf4-a2447d6c3d9c"
      unitRef="usd">900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i50d502c033d34a2bb8803baed7932450_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfNS01LTEtMS0w_aa31128c-ab48-449e-8aa2-02c343b51d9f"
      unitRef="usd">5800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if6b35b549a824fe8a766f46dd9432198_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfNS03LTEtMS0w_e9798f72-cc2d-46f7-b0d0-ab681e0f46aa"
      unitRef="usd">700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i56683a8f54f2401e93b699a3ebeca829_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfNi0xLTEtMS0w_9b961a8a-cf3c-4fba-a7c2-ebfca010debc"
      unitRef="usd">900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i23484c1a1c1f47c7a08373f58c84bc7a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfNi0zLTEtMS0w_6ba27f05-e0c7-4479-8a35-aa002de16d31"
      unitRef="usd">4300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2143a91feda349708ea3355e40ad18d5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfNi01LTEtMS0w_b063ca65-fef3-40c0-a064-26ab68ef5f2f"
      unitRef="usd">700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3f223d39fb294552a8bcfb3bc81d4ebd_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl8zNy9mcmFnOjc0MTg0YTc5MmI4NjQwZDA5NTEyYTdkNmIzMzhlYmIwL3RhYmxlOmI0YTYzOTQ5MzFkOTQ5MmQ5MjA0N2NiOTA0YjZmMWE3L3RhYmxlcmFuZ2U6YjRhNjM5NDkzMWQ5NDkyZDkyMDQ3Y2I5MDRiNmYxYTdfNi03LTEtMS0w_cc3c8114-a039-4125-b3eb-ef6022293ff7"
      unitRef="usd">5400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RleHRyZWdpb246YWVkMmJhMDJlOTE0NGFiNGEzYjk0ZWFkMTVhNzk0ODJfMzI0_e132c604-55da-45ed-91e2-ace3c77f8cf4">BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Balance Sheet Details&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide details of selected balance sheet line items (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment in sales-type leases &#x2013; short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Other accrued liabilities&#x2013;short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of deferred purchase consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other accrued liabilities&#x2013;short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&#x2013;long-term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&#x2013;long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;447.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Supplemental Cash Flow Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides supplemental non-cash investing and financing activities (in millions):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition of property, plant, and equipment in accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred payments and contingent consideration related to business combinations and asset acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RleHRyZWdpb246YWVkMmJhMDJlOTE0NGFiNGEzYjk0ZWFkMTVhNzk0ODJfMzQy_ff79a513-b5a2-40d5-8155-44654d12645a">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide details of selected balance sheet line items (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmYxODVkYzRmZjI4MTQ1MmFiMWFiMzhlYTQ4ZWNmNmVmL3RhYmxlcmFuZ2U6ZjE4NWRjNGZmMjgxNDUyYWIxYWIzOGVhNDhlY2Y2ZWZfMi0xLTEtMS0w_7e296034-d205-4733-9f4c-b0f536053b70"
      unitRef="usd">181400000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmYxODVkYzRmZjI4MTQ1MmFiMWFiMzhlYTQ4ZWNmNmVmL3RhYmxlcmFuZ2U6ZjE4NWRjNGZmMjgxNDUyYWIxYWIzOGVhNDhlY2Y2ZWZfMi0zLTEtMS0w_20f20e72-c7de-4819-8da5-7863da92ee4f"
      unitRef="usd">184100000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmYxODVkYzRmZjI4MTQ1MmFiMWFiMzhlYTQ4ZWNmNmVmL3RhYmxlcmFuZ2U6ZjE4NWRjNGZmMjgxNDUyYWIxYWIzOGVhNDhlY2Y2ZWZfMy0xLTEtMS0w_103d4240-84d5-49e0-b4c0-d819b59cc8c3"
      unitRef="usd">85700000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmYxODVkYzRmZjI4MTQ1MmFiMWFiMzhlYTQ4ZWNmNmVmL3RhYmxlcmFuZ2U6ZjE4NWRjNGZmMjgxNDUyYWIxYWIzOGVhNDhlY2Y2ZWZfMy0zLTEtMS0w_f1841fe1-eeaa-409f-ad9d-99c65268ff2d"
      unitRef="usd">75600000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmYxODVkYzRmZjI4MTQ1MmFiMWFiMzhlYTQ4ZWNmNmVmL3RhYmxlcmFuZ2U6ZjE4NWRjNGZmMjgxNDUyYWIxYWIzOGVhNDhlY2Y2ZWZfNC0xLTEtMS0w_5d46d4e9-1470-42bf-9773-f1e92410e7d4"
      unitRef="usd">317800000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmYxODVkYzRmZjI4MTQ1MmFiMWFiMzhlYTQ4ZWNmNmVmL3RhYmxlcmFuZ2U6ZjE4NWRjNGZmMjgxNDUyYWIxYWIzOGVhNDhlY2Y2ZWZfNC0zLTEtMS0w_2d6e3763-5761-40b0-a7f9-f0ed02566c56"
      unitRef="usd">341800000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmYxODVkYzRmZjI4MTQ1MmFiMWFiMzhlYTQ4ZWNmNmVmL3RhYmxlcmFuZ2U6ZjE4NWRjNGZmMjgxNDUyYWIxYWIzOGVhNDhlY2Y2ZWZfNS0xLTEtMS0w_06c92d83-66fa-4686-bef0-4db8fdf2cfcd"
      unitRef="usd">584900000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmYxODVkYzRmZjI4MTQ1MmFiMWFiMzhlYTQ4ZWNmNmVmL3RhYmxlcmFuZ2U6ZjE4NWRjNGZmMjgxNDUyYWIxYWIzOGVhNDhlY2Y2ZWZfNS0zLTEtMS0w_24050411-6674-4f83-8e70-eeed22bd2750"
      unitRef="usd">601500000</us-gaap:InventoryNet>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RleHRyZWdpb246YWVkMmJhMDJlOTE0NGFiNGEzYjk0ZWFkMTVhNzk0ODJfMzQ1_9958959e-e401-4bc9-ab8e-194c531648b0">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment in sales-type leases &#x2013; short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RleHRyZWdpb246YWVkMmJhMDJlOTE0NGFiNGEzYjk0ZWFkMTVhNzk0ODJfMzQ5_f89ace20-f1c3-4abb-965e-7606b244c1ca">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment in sales-type leases &#x2013; short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:PrepaidTaxes
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfMi0xLTEtMS0w_bd26ed9b-2a9e-4a85-ae9f-59a3c6951e58"
      unitRef="usd">78200000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfMi0zLTEtMS0w_a93fdd7e-98d3-4d18-a807-81d379c47238"
      unitRef="usd">28900000</us-gaap:PrepaidTaxes>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfMy0xLTEtMS0w_64b021ad-556d-403a-8e50-79a70de8868e"
      unitRef="usd">43800000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfMy0zLTEtMS0w_768166b5-efab-4d44-a1df-2599e909b9bb"
      unitRef="usd">60100000</us-gaap:EquitySecuritiesFvNi>
    <isrg:SalesTypeLeaseNetInvestmentInLeaseCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfNC0xLTEtMS0w_4b5fbfa5-4e7f-4546-b078-4dca9f48a9f8"
      unitRef="usd">98600000</isrg:SalesTypeLeaseNetInvestmentInLeaseCurrent>
    <isrg:SalesTypeLeaseNetInvestmentInLeaseCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfNC0zLTEtMS0w_4b9c3ea6-b9fc-4b30-afc3-4dc300383508"
      unitRef="usd">81100000</isrg:SalesTypeLeaseNetInvestmentInLeaseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfNS0xLTEtMS0w_be3295b9-95f6-4ddc-bf7f-6c22446dd0d9"
      unitRef="usd">139300000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfNS0zLTEtMS0w_319419d7-bc00-41b6-abb7-cc900c1c7592"
      unitRef="usd">97400000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfNi0xLTEtMS0w_58160aaf-09d3-4411-8f83-c088fc683364"
      unitRef="usd">359900000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjY4NTQ4Y2M0Nzg2ODRhN2E5NTEyZGI2ZGI2MmU3YmI4L3RhYmxlcmFuZ2U6Njg1NDhjYzQ3ODY4NGE3YTk1MTJkYjZkYjYyZTdiYjhfNi0zLTEtMS0w_362ff627-0480-46fe-bb1d-cba67d5fc2fc"
      unitRef="usd">267500000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RleHRyZWdpb246YWVkMmJhMDJlOTE0NGFiNGEzYjk0ZWFkMTVhNzk0ODJfMzQw_e660b37e-5b41-46b4-92ab-b116cd5872d8">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Other accrued liabilities&#x2013;short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of deferred purchase consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other accrued liabilities&#x2013;short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:TaxesPayableCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfMi0xLTEtMS0w_3f49d0c2-0e8a-43f2-b29f-363b8dba9fef"
      unitRef="usd">65900000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfMi0zLTEtMS0w_9dd95a5a-35c2-4a20-8724-e496e34c2fc3"
      unitRef="usd">47200000</us-gaap:TaxesPayableCurrent>
    <isrg:DeferredPurchaseConsiderationPaymentsCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfNC0xLTEtMS0w_0f4d42dc-8a2c-48f8-a76c-c3359bd6e1ce"
      unitRef="usd">12200000</isrg:DeferredPurchaseConsiderationPaymentsCurrent>
    <isrg:DeferredPurchaseConsiderationPaymentsCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfNC0zLTEtMS0w_02882963-af11-4a2b-afa5-f08e820849f2"
      unitRef="usd">10400000</isrg:DeferredPurchaseConsiderationPaymentsCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfNS0xLTEtMS0w_94fdc2d9-5e21-440a-89f7-3cf65d08336b"
      unitRef="usd">600000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfNS0zLTEtMS0w_bc8ec5c7-bbc9-43bd-a0ca-729a8e41a834"
      unitRef="usd">15100000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfNi0xLTEtMS0w_00191968-bed9-4eb4-92d6-8b1df1e258a7"
      unitRef="usd">214800000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfNi0zLTEtMS0w_3dc62cdf-57f2-49b5-ac1c-d5c56d6a5112"
      unitRef="usd">225600000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfNy0xLTEtMS0w_91319625-42bf-440e-a8ac-2ed2717b0e21"
      unitRef="usd">293500000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmFkMzQzYWE4YmViYjRjZjI4Mjk3NTU3MjU1NzcwY2MyL3RhYmxlcmFuZ2U6YWQzNDNhYThiZWJiNGNmMjgyOTc1NTcyNTU3NzBjYzJfNy0zLTEtMS0w_8b30e1fb-e577-4c02-a28a-cae859ee1099"
      unitRef="usd">298300000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RleHRyZWdpb246YWVkMmJhMDJlOTE0NGFiNGEzYjk0ZWFkMTVhNzk0ODJfMzU2_5dbc33ea-8316-4cb8-87bc-b4af8226df7a">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&#x2013;long-term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&#x2013;long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;447.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmY5NmZlYTZlOWNmYzQ0Mjg4NzU1NWNlOTBkZjcyMzBhL3RhYmxlcmFuZ2U6Zjk2ZmVhNmU5Y2ZjNDQyODg3NTU1Y2U5MGRmNzIzMGFfMi0xLTEtMS0w_aef26862-faf8-44aa-9af5-36efaa217b74"
      unitRef="usd">309200000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmY5NmZlYTZlOWNmYzQ0Mjg4NzU1NWNlOTBkZjcyMzBhL3RhYmxlcmFuZ2U6Zjk2ZmVhNmU5Y2ZjNDQyODg3NTU1Y2U5MGRmNzIzMGFfMi0zLTEtMS0w_c293ab17-a419-402b-b621-462105d2f28a"
      unitRef="usd">305600000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmY5NmZlYTZlOWNmYzQ0Mjg4NzU1NWNlOTBkZjcyMzBhL3RhYmxlcmFuZ2U6Zjk2ZmVhNmU5Y2ZjNDQyODg3NTU1Y2U5MGRmNzIzMGFfMy0xLTEtMS0w_b942e620-96a7-42d6-895f-178ef20e9d23"
      unitRef="usd">35000000.0</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmY5NmZlYTZlOWNmYzQ0Mjg4NzU1NWNlOTBkZjcyMzBhL3RhYmxlcmFuZ2U6Zjk2ZmVhNmU5Y2ZjNDQyODg3NTU1Y2U5MGRmNzIzMGFfMy0zLTEtMS0w_0590d4fa-c1f7-409b-9e71-16f7ce87e4bf"
      unitRef="usd">32100000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmY5NmZlYTZlOWNmYzQ0Mjg4NzU1NWNlOTBkZjcyMzBhL3RhYmxlcmFuZ2U6Zjk2ZmVhNmU5Y2ZjNDQyODg3NTU1Y2U5MGRmNzIzMGFfNC0xLTEtMS0w_d8e0368d-9e7d-475b-bae9-7b16f4db8ca9"
      unitRef="usd">103600000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmY5NmZlYTZlOWNmYzQ0Mjg4NzU1NWNlOTBkZjcyMzBhL3RhYmxlcmFuZ2U6Zjk2ZmVhNmU5Y2ZjNDQyODg3NTU1Y2U5MGRmNzIzMGFfNC0zLTEtMS0w_f7891364-2bb5-4d42-8950-bd718e6c1e0b"
      unitRef="usd">106900000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmY5NmZlYTZlOWNmYzQ0Mjg4NzU1NWNlOTBkZjcyMzBhL3RhYmxlcmFuZ2U6Zjk2ZmVhNmU5Y2ZjNDQyODg3NTU1Y2U5MGRmNzIzMGFfNS0xLTEtMS0w_ba5e2565-0115-4095-a60b-c1d55a00599c"
      unitRef="usd">447800000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOmY5NmZlYTZlOWNmYzQ0Mjg4NzU1NWNlOTBkZjcyMzBhL3RhYmxlcmFuZ2U6Zjk2ZmVhNmU5Y2ZjNDQyODg3NTU1Y2U5MGRmNzIzMGFfNS0zLTEtMS0w_c8e498e8-6206-43c7-a2e2-c7997de4b62a"
      unitRef="usd">444600000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RleHRyZWdpb246YWVkMmJhMDJlOTE0NGFiNGEzYjk0ZWFkMTVhNzk0ODJfMzQ2_db307501-d4dd-497d-abc8-23bcad5781bc">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides supplemental non-cash investing and financing activities (in millions):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition of property, plant, and equipment in accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred payments and contingent consideration related to business combinations and asset acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTransfersAndChanges
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjNjYjk3YTg1YWJjNTQ1YTc5OWNhNTQzODQ5MDM2YTBhL3RhYmxlcmFuZ2U6M2NiOTdhODVhYmM1NDVhNzk5Y2E1NDM4NDkwMzZhMGFfMi00LTEtMS0w_0f969493-105a-4595-a1de-e9d283da532e"
      unitRef="usd">229200000</us-gaap:PropertyPlantAndEquipmentTransfersAndChanges>
    <us-gaap:PropertyPlantAndEquipmentTransfersAndChanges
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjNjYjk3YTg1YWJjNTQ1YTc5OWNhNTQzODQ5MDM2YTBhL3RhYmxlcmFuZ2U6M2NiOTdhODVhYmM1NDVhNzk5Y2E1NDM4NDkwMzZhMGFfMi02LTEtMS0w_b0b4549f-e99e-48c4-8051-73a9bbc88f1d"
      unitRef="usd">123600000</us-gaap:PropertyPlantAndEquipmentTransfersAndChanges>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjNjYjk3YTg1YWJjNTQ1YTc5OWNhNTQzODQ5MDM2YTBhL3RhYmxlcmFuZ2U6M2NiOTdhODVhYmM1NDVhNzk5Y2E1NDM4NDkwMzZhMGFfMy00LTEtMS0w_e1f17577-6847-424a-880e-5ef133f73db9"
      unitRef="usd">29900000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjNjYjk3YTg1YWJjNTQ1YTc5OWNhNTQzODQ5MDM2YTBhL3RhYmxlcmFuZ2U6M2NiOTdhODVhYmM1NDVhNzk5Y2E1NDM4NDkwMzZhMGFfMy02LTEtMS0w_342db21d-0dad-465e-9afa-9bea0dc04022"
      unitRef="usd">44100000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <isrg:BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjNjYjk3YTg1YWJjNTQ1YTc5OWNhNTQzODQ5MDM2YTBhL3RhYmxlcmFuZ2U6M2NiOTdhODVhYmM1NDVhNzk5Y2E1NDM4NDkwMzZhMGFfNC00LTEtMS0w_2b25eac3-6fd7-46c1-a64d-7d9badd0abf9"
      unitRef="usd">7500000</isrg:BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments>
    <isrg:BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80MC9mcmFnOmFlZDJiYTAyZTkxNDRhYjRhM2I5NGVhZDE1YTc5NDgyL3RhYmxlOjNjYjk3YTg1YWJjNTQ1YTc5OWNhNTQzODQ5MDM2YTBhL3RhYmxlcmFuZ2U6M2NiOTdhODVhYmM1NDVhNzk5Y2E1NDM4NDkwMzZhMGFfNC02LTEtMS0w_c1fce476-b96d-4f95-8ab3-76cd8e91508b"
      unitRef="usd">4100000</isrg:BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfOTg5NTYwNDY1NDkyNg_35658d20-4c0b-4353-9081-713c3a0bd021">REVENUE AND CONTRACT ACQUISITION COSTS&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue disaggregated by types and geography (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments and accessories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,227.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;447.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total U.S. revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,060.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Outside of U.S. (&#x201c;OUS&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments and accessories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;479.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total OUS revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,353.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments and accessories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;630.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,708.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,223.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,403.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,159.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,029.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Remaining Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which revenue has not yet been recognized. A significant portion of these performance obligations relate to service obligations in the Company's system sale and lease arrangements that will be satisfied and recognized as revenue in future periods. The transaction price allocated to the remaining performance obligations was $1,723 million as of September&#160;30, 2021. The remaining performance obligations are expected to be satisfied over the term of the system sale and lease arrangements, which generally are up to 5 years. Service revenue associated with the lease arrangements will be recognized over the service period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following information summarizes the Company&#x2019;s contract assets and liabilities (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company invoices its customers based on the billing schedules in its sales arrangements. Payments are generally due 30 to 60 days from date of invoice. Contract assets for the periods presented primarily represent the difference between the revenue that was recognized based on the relative standalone selling price of the related performance obligations satisfied and the contractual billing terms in the arrangements. Deferred revenue for the periods presented primarily relates to service contracts where the service fees are billed up-front, generally quarterly or annually, prior to those services having been performed. The associated deferred revenue is generally recognized over the term of the service period. The Company did not have any significant impairment losses on its contract assets for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2021, the Company recognized $66.1&#160;million and $319.3&#160;million of revenue, respectively, that was included in the deferred revenue balance as of December&#160;31, 2020. During the three and nine months ended September&#160;30, 2020, the Company recognized $58.1&#160;million and $249.7&#160;million of revenue, respectively, net of the impact of the Customer Relief Program, that was included in the deferred revenue balance as of December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intuitive System Leasing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue from Intuitive System Leasing arrangements (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended September&#160;30, 2021, and 2020, variable lease revenue relating to usage-based arrangements was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Trade Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The allowance for doubtful accounts is based on the Company&#x2019;s assessment of the collectibility of customer accounts. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, the age of the accounts receivable balances, and current economic conditions that may affect a customer&#x2019;s ability to pay. For the three and nine months ended September&#160;30, 2021, and 2020, bad debt expense was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. Although the Company has historically not experienced significant credit losses, it is possible that there could be a material adverse impact from potential adjustments of the carrying amount of lease and trade receivables as hospital cash flows are impacted by their response to the COVID-19 pandemic and deferral of elective surgical procedures.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMzg2MA_6e7b7287-2827-44cc-b96d-b06846dd10a7">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue disaggregated by types and geography (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments and accessories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,227.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;447.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total U.S. revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,060.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Outside of U.S. (&#x201c;OUS&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments and accessories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;479.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total OUS revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,353.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments and accessories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;630.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,708.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,223.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,403.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,159.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,029.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iecb4ff6e5fe5459f9bc00395116a38fb_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMi0xLTEtMS0w_72bc5e38-308b-4e16-9b9f-2475a690ad48"
      unitRef="usd">535700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf31bd19117d49ad9339442660f985f1_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMi0zLTEtMS0w_de8efd83-eee2-4565-a195-1832c1a888bc"
      unitRef="usd">467300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife0812e0ddbd443b89d9604955851763_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMi01LTEtMS0w_824d2359-ffb1-4ab6-96ae-d99e421a0d2a"
      unitRef="usd">1614000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2604357eba845b084dd3bf73b2757e5_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMi03LTEtMS0w_52bdf9b0-765d-461b-84e9-d1198745699b"
      unitRef="usd">1227200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i41d6f85820774298aee1036152f3f737_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMy0xLTEtMS0w_d8e1ae5b-54dc-467d-bced-593050f9603f"
      unitRef="usd">263400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25dca51a46e14c27ba59a12aad400497_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMy0zLTEtMS0w_1c97bea5-2827-4f60-a491-766b375c9853"
      unitRef="usd">157700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id89c6d81b52d4816b2252aef11227497_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMy01LTEtMS0w_69c84525-4837-40b3-ab09-5718b1824805"
      unitRef="usd">743700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c75d5f4a15f44ca9ac400c2f1889d82_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMy03LTEtMS0w_d203d611-f28d-46cf-a492-395f3c9c1d60"
      unitRef="usd">495800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i406fb20eeca84b7d92fe357463e85f6c_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfNC0xLTEtMS0w_f940126f-dbc0-4868-a3c3-add34ac1fdfe"
      unitRef="usd">153100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad16e7fe313c4489a4b36c3fbd634251_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfNC0zLTEtMS0w_3e030188-6960-40c4-8138-4540f10e2bc4"
      unitRef="usd">118800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3925b0e265e6407ba522b052f71f3c41_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfNC01LTEtMS0w_c879b03e-00a6-4302-9df0-552e767d4206"
      unitRef="usd">447800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7caf933d32a44a348550d2fe3f894b90_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfNC03LTEtMS0w_bc9401ba-fde3-4d8e-91a9-c4c77003af00"
      unitRef="usd">337800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f847939b19c491f9f7d865b8bed8ca5_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfNS0xLTEtMS0w_60254c43-eb4e-4d2e-9322-757bfc615cf5"
      unitRef="usd">952200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4aecb14552b54937b40537850614044e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfNS0zLTEtMS0w_077b9323-d1aa-46e2-a3fb-f6c5dca5b85c"
      unitRef="usd">743800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88e4709c5bac4f04a4f648b34d11dcfc_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfNS01LTEtMS0w_905144c6-cd73-48ef-9c22-516b6d9d4da4"
      unitRef="usd">2805500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7dda0f930e68405ab3bc179a126443d9_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfNS03LTEtMS0w_1b665d8a-a185-4ebb-b4c1-c6e43ee44583"
      unitRef="usd">2060800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f77153a86ef4445b2643323afa75e0d_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfOC0xLTEtMS0w_7d79a181-c4b1-4e41-ad29-1f674d373d2c"
      unitRef="usd">219700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6decb5bae0bb4ac8a4dd1cb95e052fb1_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfOC0zLTEtMS0w_60579da4-209b-4f79-824c-b9e729f1fee4"
      unitRef="usd">163200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e03e6e08b894f258a0ae7e5baf29d4d_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfOC01LTEtMS0w_0976e3ba-7b5c-4730-bee1-36c6e8370638"
      unitRef="usd">643700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i577d8ffa87da4e9f87387883bec6f02b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfOC03LTEtMS0w_589e34ee-35bc-4050-b7b6-d9b5121a8b02"
      unitRef="usd">481600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77bac0e4769042e483f91c8ebb08ee8e_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfOS0xLTEtMS0w_d91e6375-555a-413a-9d98-2792c7d53a9b"
      unitRef="usd">151800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice87d9c6353945688b8d23575204c383_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfOS0zLTEtMS0w_699a5157-b2a8-4eb9-86bb-369ac9438b8e"
      unitRef="usd">110100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9db5f294e20446a485b225b9c62bd623_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfOS01LTEtMS0w_dd719c2a-ee58-40b8-9a9d-ab0f5d09f99e"
      unitRef="usd">479700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4dcb119f285471db2ed01f635d0158b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfOS03LTEtMS0w_88ba1f7c-034c-4af7-975e-9f76cea543a7"
      unitRef="usd">316300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e116d872911487b964787a5ad7b829e_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTAtMS0xLTEtMA_eba7b16c-96ed-4d61-9934-974f5eff0e70"
      unitRef="usd">79600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b8fa49940cf4659848e727c825f73c9_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTAtMy0xLTEtMA_00e18b15-ca70-4003-817b-a126964045e0"
      unitRef="usd">60600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bbf79c7461d494abe77f32ab6fa2494_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTAtNS0xLTEtMA_efe4232b-d183-4134-abe7-a8fd41782e29"
      unitRef="usd">230500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbabbfafefa044f6b3ce8e02746f0a49_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTAtNy0xLTEtMA_5fade72d-4853-4367-ade3-99bb5b29e905"
      unitRef="usd">170600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i412f99609e454649a82b61eed8aa58ac_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTEtMS0xLTEtMA_8143e169-ba99-4e51-ae5e-e393478255ba"
      unitRef="usd">451100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i996abb0f87034c4f91f7b2f0ad4eda06_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTEtMy0xLTEtMA_960cdb96-e2c0-4baa-8d7c-0f16d9d326f3"
      unitRef="usd">333900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i672905085bc3459a9d00cbc325e97bb4_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTEtNS0xLTEtMA_cbeaab61-d167-447f-9185-bd298ddbe393"
      unitRef="usd">1353900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f0a990e6c394d8c8008639d37935b0a_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTEtNy0xLTEtMA_ede9db59-0b0f-4b13-a8b2-c6f8bd8d0e7b"
      unitRef="usd">968500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b1f121a531948669a508b4480804ca0_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTQtMS0xLTEtMA_60dd92e8-c9b4-4f9c-afd3-204b7586f0d1"
      unitRef="usd">755400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ae8d93de5f54b1ab269fde30dd6b190_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTQtMy0xLTEtMA_9d5de290-7a6a-400b-bd26-9ad9138d4df2"
      unitRef="usd">630500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idab02e2b14ea4d82817b4d902d15adc7_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTQtNS0xLTEtMA_d21195e2-1ab1-4b90-ac1e-75cbac9ddf73"
      unitRef="usd">2257700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i620c79857bce477992bc9f8b37092c6c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTQtNy0xLTEtMA_403b6fea-2ce2-4a5e-8a0f-4a7679d85d1a"
      unitRef="usd">1708800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if10e966d0d6b4c70a5fb900ee48bfb44_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTUtMS0xLTEtMA_b1bccbec-48db-48f1-bd0b-98a2611661ee"
      unitRef="usd">415200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1901af46aeed45319e6c22a2482f0527_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTUtMy0xLTEtMA_5d382aec-f35e-4b6c-866f-c92c31aff8ea"
      unitRef="usd">267800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2075d28d68b94983bd02ac4a20ff18d2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTUtNS0xLTEtMA_f39880e6-6782-4444-a5b9-eef5e609cc73"
      unitRef="usd">1223400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i977db1115aba4294ab954fafbee1ba05_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTUtNy0xLTEtMA_378c7d70-fe65-45c5-ae5b-1b6457085ec2"
      unitRef="usd">812100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ica0e2ab5444c405588f03410c79beb75_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTYtMS0xLTEtMA_2a38559e-87b5-4bf3-825f-62d1518e4c35"
      unitRef="usd">232700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37656fec38db4901b77f277074155cce_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTYtMy0xLTEtMA_eac3e661-8259-4883-bd58-ea92925570d3"
      unitRef="usd">179400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1022821765b944a7a6645ef3d885d0d8_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTYtNS0xLTEtMA_f104b445-18cb-44ff-9367-983a05b9c6d8"
      unitRef="usd">678300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i89a0602b4836416f90adbc080a012a8e_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTYtNy0xLTEtMA_ac48b056-e136-4862-99cc-094449f0e2cd"
      unitRef="usd">508400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTctMS0xLTEtMA_7d41351e-1d5b-48c6-83c5-8cc320e86987"
      unitRef="usd">1403300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTctMy0xLTEtMA_1ccc796f-6d32-43e1-ad92-11e9d3294c3a"
      unitRef="usd">1077700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTctNS0xLTEtMA_ce387a61-4372-4828-8ff0-d8225b4b2122"
      unitRef="usd">4159400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOjZkMzRhM2FiZWQxMTQ1MjViMWZkZWIyYmE4M2VhY2FhL3RhYmxlcmFuZ2U6NmQzNGEzYWJlZDExNDUyNWIxZmRlYjJiYTgzZWFjYWFfMTctNy0xLTEtMA_c8cbd6e5-f993-4146-a564-c74085a3f2d8"
      unitRef="usd">3029300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfODU1_76403e39-0957-41e4-8eab-c3cbd1cf32b7"
      unitRef="usd">1723000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ie286ee6f7f574339b7040c18df117a53_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMTAwNw_4294839f-8fc1-4440-9440-eb1ade4d475d">P5Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMzg1NQ_040a7dfd-c11b-46f2-ae2b-2aaef0f51329">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following information summarizes the Company&#x2019;s contract assets and liabilities (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmU1MDY3NDNjNWYyMzRmNjFhNGRhNjJmNjkyYTk3YzJiL3RhYmxlcmFuZ2U6ZTUwNjc0M2M1ZjIzNGY2MWE0ZGE2MmY2OTJhOTdjMmJfMy0xLTEtMS0w_a1445658-f9b5-4f10-978a-57aa6f40d231"
      unitRef="usd">44800000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmU1MDY3NDNjNWYyMzRmNjFhNGRhNjJmNjkyYTk3YzJiL3RhYmxlcmFuZ2U6ZTUwNjc0M2M1ZjIzNGY2MWE0ZGE2MmY2OTJhOTdjMmJfMy0zLTEtMS0w_cc2c6caa-a342-4363-b79e-e5bb627e0f45"
      unitRef="usd">34600000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmU1MDY3NDNjNWYyMzRmNjFhNGRhNjJmNjkyYTk3YzJiL3RhYmxlcmFuZ2U6ZTUwNjc0M2M1ZjIzNGY2MWE0ZGE2MmY2OTJhOTdjMmJfNC0xLTEtMS0w_353e8336-85f5-4d90-ba13-efbaf9cd7537"
      unitRef="usd">383500000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmU1MDY3NDNjNWYyMzRmNjFhNGRhNjJmNjkyYTk3YzJiL3RhYmxlcmFuZ2U6ZTUwNjc0M2M1ZjIzNGY2MWE0ZGE2MmY2OTJhOTdjMmJfNC0zLTEtMS0w_4e04e6ab-137b-449a-ae05-556d9539491b"
      unitRef="usd">382300000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMjE3OQ_033ffae9-ba2b-4698-a8d8-b62c5ef3082d"
      unitRef="usd">66100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMjE4Ng_d61a338c-26f5-46aa-be2c-98f667872e9f"
      unitRef="usd">319300000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMjMyOQ_85b1dff1-f65b-4ca4-851b-bade4531638c"
      unitRef="usd">58100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMjMzNg_fbc62c81-97c8-48b7-b270-1eee722d6dca"
      unitRef="usd">249700000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:OperatingLeaseLeaseIncomeTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMzg1Nw_d0fc623a-4f49-4736-b65b-dcc351436a88">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue from Intuitive System Leasing arrangements (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OperatingLeaseLeaseIncomeTableTextBlock>
    <us-gaap:SalesTypeLeaseLeaseIncomeTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RleHRyZWdpb246ZTE2Njk5NDZjYTVkNDg0Yjg0ZTc1NGYyOTdjZWRhNmZfMzg1OA_5939fbe1-053d-4ae0-899a-af2c6602d20e">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue from Intuitive System Leasing arrangements (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SalesTypeLeaseLeaseIncomeTableTextBlock>
    <us-gaap:SalesTypeLeaseLeaseIncome
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmEwZDFhMzI3YWYyZTQyMTk5OWYwNWQ2Y2Y2M2YwOTVkL3RhYmxlcmFuZ2U6YTBkMWEzMjdhZjJlNDIxOTk5ZjA1ZDZjZjYzZjA5NWRfMi0xLTEtMS0w_ac66dbea-6d25-4edb-8c4f-a0a5d736d1c5"
      unitRef="usd">39000000.0</us-gaap:SalesTypeLeaseLeaseIncome>
    <us-gaap:SalesTypeLeaseLeaseIncome
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmEwZDFhMzI3YWYyZTQyMTk5OWYwNWQ2Y2Y2M2YwOTVkL3RhYmxlcmFuZ2U6YTBkMWEzMjdhZjJlNDIxOTk5ZjA1ZDZjZjYzZjA5NWRfMi0zLTEtMS0w_e09e347a-a0ac-41d8-afc1-1ed9065bc40d"
      unitRef="usd">24700000</us-gaap:SalesTypeLeaseLeaseIncome>
    <us-gaap:SalesTypeLeaseLeaseIncome
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmEwZDFhMzI3YWYyZTQyMTk5OWYwNWQ2Y2Y2M2YwOTVkL3RhYmxlcmFuZ2U6YTBkMWEzMjdhZjJlNDIxOTk5ZjA1ZDZjZjYzZjA5NWRfMi01LTEtMS0w_f6a80365-c32d-4739-84c3-b1920860d019"
      unitRef="usd">140300000</us-gaap:SalesTypeLeaseLeaseIncome>
    <us-gaap:SalesTypeLeaseLeaseIncome
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmEwZDFhMzI3YWYyZTQyMTk5OWYwNWQ2Y2Y2M2YwOTVkL3RhYmxlcmFuZ2U6YTBkMWEzMjdhZjJlNDIxOTk5ZjA1ZDZjZjYzZjA5NWRfMi03LTEtMS0w_f37c54c2-7d51-474f-8524-bb1dd5addcb4"
      unitRef="usd">96500000</us-gaap:SalesTypeLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmEwZDFhMzI3YWYyZTQyMTk5OWYwNWQ2Y2Y2M2YwOTVkL3RhYmxlcmFuZ2U6YTBkMWEzMjdhZjJlNDIxOTk5ZjA1ZDZjZjYzZjA5NWRfMy0xLTEtMS0w_20c0f46f-9f1c-4328-b317-9ec65657e157"
      unitRef="usd">72500000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmEwZDFhMzI3YWYyZTQyMTk5OWYwNWQ2Y2Y2M2YwOTVkL3RhYmxlcmFuZ2U6YTBkMWEzMjdhZjJlNDIxOTk5ZjA1ZDZjZjYzZjA5NWRfMy0zLTEtMS0w_67fa5e6d-1b37-463a-ab26-a4c47e12be39"
      unitRef="usd">45700000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmEwZDFhMzI3YWYyZTQyMTk5OWYwNWQ2Y2Y2M2YwOTVkL3RhYmxlcmFuZ2U6YTBkMWEzMjdhZjJlNDIxOTk5ZjA1ZDZjZjYzZjA5NWRfMy01LTEtMS0w_151dddb7-bc20-40d0-be9a-35c4aa9d4907"
      unitRef="usd">198800000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80My9mcmFnOmUxNjY5OTQ2Y2E1ZDQ4NGI4NGU3NTRmMjk3Y2VkYTZmL3RhYmxlOmEwZDFhMzI3YWYyZTQyMTk5OWYwNWQ2Y2Y2M2YwOTVkL3RhYmxlcmFuZ2U6YTBkMWEzMjdhZjJlNDIxOTk5ZjA1ZDZjZjYzZjA5NWRfMy03LTEtMS0w_f56046c3-1ce5-4f49-9ef9-be38f1a9f834"
      unitRef="usd">127000000.0</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:LessorSalesTypeLeasesTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RleHRyZWdpb246NWQzOTE5ZDFlYmU3NDNhMTgwOTFiZTQ2YTM3ZDQ1ZGNfMTcxNA_bec8e3a8-6faf-4c4b-a34c-a1f08b4ff544">LEASES&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessor Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sales-type Leases. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease receivables relating to sales-type lease arrangements are presented on the Condensed Consolidated Balance Sheets as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross lease receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment in sales-type leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible and other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual maturities of gross lease receivables at September&#160;30, 2021, are as follows (in millions):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into sales-type leases with certain qualified customers to purchase its systems. Sales-type leases have terms that generally range from 24 to 84 months and are usually collateralized by a security interest in the underlying assets. The allowance for loan loss is based on the Company&#x2019;s assessment of current expected lifetime loss on lease receivables. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, the age of the lease receivable balances, and current economic conditions that may affect a customer&#x2019;s ability to pay. Lease receivables are considered past due 90 days after invoice.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages the credit risk in net investment in sales-type leases using a number of factors, including, but not limited to the following: size of operations; profitability, liquidity, and debt ratios; payment history; and past due amounts. The Company also uses credit scores obtained from external providers as a key credit quality indicator for the purposes of determining credit quality. The following table presents credit quality by class of net investment in sales-type leases as of September&#160;30, 2021. The following table summarizes the amortized cost basis by year of origination and credit quality indicator as of September&#160;30, 2021 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Credit Rating:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;High&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Moderate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Low&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended September&#160;30, 2021, and 2020, credit losses related to net investment in sales-type leases were not significant.&lt;/span&gt;&lt;/div&gt;</us-gaap:LessorSalesTypeLeasesTextBlock>
    <isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RleHRyZWdpb246NWQzOTE5ZDFlYmU3NDNhMTgwOTFiZTQ2YTM3ZDQ1ZGNfMTczNQ_e56c5c28-1fe3-49d8-bd3f-1ca81e61e687">Lease receivables relating to sales-type lease arrangements are presented on the Condensed Consolidated Balance Sheets as follows (in millions):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross lease receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment in sales-type leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible and other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock>
    <isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RleHRyZWdpb246NWQzOTE5ZDFlYmU3NDNhMTgwOTFiZTQ2YTM3ZDQ1ZGNfMTc0Mg_92207806-1b2b-4f86-8a53-c79dea42b16a">Lease receivables relating to sales-type lease arrangements are presented on the Condensed Consolidated Balance Sheets as follows (in millions):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross lease receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment in sales-type leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible and other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock>
    <isrg:SalesTypeLeaseGrossInvestmentInLease
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfMi0xLTEtMS0w_ec3431a1-b912-4d50-81f4-fe6181b850c5"
      unitRef="usd">356100000</isrg:SalesTypeLeaseGrossInvestmentInLease>
    <isrg:SalesTypeLeaseGrossInvestmentInLease
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfMi0zLTEtMS0w_49592245-3545-49e9-bec0-736fb18dd65d"
      unitRef="usd">286100000</isrg:SalesTypeLeaseGrossInvestmentInLease>
    <isrg:SalestypeLeaseDeferredSellingProfit
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfMy0xLTEtMS0w_f4c6f862-f93b-4588-b404-2aead567f124"
      unitRef="usd">11700000</isrg:SalestypeLeaseDeferredSellingProfit>
    <isrg:SalestypeLeaseDeferredSellingProfit
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfMy0zLTEtMS0w_97e65076-b367-4230-812a-89f2ca8c1a4f"
      unitRef="usd">11100000</isrg:SalestypeLeaseDeferredSellingProfit>
    <us-gaap:SalesTypeLeaseNetInvestmentInLease
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfNC0xLTEtMS0w_cea8963a-517e-44a2-99f4-abf9e80eed2d"
      unitRef="usd">344400000</us-gaap:SalesTypeLeaseNetInvestmentInLease>
    <us-gaap:SalesTypeLeaseNetInvestmentInLease
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfNC0zLTEtMS0w_61add7ec-d578-48bd-8854-e98f6eb97d33"
      unitRef="usd">275000000.0</us-gaap:SalesTypeLeaseNetInvestmentInLease>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfNS0xLTEtMS0w_082f4ccc-87ee-44bd-90b0-4386c460700c"
      unitRef="usd">3700000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfNS0zLTEtMS0w_6ab6f57a-b1b7-423b-bb44-ea780f9af5db"
      unitRef="usd">4400000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfNi0xLTEtMS0w_41fa65e8-ff7a-4faf-aec8-e1805487d170"
      unitRef="usd">340700000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfNi0zLTEtMS0w_a50c1ed9-8d60-4f13-817c-aa9efbd5faf7"
      unitRef="usd">270600000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="i40ae7c3cefde401583c8e526051dd07b_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfOC0xLTEtMS0w_c05c16bc-99d7-4318-b304-ff700a90b255"
      unitRef="usd">98600000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="ifb5a865f78164fc18aef9ad29f31e8ff_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfOC0zLTEtMS0w_557d7783-18d8-41d2-8406-2b62ffcbd9c6"
      unitRef="usd">81100000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="id4d7cc4e81e94501bcf79b671e5df53c_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfOS0xLTEtMS0w_57e2b13b-0148-46e9-8022-2175c4dc301f"
      unitRef="usd">242100000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="i49470d81e3c048edbcda45a279c28a74_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfOS0zLTEtMS0w_3b89627d-ba69-4df5-92a1-3c760af90770"
      unitRef="usd">189500000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfMTAtMS0xLTEtMA_9e5bdc5f-6ea3-4357-bda3-15979c6e88be"
      unitRef="usd">340700000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOmUxOGIzOWVkMDMyYTRkN2JiM2E5NTE1MTUxNGExMjFmL3RhYmxlcmFuZ2U6ZTE4YjM5ZWQwMzJhNGQ3YmIzYTk1MTUxNTE0YTEyMWZfMTAtMy0xLTEtMA_668cd5d4-4aea-4f90-9bb0-606ffc877e1b"
      unitRef="usd">270600000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RleHRyZWdpb246NWQzOTE5ZDFlYmU3NDNhMTgwOTFiZTQ2YTM3ZDQ1ZGNfMTcyMQ_0a5b0846-ee73-436b-bef9-8a2a8b66c714">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual maturities of gross lease receivables at September&#160;30, 2021, are as follows (in millions):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjE1OTk1MDU1ODY1ODRkNmQ5OTNjZDIzNWE1ODBkMzMyL3RhYmxlcmFuZ2U6MTU5OTUwNTU4NjU4NGQ2ZDk5M2NkMjM1YTU4MGQzMzJfMS0xLTEtMS0w_d3f72235-b080-41ac-a8d7-5f06220c4f0b"
      unitRef="usd">25600000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjE1OTk1MDU1ODY1ODRkNmQ5OTNjZDIzNWE1ODBkMzMyL3RhYmxlcmFuZ2U6MTU5OTUwNTU4NjU4NGQ2ZDk5M2NkMjM1YTU4MGQzMzJfMi0xLTEtMS0w_7ac4b6b8-2e7a-46c6-935c-9d00fcf5e7f1"
      unitRef="usd">101400000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjE1OTk1MDU1ODY1ODRkNmQ5OTNjZDIzNWE1ODBkMzMyL3RhYmxlcmFuZ2U6MTU5OTUwNTU4NjU4NGQ2ZDk5M2NkMjM1YTU4MGQzMzJfMy0xLTEtMS0w_6cf16ed6-bcda-4908-8c12-5b2182bf0052"
      unitRef="usd">86500000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjE1OTk1MDU1ODY1ODRkNmQ5OTNjZDIzNWE1ODBkMzMyL3RhYmxlcmFuZ2U6MTU5OTUwNTU4NjU4NGQ2ZDk5M2NkMjM1YTU4MGQzMzJfNC0xLTEtMS0w_f83b0af8-1669-4c52-9bb8-a0c56990d161"
      unitRef="usd">74200000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjE1OTk1MDU1ODY1ODRkNmQ5OTNjZDIzNWE1ODBkMzMyL3RhYmxlcmFuZ2U6MTU5OTUwNTU4NjU4NGQ2ZDk5M2NkMjM1YTU4MGQzMzJfNS0xLTEtMS0w_77f5288a-b5bf-4f17-8d34-646b9a1142f6"
      unitRef="usd">49400000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears>
    <isrg:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjE1OTk1MDU1ODY1ODRkNmQ5OTNjZDIzNWE1ODBkMzMyL3RhYmxlcmFuZ2U6MTU5OTUwNTU4NjU4NGQ2ZDk5M2NkMjM1YTU4MGQzMzJfNi0xLTEtMS0w_85da27ce-9716-443d-bc6c-b7eccced82ba"
      unitRef="usd">19000000.0</isrg:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjE1OTk1MDU1ODY1ODRkNmQ5OTNjZDIzNWE1ODBkMzMyL3RhYmxlcmFuZ2U6MTU5OTUwNTU4NjU4NGQ2ZDk5M2NkMjM1YTU4MGQzMzJfNy0xLTEtMS0w_9dedcb1c-cdd0-4ed3-b7a3-6b7f968e1068"
      unitRef="usd">356100000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived>
    <us-gaap:LessorSalesTypeLeaseTermOfContract1
      contextRef="i77ba4e1aaa0a40daa59040ab5003d99d_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RleHRyZWdpb246NWQzOTE5ZDFlYmU3NDNhMTgwOTFiZTQ2YTM3ZDQ1ZGNfNDQ4_998911ba-91b5-46dd-98d6-5167bf165560">P24M</us-gaap:LessorSalesTypeLeaseTermOfContract1>
    <us-gaap:LessorSalesTypeLeaseTermOfContract1
      contextRef="ib82660af9cff4336adca1f99b02c09c4_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RleHRyZWdpb246NWQzOTE5ZDFlYmU3NDNhMTgwOTFiZTQ2YTM3ZDQ1ZGNfNDU0_288c9b47-6c0f-4ffd-be73-96264f3e3ec2">P84M</us-gaap:LessorSalesTypeLeaseTermOfContract1>
    <us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RleHRyZWdpb246NWQzOTE5ZDFlYmU3NDNhMTgwOTFiZTQ2YTM3ZDQ1ZGNfMTcxOQ_23196dbf-0fc6-4e07-83a7-470ba150f53a">The following table summarizes the amortized cost basis by year of origination and credit quality indicator as of September&#160;30, 2021 (in millions):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Credit Rating:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;High&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Moderate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Low&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear
      contextRef="ief72904a51c44045bc02018f15b8f0ed_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMi0xLTEtMS0w_f57b19e6-b7ce-4732-9630-24faf9a63728"
      unitRef="usd">76000000.0</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear
      contextRef="ief72904a51c44045bc02018f15b8f0ed_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMi0zLTEtMS0w_9bb2082b-3305-4517-b775-036f37309083"
      unitRef="usd">56000000.0</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear
      contextRef="ief72904a51c44045bc02018f15b8f0ed_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMi01LTEtMS0w_aaaa91ae-0f7d-49ee-b259-988fe7353d37"
      unitRef="usd">25800000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear
      contextRef="ief72904a51c44045bc02018f15b8f0ed_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMi03LTEtMS0w_7276381f-346c-4eff-9ea2-1bb9f82c1fdb"
      unitRef="usd">5500000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear
      contextRef="ief72904a51c44045bc02018f15b8f0ed_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMi05LTEtMS0w_bfd34e51-41c5-498c-83f6-cc6fdfb20b92"
      unitRef="usd">3600000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
      contextRef="ief72904a51c44045bc02018f15b8f0ed_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMi0xMS0xLTEtMA_dfbc7bc9-6193-452e-9747-66b6857ef709"
      unitRef="usd">900000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLease
      contextRef="ief72904a51c44045bc02018f15b8f0ed_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMi0xMy0xLTEtMA_58295b77-cf94-4ef2-bf62-a13c32b1d5af"
      unitRef="usd">167800000</us-gaap:SalesTypeLeaseNetInvestmentInLease>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear
      contextRef="i1b5e071604dd4ac48f9826527375a58a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMy0xLTEtMS0w_5b2d79ff-af21-4da5-a99c-e30a25c36a26"
      unitRef="usd">70500000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear
      contextRef="i1b5e071604dd4ac48f9826527375a58a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMy0zLTEtMS0w_c42542c1-8c73-4493-9039-755e1ca027d8"
      unitRef="usd">67400000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear
      contextRef="i1b5e071604dd4ac48f9826527375a58a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMy01LTEtMS0w_708f7af4-dc88-44e4-9d4c-1722164ee875"
      unitRef="usd">18600000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear
      contextRef="i1b5e071604dd4ac48f9826527375a58a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMy03LTEtMS0w_c16933b2-8013-4d4a-9bd5-76341fadac2a"
      unitRef="usd">11500000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear
      contextRef="i1b5e071604dd4ac48f9826527375a58a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMy05LTEtMS0w_cfd670ee-4111-4c91-96d4-354eac9adc0d"
      unitRef="usd">2500000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
      contextRef="i1b5e071604dd4ac48f9826527375a58a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMy0xMS0xLTEtMA_18a96cc4-ee6a-478c-b911-def0e127a873"
      unitRef="usd">500000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLease
      contextRef="i1b5e071604dd4ac48f9826527375a58a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfMy0xMy0xLTEtMA_0a79744d-8720-4be6-9bb6-2ccd1f4da0a2"
      unitRef="usd">171000000.0</us-gaap:SalesTypeLeaseNetInvestmentInLease>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear
      contextRef="icfeb8a45a0084daf9e15f7fde113be1c_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNC0xLTEtMS0w_c0cc9bd9-fa34-4c71-8447-f55e0eb86b30"
      unitRef="usd">700000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear
      contextRef="icfeb8a45a0084daf9e15f7fde113be1c_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNC0zLTEtMS0w_53c90b78-10ec-4692-88a9-2cd3cfb9dd5f"
      unitRef="usd">4700000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear
      contextRef="icfeb8a45a0084daf9e15f7fde113be1c_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNC01LTEtMS0w_1682acc0-52fa-431c-8955-6c8c6b676b9b"
      unitRef="usd">200000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear
      contextRef="icfeb8a45a0084daf9e15f7fde113be1c_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNC03LTEtMS0w_84faf1fb-ff66-42ec-8b87-55ab98f9d4fa"
      unitRef="usd">0</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear
      contextRef="icfeb8a45a0084daf9e15f7fde113be1c_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNC05LTEtMS0w_d8282b94-3fea-49fc-a558-3c2619c1a5d6"
      unitRef="usd">0</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
      contextRef="icfeb8a45a0084daf9e15f7fde113be1c_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNC0xMS0xLTEtMA_0fa394f4-4e68-4dd8-a5eb-f5906e40ced6"
      unitRef="usd">0</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLease
      contextRef="icfeb8a45a0084daf9e15f7fde113be1c_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNC0xMy0xLTEtMA_c1b24db3-3336-470c-a265-3db36aa02055"
      unitRef="usd">5600000</us-gaap:SalesTypeLeaseNetInvestmentInLease>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNS0xLTEtMS0w_5b92b722-2a81-4610-b56b-06cb3485ace7"
      unitRef="usd">147200000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNS0zLTEtMS0w_6de23e27-503b-48bc-b2ef-0cd60f099fe6"
      unitRef="usd">128100000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNS01LTEtMS0w_b8f3ef63-e028-474b-8c0c-41f1d86f5d75"
      unitRef="usd">44600000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNS03LTEtMS0w_f18291c2-7481-4d87-b88f-8203e563fa54"
      unitRef="usd">17000000.0</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNS05LTEtMS0w_f910b581-2df5-4d4b-8884-0583b4d12705"
      unitRef="usd">6100000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNS0xMS0xLTEtMA_caa311b7-cfdc-448a-955b-3eebdfada1b9"
      unitRef="usd">1400000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLease
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80Ni9mcmFnOjVkMzkxOWQxZWJlNzQzYTE4MDkxYmU0NmEzN2Q0NWRjL3RhYmxlOjdhNzI4NTVhYjhiZTRjZmI5OTk0NDNkOTNiZjkxOTM5L3RhYmxlcmFuZ2U6N2E3Mjg1NWFiOGJlNGNmYjk5OTQ0M2Q5M2JmOTE5MzlfNS0xMy0xLTEtMA_ed2bf3da-f43b-46e1-a466-4140b683e2aa"
      unitRef="usd">344400000</us-gaap:SalesTypeLeaseNetInvestmentInLease>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RleHRyZWdpb246NDk4ZTM2NmI2Y2Y3NDljZGFiZjUxODBmODI1NTA5NjhfMTY0OQ_50649a1a-3b18-49c2-ae76-b15d1ccdfd5e">GOODWILL AND INTANGIBLE ASSETS&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions in 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no material acquisitions for the three and nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions in 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Orpheus Medical&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2020, the Company acquired Orpheus Medical Ltd. and its wholly owned subsidiaries (&#x201c;Orpheus Medical&#x201d;) to deepen and expand our integrated informatics platform (the &#x201c;Orpheus Medical Acquisition&#x201d;). Orpheus Medical provides hospitals with information technology connectivity, as well as expertise in capturing, processing, and archiving clinical videos across the hospital. The Orpheus Medical Acquisition did not have a material impact on the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the carrying amount of goodwill (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition activity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of gross intangible assets, accumulated amortization, and net intangible asset balances as of September&#160;30, 2021, and December&#160;31, 2020 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution rights and others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(200.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense related to intangible assets was $6.3 million and $12.6 million for the three months ended September&#160;30, 2021, and 2020, respectively. Amortization expense related to intangible assets was $20.8 million and $37.3 million for the nine months ended September&#160;30, 2021, and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated future amortization expense related to intangible assets as of September&#160;30, 2021, is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preceding expected amortization expense is an estimate. Actual amounts of amortization expense may differ from estimated amounts due to additional intangible asset acquisitions, measurement-period adjustments to intangible assets, changes in foreign currency exchange rates, impairments of intangible assets, accelerated amortization of intangible assets, and other events.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RleHRyZWdpb246NDk4ZTM2NmI2Y2Y3NDljZGFiZjUxODBmODI1NTA5NjhfMTY1MA_747f656e-61e3-4be8-ae20-cf352a0c7873">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the carrying amount of goodwill (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition activity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOmU3NTQwNjFjYjhlZDQ0NDBhZWMxZWI1NWJmOWNhNjBjL3RhYmxlcmFuZ2U6ZTc1NDA2MWNiOGVkNDQ0MGFlYzFlYjU1YmY5Y2E2MGNfMS0xLTEtMS0w_99ae2110-c4c6-4c62-b410-7851c4e73849"
      unitRef="usd">336700000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOmU3NTQwNjFjYjhlZDQ0NDBhZWMxZWI1NWJmOWNhNjBjL3RhYmxlcmFuZ2U6ZTc1NDA2MWNiOGVkNDQ0MGFlYzFlYjU1YmY5Y2E2MGNfMi0xLTEtMS0w_05aee826-8b84-4916-ba93-f9dd72dbde4b"
      unitRef="usd">8000000.0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOmU3NTQwNjFjYjhlZDQ0NDBhZWMxZWI1NWJmOWNhNjBjL3RhYmxlcmFuZ2U6ZTc1NDA2MWNiOGVkNDQ0MGFlYzFlYjU1YmY5Y2E2MGNfMy0xLTEtMS0w_265ee145-d264-4622-9484-0b68a61b605e"
      unitRef="usd">-400000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOmU3NTQwNjFjYjhlZDQ0NDBhZWMxZWI1NWJmOWNhNjBjL3RhYmxlcmFuZ2U6ZTc1NDA2MWNiOGVkNDQ0MGFlYzFlYjU1YmY5Y2E2MGNfNC0xLTEtMS0w_043147ae-21bf-4614-8701-e7e81a88f9c7"
      unitRef="usd">344300000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RleHRyZWdpb246NDk4ZTM2NmI2Y2Y3NDljZGFiZjUxODBmODI1NTA5NjhfMTY1MQ_3b9c5eb4-b6ef-460a-bc94-92853d4daa15">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of gross intangible assets, accumulated amortization, and net intangible asset balances as of September&#160;30, 2021, and December&#160;31, 2020 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution rights and others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(200.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibccf075334db4130accdd0e847125918_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMi0yLTEtMS0w_85467d66-2336-4fdf-9012-c6e9d0a4ad3e"
      unitRef="usd">219300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibccf075334db4130accdd0e847125918_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMi00LTEtMS0w_7a3d0e20-baaf-44fa-9c7c-75a8b94505fd"
      unitRef="usd">169300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibccf075334db4130accdd0e847125918_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMi02LTEtMS0w_d3f21513-3382-4a45-bd66-51e8913beac7"
      unitRef="usd">50000000.0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0040668084154bd5bbaa4b3954aa2f3b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMi04LTEtMS0w_747ab423-3305-45f1-9f76-b35904caf941"
      unitRef="usd">198400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0040668084154bd5bbaa4b3954aa2f3b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMi0xMC0xLTEtMA_a55f14f9-e9bf-471e-819d-a2c46d64c490"
      unitRef="usd">158700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0040668084154bd5bbaa4b3954aa2f3b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMi0xMi0xLTEtMA_d63031c8-1ee1-4e6c-9ee6-8776c922e70d"
      unitRef="usd">39700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id153e77c855a4d55ae7589981388d8e2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMy0yLTEtMS0w_f5c983d7-30c5-42eb-aa98-7a31be183837"
      unitRef="usd">26300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id153e77c855a4d55ae7589981388d8e2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMy00LTEtMS0w_52865a6c-cf45-474d-853f-4f220db39e9d"
      unitRef="usd">17800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id153e77c855a4d55ae7589981388d8e2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMy02LTEtMS0w_f9baa51f-7fe9-456f-9301-e6be3d5cf4e8"
      unitRef="usd">8500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6019979522c14652baffb83a0302dc78_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMy04LTEtMS0w_9b8eade5-e0d8-4bcf-a5f9-f71c29b383ad"
      unitRef="usd">91900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6019979522c14652baffb83a0302dc78_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMy0xMC0xLTEtMA_d6697428-e204-4fc2-923e-ec5c09dfc3b8"
      unitRef="usd">77400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6019979522c14652baffb83a0302dc78_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfMy0xMi0xLTEtMA_3e67bd31-aafd-4620-8ed9-fd81b868f7ea"
      unitRef="usd">14500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iad348be44e784609b63102d7bd423e75_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNC0yLTEtMS0w_9ef597e8-11ec-4153-8576-df4638134470"
      unitRef="usd">31800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iad348be44e784609b63102d7bd423e75_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNC00LTEtMS0w_2bf2bddb-9650-4cf3-8b48-4c3a50ec0ab2"
      unitRef="usd">13100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iad348be44e784609b63102d7bd423e75_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNC02LTEtMS0w_0b037b6c-18ab-41bf-88eb-41e0f061f945"
      unitRef="usd">18700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3a10116d504946cbab544899d14169f4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNC04LTEtMS0w_19cd74ac-69ce-4529-a4ca-4bb68b1c3f62"
      unitRef="usd">59000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3a10116d504946cbab544899d14169f4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNC0xMC0xLTEtMA_da5684a6-477a-44dd-8d40-59119aebbe99"
      unitRef="usd">35800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3a10116d504946cbab544899d14169f4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNC0xMi0xLTEtMA_b6b53483-fdf0-420d-b7c9-1ad7a18787e8"
      unitRef="usd">23200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNS0yLTEtMS0w_3736a174-0d4c-4c3f-873b-4fde4944ee94"
      unitRef="usd">277400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNS00LTEtMS0w_90b475ed-86aa-4693-9909-25d1d4312455"
      unitRef="usd">200200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNS02LTEtMS0w_2072732a-5baf-43cc-88d0-dafe96ec1518"
      unitRef="usd">77200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNS04LTEtMS0w_c61fe2d3-f877-434e-9968-a49c475502d1"
      unitRef="usd">349300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNS0xMC0xLTEtMA_3ae78d29-74d6-41d3-b692-2d79ace3bda9"
      unitRef="usd">271900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjU3MzlkZTdiNDA2ZDQzNmFhMzQ0MzM3N2JhZTlkODczL3RhYmxlcmFuZ2U6NTczOWRlN2I0MDZkNDM2YWEzNDQzMzc3YmFlOWQ4NzNfNS0xMi0xLTEtMA_52aacae2-a14b-4199-b308-98edf86dedc9"
      unitRef="usd">77400000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RleHRyZWdpb246NDk4ZTM2NmI2Y2Y3NDljZGFiZjUxODBmODI1NTA5NjhfOTg2_1e7c6dbc-5e4a-4aed-b720-84be12afb1ec"
      unitRef="usd">6300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RleHRyZWdpb246NDk4ZTM2NmI2Y2Y3NDljZGFiZjUxODBmODI1NTA5NjhfOTkz_da712581-ffee-4f6b-8f55-815ed617e57d"
      unitRef="usd">12600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RleHRyZWdpb246NDk4ZTM2NmI2Y2Y3NDljZGFiZjUxODBmODI1NTA5NjhfMTEwMA_44ebb482-259e-4db6-ae13-292d799466cb"
      unitRef="usd">20800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RleHRyZWdpb246NDk4ZTM2NmI2Y2Y3NDljZGFiZjUxODBmODI1NTA5NjhfMTEwNw_151c91ce-7a62-4303-880f-d92efe5e2346"
      unitRef="usd">37300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RleHRyZWdpb246NDk4ZTM2NmI2Y2Y3NDljZGFiZjUxODBmODI1NTA5NjhfMTY0OA_e7595410-0d2d-47eb-9273-6ec4b576d08a">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated future amortization expense related to intangible assets as of September&#160;30, 2021, is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjYxMzNhZWEyYzc1MzRmMWI5NDUzNTAyZjFjNzI2OGRlL3RhYmxlcmFuZ2U6NjEzM2FlYTJjNzUzNGYxYjk0NTM1MDJmMWM3MjY4ZGVfMS0xLTEtMS0w_7d426d7a-459a-48ce-bf8a-253f2723d2d2"
      unitRef="usd">6100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjYxMzNhZWEyYzc1MzRmMWI5NDUzNTAyZjFjNzI2OGRlL3RhYmxlcmFuZ2U6NjEzM2FlYTJjNzUzNGYxYjk0NTM1MDJmMWM3MjY4ZGVfMi0xLTEtMS0w_e8042e25-d9ee-4ad1-a769-149e590f7df4"
      unitRef="usd">23600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjYxMzNhZWEyYzc1MzRmMWI5NDUzNTAyZjFjNzI2OGRlL3RhYmxlcmFuZ2U6NjEzM2FlYTJjNzUzNGYxYjk0NTM1MDJmMWM3MjY4ZGVfMy0xLTEtMS0w_8652cb66-3f47-428e-bc08-e48018ec938f"
      unitRef="usd">19000000.0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjYxMzNhZWEyYzc1MzRmMWI5NDUzNTAyZjFjNzI2OGRlL3RhYmxlcmFuZ2U6NjEzM2FlYTJjNzUzNGYxYjk0NTM1MDJmMWM3MjY4ZGVfNC0xLTEtMS0w_ac107911-fa89-49d7-97bf-1128fe20986f"
      unitRef="usd">14500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjYxMzNhZWEyYzc1MzRmMWI5NDUzNTAyZjFjNzI2OGRlL3RhYmxlcmFuZ2U6NjEzM2FlYTJjNzUzNGYxYjk0NTM1MDJmMWM3MjY4ZGVfNS0xLTEtMS0w_18af67d4-e666-477c-be0d-6f7800420085"
      unitRef="usd">9700000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <isrg:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjYxMzNhZWEyYzc1MzRmMWI5NDUzNTAyZjFjNzI2OGRlL3RhYmxlcmFuZ2U6NjEzM2FlYTJjNzUzNGYxYjk0NTM1MDJmMWM3MjY4ZGVfNi0xLTEtMS0w_7eac49a5-1fa4-4b52-b20d-ce5ea88e15dc"
      unitRef="usd">4300000</isrg:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl80OS9mcmFnOjQ5OGUzNjZiNmNmNzQ5Y2RhYmY1MTgwZjgyNTUwOTY4L3RhYmxlOjYxMzNhZWEyYzc1MzRmMWI5NDUzNTAyZjFjNzI2OGRlL3RhYmxlcmFuZ2U6NjEzM2FlYTJjNzUzNGYxYjk0NTM1MDJmMWM3MjY4ZGVfNy0xLTEtMS0w_ea168112-1399-463d-a226-4d200ae1adf1"
      unitRef="usd">77200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81Mi9mcmFnOjg5N2NlMWIyMTRiNTQ0YTc5NDdkZDE2MWZjYjNjOWU1L3RleHRyZWdpb246ODk3Y2UxYjIxNGI1NDRhNzk0N2RkMTYxZmNiM2M5ZTVfMTEyNjc_4cdf7f7c-8e4a-4f5c-8e88-01d04526b9f2">CONTINGENCIES&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company is involved in a variety of claims, lawsuits, investigations, and proceedings relating to securities laws, product liability, intellectual property, insurance, contract disputes, employment, and other matters. Certain of these lawsuits and claims are described in further detail below. It is not possible to predict what the outcome of these matters will be, and the Company cannot guarantee that any resolution will be reached on commercially reasonable terms, if at all.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A liability and related charge to earnings are recorded in the Financial Statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to each case. Nevertheless, it is possible that additional future legal costs (including settlements, judgments, legal fees, and other related defense costs) could have a material adverse effect on the Company&#x2019;s business, financial position, and future results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Product Liability Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is currently named as a defendant in a number of individual product liability lawsuits filed in various state and federal courts. The plaintiffs generally allege that they or a family member underwent surgical procedures that utilized the da Vinci Surgical System and sustained a variety of personal injuries and, in some cases, death as a result of such surgery. Several of the filed cases have trial dates in the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cases raise a variety of allegations including, to varying degrees, that plaintiffs&#x2019; injuries resulted from purported defects in the da Vinci Surgical System and/or failure on the Company&#x2019;s part to provide adequate training resources to the healthcare professionals who performed plaintiffs&#x2019; surgeries. The cases further allege that the Company failed to adequately disclose and/or misrepresented the potential risks and/or benefits of the da Vinci Surgical System. Plaintiffs also assert a variety of causes of action, including, for example, strict liability based on purported design defects, negligence, fraud, breach of express and implied warranties, unjust enrichment, and loss of consortium. Plaintiffs seek recovery for alleged personal injuries and, in many cases, punitive damages. The Company disputes these allegations and is defending against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimate of the anticipated cost of resolving the pending cases is based on negotiations with attorneys for the claimants. The final outcome of the pending lawsuits and claims, and others that might arise, is dependent on many variables that are difficult to predict, and the ultimate cost associated with these product liability lawsuits and claims may be materially different than the amount of the current estimate and accruals and could have a material adverse effect on the Company&#x2019;s business, financial position, and future results of operations. Although there is a reasonable possibility that a loss in excess of the amount recognized exists, the Company is unable to estimate the possible loss or range of loss in excess of the amount recognized at this time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Patent Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2017, Ethicon LLC, Ethicon Endo-Surgery, Inc., and Ethicon US LLC (collectively, &#x201c;Ethicon&#x201d;) filed a complaint for patent infringement against the Company in the U.S. District Court for the District of Delaware. The complaint, which was served on the Company on July 12, 2017, alleges that the Company&#x2019;s EndoWrist&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stapler instruments infringe several of Ethicon&#x2019;s patents. Ethicon asserts infringement of U.S. Patent Nos. 9,585,658, 8,479,969, 9,113,874, 8,998,058, 8,991,677, 9,084,601, and 8,616,431. A claim construction hearing occurred on October 1, 2018, and the court issued a scheduling order on December 28, 2018. On March 20, 2019, the court granted the Company&#x2019;s Motion to Stay pending an Inter Partes Review to be held at the Patent Trademark and Appeals Board to review patentability of six of the seven patents noted above and vacated the trial date. On August 1, 2019, the court granted the parties&#x2019; joint stipulation to modify the stay in light of Ethicon&#x2019;s U.S. International Trade Commission (&#x201c;USITC&#x201d;) complaint against Intuitive involving U.S. Patent Nos. 8,479,969 and 9,113,874, discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 27, 2018, Ethicon filed a second complaint for patent infringement against the Company in the U.S. District Court for the District of Delaware. The complaint alleges that the Company&#x2019;s SureForm 60 Staplers infringe five of Ethicon&#x2019;s patents. Ethicon asserts infringement of U.S. Patent Nos. 9,884,369, 7,490,749, 8,602,288, 8,602,287, and 9,326,770. The Company filed an answer denying all claims. On March 19, 2019, Ethicon filed a Motion for Leave to File a First Amended Complaint, removing allegations related to U.S. Patent No. 9,326,770 and adding allegations related to U.S. Patent Nos. 9,844,379 and 8,479,969. On July 17, 2019, the court entered an order denying the amendment, without prejudice, and granting the parties&#x2019; joint stipulation to stay the case in its entirety in light of the USITC investigation involving U.S. Patent Nos. 9,844,369 and 7,490,749, discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 30, 2019, Ethicon filed a complaint with the USITC, asserting infringement of U.S. Patent Nos. 9,884,369 (&#x201c;&#x2019;369&#x201d;), 7,490,749 (&#x201c;&#x2019;749&#x201d;), 9,844,379 (&#x201c;&#x2019;379&#x201d;), 9,113,874 (&#x201c;&#x2019;874&#x201d;), and 8,479,969 (&#x201c;&#x2019;969&#x201d;). On June 28, 2019, the USITC voted to institute an investigation (No. 337-TA-1167) with respect to the claims in this complaint. The accused products include the Company&#x2019;s EndoWrist 30, EndoWrist 45, SureForm 45, and SureForm 60 Staplers, as well as the stapler reload cartridges. In March 2020, Ethicon dismissed its claims concerning the &#x2019;749 patent. The evidentiary hearing took place in February 2021. On June 8, 2021, the Chief Administrative Law Judge issued an Initial Determination concluding that (1) the accused products do not infringe the asserted claims in the &#x2019;874 or &#x2019;969 patents; (2) the asserted claims in the &#x2019;874 and &#x2019;969 patents are invalid; (3) the accused SureForm staplers and associated reload cartridges infringe two claims of the &#x2019;369 patent; (4) the accused SureForm staplers and associated reload cartridges infringe two claims of the &#x2019;379 patent; and (5) the Company was estopped from contending that the asserted claims in the &#x2019;379 patent are invalid. Ethicon has not challenged the Initial Determination with regard to the findings that absolve Intuitive of any liability regarding the accused EndoWrist staplers and associated reload cartridges. On October 14, 2021, the USITC issued its Opinion in which it made the following rulings: (1) the USITC absolved Intuitive from any liability regarding the &#x2019;874, &#x2019;969, and &#x2019;369 patents; and (2) the USITC found that, while the SureForm staplers and their associated reload cartridges infringe the asserted claims in the &#x2019;379 patent, it has suspended the imposition of any remedial order pending an opinion from the Federal Circuit Court of Appeal of whether the Patent and Trademark Office correctly found the asserted claims in this patent to be invalid. A lifting of the suspension of any remedial order by the USITC could result in a prohibition on importing the accused SureForm products into the U.S. or necessitating workarounds. Based on currently available information, the Company does not believe that any losses arising from this matter would be material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commercial Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 27, 2019, Restore Robotics LLC and Restore Repair LLC (&#x201c;Restore&#x201d;) filed a complaint alleging anti-trust claims against the Company. On May 13, 2019, Restore filed an amended complaint alleging anti-trust claims relating to the da Vinci Surgical System and EndoWrist service, maintenance, and repair processes. On September 16, 2019, the Court partially granted and partially denied the Company&#x2019;s Motion to Dismiss the amended complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2019, the Company filed an answer denying the anti-trust allegations and filed a counterclaim against Restore. The Company filed amended counterclaims after the Court partially granted and partially denied Restore&#x2019;s Motion to Dismiss the counterclaim. The amended counterclaims allege that Restore violated the Federal Lanham Act, the Federal Computer Fraud and Abuse Act, and Florida&#x2019;s Deceptive and Unfair Trade Practices Act and that Restore is also liable to the Company for Unfair Competition and Tortious Interference with Contract. On January 7, 2020, the Court denied Restore&#x2019;s Motion to Dismiss the amended counterclaims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In its initial scheduling order, the Court stated that it anticipated trial in this case to occur in or before February 2022. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 28, 2020, Rebotix Repair Inc. (&#x201c;Rebotix&#x201d;) filed a complaint alleging anti-trust claims against the Company relating to EndoWrist service, maintenance, and repair processes. The complaint was formally served on the Company on October 6, 2020. On March 8, 2021, the Court partially granted and partially denied the Company&#x2019;s Motion to Dismiss the complaint. The Company filed an answer denying the anti-trust allegations and filed counterclaims against Rebotix. The counterclaims allege that Rebotix violated the Federal Lanham Act and Florida&#x2019;s Deceptive and Unfair Trade Practices Act and that Rebotix is also liable to the Company for Tortious Interference with Contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Court stated that it anticipated trial in this case to occur in or around April 2022. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from this matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Similar to the claims asserted in the Restore case, on May 10, 2021, Surgical Instrument Service Company, Inc. (&#x201c;SIS&#x201d;) filed a complaint in the Northern District of California Court alleging anti-trust claims against the Company relating to EndoWrist service, maintenance, and repair processes. The Company filed a Motion to Dismiss on which a hearing was held on October 7, 2021. The Court has not yet issued an Order on this Motion to Dismiss. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from this matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three class action complaints were filed against the Company in the Northern District of California Court alleging anti-trust allegations relating to the service and repair of certain instruments manufactured by the Company. A complaint by Larkin Community Hospital was filed on May 20, 2021, a complaint by Franciscan Alliance, Inc. and King County Public Hospital District No. 1 was filed on July 6, 2021, and a complaint by Kaleida Health was filed on July 8, 2021. The Court has consolidated the Franciscan Alliance, Inc. and King County Public Hospital District No. 1 and Kaleida Health cases with the Larkin Community Hospital case, which is now captioned on the Larkin docket as &#x201c;In Re: da Vinci Surgical Robot Antitrust Litigation.&#x201d; A Consolidated Amended Class Action Complaint has been filed on behalf of each plaintiff named in the earlier-filed cases. The Company filed a Motion to Dismiss this Consolidated Amended Class Action Complaint on October 11, 2021. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from these matters.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RleHRyZWdpb246NDI0MWEzZGI3OTEzNDI1YmFhZjAxMDc0YjYzNDY1ODJfOTM2_590d6b53-1f7a-4380-a8ed-c0561a30a964">STOCKHOLDERS&#x2019; EQUITY&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stockholders&#x2019; Equity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the changes in stockholders&#x2019; equity (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Additional Paid-In Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Intuitive Surgical, Inc. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest in Joint Venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,804.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,022.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,837.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,879.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock through employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares withheld related to net share settlement of equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Intuitive Surgical, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interest in joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,015.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,390.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,410.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,459.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Additional&lt;br/&gt;Paid-In&lt;br/&gt;Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Intuitive Surgical, Inc. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest in Joint Venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,084.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,633.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,740.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,766.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock through employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares withheld related to net share settlement of equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Intuitive Surgical, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interest in joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,304.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,937.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,257.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,286.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.184%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.507%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.507%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Additional Paid-In Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Intuitive Surgical, Inc. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest in Joint Venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,444.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,261.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,731.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,759.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock through employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares withheld related to net share settlement of equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Intuitive Surgical, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interest in joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,015.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,390.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,410.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,459.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Additional&lt;br/&gt;Paid-In&lt;br/&gt;Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Intuitive Surgical, Inc. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest in Joint Venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,756.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,494.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,263.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,284.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock through employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares withheld related to net share settlement of equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repurchase and retirement of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Intuitive Surgical, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interest in joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,304.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,937.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,257.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,286.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;) has authorized an aggregate of&#160;$7.5 billion of funding for the Company&#x2019;s common stock repurchase program (the &#x201c;Repurchase Program&#x201d;) since its establishment in March 2009. The most recent authorization occurred in January 2019 when the Board increased the authorized amount available under the Repurchase Program to&#160;$2.0 billion. As of September&#160;30, 2021, the remaining amount of share repurchases authorized by the Board was $1.6 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides share repurchase activities (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Income (Loss), Net of Tax, Attributable to Intuitive&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated other comprehensive income (loss), net of tax, attributable to Intuitive are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&lt;br/&gt;on&#160;Hedge&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses)&#160;on Available-for-Sale Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Gains&#160;(Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&lt;br/&gt;on&#160;Hedge&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses)&#160;on Available-for-Sale Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Gains&#160;(Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&lt;br/&gt;on&#160;Hedge&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses)&#160;on Available-for-Sale Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Gains&#160;(Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&lt;br/&gt;on&#160;Hedge&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses)&#160;on Available-for-Sale Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Gains&#160;(Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RleHRyZWdpb246NDI0MWEzZGI3OTEzNDI1YmFhZjAxMDc0YjYzNDY1ODJfOTMy_d57c8025-a018-4a98-88bf-3133ea9436de">&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the changes in stockholders&#x2019; equity (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Additional Paid-In Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Intuitive Surgical, Inc. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest in Joint Venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,804.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,022.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,837.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,879.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock through employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares withheld related to net share settlement of equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Intuitive Surgical, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interest in joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,015.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,390.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,410.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,459.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Additional&lt;br/&gt;Paid-In&lt;br/&gt;Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Intuitive Surgical, Inc. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest in Joint Venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,084.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,633.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,740.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,766.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock through employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares withheld related to net share settlement of equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Intuitive Surgical, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interest in joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,304.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,937.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,257.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,286.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.184%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.507%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.507%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Additional Paid-In Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Intuitive Surgical, Inc. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest in Joint Venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,444.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,261.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,731.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,759.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock through employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares withheld related to net share settlement of equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Intuitive Surgical, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interest in joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,015.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,390.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,410.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,459.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Additional&lt;br/&gt;Paid-In&lt;br/&gt;Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Intuitive Surgical, Inc. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest in Joint Venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,756.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,494.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,263.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,284.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock through employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares withheld related to net share settlement of equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repurchase and retirement of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Intuitive Surgical, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interest in joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,304.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,937.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,257.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,286.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib1d61c223bb747ee95152c8eee22b13c_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMy0xLTEtMS0w_521cfd42-d94b-4359-8b2c-6ab941ad8464"
      unitRef="shares">356200000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib1d61c223bb747ee95152c8eee22b13c_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMy0zLTEtMS0w_259f3151-9eed-47ce-a06d-a9556bb13947"
      unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ice3d62c192824cc4b074c71a8ae80571_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMy01LTEtMS0w_5b71e6f4-52a7-466d-a057-7941107debf8"
      unitRef="usd">6804100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i66e41b3c2e834c119d0176db2e8af060_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMy03LTEtMS0w_b9c79e45-295c-4bc8-b1b7-10b51b7bb92b"
      unitRef="usd">4022700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i17c6dd038d1e4e839081d843139db4ba_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMy05LTEtMS0w_5a993c22-20bb-42ff-a440-8637c9e52789"
      unitRef="usd">10300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i18955016352d4c2f9c1114363b8cf2d5_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMy0xMS0xLTEtMA_b9beee9e-71f2-4dae-90e5-b386f450c5f4"
      unitRef="usd">10837500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i91f3018ef47c4b5fa0e52396465d7744_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMy0xMy0xLTEtMA_9572b0bb-ce0e-403b-b01c-de88dbd28a14"
      unitRef="usd">42000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iecbbf0bac773402585e5625778664eaf_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMy0xNS0xLTEtMA_bee9607f-e663-4718-b950-490363f9d654"
      unitRef="usd">10879500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i9d4217ee5ed9439ca27f0168c8e3920a_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNS0xLTEtMS0w_04ca6bd2-3752-48b2-bd58-e94fd600b05c"
      unitRef="shares">1100000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9a616a50f9f54a62a3dff6cc537b74d5_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNS01LTEtMS0w_5127c41e-3a52-480c-8c0a-86e52604576b"
      unitRef="usd">91100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2f10f7a841b9428193c67c65a7651180_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNS0xMS0xLTEtMA_c9b1bb5d-0ff7-4e44-9f26-f9e4b1d5c0d3"
      unitRef="usd">91100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNS0xNS0xLTEtMA_1731deff-39ea-4033-8392-3e77ad66caff"
      unitRef="usd">91100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i9d4217ee5ed9439ca27f0168c8e3920a_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNi0xLTEtMS0w_17afb613-8cdb-4959-899d-d5724f3c8166"
      unitRef="shares">100000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9a616a50f9f54a62a3dff6cc537b74d5_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNi01LTEtMS0w_9a5d704e-0238-48c0-be18-dac658f41061"
      unitRef="usd">200000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3b4dddac366f478ba48b52ac99d622cd_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNi03LTEtMS0w_e06b91fb-eaf4-4afb-bdf2-3569c4dfe926"
      unitRef="usd">13100000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i2f10f7a841b9428193c67c65a7651180_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNi0xMS0xLTEtMA_5c88230b-9863-44bc-9903-3a5708319865"
      unitRef="usd">13300000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNi0xNS0xLTEtMA_07bd862d-bdc3-4606-b9b3-38ba7d9a692d"
      unitRef="usd">13300000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9a616a50f9f54a62a3dff6cc537b74d5_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNy01LTEtMS0w_82d9ae17-de70-4ba8-b6cc-242d3b931e85"
      unitRef="usd">120100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2f10f7a841b9428193c67c65a7651180_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNy0xMS0xLTEtMA_a7579920-9b96-4c48-b1ab-55bec52724e7"
      unitRef="usd">120100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfNy0xNS0xLTEtMA_1d7aca7c-a588-4b05-9cb8-f3c7f2ee1022"
      unitRef="usd">120100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i3b4dddac366f478ba48b52ac99d622cd_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfOS03LTEtMS0w_7fbd8345-194f-4d78-91c6-027deac09141"
      unitRef="usd">380500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2f10f7a841b9428193c67c65a7651180_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfOS0xMS0xLTEtMA_533477eb-4954-4526-9d3b-3b894cd40461"
      unitRef="usd">380500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfOS0xNS0xLTEtMA_d841fb57-07d4-4b34-be6c-0f120d6f41e5"
      unitRef="usd">380500000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0939772d62d942b796188dfdf7fcc61e_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTAtOS0xLTEtMA_d7540b13-d3de-48aa-b911-508ec106cec0"
      unitRef="usd">-5000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2f10f7a841b9428193c67c65a7651180_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTAtMTEtMS0xLTA_47d49fea-0e7c-44db-9e51-cf230ae094f9"
      unitRef="usd">-5000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8f38a035988a4b04bc207db50d81f2e6_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTAtMTMtMS0xLTA_fa1db570-f3a6-403e-a6dc-05f5ffb80203"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTAtMTUtMS0xLTA_33732aa9-3951-47c5-a1b2-b58a264627f3"
      unitRef="usd">-5100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8f38a035988a4b04bc207db50d81f2e6_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTItMTMtMS0xLTA_3b2c6bae-ff3b-45ed-a5d8-c1e3d1b262fe"
      unitRef="usd">6700000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTItMTUtMS0xLTA_33b70a34-ec15-43c6-9e6b-b7355724b157"
      unitRef="usd">6700000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7722e2881b60414b88d5e47e4ff0c212_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTMtMS0xLTEtMA_ccfecffc-ea13-4bdc-bd52-a8aae4a4a8e5"
      unitRef="shares">357200000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7722e2881b60414b88d5e47e4ff0c212_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTMtMy0xLTEtMA_45eba0c5-b202-4f2a-9586-d3ad89553e19"
      unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i12b4985e5aab46088463bd2ea8c718c3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTMtNS0xLTEtMA_16a3c1f6-c1e6-4cc9-b52b-232442fd7a4e"
      unitRef="usd">7015100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i494c07d22f024c88948a992d708aea7e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTMtNy0xLTEtMA_93cd05fa-ba0c-489e-93ee-ca51fae412cd"
      unitRef="usd">4390100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4acd3901acf4471db1cf795db1c4a248_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTMtOS0xLTEtMA_23f6cdc5-2795-425b-a9aa-0f058aa68662"
      unitRef="usd">5300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib32048ff4ad6455287e4c2b2f78d13a1_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTMtMTEtMS0xLTA_8210fbb1-48a9-4978-a86f-3bb181d79d2e"
      unitRef="usd">11410900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia693b8c7b00c4855b184870531142247_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTMtMTMtMS0xLTA_5890a6e8-79f9-44d3-b36f-f8c596523f69"
      unitRef="usd">48600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjgyZDRmNmM3OTZiYzQ0NzM5YzQyYTYwZjhhYjY5Njk3L3RhYmxlcmFuZ2U6ODJkNGY2Yzc5NmJjNDQ3MzljNDJhNjBmOGFiNjk2OTdfMTMtMTUtMS0xLTA_7767e40d-a8bc-4c73-8303-fc3a3e0b4201"
      unitRef="usd">11459500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i278f38b19568472ebae990bee1c0db33_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMTgtMS0xLTEtMA_e60d3d01-805e-43c2-9c5c-d54bb9ef002f"
      unitRef="shares">351000000.0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i278f38b19568472ebae990bee1c0db33_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMTgtMy0xLTEtMA_5eeb2235-789a-4adb-b260-ac7138456f48"
      unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9a1f00bb40df4d9597f66832f85ab8ef_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMTgtNS0xLTEtMA_cdcf4f38-7933-4efe-b71a-ee38e27bffa6"
      unitRef="usd">6084800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id7ef2803613641c69436d6aa1c5b43d6_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMTgtNy0xLTEtMA_15fa1439-5fbf-4c20-be3a-fe753e7bd7bc"
      unitRef="usd">2633000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i16ae1d800ab0420085daf458dee535a2_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMTgtOS0xLTEtMA_f623cd02-01ea-40d8-aad7-13a5ebb4744a"
      unitRef="usd">22300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6975f86655b24c28bb3402aa5c5ca96b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMTgtMTEtMS0xLTA_e6993c3b-1036-45d8-8dc9-c67823da96e5"
      unitRef="usd">8740500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i29efc4bde4c9438ab296aa4811b7ca13_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMTgtMTMtMS0xLTA_ff11f655-f8b1-4bd8-9461-0e3f57ad8f12"
      unitRef="usd">25900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib780080ab3a8424fbe082969241fa1f5_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMTgtMTUtMS0xLTA_a83bc3c2-8cac-4c5c-ab12-b8f002622759"
      unitRef="usd">8766400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i49309f63539141078a0b3ba243955ca1_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjAtMS0xLTEtMA_a13d6105-b21a-440d-afe3-4d44c69cae32"
      unitRef="shares">1600000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifbbd8d73ef944adc832fbdfb193e657e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjAtNS0xLTEtMA_e3c28665-d429-4748-91fb-78ba7e534889"
      unitRef="usd">113900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iacea1d90eb614cbba03fd2b9f5332772_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjAtMTEtMS0xLTA_d8714757-2be3-4762-acb2-ae12f4c70e0e"
      unitRef="usd">113900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjAtMTUtMS0xLTA_e85bad1a-2101-48bc-b5fe-ae6cd8ca74c8"
      unitRef="usd">113900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i49309f63539141078a0b3ba243955ca1_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjEtMS0xLTEtMA_8a465b8d-aa12-46d1-9266-c5286d834558"
      unitRef="shares">0</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ifbbd8d73ef944adc832fbdfb193e657e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjEtNS0xLTEtMA_eaca6a10-2568-4ec5-b179-c9dd3cc97502"
      unitRef="usd">500000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i91590958a4e84c3fba1738213a5cff5e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjEtNy0xLTEtMA_313dd7b1-abee-4fe6-a8bb-b7c913ad1578"
      unitRef="usd">9700000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iacea1d90eb614cbba03fd2b9f5332772_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjEtMTEtMS0xLTA_ee526ac5-d252-4400-9286-db4fc6a45132"
      unitRef="usd">10200000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjEtMTUtMS0xLTA_24a1e2ba-2035-4473-99de-c64f1bbb7eb4"
      unitRef="usd">10200000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifbbd8d73ef944adc832fbdfb193e657e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjItNS0xLTEtMA_a6cc9658-845a-4627-be6e-96e8d23b8ce7"
      unitRef="usd">105800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iacea1d90eb614cbba03fd2b9f5332772_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjItMTEtMS0xLTA_06b27646-1686-462c-af17-52df956fd7e5"
      unitRef="usd">105800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjItMTUtMS0xLTA_26c0e3ad-a449-41e8-bdba-58953b48af20"
      unitRef="usd">105800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i91590958a4e84c3fba1738213a5cff5e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjQtNy0xLTEtMA_5f6f0470-ffd2-4130-9e52-cfe7fe8d25b2"
      unitRef="usd">313900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iacea1d90eb614cbba03fd2b9f5332772_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjQtMTEtMS0xLTA_934ea68f-87f2-4bcc-aca8-22d1ef485d31"
      unitRef="usd">313900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjQtMTUtMS0xLTA_e6f57f71-72cc-4623-bf54-74a141a44eb3"
      unitRef="usd">313900000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i08eb4b64387b42b3aac663f9c29cced9_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjUtOS0xLTEtMA_b5dff5bd-9748-47ad-8258-f18c6a72f30f"
      unitRef="usd">-6100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iacea1d90eb614cbba03fd2b9f5332772_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjUtMTEtMS0xLTA_2bc9a522-4995-41cb-8dc2-f2847df299d6"
      unitRef="usd">-6100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie46138cc218c44bdab5454b674d97eb7_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjUtMTMtMS0xLTA_aadc967c-8074-4195-a874-39bc6957b99b"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjUtMTUtMS0xLTA_91b1302d-5354-4148-84c0-994f6187d65a"
      unitRef="usd">-6000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie46138cc218c44bdab5454b674d97eb7_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjYtMTMtMS0xLTA_485011f8-f3bf-41c8-b346-8e2e0f961bb0"
      unitRef="usd">2900000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjYtMTUtMS0xLTA_5ebfd6c1-c589-4cdb-b3e6-cb282993e7bb"
      unitRef="usd">2900000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i53f8ced32a444ff4b52e4928b94175dd_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjctMS0xLTEtMA_4c9decf3-2be5-4b81-8b08-552b8fc0849f"
      unitRef="shares">352600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53f8ced32a444ff4b52e4928b94175dd_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjctMy0xLTEtMA_7a47a836-2d03-480b-9437-ef3df3fc546f"
      unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i879d429e085f447493c82a85ba62c318_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjctNS0xLTEtMA_bebc327c-6787-4756-8d8f-588fd39cab42"
      unitRef="usd">6304000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i818cc058723f4fab9e6730e25fd2ff75_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjctNy0xLTEtMA_2833d51e-c429-413b-a249-f1e1593c23b8"
      unitRef="usd">2937200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if4abb28eb95f4310a27bcff42b173ed8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjctOS0xLTEtMA_fd033ce5-1153-43bd-9921-9361eb652f12"
      unitRef="usd">16200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73ec9b1829e641dda129e28b2a310e58_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjctMTEtMS0xLTA_f8bfdf39-1214-4057-8f98-6bee3e9bc3dc"
      unitRef="usd">9257800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i22d1823a37a8412087b1432940f4c878_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjctMTMtMS0xLTA_cdac5620-32f8-4546-a091-fc2a3b24ae26"
      unitRef="usd">28900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id79ce19a534e4d139e67bf0750158934_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmMwYzZhMGE5ZjdmYTQ0NGY4ODJiNGJlY2FhMzQ4ODgxL3RhYmxlcmFuZ2U6YzBjNmEwYTlmN2ZhNDQ0Zjg4MmI0YmVjYWEzNDg4ODFfMjctMTUtMS0xLTA_98c43d81-cf6f-4e64-bfb2-20ad29553092"
      unitRef="usd">9286700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i42eb9966ff944cf086ee492f9ee5720c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMy0xLTEtMS0w_e33bc23c-ad66-44b7-b668-5267080cd106"
      unitRef="shares">353100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i42eb9966ff944cf086ee492f9ee5720c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMy0zLTEtMS0w_9857717e-638e-4a25-80aa-802722f0903b"
      unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i298e438389654f6da638e3e8d14778e7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMy01LTEtMS0w_590d60b2-29db-43ad-9ef1-3f85fa8eb56a"
      unitRef="usd">6444900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1ecdb391c0e74585907d8294c4b4d69e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMy03LTEtMS0w_0e22671e-bb91-4e56-922c-b2fbda17bbd0"
      unitRef="usd">3261300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac9eea68e98844389ba6177116b318aa_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMy05LTEtMS0w_0d5de4d2-2db1-4a51-98c4-0759a5da9483"
      unitRef="usd">24900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if74d89ff156145239e2267161cac4cd1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMy0xMS0xLTEtMA_0009d5a9-f2e5-47c4-8486-01f86f27558a"
      unitRef="usd">9731500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f0850dbce3d4403ad215d9950255074_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMy0xMy0xLTEtMA_97595645-b707-441b-a23e-df1fb3435328"
      unitRef="usd">27600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMy0xNS0xLTEtMA_7c140454-a389-4603-b0aa-56e4222b06a0"
      unitRef="usd">9759100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="icfef3e14f8544cecabe32b0486e9b751_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNS0xLTEtMS0w_6904e57e-a9e6-474f-ad22-bf1216f954b7"
      unitRef="shares">4900000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3f2fc119452d4229a0c5865465b20e5c_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNS01LTEtMS0w_cfd8db5a-c845-4695-a1a5-9cec28702fe8"
      unitRef="usd">244800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3578980607fc4e1dbb9e534383697716_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNS0xMS0xLTEtMA_43c50ddf-4d94-40bf-9068-4eb8e1c56863"
      unitRef="usd">244800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNS0xNS0xLTEtMA_9f3d098b-bd81-4a90-97a2-b8e0343b71f7"
      unitRef="usd">244800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="icfef3e14f8544cecabe32b0486e9b751_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNi0xLTEtMS0w_370ed213-8877-4f10-8156-698ef4861bff"
      unitRef="shares">800000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3f2fc119452d4229a0c5865465b20e5c_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNi01LTEtMS0w_06b5c847-1b5e-4a3d-962b-63354ca34854"
      unitRef="usd">6000000.0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i20ecaa1bd9224b37ba51ddb3346bde9b_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNi03LTEtMS0w_e130939e-58d6-4f35-9321-f92624cb1a04"
      unitRef="usd">195200000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3578980607fc4e1dbb9e534383697716_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNi0xMS0xLTEtMA_2bccd5c4-a8de-439c-ad8d-97f16ae22239"
      unitRef="usd">201200000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNi0xNS0xLTEtMA_f0d30b3a-ce79-4911-9f06-8cd196e006eb"
      unitRef="usd">201200000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3f2fc119452d4229a0c5865465b20e5c_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNy01LTEtMS0w_60b0100d-3c7a-43a0-8909-71d1d9a10d34"
      unitRef="usd">331400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3578980607fc4e1dbb9e534383697716_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNy0xMS0xLTEtMA_f3cdd27b-f3d8-4473-9de7-dfcc52851a41"
      unitRef="usd">331400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfNy0xNS0xLTEtMA_99c317cc-62c3-4a15-a8ff-ed203ff35005"
      unitRef="usd">331400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i20ecaa1bd9224b37ba51ddb3346bde9b_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfOS03LTEtMS0w_b158f6c6-f880-4177-8c2d-1cf4d55639e1"
      unitRef="usd">1324000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3578980607fc4e1dbb9e534383697716_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfOS0xMS0xLTEtMA_d63220e1-74af-4ee0-9cdc-69575b766680"
      unitRef="usd">1324000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfOS0xNS0xLTEtMA_13fb0b81-9c1f-4065-af9e-b7bc2ef07943"
      unitRef="usd">1324000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ida4fee943cff4029b9a8507c4a72da04_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTAtOS0xLTEtMA_4267d5bc-c45a-4ee4-b9e6-963fac96d748"
      unitRef="usd">-19600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3578980607fc4e1dbb9e534383697716_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTAtMTEtMS0xLTA_e822a49d-1f96-4b95-a307-569cc30235bd"
      unitRef="usd">-19600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7a2ef2720e5d48859c0e54b81ae7ab52_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTAtMTMtMS0xLTA_1d385007-8929-466c-97ea-219cd5a23367"
      unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTAtMTUtMS0xLTA_6b197f7a-262d-4e46-a220-c6dd19485380"
      unitRef="usd">-20000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7a2ef2720e5d48859c0e54b81ae7ab52_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTItMTMtMS0xLTA_b4328b4e-2b2e-40bc-a11c-838eecf9cb6e"
      unitRef="usd">21400000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTItMTUtMS0xLTA_7d5031bd-bc31-42cb-bd52-9333987c4189"
      unitRef="usd">21400000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7722e2881b60414b88d5e47e4ff0c212_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTMtMS0xLTEtMA_dda48bad-da6b-462a-9a58-ab4f6e31a6ee"
      unitRef="shares">357200000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7722e2881b60414b88d5e47e4ff0c212_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTMtMy0xLTEtMA_eb919975-054d-4516-9ada-9b6e15b9b4da"
      unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i12b4985e5aab46088463bd2ea8c718c3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTMtNS0xLTEtMA_7432f540-bb92-42db-8fd9-984156e687c5"
      unitRef="usd">7015100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i494c07d22f024c88948a992d708aea7e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTMtNy0xLTEtMA_a4bca302-12c7-45af-a139-6ce237c863e4"
      unitRef="usd">4390100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4acd3901acf4471db1cf795db1c4a248_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTMtOS0xLTEtMA_d7d65681-e6e5-45f0-872a-b2f1a3b9e14e"
      unitRef="usd">5300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib32048ff4ad6455287e4c2b2f78d13a1_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTMtMTEtMS0xLTA_628314d5-11d3-4e19-b549-c923de653fda"
      unitRef="usd">11410900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia693b8c7b00c4855b184870531142247_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTMtMTMtMS0xLTA_222a71e3-021b-4c5b-adfb-3237b34f8a0d"
      unitRef="usd">48600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjljNzE4ZDI3Yzc0ZjRkMWY5ODQ4NzlhNmUzNWY3MDA3L3RhYmxlcmFuZ2U6OWM3MThkMjdjNzRmNGQxZjk4NDg3OWE2ZTM1ZjcwMDdfMTMtMTUtMS0xLTA_8e0c9044-1928-4e76-8c49-72ab11c1a458"
      unitRef="usd">11459500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i23d7cb9591264bbe8dc96ff49f2da4c2_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTgtMS0xLTEtMA_2cf1a42b-3eb7-4ff6-a910-9ed0faf8ea98"
      unitRef="shares">347900000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i23d7cb9591264bbe8dc96ff49f2da4c2_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTgtMy0xLTEtMA_cc433c9d-1ee3-4dee-ae3b-386623c6cd48"
      unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6da3e57aeb6d40558803471b05c62423_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTgtNS0xLTEtMA_3cf515d1-7075-44c9-b914-00429741a11b"
      unitRef="usd">5756500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifebe86d96c974e9995f2ab3c8bee539a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTgtNy0xLTEtMA_11ae961f-f000-4167-aa62-de60c8103d9d"
      unitRef="usd">2494500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia41fc6f9fdbc465a9ff6c912c6a47cc8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTgtOS0xLTEtMA_d0ae223d-00e9-40d3-8920-a73f49f1973c"
      unitRef="usd">12400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if153039c790149ae84e26285a922687c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTgtMTEtMS0xLTA_d690b740-f7f1-4649-8678-cefcb049e43d"
      unitRef="usd">8263800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iabc57ded48384f2291a996748a5d75e9_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTgtMTMtMS0xLTA_e3ad7dda-6a0a-4909-b9bc-76f217364fda"
      unitRef="usd">20900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic452fc69ad0b4328b92b435105261628_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTgtMTUtMS0xLTA_97c2a132-7231-4e6a-85a7-ab39a2a301cf"
      unitRef="usd">8284700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6bb77f1efb29470393902b43dc1a6d3b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTktNy0xLTEtMA_4b752fe2-6c9f-4838-b062-b89b743e1dcc"
      unitRef="usd">-100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8b9791a8b20a4038bdc81c09768ee380_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTktMTEtMS0xLTA_5ec23ba0-6cd1-42fc-9f41-3d1758c1c56e"
      unitRef="usd">-100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie1f58decd61f48438b11935b7b7b714b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMTktMTUtMS0xLTA_32f6ba59-2a93-431f-b408-1ffa85fd5297"
      unitRef="usd">-100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ieb71bb2eb1d2412590a4afbcb608ddd3_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjAtMS0xLTEtMA_ce8b595f-142c-4537-a1cc-63c2f6098c32"
      unitRef="shares">6100000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ibc1061d70ad5423599fbd327cc33d223_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjAtNS0xLTEtMA_38438af7-0300-42c0-af4c-95ab081b9f88"
      unitRef="usd">267900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8c546426be6a4e028b9617594f0b1719_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjAtMTEtMS0xLTA_dddea9da-3fe2-43bd-9446-2b179130e6cf"
      unitRef="usd">267900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjAtMTUtMS0xLTA_4b9d66eb-a050-4996-b14c-04030d3247b1"
      unitRef="usd">267900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ieb71bb2eb1d2412590a4afbcb608ddd3_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjEtMS0xLTEtMA_a292e984-a331-4478-b7f7-789f22902371"
      unitRef="shares">800000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ibc1061d70ad5423599fbd327cc33d223_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjEtNS0xLTEtMA_6408383e-1bf8-4b2a-a531-ba37e92e2b94"
      unitRef="usd">7500000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3a2243e61faf45dab6768e7f1d20f6ca_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjEtNy0xLTEtMA_34de7a5e-1d96-419c-8f37-616cf81338eb"
      unitRef="usd">157800000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8c546426be6a4e028b9617594f0b1719_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjEtMTEtMS0xLTA_3a0b23c0-9bc5-4d3a-ba6f-993ef0aca561"
      unitRef="usd">165300000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjEtMTUtMS0xLTA_bf5a8dc9-ae00-4c6b-93c0-aab046eca066"
      unitRef="usd">165300000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibc1061d70ad5423599fbd327cc33d223_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjItNS0xLTEtMA_79d95c68-2f1e-4261-ad6a-297afc11d1bb"
      unitRef="usd">292300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8c546426be6a4e028b9617594f0b1719_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjItMTEtMS0xLTA_87acb8ed-d6f8-457f-96a5-b86f1d44fb92"
      unitRef="usd">292300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjItMTUtMS0xLTA_c0a072b3-b227-4761-99c3-82d722f4b7cf"
      unitRef="usd">292300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ieb71bb2eb1d2412590a4afbcb608ddd3_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjMtMS0xLTEtMA_0af93d4d-82bb-470d-8c38-e53e07e996ca"
      unitRef="shares">600000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ieb71bb2eb1d2412590a4afbcb608ddd3_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjMtMy0xLTEtMA_5668d6c8-f9a0-4d53-825b-ec04a42c7316"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ibc1061d70ad5423599fbd327cc33d223_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjMtNS0xLTEtMA_ee1d0a2e-2e23-4f50-9d31-f7f5d433e9aa"
      unitRef="usd">5200000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i3a2243e61faf45dab6768e7f1d20f6ca_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjMtNy0xLTEtMA_5e75b8a6-db0e-4e6a-9953-64e7e5a1fc5a"
      unitRef="usd">94800000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i8c546426be6a4e028b9617594f0b1719_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjMtMTEtMS0xLTA_ec9d66c3-7315-45c7-8fb1-83f8e6ce262c"
      unitRef="usd">100000000.0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjMtMTUtMS0xLTA_9ff8f0c6-46d9-49d5-9e2a-a1e1b61aeafa"
      unitRef="usd">100000000.0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:NetIncomeLoss
      contextRef="i3a2243e61faf45dab6768e7f1d20f6ca_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjQtNy0xLTEtMA_fdb9c809-9e25-4014-8f03-5571f8ff889a"
      unitRef="usd">695400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8c546426be6a4e028b9617594f0b1719_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjQtMTEtMS0xLTA_e7255aba-e244-4db1-9af9-f173ef0b62c6"
      unitRef="usd">695400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjQtMTUtMS0xLTA_7a3b0324-1743-45a0-8b15-7a555fe61626"
      unitRef="usd">695400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7a19e6703be642579f343e142e25ceb2_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjUtOS0xLTEtMA_2cefdd24-b0a4-48ac-b09d-6840c8f374ee"
      unitRef="usd">3800000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8c546426be6a4e028b9617594f0b1719_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjUtMTEtMS0xLTA_ba9fe4bc-b421-4c1c-81dc-e674e3e145fe"
      unitRef="usd">3800000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idd3fcfe8635544479553199fd6d5870b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjUtMTMtMS0xLTA_197dab37-75a8-4bcc-b0e0-85ad78c2643a"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjUtMTUtMS0xLTA_f688bb62-bd9d-4d50-823d-3b0c3c36cabe"
      unitRef="usd">4000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="idd3fcfe8635544479553199fd6d5870b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjYtMTMtMS0xLTA_4717dac8-2749-44de-89ea-23ee96f4cf17"
      unitRef="usd">7800000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjYtMTUtMS0xLTA_094a1274-9667-43c7-a39c-2964e15ded1b"
      unitRef="usd">7800000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i53f8ced32a444ff4b52e4928b94175dd_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjctMS0xLTEtMA_22c479a9-6af0-41a1-b05a-52e292d79b14"
      unitRef="shares">352600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53f8ced32a444ff4b52e4928b94175dd_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjctMy0xLTEtMA_553fff36-8b44-4bec-a18f-3d0ffbf48765"
      unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i879d429e085f447493c82a85ba62c318_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjctNS0xLTEtMA_7de03433-fac5-4a20-98cd-99138e69b519"
      unitRef="usd">6304000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i818cc058723f4fab9e6730e25fd2ff75_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjctNy0xLTEtMA_bcd60036-efe4-4c04-a422-2566207982b1"
      unitRef="usd">2937200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if4abb28eb95f4310a27bcff42b173ed8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjctOS0xLTEtMA_f32372c6-ecbc-4c92-8fa4-ba688a73dfd1"
      unitRef="usd">16200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73ec9b1829e641dda129e28b2a310e58_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjctMTEtMS0xLTA_878d356f-3c4c-44e7-8cc7-c9c0505d9190"
      unitRef="usd">9257800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i22d1823a37a8412087b1432940f4c878_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjctMTMtMS0xLTA_80c4234e-7f37-4206-bfc2-29637f381d71"
      unitRef="usd">28900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id79ce19a534e4d139e67bf0750158934_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjI4ZjMwN2NkMjgzMjRmODc4ZDQ3YTc2MjM2OTlhM2FiL3RhYmxlcmFuZ2U6MjhmMzA3Y2QyODMyNGY4NzhkNDdhNzYyMzY5OWEzYWJfMjctMTUtMS0xLTA_d5654c2f-9a60-45fc-9cf0-55febdf617ef"
      unitRef="usd">9286700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ibbc28f1ab9984d34933140b676cdeda5_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RleHRyZWdpb246NDI0MWEzZGI3OTEzNDI1YmFhZjAxMDc0YjYzNDY1ODJfMjQ2_b2817742-9e53-4239-aff3-c5126b4f7797"
      unitRef="usd">7500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <isrg:StockRepurchaseProgramincreasedtoauthorizedamount
      contextRef="ibb62ec09022f420caf06b91fbe4483c6_I20190131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RleHRyZWdpb246NDI0MWEzZGI3OTEzNDI1YmFhZjAxMDc0YjYzNDY1ODJfNTIw_aa468f03-2824-45ff-ba93-eba5e20def0e"
      unitRef="usd">2000000000</isrg:StockRepurchaseProgramincreasedtoauthorizedamount>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ibbc28f1ab9984d34933140b676cdeda5_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RleHRyZWdpb246NDI0MWEzZGI3OTEzNDI1YmFhZjAxMDc0YjYzNDY1ODJfNjA0_c9bfc8c9-1228-4655-b543-6c1bc8cee2aa"
      unitRef="usd">1600000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RleHRyZWdpb246NDI0MWEzZGI3OTEzNDI1YmFhZjAxMDc0YjYzNDY1ODJfOTQ3_2541cde8-b6e6-4d51-ab99-39fed54292b9">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides share repurchase activities (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i45ed2df55a904b73a9495b2d3967029c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfMi0xLTEtMS0w_758247b7-fba4-45cb-af5b-64ef75cfe4f5"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i4dc58ace2562461ab1b5006b2f252b53_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfMi0zLTEtMS0w_99d7654b-101e-4d19-8562-ab959efa2d22"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i553f65ed4f294d7bbb0fb4e0b36c4669_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfMi01LTEtMS0w_c75bc6a1-306d-405c-af2b-05e3f5df2c93"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="id90bdf528ea1473fb22ba73a9cf8fec7_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfMi03LTEtMS0w_39e3ec30-7643-40b3-be5c-e5b2484be373"
      unitRef="shares">600000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i45ed2df55a904b73a9495b2d3967029c_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfMy0xLTEtMS0w_5a233a87-1035-4520-9e78-b1d8218aa776"
      unitRef="usdPerShare">0</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i4dc58ace2562461ab1b5006b2f252b53_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfMy0zLTEtMS0w_d3082747-8a48-459a-ad9d-25e247fc3770"
      unitRef="usdPerShare">0</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i553f65ed4f294d7bbb0fb4e0b36c4669_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfMy01LTEtMS0w_932d9d16-5862-4905-b45c-668927477c4c"
      unitRef="usdPerShare">0</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="id90bdf528ea1473fb22ba73a9cf8fec7_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfMy03LTEtMS0w_9d7f98b5-65ef-4d94-8a7b-688c9cc81510"
      unitRef="usdPerShare">173.94</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i45ed2df55a904b73a9495b2d3967029c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfNC0xLTEtMS0w_800e54c0-abb4-4890-83f2-4f6acc56d496"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i4dc58ace2562461ab1b5006b2f252b53_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfNC0zLTEtMS0w_69214de3-f20b-4742-ba2a-5a933b3de241"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i553f65ed4f294d7bbb0fb4e0b36c4669_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfNC01LTEtMS0w_ec3bd792-b6da-4bfe-9b5f-19a68db48154"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="id90bdf528ea1473fb22ba73a9cf8fec7_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmI2MTBiMTgwYjIyNjQyMzliYWU5YTM1ZTVjZDAyY2I4L3RhYmxlcmFuZ2U6YjYxMGIxODBiMjI2NDIzOWJhZTlhMzVlNWNkMDJjYjhfNC03LTEtMS0w_e4792a93-6d8c-4506-957f-a27c060ff9f1"
      unitRef="usd">100000000.0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RleHRyZWdpb246NDI0MWEzZGI3OTEzNDI1YmFhZjAxMDc0YjYzNDY1ODJfOTM1_4b88d478-36b8-469c-929e-9c1d416b147a">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated other comprehensive income (loss), net of tax, attributable to Intuitive are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&lt;br/&gt;on&#160;Hedge&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses)&#160;on Available-for-Sale Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Gains&#160;(Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&lt;br/&gt;on&#160;Hedge&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses)&#160;on Available-for-Sale Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Gains&#160;(Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&lt;br/&gt;on&#160;Hedge&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses)&#160;on Available-for-Sale Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Gains&#160;(Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&lt;br/&gt;on&#160;Hedge&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses)&#160;on Available-for-Sale Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Gains&#160;(Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="iecbbf0bac773402585e5625778664eaf_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMi0xLTEtMS0w_8fc46793-7e48-4cb1-a61b-ea8176e7b9a7"
      unitRef="usd">3100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iecbbf0bac773402585e5625778664eaf_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMi0zLTEtMS0w_a1519d38-2f8d-4b41-836d-e548546a7adf"
      unitRef="usd">13500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="iecbbf0bac773402585e5625778664eaf_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMi01LTEtMS0w_ea3e93a9-a597-4377-a99a-728ec4461384"
      unitRef="usd">-100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="iecbbf0bac773402585e5625778664eaf_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMi03LTEtMS0w_e803e38a-2f8f-49e7-b1da-6f79d0622d8d"
      unitRef="usd">-6200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iecbbf0bac773402585e5625778664eaf_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMi05LTEtMS0w_b30500e4-e627-4dd6-b041-6b33f6e43f95"
      unitRef="usd">10300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMy0xLTEtMS0w_cbb8e529-830d-4705-94bb-f3ed437cd945"
      unitRef="usd">4200000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMy0zLTEtMS0w_013e351d-a5cc-4dad-a58e-d7d59533cc78"
      unitRef="usd">-3400000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMy01LTEtMS0w_a6e37453-b72e-41ed-9c70-9ac7b5676324"
      unitRef="usd">-2700000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMy03LTEtMS0w_bfa13d4b-b651-4b83-b9ac-de8e810285ff"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfMy05LTEtMS0w_a172977f-b1a4-4edc-b40f-5e5f7758382e"
      unitRef="usd">-1900000</isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNC0xLTEtMS0w_4931ec5d-d2a3-4199-8cd9-b6278257114a"
      unitRef="usd">2200000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNC0zLTEtMS0w_e959eda0-8d55-4177-9274-50107b18852d"
      unitRef="usd">1100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNC01LTEtMS0w_7f9061c5-ac20-4a48-9f22-b783abe876d4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNC03LTEtMS0w_b7ecaa3f-a686-4676-8fb7-2a223cdd9abb"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNC05LTEtMS0w_e06c7328-2b83-4cd2-903c-2522c421a5ef"
      unitRef="usd">3100000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNS0xLTEtMS0w_bb6e375b-1154-4f70-98e9-2a391c528ee2"
      unitRef="usd">2000000.0</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNS0zLTEtMS0w_e621bf12-a2ce-4f3e-a427-2ac7af8c063b"
      unitRef="usd">-4500000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNS01LTEtMS0w_5ac1d26f-8db4-4f20-bbbf-15e1ac2a0d85"
      unitRef="usd">-2700000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNS03LTEtMS0w_fee334ad-dc5c-4ff1-a0d5-ad4d3fd40dce"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNS05LTEtMS0w_fdc46e77-f8a2-4549-8781-73d2fc27cfea"
      unitRef="usd">-5000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNi0xLTEtMS0w_ebb6d59f-26c9-485b-8330-424873c2ebd5"
      unitRef="usd">5100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNi0zLTEtMS0w_bee0fffe-2e38-44f9-bf9e-47ee38026d4c"
      unitRef="usd">9000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNi01LTEtMS0w_b65b6083-3d36-4914-b40c-ac5bce819e16"
      unitRef="usd">-2800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNi03LTEtMS0w_30ad3090-853a-48d4-8569-414300acef37"
      unitRef="usd">-6000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmNlZTBkOWJiNzE4ZDQxMmFiNjY3YTRiN2YwNmY3YmQ3L3RhYmxlcmFuZ2U6Y2VlMGQ5YmI3MThkNDEyYWI2NjdhNGI3ZjA2ZjdiZDdfNi05LTEtMS0w_aecfa2ab-008d-438a-93ce-1c5207c3c1cc"
      unitRef="usd">5300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="ib780080ab3a8424fbe082969241fa1f5_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMi0xLTEtMS0w_9154af80-d7cc-4958-b586-4f9c5610409f"
      unitRef="usd">400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ib780080ab3a8424fbe082969241fa1f5_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMi0zLTEtMS0w_2bbc170c-17c1-4b86-9f1c-12e30d80fc62"
      unitRef="usd">44100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ib780080ab3a8424fbe082969241fa1f5_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMi01LTEtMS0w_3148c7d2-b3a1-46ee-939a-3c5c4d01664a"
      unitRef="usd">-13800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ib780080ab3a8424fbe082969241fa1f5_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMi03LTEtMS0w_14196076-a69b-4b30-bff1-f04c70beb790"
      unitRef="usd">-8400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib780080ab3a8424fbe082969241fa1f5_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMi05LTEtMS0w_ee72ba17-1c35-44bb-abb6-9c643ccf9a21"
      unitRef="usd">22300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMy0xLTEtMS0w_0396c641-ee4b-434d-b1ad-516a03473e67"
      unitRef="usd">-800000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMy0zLTEtMS0w_01c3bd60-9aec-404a-b34b-72f2912329c4"
      unitRef="usd">-7100000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMy01LTEtMS0w_c3cb7e87-4513-47f4-9be9-8e7ba374899d"
      unitRef="usd">2200000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMy03LTEtMS0w_7bbeded0-0f82-4a18-8f42-116c2ec72712"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfMy05LTEtMS0w_8cfe1a29-e66a-467a-a7b2-74c78677b29a"
      unitRef="usd">-5700000</isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNC0xLTEtMS0w_f495eaee-9cd0-4b90-9690-5a7b4c52219e"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNC0zLTEtMS0w_2893cb6b-96cc-471f-809d-f8f8846c6ff1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNC01LTEtMS0w_5ab60dc7-63f1-48a2-9244-5ddaad6b02a0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNC03LTEtMS0w_9aff0843-57f3-48ea-9dfc-b25ac8f57572"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNC05LTEtMS0w_71a21289-47cc-44cb-8309-2e77a72e8872"
      unitRef="usd">400000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNS0xLTEtMS0w_8306a080-bffe-4a9a-8515-5ae9680816b9"
      unitRef="usd">-1400000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNS0zLTEtMS0w_3be31afc-dd95-4dbc-8772-b13855a8f9a8"
      unitRef="usd">-7100000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNS01LTEtMS0w_3d3eaa89-7848-4708-b591-079d49aed159"
      unitRef="usd">2200000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNS03LTEtMS0w_f91021a8-17a6-44d5-942f-114d1e32934e"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNS05LTEtMS0w_1303ab7b-a980-412a-b82c-22cb6d9b060d"
      unitRef="usd">-6100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="id79ce19a534e4d139e67bf0750158934_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNi0xLTEtMS0w_c2ffde01-73ca-4456-a237-313fccf5c1a8"
      unitRef="usd">-1000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="id79ce19a534e4d139e67bf0750158934_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNi0zLTEtMS0w_2ca62957-a04e-4980-8937-3597ec9f009a"
      unitRef="usd">37000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="id79ce19a534e4d139e67bf0750158934_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNi01LTEtMS0w_6dbafb5b-8291-44e3-8e32-9bcc6201ea5f"
      unitRef="usd">-11600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="id79ce19a534e4d139e67bf0750158934_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNi03LTEtMS0w_d806f3d4-c4ee-4628-990b-82508019e6d7"
      unitRef="usd">-8200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id79ce19a534e4d139e67bf0750158934_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjUzZjkxZGQ4ZGNiNzQwYTM5MGVkZDdkYjdjMDE1YzJiL3RhYmxlcmFuZ2U6NTNmOTFkZDhkY2I3NDBhMzkwZWRkN2RiN2MwMTVjMmJfNi05LTEtMS0w_04557101-d9c7-42ce-8918-2ce70273f9c8"
      unitRef="usd">16200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMi0xLTEtMS0w_16ecab9d-7cd7-4699-a62e-f75917040a10"
      unitRef="usd">-2900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMi0zLTEtMS0w_366aa76f-eeb8-4930-bf44-b339375f1385"
      unitRef="usd">29500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMi01LTEtMS0w_9d479a35-53a5-485a-814a-45ce70f29791"
      unitRef="usd">4700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMi03LTEtMS0w_24733c9a-8b75-47e3-8ec8-3d925e8af6f2"
      unitRef="usd">-6400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMi05LTEtMS0w_4d24c182-8087-4231-b324-02c1134b04fa"
      unitRef="usd">24900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMy0xLTEtMS0w_c5ae492e-199a-47a5-9a6a-fd340a436010"
      unitRef="usd">9300000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMy0zLTEtMS0w_5fdac6a9-77d5-426b-b9ed-4520b5cba905"
      unitRef="usd">-19400000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMy01LTEtMS0w_842ab3cd-bb6c-427e-a67e-0abe21dac0d7"
      unitRef="usd">-7500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMy03LTEtMS0w_ada22512-0a5e-453b-a326-e534c38e22f3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfMy05LTEtMS0w_7e341f9b-692c-48fc-90e2-936967e21c3b"
      unitRef="usd">-17600000</isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNC0xLTEtMS0w_bb783325-7bb8-470c-aaf1-2ffb9fd402fc"
      unitRef="usd">1300000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNC0zLTEtMS0w_d23daaf9-9e2d-4836-b545-aae059839f4d"
      unitRef="usd">1100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNC01LTEtMS0w_91b4f8fe-768c-4f0c-b2d8-09ebd3dd1fee"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNC03LTEtMS0w_bfb3f346-9d22-4aae-a9c5-9b53bee0f700"
      unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNC05LTEtMS0w_c93e3e91-a5e2-4477-832f-aed462c7765d"
      unitRef="usd">2000000.0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNS0xLTEtMS0w_34fafe2f-43d1-4c96-bfbe-43949eb2b3f6"
      unitRef="usd">8000000.0</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNS0zLTEtMS0w_56929605-7a27-4c0e-8d69-3f49c4cef1cc"
      unitRef="usd">-20500000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNS01LTEtMS0w_8f6152e9-eaff-4363-b2d4-18aa95717718"
      unitRef="usd">-7500000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNS03LTEtMS0w_b2303cea-788c-4f4b-936d-8a202529cf9e"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNS05LTEtMS0w_251ac0c3-03a1-4ec9-9c86-ef34b2e63822"
      unitRef="usd">-19600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNi0xLTEtMS0w_e760a8f1-029a-4c4a-ac22-e898ec0c2798"
      unitRef="usd">5100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNi0zLTEtMS0w_e31f9240-2e1a-4523-b189-296c20d9662a"
      unitRef="usd">9000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNi01LTEtMS0w_078703ab-3275-41c7-b31f-86900f2ad8a1"
      unitRef="usd">-2800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNi03LTEtMS0w_d31ab049-9abc-4f60-98dd-d81f0aa171de"
      unitRef="usd">-6000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOjQ3YzMwNTllMDJkODQ5ZmRiYmUzNWFiMDdjNTkyMWE0L3RhYmxlcmFuZ2U6NDdjMzA1OWUwMmQ4NDlmZGJiZTM1YWIwN2M1OTIxYTRfNi05LTEtMS0w_40a57ce7-f354-4f95-b251-8a3f1cdd8555"
      unitRef="usd">5300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="ic452fc69ad0b4328b92b435105261628_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMi0xLTEtMS0w_9e9c5046-1bb5-452e-b9ea-7e057ed486cd"
      unitRef="usd">700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ic452fc69ad0b4328b92b435105261628_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMi0zLTEtMS0w_aa183819-66ff-4e58-8d0b-3eb64bd777b7"
      unitRef="usd">20400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ic452fc69ad0b4328b92b435105261628_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMi01LTEtMS0w_51b9208f-a447-4899-b33c-6844df7ea938"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ic452fc69ad0b4328b92b435105261628_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMi03LTEtMS0w_3d865b18-3cc1-42a8-aa98-4b11c5340ccc"
      unitRef="usd">-8700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic452fc69ad0b4328b92b435105261628_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMi05LTEtMS0w_a76d6e7c-0d90-488a-baaf-11695cd38980"
      unitRef="usd">12400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMy0xLTEtMS0w_4a8a2d56-3ee9-474b-ae9f-5c91625fbadc"
      unitRef="usd">2000000.0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMy0zLTEtMS0w_f1b95946-595e-4caa-9a87-2a19cd97411c"
      unitRef="usd">21300000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMy01LTEtMS0w_80f74221-1246-45b9-bd67-9193749f6794"
      unitRef="usd">-11600000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMy03LTEtMS0w_84fd2817-4c72-4167-87f7-860dc848619c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfMy05LTEtMS0w_7bbe4804-7b48-4ceb-b3c8-2153010704e6"
      unitRef="usd">11700000</isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNC0xLTEtMS0w_c9c30745-f4de-43a9-9aed-66493cf2101c"
      unitRef="usd">3700000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNC0zLTEtMS0w_acc0585b-1c3f-4b06-b86a-521ba85f50aa"
      unitRef="usd">4700000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNC01LTEtMS0w_3f44fdc6-4e45-4683-8384-7b540111478f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNC03LTEtMS0w_b331576e-f58c-4744-b49f-6b734c69f986"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNC05LTEtMS0w_71d7b037-8534-4aa3-9da1-1545c85a1607"
      unitRef="usd">7900000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNS0xLTEtMS0w_7b24c4d0-446a-44a5-8c3b-cc4ca181c123"
      unitRef="usd">-1700000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNS0zLTEtMS0w_21f0824f-3c24-4965-8435-4c95fe666037"
      unitRef="usd">16600000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNS01LTEtMS0w_a4621318-99a6-4293-93d4-a257992e92ba"
      unitRef="usd">-11600000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNS03LTEtMS0w_81dfb4e5-8ec9-4dfb-a368-5ae8adb7a8ab"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNS05LTEtMS0w_bcb8c1d1-f803-46ff-8792-2c92dd655543"
      unitRef="usd">3800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="id79ce19a534e4d139e67bf0750158934_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNi0xLTEtMS0w_de6ecb6f-aa82-430a-a3bf-3d952fe16456"
      unitRef="usd">-1000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="id79ce19a534e4d139e67bf0750158934_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNi0zLTEtMS0w_d44e5c02-5386-4fad-8606-784373856bf5"
      unitRef="usd">37000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="id79ce19a534e4d139e67bf0750158934_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNi01LTEtMS0w_3bcb4e17-e48f-46cb-a752-f3988083a4d5"
      unitRef="usd">-11600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="id79ce19a534e4d139e67bf0750158934_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNi03LTEtMS0w_1ca142a1-4b51-49a6-af8a-0f39bbc0ccd7"
      unitRef="usd">-8200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id79ce19a534e4d139e67bf0750158934_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81NS9mcmFnOjQyNDFhM2RiNzkxMzQyNWJhYWYwMTA3NGI2MzQ2NTgyL3RhYmxlOmYwYTBmNmU2MWY5YTRhYTg5MDgxZjE2ZTM5NmI5OTk1L3RhYmxlcmFuZ2U6ZjBhMGY2ZTYxZjlhNGFhODkwODFmMTZlMzk2Yjk5OTVfNi05LTEtMS0w_9fd4f303-83ca-41a7-a2cd-c5dfccb779e0"
      unitRef="usd">16200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTg0Nw_c66ca445-e8e5-45a6-b4b6-310223be3b55">SHARE-BASED COMPENSATION&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Company&#x2019;s shareholders approved an amended and restated 2010 Incentive Award Plan to provide for an increase in the number of shares of common stock reserved for issuance thereunder from 32,450,000 to 34,450,000 (or, after giving effect to the Stock Split, 97,350,000 to 103,350,000). As of&#160;September&#160;30, 2021, approximately&#160;25.5 million&#160;shares were reserved for future issuance under the Company&#x2019;s stock plans. A maximum of approximately&#160;11.1 million&#160;of these shares can be awarded as restricted stock units (&#x201c;RSUs&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Option Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of stock option activity under all stock plans for the nine months ended September&#160;30, 2021, is presented as follows (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Exercise&#160;Price Per&lt;br/&gt;Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options forfeited/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, options to purchase an aggregate of 9.5 million shares of common stock were exercisable at a weighted average price of $94.76 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of RSUs activity under all stock plans for the nine months ended September&#160;30, 2021, is presented as follows (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested balance at December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested balance at September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;), employees purchased approximately 0.5 million shares for $75.9 million and approximately 0.5 million shares for $71.2 million during the nine months ended September&#160;30, 2021, and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes share-based compensation expense for the three and nine months ended September&#160;30, 2021, and 2020 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales &#x2013; products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales &#x2013; services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense after income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes option pricing model is used to estimate the fair value of stock options granted under the Company&#x2019;s share-based compensation plans and rights to acquire stock granted under the ESPP. The weighted average estimated fair values of stock options and the rights to acquire stock under the ESPP, as well as the weighted average assumptions used in calculating the fair values of stock options and the rights to acquire stock under the ESPP that were granted during the three and nine months ended September&#160;30, 2021, and 2020, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$87.35&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$62.65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$78.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$53.57&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$91.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$67.85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$89.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$57.29&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i2ec0403c801644f7b94ced14e5abe91e_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMjQ1_066a770d-8853-497d-8e27-082d1a954531"
      unitRef="shares">32450000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i3ba50cc2545940ee9b0e537bcee9fecb_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMjUx_012c1c97-6d6f-4481-bb9c-896e4292ac27"
      unitRef="shares">34450000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <isrg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit
      contextRef="i90d117c8ce8b4a12a61bca2bc0d175ea_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTA5OTUxMTYyOTgwMA_a8a49296-5014-4ebf-ba95-1dea7889f98d"
      unitRef="shares">97350000</isrg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit>
    <isrg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit
      contextRef="i3a351862876548c3806015af800a7f8b_I20210430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTA5OTUxMTYyOTc4Nw_c3ad517b-f069-4e52-8b44-f7e248e2761c"
      unitRef="shares">103350000</isrg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i120ec0e7f5d74c85a3c972e2814bae13_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMjc5_84e164f0-1e30-4a48-9580-7fd5142b5b98"
      unitRef="shares">25500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i24b8332d62be4e67924e1b675742a795_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMzgz_655515bb-fea4-49c1-97e7-fdc161b1f3cf"
      unitRef="shares">11100000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTg1OA_d8cb0e42-2633-4f0d-8423-4bcd4cadab98">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of stock option activity under all stock plans for the nine months ended September&#160;30, 2021, is presented as follows (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Exercise&#160;Price Per&lt;br/&gt;Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options forfeited/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfMi0yLTEtMS0w_acb7db50-ce21-47f9-9518-3390db250bc7"
      unitRef="shares">13400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfMi00LTEtMS0w_a9b5ed28-632c-4d9e-a331-4c9b7514bf01"
      unitRef="usdPerShare">101.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfNC0yLTEtMS0w_c84cfff8-ce21-45f8-b62c-de3b5e2b22cd"
      unitRef="shares">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfNC00LTEtMS0w_79f7fde3-e979-4366-89d9-33a4b3fb752a"
      unitRef="usdPerShare">294.53</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfNS0yLTEtMS0w_a937113e-9544-4695-b987-c6b4de0a2f12"
      unitRef="shares">2300000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfNS00LTEtMS0w_5813f6bc-e288-4a51-8ce1-c4c2383ecbbe"
      unitRef="usdPerShare">74.06</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfNi0yLTEtMS0w_9e740a9e-9365-417f-a369-264d0bce0206"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfNi00LTEtMS0w_5893ab18-a6fa-4229-bad7-82bca99458c0"
      unitRef="usdPerShare">194.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfNy0yLTEtMS0w_9571cc6f-1bf6-4bf8-acb8-faf3569db966"
      unitRef="shares">12100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmYyZDhjYzVmNWQyNzRkZDY5ZjZjYzdkMWQ0ODJjNzRlL3RhYmxlcmFuZ2U6ZjJkOGNjNWY1ZDI3NGRkNjlmNmNjN2QxZDQ4MmM3NGVfNy00LTEtMS0w_56f99769-4339-4b3c-b607-c9aeabad0cc0"
      unitRef="usdPerShare">123.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfNjc2_5495ac56-e993-41f5-9a00-6d20ceeaab6f"
      unitRef="shares">9500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i1799f673ba7c41f0a5ee2d85aab09d18_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfNzUw_803ae584-a1e8-4375-88dc-c32fc34a0850"
      unitRef="usdPerShare">94.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTg0NQ_a8db68bc-b6a4-468e-aa89-3291b0cf5607">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of RSUs activity under all stock plans for the nine months ended September&#160;30, 2021, is presented as follows (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested balance at December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested balance at September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i027fee4566074a4f9475d1aa2d3fbb42_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfMS0xLTEtMS0w_d58af212-67c3-4679-b510-af592fc82354"
      unitRef="shares">5300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i027fee4566074a4f9475d1aa2d3fbb42_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfMS0zLTEtMS0w_9c1b3c76-777e-4946-b62a-321f423ddd3b"
      unitRef="usdPerShare">163.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if4414a789bd34fbebcd0395bb363b24f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfMi0xLTEtMS0w_9fac5c42-77cd-493c-9572-57aa80e529c5"
      unitRef="shares">1900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if4414a789bd34fbebcd0395bb363b24f_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfMi0zLTEtMS0w_50f117b3-02dd-42ae-8771-9f66278d82ba"
      unitRef="usdPerShare">252.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="if4414a789bd34fbebcd0395bb363b24f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfMy0xLTEtMS0w_a238291b-e8cb-489f-845c-e9af70480ee3"
      unitRef="shares">2100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="if4414a789bd34fbebcd0395bb363b24f_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfMy0zLTEtMS0w_42ab9e00-8e7a-40ab-a7a3-84c62a231fb6"
      unitRef="usdPerShare">144.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="if4414a789bd34fbebcd0395bb363b24f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfNC0xLTEtMS0w_ff8c1659-a3bf-4f8a-a7b7-701a2eaf23f1"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="if4414a789bd34fbebcd0395bb363b24f_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfNC0zLTEtMS0w_307949cd-e92f-4e2e-a408-4a0667a118da"
      unitRef="usdPerShare">191.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i4ac96970f42e4066a4c840390044d4b5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfNS0xLTEtMS0w_4280d6a0-3b29-4605-93a7-ca0d84486436"
      unitRef="shares">4800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i4ac96970f42e4066a4c840390044d4b5_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjU1MjQ1ZDAzMTZjYzQwNmI5NjJkODYyNzQ5OWZlODI4L3RhYmxlcmFuZ2U6NTUyNDVkMDMxNmNjNDA2Yjk2MmQ4NjI3NDk5ZmU4MjhfNS0zLTEtMS0w_44199b24-5f7d-4c12-96ad-7d47ec32eb3b"
      unitRef="usdPerShare">204.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTA1NQ_3dc6ec0a-0469-47f1-a9f5-abfe92e914fc"
      unitRef="shares">500000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i92cbadc1b4dc43c78d9b42fe98dc9359_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTA2OQ_fcabf121-cbfd-4eff-a323-b68ac81d8a21"
      unitRef="usd">75900000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTA5MA_645912af-4129-4c94-8e76-e6a5630ca56d"
      unitRef="shares">500000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i97592680c7ea4d0c98add45dc8ac42d6_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTEwNA_6c25c166-365a-460e-9571-9dc8ff5675d9"
      unitRef="usd">71200000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTg3OQ_8380cbfc-e28f-48d6-8505-33060add365e">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes share-based compensation expense for the three and nine months ended September&#160;30, 2021, and 2020 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales &#x2013; products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales &#x2013; services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense after income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie3dc8c8c90db4f51afb0d492dbb4b82e_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfMi0xLTEtMS0w_88057c93-102f-4ccf-9393-9056fd0ecc94"
      unitRef="usd">19000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i53ae1d88875d4f12a62bc03a44e1b07f_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfMi0zLTEtMS0w_1386eaa9-f204-40b9-bd68-e5a2d593bc5c"
      unitRef="usd">16200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie24d4b4f022c47c9803198a89abebb1c_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfMi01LTEtMS0w_7c0dc14a-1245-4c0d-8984-7b2f7ec85304"
      unitRef="usd">50900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i553935c5696341248be4dde6c6466dc1_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfMi03LTEtMS0w_77a8fd94-f1a8-4160-8281-cfdfdc63564d"
      unitRef="usd">43000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i636e52596b904d9aabe71c6e5c662679_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfMy0xLTEtMS0w_6c33818b-d828-4080-ba1d-319993bbfee7"
      unitRef="usd">6000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6fcd59b1068d47cba389bdf071fe2a4a_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfMy0zLTEtMS0w_c267e045-7667-487d-a62d-9f6a11615b33"
      unitRef="usd">7100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1f6cbcbf701a42bf9968bf5dc8e400e2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfMy01LTEtMS0w_ebfb55f1-c178-43f6-8358-51a930f3de75"
      unitRef="usd">16900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5299dae533374f869f3916eb74f78a0d_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfMy03LTEtMS0w_fcba0c86-97b9-4b39-ad2f-278825abee6f"
      unitRef="usd">17800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i23ec5af0dc794a8b819199e06c9c7e0e_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNC0xLTEtMS0w_2c191661-2bd3-4ebf-b5ff-2ad18f16358d"
      unitRef="usd">25000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie0e0073a5326490ca14b42218c217b9a_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNC0zLTEtMS0w_071923c9-4ec6-4196-a0af-4e8698d90cbd"
      unitRef="usd">23300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic17eef63e1f745a382c154accc3d123e_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNC01LTEtMS0w_6de8679f-4e54-4e37-9aa3-c6e0a2708a36"
      unitRef="usd">67800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iec5a6bdd4379479bbf40a5d7ea2ea843_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNC03LTEtMS0w_7615e901-32ee-417c-9609-3f9b1bb3dd54"
      unitRef="usd">60800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ief8e8ca8a5314cf29b3f0cd00926ccf6_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNS0xLTEtMS0w_d6109182-f16c-484e-b643-31e4d40a050e"
      unitRef="usd">62500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic5991df12b084f31a3209fb60aac8919_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNS0zLTEtMS0w_32693881-852a-470f-8fd8-98ae9dfc4281"
      unitRef="usd">54200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6bdc2cf5e4434be7a2c05799c2f073a0_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNS01LTEtMS0w_71337bfb-721e-48ef-bcd9-195b1ece1ce6"
      unitRef="usd">171300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie98c2152fa284185b7a3eec1e86e9308_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNS03LTEtMS0w_1105571e-e791-4ea6-a85d-89832dccd5c1"
      unitRef="usd">149500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ida259e2fffb84c6daef0d3ae72179664_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNi0xLTEtMS0w_79682929-a639-486e-aaec-573ffacb3c71"
      unitRef="usd">35400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i17cd59475f274e609d82992c047d3bef_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNi0zLTEtMS0w_23dceb9c-bb2a-480c-9f48-51554346d213"
      unitRef="usd">29500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icf5c832845ad43ffaae3030609897c12_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNi01LTEtMS0w_d80ad783-0879-439d-a21b-5dcfd89d4f0a"
      unitRef="usd">98100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib1fc23134d92414983b8c9ffd7172fcc_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNi03LTEtMS0w_81e42d04-43ca-478c-b681-3aa42abf9abc"
      unitRef="usd">84100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNy0xLTEtMS0w_03d64587-365b-4fef-9751-c3974635f2ae"
      unitRef="usd">122900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNy0zLTEtMS0w_3e476ffe-0d67-483b-b0f5-64dd48fbea95"
      unitRef="usd">107000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNy01LTEtMS0w_e230c2fa-4366-477c-925e-460bc9c2e30e"
      unitRef="usd">337200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfNy03LTEtMS0w_ce27fd1a-1948-422b-a094-36292070aa97"
      unitRef="usd">294400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfOC0xLTEtMS0w_64c9d875-8fbf-40e1-9454-9000364d7f97"
      unitRef="usd">24800000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfOC0zLTEtMS0w_7e276510-7430-40a2-9d40-341f0cec457f"
      unitRef="usd">22300000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfOC01LTEtMS0w_2513616c-ec55-416a-be31-62d10b5c2f39"
      unitRef="usd">67900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfOC03LTEtMS0w_f3434256-a4f4-4aee-a051-e25ca7b549ef"
      unitRef="usd">61200000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfOS0xLTEtMS0w_c337ebdb-8fe3-45af-b154-45d3fae3e2ec"
      unitRef="usd">98100000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfOS0zLTEtMS0w_b289cc4b-c30e-4ecf-8e33-bbf7af7b4a4b"
      unitRef="usd">84700000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfOS01LTEtMS0w_1217407c-44b0-4e57-8aed-de5b26eda6cc"
      unitRef="usd">269300000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOjJmN2NkMzdiMDZhMDRiY2Q5YzBlY2Y3OTlhNzE1NmZhL3RhYmxlcmFuZ2U6MmY3Y2QzN2IwNmEwNGJjZDljMGVjZjc5OWE3MTU2ZmFfOS03LTEtMS0w_ee571775-6b0e-40e2-9754-4f3401ad168d"
      unitRef="usd">233200000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RleHRyZWdpb246NzhkYjA5MDNjMWFiNDZhN2JiNGU0NWRmYmEyMmFkZmZfMTg4MQ_ae589ba1-1ee7-47f9-b622-4d7d3079d403">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes option pricing model is used to estimate the fair value of stock options granted under the Company&#x2019;s share-based compensation plans and rights to acquire stock granted under the ESPP. The weighted average estimated fair values of stock options and the rights to acquire stock under the ESPP, as well as the weighted average assumptions used in calculating the fair values of stock options and the rights to acquire stock under the ESPP that were granted during the three and nine months ended September&#160;30, 2021, and 2020, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$87.35&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$62.65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$78.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$53.57&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$91.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$67.85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$89.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$57.29&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i39d2400983df44e786e5f043ff29f072_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMy0xLTEtMS0w_2ee7a102-5d4c-451d-ae9e-26ad18ddf0df"
      unitRef="number">0.008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i86ee9cb414864a739611fb6aa952b4b5_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMy0zLTEtMS0w_cc99f5dd-c761-46c7-b013-7696a86c3b18"
      unitRef="number">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i19f02cddebeb45688a3df400d1f96f9f_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMy01LTEtMS0w_bf0308ec-2c4f-41e8-b48b-42fb4d4f962b"
      unitRef="number">0.008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i26618f20dcf34488b46dc5d1ad566328_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMy03LTEtMS0w_a0bf6369-13d7-4d5b-bef2-464a2e61558b"
      unitRef="number">0.006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i39d2400983df44e786e5f043ff29f072_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNC0xLTEtMS0w_c6540ebc-e509-44d4-ae2f-f62e0172e9ff">P3Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i86ee9cb414864a739611fb6aa952b4b5_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNC0zLTEtMS0w_dec91cec-adc3-4276-b84d-dbd8f74be995">P3Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i19f02cddebeb45688a3df400d1f96f9f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNC01LTEtMS0w_451541a9-eb2d-4820-84f1-9037968a285c">P4Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i26618f20dcf34488b46dc5d1ad566328_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNC03LTEtMS0w_b5cd947f-b9a3-44a3-9ac0-da6eb4c3b29b">P4Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i39d2400983df44e786e5f043ff29f072_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNS0xLTEtMS0w_2ad3b239-445b-49e6-864e-c28be576100d"
      unitRef="number">0.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i86ee9cb414864a739611fb6aa952b4b5_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNS0zLTEtMS0w_be63b632-9a85-4fc6-9a4e-2c3edbe78d76"
      unitRef="number">0.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i19f02cddebeb45688a3df400d1f96f9f_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNS01LTEtMS0w_fe158b16-aa84-4778-bd79-1131067f5b4a"
      unitRef="number">0.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i26618f20dcf34488b46dc5d1ad566328_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNS03LTEtMS0w_cd20f4a6-f9d6-485b-8f2a-f958f498ccae"
      unitRef="number">0.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i39d2400983df44e786e5f043ff29f072_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNi0xLTEtMS0w_c209a0a0-bf87-4946-b845-06ae44a0696f"
      unitRef="usdPerShare">87.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i86ee9cb414864a739611fb6aa952b4b5_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNi0zLTEtMS0w_4fca772b-a769-4629-8987-55bfcabed375"
      unitRef="usdPerShare">62.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i19f02cddebeb45688a3df400d1f96f9f_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNi01LTEtMS0w_c98c6f5d-06df-4d96-b125-55e2ac7f366d"
      unitRef="usdPerShare">78.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i26618f20dcf34488b46dc5d1ad566328_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfNi03LTEtMS0w_5c6b43ef-597d-4a78-80c9-0527151219eb"
      unitRef="usdPerShare">53.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i3ee2fa93adb64b729a028c991c27406a_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfOC0xLTEtMS0w_708cdaf0-afb3-4fcc-8db3-ccd500a6a0ef"
      unitRef="number">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i69e0aa09b22945fe8e76dfb3e9ac826e_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfOC0zLTEtMS0w_cf0c0761-ebc3-4877-b78e-18a1e8951b0e"
      unitRef="number">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i92cbadc1b4dc43c78d9b42fe98dc9359_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfOC01LTEtMS0w_c2863ebe-de55-45b2-b37c-2453581ab79c"
      unitRef="number">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i97592680c7ea4d0c98add45dc8ac42d6_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfOC03LTEtMS0w_eb608e53-2165-4764-b9a7-22422b94aa48"
      unitRef="number">0.009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i3ee2fa93adb64b729a028c991c27406a_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfOS0xLTEtMS0w_adf4103a-57e4-4271-809f-a00d7fcd45b3">P1Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i69e0aa09b22945fe8e76dfb3e9ac826e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfOS0zLTEtMS0w_ce68f0a5-74c4-448c-ba68-58fef84e9d8c">P1Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i92cbadc1b4dc43c78d9b42fe98dc9359_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfOS01LTEtMS0w_917204a0-2e13-42c7-b0a3-4b911d27456b">P1Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i97592680c7ea4d0c98add45dc8ac42d6_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfOS03LTEtMS0w_613210c4-2468-4c5f-b606-4ebee60fdcce">P1Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i3ee2fa93adb64b729a028c991c27406a_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMTAtMS0xLTEtMA_76efb359-0642-4147-b6a7-0f5b7d025d66"
      unitRef="number">0.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i69e0aa09b22945fe8e76dfb3e9ac826e_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMTAtMy0xLTEtMA_76365435-7309-474e-8abf-f0b5ecba5dc8"
      unitRef="number">0.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i92cbadc1b4dc43c78d9b42fe98dc9359_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMTAtNS0xLTEtMA_11be14dd-ac96-43f6-804b-ea7c4d2b36e3"
      unitRef="number">0.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i97592680c7ea4d0c98add45dc8ac42d6_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMTAtNy0xLTEtMA_a35d56d7-e062-446d-9f21-d9a830bb3720"
      unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3ee2fa93adb64b729a028c991c27406a_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMTEtMS0xLTEtMA_572a53e1-d6b5-4a26-bc03-e8f09de56ed0"
      unitRef="usdPerShare">91.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i69e0aa09b22945fe8e76dfb3e9ac826e_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMTEtMy0xLTEtMA_ac5f1ee3-46bb-4443-a630-633b1f289787"
      unitRef="usdPerShare">67.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i92cbadc1b4dc43c78d9b42fe98dc9359_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMTEtNS0xLTEtMA_7e48c62b-71c5-4b7a-8491-e9e06be88c2c"
      unitRef="usdPerShare">89.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i97592680c7ea4d0c98add45dc8ac42d6_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl81OC9mcmFnOjc4ZGIwOTAzYzFhYjQ2YTdiYjRlNDVkZmJhMjJhZGZmL3RhYmxlOmU3OWIzNjRlMGQ0NjRmZmI4MWJkNzA1NTMwMmJlYmE0L3RhYmxlcmFuZ2U6ZTc5YjM2NGUwZDQ2NGZmYjgxYmQ3MDU1MzAyYmViYTRfMTEtNy0xLTEtMA_d6235139-0d04-4b04-b36d-abed7133762b"
      unitRef="usdPerShare">57.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMzM2Ng_4e712029-a896-44b3-a2ac-f83fbf952893">INCOME TAXES&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense for the three months ended September&#160;30, 2021, was $73.9&#160;million, or 16.0% of income before taxes, compared to $38.4&#160;million, or 10.8% of income before taxes, for the three months ended September&#160;30, 2020. Income tax expense for the nine months ended September&#160;30, 2021, was $90.7 million, or 6.3% of income before taxes, compared to $67.3&#160;million, or 8.7% of income before taxes, for the nine months ended September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rate for the three and nine months ended September&#160;30, 2021, and 2020, differs from the U.S. federal statutory rate of 21% mainly due to excess tax benefits associated with employee equity plans, the effect of income earned by certain overseas entities being taxed at rates lower than the federal statutory rate, and the federal research and development (&#x201c;R&amp;amp;D&#x201d;) credit benefit, partially offset by U.S. tax on foreign earnings and state income taxes (net of federal benefit).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rate for the nine months ended September&#160;30, 2021, included a one-time benefit of $66.4&#160;million from re-measurement of the Company&#x2019;s Swiss deferred tax assets resulting from the extension of the economic useful life of certain intangible assets. The effective tax rate for the nine months ended September&#160;30, 2020, reflected a one-time increase of $36.8&#160;million in unrecognized tax benefits with a corresponding increase to income tax expense. This increase was related to intercompany charges for share-based compensation for relevant periods prior to 2020, triggered by the finalization of a Ninth Circuit Court of Appeals opinion (the &#x201c;Ninth Circuit Opinion&#x201d;) involving an independent third party. An additional charge of $11.1&#160;million related to this matter was recorded to income tax expense for the three and nine months ended September&#160;30, 2021, as a result of additional IRS guidance issued in July 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes for the three and nine months ended September&#160;30, 2021, included excess tax benefits associated with employee equity plans of $41.9&#160;million and $158.9&#160;million, which reduced our effective tax rate by 9.1 and 11.1 percentage points, respectively. The provision for income taxes for the three and nine months ended September&#160;30, 2020, included excess tax benefits associated with employee equity plans of $47.9&#160;million and $144.8&#160;million, which reduced our effective tax rate by 13.5 and 18.8 percentage points, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files federal, state, and foreign income tax returns in many U.S. and OUS jurisdictions. Years before 2016 are closed for the significant jurisdictions. Certain of the Company&#x2019;s unrecognized tax benefits could change due to activities of various tax authorities, including potential assessment of additional tax, possible settlement of audits, or through normal expiration of various statutes of limitations, which could affect the Company&#x2019;s effective tax rate in the period in which they change. Due to the uncertainty related to the timing and potential outcome of audits, the Company cannot estimate the range of reasonably possible change in unrecognized tax benefits that may occur in the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to the examination of its income tax returns by the Internal Revenue Service and other tax authorities. The outcome of these audits cannot be predicted with certainty. The Company&#x2019;s management regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#x2019;s provision for income taxes. If any issues addressed in the Company&#x2019;s tax audits are resolved in a manner not consistent with management&#x2019;s expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfNzg_c39b9507-a9f1-4c3a-88aa-8b64be3d2f89"
      unitRef="usd">73900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfODU_5a4ed1b7-8193-4508-bdbc-bffb145456c7"
      unitRef="number">0.160</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTI0_b0eb475d-f4e2-46d9-b4a1-93008e0790d1"
      unitRef="usd">38400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTMx_ddcfe40e-5ed1-4cb7-b3e0-6713ac571a8b"
      unitRef="number">0.108</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMjM3_614c2f1d-5169-492c-b1c7-c2379aec4399"
      unitRef="usd">90700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMjQ0_53590e57-2842-4f95-bec8-681584247504"
      unitRef="number">0.063</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMjgz_9541cf1d-5014-4841-ba0b-3c75a108bbab"
      unitRef="usd">67300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMjkw_f591717d-98f8-4ddc-bdbb-968ca1f63296"
      unitRef="number">0.087</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ic8e60490c05d45a5903e47f96d9854af_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfODkw_7e3d4ed2-707a-4279-a659-1f6780c124f0"
      unitRef="usd">66400000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i86f7d62644344bb5b63935be28a53d36_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfODkw_8ac1b60e-02e2-4776-b735-99d967631c3c"
      unitRef="usd">66400000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTEyNw_867a7976-79f3-48dd-aff0-906229bd2960"
      unitRef="usd">36800000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTEyNw_d0f0b7a4-48e4-42d7-8d13-eb9e4928235a"
      unitRef="usd">36800000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfODI0NjMzNzIxMjUxNw_8b1852f2-7708-4f10-9a5e-8c400cf2e663"
      unitRef="usd">11100000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfODI0NjMzNzIxMjUxNw_da76fa52-c6ff-45fc-b045-b450905307ee"
      unitRef="usd">11100000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTcxOA_503fef1f-8cc1-4da4-bcdf-d238d00e4217"
      unitRef="usd">41900000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTcyNQ_be2674d5-103f-4a30-9f05-e0b6fc5babc0"
      unitRef="usd">158900000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTc2OQ_0e7eb9df-4d5b-4f6f-8cfb-ac8f2b72aa58"
      unitRef="number">0.091</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTc3Ng_3e413184-0ae6-4dd5-8b38-ea6fe5b87951"
      unitRef="number">0.111</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTk0MQ_cb107216-86c2-4d55-b1a1-d5801992b6e0"
      unitRef="usd">47900000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTk0OA_c0ea66e2-7822-4e1c-ac9e-e12365f9f087"
      unitRef="usd">144800000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTk5Mg_7352f307-09df-422c-afd8-24fb93b11d24"
      unitRef="number">0.135</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82MS9mcmFnOmRmNzViZjU1MjRiYzRlMjliMjkyY2ExNmI5ZTVlMGFmL3RleHRyZWdpb246ZGY3NWJmNTUyNGJjNGUyOWIyOTJjYTE2YjllNWUwYWZfMTk5OQ_af1c0cd1-8e1c-49fa-a264-f52a210e26ef"
      unitRef="number">0.188</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RleHRyZWdpb246ZmU0OTRmYmQ0YzM5NDJhODk4NTgzZWMzZjg1YjU3MDBfNjcy_9063dd0d-11d9-4184-9198-c4c94ccb0e7f">NET INCOME PER SHARE&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the computation of basic and diluted net income per share attributable to Intuitive Surgical, Inc. (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Intuitive Surgical, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding used in basic calculation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: dilutive effect of potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding used in diluted calculation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share attributable to Intuitive Surgical, Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation awards of approximately 0.2&#160;million and 0.6&#160;million shares for the three months ended September&#160;30, 2021, and 2020, respectively, and approximately 0.7&#160;million and 2.6&#160;million shares for the nine months ended September&#160;30, 2021, and 2020, respectively, were outstanding but were not included in the computation of diluted net income per share attributable to Intuitive Surgical, Inc. common stockholders, because the effect of including such shares would have been anti-dilutive in the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RleHRyZWdpb246ZmU0OTRmYmQ0YzM5NDJhODk4NTgzZWMzZjg1YjU3MDBfNjY0_25ebf740-8bf9-48e9-a806-9d562218028b">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the computation of basic and diluted net income per share attributable to Intuitive Surgical, Inc. (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Intuitive Surgical, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding used in basic calculation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: dilutive effect of potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding used in diluted calculation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share attributable to Intuitive Surgical, Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfMy0xLTEtMS0w_68942a9e-9837-4d89-b814-7cacb41b7a74"
      unitRef="usd">380500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfMy0zLTEtMS0w_caf90ee9-b7ac-4697-85d2-a84705589f78"
      unitRef="usd">313900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfMy01LTEtMS0w_a7c610dc-ca50-4736-8d08-5f3f185a0f4a"
      unitRef="usd">1324000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfMy03LTEtMS0w_309003a8-4eca-431b-9641-d3b99e7b5405"
      unitRef="usd">695400000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNS0xLTEtMS0w_053b2954-9552-445b-abd8-b8786474c1a9"
      unitRef="shares">356800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNS0zLTEtMS0w_2ad0d4a3-1607-4432-b720-a51b68fc9bd3"
      unitRef="shares">352000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNS01LTEtMS0w_b453a38a-2ab8-48b9-96cf-c0a2b339bacb"
      unitRef="shares">355600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNS03LTEtMS0w_4c00a0ae-4366-4a45-a6bd-62e67e823702"
      unitRef="shares">350500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNi0xLTEtMS0w_91b0cd70-01f3-406f-af82-664e90bb6e21"
      unitRef="shares">10000000.0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNi0zLTEtMS0w_9b85d7f1-7990-4f5e-aecc-400a29d632e7"
      unitRef="shares">9900000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNi01LTEtMS0w_c36ce3fd-c549-44c7-8bd0-4f54a72d4472"
      unitRef="shares">9500000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNi03LTEtMS0w_e944fdeb-3972-4983-bbc0-3f40318e31d1"
      unitRef="shares">9600000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNy0xLTEtMS0w_e56e9c2d-88d6-4f47-8346-23b5e45cdda8"
      unitRef="shares">366800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNy0zLTEtMS0w_0da0d785-fb9f-45b6-a688-c22f7a1082dc"
      unitRef="shares">361900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNy01LTEtMS0w_63f9da8b-d241-45ff-bbf2-a1b91c2450ec"
      unitRef="shares">365100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfNy03LTEtMS0w_3cf468cb-9aab-430d-95a0-9bf02ee6e48c"
      unitRef="shares">360100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfOS0xLTEtMS0w_61d68460-667d-4093-a239-3517144560d2"
      unitRef="usdPerShare">1.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfOS0zLTEtMS0w_c3407ea3-10bd-4917-82d4-61c77398434d"
      unitRef="usdPerShare">0.89</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfOS01LTEtMS0w_8a36d776-e25a-492f-a9f9-fce7cc7492f3"
      unitRef="usdPerShare">3.72</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfOS03LTEtMS0w_d3fcd758-1622-4420-b7d1-f934b091b22d"
      unitRef="usdPerShare">1.98</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfMTAtMS0xLTEtMA_f97baa05-c885-428d-9814-ea484fe65dfc"
      unitRef="usdPerShare">1.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfMTAtMy0xLTEtMA_534102fa-e22f-4e70-a07f-72a224049850"
      unitRef="usdPerShare">0.87</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfMTAtNS0xLTEtMA_80163d1f-0175-4860-9cd4-739c36ebcd79"
      unitRef="usdPerShare">3.63</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RhYmxlOjg3OTMyNjQ5MDA4NzRiZjE4NDEyZTE0NGIwN2RjZjY4L3RhYmxlcmFuZ2U6ODc5MzI2NDkwMDg3NGJmMTg0MTJlMTQ0YjA3ZGNmNjhfMTAtNy0xLTEtMA_d37bf89c-f1af-4eb2-ac3b-2df79b0e3818"
      unitRef="usdPerShare">1.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RleHRyZWdpb246ZmU0OTRmYmQ0YzM5NDJhODk4NTgzZWMzZjg1YjU3MDBfMjU1_42631ca1-3a39-466c-b939-61a2686eec14"
      unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RleHRyZWdpb246ZmU0OTRmYmQ0YzM5NDJhODk4NTgzZWMzZjg1YjU3MDBfMjYy_c6499a1f-4338-4167-aea8-c28baa430a6a"
      unitRef="shares">600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i24def724605546e8b248a658364e4bd2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RleHRyZWdpb246ZmU0OTRmYmQ0YzM5NDJhODk4NTgzZWMzZjg1YjU3MDBfMzQw_3979b20f-6a13-44dd-b2f9-991e8226e0ba"
      unitRef="shares">700000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk0NGYzMDBiOGMyOTQ2M2FhNTYxMzllZDdlYWNhMjk2L3NlYzo5NDRmMzAwYjhjMjk0NjNhYTU2MTM5ZWQ3ZWFjYTI5Nl82NC9mcmFnOmZlNDk0ZmJkNGMzOTQyYTg5ODU4M2VjM2Y4NWI1NzAwL3RleHRyZWdpb246ZmU0OTRmYmQ0YzM5NDJhODk4NTgzZWMzZjg1YjU3MDBfMzQ3_7186e07a-a53a-4955-91d9-2e58496f2759"
      unitRef="shares">2600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701356004760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Oct. 14, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Intuitive Surgical, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">State or Other Jurisdiction of Incorporation or Organization</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">I.R.S. Employer Identification No.</a></td>
<td class="text">77-0416458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1020 Kifer Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Sunnyvale<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">523-2100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of each class</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol(s)</a></td>
<td class="text">ISRG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">357,236,861<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001035267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701355969112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,346.7<span></span>
</td>
<td class="nump">$ 1,622.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">2,741.5<span></span>
</td>
<td class="nump">3,488.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">695.0<span></span>
</td>
<td class="nump">645.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">584.9<span></span>
</td>
<td class="nump">601.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaids and other current assets</a></td>
<td class="nump">359.9<span></span>
</td>
<td class="nump">267.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">5,728.0<span></span>
</td>
<td class="nump">6,625.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">1,737.9<span></span>
</td>
<td class="nump">1,577.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long-term investments</a></td>
<td class="nump">4,131.5<span></span>
</td>
<td class="nump">1,757.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">411.5<span></span>
</td>
<td class="nump">367.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_IntangibleAndOtherAssets', window );">Intangible and other assets, net</a></td>
<td class="nump">581.4<span></span>
</td>
<td class="nump">503.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">344.3<span></span>
</td>
<td class="nump">336.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">12,934.6<span></span>
</td>
<td class="nump">11,168.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">120.0<span></span>
</td>
<td class="nump">81.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and employee benefits</a></td>
<td class="nump">265.3<span></span>
</td>
<td class="nump">235.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">348.5<span></span>
</td>
<td class="nump">350.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">293.5<span></span>
</td>
<td class="nump">298.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,027.3<span></span>
</td>
<td class="nump">965.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">447.8<span></span>
</td>
<td class="nump">444.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,475.1<span></span>
</td>
<td class="nump">1,409.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Contingencies (Note 8)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of September&#160;30, 2021, and December&#160;31, 2020</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, 600.0 shares authorized, $0.001 par value, 357.2 shares and 353.1 shares issued and outstanding as of September&#160;30, 2021, and December&#160;31, 2020, respectively</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">7,015.1<span></span>
</td>
<td class="nump">6,444.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">4,390.1<span></span>
</td>
<td class="nump">3,261.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">24.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Intuitive Surgical, Inc. stockholders&#8217; equity</a></td>
<td class="nump">11,410.9<span></span>
</td>
<td class="nump">9,731.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest in joint venture</a></td>
<td class="nump">48.6<span></span>
</td>
<td class="nump">27.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">11,459.5<span></span>
</td>
<td class="nump">9,759.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 12,934.6<span></span>
</td>
<td class="nump">$ 11,168.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_IntangibleAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges and other non-current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_IntangibleAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701442122232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">600,000,000.0<span></span>
</td>
<td class="nump">600,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">357,200,000<span></span>
</td>
<td class="nump">353,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">357,200,000<span></span>
</td>
<td class="nump">353,100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701360184168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,403.3<span></span>
</td>
<td class="nump">$ 1,077.7<span></span>
</td>
<td class="nump">$ 4,159.4<span></span>
</td>
<td class="nump">$ 3,029.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of revenue</a></td>
<td class="nump">431.9<span></span>
</td>
<td class="nump">353.4<span></span>
</td>
<td class="nump">1,261.7<span></span>
</td>
<td class="nump">1,063.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">971.4<span></span>
</td>
<td class="nump">724.3<span></span>
</td>
<td class="nump">2,897.7<span></span>
</td>
<td class="nump">1,965.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">363.3<span></span>
</td>
<td class="nump">298.9<span></span>
</td>
<td class="nump">1,039.5<span></span>
</td>
<td class="nump">886.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">165.5<span></span>
</td>
<td class="nump">155.0<span></span>
</td>
<td class="nump">487.6<span></span>
</td>
<td class="nump">445.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">528.8<span></span>
</td>
<td class="nump">453.9<span></span>
</td>
<td class="nump">1,527.1<span></span>
</td>
<td class="nump">1,331.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">442.6<span></span>
</td>
<td class="nump">270.4<span></span>
</td>
<td class="nump">1,370.6<span></span>
</td>
<td class="nump">634.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Interest and other income, net</a></td>
<td class="nump">18.5<span></span>
</td>
<td class="nump">84.8<span></span>
</td>
<td class="nump">65.5<span></span>
</td>
<td class="nump">136.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before taxes</a></td>
<td class="nump">461.1<span></span>
</td>
<td class="nump">355.2<span></span>
</td>
<td class="nump">1,436.1<span></span>
</td>
<td class="nump">770.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">73.9<span></span>
</td>
<td class="nump">38.4<span></span>
</td>
<td class="nump">90.7<span></span>
</td>
<td class="nump">67.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">387.2<span></span>
</td>
<td class="nump">316.8<span></span>
</td>
<td class="nump">1,345.4<span></span>
</td>
<td class="nump">703.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: net income attributable to noncontrolling interest in joint venture</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">21.4<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Intuitive Surgical, Inc.</a></td>
<td class="nump">$ 380.5<span></span>
</td>
<td class="nump">$ 313.9<span></span>
</td>
<td class="nump">$ 1,324.0<span></span>
</td>
<td class="nump">$ 695.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share attributable to Intuitive Surgical, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 1.07<span></span>
</td>
<td class="nump">$ 0.89<span></span>
</td>
<td class="nump">$ 3.72<span></span>
</td>
<td class="nump">$ 1.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.04<span></span>
</td>
<td class="nump">$ 0.87<span></span>
</td>
<td class="nump">$ 3.63<span></span>
</td>
<td class="nump">$ 1.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Shares used in computing net income per share attributable to Intuitive Surgical, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">356.8<span></span>
</td>
<td class="nump">352.0<span></span>
</td>
<td class="nump">355.6<span></span>
</td>
<td class="nump">350.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">366.8<span></span>
</td>
<td class="nump">361.9<span></span>
</td>
<td class="nump">365.1<span></span>
</td>
<td class="nump">360.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income</a></td>
<td class="nump">$ 382.1<span></span>
</td>
<td class="nump">$ 310.8<span></span>
</td>
<td class="nump">$ 1,325.4<span></span>
</td>
<td class="nump">$ 707.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: comprehensive income attributable to noncontrolling interest</a></td>
<td class="nump">6.6<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">21.0<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to Intuitive Surgical, Inc.</a></td>
<td class="nump">375.5<span></span>
</td>
<td class="nump">307.8<span></span>
</td>
<td class="nump">1,304.4<span></span>
</td>
<td class="nump">699.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,170.6<span></span>
</td>
<td class="nump">898.4<span></span>
</td>
<td class="nump">3,481.1<span></span>
</td>
<td class="nump">2,521.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of revenue</a></td>
<td class="nump">355.8<span></span>
</td>
<td class="nump">287.7<span></span>
</td>
<td class="nump">1,049.1<span></span>
</td>
<td class="nump">868.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">232.7<span></span>
</td>
<td class="nump">179.3<span></span>
</td>
<td class="nump">678.3<span></span>
</td>
<td class="nump">508.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of revenue</a></td>
<td class="nump">$ 76.1<span></span>
</td>
<td class="nump">$ 65.7<span></span>
</td>
<td class="nump">$ 212.6<span></span>
</td>
<td class="nump">$ 195.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701355830504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,345.4<span></span>
</td>
<td class="nump">$ 703.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and loss on disposal of property, plant, and equipment</a></td>
<td class="nump">208.5<span></span>
</td>
<td class="nump">159.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">20.8<span></span>
</td>
<td class="nump">37.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Loss (gain) on investments, accretion, and amortization, net</a></td>
<td class="num">(2.1)<span></span>
</td>
<td class="num">(64.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(40.6)<span></span>
</td>
<td class="nump">71.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">331.4<span></span>
</td>
<td class="nump">292.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of contract acquisition assets</a></td>
<td class="nump">15.5<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of effects of acquisition:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(54.7)<span></span>
</td>
<td class="nump">57.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(189.2)<span></span>
</td>
<td class="num">(177.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaids and other assets</a></td>
<td class="num">(216.7)<span></span>
</td>
<td class="num">(118.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">35.8<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and employee benefits</a></td>
<td class="nump">30.3<span></span>
</td>
<td class="num">(76.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="num">(9.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">35.0<span></span>
</td>
<td class="num">(26.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,521.7<span></span>
</td>
<td class="nump">857.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of investments</a></td>
<td class="num">(5,213.7)<span></span>
</td>
<td class="num">(3,023.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities', window );">Proceeds from sales of investments</a></td>
<td class="nump">72.4<span></span>
</td>
<td class="nump">800.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from maturities of investments</a></td>
<td class="nump">3,532.1<span></span>
</td>
<td class="nump">1,933.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchase of property, plant, and equipment and intellectual property</a></td>
<td class="num">(202.6)<span></span>
</td>
<td class="num">(279.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of businesses, net of cash</a></td>
<td class="num">(8.7)<span></span>
</td>
<td class="num">(37.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,820.5)<span></span>
</td>
<td class="num">(606.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from issuance of common stock relating to employee stock plans</a></td>
<td class="nump">244.8<span></span>
</td>
<td class="nump">267.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(201.2)<span></span>
</td>
<td class="num">(165.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Payment of deferred purchase consideration</a></td>
<td class="num">(19.2)<span></span>
</td>
<td class="num">(48.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">24.4<span></span>
</td>
<td class="num">(45.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(276.7)<span></span>
</td>
<td class="nump">203.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash, beginning of period</a></td>
<td class="nump">1,638.5<span></span>
</td>
<td class="nump">1,182.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash, end of period</a></td>
<td class="nump">$ 1,361.8<span></span>
</td>
<td class="nump">$ 1,385.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701352233448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF THE BUSINESS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF THE BUSINESS</a></td>
<td class="text">DESCRIPTION OF THE BUSINESS<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intuitive Surgical, Inc. (&#8220;Intuitive&#8221; or the &#8220;Company&#8221;) develops, manufactures, and markets the da Vinci</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Surgical System and the Ion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> endoluminal system.&#160;The Company&#8217;s products and related services enable physicians and healthcare providers to improve the quality of and access to minimally invasive care. The da Vinci Surgical System consists of a surgeon console or consoles, a patient-side cart, a high-performance vision system, and proprietary instruments and accessories. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform that utilizes instruments and accessories for lung biopsies.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701350160136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements (&#8220;Financial Statements&#8221;) of Intuitive Surgical, Inc. and its wholly and majority-owned subsidiaries have been prepared on a consistent basis with the audited Consolidated Financial Statements for the fiscal year ended December&#160;31, 2020, and include all adjustments, consisting of only normal, recurring adjustments, necessary to fairly state the information set forth herein. The Financial Statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and, therefore, omit certain information and footnote disclosure necessary to present the Financial Statements in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). These Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, which was filed with the SEC on February&#160;10, 2021. The results of operations for the first nine months of fiscal year 2021 are not necessarily indicative of the results to be expected for the entire fiscal year or any future periods.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Financial Statements include the results and the balances of the Company&#8217;s majority-owned joint venture (referred to herein as the &#8220;Joint Venture&#8221;) with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (&#8220;Fosun Pharma&#8221;). The Company holds a controlling financial interest in the Joint Venture, and the noncontrolling interest is reflected as a separate component of consolidated stockholders&#8217; equity. The noncontrolling interest&#8217;s share of the earnings in the Joint Venture is presented separately in the condensed consolidated statements of comprehensive income.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Split</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares issued pursuant to the three-for-one stock split (the "Stock Split") of the Company's issued and outstanding common stock, par value $0.001 per share, were distributed on October 4, 2021, to stockholders of record as of September 27, 2021. All share and per-share information presented in the Financial Statements have been retroactively adjusted to reflect the Stock Split.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to additional risks and uncertainties due to the COVID-19 pandemic. The extent of the impact on the Company&#8217;s business is highly uncertain and difficult to predict. In certain regions, the Company&#8217;s customers continue to divert resources to treat COVID-19 patients and defer some elective surgical procedures, both of which may impact the Company&#8217;s customers&#8217; ability to meet their obligations, including to the Company. Furthermore, economies worldwide have been negatively impacted by the COVID-19 pandemic, and it is possible that the impact could cause an extended local and/or global economic recession. Such economic disruption could have a material adverse effect on our business as hospitals curtail and reduce capital and overall spending. Policymakers around the globe have responded with fiscal policy actions to support the healthcare industry and their economies. However, the magnitude and overall effectiveness of these actions remains uncertain.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The severity of the impact of the COVID-19 pandemic on the Company&#8217;s business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on the Company&#8217;s customers, all of which are uncertain and cannot be predicted. The Company&#8217;s future results of operations and liquidity could be materially adversely affected by delays in payments of outstanding receivables, supply chain disruptions, including shortages and inflationary pressure, uncertain or reduced demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operational challenges faced by its customers.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, we have experienced increased difficulties in obtaining a sufficient amount of component materials used in our products, including those in the semiconductor market, as global supply has become significantly constrained due to increased demand in semiconductors and other materials. Additionally, prices of such materials have increased due to the increased demand and supply shortage. The Company is engaged in activities to seek to mitigate supply disruptions by, for example, increasing our communications with our suppliers and modifying our purchase order coverage and inventory levels. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, the global semiconductor supply shortage is likely to remain a challenge for the foreseeable future. We have also experienced challenges in logistics, as certain shipping routes have been impacted by port closures. Such global shortages in important components and logistics challenges have resulted in, and will continue to cause, inflationary cost pressure in our supply chain. To date, these challenges have not materially impacted our ability to deliver product and services to our customers. However, if shortages in important supply chain materials in the semiconductor or other markets continue, we could fail to meet product demand, which would adversely impact our business, financial condition, results of operations, or cash flows.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased labor shortages globally, including staff burnout and attrition, could also impact our ability to hire and retain personnel critical to our manufacturing, logistics, and commercial operations. We are also highly dependent on the principal members of our management and scientific staff. Attracting and retaining qualified personnel is critical to our success, and competition for them has become more intense. The loss of critical members of our team, or our inability to attract and retain qualified personnel, could significantly harm our operations, business, and ability to compete. In addition, hospitals are also experiencing staffing shortages and supply chain issues that could impact their ability to provide patient care. As of the date of issuance of these Financial Statements, the extent to which the COVID-19 pandemic may materially adversely affect the Company&#8217;s financial condition, liquidity, or results of operations is uncertain.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Leases with Variable Lease Payments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2021-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessors - Certain Leases with Variable Lease Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which amends the lessor lease classification guidance in ASC 842 for leases that include any amount of variable lease payments that are not based on an index or rate. The Company has early adopted this ASU as of July 1, 2021, on a prospective basis. The standard had no impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div>There have been no new or material changes to the significant accounting policies discussed in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701352221288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">FINANCIAL INSTRUMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Investments</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s cash and available-for-sale marketable securities&#8217; amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant investment category reported as cash and cash equivalents, short-term investments, or long-term investments as of September&#160;30, 2021, and December&#160;31, 2020 (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and<br/>Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-<br/>term<br/>Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-<br/>term<br/>Investments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,250.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,258.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,153.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,062.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,070.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,153.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,265.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,610.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,614.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,977.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,207.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,219.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,131.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and<br/>Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-<br/>term<br/>Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-<br/>term<br/>Investments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,626.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,649.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,567.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,252.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,567.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,036.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,933.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,949.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,829.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,869.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,622.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,488.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the contractual maturities of the Company&#8217;s cash equivalents and available-for-sale investments (excluding cash and money market funds), as of September&#160;30, 2021 (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in less than one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,735.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in one to five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,125.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,131.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,860.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from contractual maturities, because certain borrowers have the right to call or prepay certain obligations. Gross realized gains recognized on the sale of investments were not material for the three and nine months ended September&#160;30, 2021, and not significant and $8.3&#160;million for the three and nine months ended September&#160;30, 2020, respectively. Gross realized losses recognized on the sale of investments were not material for any of the periods presented.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment portfolio at any point in time contains available-for-sale debt securities including investments in U.S. treasury and U.S. government agency securities, taxable and tax-exempt municipal notes, corporate notes and bonds, commercial paper, non-U.S. government agency securities, cash deposits, and money market funds. The Company segments its portfolio based on the underlying risk profiles of the securities and have a zero-loss expectation for U.S. treasury and U.S. government agency securities. The Company regularly reviews the securities in an unrealized loss position and evaluates the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, and current economic conditions. For the nine months ended September&#160;30, 2021, the credit losses related to available-for-sales debt securities were not significant.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Investments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds equity investments with readily determinable fair values and equity investments without readily determinable fair values. The Company generally recognizes equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the activity related to equity investments (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:24.229%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.687%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020<br/>Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Changes in Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sales/Purchases/Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September&#160;30, 2021</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prepaids and other current assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible and other assets, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity investments with readily determinable value (Level 1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity investments without readily determinable value (Level 2)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Recorded in Interest and other income, net.</span></div></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Other includes conversion of certain equity investments without readily determinable value to equity investments with readily determinable value.</span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized a $34.5&#160;million increase in fair value, which was reflected in Interest and other income, net, due to changes in observable prices for certain equity investments that had been held at cost, because they lacked readily determinable market values (Level 2). A total of $34.2&#160;million of this increase in fair value was related to an equity investment in preferred shares of Broncus Medical, Inc. (&#8220;Broncus&#8221;). There were no decreases in fair value reflected in net income due to impairments.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, Broncus completed its initial public offering (&#8220;IPO&#8221;). Upon completion of its IPO, the Company&#8217;s preferred shares were converted to common shares, which have a readily determinable value (Level 1). The Company is restricted from selling these shares for a period of six months. Subsequent to the IPO, the Company recognized a $12.3&#160;million decrease in fair value from this investment. As such, for the nine months ended September&#160;30, 2021, the Company has recognized a net gain of $21.9 million related to Broncus, comprised of the $34.2&#160;million gain reflected in changes in fair value for Level 2 equity investments, offset by the $12.3&#160;million loss reflected in changes in fair value for Level 1 equity investments, both of which were reflected in Interest and other income, net.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company sold all of its shares of Teladoc Health, Inc. (&#8220;Teladoc&#8221;), a publicly traded company, for $71.5&#160;million and recognized a gain of $11.4&#160;million, which was reflected in Interest and other income, net. This gain was offset by a $7.5&#160;million loss recognized upon the settlement of a corresponding derivative collar contract.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Derivatives</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The objective of the Company&#8217;s hedging program is to mitigate the impact of changes in currency exchange rates on net cash flow from foreign currency-denominated sales, expenses, intercompany balances, and other monetary assets or liabilities denominated in currencies other than the U.S. dollar (&#8220;USD&#8221;). The terms of the Company&#8217;s derivative contracts are generally twelve months or shorter. The derivative assets and liabilities are measured using Level 2 fair value inputs.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into currency forward contracts as cash flow hedges to hedge certain forecasted revenue transactions denominated in currencies other than the USD, primarily the Euro (&#8220;EUR&#8221;), the British Pound (&#8220;GBP&#8221;), the Japanese Yen (&#8220;JPY&#8221;),&#160;and the Korean Won (&#8220;KRW&#8221;). The Company also enters into currency forward contracts as cash flow hedges to hedge certain forecasted expense transactions denominated in EUR and the Swiss Franc (&#8220;CHF&#8221;).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For these derivatives, the Company reports the unrealized after-tax gain or loss from the hedge as a component of accumulated other comprehensive income/(loss) in stockholders&#8217; equity and reclassifies the amount into earnings in the same period in which the hedged transaction affects earnings. The amounts reclassified to revenue and expenses related to the hedged transactions and the ineffective portions of cash flow hedges were not material for the periods presented.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Derivatives Not Designated as Hedging Instruments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other derivatives not designated as hedging instruments consist primarily of forward contracts that the Company uses to hedge intercompany balances and other monetary assets or liabilities denominated in currencies other than the USD, primarily the EUR, GBP, JPY, KRW, CHF, Indian Rupee ("INR"), Mexican Peso ("MXN"), Chinese Yuan ("CNY"), and New Taiwan Dollar ("TWD").</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These derivative instruments are used to hedge against balance sheet foreign currency exposures. The related gains and losses were as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized gains/(losses) in Interest and other income, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gains/(losses) related to balance sheet re-measurement</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in January 2021, the Company settled a collar contract previously entered into to hedge its equity investment in Teladoc Health, Inc. For the nine months ended September&#160;30, 2021, a loss of $7.5&#160;million was recognized in Interest and other income, net.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts for derivative instruments provide one measure of the transaction volume. Total gross notional amounts (in USD) for outstanding derivatives and the aggregate gross fair value at the end of each period were as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:47.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.257%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notional amounts:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross fair value recorded in:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701350100616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION</a></td>
<td class="text">BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Balance Sheet Details</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide details of selected balance sheet line items (in millions):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Inventory</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Prepaids and other current assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases &#8211; short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaids and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaids and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other accrued liabilities&#8211;short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of deferred purchase consideration payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other accrued liabilities&#8211;short-term</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other long-term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes&#8211;long-term</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue&#8211;long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides supplemental non-cash investing and financing activities (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of property, plant, and equipment in accounts payable and accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred payments and contingent consideration related to business combinations and asset acquisitions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701350257496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND CONTRACT ACQUISITION COSTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE AND CONTRACT ACQUISITION COSTS</a></td>
<td class="text">REVENUE AND CONTRACT ACQUISITION COSTS<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue disaggregated by types and geography (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,227.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. revenue</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Outside of U.S. (&#8220;OUS&#8221;)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total OUS revenue</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Total </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,708.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,159.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,029.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which revenue has not yet been recognized. A significant portion of these performance obligations relate to service obligations in the Company's system sale and lease arrangements that will be satisfied and recognized as revenue in future periods. The transaction price allocated to the remaining performance obligations was $1,723 million as of September&#160;30, 2021. The remaining performance obligations are expected to be satisfied over the term of the system sale and lease arrangements, which generally are up to 5 years. Service revenue associated with the lease arrangements will be recognized over the service period.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information summarizes the Company&#8217;s contract assets and liabilities (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invoices its customers based on the billing schedules in its sales arrangements. Payments are generally due 30 to 60 days from date of invoice. Contract assets for the periods presented primarily represent the difference between the revenue that was recognized based on the relative standalone selling price of the related performance obligations satisfied and the contractual billing terms in the arrangements. Deferred revenue for the periods presented primarily relates to service contracts where the service fees are billed up-front, generally quarterly or annually, prior to those services having been performed. The associated deferred revenue is generally recognized over the term of the service period. The Company did not have any significant impairment losses on its contract assets for the periods presented.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2021, the Company recognized $66.1&#160;million and $319.3&#160;million of revenue, respectively, that was included in the deferred revenue balance as of December&#160;31, 2020. During the three and nine months ended September&#160;30, 2020, the Company recognized $58.1&#160;million and $249.7&#160;million of revenue, respectively, net of the impact of the Customer Relief Program, that was included in the deferred revenue balance as of December&#160;31, 2019.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intuitive System Leasing</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue from Intuitive System Leasing arrangements (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2021, and 2020, variable lease revenue relating to usage-based arrangements was not material.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Accounts Receivable</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for doubtful accounts is based on the Company&#8217;s assessment of the collectibility of customer accounts. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, the age of the accounts receivable balances, and current economic conditions that may affect a customer&#8217;s ability to pay. For the three and nine months ended September&#160;30, 2021, and 2020, bad debt expense was not material.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. Although the Company has historically not experienced significant credit losses, it is possible that there could be a material adverse impact from potential adjustments of the carrying amount of lease and trade receivables as hospital cash flows are impacted by their response to the COVID-19 pandemic and deferral of elective surgical procedures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701444414632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorSalesTypeLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessor Information</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales-type Leases. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease receivables relating to sales-type lease arrangements are presented on the Condensed Consolidated Balance Sheets as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross lease receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible and other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of gross lease receivables at September&#160;30, 2021, are as follows (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into sales-type leases with certain qualified customers to purchase its systems. Sales-type leases have terms that generally range from 24 to 84 months and are usually collateralized by a security interest in the underlying assets. The allowance for loan loss is based on the Company&#8217;s assessment of current expected lifetime loss on lease receivables. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, the age of the lease receivable balances, and current economic conditions that may affect a customer&#8217;s ability to pay. Lease receivables are considered past due 90 days after invoice.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages the credit risk in net investment in sales-type leases using a number of factors, including, but not limited to the following: size of operations; profitability, liquidity, and debt ratios; payment history; and past due amounts. The Company also uses credit scores obtained from external providers as a key credit quality indicator for the purposes of determining credit quality. The following table presents credit quality by class of net investment in sales-type leases as of September&#160;30, 2021. The following table summarizes the amortized cost basis by year of origination and credit quality indicator as of September&#160;30, 2021 (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.311%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Credit Rating:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moderate</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.4&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.0&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Low</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2021, and 2020, credit losses related to net investment in sales-type leases were not significant.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorSalesTypeLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of lessor's sales-type leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorSalesTypeLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701352130152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions in 2021</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material acquisitions for the three and nine months ended September&#160;30, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions in 2020</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Orpheus Medical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company acquired Orpheus Medical Ltd. and its wholly owned subsidiaries (&#8220;Orpheus Medical&#8221;) to deepen and expand our integrated informatics platform (the &#8220;Orpheus Medical Acquisition&#8221;). Orpheus Medical provides hospitals with information technology connectivity, as well as expertise in capturing, processing, and archiving clinical videos across the hospital. The Orpheus Medical Acquisition did not have a material impact on the financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition activity</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344.3&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of gross intangible assets, accumulated amortization, and net intangible asset balances as of September&#160;30, 2021, and December&#160;31, 2020 (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:29.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution rights and others</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets was $6.3 million and $12.6 million for the three months ended September&#160;30, 2021, and 2020, respectively. Amortization expense related to intangible assets was $20.8 million and $37.3 million for the nine months ended September&#160;30, 2021, and 2020, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future amortization expense related to intangible assets as of September&#160;30, 2021, is as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preceding expected amortization expense is an estimate. Actual amounts of amortization expense may differ from estimated amounts due to additional intangible asset acquisitions, measurement-period adjustments to intangible assets, changes in foreign currency exchange rates, impairments of intangible assets, accelerated amortization of intangible assets, and other events.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701351650184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">CONTINGENCIES</a></td>
<td class="text">CONTINGENCIES<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is involved in a variety of claims, lawsuits, investigations, and proceedings relating to securities laws, product liability, intellectual property, insurance, contract disputes, employment, and other matters. Certain of these lawsuits and claims are described in further detail below. It is not possible to predict what the outcome of these matters will be, and the Company cannot guarantee that any resolution will be reached on commercially reasonable terms, if at all.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A liability and related charge to earnings are recorded in the Financial Statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to each case. Nevertheless, it is possible that additional future legal costs (including settlements, judgments, legal fees, and other related defense costs) could have a material adverse effect on the Company&#8217;s business, financial position, and future results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently named as a defendant in a number of individual product liability lawsuits filed in various state and federal courts. The plaintiffs generally allege that they or a family member underwent surgical procedures that utilized the da Vinci Surgical System and sustained a variety of personal injuries and, in some cases, death as a result of such surgery. Several of the filed cases have trial dates in the next 12 months.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cases raise a variety of allegations including, to varying degrees, that plaintiffs&#8217; injuries resulted from purported defects in the da Vinci Surgical System and/or failure on the Company&#8217;s part to provide adequate training resources to the healthcare professionals who performed plaintiffs&#8217; surgeries. The cases further allege that the Company failed to adequately disclose and/or misrepresented the potential risks and/or benefits of the da Vinci Surgical System. Plaintiffs also assert a variety of causes of action, including, for example, strict liability based on purported design defects, negligence, fraud, breach of express and implied warranties, unjust enrichment, and loss of consortium. Plaintiffs seek recovery for alleged personal injuries and, in many cases, punitive damages. The Company disputes these allegations and is defending against these claims.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimate of the anticipated cost of resolving the pending cases is based on negotiations with attorneys for the claimants. The final outcome of the pending lawsuits and claims, and others that might arise, is dependent on many variables that are difficult to predict, and the ultimate cost associated with these product liability lawsuits and claims may be materially different than the amount of the current estimate and accruals and could have a material adverse effect on the Company&#8217;s business, financial position, and future results of operations. Although there is a reasonable possibility that a loss in excess of the amount recognized exists, the Company is unable to estimate the possible loss or range of loss in excess of the amount recognized at this time.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Litigation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2017, Ethicon LLC, Ethicon Endo-Surgery, Inc., and Ethicon US LLC (collectively, &#8220;Ethicon&#8221;) filed a complaint for patent infringement against the Company in the U.S. District Court for the District of Delaware. The complaint, which was served on the Company on July 12, 2017, alleges that the Company&#8217;s EndoWrist</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stapler instruments infringe several of Ethicon&#8217;s patents. Ethicon asserts infringement of U.S. Patent Nos. 9,585,658, 8,479,969, 9,113,874, 8,998,058, 8,991,677, 9,084,601, and 8,616,431. A claim construction hearing occurred on October 1, 2018, and the court issued a scheduling order on December 28, 2018. On March 20, 2019, the court granted the Company&#8217;s Motion to Stay pending an Inter Partes Review to be held at the Patent Trademark and Appeals Board to review patentability of six of the seven patents noted above and vacated the trial date. On August 1, 2019, the court granted the parties&#8217; joint stipulation to modify the stay in light of Ethicon&#8217;s U.S. International Trade Commission (&#8220;USITC&#8221;) complaint against Intuitive involving U.S. Patent Nos. 8,479,969 and 9,113,874, discussed below.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 27, 2018, Ethicon filed a second complaint for patent infringement against the Company in the U.S. District Court for the District of Delaware. The complaint alleges that the Company&#8217;s SureForm 60 Staplers infringe five of Ethicon&#8217;s patents. Ethicon asserts infringement of U.S. Patent Nos. 9,884,369, 7,490,749, 8,602,288, 8,602,287, and 9,326,770. The Company filed an answer denying all claims. On March 19, 2019, Ethicon filed a Motion for Leave to File a First Amended Complaint, removing allegations related to U.S. Patent No. 9,326,770 and adding allegations related to U.S. Patent Nos. 9,844,379 and 8,479,969. On July 17, 2019, the court entered an order denying the amendment, without prejudice, and granting the parties&#8217; joint stipulation to stay the case in its entirety in light of the USITC investigation involving U.S. Patent Nos. 9,844,369 and 7,490,749, discussed below.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from these matters.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 30, 2019, Ethicon filed a complaint with the USITC, asserting infringement of U.S. Patent Nos. 9,884,369 (&#8220;&#8217;369&#8221;), 7,490,749 (&#8220;&#8217;749&#8221;), 9,844,379 (&#8220;&#8217;379&#8221;), 9,113,874 (&#8220;&#8217;874&#8221;), and 8,479,969 (&#8220;&#8217;969&#8221;). On June 28, 2019, the USITC voted to institute an investigation (No. 337-TA-1167) with respect to the claims in this complaint. The accused products include the Company&#8217;s EndoWrist 30, EndoWrist 45, SureForm 45, and SureForm 60 Staplers, as well as the stapler reload cartridges. In March 2020, Ethicon dismissed its claims concerning the &#8217;749 patent. The evidentiary hearing took place in February 2021. On June 8, 2021, the Chief Administrative Law Judge issued an Initial Determination concluding that (1) the accused products do not infringe the asserted claims in the &#8217;874 or &#8217;969 patents; (2) the asserted claims in the &#8217;874 and &#8217;969 patents are invalid; (3) the accused SureForm staplers and associated reload cartridges infringe two claims of the &#8217;369 patent; (4) the accused SureForm staplers and associated reload cartridges infringe two claims of the &#8217;379 patent; and (5) the Company was estopped from contending that the asserted claims in the &#8217;379 patent are invalid. Ethicon has not challenged the Initial Determination with regard to the findings that absolve Intuitive of any liability regarding the accused EndoWrist staplers and associated reload cartridges. On October 14, 2021, the USITC issued its Opinion in which it made the following rulings: (1) the USITC absolved Intuitive from any liability regarding the &#8217;874, &#8217;969, and &#8217;369 patents; and (2) the USITC found that, while the SureForm staplers and their associated reload cartridges infringe the asserted claims in the &#8217;379 patent, it has suspended the imposition of any remedial order pending an opinion from the Federal Circuit Court of Appeal of whether the Patent and Trademark Office correctly found the asserted claims in this patent to be invalid. A lifting of the suspension of any remedial order by the USITC could result in a prohibition on importing the accused SureForm products into the U.S. or necessitating workarounds. Based on currently available information, the Company does not believe that any losses arising from this matter would be material.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Litigation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2019, Restore Robotics LLC and Restore Repair LLC (&#8220;Restore&#8221;) filed a complaint alleging anti-trust claims against the Company. On May 13, 2019, Restore filed an amended complaint alleging anti-trust claims relating to the da Vinci Surgical System and EndoWrist service, maintenance, and repair processes. On September 16, 2019, the Court partially granted and partially denied the Company&#8217;s Motion to Dismiss the amended complaint.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, the Company filed an answer denying the anti-trust allegations and filed a counterclaim against Restore. The Company filed amended counterclaims after the Court partially granted and partially denied Restore&#8217;s Motion to Dismiss the counterclaim. The amended counterclaims allege that Restore violated the Federal Lanham Act, the Federal Computer Fraud and Abuse Act, and Florida&#8217;s Deceptive and Unfair Trade Practices Act and that Restore is also liable to the Company for Unfair Competition and Tortious Interference with Contract. On January 7, 2020, the Court denied Restore&#8217;s Motion to Dismiss the amended counterclaims.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its initial scheduling order, the Court stated that it anticipated trial in this case to occur in or before February 2022. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from these matters.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, Rebotix Repair Inc. (&#8220;Rebotix&#8221;) filed a complaint alleging anti-trust claims against the Company relating to EndoWrist service, maintenance, and repair processes. The complaint was formally served on the Company on October 6, 2020. On March 8, 2021, the Court partially granted and partially denied the Company&#8217;s Motion to Dismiss the complaint. The Company filed an answer denying the anti-trust allegations and filed counterclaims against Rebotix. The counterclaims allege that Rebotix violated the Federal Lanham Act and Florida&#8217;s Deceptive and Unfair Trade Practices Act and that Rebotix is also liable to the Company for Tortious Interference with Contract.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Court stated that it anticipated trial in this case to occur in or around April 2022. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from this matter.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar to the claims asserted in the Restore case, on May 10, 2021, Surgical Instrument Service Company, Inc. (&#8220;SIS&#8221;) filed a complaint in the Northern District of California Court alleging anti-trust claims against the Company relating to EndoWrist service, maintenance, and repair processes. The Company filed a Motion to Dismiss on which a hearing was held on October 7, 2021. The Court has not yet issued an Order on this Motion to Dismiss. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from this matter.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three class action complaints were filed against the Company in the Northern District of California Court alleging anti-trust allegations relating to the service and repair of certain instruments manufactured by the Company. A complaint by Larkin Community Hospital was filed on May 20, 2021, a complaint by Franciscan Alliance, Inc. and King County Public Hospital District No. 1 was filed on July 6, 2021, and a complaint by Kaleida Health was filed on July 8, 2021. The Court has consolidated the Franciscan Alliance, Inc. and King County Public Hospital District No. 1 and Kaleida Health cases with the Larkin Community Hospital case, which is now captioned on the Larkin docket as &#8220;In Re: da Vinci Surgical Robot Antitrust Litigation.&#8221; A Consolidated Amended Class Action Complaint has been filed on behalf of each plaintiff named in the earlier-filed cases. The Company filed a Motion to Dismiss this Consolidated Amended Class Action Complaint on October 11, 2021. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from these matters.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701350185864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stockholders&#8217; Equity</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the changes in stockholders&#8217; equity (in millions):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,804.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,022.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,837.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,879.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,015.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,390.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,410.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,459.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:25.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.170%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,084.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,633.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,740.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,766.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,304.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,937.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,257.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,286.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:25.184%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.507%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.507%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.157%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,444.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,261.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,731.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,759.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,015.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,390.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,410.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,459.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:25.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.170%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,756.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,494.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,263.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,284.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adoption of new accounting standard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,304.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,937.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,257.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,286.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Board of Directors (the &#8220;Board&#8221;) has authorized an aggregate of&#160;$7.5 billion of funding for the Company&#8217;s common stock repurchase program (the &#8220;Repurchase Program&#8221;) since its establishment in March 2009. The most recent authorization occurred in January 2019 when the Board increased the authorized amount available under the Repurchase Program to&#160;$2.0 billion. As of September&#160;30, 2021, the remaining amount of share repurchases authorized by the Board was $1.6 billion.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides share repurchase activities (in millions, except per share amounts):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss), Net of Tax, Attributable to Intuitive</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive income (loss), net of tax, attributable to Intuitive are as follows (in millions):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701350243240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">SHARE-BASED COMPENSATION</a></td>
<td class="text">SHARE-BASED COMPENSATION<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company&#8217;s shareholders approved an amended and restated 2010 Incentive Award Plan to provide for an increase in the number of shares of common stock reserved for issuance thereunder from 32,450,000 to 34,450,000 (or, after giving effect to the Stock Split, 97,350,000 to 103,350,000). As of&#160;September&#160;30, 2021, approximately&#160;25.5 million&#160;shares were reserved for future issuance under the Company&#8217;s stock plans. A maximum of approximately&#160;11.1 million&#160;of these shares can be awarded as restricted stock units (&#8220;RSUs&#8221;).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Option Information</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity under all stock plans for the nine months ended September&#160;30, 2021, is presented as follows (in millions, except per share amounts):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options Outstanding</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Exercise&#160;Price Per<br/>Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited/expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, options to purchase an aggregate of 9.5 million shares of common stock were exercisable at a weighted average price of $94.76 per share.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units Information</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSUs activity under all stock plans for the nine months ended September&#160;30, 2021, is presented as follows (in millions, except per share amounts):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Employee Stock Purchase Plan (&#8220;ESPP&#8221;), employees purchased approximately 0.5 million shares for $75.9 million and approximately 0.5 million shares for $71.2 million during the nine months ended September&#160;30, 2021, and 2020, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation Expense</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes share-based compensation expense for the three and nine months ended September&#160;30, 2021, and 2020 (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales &#8211; products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales &#8211; services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense after income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options granted under the Company&#8217;s share-based compensation plans and rights to acquire stock granted under the ESPP. The weighted average estimated fair values of stock options and the rights to acquire stock under the ESPP, as well as the weighted average assumptions used in calculating the fair values of stock options and the rights to acquire stock under the ESPP that were granted during the three and nine months ended September&#160;30, 2021, and 2020, were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$87.35</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$62.65</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$78.17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$53.57</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$91.07</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$67.85</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$89.98</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$57.29</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701352226584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense for the three months ended September&#160;30, 2021, was $73.9&#160;million, or 16.0% of income before taxes, compared to $38.4&#160;million, or 10.8% of income before taxes, for the three months ended September&#160;30, 2020. Income tax expense for the nine months ended September&#160;30, 2021, was $90.7 million, or 6.3% of income before taxes, compared to $67.3&#160;million, or 8.7% of income before taxes, for the nine months ended September&#160;30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three and nine months ended September&#160;30, 2021, and 2020, differs from the U.S. federal statutory rate of 21% mainly due to excess tax benefits associated with employee equity plans, the effect of income earned by certain overseas entities being taxed at rates lower than the federal statutory rate, and the federal research and development (&#8220;R&amp;D&#8221;) credit benefit, partially offset by U.S. tax on foreign earnings and state income taxes (net of federal benefit).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the nine months ended September&#160;30, 2021, included a one-time benefit of $66.4&#160;million from re-measurement of the Company&#8217;s Swiss deferred tax assets resulting from the extension of the economic useful life of certain intangible assets. The effective tax rate for the nine months ended September&#160;30, 2020, reflected a one-time increase of $36.8&#160;million in unrecognized tax benefits with a corresponding increase to income tax expense. This increase was related to intercompany charges for share-based compensation for relevant periods prior to 2020, triggered by the finalization of a Ninth Circuit Court of Appeals opinion (the &#8220;Ninth Circuit Opinion&#8221;) involving an independent third party. An additional charge of $11.1&#160;million related to this matter was recorded to income tax expense for the three and nine months ended September&#160;30, 2021, as a result of additional IRS guidance issued in July 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes for the three and nine months ended September&#160;30, 2021, included excess tax benefits associated with employee equity plans of $41.9&#160;million and $158.9&#160;million, which reduced our effective tax rate by 9.1 and 11.1 percentage points, respectively. The provision for income taxes for the three and nine months ended September&#160;30, 2020, included excess tax benefits associated with employee equity plans of $47.9&#160;million and $144.8&#160;million, which reduced our effective tax rate by 13.5 and 18.8 percentage points, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files federal, state, and foreign income tax returns in many U.S. and OUS jurisdictions. Years before 2016 are closed for the significant jurisdictions. Certain of the Company&#8217;s unrecognized tax benefits could change due to activities of various tax authorities, including potential assessment of additional tax, possible settlement of audits, or through normal expiration of various statutes of limitations, which could affect the Company&#8217;s effective tax rate in the period in which they change. Due to the uncertainty related to the timing and potential outcome of audits, the Company cannot estimate the range of reasonably possible change in unrecognized tax benefits that may occur in the next 12 months.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to the examination of its income tax returns by the Internal Revenue Service and other tax authorities. The outcome of these audits cannot be predicted with certainty. The Company&#8217;s management regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#8217;s provision for income taxes. If any issues addressed in the Company&#8217;s tax audits are resolved in a manner not consistent with management&#8217;s expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701351394936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET INCOME PER SHARE</a></td>
<td class="text">NET INCOME PER SHARE<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the computation of basic and diluted net income per share attributable to Intuitive Surgical, Inc. (in millions, except per share amounts):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding used in basic calculation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: dilutive effect of potential common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding used in diluted calculation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to Intuitive Surgical, Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.87&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.63&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.93&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation awards of approximately 0.2&#160;million and 0.6&#160;million shares for the three months ended September&#160;30, 2021, and 2020, respectively, and approximately 0.7&#160;million and 2.6&#160;million shares for the nine months ended September&#160;30, 2021, and 2020, respectively, were outstanding but were not included in the computation of diluted net income per share attributable to Intuitive Surgical, Inc. common stockholders, because the effect of including such shares would have been anti-dilutive in the periods presented.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701351691064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements (&#8220;Financial Statements&#8221;) of Intuitive Surgical, Inc. and its wholly and majority-owned subsidiaries have been prepared on a consistent basis with the audited Consolidated Financial Statements for the fiscal year ended December&#160;31, 2020, and include all adjustments, consisting of only normal, recurring adjustments, necessary to fairly state the information set forth herein. The Financial Statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and, therefore, omit certain information and footnote disclosure necessary to present the Financial Statements in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). These Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, which was filed with the SEC on February&#160;10, 2021. The results of operations for the first nine months of fiscal year 2021 are not necessarily indicative of the results to be expected for the entire fiscal year or any future periods.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Consolidation and Joint Ventures</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Financial Statements include the results and the balances of the Company&#8217;s majority-owned joint venture (referred to herein as the &#8220;Joint Venture&#8221;) with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (&#8220;Fosun Pharma&#8221;). The Company holds a controlling financial interest in the Joint Venture, and the noncontrolling interest is reflected as a separate component of consolidated stockholders&#8217; equity. The noncontrolling interest&#8217;s share of the earnings in the Joint Venture is presented separately in the condensed consolidated statements of comprehensive income.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Split</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares issued pursuant to the three-for-one stock split (the "Stock Split") of the Company's issued and outstanding common stock, par value $0.001 per share, were distributed on October 4, 2021, to stockholders of record as of September 27, 2021. All share and per-share information presented in the Financial Statements have been retroactively adjusted to reflect the Stock Split.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Leases with Variable Lease Payments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2021-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessors - Certain Leases with Variable Lease Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which amends the lessor lease classification guidance in ASC 842 for leases that include any amount of variable lease payments that are not based on an index or rate. The Company has early adopted this ASU as of July 1, 2021, on a prospective basis. The standard had no impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div>There have been no new or material changes to the significant accounting policies discussed in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701352615064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesTextBlock', window );">Summary of Cash and Available-For-Sale Securities</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s cash and available-for-sale marketable securities&#8217; amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant investment category reported as cash and cash equivalents, short-term investments, or long-term investments as of September&#160;30, 2021, and December&#160;31, 2020 (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and<br/>Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-<br/>term<br/>Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-<br/>term<br/>Investments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,250.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,258.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,153.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,062.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,070.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,153.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,265.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,610.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,614.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,977.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,207.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,219.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,131.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and<br/>Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-<br/>term<br/>Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-<br/>term<br/>Investments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,626.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,649.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,567.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,252.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,567.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,036.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,933.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,949.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,829.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,869.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,622.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,488.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the contractual maturities of the Company&#8217;s cash equivalents and available-for-sale investments (excluding cash and money market funds), as of September&#160;30, 2021 (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in less than one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,735.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in one to five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,125.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,131.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,860.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock', window );">Summary of Equity Investment Activity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the activity related to equity investments (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:24.229%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.687%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020<br/>Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Changes in Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sales/Purchases/Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September&#160;30, 2021</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prepaids and other current assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible and other assets, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity investments with readily determinable value (Level 1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity investments without readily determinable value (Level 2)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Recorded in Interest and other income, net.</span></div></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Other includes conversion of certain equity investments without readily determinable value to equity investments with readily determinable value.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These derivative instruments are used to hedge against balance sheet foreign currency exposures. The related gains and losses were as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized gains/(losses) in Interest and other income, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gains/(losses) related to balance sheet re-measurement</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Gross Notional Amounts for Derivatives and Aggregate Gross Fair Value Outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts for derivative instruments provide one measure of the transaction volume. Total gross notional amounts (in USD) for outstanding derivatives and the aggregate gross fair value at the end of each period were as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:47.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.257%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notional amounts:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross fair value recorded in:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701351423608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventory Details</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide details of selected balance sheet line items (in millions):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Inventory</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Prepaids and Other Current Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Prepaids and other current assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases &#8211; short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaids and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaids and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Other Accrued Liabilities - Short-term</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other accrued liabilities&#8211;short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of deferred purchase consideration payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other accrued liabilities&#8211;short-term</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other Long-term Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other long-term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes&#8211;long-term</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue&#8211;long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides supplemental non-cash investing and financing activities (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of property, plant, and equipment in accounts payable and accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred payments and contingent consideration related to business combinations and asset acquisitions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701351654248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND CONTRACT ACQUISITION COSTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Revenue Disaggregated by Types and Geography</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue disaggregated by types and geography (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,227.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. revenue</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Outside of U.S. (&#8220;OUS&#8221;)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total OUS revenue</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Total </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,708.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,159.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,029.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Summary of Contract Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information summarizes the Company&#8217;s contract assets and liabilities (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock', window );">Sales-type Lease Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue from Intuitive System Leasing arrangements (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock', window );">Operating Lease Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue from Intuitive System Leasing arrangements (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of income from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of income from sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701350247288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock', window );">Schedule of Lease Receivables</a></td>
<td class="text">Lease receivables relating to sales-type lease arrangements are presented on the Condensed Consolidated Balance Sheets as follows (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross lease receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible and other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock', window );">Schedule of Contractual Maturities of Gross Lease Receivables</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of gross lease receivables at September&#160;30, 2021, are as follows (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock', window );">Amortized Cost Basis by Year of Origination and Credit Quality Indicator</a></td>
<td class="text">The following table summarizes the amortized cost basis by year of origination and credit quality indicator as of September&#160;30, 2021 (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.311%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Credit Rating:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moderate</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.4&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.0&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Low</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessor, Sales-type Lease, Lease Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financing receivables by credit quality indicator. The credit quality indicator is a statistic about the credit quality of financing receivables. Examples include, but not limited to, consumer credit risk scores, credit-rating-agency ratings, an entity's internal credit risk grades, loan-to-value ratios, collateral, collection experience and other internal metrics.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953659-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity of undiscounted cash flows to be received on annual basis for sales-type and direct financing leases receivable. Includes, but is not limited to, reconciliation to lease receivable recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701350239144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Summary of Changes in Goodwill</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition activity</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344.3&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of gross intangible assets, accumulated amortization, and net intangible asset balances as of September&#160;30, 2021, and December&#160;31, 2020 (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:29.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution rights and others</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule Of Estimated Future Amortization Expense Of Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future amortization expense related to intangible assets as of September&#160;30, 2021, is as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701352211512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Stockholders Equity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the changes in stockholders&#8217; equity (in millions):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,804.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,022.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,837.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,879.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,015.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,390.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,410.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,459.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:25.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.170%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,084.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,633.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,740.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,766.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,304.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,937.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,257.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,286.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:25.184%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.507%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.507%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.157%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,444.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,261.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,731.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,759.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,015.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,390.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,410.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,459.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:25.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.170%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,756.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,494.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,263.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,284.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adoption of new accounting standard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,304.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,937.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,257.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,286.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Schedule of Share Repurchase Activities</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides share repurchase activities (in millions, except per share amounts):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Components of Accumulated Other Comprehensive Income, Net of Tax</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive income (loss), net of tax, attributable to Intuitive are as follows (in millions):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701355359528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity Under All Stock Plans</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity under all stock plans for the nine months ended September&#160;30, 2021, is presented as follows (in millions, except per share amounts):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options Outstanding</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Exercise&#160;Price Per<br/>Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited/expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of RSU Activity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSUs activity under all stock plans for the nine months ended September&#160;30, 2021, is presented as follows (in millions, except per share amounts):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Summary of Share-Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes share-based compensation expense for the three and nine months ended September&#160;30, 2021, and 2020 (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales &#8211; products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales &#8211; services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense after income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock', window );">Schedule of Estimated Fair Value of the Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options granted under the Company&#8217;s share-based compensation plans and rights to acquire stock granted under the ESPP. The weighted average estimated fair values of stock options and the rights to acquire stock under the ESPP, as well as the weighted average assumptions used in calculating the fair values of stock options and the rights to acquire stock under the ESPP that were granted during the three and nine months ended September&#160;30, 2021, and 2020, were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$87.35</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$62.65</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$78.17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$53.57</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$91.07</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$67.85</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$89.98</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$57.29</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701350125272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Net Income Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the computation of basic and diluted net income per share attributable to Intuitive Surgical, Inc. (in millions, except per share amounts):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding used in basic calculation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: dilutive effect of potential common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding used in diluted calculation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to Intuitive Surgical, Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.87&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.63&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.93&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701435747272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Summary of Cash and Available-For-Sale Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,346.7<span></span>
</td>
<td class="nump">$ 1,622.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">6,860.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost', window );">Total assets measured at fair value, Amortized Cost</a></td>
<td class="nump">8,207.6<span></span>
</td>
<td class="nump">6,829.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">17.6<span></span>
</td>
<td class="nump">39.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(5.5)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue', window );">Total assets measured at fair value, Fair Value</a></td>
<td class="nump">8,219.7<span></span>
</td>
<td class="nump">6,869.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">2,741.5<span></span>
</td>
<td class="nump">3,488.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">4,131.5<span></span>
</td>
<td class="nump">1,757.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashMember', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">534.5<span></span>
</td>
<td class="nump">644.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">534.5<span></span>
</td>
<td class="nump">644.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">812.2<span></span>
</td>
<td class="nump">838.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">4,062.9<span></span>
</td>
<td class="nump">3,252.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">10.6<span></span>
</td>
<td class="nump">23.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">4,070.7<span></span>
</td>
<td class="nump">3,275.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">1,104.6<span></span>
</td>
<td class="nump">1,567.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">2,153.9<span></span>
</td>
<td class="nump">869.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">812.2<span></span>
</td>
<td class="nump">625.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">812.2<span></span>
</td>
<td class="nump">625.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | U.S. treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">212.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">3,250.7<span></span>
</td>
<td class="nump">2,626.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">10.6<span></span>
</td>
<td class="nump">23.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">3,258.5<span></span>
</td>
<td class="nump">2,649.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">1,104.6<span></span>
</td>
<td class="nump">1,567.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">2,153.9<span></span>
</td>
<td class="nump">869.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">140.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">3,610.2<span></span>
</td>
<td class="nump">2,933.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">7.0<span></span>
</td>
<td class="nump">16.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2.7)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">3,614.5<span></span>
</td>
<td class="nump">2,949.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">1,636.9<span></span>
</td>
<td class="nump">1,920.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">1,977.6<span></span>
</td>
<td class="nump">888.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">64.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">632.7<span></span>
</td>
<td class="nump">671.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">632.7<span></span>
</td>
<td class="nump">671.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">632.7<span></span>
</td>
<td class="nump">607.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">2,262.4<span></span>
</td>
<td class="nump">1,425.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">11.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2.0)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,265.7<span></span>
</td>
<td class="nump">1,437.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">794.4<span></span>
</td>
<td class="nump">1,036.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">1,471.3<span></span>
</td>
<td class="nump">397.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">72.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">538.3<span></span>
</td>
<td class="nump">716.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">538.3<span></span>
</td>
<td class="nump">719.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">150.8<span></span>
</td>
<td class="nump">233.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">387.5<span></span>
</td>
<td class="nump">412.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">176.8<span></span>
</td>
<td class="nump">119.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">177.8<span></span>
</td>
<td class="nump">121.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">59.0<span></span>
</td>
<td class="nump">43.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">$ 118.8<span></span>
</td>
<td class="nump">$ 78.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash and Cash Equivalents and Debt Securities, Available-for-sale, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash and Cash Equivalents and Debt Securities, Available-for-sale, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701355380632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Mature in less than one year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,735.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Mature in one to five years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,125.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,860.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Mature in less than one year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,741.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Mature in one to five years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,131.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,873.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Realized investment gains (losses)</a></td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Available For Sale Securities Debt Maturities Fair Value Total</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701354574248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Summary of Equity Investment Activity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments with readily determinable value beginning balance, Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.1<span></span>
</td>
<td class="nump">$ 60.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Net unrealized gains/(losses) on investments</a></td>
<td class="nump">$ 12.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity', window );">Proceeds from sale of available-for-sale securities, equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfEquityInvestments', window );">Gain (loss) on sale of equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfDerivatives', window );">Gain (loss) on sale of derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Realized investment gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments with readily determinable value beginning balance, Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.1<span></span>
</td>
<td class="nump">60.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Changes in fair value, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments', window );">Sales/Purchases/Others, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investments without readily determinable value, Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.2<span></span>
</td>
<td class="nump">30.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss', window );">Changes in fair value, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments', window );">Sales/Purchases/Others, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares', window );">Equity investments without readily determinable value, portion attributable to investment in preferred shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Sales, Purchases and Other Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities without Readily Determinable Fair Value, Sales, Purchases and Other Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss), Portion Attributable to Investment in Preferred Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.13(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of equity securities, not separately or otherwise categorized as trading or available-for-sale. This element includes investments in which the entity holds a small ownership stake (generally, less than 20% of the shares outstanding) and cannot exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity securities classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701464522104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Derivative Instruments Used to Hedge against Balance Sheet Foreign Currency Exposures (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange gains/(losses) related to balance sheet re-measurement</a></td>
<td class="num">$ (6.4)<span></span>
</td>
<td class="nump">$ 5.9<span></span>
</td>
<td class="num">$ (12.4)<span></span>
</td>
<td class="num">$ (1.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward contracts | Other income | Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Recognized gains/(losses) in Interest and other income, net</a></td>
<td class="nump">$ 4.4<span></span>
</td>
<td class="num">$ (5.0)<span></span>
</td>
<td class="nump">11.8<span></span>
</td>
<td class="num">$ (3.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=isrg_CollarContractMember', window );">Collar Contract | Other income | Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Recognized gains/(losses) in Interest and other income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=isrg_CollarContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=isrg_CollarContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701355976200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Gross Notional Amounts for Outstanding Derivatives (Details) - Forward contracts - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Derivatives Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of outstanding currency forward contracts</a></td>
<td class="nump">$ 203.7<span></span>
</td>
<td class="nump">$ 154.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Derivatives Designated as Hedging Instruments | Prepaids and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of outstanding currency forward contracts</a></td>
<td class="nump">6.8<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Derivatives Designated as Hedging Instruments | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of outstanding currency forward contracts</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of outstanding currency forward contracts</a></td>
<td class="nump">285.8<span></span>
</td>
<td class="nump">309.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Derivatives Not Designated as Hedging Instruments | Prepaids and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of outstanding currency forward contracts</a></td>
<td class="nump">5.8<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Derivatives Not Designated as Hedging Instruments | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of outstanding currency forward contracts</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701360173176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Inventory (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 181.4<span></span>
</td>
<td class="nump">$ 184.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">85.7<span></span>
</td>
<td class="nump">75.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">317.8<span></span>
</td>
<td class="nump">341.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 584.9<span></span>
</td>
<td class="nump">$ 601.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701354164872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Prepaids and Other Current Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="nump">$ 78.2<span></span>
</td>
<td class="nump">$ 28.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments</a></td>
<td class="nump">43.8<span></span>
</td>
<td class="nump">60.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent', window );">Net investment in sales-type leases &#8211; short-term</a></td>
<td class="nump">98.6<span></span>
</td>
<td class="nump">81.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other prepaids and other current assets</a></td>
<td class="nump">139.3<span></span>
</td>
<td class="nump">97.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaids and other current assets</a></td>
<td class="nump">$ 359.9<span></span>
</td>
<td class="nump">$ 267.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales-type Lease, Net Investment in Lease, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701354762104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Accrued Liabilities - Short-term (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Taxes payable</a></td>
<td class="nump">$ 65.9<span></span>
</td>
<td class="nump">$ 47.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_DeferredPurchaseConsiderationPaymentsCurrent', window );">Current portion of deferred purchase consideration payments</a></td>
<td class="nump">12.2<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Current portion of contingent consideration</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">15.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">214.8<span></span>
</td>
<td class="nump">225.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Total other accrued liabilities&#8211;short-term</a></td>
<td class="nump">$ 293.5<span></span>
</td>
<td class="nump">$ 298.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_DeferredPurchaseConsiderationPaymentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Purchase Consideration Payments, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_DeferredPurchaseConsiderationPaymentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701355533192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Long-term Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Income taxes&#8211;long-term</a></td>
<td class="nump">$ 309.2<span></span>
</td>
<td class="nump">$ 305.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue&#8211;long-term</a></td>
<td class="nump">35.0<span></span>
</td>
<td class="nump">32.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">103.6<span></span>
</td>
<td class="nump">106.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent', window );">Total other long-term liabilities</a></td>
<td class="nump">$ 447.8<span></span>
</td>
<td class="nump">$ 444.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701353170840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental non-cash investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges', window );">Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment</a></td>
<td class="nump">$ 229.2<span></span>
</td>
<td class="nump">$ 123.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Acquisition of property, plant, and equipment in accounts payable and accrued liabilities</a></td>
<td class="nump">29.9<span></span>
</td>
<td class="nump">44.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments', window );">Deferred payments and contingent consideration related to business combinations and asset acquisitions</a></td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Present Value of Future Cash Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of physical assets used in the normal conduct of business and not intended for resale, from reclassification, impairment, donation, or changes classified as other. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTransfersAndChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701353088312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND CONTRACT ACQUISITION COSTS - Revenue Disaggregated by Types and Geography (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,403.3<span></span>
</td>
<td class="nump">$ 1,077.7<span></span>
</td>
<td class="nump">$ 4,159.4<span></span>
</td>
<td class="nump">$ 3,029.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=isrg_InstrumentsandAccessoriesMember', window );">Instruments and accessories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">755.4<span></span>
</td>
<td class="nump">630.5<span></span>
</td>
<td class="nump">2,257.7<span></span>
</td>
<td class="nump">1,708.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=isrg_SystemsMember', window );">Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">415.2<span></span>
</td>
<td class="nump">267.8<span></span>
</td>
<td class="nump">1,223.4<span></span>
</td>
<td class="nump">812.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=isrg_ServicesMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">232.7<span></span>
</td>
<td class="nump">179.4<span></span>
</td>
<td class="nump">678.3<span></span>
</td>
<td class="nump">508.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">952.2<span></span>
</td>
<td class="nump">743.8<span></span>
</td>
<td class="nump">2,805.5<span></span>
</td>
<td class="nump">2,060.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">U.S. | Instruments and accessories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">535.7<span></span>
</td>
<td class="nump">467.3<span></span>
</td>
<td class="nump">1,614.0<span></span>
</td>
<td class="nump">1,227.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">U.S. | Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">263.4<span></span>
</td>
<td class="nump">157.7<span></span>
</td>
<td class="nump">743.7<span></span>
</td>
<td class="nump">495.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">U.S. | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">153.1<span></span>
</td>
<td class="nump">118.8<span></span>
</td>
<td class="nump">447.8<span></span>
</td>
<td class="nump">337.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">Outside of U.S. (&#8220;OUS&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">451.1<span></span>
</td>
<td class="nump">333.9<span></span>
</td>
<td class="nump">1,353.9<span></span>
</td>
<td class="nump">968.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">Outside of U.S. (&#8220;OUS&#8221;) | Instruments and accessories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">219.7<span></span>
</td>
<td class="nump">163.2<span></span>
</td>
<td class="nump">643.7<span></span>
</td>
<td class="nump">481.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">Outside of U.S. (&#8220;OUS&#8221;) | Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">151.8<span></span>
</td>
<td class="nump">110.1<span></span>
</td>
<td class="nump">479.7<span></span>
</td>
<td class="nump">316.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">Outside of U.S. (&#8220;OUS&#8221;) | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 79.6<span></span>
</td>
<td class="nump">$ 60.6<span></span>
</td>
<td class="nump">$ 230.5<span></span>
</td>
<td class="nump">$ 170.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=isrg_InstrumentsandAccessoriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=isrg_InstrumentsandAccessoriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=isrg_SystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=isrg_SystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=isrg_ServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=isrg_ServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701351942104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND CONTRACT ACQUISITION COSTS - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Price allocated to remaining performance obligations</a></td>
<td class="nump">$ 1,723.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,723.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">$ 66.1<span></span>
</td>
<td class="nump">$ 58.1<span></span>
</td>
<td class="nump">$ 319.3<span></span>
</td>
<td class="nump">$ 249.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-04-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-04-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-04-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-04-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701351519336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUE AND CONTRACT ACQUISITION COSTS - Summary of Contract Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">$ 44.8<span></span>
</td>
<td class="nump">$ 34.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 383.5<span></span>
</td>
<td class="nump">$ 382.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701350011480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND CONTRACT ACQUISITION COSTS - Sales-type and Operating Lease Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseLeaseIncome', window );">Sales-type lease revenue</a></td>
<td class="nump">$ 39.0<span></span>
</td>
<td class="nump">$ 24.7<span></span>
</td>
<td class="nump">$ 140.3<span></span>
</td>
<td class="nump">$ 96.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Operating lease revenue</a></td>
<td class="nump">$ 72.5<span></span>
</td>
<td class="nump">$ 45.7<span></span>
</td>
<td class="nump">$ 198.8<span></span>
</td>
<td class="nump">$ 127.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919311-209978<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease income from variable lease payments, interest income from net investment on sales-type lease, and profit (loss) recognized at commencement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919311-209978<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701355677176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Lease Receivables (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasedAssetsLineItems', window );"><strong>Capital Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_SalesTypeLeaseGrossInvestmentInLease', window );">Gross lease receivables</a></td>
<td class="nump">$ 356.1<span></span>
</td>
<td class="nump">$ 286.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_SalestypeLeaseDeferredSellingProfit', window );">Unearned income</a></td>
<td class="num">(11.7)<span></span>
</td>
<td class="num">(11.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLease', window );">Net Investment</a></td>
<td class="nump">344.4<span></span>
</td>
<td class="nump">275.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss', window );">Allowance for credit loss</a></td>
<td class="num">(3.7)<span></span>
</td>
<td class="num">(4.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseLeaseReceivable', window );">Lease receivables</a></td>
<td class="nump">340.7<span></span>
</td>
<td class="nump">270.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaids and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasedAssetsLineItems', window );"><strong>Capital Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseLeaseReceivable', window );">Lease receivables</a></td>
<td class="nump">98.6<span></span>
</td>
<td class="nump">81.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Intangible and other assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasedAssetsLineItems', window );"><strong>Capital Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseLeaseReceivable', window );">Lease receivables</a></td>
<td class="nump">$ 242.1<span></span>
</td>
<td class="nump">$ 189.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_SalesTypeLeaseGrossInvestmentInLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales-type Lease, Gross Investment in Lease</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_SalesTypeLeaseGrossInvestmentInLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_SalestypeLeaseDeferredSellingProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales-type Lease, Deferred Selling Profit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_SalestypeLeaseDeferredSellingProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseLeaseReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseLeaseReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of net investment in sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on net investment in sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701355419144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Schedule of Contractual Maturities of Gross Lease Receivables (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear', window );">Remainder of 2021</a></td>
<td class="nump">$ 25.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths', window );">2022</a></td>
<td class="nump">101.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears', window );">2023</a></td>
<td class="nump">86.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears', window );">2024</a></td>
<td class="nump">74.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears', window );">2025</a></td>
<td class="nump">49.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter', window );">2026 and thereafter</a></td>
<td class="nump">19.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived', window );">Total</a></td>
<td class="nump">$ 356.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Year Five and Thereafter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701436222696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Credit Quality Indicator (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems', window );"><strong>Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear', window );">2021</a></td>
<td class="nump">$ 147.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear', window );">2020</a></td>
<td class="nump">128.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear', window );">2019</a></td>
<td class="nump">44.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear', window );">2018</a></td>
<td class="nump">17.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear', window );">2017</a></td>
<td class="nump">6.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear', window );">Prior</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLease', window );">Net Investment</a></td>
<td class="nump">344.4<span></span>
</td>
<td class="nump">$ 275.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InternalCreditAssessmentAxis=isrg_HighMember', window );">High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems', window );"><strong>Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear', window );">2021</a></td>
<td class="nump">76.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear', window );">2020</a></td>
<td class="nump">56.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear', window );">2019</a></td>
<td class="nump">25.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear', window );">2018</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear', window );">2017</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear', window );">Prior</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLease', window );">Net Investment</a></td>
<td class="nump">167.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InternalCreditAssessmentAxis=isrg_ModerateMember', window );">Moderate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems', window );"><strong>Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear', window );">2021</a></td>
<td class="nump">70.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear', window );">2020</a></td>
<td class="nump">67.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear', window );">2019</a></td>
<td class="nump">18.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear', window );">2018</a></td>
<td class="nump">11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear', window );">2017</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear', window );">Prior</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLease', window );">Net Investment</a></td>
<td class="nump">171.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InternalCreditAssessmentAxis=isrg_LowMember', window );">Low</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems', window );"><strong>Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear', window );">2020</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear', window );">2019</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear', window );">2018</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear', window );">2017</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear', window );">Prior</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLease', window );">Net Investment</a></td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of net investment in sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net investment in sales-type lease originated more than five years prior to current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net investment in sales-type lease originated four years prior to current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net investment in sales-type lease originated in current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net investment in sales-type lease originated in fiscal year prior to current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net investment in sales-type lease originated three years prior to current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net investment in sales-type lease originated two years prior to current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=isrg_HighMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=isrg_HighMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=isrg_ModerateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=isrg_ModerateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=isrg_LowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=isrg_LowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701443911560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Additional Information (Details)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorSalesTypeLeaseTermOfContract1', window );">Sales-type leases terms</a></td>
<td class="text">24 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorSalesTypeLeaseTermOfContract1', window );">Sales-type leases terms</a></td>
<td class="text">84 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorSalesTypeLeaseTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessor's sales-type lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919359-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorSalesTypeLeaseTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701351699432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Schedule of Summary of Changes in Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">$ 336.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisition activity</a></td>
<td class="nump">8.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Translation and other</a></td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">$ 344.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701354304248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 277.4<span></span>
</td>
<td class="nump">$ 349.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(200.2)<span></span>
</td>
<td class="num">(271.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">77.2<span></span>
</td>
<td class="nump">77.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Patents and developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">219.3<span></span>
</td>
<td class="nump">198.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(169.3)<span></span>
</td>
<td class="num">(158.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">50.0<span></span>
</td>
<td class="nump">39.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember', window );">Distribution rights and others</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">26.3<span></span>
</td>
<td class="nump">91.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(17.8)<span></span>
</td>
<td class="num">(77.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="nump">14.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">31.8<span></span>
</td>
<td class="nump">59.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(13.1)<span></span>
</td>
<td class="num">(35.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 18.7<span></span>
</td>
<td class="nump">$ 23.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701355554472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Schedule Of Estimated Future Amortization Expense Of Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of 2021</a></td>
<td class="nump">$ 6.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">23.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">19.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">14.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">9.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour', window );">2026 and thereafter</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 77.2<span></span>
</td>
<td class="nump">$ 77.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Amortization Expense, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701435545240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Schedule of Stockholders Equity (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">353,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 10,879.5<span></span>
</td>
<td class="nump">$ 8,766.4<span></span>
</td>
<td class="nump">$ 9,759.1<span></span>
</td>
<td class="nump">$ 8,284.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock through employee stock plans</a></td>
<td class="nump">91.1<span></span>
</td>
<td class="nump">113.9<span></span>
</td>
<td class="nump">244.8<span></span>
</td>
<td class="nump">267.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld related to net share settlement of equity awards</a></td>
<td class="num">(13.3)<span></span>
</td>
<td class="num">(10.2)<span></span>
</td>
<td class="num">(201.2)<span></span>
</td>
<td class="num">(165.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense related to employee stock plans</a></td>
<td class="nump">120.1<span></span>
</td>
<td class="nump">105.8<span></span>
</td>
<td class="nump">331.4<span></span>
</td>
<td class="nump">292.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Intuitive Surgical, Inc.</a></td>
<td class="nump">380.5<span></span>
</td>
<td class="nump">313.9<span></span>
</td>
<td class="nump">1,324.0<span></span>
</td>
<td class="nump">695.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(5.1)<span></span>
</td>
<td class="num">(6.0)<span></span>
</td>
<td class="num">(20.0)<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interest in joint venture</a></td>
<td class="nump">$ 6.7<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">$ 21.4<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares)</a></td>
<td class="nump">357,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">357,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 11,459.5<span></span>
</td>
<td class="nump">$ 9,286.7<span></span>
</td>
<td class="nump">$ 11,459.5<span></span>
</td>
<td class="nump">9,286.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares)</a></td>
<td class="nump">356,200<span></span>
</td>
<td class="nump">351,000<span></span>
</td>
<td class="nump">353,100<span></span>
</td>
<td class="nump">347,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock through employee stock plans (in shares)</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="nump">4,900<span></span>
</td>
<td class="nump">6,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld related to net share settlement of equity awards (in shares)</a></td>
<td class="num">(100)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(800)<span></span>
</td>
<td class="num">(800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares)</a></td>
<td class="nump">357,200<span></span>
</td>
<td class="nump">352,600<span></span>
</td>
<td class="nump">357,200<span></span>
</td>
<td class="nump">352,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">6,804.1<span></span>
</td>
<td class="nump">6,084.8<span></span>
</td>
<td class="nump">6,444.9<span></span>
</td>
<td class="nump">5,756.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock through employee stock plans</a></td>
<td class="nump">91.1<span></span>
</td>
<td class="nump">113.9<span></span>
</td>
<td class="nump">244.8<span></span>
</td>
<td class="nump">267.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld related to net share settlement of equity awards</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(6.0)<span></span>
</td>
<td class="num">(7.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense related to employee stock plans</a></td>
<td class="nump">120.1<span></span>
</td>
<td class="nump">105.8<span></span>
</td>
<td class="nump">331.4<span></span>
</td>
<td class="nump">292.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">7,015.1<span></span>
</td>
<td class="nump">6,304.0<span></span>
</td>
<td class="nump">7,015.1<span></span>
</td>
<td class="nump">6,304.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">4,022.7<span></span>
</td>
<td class="nump">2,633.0<span></span>
</td>
<td class="nump">3,261.3<span></span>
</td>
<td class="nump">2,494.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld related to net share settlement of equity awards</a></td>
<td class="num">(13.1)<span></span>
</td>
<td class="num">(9.7)<span></span>
</td>
<td class="num">(195.2)<span></span>
</td>
<td class="num">(157.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(94.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Intuitive Surgical, Inc.</a></td>
<td class="nump">380.5<span></span>
</td>
<td class="nump">313.9<span></span>
</td>
<td class="nump">1,324.0<span></span>
</td>
<td class="nump">695.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">4,390.1<span></span>
</td>
<td class="nump">2,937.2<span></span>
</td>
<td class="nump">4,390.1<span></span>
</td>
<td class="nump">2,937.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings | Adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">22.3<span></span>
</td>
<td class="nump">24.9<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(5.0)<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
<td class="num">(19.6)<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_ParentMember', window );">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">10,837.5<span></span>
</td>
<td class="nump">8,740.5<span></span>
</td>
<td class="nump">9,731.5<span></span>
</td>
<td class="nump">8,263.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock through employee stock plans</a></td>
<td class="nump">91.1<span></span>
</td>
<td class="nump">113.9<span></span>
</td>
<td class="nump">244.8<span></span>
</td>
<td class="nump">267.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld related to net share settlement of equity awards</a></td>
<td class="num">(13.3)<span></span>
</td>
<td class="num">(10.2)<span></span>
</td>
<td class="num">(201.2)<span></span>
</td>
<td class="num">(165.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense related to employee stock plans</a></td>
<td class="nump">120.1<span></span>
</td>
<td class="nump">105.8<span></span>
</td>
<td class="nump">331.4<span></span>
</td>
<td class="nump">292.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Intuitive Surgical, Inc.</a></td>
<td class="nump">380.5<span></span>
</td>
<td class="nump">313.9<span></span>
</td>
<td class="nump">1,324.0<span></span>
</td>
<td class="nump">695.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(5.0)<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
<td class="num">(19.6)<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">11,410.9<span></span>
</td>
<td class="nump">9,257.8<span></span>
</td>
<td class="nump">11,410.9<span></span>
</td>
<td class="nump">9,257.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_ParentMember', window );">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity | Adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interest in Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">42.0<span></span>
</td>
<td class="nump">25.9<span></span>
</td>
<td class="nump">27.6<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interest in joint venture</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">21.4<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 48.6<span></span>
</td>
<td class="nump">$ 28.9<span></span>
</td>
<td class="nump">$ 48.6<span></span>
</td>
<td class="nump">$ 28.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_ParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_ParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701356049064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Schedule of Share Repurchase Activities (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Value of shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Value of shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price per share (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 173.94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Value of shares repurchased</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=isrg_CommonStockRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=isrg_CommonStockRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701352684264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details) - Repurchase Program - Common Stock - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jan. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Amount of share repurchases authorized</a></td>
<td class="nump">$ 7,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_StockRepurchaseProgramincreasedtoauthorizedamount', window );">Stock repurchase program, increased to authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining amount of share repurchases authorized</a></td>
<td class="nump">$ 1,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_StockRepurchaseProgramincreasedtoauthorizedamount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increased to authorized shares repurchase amount for Stock Repurchase Program</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_StockRepurchaseProgramincreasedtoauthorizedamount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=isrg_CommonStockRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=isrg_CommonStockRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701358916728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Components of Accumulated Other Comprehensive Income, Net of Tax (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract', window );"><strong>Gains&#160;(Losses) on&#160;Hedge Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Beginning balance</a></td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="num">$ (2.9)<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">4.2<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="nump">9.3<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Ending balance</a></td>
<td class="nump">5.1<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract', window );"><strong>Unrealized Gains (Losses)&#160;on Available-for-Sale Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Beginning balance</a></td>
<td class="nump">13.5<span></span>
</td>
<td class="nump">44.1<span></span>
</td>
<td class="nump">29.5<span></span>
</td>
<td class="nump">20.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(7.1)<span></span>
</td>
<td class="num">(19.4)<span></span>
</td>
<td class="nump">21.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="num">(4.5)<span></span>
</td>
<td class="num">(7.1)<span></span>
</td>
<td class="num">(20.5)<span></span>
</td>
<td class="nump">16.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Ending balance</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward', window );"><strong>Foreign Currency Translation Gains&#160;(Losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Beginning balance</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(13.8)<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(2.7)<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="num">(7.5)<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="num">(2.7)<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="num">(7.5)<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Ending balance</a></td>
<td class="num">(2.8)<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Employee Benefit Plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Beginning balance</a></td>
<td class="num">(6.2)<span></span>
</td>
<td class="num">(8.4)<span></span>
</td>
<td class="num">(6.4)<span></span>
</td>
<td class="num">(8.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Ending balance</a></td>
<td class="num">(6.0)<span></span>
</td>
<td class="num">(8.2)<span></span>
</td>
<td class="num">(6.0)<span></span>
</td>
<td class="num">(8.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">22.3<span></span>
</td>
<td class="nump">24.9<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(1.9)<span></span>
</td>
<td class="num">(5.7)<span></span>
</td>
<td class="num">(17.6)<span></span>
</td>
<td class="nump">11.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="num">(7.9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="num">(5.0)<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
<td class="num">(19.6)<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="nump">$ 5.3<span></span>
</td>
<td class="nump">$ 16.2<span></span>
</td>
<td class="nump">$ 5.3<span></span>
</td>
<td class="nump">$ 16.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss), Available-For-Sale Securities Adjustment, Net of Tax [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Before Reclassification Adjustments, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeTranslationAdjustmentSummaryRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e709-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 40<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116633155&amp;loc=d3e31531-110899<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph c<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701356196168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant, Giving Effect to Future Stock Split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,350,000<span></span>
</td>
<td class="nump">97,350,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable, number of shares</a></td>
<td class="nump">9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable, weighted-average exercise price (usd per share)</a></td>
<td class="nump">$ 94.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee Stock Purchase Plan, number of shares purchased by employees</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=isrg_A2010IncentiveAwardPlanMember', window );">2010 Incentive Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Common stock reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,450,000<span></span>
</td>
<td class="nump">32,450,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares reserved for future issuance</a></td>
<td class="nump">25,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | 2010 Incentive Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares reserved for future issuance</a></td>
<td class="nump">11,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee Stock Purchase Plan, value of shares purchased by employees</a></td>
<td class="nump">$ 75.9<span></span>
</td>
<td class="nump">$ 71.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant, Giving Effect to Future Stock Split</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=isrg_A2010IncentiveAwardPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=isrg_A2010IncentiveAwardPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701443719784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Summary of Stock Option Activity Under All Stock Plans (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance, Number Outstanding | shares</a></td>
<td class="nump">13.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted, Number Outstanding | shares</a></td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised, Number Outstanding | shares</a></td>
<td class="num">(2.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Options forfeited/expired, Number Outstanding | shares</a></td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance, Number Outstanding | shares</a></td>
<td class="nump">12.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract', window );"><strong>Weighted&#160;Average Exercise&#160;Price Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance, Weighted Average Exercise Price Per Share | $ / shares</a></td>
<td class="nump">$ 101.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted, Weighted Average Exercise Price Per Share | $ / shares</a></td>
<td class="nump">294.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised, Weighted Average Exercise Price Per Share | $ / shares</a></td>
<td class="nump">74.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Options forfeited/expired, Weighted Average Exercise Price Per Share | $ / shares</a></td>
<td class="nump">194.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance, Weighted Average Exercise Price Per Share | $ / shares</a></td>
<td class="nump">$ 123.58<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701351895032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Summary of RSU Activity (Details) - Restricted Stock Units (RSUs)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested beginning balance (in shares) | shares</a></td>
<td class="nump">5.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(2.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested ending balance (in shares) | shares</a></td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted&#160;Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested beginning balance (USD per share) | $ / shares</a></td>
<td class="nump">$ 163.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">252.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (USD per share) | $ / shares</a></td>
<td class="nump">144.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">191.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested ending balance (USD per share) | $ / shares</a></td>
<td class="nump">$ 204.31<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701351870360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense before income taxes</a></td>
<td class="nump">$ 122.9<span></span>
</td>
<td class="nump">$ 107.0<span></span>
</td>
<td class="nump">$ 337.2<span></span>
</td>
<td class="nump">$ 294.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit</a></td>
<td class="nump">24.8<span></span>
</td>
<td class="nump">22.3<span></span>
</td>
<td class="nump">67.9<span></span>
</td>
<td class="nump">61.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense after income taxes</a></td>
<td class="nump">98.1<span></span>
</td>
<td class="nump">84.7<span></span>
</td>
<td class="nump">269.3<span></span>
</td>
<td class="nump">233.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Total cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense before income taxes</a></td>
<td class="nump">25.0<span></span>
</td>
<td class="nump">23.3<span></span>
</td>
<td class="nump">67.8<span></span>
</td>
<td class="nump">60.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Total cost of sales | Cost of sales - products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense before income taxes</a></td>
<td class="nump">19.0<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
<td class="nump">50.9<span></span>
</td>
<td class="nump">43.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Total cost of sales | Cost of sales - services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense before income taxes</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
<td class="nump">16.9<span></span>
</td>
<td class="nump">17.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=isrg_SellingGeneralAndAdministrativeMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense before income taxes</a></td>
<td class="nump">62.5<span></span>
</td>
<td class="nump">54.2<span></span>
</td>
<td class="nump">171.3<span></span>
</td>
<td class="nump">149.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=isrg_ResearchAndDevelopmentMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense before income taxes</a></td>
<td class="nump">$ 35.4<span></span>
</td>
<td class="nump">$ 29.5<span></span>
</td>
<td class="nump">$ 98.1<span></span>
</td>
<td class="nump">$ 84.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_ConsolidatingReportingAxis=isrg_CostOfSalesProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_ConsolidatingReportingAxis=isrg_CostOfSalesProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_ConsolidatingReportingAxis=isrg_CostOfSalesServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_ConsolidatingReportingAxis=isrg_CostOfSalesServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=isrg_SellingGeneralAndAdministrativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=isrg_SellingGeneralAndAdministrativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=isrg_ResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=isrg_ResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701354612920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Schedule of Estimated Fair Value of Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
<td class="text">3 years 10 months 24 days<span></span>
</td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility (percent)</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value at grant date (usd per share)</a></td>
<td class="nump">$ 87.35<span></span>
</td>
<td class="nump">$ 62.65<span></span>
</td>
<td class="nump">$ 78.17<span></span>
</td>
<td class="nump">$ 53.57<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
<td class="text">1 year 3 months 18 days<span></span>
</td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility (percent)</a></td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value at grant date (usd per share)</a></td>
<td class="nump">$ 91.07<span></span>
</td>
<td class="nump">$ 67.85<span></span>
</td>
<td class="nump">$ 89.98<span></span>
</td>
<td class="nump">$ 57.29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701509061880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">$ 73.9<span></span>
</td>
<td class="nump">$ 38.4<span></span>
</td>
<td class="nump">$ 90.7<span></span>
</td>
<td class="nump">$ 67.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax expense, percentage of pre-tax income</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">10.80%<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="nump">8.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities', window );">Increase in unrecognized tax benefits</a></td>
<td class="nump">$ 11.1<span></span>
</td>
<td class="nump">$ 36.8<span></span>
</td>
<td class="nump">$ 11.1<span></span>
</td>
<td class="nump">$ 36.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Excess tax benefits associated with employee equity plans</a></td>
<td class="nump">$ 41.9<span></span>
</td>
<td class="nump">$ 47.9<span></span>
</td>
<td class="nump">$ 158.9<span></span>
</td>
<td class="nump">$ 144.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Excess tax benefits associated with employee equity plans (in percent)</a></td>
<td class="nump">9.10%<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="nump">11.10%<span></span>
</td>
<td class="nump">18.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Swiss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Re-measurement of deferred tax assets</a></td>
<td class="nump">$ 66.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701354995880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE - Computation of Basic and Diluted Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Intuitive Surgical, Inc.</a></td>
<td class="nump">$ 380.5<span></span>
</td>
<td class="nump">$ 313.9<span></span>
</td>
<td class="nump">$ 1,324.0<span></span>
</td>
<td class="nump">$ 695.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding used in basic calculation</a></td>
<td class="nump">356.8<span></span>
</td>
<td class="nump">352.0<span></span>
</td>
<td class="nump">355.6<span></span>
</td>
<td class="nump">350.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Add: dilutive effect of potential common shares</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding used in diluted calculation</a></td>
<td class="nump">366.8<span></span>
</td>
<td class="nump">361.9<span></span>
</td>
<td class="nump">365.1<span></span>
</td>
<td class="nump">360.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net income per share attributable to Intuitive Surgical, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 1.07<span></span>
</td>
<td class="nump">$ 0.89<span></span>
</td>
<td class="nump">$ 3.72<span></span>
</td>
<td class="nump">$ 1.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.04<span></span>
</td>
<td class="nump">$ 0.87<span></span>
</td>
<td class="nump">$ 3.63<span></span>
</td>
<td class="nump">$ 1.93<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701351507080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE - Additional Information (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Employee stock options excluded from computation of diluted net income per share</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139701356187688">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AmortizationOfIntangibleAssets</td>
<td class="nump">$ 12,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AmortizationOfIntangibleAssets</td>
<td class="nump">6,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI, Current</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_EquitySecuritiesFvNi</td>
<td class="nump">43,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity Securities without Readily Determinable Fair Value, Amount</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
<td class="nump">12,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI, Current</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_EquitySecuritiesFvNi</td>
<td class="nump">43,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity Securities without Readily Determinable Fair Value, Amount</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=isrg_IntangibleAndOtherAssetsNetMember', window );">Intangible and Other Assets, Net [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI, Current</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_EquitySecuritiesFvNi</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=isrg_IntangibleAndOtherAssetsNetMember', window );">Intangible and Other Assets, Net [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity Securities without Readily Determinable Fair Value, Amount</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
<td class="nump">$ 12,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=isrg_IntangibleAndOtherAssetsNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=isrg_IntangibleAndOtherAssetsNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>73
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8.9_
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ME1T [U=2FGW#?J"^;)W\!U!+ P04    "  (B%13DW@RT7T&  "$&0  &
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M9[7^!+6@CLN7*F'\+UE7L=U>0-*EL:JHP<B@X+*ZL]^U$1N J+T'$-> ^%1
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MATET=6ZH)E:5?NN=*8L;N1_F>-8"[0+P^5PI^SIQNWES>AO] U!+ P04
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M>RX3#][Q_ BN:T23,?6CG;=HYT&TO]IPGSV SIS;J(ORD3<I E%.4\6M&W7
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M/:I^V57?&+FMWA>MI#&RJ"XWG %'6@/X?2VEV=_8!=I7CC?_ 5!+ P04
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MZVHXEVQR:M/5?!)G%#U<DLH(7EKQ^J&HI-DH>+1IM&?XSFFP?'W51QUK.<T
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M4&S\)!(9?H-6.XW@BH=#GBH4NN),V%8(;B%#!)4A.(UCL\<@SA)U*=BA.JT
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MA*%-DZY/ QSR@]B';"W:MVYE+M>P7U (KX1]I)KA\\:3X5/5I6(?&P-K777
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M((NMA_0[BIC2=])YA@/#%W %4_)^,L(S&_63([J1*V,9#^&.Z=K*E5 ET-"
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M]PA<;[0%=PWN>YK7\]CX])+SJ@A@9I7G:X'\UX"?/WXJ+-8%PNT>N]>XBH
MOY.T:WI_(+YGI[ !@ZO2,XRZ/(R9-$,>]<!D4 FC?LU C,!+4 R#80B6J4MR
MACHNN&[53%NQB(/&_3Y!(\"YX@"3W9JS"9OQZTV*^!;@*[Y1!+0AZKUJA5RB
MJ<QF<#^SIMC*\5HSK8AS*=,T%.H]Y^#1M:4E"I)\:>.N\PN:I#*PE?Z%HQ?Z
MT-Y]:6TW'! &%WATU<I:TLD26.M5P1<#R'*S4[98U^G]%1J/#?ND0C\GOFDQ
MJ%/<*_?=,MM;-WO4D'EXOSCT#&2ION1O9C=/I$G],G@0K]]7[Z2=*US.<II!
MM1.-!HVZG*T_O"G#.V%J/ I6&&9XYI%E :S/C/'K#W:P>3B>_@U02P,$%
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MLJ;[*V7#92A5MB7V6D+CI%=1:;?JO,(\JEG59DM&"1LPD,?"J[U7UHW$)>8
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M"'X^',5C&C."SX?#>$2C,[XHRVE(AF.(^SW=2"Y3C;*41,Z$2V%- )VU?DH
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M"1U&H,/;'196-?Z]W"E+KZ^?5O2[@]H)T/E>4=]V"V?@_ ,U_PI02P,$%
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MW"F-9@:",]/=.L4XEGYC6-*ZQK4D_T2W>XC(GU#61<'EG-]-B)"6J(:U.V@
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MG$H\.ZF3 [^OM4*.HH-P'^R.FG#X>"\;JWC'J@/P7,GJ.9\*<^S5#FS. M0
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MS5P+7UU\D!O!?9<;!N0V5NA00ZXQ]L(F+QQ@B(:Q#^!99"TH#H&+)B_H"Q%
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MTL)7/(3L/&FM>L\PU6^9ZI]E"I"U%?_Y7#06.6B$H<5+O1_ _UV+E9"LOK@
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M91UH?R6EV2UL@N:5.?D%4$L#!!0    (  B(5%-JV3 6S <  %X>   9
M>&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;.U9;7/;-A+^*Q@U<[5G&(EOXDMJ
M>\9VG=9W;>*SG=S<=/H!)B&)#4FH &0[_?7=75 T&5NR*BL?[J8?"()X62QV
MGV?QPH,[J3[IF1"&W5=EK0\',V/F;T8CG<U$Q?50SD4--1.I*F[@4TU'>JX$
MSZE358Y\UXU&%2_JP=$!E5VHHP.Y,&51BPO%]**JN/I\(DIY=SCP!LN"RV(Z
M,U@P.CJ8\ZFX$N;#_$+!UZB5DA>5J'4A:Z;$Y'!P[+TYB; ]-?A8B#O=R3.<
MR8V4G_#C/#\<N*B0*$5F4 *'UZTX%66)@D"-WQN9@W9([-C-+Z6_I;G#7&ZX
M%J>R_$^1F]GA(!FP7$SXHC27\NY'T<QGC/(R66I*V9UM&XT'+%MH(ZNF,VA0
M%;5]\_O&#IT.B;NB@]]T\$EO.Q!I^3TW_.A R3NFL#5(PPQ-E7J#<D6-3KDR
M"FH+Z&>.KJ[?G_[KQ_<_?7]V>?4M._OWA_/K_[*]:WY3"KU_,#(P!#8<98VX
M$RO.7R$N93_+VLPT.ZMSD??[CT"U5C]_J=^)OU;@E9@/6> ZS'=];XV\H)UO
M0/*"%?+.?E\4YC/[Y?A&&P60^'6-S+"5&9+,<)6.P)1\40HF)^S*R.S33):Y
M4& $&NPI*ZX5B$1\H^<\$X<#8)H6ZE8,CJYG@DUD"2PJZBDSY"%&U;5A!BJS
M&:^G4%;43'>T^,<WB>_%WS%A9[X'U551ED )O?^&7<^4$#VG,3"Y$=6-4*W=
MV:FL*J 038X=YWF!C.(EN^!%_OJ\9J=\7ACXOA0&X@#(...J!C4U.\ZR1;4H
MN8'"]Z"E0EF@]0QY?2O8>9W)2K!KB=W/:P,Z8O'50DV+C)<.-ACVK+J<3^/)
M=Q(DU$:!9= N($* 30Q:X9^R --\!/LLU'*(-9*N9AQZLN-*+J#;B9@6-<X!
M2%_R.A,L&$=#G[UB[C"$-'(2-QQZD L=U_>',>0\=QC0RTF">#C&.G_H-B5Q
M"B7G6B](&$ ELT8E7X$#E5Q,9TQ4\U)^!I?8XCD,K9D'XY"R_G<LQ8^'I%'Z
MKC"SF2ASB)/6UD:R&D*ZQFJFA3&EJ! H,&X#!'['5:[9GCOT]EOI\.7OLSTO
MP$)\!>V+1GJ-$3!'U6%5T)P"J[C'O.@._?0L?!BJE[X3Z"<" #=&%3<+@C5*
M6 F%(''!CMW4PBKKP:J1NE=*K6$&XZ';IC1?R$.Z9ORZ#ZNB ZO?"%:W#:R6
MEHL  ?@ A_J@B3N@B1W7&S>@"5*7<F.+&<\) 3XI5B7#J"D9(V8VH:B[DJ(M
M);M,_-^@FT?<6=+-3<)A CG?B8* :H!U:+K$B4.7V.:/R8!0$$70:UNR1:U3
M/8!^VDM?S+>EZ [CQH#'=!@CTQKZT>OEA'/'8+%NNA7A:-[== /"140R2A'E
MD'-W2S<?],#G$=U\(L\2- '$:(**DP:6B)X-XJGC S,)3PF!!@H2Y.\[(,O?
MZ^%F! TH@"UM'88A63)P_,@C9OIA8]HX\"Q!8_(.%$!D\[8D* IM81!B4.BF
MNU@0D\Z"2,C=\](Q,=-WO>[[Q10-P#!A+]V&HIX3^(CS+]\;$-5+A]'#"UQ)
MD]LY6W%FE.Q^>=R L/^/JV,8DS6LX<9 J,@RS G3D'*>3U4)L#&P@<YM5D<?
M5M(8K"#GA%5@0 VG9YYE.!8.H@VO<R##<K/42;>C;-39P/H1:MY-=TW9F%94
M#^,[OJ.QW<7:]XLIZZ>X[>BFEV*^4'#Z@LY@-Q!@"M5JVC,2*!IU%+4Q!?Q%
M>KJN#37N<_1;B<P(HE382Y^/ (@-?&#+P3!F[)+VN,#BL_-%>LVA?=P>VL>;
M']H)81TW'N-=$9A8Z*<.[VL%;WQXA[.[O"UR +X%N.J@J!V^=UQW *,9Q#8V
M!Y_:3ISBPT8'^8TV-A0L'W(-,Q]4RQ_M7Y=O0#8[OA6*3W%F!;CY0<LOV[[J
MY+P8MI0A^\C+!?E"/S]DKSNR91T>HA8/T5H\X#9,U@!@C5ILMDUSB"W0_)K?
M/P64M2.N!DK64X5W5)'/T=FAB F]#+]WU@0.PHYN(*FWNQ3Z 59.Z/H3C"L@
MD'RHE>!E\0<TMC5OI1+%M&9GRRAZ(FHQ*0R[H#AJE\#'*QML(&GAAZ,&+F-V
MV7F%&S%_?WG'\GQ8NQ$32:3*2JYU,8$HB5$>=X\^VPOL/@?/7&TP]H;I?K/>
MZDX_F,Y$R>JON0%ETT&N>[?BVI&;>X=LH12X^#6PI)";B,2;I+V0EC92G,31
ME<87X17W3&C E((J-$X:^[G[S7YJLQN%K^9?&_=#>WN&MTM6P02=TISJ7^!@
MNQF 38"'-O.[JVV\0P?W5O*>BVD3O96+ 2]A5W421X?H1RZ&IN1.6##)RYZ'
M^I 5+4UP!=THY'\U-P/R4G)H:J]"Z8H4IF.]'&YTD;#2RRF !$\MUE[C+H]C
MM,3._.S9S6.?R"%.SMW2RPD2V;?7/J0ZR;,GL+],Y8U./U^1R;$]6(2]11E
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M*>;GG9%S.AZ0O!'X%HN5VAHS6LDLSQ_IY6MTWK$)D$A$J,D"Q^-)7(HD(4.
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MPM(JG8+2R9 ,+=(9=-89.6:Q8L9GIB' 23M!L2OV(<[ V22!0W7,Q',(759
M55$&&$_S,M/JZ'0G,HK=EEIIGD5QMF WI?'UW507K(^>A$2S8&,.G"%L:/9)
MA#4@QP"RF>-9/CM@CNU8_: QNT"&R81C.9AT ]_J><VD>!8RC(D1'US+.X+
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M%H#NFGJWL:KQC?2H++5EOZSH'T3M!.B^5)2F?N,,##_KZA]02P,$%     @
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MDH.@Y-"C138)Y_AA(G6%#R>CC)RL'M!1(KEW,EJXDS#<7Q#QB<MLC"/FSD=
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MR]&P+UV>RY@Y*P>0X<A<%WBV::7EOAR+^Q+(]]E!D.RLNCH:>R.4M % #@T
M[5[^??&HR[QQBY)[G2_#_)>6__+=^"\M_^6(_)?'^2]=_DOOGKZT 4"^,@!(
MZ)$9Y4X-5R:Q?Q);_,NQ\"]=LD?N XJNR#]XO:<HQWN,$B2[8W-PQB\M_.6(
M\)?'X1^4''JT\)=O@;]TH0Y.Q=C=^,.>"*\L^-5HX%?0+GWDW+8!9(12WQ,=
MRG)?C<5]!?!<26<V C*&B2]I4A;[:BCVK[=YNDPW238LY5<6^>K=D*\L\M6(
MR%?'D1^4''JTO%>OY+T"$GDIW,D+R+#WIIFRO%=C\5X!F;QS%T(!-W ]%BWM
MU6BT5T?R^,[D8-JKWD/S8SXU/^"Q^<&T5Y;VZBVT5T *+Z4[$0$9P;Z)&%O>
MQZ/Q/G:?O^'/=_5C%_;,R_K8LCX>B_5=10?O!6'E#"<@D\K)\&>]-]*:UP&O
MD_+>+%.4Z3M3+)HVV6"Y>\-N]Z$N-NU+:K=%71?K]O!!)RM=-@+S_5U1U-\_
M-.^][=]S//\_4$L#!!0    (  B(5%.8-U.5 0,  'D(   9    >&PO=V]R
M:W-H965T<R]S:&5E=#(X+GAM;*U6VT[C,!#]E5&T#R MS:U7U%8J!;25M@BU
MP#Z[S;2Q<.QB.RWLUZ_MA% @K="*/C2^G3-G9N*9]'="/JH44<-SQK@:>*G6
MFW/?5\L4,Z(:8H/<[*R$S(@V4[GVU48B21PH8WX4!&T_(Y1[P[Y;NY7#OL@U
MHQQO):@\RXA\N4 F=@,O]%X79G2=:KO@#_L;LL8YZOO-K30SOV)):(9<4<%!
MXFK@C<+S<>@ [L0#Q9W:&X-U92'$HYU,DH$76$7(<*DM!3&/+8Z1,<MD=#R5
MI%YETP+WQZ_LU\YYX\R"*!P+]H<F.AUX70\27)&<Z9G8_<+2H9;E6PJFW#_L
MRK.!!\M<:9&58*,@H[QXDN<R$'L PU,/B$I ]!'0/ "(2T#L'"V4.;<NB2;#
MOA0[D/:T8;,#%QN'-MY0;M,XU]+L4H/3P^O)S>AF/!G]ALG-_&YV/[VZN9O#
M&<R+M()8P5AP+4VX<\)@2G0NJ::HW Y1*5P]Y71+&'*M@/ $1EM"&5DP/#-Q
M/IN;'9CP+2J=N2,GEZC- 75JC-S/+^'DQRG\ ,IA2ADSB55]7QN_K#I_6?IP
M4?@0'?"A!U,C,55PQ1-,WN-]$X\J*-%K4"ZBHX1SW#0@#GY"%$1!C9[QU^'A
M$3EQE:/8\<4'^$:9D)K^Q<2D0NDCA,V*L.D(FP<(71;1!IVA4J!3PD%PA!<D
MLL[=@JWMV&Q=V ZC3MQJQ'U_6Z.B5:EH?5&%M:T%K,R%=AKJWH%Q0=;9$]$,
MHU:C72^B78EH'Q5Q)S1A=>;:G\RUN^V@T:LWUZG,=8ZF\II0"0^$Y7@DC=V*
MK/NM:>Q^<BGJ-,-&J]ZE7J6B]YUI[-6D,3XH(@S>ZECP?XDL<;UWF>P<>'?#
MO;H9'K4W0\+<G:15<8.U:9NFPC&A%*K3VD(6?KI*W48<[/_"#\K\O>*>H5R[
MGJ=@*7*NBSI?K59]=>2ZB?]VO&C*4R+75B'#E8$&C8ZY4[+H<\5$BXUK%0NA
M3>-QP]1\&Z"T!\S^2@C].K$&JJ^-X3]02P,$%     @ "(A44[YMQCB,!
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M(PDL62;LO=J^@R*@CM,7*V'R7[(M9 ./Q)FQ*BW Z$'*Y>Z??2D240/0]A%
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M:I//08_*XE25/ZYQ\ 7M!/#]4BG[O'"C53E*C_X'4$L#!!0    (  B(5%,
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MPQ65-3?P$R'2&,#\2@A][)A[JO@M=?\!4$L#!!0    (  B(5%/Z61.M#@,
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MB#HU4:<@ZIXA6K-G^@PY^\$V MOJ6\K[A=SN\J=QO^=^]AL_JNM3LZ2GBN[
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M8$&R',"_7Z8I>[_)&ZC?X0S^!U!+ P04    "  (B%13%Y2Q4$T#  !*"@
M&0   'AL+W=O<FMS:&5E=',O<VAE970S."YX;6S-5EMOVC 4_BM'T1XVJ24W
M+J4") A,0UI;1NCV,.W!) :L.79FF]+NU\]V0D;;E*%N#^.!V"?G.Y?/QR>G
MM^/BN]Q@K. ^HTSVG8U2^:7KRF2#,R0;/,=,OUEQD2&EMV+MREQ@E%I01MW
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MT<,>%D9!OU]QKO8;XZ :'P>_ %!+ P04    "  (B%13C9[K"UT"  !.!0
M&0   'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6R-5%%/VS 0_BNGB >0MB1-
M D.HC512IE4:A34M>YCVX#:7QL*),]MMX-_/=D)6H$5[:7SG^^Z^^Z[G8</%
MHRP0%3R5K)(CIU"JOO(\N2ZP)-+E-5;Z)N>B)$J;8N/)6B#)+*AD7N#[%UY)
M:.7$0^N[%_&0;Q6C%=X+D-NR).+Y&AEO1L[ >7',Z:90QN'%PYIL,$6UK.^%
MMKP^2T9+K"3E%0C,1\YX<)5$)MX&/%!LY-X93"<KSA^-,<U&CF\((<.U,AF(
M_NPP0<9,(DWC3Y?3Z4L:X/[Y)?M7V[ON944D)IS]I)DJ1LZE QGF9,O4G#??
ML.OGW.1;<R;M+S1=K._ >BL5+SNP9E#2JOV2ITZ'/< @.@((.D#POX"P X2V
MT9:9;6M"%(F'@C<@3+3.9@Y6&XO6W=#*3#%50M]2C5/Q_.;A9K:\@?%L LG=
M;#$?)PL8)S^6TW2ZF-[-M#-=I/ 9TG;,P'-(>*6$UA_&4J*20*H,OE.RHHPJ
MBA).)Z@(9?),PY;I!$Y/SN $: 6WE#$].SGTE*9N"'CKCN9U2S,X0C/%VH70
M_P2!'PP.P)./X1-<:_C POW7<$\+UJL6]*H%-E]X3#7<8;5%R 4O_\G14%5
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MT++*+#L6TT0RGB!!]U-CCM\M'%L'9(COC)YD[1[IH6PY_ZT;J]W4L#4C&M%
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MCNXD48[]<J/XUD[.)5=Z#MOE1I^4((R!?IYQKMXW9AC79^_P+U!+ P04
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MWW)(0J3A]5X$UU(;R)MS&0L9LU+J6<M]>ANN@NB-O+::@$QOZUZ=V5H.A&#
MHUW!ZG-U,&K?(L 8\VCM3C9=4E--CM$E[\6&IT7HIGR3RV;I@<I%KZ(D PGH
MHK+9>)BH%J$5JG$367OR  ;9[;GKH*YY(S5O]-A0B!-Y/1:II/F<#<-8<)D
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MI:UFV7Z78+]+6+L<U$6NMRW8ZRWX\@ESM>5 P4FL/C&O:C55)XQ2Q,76VBV
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MM2?">E,T3(Y!ZZ*T%.1=+,4) K!FOY0$SS7MV4ZU-CA8[W">68L!_T'D/-8
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M-+LMR%XXV:CC\ OAXG"M'E<8A9A* _%]00@_OD@'Q9W-\#]02P,$%     @
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M5VH>]_!I0H0&P/LMAVI8#;2#^F-G]@]02P,$%     @ "(A44^AQTQN; @
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MSB4G'FP8?Q0^@$3/ 0W%T/*EC$YL6\Q]"+ X9A&$ZLZ2\0!+M>0K6T0<\,*
M FI[CM.Q TQ":S0PUZ9\-&"QI"2$*4<B#@+,7\Z LLW0<JWMA5NR\J6^8(\&
M$5[!'<AOT92KE9VQ+$@ H2 L1!R60^O4/1F[;0TP3]P3V(C".=)29HP]ZL7E
M8F@YVB.@,)>: JO#&L9 J692?CREI%9F4P.+YUOVB1&OQ,RP@#&C#V0A_:'5
ML] "ECBF\I9MOD JR#@X9U28?[1)GW4L-(^%9$$*5AX$)$R.^#D-1 '0Z50
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M)5&4)'X$,+^"*,(0>!MQ!%, &C DBJI]<&\_"M?[5+CY_VOX"U!+ P04
M"  (B%13EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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MWQ[=/6],U1[S6?]+S>P-4$L! A0#%     @ "(A44P=!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  (
MB%13H;O82NP    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    "  (B%13F5R<(Q &  "<)P  $P
M@ '* 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (  B(5%-N0R4F
M6 4  '@5   8              " @0L(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    "  (B%13DW@RT7T&  "$&0  &
M@(&9#0  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ "(A4
M4V?RG7K7 @  R0D  !@              ("!3!0  'AL+W=O<FMS:&5E=',O
M<VAE970S+GAM;%!+ 0(4 Q0    (  B(5%.#"49](@<  !,A   8
M      " @5D7  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M"  (B%13;G^EK#8'  !^'   &               @(&Q'@  >&PO=V]R:W-H
M965T<R]S:&5E=#4N>&UL4$L! A0#%     @ "(A44S<Q7EY+ P  !@<  !@
M             ("!'28  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4
M Q0    (  B(5%.X>++SFPP  %(@   8              " @9XI  !X;"]W
M;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    "  (B%13Y2BFBR0/  #A
M*P  &               @(%O-@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL
M4$L! A0#%     @ "(A44X9BPP3@!   > L  !@              ("!R44
M 'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    (  B(5%,0,DRZ
M^ @  "@7   9              " @=]*  !X;"]W;W)K<VAE971S+W-H965T
M,3 N>&UL4$L! A0#%     @ "(A44UHVE^<^!@  ]@T  !D
M ("!#E0  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    "  (
MB%13@E#P%L %  !$#@  &0              @(&#6@  >&PO=V]R:W-H965T
M<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    (  B(5%/0:<%*ZA    8T   9
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M970Q-RYX;6Q02P$"% ,4    "  (B%139HSU\PT'  !4$0  &0
M    @('SC   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (
M  B(5%-A='J,C@@  #08   9              " @3>4  !X;"]W;W)K<VAE
M971S+W-H965T,3DN>&UL4$L! A0#%     @ "(A44YW( '(Y!0  F@T  !D
M             ("!_)P  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"
M% ,4    "  (B%13DPRZ3YH$  "E#   &0              @(%LH@  >&PO
M=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (  B(5%/\DU1$>@0
M %,*   9              " @3VG  !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&UL4$L! A0#%     @ "(A44T$%5#XY!   <0H  !D              ("!
M[JL  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    "  (B%13
M:MDP%LP'  !>'@  &0              @(%>L   >&PO=V]R:W-H965T<R]S
M:&5E=#(T+GAM;%!+ 0(4 Q0    (  B(5%.U<?$P% 8  'X0   9
M      " @6&X  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%
M  @ "(A44Z>=O/I0 P  90<  !D              ("!K+X  'AL+W=O<FMS
M:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    "  (B%13IC0NTZ8(  #S.
M&0              @($SP@  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+
M 0(4 Q0    (  B(5%.8-U.5 0,  'D(   9              " @1#+  !X
M;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ "(A44[YMQCB,
M!   OA   !D              ("!2,X  'AL+W=O<FMS:&5E=',O<VAE970R
M.2YX;6Q02P$"% ,4    "  (B%137T@?19X#  !T"P  &0
M@($+TP  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (  B(
M5%//M'UHA@,  %8/   9              " @>#6  !X;"]W;W)K<VAE971S
M+W-H965T,S$N>&UL4$L! A0#%     @ "(A44P"4?8/  @  H@8  !D
M         ("!G=H  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4
M    "  (B%13^ED3K0X#  #"!P  &0              @(&4W0  >&PO=V]R
M:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    (  B(5%/"]?B/%P,  ,P'
M   9              " @=G@  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL
M4$L! A0#%     @ "(A44^->S(W- @  Y 8  !D              ("!)^0
M 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    "  (B%13F(0E
M0"D#  "(!P  &0              @($KYP  >&PO=V]R:W-H965T<R]S:&5E
M=#,V+GAM;%!+ 0(4 Q0    (  B(5%,$S4,Z0@4  ,\9   9
M  " @8OJ  !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @
M"(A44Q>4L5!- P  2@H  !D              ("!!/   'AL+W=O<FMS:&5E
M=',O<VAE970S."YX;6Q02P$"% ,4    "  (B%13C9[K"UT"  !.!0  &0
M            @(&(\P  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4
M Q0    (  B(5%.Z>@,\T (  ,<'   9              " @1SV  !X;"]W
M;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ "(A44WOYN-@4 P
MZ0D  !D              ("!(_D  'AL+W=O<FMS:&5E=',O<VAE970T,2YX
M;6Q02P$"% ,4    "  (B%13[+7J5'P"  "'!@  &0              @(%N
M_   >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    (  B(5%,,
M/B,@" 0  /82   9              " @2'_  !X;"]W;W)K<VAE971S+W-H
M965T-#,N>&UL4$L! A0#%     @ "(A44Y*$>H@2 @  > 4  !D
M     ("!8 ,! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  B(5%/]:NV^7P,    ,   9              "
M@8H9 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ "(A4
M4PQ6UN!S @  VP4  !D              ("!(!T! 'AL+W=O<FMS:&5E=',O
M<VAE970U,"YX;6Q02P$"% ,4    "  (B%13"I;:%%H&   9(0  &0
M        @('*'P$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0
M   (  B(5%.D'7VI5P0  !,0   9              " @5LF 0!X;"]W;W)K
M<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ "(A44Y"F/Q)" P  & L
M !D              ("!Z2H! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q0
M2P$"% ,4    "  (B%1390X/[30#   R"@  &0              @(%B+@$
M>&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    (  B(5%.5\TVK
M= 0  *T3   9              " @<TQ 0!X;"]W;W)K<VAE971S+W-H965T
M-34N>&UL4$L! A0#%     @ "(A44Q?'G2I'!   OQ$  !D
M ("!>#8! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    "  (
MB%13LI-;C;4#  #^#   &0              @('V.@$ >&PO=V]R:W-H965T
M<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    (  B(5%-TBNW,YP,  /@,   9
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M 0!X;"]S='EL97,N>&UL4$L! A0#%     @ "(A44Y>*NQS     $P(   L
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64$L%!@    !$ $0 DQ(  -56 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>230</ContextCount>
  <ElementCount>373</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>52</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - DESCRIPTION OF THE BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS</Role>
      <ShortName>DESCRIPTION OF THE BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2104103 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2111104 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION</Role>
      <ShortName>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2118105 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS</Role>
      <ShortName>REVENUE AND CONTRACT ACQUISITION COSTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2124106 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2130107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2135108 - Disclosure - CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/CONTINGENCIES</Role>
      <ShortName>CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2136109 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2142110 - Disclosure - SHARE-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION</Role>
      <ShortName>SHARE-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2149111 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2151112 - Disclosure - NET INCOME PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE</Role>
      <ShortName>NET INCOME PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2312302 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables</Role>
      <ShortName>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2319303 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables</Role>
      <ShortName>REVENUE AND CONTRACT ACQUISITION COSTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2325304 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/LEASES</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2331305 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2337306 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2343307 - Disclosure - SHARE-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables</Role>
      <ShortName>SHARE-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2352308 - Disclosure - NET INCOME PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables</Role>
      <ShortName>NET INCOME PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2406401 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Cash and Available-For-Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Summary of Cash and Available-For-Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Equity Investment Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Summary of Equity Investment Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - FINANCIAL INSTRUMENTS - Derivative Instruments Used to Hedge against Balance Sheet Foreign Currency Exposures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Derivative Instruments Used to Hedge against Balance Sheet Foreign Currency Exposures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2410405 - Disclosure - FINANCIAL INSTRUMENTS - Gross Notional Amounts for Outstanding Derivatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Gross Notional Amounts for Outstanding Derivatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails</Role>
      <ShortName>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Prepaids and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails</Role>
      <ShortName>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Prepaids and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2415408 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Accrued Liabilities - Short-term (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails</Role>
      <ShortName>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Accrued Liabilities - Short-term (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2416409 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Long-term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails</Role>
      <ShortName>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Long-term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2417410 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails</Role>
      <ShortName>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2420411 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Revenue Disaggregated by Types and Geography (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails</Role>
      <ShortName>REVENUE AND CONTRACT ACQUISITION COSTS - Revenue Disaggregated by Types and Geography (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2421412 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails</Role>
      <ShortName>REVENUE AND CONTRACT ACQUISITION COSTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2422413 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Summary of Contract Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails</Role>
      <ShortName>REVENUE AND CONTRACT ACQUISITION COSTS - Summary of Contract Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2423414 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Sales-type and Operating Lease Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails</Role>
      <ShortName>REVENUE AND CONTRACT ACQUISITION COSTS - Sales-type and Operating Lease Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2426415 - Disclosure - LEASES - Lease Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails</Role>
      <ShortName>LEASES - Lease Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2427416 - Disclosure - LEASES - Schedule of Contractual Maturities of Gross Lease Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails</Role>
      <ShortName>LEASES - Schedule of Contractual Maturities of Gross Lease Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2428417 - Disclosure - LEASES - Credit Quality Indicator (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails</Role>
      <ShortName>LEASES - Credit Quality Indicator (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2429418 - Disclosure - LEASES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails</Role>
      <ShortName>LEASES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2432419 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Summary of Changes in Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Schedule of Summary of Changes in Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2433420 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2434421 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule Of Estimated Future Amortization Expense Of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Schedule Of Estimated Future Amortization Expense Of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2438422 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Stockholders Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Schedule of Stockholders Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2439423 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Share Repurchase Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Schedule of Share Repurchase Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2440424 - Disclosure - STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2441425 - Disclosure - STOCKHOLDERS' EQUITY - Components of Accumulated Other Comprehensive Income, Net of Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Components of Accumulated Other Comprehensive Income, Net of Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2444426 - Disclosure - SHARE-BASED COMPENSATION - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2445427 - Disclosure - SHARE-BASED COMPENSATION - Summary of Stock Option Activity Under All Stock Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Summary of Stock Option Activity Under All Stock Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2446428 - Disclosure - SHARE-BASED COMPENSATION - Summary of RSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Summary of RSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2447429 - Disclosure - SHARE-BASED COMPENSATION - Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2448430 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Estimated Fair Value of Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Schedule of Estimated Fair Value of Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2450431 - Disclosure - INCOME TAXES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails</Role>
      <ShortName>INCOME TAXES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2453432 - Disclosure - NET INCOME PER SHARE - Computation of Basic and Diluted Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails</Role>
      <ShortName>NET INCOME PER SHARE - Computation of Basic and Diluted Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2454433 - Disclosure - NET INCOME PER SHARE - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails</Role>
      <ShortName>NET INCOME PER SHARE - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="isrg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - isrg-20210930.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - isrg-20210930.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="isrg-20210930.htm">isrg-20210930.htm</File>
    <File>ex-311q321.htm</File>
    <File>ex-312q321.htm</File>
    <File>ex-321q321.htm</File>
    <File>ex-322q321.htm</File>
    <File>exhibit31-arcertificateofi.htm</File>
    <File>isrg-20210930.xsd</File>
    <File>isrg-20210930_cal.xml</File>
    <File>isrg-20210930_def.xml</File>
    <File>isrg-20210930_lab.xml</File>
    <File>isrg-20210930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>79
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "isrg-20210930.htm": {
   "axisCustom": 1,
   "axisStandard": 18,
   "contextCount": 230,
   "dts": {
    "calculationLink": {
     "local": [
      "isrg-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "isrg-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "isrg-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "isrg-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "isrg-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "isrg-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 472,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 5
   },
   "keyCustom": 19,
   "keyStandard": 354,
   "memberCustom": 14,
   "memberStandard": 38,
   "nsprefix": "isrg",
   "nsuri": "http://www.intuitivesurgical.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.intuitivesurgical.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118105 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS",
     "role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS",
     "shortName": "REVENUE AND CONTRACT ACQUISITION COSTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorSalesTypeLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124106 - Disclosure - LEASES",
     "role": "http://www.intuitivesurgical.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorSalesTypeLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "role": "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135108 - Disclosure - CONTINGENCIES",
     "role": "http://www.intuitivesurgical.com/role/CONTINGENCIES",
     "shortName": "CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136109 - Disclosure - STOCKHOLDERS' EQUITY",
     "role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142110 - Disclosure - SHARE-BASED COMPENSATION",
     "role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION",
     "shortName": "SHARE-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2149111 - Disclosure - INCOME TAXES",
     "role": "http://www.intuitivesurgical.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151112 - Disclosure - NET INCOME PER SHARE",
     "role": "http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE",
     "shortName": "NET INCOME PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "role": "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312302 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION (Tables)",
     "role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables",
     "shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319303 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS (Tables)",
     "role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables",
     "shortName": "REVENUE AND CONTRACT ACQUISITION COSTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325304 - Disclosure - LEASES (Tables)",
     "role": "http://www.intuitivesurgical.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331305 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "role": "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2337306 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2343307 - Disclosure - SHARE-BASED COMPENSATION (Tables)",
     "role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables",
     "shortName": "SHARE-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2352308 - Disclosure - NET INCOME PER SHARE (Tables)",
     "role": "http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables",
     "shortName": "NET INCOME PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406401 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Cash and Available-For-Sale Securities (Details)",
     "role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Summary of Cash and Available-For-Sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AvailableForSaleSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments (Details)",
     "role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Equity Investment Activity (Details)",
     "role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Summary of Equity Investment Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i319aeb288bcf4439b7aa385bd35027af_D20210901-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - FINANCIAL INSTRUMENTS - Derivative Instruments Used to Hedge against Balance Sheet Foreign Currency Exposures (Details)",
     "role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Derivative Instruments Used to Hedge against Balance Sheet Foreign Currency Exposures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "id0fa4f45ec164a5ebc9a515e1b8f57b3_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410405 - Disclosure - FINANCIAL INSTRUMENTS - Gross Notional Amounts for Outstanding Derivatives (Details)",
     "role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Gross Notional Amounts for Outstanding Derivatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "id0fa4f45ec164a5ebc9a515e1b8f57b3_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Inventory (Details)",
     "role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails",
     "shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Prepaids and Other Current Assets (Details)",
     "role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails",
     "shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Prepaids and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TaxesPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415408 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Accrued Liabilities - Short-term (Details)",
     "role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails",
     "shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Accrued Liabilities - Short-term (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TaxesPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416409 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Long-term Liabilities (Details)",
     "role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails",
     "shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Long-term Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTransfersAndChanges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417410 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Supplemental Cash Flow Information (Details)",
     "role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails",
     "shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTransfersAndChanges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420411 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Revenue Disaggregated by Types and Geography (Details)",
     "role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails",
     "shortName": "REVENUE AND CONTRACT ACQUISITION COSTS - Revenue Disaggregated by Types and Geography (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1b1f121a531948669a508b4480804ca0_D20210701-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421412 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Additional Information (Details)",
     "role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails",
     "shortName": "REVENUE AND CONTRACT ACQUISITION COSTS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422413 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Summary of Contract Assets and Liabilities (Details)",
     "role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails",
     "shortName": "REVENUE AND CONTRACT ACQUISITION COSTS - Summary of Contract Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)",
     "role": "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SalesTypeLeaseLeaseIncomeTableTextBlock",
       "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeLeaseLeaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423414 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Sales-type and Operating Lease Revenue (Details)",
     "role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails",
     "shortName": "REVENUE AND CONTRACT ACQUISITION COSTS - Sales-type and Operating Lease Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SalesTypeLeaseLeaseIncomeTableTextBlock",
       "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeLeaseLeaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "isrg:SalesTypeLeaseGrossInvestmentInLease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426415 - Disclosure - LEASES - Lease Receivables (Details)",
     "role": "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails",
     "shortName": "LEASES - Lease Receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "isrg:SalesTypeLeaseGrossInvestmentInLease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427416 - Disclosure - LEASES - Schedule of Contractual Maturities of Gross Lease Receivables (Details)",
     "role": "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails",
     "shortName": "LEASES - Schedule of Contractual Maturities of Gross Lease Receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428417 - Disclosure - LEASES - Credit Quality Indicator (Details)",
     "role": "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails",
     "shortName": "LEASES - Credit Quality Indicator (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i77ba4e1aaa0a40daa59040ab5003d99d_I20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorSalesTypeLeaseTermOfContract1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429418 - Disclosure - LEASES - Additional Information (Details)",
     "role": "http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails",
     "shortName": "LEASES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i77ba4e1aaa0a40daa59040ab5003d99d_I20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorSalesTypeLeaseTermOfContract1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432419 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Summary of Changes in Goodwill (Details)",
     "role": "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule of Summary of Changes in Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433420 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details)",
     "role": "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434421 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule Of Estimated Future Amortization Expense Of Intangible Assets (Details)",
     "role": "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule Of Estimated Future Amortization Expense Of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i1799f673ba7c41f0a5ee2d85aab09d18_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438422 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Stockholders Equity (Details)",
     "role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Schedule of Stockholders Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "iecbbf0bac773402585e5625778664eaf_I20210630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "if3b324c46fd24271ba5dff8930ae60c4_D20200101-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439423 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Share Repurchase Activities (Details)",
     "role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Schedule of Share Repurchase Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i45ed2df55a904b73a9495b2d3967029c_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "ibbc28f1ab9984d34933140b676cdeda5_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440424 - Disclosure - STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)",
     "role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "ibbc28f1ab9984d34933140b676cdeda5_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "iecbbf0bac773402585e5625778664eaf_I20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441425 - Disclosure - STOCKHOLDERS' EQUITY - Components of Accumulated Other Comprehensive Income, Net of Tax (Details)",
     "role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Components of Accumulated Other Comprehensive Income, Net of Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "iecbbf0bac773402585e5625778664eaf_I20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i3a351862876548c3806015af800a7f8b_I20210430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "isrg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444426 - Disclosure - SHARE-BASED COMPENSATION - Additional Information (Details)",
     "role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
     "shortName": "SHARE-BASED COMPENSATION - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i3a351862876548c3806015af800a7f8b_I20210430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "isrg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445427 - Disclosure - SHARE-BASED COMPENSATION - Summary of Stock Option Activity Under All Stock Plans (Details)",
     "role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails",
     "shortName": "SHARE-BASED COMPENSATION - Summary of Stock Option Activity Under All Stock Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i55df7dc07b7448c9bfdcf8c0fa67c396_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i027fee4566074a4f9475d1aa2d3fbb42_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446428 - Disclosure - SHARE-BASED COMPENSATION - Summary of RSU Activity (Details)",
     "role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails",
     "shortName": "SHARE-BASED COMPENSATION - Summary of RSU Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i027fee4566074a4f9475d1aa2d3fbb42_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447429 - Disclosure - SHARE-BASED COMPENSATION - Stock-Based Compensation Expense (Details)",
     "role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails",
     "shortName": "SHARE-BASED COMPENSATION - Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i39d2400983df44e786e5f043ff29f072_D20210701-20210930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448430 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Estimated Fair Value of Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions (Details)",
     "role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails",
     "shortName": "SHARE-BASED COMPENSATION - Schedule of Estimated Fair Value of Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i39d2400983df44e786e5f043ff29f072_D20210701-20210930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450431 - Disclosure - INCOME TAXES - Additional Information (Details)",
     "role": "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails",
     "shortName": "INCOME TAXES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453432 - Disclosure - NET INCOME PER SHARE - Computation of Basic and Diluted Net Income Per Share (Details)",
     "role": "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails",
     "shortName": "NET INCOME PER SHARE - Computation of Basic and Diluted Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454433 - Disclosure - NET INCOME PER SHARE - Additional Information (Details)",
     "role": "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails",
     "shortName": "NET INCOME PER SHARE - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i76cf319545da43fc9f4aacb7ee3858ba_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - DESCRIPTION OF THE BUSINESS",
     "role": "http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS",
     "shortName": "DESCRIPTION OF THE BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104103 - Disclosure - FINANCIAL INSTRUMENTS",
     "role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111104 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION",
     "role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION",
     "shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "i24def724605546e8b248a658364e4bd2_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - isrg-20210930.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - isrg-20210930.htm",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210930.htm",
      "contextRef": "ie6cfe02b5ba04eeea251a8434b14df93_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 52,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "State or Other Jurisdiction of Incorporation or Organization"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "I.R.S. Employer Identification No."
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of each class"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol(s)"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "isrg_A2010IncentiveAwardPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2010 Incentive Award Plan",
        "label": "2010 Incentive Award Plan [Member]",
        "terseLabel": "2010 Incentive Award Plan"
       }
      }
     },
     "localname": "A2010IncentiveAwardPlanMember",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss), Available-For-Sale Securities Adjustment, Net of Tax [Abstract]",
        "label": "Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax [Abstract]",
        "terseLabel": "Unrealized Gains (Losses)\u00a0on Available-for-Sale Securities"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax [Abstract]",
        "label": "Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax [Abstract]",
        "terseLabel": "Gains\u00a0(Losses) on\u00a0Hedge Instruments"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "isrg_AccumulatedOtherComprehensiveIncomeRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income [Roll Forward]",
        "label": "Accumulated Other Comprehensive Income [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income [Roll Forward]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeRollForward",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Securities Debt Maturities Fair Value Total",
        "label": "Available For Sale Securities Debt Maturities Fair Value Total",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Present Value of Future Cash Payments",
        "label": "Business Combination, Consideration Transferred, Present Value of Future Cash Payments",
        "terseLabel": "Deferred payments and contingent consideration related to business combinations and asset acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and Cash Equivalents and Debt Securities, Available-for-sale, Amortized Cost",
        "label": "Cash and Cash Equivalents and Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Total assets measured at fair value, Amortized Cost"
       }
      }
     },
     "localname": "CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1": {
       "order": 3.0,
       "parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and Cash Equivalents and Debt Securities, Available-for-sale, Fair Value",
        "label": "Cash and Cash Equivalents and Debt Securities, Available-for-sale, Fair Value",
        "totalLabel": "Total assets measured at fair value, Fair Value"
       }
      }
     },
     "localname": "CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_CollarContractMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collar Contract",
        "label": "Collar Contract [Member]",
        "terseLabel": "Collar Contract"
       }
      }
     },
     "localname": "CollarContractMember",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_CommonStockRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Repurchase Program [Member]",
        "label": "Common Stock Repurchase Program [Member]",
        "terseLabel": "Repurchase Program"
       }
      }
     },
     "localname": "CommonStockRepurchaseProgramMember",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_ConsolidatingReportingAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidating Reporting [Axis]",
        "label": "Consolidating Reporting [Axis]",
        "terseLabel": "Consolidating Reporting [Axis]"
       }
      }
     },
     "localname": "ConsolidatingReportingAxis",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "isrg_ConsolidatingReportingDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidating Reporting [Domain]",
        "label": "Consolidating Reporting [Domain]",
        "terseLabel": "Consolidating Reporting [Domain]"
       }
      }
     },
     "localname": "ConsolidatingReportingDomain",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_CostOfSalesProductMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Of Sales Product [Member]",
        "label": "Cost Of Sales Product [Member]",
        "terseLabel": "Cost of sales - products"
       }
      }
     },
     "localname": "CostOfSalesProductMember",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_CostOfSalesServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Of Sales Service [Member]",
        "label": "Cost Of Sales Service [Member]",
        "terseLabel": "Cost of sales - services"
       }
      }
     },
     "localname": "CostOfSalesServiceMember",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_DeferredPurchaseConsiderationPaymentsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Purchase Consideration Payments, Current",
        "label": "Deferred Purchase Consideration Payments, Current",
        "terseLabel": "Current portion of deferred purchase consideration payments"
       }
      }
     },
     "localname": "DeferredPurchaseConsiderationPaymentsCurrent",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Sales, Purchases and Other Adjustments",
        "label": "Equity Securities, FV-NI, Sales, Purchases and Other Adjustments",
        "terseLabel": "Sales/Purchases/Others, Level 1"
       }
      }
     },
     "localname": "EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities without Readily Determinable Fair Value, Sales, Purchases and Other Adjustments",
        "label": "Equity Securities without Readily Determinable Fair Value, Sales, Purchases and Other Adjustments",
        "terseLabel": "Sales/Purchases/Others, Level 2"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss)",
        "label": "Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss)",
        "terseLabel": "Changes in fair value, Level 2"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss), Portion Attributable to Investment in Preferred Shares",
        "label": "Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss), Portion Attributable to Investment in Preferred Shares",
        "terseLabel": "Equity investments without readily determinable value, portion attributable to investment in preferred shares"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLossPortionAttributableToInvestmentInPreferredShares",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Amortization Expense, after Year Four",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, after Year Four",
        "terseLabel": "2026 and thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_HighMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "High",
        "label": "High [Member]",
        "terseLabel": "High"
       }
      }
     },
     "localname": "HighMember",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_InstrumentsandAccessoriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instruments and Accessories [Member]",
        "label": "Instruments and Accessories [Member]",
        "terseLabel": "Instruments and accessories"
       }
      }
     },
     "localname": "InstrumentsandAccessoriesMember",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_IntangibleAndOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges and other non-current assets.",
        "label": "Intangible And Other Assets",
        "terseLabel": "Intangible and other assets, net"
       }
      }
     },
     "localname": "IntangibleAndOtherAssets",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_IntangibleAndOtherAssetsNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible and Other Assets, Net",
        "label": "Intangible and Other Assets, Net [Member]",
        "terseLabel": "Intangible and other assets, net"
       }
      }
     },
     "localname": "IntangibleAndOtherAssetsNetMember",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessor, Sales-type Lease, Lease Income",
        "label": "Lessor, Sales-type Lease, Lease Income [Table Text Block]",
        "terseLabel": "Schedule of Lease Receivables"
       }
      }
     },
     "localname": "LessorSalesTypeLeaseLeaseIncomeTableTextBlock",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "isrg_LowMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Low",
        "label": "Low [Member]",
        "terseLabel": "Low"
       }
      }
     },
     "localname": "LowMember",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_ModerateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Moderate",
        "label": "Moderate [Member]",
        "terseLabel": "Moderate"
       }
      }
     },
     "localname": "ModerateMember",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Before Reclassification Adjustments, Net of Tax",
        "label": "Other Comprehensive Income Loss Before Reclassification Adjustments Net Of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_ResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development [Member]",
        "label": "Research And Development [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentMember",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Year Five and Thereafter",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Year Five and Thereafter",
        "terseLabel": "2026 and thereafter"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_SalesTypeLeaseGrossInvestmentInLease": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales-type Lease, Gross Investment in Lease",
        "label": "Sales-type Lease, Gross Investment in Lease",
        "terseLabel": "Gross lease receivables"
       }
      }
     },
     "localname": "SalesTypeLeaseGrossInvestmentInLease",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales-type Lease, Net Investment in Lease, Current",
        "label": "Sales-type Lease, Net Investment in Lease, Current",
        "verboseLabel": "Net investment in sales-type leases \u2013 short-term"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseCurrent",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_SalestypeLeaseDeferredSellingProfit": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales-type Lease, Deferred Selling Profit",
        "label": "Sales-type Lease, Deferred Selling Profit",
        "negatedLabel": "Unearned income"
       }
      }
     },
     "localname": "SalestypeLeaseDeferredSellingProfit",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_SellingGeneralAndAdministrativeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs related to selling, general and administrative activities.",
        "label": "Selling General And Administrative [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeMember",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_ServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Services [Member]",
        "label": "Services [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServicesMember",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant, Giving Effect to Future Stock Split",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant, Giving Effect to Future Stock Split",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant, Giving Effect to Future Stock Split"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGivingEffectToFutureStockSplit",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted\u00a0Average Exercise\u00a0Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "isrg_StockRepurchaseProgramincreasedtoauthorizedamount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increased to authorized shares repurchase amount for Stock Repurchase Program",
        "label": "Stock Repurchase Program, increased to authorized amount",
        "terseLabel": "Stock repurchase program, increased to authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramincreasedtoauthorizedamount",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_SystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Systems [Member]",
        "label": "Systems [Member]",
        "terseLabel": "Systems"
       }
      }
     },
     "localname": "SystemsMember",
     "nsuri": "http://www.intuitivesurgical.com/20210930",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r0",
      "r122",
      "r127",
      "r133",
      "r199",
      "r367",
      "r368",
      "r369",
      "r392",
      "r393",
      "r454",
      "r455",
      "r456",
      "r457",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Adoption of new accounting standard"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r0",
      "r122",
      "r127",
      "r133",
      "r199",
      "r367",
      "r368",
      "r369",
      "r392",
      "r393",
      "r454",
      "r455",
      "r456",
      "r457",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r0",
      "r122",
      "r127",
      "r133",
      "r199",
      "r367",
      "r368",
      "r369",
      "r392",
      "r393",
      "r454",
      "r455",
      "r456",
      "r457",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r264",
      "r274",
      "r338",
      "r339",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r523",
      "r566",
      "r568",
      "r577",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r264",
      "r274",
      "r338",
      "r339",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r523",
      "r566",
      "r568",
      "r577",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r167",
      "r315",
      "r319",
      "r525",
      "r565",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r167",
      "r315",
      "r319",
      "r525",
      "r565",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r264",
      "r274",
      "r327",
      "r338",
      "r339",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r523",
      "r566",
      "r568",
      "r577",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r264",
      "r274",
      "r327",
      "r338",
      "r339",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r523",
      "r566",
      "r568",
      "r577",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r42",
      "r492"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r5",
      "r23",
      "r170",
      "r171"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Loss (gain) on investments, accretion, and amortization, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r20",
      "r530",
      "r550"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Income taxes\u2013long-term"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax": {
     "auth_ref": [
      "r59",
      "r64",
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r62",
      "r66",
      "r336"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r57",
      "r64",
      "r65",
      "r66",
      "r464"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r26",
      "r64",
      "r65",
      "r66",
      "r551",
      "r573",
      "r574"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r63",
      "r66",
      "r76",
      "r77",
      "r78",
      "r119",
      "r120",
      "r121",
      "r423",
      "r569",
      "r570",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r119",
      "r120",
      "r121",
      "r367",
      "r368",
      "r369",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares withheld related to net share settlement of equity awards"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r340",
      "r342",
      "r373",
      "r374"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation expense related to employee stock plans"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r342",
      "r365",
      "r372"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation expense before income taxes"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "totalLabel": "Share-based compensation expense after income taxes"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r103",
      "r232",
      "r237"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Employee stock options excluded from computation of diluted net income per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r113",
      "r156",
      "r159",
      "r165",
      "r198",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r416",
      "r424",
      "r465",
      "r490",
      "r492",
      "r529",
      "r549"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r9",
      "r11",
      "r55",
      "r113",
      "r198",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r416",
      "r424",
      "r465",
      "r490",
      "r492"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r180"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      },
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1": {
       "order": 1.0,
       "parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r181"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      },
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1": {
       "order": 2.0,
       "parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r177",
      "r214"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
       "weight": 1.0
      },
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r185"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Mature in one to five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r182",
      "r185",
      "r547"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Mature in one to five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r184"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Mature in less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r182",
      "r184",
      "r546"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Mature in less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r175",
      "r178",
      "r214",
      "r533"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Available-for-sale Securities [Table Text Block]",
        "terseLabel": "Summary of Cash and Available-For-Sale Securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r344",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]",
        "verboseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails",
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r436",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails",
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r407",
      "r408"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Current portion of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r106",
      "r107",
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Acquisition of property, plant, and equipment in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Capital Leased Assets [Line Items]",
        "terseLabel": "Capital Leased Assets [Line Items]"
       }
      }
     },
     "localname": "CapitalLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalizedContractCostAmortization": {
     "auth_ref": [
      "r224"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Amortization",
        "terseLabel": "Amortization of contract acquisition assets"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r39",
      "r105"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r100",
      "r105",
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash, end of period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r100",
      "r472"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r296",
      "r297",
      "r298",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r49",
      "r249",
      "r534",
      "r556"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Contingencies (Note 8)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r246",
      "r247",
      "r248",
      "r250",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Number of shares reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r119",
      "r120",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r22",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r22",
      "r492"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, 600.0 shares authorized, $0.001 par value, 357.2 shares and 353.1 shares issued and outstanding as of September\u00a030, 2021, and December\u00a031, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r72",
      "r74",
      "r75",
      "r83",
      "r538",
      "r560"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income attributable to Intuitive Surgical, Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r72",
      "r74",
      "r82",
      "r414",
      "r428",
      "r537",
      "r559"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Total comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "terseLabel": "Consolidation and Joint Ventures"
       }
      }
     },
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Summary of Contract Assets and Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r301",
      "r303",
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "terseLabel": "Contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r301",
      "r302",
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r317"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r328",
      "r337",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r86",
      "r525"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Total cost of revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Cost of revenue:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Total cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CumulativeTranslationAdjustmentSummaryRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Cumulative Translation Adjustment Summary [Roll Forward]",
        "terseLabel": "Foreign Currency Translation Gains\u00a0(Losses)"
       }
      }
     },
     "localname": "CumulativeTranslationAdjustmentSummaryRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r179",
      "r214",
      "r217",
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Allowance for Credit Loss",
        "terseLabel": "Allowance for Credit Loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "terseLabel": "Prepaids and Other Current Assets"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r378",
      "r379"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r103",
      "r114",
      "r390",
      "r396",
      "r397",
      "r398"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "terseLabel": "Deferred revenue\u2013long-term"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r103",
      "r241"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation and loss on disposal of property, plant, and equipment"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r438"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Recognized gains/(losses) in Interest and other income, net"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r56",
      "r437",
      "r439",
      "r443",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r430",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amounts of outstanding currency forward contracts"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives Designated as Hedging Instruments"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r315",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Revenue Disaggregated by Types and Geography"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "SHARE-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DistributionRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal rights, generally of a limited duration, to distribute a product or products, often within specific geographic areas or supply channels.",
        "label": "Distribution Rights [Member]",
        "terseLabel": "Distribution rights and others"
       }
      }
     },
     "localname": "DistributionRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share attributable to Intuitive Surgical, Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r84",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r134",
      "r136",
      "r138",
      "r139",
      "r140",
      "r144",
      "r145",
      "r457",
      "r458",
      "r539",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Net income per share attributable to Intuitive Surgical, Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r84",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r136",
      "r138",
      "r139",
      "r140",
      "r144",
      "r145",
      "r457",
      "r458",
      "r539",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r141",
      "r142",
      "r143",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET INCOME PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Income tax expense, percentage of pre-tax income"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r375",
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount",
        "terseLabel": "Excess tax benefits associated with employee equity plans"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "auth_ref": [
      "r375",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent",
        "terseLabel": "Excess tax benefits associated with employee equity plans (in percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and employee benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r365"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Income tax benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "verboseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r76",
      "r77",
      "r78",
      "r119",
      "r120",
      "r121",
      "r124",
      "r130",
      "r132",
      "r148",
      "r199",
      "r288",
      "r295",
      "r367",
      "r368",
      "r369",
      "r392",
      "r393",
      "r456",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r481",
      "r569",
      "r570",
      "r571",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r463"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "periodStartLabel": "Equity investments with readily determinable value beginning balance, Carrying Value",
        "terseLabel": "Equity investments"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r197",
      "r562"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "terseLabel": "Changes in fair value, Level 1"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r194"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "periodStartLabel": "Equity investments without readily determinable value, Carrying Value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r459",
      "r460",
      "r461",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r265",
      "r267",
      "r268",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r337",
      "r460",
      "r496",
      "r497",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value, Hierarchy"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r265",
      "r328",
      "r329",
      "r334",
      "r337",
      "r460",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r265",
      "r267",
      "r268",
      "r328",
      "r329",
      "r334",
      "r337",
      "r460",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r265",
      "r267",
      "r268",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r337",
      "r496",
      "r497",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r187",
      "r188",
      "r194",
      "r195",
      "r196",
      "r201",
      "r204",
      "r205",
      "r206",
      "r207",
      "r215",
      "r216",
      "r219",
      "r220",
      "r266",
      "r286",
      "r453",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r585",
      "r586",
      "r587",
      "r588",
      "r593",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock": {
     "auth_ref": [
      "r172",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financing receivables by credit quality indicator. The credit quality indicator is a statistic about the credit quality of financing receivables. Examples include, but not limited to, consumer credit risk scores, credit-rating-agency ratings, an entity's internal credit risk grades, loan-to-value ratios, collateral, collection experience and other internal metrics.",
        "label": "Financing Receivable Credit Quality Indicators [Table Text Block]",
        "terseLabel": "Amortized Cost Basis by Year of Origination and Credit Quality Indicator"
       }
      }
     },
     "localname": "FinancingReceivableCreditQualityIndicatorsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r236"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r238"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r238"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r238"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r238"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r233",
      "r234",
      "r236",
      "r239",
      "r526",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r236",
      "r527"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r233",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Patents and developed technology"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r236",
      "r526"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails",
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Swiss"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r466",
      "r468",
      "r470",
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "terseLabel": "Foreign exchange gains/(losses) related to balance sheet re-measurement"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfDerivatives": {
     "auth_ref": [
      "r103",
      "r540"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.",
        "label": "Gain (Loss) on Sale of Derivatives",
        "terseLabel": "Gain (loss) on sale of derivatives"
       }
      }
     },
     "localname": "GainLossOnSaleOfDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfEquityInvestments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of equity securities, not separately or otherwise categorized as trading or available-for-sale. This element includes investments in which the entity holds a small ownership stake (generally, less than 20% of the shares outstanding) and cannot exert significant influence.",
        "label": "Gain (Loss) on Sale of Equity Investments",
        "terseLabel": "Gain (loss) on sale of equity investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfEquityInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicDistributionAxis": {
     "auth_ref": [
      "r209",
      "r541",
      "r542",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.",
        "label": "Geographic Distribution [Axis]",
        "terseLabel": "Geographic Distribution [Axis]"
       }
      }
     },
     "localname": "GeographicDistributionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GeographicDistributionDomain": {
     "auth_ref": [
      "r541",
      "r542",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities.",
        "label": "Geographic Distribution [Domain]",
        "terseLabel": "Geographic Distribution [Domain]"
       }
      }
     },
     "localname": "GeographicDistributionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicDistributionDomesticMember": {
     "auth_ref": [
      "r210",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as domestic.",
        "label": "Geographic Distribution, Domestic [Member]",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "GeographicDistributionDomesticMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicDistributionForeignMember": {
     "auth_ref": [
      "r211",
      "r541",
      "r542",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as foreign.",
        "label": "Geographic Distribution, Foreign [Member]",
        "terseLabel": "Outside of U.S. (\u201cOUS\u201d)"
       }
      }
     },
     "localname": "GeographicDistributionForeignMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r225",
      "r226",
      "r492",
      "r528"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, Ending Balance",
        "periodStartLabel": "Goodwill, Beginning Balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisition activity"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r228",
      "r229",
      "r404"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Translation and other"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r85",
      "r113",
      "r156",
      "r158",
      "r161",
      "r164",
      "r166",
      "r198",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r465"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r433",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r156",
      "r158",
      "r161",
      "r164",
      "r166"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r244",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r384",
      "r386",
      "r388",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r115",
      "r382",
      "r387",
      "r389",
      "r394",
      "r399",
      "r401",
      "r402",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r116",
      "r131",
      "r132",
      "r155",
      "r380",
      "r395",
      "r400",
      "r563"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense",
        "verboseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Re-measurement of deferred tax assets"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and employee benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of effects of acquisition:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaids and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InternalCreditAssessmentAxis": {
     "auth_ref": [
      "r172",
      "r207",
      "r212",
      "r213",
      "r251",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by entity-defined rating.",
        "label": "Internal Credit Assessment [Axis]",
        "terseLabel": "Internal Credit Assessment [Axis]"
       }
      }
     },
     "localname": "InternalCreditAssessmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InternalCreditAssessmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity defined credit risk rating.",
        "label": "Internal Credit Assessment [Domain]",
        "terseLabel": "Internal Credit Assessment [Domain]"
       }
      }
     },
     "localname": "InternalCreditAssessmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r31",
      "r221"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r4",
      "r54",
      "r492"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails",
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r33",
      "r221"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r32",
      "r221"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]",
        "terseLabel": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LessorSalesTypeLeaseTermOfContract1": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessor's sales-type lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessor, Sales-type Lease, Term of Contract",
        "terseLabel": "Sales-type leases terms"
       }
      }
     },
     "localname": "LessorSalesTypeLeaseTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails",
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LessorSalesTypeLeasesTextBlock": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of lessor's sales-type leases.",
        "label": "Lessor, Sales-type Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LessorSalesTypeLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r44",
      "r113",
      "r160",
      "r198",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r417",
      "r424",
      "r425",
      "r465",
      "r490",
      "r491"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r29",
      "r113",
      "r198",
      "r465",
      "r492",
      "r532",
      "r554"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r47",
      "r113",
      "r198",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r417",
      "r424",
      "r425",
      "r465",
      "r490",
      "r491",
      "r492"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.",
        "label": "Liabilities, Other than Long-term Debt, Noncurrent",
        "terseLabel": "Other long-term liabilities",
        "totalLabel": "Total other long-term liabilities"
       }
      }
     },
     "localname": "LiabilitiesOtherThanLongtermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails",
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r6",
      "r45"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Short- term Investments",
        "verboseLabel": "Short-term investments"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Long- term Investments",
        "verboseLabel": "Long-term investments"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r53",
      "r113",
      "r198",
      "r253",
      "r257",
      "r258",
      "r259",
      "r262",
      "r263",
      "r465",
      "r531",
      "r553"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interest in joint venture"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MunicipalNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.",
        "label": "Municipal Notes [Member]",
        "terseLabel": "Municipal securities"
       }
      }
     },
     "localname": "MunicipalNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r151",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "DESCRIPTION OF THE BUSINESS"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r100",
      "r101",
      "r104"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r70",
      "r73",
      "r78",
      "r80",
      "r104",
      "r113",
      "r123",
      "r125",
      "r126",
      "r127",
      "r128",
      "r131",
      "r132",
      "r137",
      "r156",
      "r158",
      "r161",
      "r164",
      "r166",
      "r198",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r458",
      "r465",
      "r535",
      "r557"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income attributable to Intuitive Surgical, Inc.",
        "totalLabel": "Net income attributable to Intuitive Surgical, Inc."
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r70",
      "r73",
      "r78",
      "r131",
      "r132",
      "r420",
      "r427"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: net income attributable to noncontrolling interest in joint venture",
        "verboseLabel": "Net income attributable to noncontrolling interest in joint venture"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r119",
      "r120",
      "r121",
      "r295",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest in Joint Venture"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Interest and other income, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r156",
      "r158",
      "r161",
      "r164",
      "r166"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "auth_ref": [
      "r147",
      "r484",
      "r487"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.",
        "label": "Operating Lease, Lease Income",
        "terseLabel": "Operating lease revenue"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncomeTableTextBlock": {
     "auth_ref": [
      "r147",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of income from operating lease.",
        "label": "Operating Lease, Lease Income [Table Text Block]",
        "terseLabel": "Operating Lease Revenue"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r46"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r62",
      "r64",
      "r414",
      "r422"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "totalLabel": "Net current-period other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent [Abstract]",
        "terseLabel": "Employee Benefit Plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r58",
      "r64",
      "r467",
      "r469",
      "r474"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r60",
      "r61"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r60",
      "r61",
      "r64"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "totalLabel": "Net current-period other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax",
        "totalLabel": "Net current-period other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "totalLabel": "Net current-period other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": {
     "auth_ref": [
      "r64",
      "r67",
      "r68",
      "r69",
      "r473"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r71",
      "r74",
      "r76",
      "r77",
      "r79",
      "r81",
      "r288",
      "r475",
      "r480",
      "r481",
      "r536",
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r71",
      "r74",
      "r414",
      "r415",
      "r422"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Less: comprehensive income attributable to noncontrolling interest"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r71",
      "r74",
      "r414",
      "r415",
      "r422"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Net current-period other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r62",
      "r64"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r64",
      "r67",
      "r69",
      "r193"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax": {
     "auth_ref": [
      "r64",
      "r67",
      "r69",
      "r434"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax": {
     "auth_ref": [
      "r64",
      "r67",
      "r69",
      "r335"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r59",
      "r64",
      "r452"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Other Accrued Liabilities - Short-term"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIncomeMember": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other revenue.",
        "label": "Other Income [Member]",
        "terseLabel": "Other income"
       }
      }
     },
     "localname": "OtherIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r46",
      "r492"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other accrued liabilities",
        "totalLabel": "Total other accrued liabilities\u2013short-term"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails",
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r436",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental non-cash investing activities:"
       }
      }
     },
     "localname": "OtherNoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Intangible and other assets, net"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Other Long-term Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r7",
      "r10",
      "r223"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Other prepaids and other current assets"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Intuitive Surgical, Inc. Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisition of businesses, net of cash"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r176"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchase of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r94",
      "r409",
      "r410",
      "r411"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "negatedLabel": "Purchase of property, plant, and equipment and intellectual property"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r344",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r21",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r21",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r21",
      "r492"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of September\u00a030, 2021, and December\u00a031, 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r9",
      "r37",
      "r38"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaids and other current assets",
        "totalLabel": "Prepaids and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails",
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaids and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails",
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r8",
      "r10",
      "r222",
      "r223"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r89",
      "r90",
      "r176"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r96",
      "r98"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Payment of deferred purchase consideration"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r91",
      "r176"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.",
        "label": "Proceeds from Sale of Available-for-sale Securities",
        "terseLabel": "Proceeds from sales of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity": {
     "auth_ref": [
      "r92",
      "r176"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of equity securities classified as available-for-sale securities.",
        "label": "Proceeds from Sale of Available-for-sale Securities, Equity",
        "terseLabel": "Proceeds from sale of available-for-sale securities, equity"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from issuance of common stock relating to employee stock plans"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r2",
      "r70",
      "r73",
      "r78",
      "r99",
      "r113",
      "r123",
      "r131",
      "r132",
      "r156",
      "r158",
      "r161",
      "r164",
      "r166",
      "r198",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r414",
      "r419",
      "r421",
      "r427",
      "r428",
      "r458",
      "r465",
      "r542"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r18",
      "r19",
      "r242",
      "r492",
      "r548",
      "r555"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTransfersAndChanges": {
     "auth_ref": [
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of physical assets used in the normal conduct of business and not intended for resale, from reclassification, impairment, donation, or changes classified as other. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Transfers and Changes",
        "terseLabel": "Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTransfersAndChanges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r564"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains (Losses)",
        "terseLabel": "Realized investment gains (losses)"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r66",
      "r76",
      "r77",
      "r79",
      "r475",
      "r479",
      "r481"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r377",
      "r524",
      "r579"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r25",
      "r295",
      "r370",
      "r492",
      "r552",
      "r572",
      "r574"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r119",
      "r120",
      "r121",
      "r124",
      "r130",
      "r132",
      "r199",
      "r367",
      "r368",
      "r369",
      "r392",
      "r393",
      "r456",
      "r569",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r153",
      "r154",
      "r157",
      "r162",
      "r163",
      "r167",
      "r168",
      "r169",
      "r314",
      "r315",
      "r525"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r312",
      "r313",
      "r318",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE AND CONTRACT ACQUISITION COSTS"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Price allocated to remaining performance obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Remaining performance obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received on annual basis for sales-type and direct financing leases receivable. Includes, but is not limited to, reconciliation to lease receivable recognized in statement of financial position.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Contractual Maturities of Gross Lease Receivables"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived": {
     "auth_ref": [
      "r485"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears": {
     "auth_ref": [
      "r485"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths": {
     "auth_ref": [
      "r485"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear": {
     "auth_ref": [
      "r485"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2021"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears": {
     "auth_ref": [
      "r485"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears": {
     "auth_ref": [
      "r485"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseLeaseIncome": {
     "auth_ref": [
      "r147",
      "r484",
      "r487"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease income from variable lease payments, interest income from net investment on sales-type lease, and profit (loss) recognized at commencement.",
        "label": "Sales-type Lease, Lease Income",
        "terseLabel": "Sales-type lease revenue"
       }
      }
     },
     "localname": "SalesTypeLeaseLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock": {
     "auth_ref": [
      "r147",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of income from sales-type lease.",
        "label": "Sales-type Lease, Lease Income [Table Text Block]",
        "terseLabel": "Sales-type Lease Revenue"
       }
      }
     },
     "localname": "SalesTypeLeaseLeaseIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SalesTypeLeaseLeaseReceivable": {
     "auth_ref": [
      "r488"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type lease.",
        "label": "Sales-type Lease, Lease Receivable",
        "terseLabel": "Lease receivables"
       }
      }
     },
     "localname": "SalesTypeLeaseLeaseReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLease": {
     "auth_ref": [
      "r173",
      "r200",
      "r205",
      "r488"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of net investment in sales-type lease.",
        "label": "Sales-Type Lease, Net Investment in Lease, before Allowance for Credit Loss",
        "totalLabel": "Net Investment"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails",
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss": {
     "auth_ref": [
      "r200",
      "r202",
      "r203"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on net investment in sales-type lease.",
        "label": "Sales-type Lease, Net Investment in Lease, Allowance for Credit Loss",
        "negatedTerseLabel": "Allowance for credit loss"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]",
        "terseLabel": "Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about credit quality indicator for net investment in sales-type lease.",
        "label": "Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Table]",
        "terseLabel": "Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Table]"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net investment in sales-type lease originated more than five years prior to current fiscal year.",
        "label": "Sales-type Lease, Net Investment in Lease, Originated, More than Five Years before Current Fiscal Year",
        "terseLabel": "Prior"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net investment in sales-type lease originated four years prior to current fiscal year.",
        "label": "Sales-type Lease, Net Investment in Lease, Year Five, Originated, Four Years before Current Fiscal Year",
        "terseLabel": "2017"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net investment in sales-type lease originated in current fiscal year.",
        "label": "Sales-type Lease, Net Investment in Lease, Year One, Originated, Current Fiscal Year",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net investment in sales-type lease originated in fiscal year prior to current fiscal year.",
        "label": "Sales-type Lease, Net Investment in Lease, Year Two, Originated, Fiscal Year before Current Fiscal Year",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net investment in sales-type lease originated three years prior to current fiscal year.",
        "label": "Sales-type Lease, Net Investment in Lease, Year Four, Originated, Three Years before Current Fiscal Year",
        "terseLabel": "2018"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net investment in sales-type lease originated two years prior to current fiscal year.",
        "label": "Sales-type Lease, Net Investment in Lease, Year Three, Originated, Two Years before Current Fiscal Year",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r66",
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Components of Accumulated Other Comprehensive Income, Net of Tax"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r183",
      "r186",
      "r189",
      "r190",
      "r191",
      "r192",
      "r544",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCapitalLeasedAsssetsTable": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a lease meeting the criteria for capitalization and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Capital Leased Assets [Table]",
        "terseLabel": "Schedule of Capital Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfCapitalLeasedAsssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Summary of Share-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r429",
      "r431",
      "r432",
      "r433",
      "r435",
      "r441",
      "r443",
      "r449",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Gross Notional Amounts for Derivatives and Aggregate Gross Fair Value Outstanding"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Computation of Basic and Diluted Net Income Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r342",
      "r364",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r233",
      "r235",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r233",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r230",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Summary of Changes in Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r16",
      "r34",
      "r35",
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventory Details"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r442",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r344",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of RSU Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r346",
      "r358",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity Under All Stock Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r50",
      "r111",
      "r149",
      "r150",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r281",
      "r286",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "terseLabel": "Schedule of Stockholders Equity"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt and Equity Securities, FV-NI [Line Items]",
        "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]",
        "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]"
       }
      }
     },
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r296",
      "r297",
      "r298",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Schedule of Share Repurchase Activities"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule Of Estimated Future Amortization Expense Of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)",
        "terseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested ending balance (in shares)",
        "periodStartLabel": "Unvested beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested ending balance (USD per share)",
        "periodStartLabel": "Unvested beginning balance (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted\u00a0Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected volatility (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Common stock reserved for issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable, number of shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Options exercisable, weighted-average exercise price (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Options forfeited/expired, Number Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options granted, Number Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value at grant date (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Estimated Fair Value of the Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r348",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance, Number Outstanding",
        "periodStartLabel": "Beginning balance, Number Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance, Weighted Average Exercise Price Per Share",
        "periodStartLabel": "Beginning balance, Weighted Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r341",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options exercised, Weighted Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Options forfeited/expired, Weighted Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options granted, Weighted Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r361",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares withheld related to net share settlement of equity awards (in shares)",
        "terseLabel": "Shares withheld related to net share settlement of equity awards"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r110",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r52",
      "r76",
      "r77",
      "r78",
      "r119",
      "r120",
      "r121",
      "r124",
      "r130",
      "r132",
      "r148",
      "r199",
      "r288",
      "r295",
      "r367",
      "r368",
      "r369",
      "r392",
      "r393",
      "r456",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r481",
      "r569",
      "r570",
      "r571",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r119",
      "r120",
      "r121",
      "r148",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r21",
      "r22",
      "r288",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Employee Stock Purchase Plan, number of shares purchased by employees"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r21",
      "r22",
      "r288",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock through employee stock plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r21",
      "r22",
      "r288",
      "r295",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised, Number Outstanding"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r21",
      "r22",
      "r288",
      "r295"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Employee Stock Purchase Plan, value of shares purchased by employees"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r21",
      "r22",
      "r295",
      "r343",
      "r359"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock through employee stock plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Amount of share repurchases authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining amount of share repurchases authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r21",
      "r22",
      "r288",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Repurchase and retirement of common stock (in shares)",
        "terseLabel": "Shares repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r21",
      "r22",
      "r288",
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Repurchase and retirement of common stock",
        "terseLabel": "Value of shares repurchased"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r22",
      "r27",
      "r28",
      "r113",
      "r174",
      "r198",
      "r465",
      "r492"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Intuitive Surgical, Inc. stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r77",
      "r113",
      "r119",
      "r120",
      "r121",
      "r124",
      "r130",
      "r198",
      "r199",
      "r295",
      "r367",
      "r368",
      "r369",
      "r392",
      "r393",
      "r412",
      "r413",
      "r426",
      "r456",
      "r465",
      "r475",
      "r476",
      "r481",
      "r570",
      "r571",
      "r605"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r112",
      "r273",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r287",
      "r295",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Patents and developed technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
        "terseLabel": "Summary of Equity Investment Activity"
       }
      }
     },
     "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r187",
      "r188",
      "r194",
      "r195",
      "r196",
      "r266",
      "r286",
      "r453",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r585",
      "r586",
      "r587",
      "r588",
      "r593",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average price per share (in dollars per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r117",
      "r328",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government agencies"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r117",
      "r328",
      "r337",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. treasuries"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "terseLabel": "Net unrealized gains/(losses) on investments"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities",
        "terseLabel": "Increase in unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Add: dilutive effect of potential common shares"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r135",
      "r140"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares outstanding used in diluted calculation"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Shares used in computing net income per share attributable to Intuitive Surgical, Inc.:",
        "verboseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r134",
      "r140"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares outstanding used in basic calculation"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=SL77927221-108306"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919232-210447"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921842-210448"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "79",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82922352-210448"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123353750&loc=SL49131252-203054"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=116633155&loc=d3e31531-110899"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123386454&loc=d3e45280-112737"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123420820&loc=SL77919311-209978"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919391-209981"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919379-209981"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888252"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.13(h))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r580": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r581": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r582": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r583": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r584": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r585": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r586": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r587": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r588": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r589": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(4)"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r590": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(5)"
  },
  "r591": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)(i)"
  },
  "r592": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)(ii)"
  },
  "r593": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r594": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r595": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r596": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "1402",
   "Subsection": "Instruction 5"
  },
  "r597": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(1)"
  },
  "r598": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(2)"
  },
  "r599": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(3)"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r600": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(4)"
  },
  "r601": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(5)"
  },
  "r602": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1406"
  },
  "r603": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e709-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>80
<FILENAME>0001035267-21-000178-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001035267-21-000178-xbrl.zip
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M#?Y2$N__,GSC.' DHGQ.4PV1I$33&'+%TBE<QU1]!L<IN48B6THVG6EH^(T
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MN2A?\4)).3$>//BR5>GUOVPA4T1UH>]O^<9S4O5;OLO9%\+]OP%02P,$%
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MO1DZ]8U]?)8ZV=]X<[:]X3]O;VSA,QY _>7.T5[G+=M'0KV7P7JB0D3"&%>
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MY" (\X3SP,$RY[0F' %]4(8S$*32MU4D;A'T:Y*.(SX$@WX$I*BMDC*!#,$
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M^D<F191 ,L9FS!'TU!1-R%ET"=#18^.CN< CY6TR.2F260";YXL($K)M2]J
M,V0)X-%CXZ.YX"/D%U"&&T>-!T.322IH*9QV,6AO10GP46D(/!?@ KD%*,WI
M #D[E2L'1'"E!9$4"$"9NLDL/('G@BBTCI"[_PN''G(B8"%)T(Y#H#3XY$N
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M$)^'8CNJ02LB.*7 &*BEH<I\XKQ3HA)3&:X[:H34H%AT-AI#<J,-3X+C8]1
MEB :/RM 1Z87@+8TD3PPDH0$P0BCDI2:LZ2%=3JFI2'-/ #=],@45$Q,$RYI
MKMKWT@"705I+O7# @UP:,LT4T$V//E3:2(,FQ#H"2 @M@DT@=(A1<&'9TM!G
MWH!N>B231HFDI430@#X2T\[E/4AKA1?>&NF6AF0S '33HPHS,7EP <$UZCAM
M'3.HYD!3ZI2W='F@PAP W?2HY%1NP(W*CEL-#)*+1".A# .:$%"(V5%I7BL
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MYNOMG6;M]=N=W;?KC6:MN5U#H-U$-%VCO+:]4Z/BE_!K;?M%K?G79NT*!K_
MW^O/F_EG:CA<6Z(%<XG([1!8KU\;'L;:?\[EK#8.K=0B>LIA^MCLB@)X%NPP
M%AV\Y&&6^R+8L^(LVGX1NS=I@O'XS,UQ(*B4>N#.8 Z?^<U[1E+*(X4*ZA,I
MP%)=&,%HH1U1WD0J+%?H-,;CX3@8R,F36E[W+\6Z]DUP=X5%Y0*QZ/9.A4&6
M$H-\J;H7%8,T^_CXH[&AI0<A]<X;LM?YN]5HMO'Z_K2QL2?V7VX25$:G=50Z
M>^P-104D]CM?@I#>V?[&3FNOLT6WW^&[?,[W;'] Y24:S<W3_>;?1_L;>(V-
M=N=+$!),LBE:6<04H<@=+@I'M4>*2' T*2&DFX 06&H0TMQ9;^QNC:!&A4)N
M1"'#"TD[AR&IW^M<6*S9/]KW-E?^YU]4DM_N\]_YO=?YTP][2[NXUY>X+& G
M3V5I#?(>;BVU$.R,<V8?,D:Z.=J]?8$W:XSS<\MHW>X,K<_J1PBM/=# /"\8
M3[;(DZT*IY@NHG ARBC 1C/:H"\X493?.EIZ"QZK@J=EW-Y@MQ/F!Y?:G7@P
MJL3K#O/4@T<GN1_>1_ ,HE(%HXX6$'DJ++A8V&!TBB89Z<G*VE9W>-+*U8JU
MW1.4&920)[6MKE^]U[;'/*S#+YNGU@]';)#3(R[)7[.#VN X^IPM%&JM;JTU
M'-2>'XYB.K]6NSF+J)!*$\P M2HHOU,TXWN_L56A[G;5'SXL+'Z,9%IJ838A
MDD&N73ON]SYFS7,]/#LV1#G-L'\\P?&C2K=)1N'S7BBG71K'2QIX_>V-1@?O
MTZF_VSK#YSS;?K<)VR__/JIO- X;G\-A@VV>UC?VOHR7,'P7J+-]?*>]T[TC
MO,_1EMAK'L!>I_ZISC8YGL?WFIN?\!FOQ4L\BUHZ[@H2/-HT$EQAO%1%KJ^1
MT7&E@UM9VXAM^\GFFKF'#IB,]<BT6?N'^83DTDN]WSLMO;1^*8Q->[HU21T>
M5YJ6V+&;M1AN78AA),0&854AE#,%"!(*AVBR\([8&)WFA*25-82>!*@$H;\K
MB-.V-;.1R9OY]Y>1?J_U^K7MX6'LU_X^Z;<&H>5'8;M>^MWUGZY=LP>C0_L'
MMMOZ//K\:Z6C2D#EK=6=U=W5VJ1RIS\FZS6U4FOT5G^]6_#9+%#([<'U\7H(
M_3@83/YYA0] 2ZF+[^ZJ;S<WWT<#RB?/"P_&%Q <+S0UK)"$\42D Q9%SD9D
MI/:_K81Z9:=GP^TWKQ\;-SW'/[?[S=ZG[J/CI;?O+9?1J$0+2[E"V^QTH0D1
M1;0Q><&L4<!6UG9/NMVSC[;]%49^\J!Y+;?SF"9D'-G2[?YK/++5]>5TE>Y#
MRP_OK=<QY,74+.@"F+%%;JE6>$N\"))&PN+*VG,4;5SC;LM^K1)F)'&O>TC4
M]G[KN+0^[9T)A>^Q]1[]3\8"1;\4G= "M#2%,RD4,CD(4D2NG5]9,T"T7""U
M?;M"A%\F-,Y1U>,^2F+KV+9K\33ZDU'<N)<0],3!K[5?D/ZUS #?CJHN*,SY
MY0'E)!NC]7ZTCU R&JC"G$R1VARB42(4H(0HG"8&ERH*$#Z98,W*&@K&EW+Q
MZT,JK]QGJOWZL-=]E!N[GQM']?<**$7S@B!3"%: 1T?><AL+%IA6E.?:;K0M
M@O$"EX\LSG;0+976Y?[/__Q+,ZI^&]2&L1V/,\TGF0-/:JC,VB?9[ZQ9E-":
M_Z[N6H"-BL>Q(W3=2#RX2;BYRF<7S5N_-6SA%?LC5HK]&&K')_W!2=Y3'/9J
M>,3(TZ?L%_=K-HXY2VO=#Y_-)R77R%7)U9TR<LTJ,]/?;J)ZE=YQ;^R'3SN?
M7:R'B3G=*C3^O7RP9FLX;@D0K3^L^;8=#,H3<;O_V_?M2(/OGG5<K_W+X)X1
MU%*]>V.2[# B?#SUA[9[@%]T:Y\.6_C-I>(J8<#]QWKZH7>,)B;@C#(W$K%2
M@L3))M%&^+#?^?O#]D:=-3YOTL;+O]N-SQ_.\OWW-PX^[S4/VXV-/P_W-[[*
M;2<-MM/9Z[R!^F=\V^9;LM=YR[>;6_BN^WB]QB&"2E)_^>)#XQ]]>G6O%E>9
M*T0=Z Y[E_=J9:'!DD(DRCDC@AIOQDF=R+"CYE=/:L>V7_MHVR>Q]M\Y)X/F
M5.?:X'#J>[F/BY$G*G*L(2LNO@47;UYPL1,\4FI3D0<'%6 #*9RWN543XQ""
M,<2DE;6MW9V7%8?>-S"<+=C7,>%S-;PYL6^E3>><-1-?V:_7G@DP4*CH8@$F
M\L)Q%PIKD$*$2>J$122%_DO##H+]3^UEN^=L&UV<-CHYM=SP( Y_O(E_Y]W-
M:PVH<G^4RK5^<-?ZBZS[HY/!L)7.;J+$5'6-N97WO=4->2,]UMQ9S1]&_Z'6
MR4TW/AW&45I%]K3[EPF^O]!?QXD&AW8P*@T)-=MNXQ&Y(C'[[_\Y:67O'9UV
M%R<'X(4G#OSX5,IS*L:HM&S\Q<2AOQ('.%= V<G/J#O7E]4"_HK>1S[TN!]]
M'/DBE-5&M=N#VB]X451SM<$)XO'!82\G'9_7;PT/[?#+5_EDKS_OJ-!E=/+D
M;7Y]4K/=4/N%77EEAQH3#W)'65CQI-'Q>&9^E,G%<JWF8/0DHR>U@V'-D%JP
M9X/5;Y8'/?3>T?.3?A\?ZV(0;-[O.QF44K7?O1=1_?/6>RF,,URF(LB$2%E9
M5VC"$6UXZDV"0)5"9V\O#KY4P?<HF'N'"YYY=7 O.3U]D JYV]W[6WS;Z,U]
M6?*M]5WJZ\JLA;,F0B74:0V'J+M&R*'?ZV:KVSZK1;3 9[6M;.RM'VT;;MBA
MK>72NB_U\^4UKD9;=T[P2"!B4MMQTAZG6>T6S=HO>;G5;XRSU<D!P\/6 )_8
M'N<2CX=6T>/GO5"Z<?#K_%3JE07.ZSO1L(]+I9XB,A;O58J4 $-OC1C4I"[8
MPH#UA8@J"A^\H#E3O-*IE4Y=9)V*:LS6VOAJL6:]1YW:MUDQ9C73ST#PQF]K
MR,W%C3\,.JB,\2[]<\B%*JB#:W#V)(-?O!SBQ+R,![6#?N_3\/#\YU6$P;&&
M^JG5;4U2F6MY6Y7A&W[CX48_T]_.#_OA =]^M/,#,^R='/R-QSP_LM4=FPO*
M7,'.=^:NHO?5Z;)1:<K5&%]ERDQ]2XZM,J&F7Z[&5[6<_O[A/=;@^R5[BMVN
MK='=MU]FE]W_0UTVHX#@"-2,]$76F0>]_ME-^:(91?:?3PXH)=B9A ;?-?"8
M38$ AC9>ON6-C76ZO_'AT]Z[%SD<*!J=^FF#;9WN-]]\&1JD>PP!4?/#::/Y
MENPW/:EO_/-AN_GG(9[[H='\P/8^;_*]HQ?MQHOK%774ZFB20'1$C2P P!>&
M"UD0'B6(I#T5:F7MU<U:?A%#WO=&&^0:"+O%JUR+OY5>J-<OB3Q&>Q-*S[LL
M:3IT_0)%+I<^;MR$^Y9')F^@W6,2S-TQ0AX+Y05,'G^< .#I2VFG%4([SIK2
M\^MK. 84HZ7^\V2 #S8H9T!ZIH "@<2;RPUSXX5PU!51BX2 PNC"AL0*:A72
MP@D;&;M=2\-;*N:?D/*'.;0$NF/S9H=Y6:SZO/7%^?*^'*WN\_'B5GKC1WKC
M[*K>D"1J2ZG,75!Y 0)=$DU5+ *+BN?.'MS%G] ;Y=\"3]\)R.72A1OCB*UT
MT[;,:#,& 6&W-]I+.1G$T5'XGN-6YC?T%NWU1_=JG^6;?VKAK?&VM2Z^6B\'
MZ3ZV!B. V;5=GSL:(^S,36WRP8.A[0;;#X-:KO%LA6^ES?-?[*\W!N=J5_]O
M82+.<X[&/\; ]^ PMMOG+%_[!1EY%((>=W'+$=Y)ZL:WPKS?WHC;BX-[;&C<
MLHGW[=9EWK9K-R]RF4W6W3<*\6]X;T5B*EA>>$NA@ "D<!;AJ[24<(B.ICP[
MX =VI]JJNW$'L[3**J="[ERUH1?C/EZ,MM?1?IUT6V,I':6GHY=X37*=HD&K
M0$'$!-0QHZQ12H %3D"#>[^5!18%%U90J?D6.IR#/U:V&B^NCP'IGG2*T!N5
M?^1#;LBA&J7/C[+G=T?/L7TR'!E@)")B> 3F>#AY=')=%^^Y\((PKXI@.()*
MB7]9KD5A021.10K1VI4U+M03QN43+2^&@9Q3>&U<># 8#UN]6J5P7IMP4:QP
M4:7PI-:[7/_<>!3/W?;#GCN/VU 83QXI]0[DXYS6^N/,90:K2ERHK+516ZAO
MTOGJJ.3CWAA]/^O'G-?T,7XU//GR'4<O1RY/L6[0:Y\,OS[EVT_QY9C@VPU]
M5BOGYQSV+Z,#![%P_6@_%#;A<CRS[4_V;+#R]%N3H85>K69#SW$V] )VA=IJ
M--]N-;?^V:SMOMUYN?5\_=63VE;C^;<UY*(\>'/]SU>;>=#(\^U&<[/1W+U)
MRKXKB(O57>#N>25JE>CI)X!HMBK5W;(QOG=9N6I@'ID:#]!5=79-&,OY0M\K
MG[D*".;9&?=V+2=?HZ$]]^]6?[Q+8A:(IK=L_?MZ?:=9VUJMO=AJK#>>;ZV_
M0B.09V"O-Z].<[\;,ISA5M%#Z(SI Z1;57S.""'=]UEN#Y$H1[0QC)V)*[;Z
M-3R:MG*L*#<]RKVXV&P8-88<5[3]<M*U)Z$UC.'79W<BYTW"6VK-,OV-ZXJ5
MI\K*,C>]R &#O(/F>]T1)!GE:SG;1@Z/>=\C(F^/PT=?3ZT=5X!^^7WF_OS?
M!U9G=W#"*N[X.>[@WU!DE7:JM--#\U_.S?J&=AI<6EU42WE7MA\/\;A<S-GJ
MXN=X45\^Q/O%D9;JXNW/"RW'N0;?TF>5!EL>#H)*@U4:;%[\)VZKP>S@L);:
MO4^7?3$J;?48N454VJK25O/B/YW+=H;X3,->5E8WJ:W++,M+!3:3T%6E>QZ<
M]G*)=4^E4.; 5(I<C7&S*L9=*LK5;=<>C#3\Q=2"C=; GPP&.>4P \_UKFV?
M#5HC!'L9$<^ =YR_GX_9B8.3]ACD;A_'\2-5%F-)6(0M<WBP4CQSB3E?VQ?E
ME<TH%^G>Y-*JUG"4.#K2__A%^_QS-A_MWN D)S*ON][)>3??VDYK\*&R"4O"
M K#,$==*L\R%K>15HP"542@7Z7(*>!\),S((K_L]'T.V 97&7Q+ZWEOCRX=5
MXU]?OB09J%NKM>WF7YL[WTP_?63Y9)4*GX>(*U:EJI:8=*_B@6V/S>ZHW7AE
M=Y>%LK#,N\65PI@+6XEKNGZ]4O;EHEV.I-5>6#_L]2L]ORQ$K?1\I2NFS5:Z
MVIHO,>G>=J\,@M^U[7%GF,W_G+2&9U?'Q.6 V]O!J _#Q &HK,*R\ !4^5J5
M:IDN6VE:;;Z7F'0;,=E1LM7;X]P@+'9;O?X5:U!I_B6A,ZA*\U?J8[IL!=4.
M>XE)5\_%8KLV183_5[*L*HV_)/2M-'ZE-J;-5NJJQA>5QB\7Z;9'G>JWNN,.
MS7BI2M<O"64K75\IC"FSE;E6B"<K75\NTFV>'K9<JRJT7AJ"@EYB%5^U>5AT
M#N0K:[NXKG9XTH^53ED2BH+YGD[Y:JC$8LR%N -C3"GM_N99.VP:PRDH63D_
MZ1[3*8"-!GA4XRGF-9[B6_-7)NPMIS\/ZI:S'L:U(;7B!^W)?Y9K^<IMWOFW
M+V8"34Q"D?7_,\FO&X6;I@05DL]MY;::F_7S*H:+J8Z7J[C;7,<#OIZ>\1.+
M*+^SB#>,4:J&G=SEP9]O-S8V&[N;&WG:R>[VJZT-I-M&[<_U5TA(?)N_-C=O
M(N&"O<4O;QOK;S>0)3=^7=))+&C!^.T&;/W,92E=E=3<Z;+?_TT\T,.RVSW0
M="-H#S/A^\)$CR[XK#7$F_D?@MR5M5:WAK=IY]X_M5_BJ8_'P\N1=8-??Z*F
M\=;C41YX ;Y;O7FM4^<(8N=NG7>MW%R"!=F(?K(>]&(]R+7U^ 'W.^L_'/1[
MB/:*R2-['R/BS-)4]*[O[EZU2M\9%/2M5YWH^@PCOCT^Z!:<\\.UO,\U?OXA
M?YKR:?1_BTCYFY7?\Y-^'R6R9@>#.!P\NQ,+?/'.=Z+00U]C2B)<&_UK%IJB
MN5USSJT?]6V._SEIH2$;>Y'7:?LSKTYJ<S7MMWSU_[[7*UY]M7Z^ZD*]VS?'
M*I\,PA<SE:DR)DG%G54>:")6Q,B"%M8Z8@+5XYG*XR'HES.5"W&KD<HG@^+
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M2I@72Y@_7PAS1&+91$)!N4)AEH(43@6*U& \)E!(W)B%63*V*A=(F*>$?DL
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M]U_^OZ\OQ+\8AI:)Q ',7"+N-1A=0D?$@@M<"\$=<8^V"5=FS!+.&":4"4;
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M!Z-"43>CJ#=-WX.,.%%*"&*PEB#.O$$V $]QFU0B-')E1?:%MI!\O&046T6
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M+:@#<L9Z;9.6J)U5AK"R-":J*(XB<*V!ON$1=YJ (6J=N$72A +A>X9PPX'
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M)(-@Z&+(8VEER P@-DAA@,( C^RD* S0%@,TLM,EB256#GE+->)6,F0"9TB
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M^=_P9];J$SM\W^U7OVW.<Y2/V4W_\,"CE=OV.':LSVY;VS^K:@H,QG#UJI!
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MO>J(-W/U7CU]F95]Z9AO.^;/RK1YQCVSE6W/:D\G^W>W\Z&$<2?WRC/NDS_
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M?+>.8T>YRMF@0+EXIY SS**D66*2$44U:6?SO=# DZ&!&VW;/S(/E&W[._#
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M\00KKO .<<8\XEYXI*VGB"CIB3>@H%DLZVU!:2E[LDP ;@1"X<B-5]XB@D5
M7'F"-'4P>T7DBF#G K?+N- ^I[(GVX/AZ6!HQQ&PX\:=T1P"I0#*E81DI6:R
M2A=H.1?&LI"XH(9:BU7"IF1O67:>VCO:&C<, F68LT!)("\D"(UDX1$S$A&G
MHH[!8(FK?%-4T@V^1/FF2MZXI4%VV1I? D0W3 <. T:(14()!?:#XLARXI$5
M6'CN8A "3'RQP0J:GQB:;Y1,Y9'A7'; [P+GAB&1(F>88HZ<R)7)O([PR"4P
M*0AEVNC (LGI5'"I@O)TD/S@BKML?3\NGAMG)"GQL#![4-B4@. .&IF@.9(^
M"6&9EX&[DFV] /M^3.FR,]X2H@\6*S0S) FF!$HA1<0=<\C1Y%$P@C-*(O%Z
M:D*+4D6T(+KLCB\7DO?J&!= <UZ<33+8<,"NSF$N'&0W80(1Z;0($DN5VLM9
M5J"\BE NV^/W!]2].5"5Q\%R8Q'#CB(N:4!.YG*_P0F&I4@TLK5-97AQ6A>8
MEFPARP7C-W,86RF(^?_9>]>EMI*D;?16%+S?WC$30=%U/G@FB* -[J&_D6C;
MN+WACZ..("PD7DG8AJO?64L2$B<;(0&2J)XP ]+24JVJS*<RLY[,U$0A%EE
MW'J,#(?]5E,GI).,>A-RP2"NR$+%JU]3NOBGC8\;M:,.C*=]"O)>LT>Q[1][
M2/XJ6#N!4QP#H3Z7+V(\6KBCD5P2:3".1I2T\86 HIW)<W"7 &V,2\@P[<&@
M2!*9 #\8D8H[DAMJZ;5-^#$[#A7"W:M7W7(*_C3Z/ ZS>V944D2@Y(U"/ @/
MGGS*/KVE+A!+F"-KFWCVUL1%FQ?X%/REU;F<@L^BSA.GX#Z /V? 4<")@CK;
M:)"Q\"?WC"<C'%4LW*W.4S<5*9J\4OMR.05?''T>;\]4$V[@OTQ28XAKJI'6
MDB*FB:&8,$V-7D1Z?%'LA5'L<M#]+$H[<=#MI(O!$HF$C *4UE*D4_3("P?2
MJT+P.!8?N:AL.>9>0#V>/.;6W(/AC".*04?$C1+(L-RYDUOI)65&)%YVWZ+*
M#]Y]RS'W/!5U?,SML# NA8"2LKF<:0K(6LP0,5@X;K1-2JUM$H'OZ*99U+2H
M:3G)?EI-'9]D*RUC)(XC(F/N?@WJ:B7LJ]YQ;).A3A*_MLFT6JB(\R_.L4.S
M=]:R%WFP\>?*7:XL5S[EE:^I+$$==@+?/+.M4I'@ 7NC28XI3HE(@?+DH]-1
M,L$2T4%K&PO98C%VR_HDV4(2X;FV F$LP?]40E8%R!"\'*3RWI) P:Q5<G:S
MMK W7[WJ%K+%T^CS^#0'5LLFKS02@2?$HZ/(:F.1U]Y[3;151((^S][RM6CS
M I,M7EJ="]EB%G6>(%MP2:6BCJ (+BWB.EGDN&:(2X)=L#AB7I$M;JMS*3FP
ML)K\+(I<R!:+H\\3)0<B2RE:AF*068MMYC8'AWQ41L$R*Z)IR6HLBEW(%B^M
MM!-D"\&U2]@&I%@*B'-.D,-,(^:X,-[')*3+/K(J/G)1V4*V6"P]OE93P$MN
MO-!(<TX1-V!7.V(\LE0)BF4*SONR^Q95+F2+%U'4,=G"T^A4 D7UF&O$,^-"
M*]AV4V ^Q92"2')M4Y@[2NT5+2U:6K@63ZNH8ZZ%M,E1X3%B.=+,C84=55.#
MF PN,JSA90RF,=$+91K/LV: $(M\@/WQW/4[?=N:I4* ZW1#[")XB#?YH7N=
M5C/41D-?;01*^<#$Q61STP\GJ2&!6$ZU-I$%$6FIL;_X@/5^\K@[<*:B-@G!
M3X8X]A)<>2-0,L%([+2D-JQMLG5)[HJI/XX=]F#]62*29\&$1V!".2I? "P8
MQ^(Q\2)*GY!Q)"$.2X<T%@IY3:DQC*@4P'91L_L8!0>6!@>F.61_:2 HA^RS
M ,'$(7L$F2(IM^EP&H# 2H.,"@E18P6X,0E7AW)W]?>;NJ)!P8#%QX!G]P_*
M\?S+(L%$J2*/G2+.(,4,1SP2GX\*/$H^ 2 DF[R8>RV$ @D%$DHO@07!@LE>
M LPK2F5"44>#.(L<&8X]BE%@1:56/#/C<ZB SRV1K&!!P8+"&'CI$,$$8\ '
MZ56B& 49  1BDLB!-X"LE(9RHZR@N!@$!01>VB H1(1YZO^8B$ -QD$3 0K/
M!>+&,Z1=%$C&Q(25+#++<E5TR>2&*?I?]'^!]+]0'&: @#'%P23L1;0*F:@D
MXLY9I"TA2(@8M#=*NY +OZP;I3;DLD! J391KER**XN@EBN7XLHBJ.7*I;AR
MGO5[B%D,\J.ZTTC?S\S'FNWU8K]7.XVV=]Z-H6;[M62;W=JW'!R;EGTZ-,P&
MQM0;!M,0.N=@=5?&V?UFVZ]=G+MF[D4]G/_S(E.S,EX?4<8DJ9BSRG.2</;^
M:-#"6H=-('HFKZ_9ZQY5P5][*_@+K]QS: SW[>5#XTD^:7$,IW(,CR:II%H'
M[BTER+'<U@:\0624\,A:KRPLMI22KVWJ=8KGX!?.4<=>.+VE(&Q!V!=&V,+#
M70 @O9@X:,><2FL09D$CSBA#CBJ*>!26@]Q+GON#D8*B!44+BLZ=Q?S2,%I8
MS+/ Z 2+V;I N-4>28\MXI0J9*E.*&+%*+=):$S7-L5,?=D*@!8 ?0T ^NR.
M?J& ORR,3E# 8^(."XY22 [<>H>1]D(@K9D47#"NC)UWC9B"IP5/"YXN>.#T
MG6UV"Z'V,>@Z0:JGQG'N64#&>0Z^/I;($$:19;!206JFA*R"IL3<D6Y7T+6@
M:T'7A477DI;PI!'3R:Z1*F(?0D!8!84XP0HY J@:@G<J.>4PMIF3R+@L,%I@
MM,#H,L)HR>F8)WA.%I?4)!D-YF<P!G%O<G_ *)!/TKAHDQ(:P).N*TYF3^PL
MX%G LX#G8H!G28B9 3\G$F)45$$&C[3,Q"<C,'(\:D09#DY:R8GG:YM\G;#5
MP,^*,/M;)4OP_Z'Y;7/T4(WS4] 6/_@[RWBS?6ZKI_PW7#9ZJ*&><+JA<JW0
MLTZOF:]YTXTMN/A;_-?W9N@?C_1HXH/#I\7CCU@'SW;>O_\C$T_F0<YC]_GA
M@.8QJ:L%'LS7Q,_C[F@P9_8H(M>-]BNR"<;ZQK:^VXO>VF_7'NFTV48WIO#F
MT]_[C"D]YAGU QYQ($, /IUNM>)O0&9C-U\%0[*+,I3:<3=#[O\T#>>)8>RT
MIX9+9JV0A)D85+3>4B._J+7-_2SAM4ZJO<UH#1[[OW^SFW>MXPUA'R"H _AF
MFBF =LTY4=9PS)QQ7N 0J:6#30 ^$\-6AG!&!$LX,6VCX8%Y8[A@$; #M@)C
MO;HNUZ>V>P1R,-0(>=U N)+T.P<FI*=>.\-T")P[ECO@8:&I2<DG+Q-\KM+M
ML=958 )+U[)GO?AF],N_1F3Z9KM:@>I#_[H^L"R<-^GO>9R#M\=RNX$'LCND
MX0^_>?CV1O76#60<O$?)AC'FWK?Q!KGWO9_=5FU(=?\G?W;7G[\GV/W?6<9:
MQOH:QJHW"'G<75]BK%3(Y1FK>MA=?Y'P],OR!N729;J4B%O7WA%3&)@,S^-!
MW[3A[DY6^Q#/.MU^SD_KO;GF'<U??)=B/J[RE/[MNK]MYF2E>WL8K/YD5)S9
M:B+&Q-GJSYR$T"L3<WMB,@TNON:9N6(&YJA9;< -K.59><5SDBD\E73\?5?N
M[VP3,4W)EL6>I7QN7[/M(?#"']4O$R?Y#YBX!\W&JYK5C\>PGZ%J*F%DI]4O
MN^UOL=<_+7/ZR#G];Z=]], IG5/5@T4M=O"S<.1V]/'4Q6Z-D?4:Q10_1-9^
M$8B?70@?W1:O#+(,L@RR#'**0<ZSW]]BE[RIS+4IBPVN,@'CKD=<&2*%2UX'
MYUF0R7%.A34I4<J)4#12GTA%I,"$,O+SU-U7Q-<]R>.H7Q[^T?AZN'UX?'#R
M ;[_$WPFG-;W#T_KVU^_'_[QH=6X_-"Z29FH?]XA]<O&UP/Z >[]KMGX(],N
MOI(&/?C1.#WXOK?_^]?#/SXQ>#U=53?XB+]_D898H4Q$*5J;>PXRY(31*'IX
M4>- ).5KFY+S#3:G\J$+5"2X@,\R@<\PK;%(79&Z(G5%ZHK4%:DK4K>:YOU5
M.O-VL^=;G5P;M9CXTYGXXLK$#T00BAU!C%*&.-42N8@Q(I'#ZN&D!6/%Q"\
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MLTP/,8M!8E1W6N'[F<%8L[U>[/=JI]'VSKLQU&R_EFRS6_N68U_3LDB'AMG
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MY6+*!3"YD]200"RG6H/$!1'I8^/7Q7=Y(I@8G\XEKR,#*P*IY!P"QQ,CS7A
M@E#%J<!&A<PHH,7Z*%@QGZ*YU G%N Y<12Z"<YY+$[$/FI(<>9QWL+A@R!-A
MR/B@S%$79*04<1(UXI0Z9&2,". C.2]"8(X],IY<8*3 R)TPPJ7 /"4??0A<
M^J@)Y3IB;2CU4GM73(X%@XO) R@C?*)6>.1H((C+Z#)56R$"*T=P4#YI\E)&
MQ_ <:73+H7RR"B,6JJ)%N?1%+KW[G%'.?-#XLTI]BUV$X25VBJ>I9O"P\]D/
MN9A@KDS;;-=V<XIS[/4G\HF;;=\YC54^\<U"F$5^[JKM\ )+6-L;+57K/,!=
MP;2 D?:RS=%)5V7\IRT/.SB(O[O<W2_RJN^5E)5LSG"]R/55>7@[52>".42Q
M']J&I9R0S5(KLW[RZ?O>^R\A>##[!$641##ZL"?(8!>1U;FWBC;8>/W3<ZY1
MQP+0VEQ4O6I%/"Z5O%[[?MSTQ[7O-A<_3JU!??-?0O1Z+0QT=K(@\HUBR8-J
MR#]!A:JL\[$--1=CNW8<6V%4MWG<3@2^^*+6LOXKC.I.'!@64A_6?;ZB\VS4
MMF!X_5R .:VT?OR5&\-UVEO]?K?ISBO8V^^,"YCOMO^"98W=;@P?CVWW%;?_
MJ.]O"7#8P-DZN&SL>]XX^N)<L,DPCC#G"O$0#-+:!Q2$2<(8370<Z-9]#)21
M;E4U7)N]>W1LJ%SC(OMW:$/^Q-EHI6J]:JGR;7_O=MK^O%>KQY -@G702[]1
M^T>."E'\K^&[U5_D7_^LJJMWXZA"?Q;+:CB]&^.YINB@S4/-'NGTN%QZ;S6Z
MA>RVQ^T0AET01O,*SWW6BM545&T]0!%S8XUSUVIZF/\T:.HPFN_=O_;&<_WI
M#%9^^/FA$.1[P#6#)@LW^Y/<6MYJF08VU% R<F\/N-/@_1$T#SMF/*2ZS/7R
M^LVJGCW@0K7454%[L"-;51WBXPA2.AQ'U3)FV"DF/T6O^6/82V*C]O$<4/U_
MS[.$POCR8]U\OL>;(HP8&QW5VOG$.3-.6<NT<($)3)5-0Z@ULT'M*&1U&SKW
MVA.-'EXQ+A[@O?U="I\A]>T="K@8F3).2P&61DR(4Z61LUJBJ#0FGJJ<<5,%
MFG[5)6D$0#?PIQ+%(6".%@ V[$'3E/6K)@I3-C6YZG!A>]=E,B/<4=5@;#I3
MX%$%X8M\SKMF_'9=[&UOP9@^7< >_KWQ_8L./! :%1))9OET#EDG) H,8P[O
M1:+,VB8E=Q2M&!5/G]R/AWM!U5H)+->JM]&@*'LQ'(OA>$, WS-PRN9F.%:P
M=,T<FW"H)A$3(''HVMSA2:UG2Z4'*.<NIA;;L@DOGHS!\[R?WR;<&K07G$+&
MR)TR!J;^<0;&8< @&Z]31 Q6QI/XT[;/<]^.VX9'KY,C&*W6R!,8>W'[L-F$
MCJ_]!X2_?WS#B1N^.7(LUK,M7OD?@^92V>[Q@V\8F$;3:+=2GD=A/77)<FR2
M2]1HS0FHI_>4A)N;$KF=)S.%=O_5[?@80^\=V'>9H[J7[N_$/-C#7JW"UT^.
M6(Y <.T,#11FWVO82*)%QDE8#!,E<1K6A(&2*_++Z%[6N6M&[V,,WN>5EO$.
M,)"5@424W2 +Q]?OC:TO7+% B,+(:\,0AW5 FCJ0$$495A)CB?-Y/[FC;-$U
MX7ADC#<'$\!%JP0I?W1L8TSGYK^L5&T#T'^K#MA>M3QQL"APH. ?D80L<V!1
M +8@':) P1,= DL19_Z(^B76# V**[ Y/QMU*([]?BN.VAO:W,4VMSK._4K;
M1[5PM1*UJK54]ZJ7^(IT#X4]#OYLU]Y6Q<;]16U"]E;"^LG!Q8X[&;2N'OG(
M-\.<QS$<Y>4^ZW:.NO8T1R'!QSZ%3?\H]S.NNF/")WPE(Q.6J!_-6OPQ>+76
MK1KP=@8AZJI[<6IUO@^B1VDXUZ-/ 1SD[KCMRJ>O^M:N5_UVV[W\6S,#W="(
MJCG;LFT?A^UU!["7&R'WLU4W*&N>NW:VFM8U6X.6MY,W'P\UOS/X>!\&7#U9
MU:HX#*1[9-]]^KA]+4!?R^YY[[[INZ8E _7HU<".G&B6VO\>6]^N(F,PU-YQ
M[G;3'=Q]X@;#A\F/.?DT^6ZG57_EK+R]O%@CWW+"'6BVS\ZG.P 8<C!0)EQ4
M8KH8RGJW++_-\O0NR]-_0&!72$%'WDC51B!K5CY7&.D6J,UWVPV3HM6;4*WC
M:BJROE:_71W>9FV#J_K5(>RWV,[G1)-M;Q^N'Q^WU_/I,$QJ/LO(+^V<=SM7
MNK+SZ</8#\KO_IZ]!1C>7[DXQM5E?_S^U_7+_K3PS/E(XR"VKZ[Z\Z^#JZL&
M.UC5=ATN_[_P/#"BSYWQQ?_WP^?K6CJ:1S!".D\UF4.$^NEDPI341N/^^+T)
M6R]LRVU_-?"W_WEW-?"5$.)A3_/>))3U;AXYY?Y>O6'_^:L^[E7'7]2W/X;>
M3W=@J@R/&^)P'6RO,DU.P2X962K>GY^>#^+!PWXA.1(<CV%Q,HX.C.+?_I'O
M]L^\)KU^QW_-G;1!*(;(/0J9#!VQ%F!O,S6'#>1MQ7T>B$^TW3:@9+7G776
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MK3_P#.5NVG8A@<P\-2L#TG.FB SQ^3HSNJ#U(]!ZDCDB-$"NM0G!DH#GE1-
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MQ[87,VKTFB D@Q@C6,@E]?+I4S1&5=G^&J["V\E%^&NX!@5NIX?;:UD:./'
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MGY7L</L];_RQ"_\^L<8^W"\K,OW[Z\'^X>E->NSA_@YMG'R%[SV$^_[]%4
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M!?&KI>[N0A@8"T^D\\B8H!!G)%<SQSP;%!A;@QT58FW3Z*4)W16R$6X2ZWV
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M/-O>L(0YY!DD(*$^8-UP[ ]R&N9!">@WR'*C&L*@C'#3^J3^=H62H]/U^IF
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M5\Z=+LVC@?UE-=%IS:IE O^[N= "4TQ:HCC"@?OLE4Q(PW[E F(11#6/T7"
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M-WA6?[[&.2.\7VEJ<^&#^O:I@M^L[XRUK[W %;=,/3]\GF,:K;UFC,RUN\?
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M:>LU*M(N)N5*C";M##!O@1MF15 Z*.FTDHP96I'6.J3-[HD$ZYGW,A*:DB:
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M.R0I"4] 8B1.1D,"0Q&SNJYXRIJ'6EK9[RK#+93A^XV3J#)\+S(\:VE[39T
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MEG[Z$X7P@8M 7%2* 'A-O%*&2*XT-31$1E7)IR+NGJ)Z46EXY QP]RO5*QS
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M#N/#2<,B3)W147ZR]T<=//EXW/^".'G[XW'^K5O%_%W3-VL9UA<2)H$,DI$
M 8/S*/+\SX816J\E:\I",LK&92'9G.G0RCAA?'4Z*$C+C]&/XUB_YM^?W!!C
M.6""O6%S/KZ2; &2G5.LN/F4I8!2(W$65;9I(9&LIW/B$^-,)2O!ZXVM)7CY
MKD?%8V8N6W,IOET1[3I,;8'M=08U3X$Q"Y+'K&181X,T2H*2GE.485FD_=T=
MGV(%[3) .PVM"2F:Z*4CP61#&I25Q#$GB<U+)C>:\H3%A@986O+>-LIPO49E
MVD6F26VLH8KJ% !9]-ZB%"704%FMF:I,:QW39K=$0 1)8TP$HBU)R7TBEBI#
M +U!%J0R2E2J59H\5) R1$R:@Z(RJT5H/ ?CE,PP 00?>:5)^V@RXU2S241J
MC2>^Y(0%9RFQVF5CU"#-:X+7+.GVT>0)G((=^UXZG[JCHR,\CITF@2?&SJC?
MZ>&HT_B%.D,<C8[Q!'NCXES#QBW=<9_<(-[.@79--ZT(L7YX; ]:\RLE4]#/
M_<&!^_Q'&;?^<>G&_$;EUMVYU9UQH0E-,7(FB#%:$TB,$L.D(LH:3'D0F4]-
MU>RKS/K'HCL +=KZ7',1OIWWK Y3:TC[ .ZS[5BRZ)8%;_AFO" >]"MM[X6V
M4S\:55X& YHP+\N171&)5=P3)82$X 3D171C2UU3*KO2=BW$.,MJ<([Y:#D'
M+[1WDL7HA0#E8U:8JABW5XRGIZJ0B3PR%HDT466E24AB!6<D6:XX!,\<S6+,
MK+RF?NA:"');KE&!LG07= 7*PUEA,[YH[D.(,@!Q)F;-0-B2R\AD]4 GIAQR
MSH7=V.*45:14I-RSCK)L/W1%RL,A9<8AG6@4U M' FI+P#)&;***F!"954BI
M0M\JI#R!",YFEA-?IGF)X#R?YQW\7%[CK'-ZH6#.MNSBM>4:3WXW\3X=1@?]
M:4[_XJC?Z4T2^C?3VU^&^)NRG3+LCO M#O[N!AQO0[[!T'_?:Z[2[$A6U"^"
M^MG$1XKZ/(XT$A&T*XF/*#&66J)99-$ZEM>!;(X*P>Z>"J[&,:S,-2H![]$T
MK@1L 0%G[><D0HQ<>Y)$- 1 "V(C:A)3")(;R1RPRL#*GE6-Y:KL:1E[9B._
M;!!,AT 4#X* 8Y(XDQ+!R*E(24A*9?O84PMYUY8KT?()A"CN82G,5*J,==S,
MV??B!;JI:M:M/$&KYHQ?IVNLY\;"P\8^+)!E(HO4N&[??_K#8=5N%M!N]M_.
MA#IX)DU209%D#"7 M"8F\$A82!"E5,)BMJO8,\'AFJBE]8E ;,LUGCQ%EN#5
MJ11Y&(K,^F>B$CPO (QH<(D (B4VQ&PR6:FEUTHI0RM'*D=6R4-3.?) ')GQ
MM3"1//6&97JPS!&J)'')(O':!XZ):@NBC1QY K$-X]+9X4+I[(E1^\-QGO97
M8DI:Y[:NUVCG-=9S.V&1F+SH("%FMH64@'+KK3.2Z@!.\^@HS+%:#?,#YU>7
M5Z9&:B_4NY\N5'G5VD\'[G-=L!;)M7BP/=J?23+!E8[2!Q) NJ+X O$E6YE5
M(KE@5=1@REF!:]+/SA^$U^(MR2J[2[!8J^P^G.SNCEU?67ZW_T3#N0,;"4M6
M$? E[Y6@FDAE0Q"4"^EC%=YU%E[MLE7!=0F9C&",M"&_@FR .-3.RWG,Q"J\
M#RF\N^?"RZ+(.E*65F-YR7*L K$:'>',AB@=%T+IZ^OC5ME="]E=@HNGRNY#
MRNY_SV57>69UTEE8%8]9:P9%'.>4!!4CLV"D*.YB3N]T4KX&T]263ZWETPZF
MZ5TH)9%;C6M)Y!>=#_W\5^=O[(U.!UB#:^HU5OH:Z[F]5_-:K<0P/:QY_8V-
MUEI':.EJ^LX%$]N#X,8#$NXYE@S*@3C& C'"((9D@U=9\^!+"'RO0MQ>(5[Z
M89<JQ/<OQ%-;6T=)!?.1^" 8 1Y*"F/)B15"6*,#,&-;)\1/()[B=:_<:<>[
MXU+SZRYEO":UU\8/\USD+H_]TV(2G3W#W4H]KA"\KDUAK#7GR(UA7E%@6?LP
M42)HA)1HR IG4_5P#FR];$JR-5G7QTF,]T]'PY%KAK$2:B%"G:D8X]C1Z,!X
M%TETRA-0W!'KI"'.0U(HF%.8M0PA]36);&YWOFYY O/(NP&/3(85+@*[_ Y:
M461>8[0MB9>U$.SCD'5:&QN]9=9J2:B$2$ RE<D:,UZSW<:DMQZBNWZ+M'*U
M<K5R=;E<9=R#-1*ERYJ-HL: $ME\1F>"9B:(F[E:JV^W';JSU;=!\"2!$N\M
MS_9V],2D:(DUP*1"E4UNN;&EGU$F[UY]NX*W@K>"]SO@!0N!ZLAYHAR",1:,
MLY9'38U#I[&"=X7!.]5V'?C@!.6$\:"SMNL2<4Q8H@)RH8-1 F%C"YX)2RMX
M*W@K>.\?O"[$+&W,A02@6?0L)&UE^3\X#J9Z$EK-UIEC3E%')95A!!7*S-9$
MB='<$<\3<\);9( ;6W)35*Y6KE:NWC-7O> 43$K@H@(IN=$(@6=9U"8RX5A5
M:%<7NK/GTQ0W@D&4A+$H"""SQ$NP)%@N(BHI4O'?,O8,&-VT%;T5O16]]XQ>
MIZSP)FA/:0 CI6<&C*92, :<@ZXJ;<OI.HUNY)P[S5"0/&">0)">N)@\$5QH
M+R 91^/&%IAK3O]6LE:R5K(N>7M,6YN4%MZ5F,1$G43DT93=,FHC^X:SH"JU
M[<?N-![5( V6 A!FN<E*K2XER[)2J[GSC 7F0)JQ4BOMIEP;]#81K3\VTRK_
M/W;_WOIG_N?LQD_<X'VW=W9_ZB+O2FF ;OJ2KS0^Z7;VL.-;S@]Z[#X.\?G9
MBQ=G!P.[O48@FR^]N/@+\N.5VVU^</SQBT_=.#IZ;NTF,%FD>!*)._GA\:=L
MLQ'P2R,P_HS+3<[%C1_337;C9]^ZK-R43-_JJM_^3 KYI.]5;[);7K7>Z[?N
MU6X*N.W]//2]FDVFX![N51AS#_=JZ<V?MJY?]7SW>J])!FH&@]JR3JJGW+(.
M5FVY$BWK1*TM5Z)EG:BUY4JTK!.UMER)EG6BUI8KT;).U-IR)5K6B5I;KD3+
M.E%KRY5H62=J;;D2+>M$K2U7HF6=J+7E2K2L$[6V7(F6WYFHW\UY#/)*VVOB
M\ .6>.B'B3?7E\+-]?6U(?([G=W<[&C8>=V+&#MO\>,(3SP..H(^ZW#*Z870
MX4E'G=WFY&(<FFZY9>?9\Z:+!!6WNV/'N4\[3?C\/-4SYGGP;U5(&/0_C5_S
M->S,[7RO)9;='?_3#W[<^M5U(]GI-:]?NH_=47Z_=O'=NO@-CEQ^,S:=^MH-
M>OG.A[57[SIQ0S@].3UVHTG'-G72QO-VMEA:\\XXPWOM\CMV^4$_XZ"STQN=
M9F3\C9VWIX/WY=:>Y??"9F?V/%-3/D6_Z(S/-=6>OZLN<;&8U,Y,,:E?FF)2
MO\]?3*IV]'>G^)PS^7J%C<F[*&P+#M1*=.HX0_U#S,VUZ[KMD_YI;S1'URW0
M.RO?]*$+"\Z<C9Q<@I3V36V-YAK=;-[U1L^);>YQJ=-DOOH=/^'[;J]W70F/
MYG#GE0Z>HX[0TZ[3P474P5MI&5?@/9H8K$H);.+106CRSK/\H6!/OD['#KS[
ML/MIC^_]M?OA_=?=#V].]E\%>/?J-W%X$/CNAUV^?W"<K_ES]_+)[=T/1^4>
MQ2'_[<O^J]TO^1EA[^O17WNOXM'>U\,ONU\/Y?X?K[\>_O%+VCUX/UNG@X?$
M''!/!'I-("5%G&646(PTN6306;.Q)4#?/171HO+PR+7"[E>N5SC=Q<+/OZ(\
MNZ9HVI)@5A-6/ [VIFF%0P A@HV$(0H"$9$X%)F"1BDN@@H1S%**:%3H5>BM
M-O14= *E=NA5!"JE,32K \Q3&10'+FZ&7DWATW8BSE2X$"%))B,CFFI) ((E
MWC(@E *W&IACS&]LR6=:JKLG\*E4K%1<;2HFS.J?BE:%+!QHK96).R^"\8A2
M6%>IN,)4G.J)C#FTBB62\LPCP)0FSBF>!TS18!@5T<:-+?X,+%0J5BH^=2HZ
M8"FH9%/T 91T-J4,2,:#<J!#,-5 ;C7X9FM#4(><BYCU/[0$:!3$6$Z)TZ+X
M.YC5(FQL,5XMY$J]ITZ]Q*2@P@9M*0/KT !RQ4W&'^>E,F#5!5<7B;.5&Z*R
MU&N@).G$""BPQ"AM2, 4/ 6+(+(R:)YQ)39-Q6+%XM/&HO-!ZH@1C#"0.+?,
M6:LT&">CEFBK,MAR\DVK*J!P4<?HB'+4$;"T. =](%HESK10T-2LX4NH5U.Q
M5[&WVM@+('DV@JV+U(/@QEN>_R\9E5RQK!96;7"5F3@M>6!UX(X)3G0>2@*H
M',DJOR;."^NX$Y2%U&B#!C;UJF!QX8C 2T5E'A5B\X7X;<?^QT:&^ZG3RU=T
M(930T!+SUP24N4&<)\)VT?(Z]1KW>(UOA6%>,T-7)-+RAT5VZ;W7V2K%Y+D%
M3845EI9U)P;F5!3^YE5GF)\SOZHK3 M6F+]F]Y[ ZZQ)("<JV$2*%44\59QX
M8[T&@2R&4&*4KI8]_\>BE71:5(:L==>H;,DJK,[&N_&<.J#"^!@,"]1J91"%
MH94MJ\&665^FQ,"%=S3#)6;M-5LLQ"9@1$2FI0DL2(45+A4N]PX79$F:3(VH
M6 (#F2Z,62&]+O\QJ(K+RL!E:AH+GI1WTA+NK" @6"(>J"$L)6=DBI);W2*X
M//0QN$<P>G>&P]-RG*T8O6&<]F-8Y*0S.LI/]OZH@R<?C_M?$"=O?SS.OW6C
M&3S'J;<5I-9B!]LPT\E[CIY%#HQ+FW4CEWSPBIH8H_CS5<E+0QEEI'DQ7_'H
M,DX87YT."JWR8_3C^+1;\^]/;HBQ)&7 WM"56ZR06@12'[9G#[X%-%Y:F0@#
M'@A(H8EC(1 E0J87M28(OK&EKF'4[5QW+=JT6',Y;A(-\!=UF-H]3 OHB#XP
MJEC4U$4)7$AKDX^"ZQ"$B)POC;6_N^-3K*A="FIGCY84M=XE3:@H0=0\4.(2
M9(-3.D\-\S89L['%U?+.&+=1BNLU*M4NNM6"! 5<>50.D):=8L6TM)"H9YK9
M2K7V4>U".&",Z&QT1!0G/0@?B050A.?1LTQ05&4#N&*MXN1AHI"%%QP"J)0-
M4IZ-4R=C2B93PY7#2E!QTD:<3)UFX&U4"CUQ5&8MR5I%/,M:$H6L-F5M%[1G
M[</)$P@8&7M@.I^ZHZ,C/(Z= 3;),CNC?J>'HT[C'>H,<30ZQA/LC8J+#1N_
M<\=]<H-X.S?:.CK_'\B/UOQ*R;_[<W]PX#[_4<:M?URZ,;]1P;4$<+V>=:0Y
M;CE: \2)$@<'VA"OL[&GC2U!WY0+S8JS_^J)B+7825Q/(;Z=#ZT.4VM8^P!.
MM.WXX70X*DO>\,UX23SH5][>#V]GO&D*J!%&(&$^&0*>.^)D)J]W0F-&,?<6
M-K;T->D(*F_70I"%XQP$*I9< AF=5R402Z>L0-&D@JN"W&9!GL9W"HBHG<R"
M'+.M!\P&8I+01#$5DF%"&/0;6TSJ=56=VG*-BI2ENZ(K4A[0%IOQ20M'/1>!
M$NN#)!"%RWJ!2L1:@8FZX*3*QAA3<E-4IE2FW"=3ENZ/KDQY2*9,'=,^25<R
M'1.'9?L^*$]L08QSGH+"X*A2K6+*$XCG;*9Y1GN>YR6>\WRB=_!S>8VS3NJ%
M0CO;LIW7EFL\^6W%^W0;'?2G5?.*PWZG-RF5UTQO?YGB;\JVRK [PK<X^+L;
M<+P?^09#_WVON4JS-5E9OQ#K=V9]2]I&*X,RA">&)!L$C+BH'.%6NQ08B\QG
MDY1;?@WJ:TC#NE[CR3/P/LWCRL V,'#6AC;:!6\PDJB*@UWJ;#XK)XDW*K$(
MD+SE%8(5/JL:UU7ATSKX3(WM0!W5W OB.=<$=-; K V"&!XUYPF\;H)*6P:?
M)Q %]@8_G@["41:)CNN5(+!1=W >[S5[I+*&>SW\L<GIX,3M7@92&9MK3E%6
M,BU$IMW9,"_JDA418B:1]QE,-+\*PA"4 JE&:U5P)<Q+M<,'6/WY2U9#EB"X
ML_D-4_=SUK"_XJ!_.X&NFL:MY'D:?2"5,E$%0Y)UE$"41<>0GF"@X( '+9@Z
MCP.\JZI1!;LUJ_)#G:ZM$GPO$CSCK$5DD3J.A",7!)*DQ$;!2G9Z&4$(M"ZO
MR'*3UQ5Y/05WZ8& 57#O47!GEE[4TANG2/04QYF#K<WKKP+4*!U+06;!M5#C
M_FJ,SHK%_56"W*/R/K-'@:$<%@V"9#5=$I!!$Y,\(T8D@RJ4^D.E/!>EF[0R
MI#)DI>+\*D/NDR$S!0SR*"4:% $5+0$;);%83A,Q9%XQARZY5C'D"<3U[>&H
MT^V%_@EVW$R6TA+&M],;G79'W;^Q\_9T\+[<[[/\7MBLH7PK=HTGOZ.]=+LU
M2\U.(S3_Z0_K)L]B:\)OLY9IBMX&0VU9"+):21EDM9(*(J5F>;%(QMB\)"@K
MEU;VM8:^5% \G'E:07$74%PP0#67TGE'D ,0B-GVM"Y9DI@N)\U\MC]5)44E
MQ:H&R552W(T44S-3.^%I'AS"- @"TE%B/)-$.REEPE(3L86D>.B(MMC]^^S:
MDTN0TKXQ&YMK='L1>Z/GQ#8$> 33=']TA(/FL-D C[ W+);HQ%3]X3@+R=0E
MD)^EQ1Z[>HUV7F,]/:D+K&':,8M*4Y'57>!2VR1*E3?@V18+Z/G":U@CL2]G
M!7:ZI.7U;3\=N,]U:5MH:?OO:'\:@,$#IICU#>*IRSJP<2&_LI$H S245"Z
MN+$EKMG&K>%3:R.U2[=1J]3>@]3.FJ[>V83@L[ "9P0""\2P&$AF+V !;M9*
MJ]BNN=C&*%)(:)20$@"TE5(P:U-441I-?17;=HCM[KG8,JNC\T(3+5W)>QC*
M:HNT%%V/V@2N0#0'$*Z&.U:Q71NQ7;J?IXKMO8CMU/V3E#'>E[+5,:O&$&66
M6"XB$9X&$80*SN?5%JZ),7@\L7W:@0:]"P51<ZMQ1=3\HO.AG__J_(V]T>D
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MG%?S*LUOQE7IK](_(_W7.:S'][G=BS/NZS,]H"[]2Y/[J3_;*10:I"!><R3
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M>%@XXEGI!LU^[_"GE%#P_4CXGNAS%ADGR3@D#86M7R>/#(X4&28-J "4>.9
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MXIQPJ[1Q@?'DHO,!,R.<8Y(YRM/B4I3O)+VG6!]@4<36G% (3;)>>$Z!V'P
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M6F9)<UD"0KI4A95Z6"$I83E<8(B#6H&<2$!(-A"=B 2=(N1N'ZOC3YQ3L*0
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M#.?BU48;Y4E)Y5\.V([M\Z"Q#4HSA+6"W9:9@"PE#HG@4] F\(3MVH;1LY_
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M[>VSG?:?<(V#M+-WR'?>?;91:.,L021&A;A*!CE)*>)!!895SC" /34"C9S
M0@UZIQ&D!43C7)S;MG?8[)Q+K;R\IQV?]@?-=#9\J=D)L%POB:YWW07S-JW;
M$!W%ZO<6X ]]\$?=W"RX6\M-=0+"#."IVMT06U6S7YWF ,&@"\\] "8>Q&H
M7TT@-]77+#AU%Z,!R,SH OWJ, L7? =@'7OUI[,$V\Y9W8Y8O>I7_=M"#R<M
M>*2ZV%$-T7Z^K_7_/6WVXN@FUR^^_>&OO]:K_#S?1D)>V:&47PPY3(RW?WW
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MY_OG$&#B.8Y( !4 [0,;.!8QDF"-6R\4K$(^'7%C0_=;.>#!&@->KWZB>'1
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MB8(N?(]3>[T?JJ0M=C.^.<!UV6%U\UF<[7I"QAOX9KM[VGG&D<\]_WUW\[/
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MTJM@ @55!+97:Z\\/%X"4QKZ)>?5Y*'+E!4&"N&*@26RGTO?/:! A7!'&6$
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MIZ'(O%L?LMO 7T;+M7G3'%'7)_8*9""F1"E_/",EH706?28V()(S0SM:W>"
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MH\O^31(&C!>/2O312+*-;/XJ<Q/33#C>U-2(7YQT="Z1Y&QIQ]-$G:0,+JR
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M)_\_-3$RU&0;D1G;0$":X6'L(D9TXHRA@[G;GI;96NZ\8#I:D=>*4WB$RTW
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MVCIN5EMX4I8_H2LKW4*9F/J_I#YN\!GU4J'Z.EOK*6G"B+>66)C*L?A#UV]
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MK^VY8LI]=-]#C2GJSA(3TX /%'H($051 [LKHZ$%H'-@6@\.LM"]"O WTIT
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M@E"$N@?S2.9A[,N!85<%F"VL-DU5/$9R@V/QO85*\6+TIPH/,"_Q+!Y<12
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M6+&31%X?8#D,?=%'M;T/:#>IT)Z'(@H\![8[=KS(& 8?5A#JCN4#4&#A@(X
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M/>R1,8H357V&2Q6I(^?CH^[E9!'#W9%Z!S#&/61P=:@X"HWH1!&U^Z7"] 9
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M7HC^5XUQ%<;C3+^JY$36HE)DW!D#"V5X$ H3R0QM"E:"G$"&REG*)*C?)!%
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M!G.L#?WH9,&<!6$>)6YRL!<$9HQ,KBM\R*^&H]>?%AY_!$G"(BD&RZ;'7Y]
M%6)UXY:$=3GZUQ47 +"(U,T^-WS!R+8-ARHNS"$"Z+]]^_D\MF7[H8KA6_\?
MS3?)9-OF0Q5JTP*MY[5'\!Y1\[K2<L!3?<13D(X_?QIT<C@;@G]<,R0?,H@E
M^UP#KQ!^4#7V<JM(U$2\ZJ>3U0HKI'R7F'W[L_A]U=Z#RD$11<450\E=;UG#
M:ZL%#T.5*A5MF\2&RO"+ZUC4Y*[^#;;XS#V<$>*Y3S;V3>IQ_V]K*/+35H!5
M%V U *$A:)E$: 7$49(Z"L@C21_]%''XUQ'4A.(?,8/FS8C'$7L'8)?IJ\'E
M8T<Q<)>X'#S D0)=9])RYM#"&90! #L0YL])R?TX-S<U^,U:3<L'?LP0.1.T
MQ!))GL?>G@$/=F=WEO-2]E"^@8<:> UBDD+  R,D.!THW+?M86O0>1QU^KW^
MW>A+^^9IV.FUA\.M,<TDI  ._,)Z73I.U#4L!Z@2_D=,"O7O$!!#(;4#0F;X
M]/"@#_[HWPT[][W.7:>E]T9ZJ]5_ZHTZO?O'?K?3ZK2WQRDG635J_&<5M8 P
M1RQ!&L6T44C\".**MA]A=#(@BGHG,"/R*E ;M68CW17S@PK^4\#FD(;/NTY/
M[[4Z>K?3&XX&3P_MWFC[+KF6B+H#:G7AY2YA%9%!"3H'CL4(CZT"_4I!2H5+
MLW;:3/>AM;B@GR2]0^\L0W\^Q^Q-NGS8-O5G3"VNF3N'#;%%AL3P&>4IIEOB
MP:MRL-R>JPIVK7:FY84=AE3)._(^@3V*^%=!@"J7 ,4BH)\"(8ZVLB5J?]9_
MC+4 WZ.][).].+;'L.'YV'K 7J F"6?[+Y\^@_X@'ER#;,<&&_%$M/@^PT^)
M@JDM[EQ+>^QY+"X6$,421K:8$#+++A.2'@US%7^N/^\M5I%N@!'!DW<QMDW,
MU 9TH>7T.)<-2#)-6 $*V1ZM(5#8+6'0B3R1['0])A:0W"=@X#E?B#DE>(KY
M[H=D1AQZ%Z%3N^4S1FSCK?VZ$)"4.DB]@UAJ"[O41/(VEX7%PJ&$=(B+ASP'
M"0%1(.%RHA\%0J)02A2)>;3(0,'WS''=GL,Y8$N?.S[H=N*PON_Q33A\CU^L
M_U)MKA!CI55!J"PRP[FL2K!'(7\4"(!  I00(6%\AVDR-WH7U-<>?FFW1[?M
MD=[I#O7>;7_TI3U(@'K7'SSH/(>[M65L2U^9*H'_TL-*P $)%BC@@8 )$ER6
M#"3B<T0X"X&"699B7)0)F'JCF?9S"Z%]B F:+0'A3IWM.:RPN[HK/_7(WX0X
MNQQ3J**(]7' WXS3(R,+3$T>M_:]&6'2T_)TUR7%X^CWD$%M/QI$S6793RB.
MB)*%0('_"?&0$.EH5YLQ%7K3#8/YQ.Q2/*:6R$8,9P[S/,(_,O@NII57#+5U
MG4)(799U28,*1$()F7@LSL6J<KF.)I83VZYC3[G"$HK\GJ:E8*\VJ3.(H<LU
M*2Z*M)VD41WM:".00W^QD%\_82O<S-2Q(9"<BW9\)W/**87:JLXAAB[+JI("
MQ7NO4$*F@S2N0?NW=N^I#?IK09@ST%LCO?7K4V?8X6IK]8<%]A3D(*D.FR_J
MZ;Q)0%0 '9)%";I($#X"E]!RP= X-V%U-'S93"?M\X%XB.'O9J4/"(2!/@%]
MXNF4D2G?43I^XP1XH'%/G"G#BUGA>+AT 90C>Z.FU5.KT#FM PI*2="2*&C\
MAH0P(LZ)Q#D.ZFO!U$V3RE1S":[!CNS4EE+7ZJFL6FY+B?D>)_J=0"JPG65G
MAD>[V ^[2&T9D6DC&&9+B%)+9J^V&9Z9+6PS:[:FA DT/N,<>I2: T@,3AW_
M<)8G1A>$@<#VM$O$A[72M7@_&\K+6FT_3:V>6L_+;S]<!G$LBLS$AF(@(4?D
MU!RB[73;^K# ]R1!-64PR9?A4TLQLN+!*;A@0+A461GT-4Z;Z05O6?T0@SK9
M\F"8,0A]%AHH.LJIJ:D'KC.MGLJH!+A4H_$GHGG 8U"&>@NXOYOH'0$K!3!^
M')KI6R1S0[/86%5N']R-IQKX<ZV>,5UQ%R)@K-X>+;>2'8TD-I(6(Q#O_<K/
M?^.[D$T U7/8;D:@IJD&^4*KIY;W(Y E81101A'I \:OU&Q5#I)J]"ZU>FKY
M/$+OF%F(L+OO]V^_=KI=B(PZO9'>N^_<<#4-VP76E%2TE/Y_LU9/;Z4)J8F@
M+::'),$C1%P+!8.%S125$403 $LY/FJX#C&R4&@Y=D[BQ-D,VU/B4OO><<P7
M:EE%A\Z2V"J'UR9$[*FM)!LL8-DS2B;JI B(VB@4XC@49P'7@>;94PI]:;?M
MDCLQ4]M&4VND-H1L91LQVT/>_)@#H?ZD[7ITSE=6[WR(+H@^=YA'_RLD;[\N
M^/%&_>]I,KL)I#8K36ND5J/SFU5_@B+1D)0-)85#@72\X-'^Q$%??7& 2[M7
MZ!BAY=IJ[^^TGM[JNE3_@+0^'/5;__[2[]ZV!\/VKT^=T1_;'_J3)J'6_UD]
MO2\T2>2?2)(Y:!@*NMJ9A-0>]GDSO2"R#I)#]*O3*DWXM9YC?)LYEDF8*S\M
M+SK;%>.BGL(NM$;Z6+1UJ*[XR@EVX0?SAS@C*2&9848&9.$S8X9=$APBL,.>
MAYV8J<W@4FND=CCD,0/.%<5L4<SW: X2(=Y18@4],KZ_L/!G/]O25X*NU;1&
M:M4U"W3.)@ETP.B(LM 0/XS7L>5!L+IA^',N(PD^XTN?#=PCGC,9X=?RS&!'
M =1V4M<:J=Q:AIW$<O#A(2%)^ 7AFE.+?T8@#B\. AVF/7W1!^T;?=B^;?4?
M'MN]8;$S"#+(*!UM"&#3G\H(0E5!"25)'3PD11UN%3&ETZTUF^E5B"QX#M+Q
M7JO:4M?]"K!0#Z>:UD@'4EF8'E<&-Z(=+1P()Z6_X,S"$[N>;(A0=,L2KQXM
M;!=WODODK;:/4ZV1O\\O[2^67IJ4(CZT3,B!0)#@O1#E:#]I# ?#IUU/L]N>
M@]H6SK1&*@^9SQ: U6&?6Y<!!>\"-Q#!F-P5!3\TN0Y0,NIY6*GA/]<:Z32H
M G[.L2I8HB3/:"7A: <1.%'F)%X>PI3]ABT?GLDA],FE]O3&PL8W* TD7?GX
MD5$#7CPX)K&^$G[A*S'U9\+PE"\>^7-1J.QYYGN)J[;'"ZV9.UI8214EEKI
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MDC,P/E+P)I0;/*@*8KEBQE6>VJ?HN08E;KC(9L-?S4M>] AZ/3GUPW&'JU3
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M*G+<89"IY$;UN&N ?&;6)M:Z22R_+;%FW?W2Z QG5RZ'8C!CDK4I3[W?FU,
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M2E\"RSZX1N[- ]I+;,:0=;2_A[W$K*5P#"T$%!:44 YJV[H:WDEED!GD?J6
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MIPWZTV^S(2Z*$"$[XJEB#%1-A$7E!'#OG?-:E)C\X:\'=\KX- ?&X='GD)H
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M@C"!'"4\1QE-LS!SF:LMVYW:9-J(7<>WMH+7R[96=/!K*[SCIKUM5]A-@0,
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MZ;HY0#-FR%/MS*IS<B\6U77>38*J5Q[;\[9Y2GF241Q!B:2 *%:&/\M3 ?,
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M6CYITZ\C?\<MP'RS4\+3> =L?0#>KTJH#W4[D1N.E'16]]H1UUB=-C"]==0
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MNO"#].&X=>']JC"MNO"#=(]S7?AAI/#AK&Y^M%,]6TB]<6#V#>8I)XBSB,&
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MU"1&_2C7<Q*3/.>YA%S04$WS4D(<8C4::1S+A H4(J<PXL--36UDMI)J/W%
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M;-'\+#>FN.Z7]>K'7$CQYN77JJ"E7LCIDL^7#TU2\%SN8BW2C"=")120(B8
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MGOW/]7;LB?[/X3_R\)Y8K^^CSUEM)IAAJ[4_)EE<K?SC"3** 3$ZKJT=,O[
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M[(#\J=;V3Y'1]R9J-(X:E2.CUDU$E3;(>D-OW!O<C3,#?EOF!99YW"9\XTS
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M]5*/L,:<%3A-T@P+*Q^ZW7!3(YE.:1CC*U]51\KU=N(F6DK+(QQ+J/OYQC^
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M$]MK4M,<]FU-E^6B=I1NJ>K^^?&1KE\Z#1!FC.:",(9!GF:IZ9Z* 96) H)
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MJ8WVCV7Y+$4WUJTBJ/(TD\T@*Y#D"=4F,9( <M.U+TL@* 0G-(5<,.R4QSY
MAJE1AY'>5/8WSFB^>GS4-DYU7A!MOJ]7SP_?(_GXM%B]2-G\^$G?75[1I6_
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MQT>Z?C&L75/&F^-4]/=_F+^[-GQZE7?$DN^G/O-C+!E]BT-U8L]>JAC3H"?
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MSI5W#E+Z9:R9\\KYP84>==T8:PH.UY[1QAU<?/]QM:RRH8ZJX\R4MH$+RF/
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MZY+*A^1S\?K!H5]<2E%^T *:X\X[=3X:;09SQ&F69(#B+ 80QA#0-(]-@*Y
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M6ERB!A@3NOC\6",X;GWXZ]X^NT7NG^:="GW*XK':?(U)5=6T626/WJGJDJI
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MS800($HBHH_@M-RZ0(KH&(YDKJ@NMJK<9-#G]+BNENRJ&LFN9]*6D _>%8N
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M5-HL1)?"7A>/EQF;CCD*GHEU75RG]N4JV/+F*FC]N=H:G;;\UTZR@+]$JJ&
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M:Z=H97L$/ZE__=N_=']1/RBIQ+_]R_\'4$L#!!0    (  B(5%-?G)>%=8$
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M!L\7*1&2 6-= 5E%HCSNU[ACUP;33VALQELZ2%S7I<+:LE\#881DB>$J#$(
MQA8)G/<,\/_!1%R35-0Y"KM%1#/NTD' M)7(&S!<I>W"<'ZQ*/(>E_M6I05<
M&H?"BK7&29M=2<N%DO^-8#VSP#V/EIIHF*ACJ=80U8SG5 ]-7:FD 5NT1D(N
M<TF-3!!$N8G):,!UHB.D;",E,O'U[73VN3ZW5\[\$+Y5/6QUI) &H/7YZKD+
MEI;74I*@BDN"0E$BXQ?.P$GN(6:O)16)2K_NHOQ>I;#WB>G[KF(W>GY8_[J7
MT!O S:T^0TOZ)1-<X98-)*;2O1##4^M5!I]C#AI%HM8V"-UOE[M-2=]'=E40
MLY>X&X#+48R+4TLW^NR&\7C\VGT=HN]UBZV!,5)8R2DD[\J-$ZG*[JS*C\E$
MHJ/UE6JF?TI;O[YW)4AUK)(&0/8ES=UPG.);-QVCKS<["N'RXG*1U'^3\C ,
MYP/.-8TF**!<Q*7 C&4"F @N:4)IDG5.?W].6[\N>260=:R2!D!VBX-%QJ,T
M9)RF\S2>#;^E93WG^\FLE')^RJ?N^\"2R$2YIF #YR!$,&"CX&!QP\^1>R],
MK&/6MB.T7Z^]EHVKJ*P&L/A0:H,2S$1++-",=EN0B+PP0\&GP!)QQ(:\KNMN
ME_%@O[68E1"UI\@;2%5]&(XGTZMN]&DV'S ,+T1* 8(E"01'^)LHT12;:#D-
MP:=4Z>K^/4KZ!<Q!$@=[";])BX-6='19NLM^+G,O4%7S^73H+Q=W9$XG)?\_
M&<^1"OS$LVNN,V>&D,R NXB.I54>',T!,C7:<(^AL#N4E=J%_G[+BWO*<%57
M= .V\6>B'? <#!4Q@)<8!PEB4FEWZ,%:GIUVV;-4_0C[4<KZF>/=U_'0_LKI
M#&S]=27\O%#->9J7/[S+5U>=">\^XM#="=<P>,@.A4+Z8J@R"J]LT0IW9U/F
MLA@$&(8%(NA8IQSS$!T*[Z:BERWCCR[GY^BE_"O%@7(Z*XG1.,_*@D@N@=7!
M@2/)\!*=)U:G8^%ZNOH^%>@8->O/!_922@,^XUUN<%%_FBXD&!>9[,]INF!P
M0)PT)#@-@EH,H[AB8(HQ=U08:@*:=EVK!\(F]/5]K'!0R'6BI.:@MUQ(Q[/9
M)2XBF4EVS$L@6GMDAQFP&(L!TRE+3I6VZ1!PNTU3W\<,/5BU'931**QNSUE)
M,3&AA2]Y0X:A/!'@&1<0%(_,<<V4JM-K\R>$]7W$T / =E5+ RA[,,KGE@M
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M=>W.[%.^=IP_IVF>3"_PA]+K_.;ER6RX\/4*0?COO24=F17),O3429D[*H(
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M.!W/T\5LD(/V,FH#SGLT^8PI\)D%R"Y8='RCSC)50>%69/8\^OH@V>IZ>FL
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MROU>_/DUDC><%W8'TDIJ64ZE<XD#X9D$$Y4%%G"7TCY%5BEOM0NU/<^%.1B
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M>=.TZWB\>&VU_PR"RTHS](*4<K:<X 8P/GH44_3<,LG$_9F;3PPAVOB1+R%
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M0QI^*XQ^<//+Z<,&G0M+F;,#IJA 7UTJ\$X;D$0PBYY[U*E.@6DW]/?K#W<
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MD%+VY62*@"<A0#*$::NR=+E.<>JN%/<[PJQ'2':@P'TMXFG-B8XW9QX#DH7
M6 >9$-X@3[ETS4=/56)L%$3.%*W_H>J&;\C:"'GRF2-O'U4\[^/!W6ZC_NPC
M#WA$6/$NZ?*Y5T'FS8W(2S=:53P,TVR2%XY^YZ>O^SVVA@(Z%$2EDUP2$T-_
M!3P7"82QIEPWSX .35!""T]#RP5YNU;??'8_%DWK3R>O5J^FN.Q4@;;Y4WXW
MG*$R_Y'<=)"58K$T#R(>F1 !-TRO;83,=6+6ZRACG112-9;:.C7> G_[EES5
M47H#.= N!/$1[<OI'VGT+7U 2W4^&_@<)/7:0#2\-)U =\%(#*6UI41XG:B-
M=2K@:W#35)EAWYC?2]4O!.ZG?TS*2D>'N(RP]U$ U:),* EE E?AG0E41DS:
MY#KE&%URT51Q8M_PWDFU+P76"-&TY)X*YK2,"ECVO-1C)7"1*LB,,\NI82&T
M:[]O^.@WB],:M'=3[PL!][O)Y73)O)-9$>D2Z%Q6MK(*G#,2'"6>:>&BM6U<
M>EC+1K]IHL:@O9MRFSCMVY/SPO4[_ 8_XO0\39/+\S(YC6K):9 @B2F]DY4#
M)Z0#HRG28#3S[%[<^;.3Y:Y)W B^JF'X-J3!%V*A!S))&H-18 (R+GPDX$TJ
MQ4-D,0\J*M&N8=X(T+IA0/>FRL[.->OF\Q^_Y[1WVGG]Q]9(*V_!2$=IXZ,0
M)I?CTM;C\V0T#,-;2,U>H/NI#/AH/8C@!1@J/41N)%7,X'9>)X7\-$WU#\D?
MU\"J?,[D;),/()66)>Z4*!HB0&A*F<4U+6*=,M:]R.XW+=P1OK8_+.]*D0WL
MX,=C_*RQ&RU96HZK*YPNKCYP@>&B4A*2=PS->>9@LC>0T::SZ*@SM,Z5O754
M]7SUZ'#@F%325,.H6Y6IRY@4MQ8=%Y,,<J,2^C%"@$W<29<YQG1U=H?U=/6+
MO.[TOR&P=E!&WZ'UWX9GYZLK"8JCU9?< Y$T@,A2@_/$@C&1:9US2-;_S%6[
M]YEMZG\7-4WVEUG?JOXPB:5G7+JZ@4*]#<1Q"*9L^,2A90TR@G3&*(K4)QHW
M4O?=S^WW#+"6RO>07=]J?S_Y8T6UY%9[EQF$;!P(Y3F4XEF@W!!%;*3D_A25
MIYHD77UDOR=BM92]F\0:<!)V=;7>7Q<NRI0D%Y0!M2@I88@#+UQ"B =O28Y&
MA+:"JO>-W/?JS<D]K,Z?!<@_38=GPW$ID#X>K^[RWJHZ$MZ)14<=HHP&(7,"
M;[B"3)W(/GCJ[N][!X/X6L*?9Q2W(\RV!GEW.G]V$+_A\U7*DRF2,,<WW^*>
M<,*") :BU2COE @XHBU(IJ3.+)-:28EN^7B>%KZ/!= I(I[9>KBJ2WJ"<R:E
M$E$32*I<NB88JUEB)"@;N:=*VZ K%Z+MS4._3O?S60<=(N&YK8'K J8G>,=5
MSP3-%@3'75!0K<!;33&(=3Q3DQBQ=6;H=,E%OS5KSV@==(F&9[82KNN=GF ]
M,9N4<1ZW/U7:^C -/B<.21,KJ" VU+YWLC\3_1:X/9]UT"46GMLR&'[#GSX@
MU^L$D)5*2&@L+=M"*78M.R*7D!/^)^0DXOUBN#X6PR:L]%LT]XR61.>X>!8+
M8T"-T)%H!YP5WR_&##8& 4[F<CM;2*W[BHC[+8]K';I;:>Z9U,NMFT>\>[G<
MVD^M42VW.1MU[E@[0IQF6@*1&8''$(+&1?1GG3/Z_V_OVYK<.G(TW_>_("+O
MEY>-*%WL4:Q;TDAR]^X3(R](B=,ETE-DN>WY]8MD456ENHF'/,F3+/=,A+KL
MDDE</B !)!+P++,LVV3VX[ZQKMLX\-O(I56ZF/]6Y7AU3Y M!2C9<4!6AU#&
MP, 9R8 +9YEB62G=)FU[@JBNWCD/P<!#NY+&$/R$)^#J8CW[$!:?<=/A$C%R
M:>F<]EA'A>3L(92Z:= IS;0V]6IS%[30I]Y""OW3791\][53XV$D)2X/E6@/
M,-C>8CM>,# 7@$7+JBT("$E*((M0RIB4BO'C F'*[I\#5'97Z7O(;V*U_VV^
MF'^]_+HEW'JAO*"87=9:OV*B0,3LP#IM7))9D;L<3?'???7$JM]'<<LQI#BU
M^L,?MPCG3D?.K 66=-T$ZF2=-BS!>>,C(P>(NST3VDW]M[]ZFJNZT=2_MQ0[
MR'X?/@%O\K. R9<0)&A%6=3FQ5,4T8-2DAD;T.IFNP&?)&SJV2'CQ@TMM-$)
MN.ZN"OR$%U_?70_>XC,K65#:BSK&Q]8)=0B>TS\B-Y9G)@//[0#V ^)Z#$[W
M!,,.FUX/T4SWLP-_?O?NU3_>_/++V=M7;]Y^.GO[\YL7M0[Q\?6GO=9%/_5Q
MXU9+=B9\I#+)S\ME_M?\_/QLD=\0Y8O/<W)J5P,K7\U7Z7Q)).)U!LVE06F4
MHC.S/HBU3$(T*"!)'@L6<G6JS1W (#(/]6,[?=G-3C[M,"7M&<20* 2P,9)A
MB@A<.^-<R2XI,YU0.EE'VPYG=WU=0^V=LMO;?_7UCS_T:"ZPX9+L80 U,EB9
M"36!2\KZBH_@DV*0D[2&!0K[0ILPYJB.\&9/R;>OO;$;7[O2;2YUDI>F<"%;
MBGMMA,)BX=DD'UN]!7B<J%-R<4,0]/BJQL/TTD'.<,/*3_/%?(V_U+D7=\5W
M9PDN<Y&G.A C(Z/3(7(+T98 E+"CTUH'M5OI^@#H[4SLM(GK%)!LH\>.H+I\
MBL6?+M=5I%^7%^OY_VSTO-T?=X=W4X1"R2(@\Y1MY>3 4[@!T6L5T2F36[66
MC<C%M+W&QP?WT35_R@'GC= ^7G[]&B[^7):77VK]=35??%/= 7T,(WWST4+7
MO<4Q27SKM"W<>@VQU&['9'.M:"<P!E%GAP9#FW6VDR3Z'Y;GYS\M+_X5+O*L
MY(PB%0-<<@[*8:CCOA"2RT7F$!UK] #P 6).*9X=@IC'4O9]]=!!</"-A9DN
M@26/'H)*) >O.7@*O"&JJ(0O%)RKMIEA'Z#96Y6/0&.07/?&PV]X,5_FC^MP
ML1X5%6?IOR_G1,2KRXLZ76OS+;.$6)3TADS$$4<V>' *+7B/.00AZS*@MC[V
M :KZR%?&1L_!\N_(PWRZ"(O5^95*%OG]Y47Z$E9X,[OM+/_7Y557[&I&#MF&
MD!5(2O\IPW(2'"H'W'BIDQ)%\C:9\A[$]I%,C(V\5MKJ") SZ9D1FDGPBD1$
M24P!'^D?G5&2256R:C0)?-"1U^RM7[,C;XA<#SSR7B]R+]GBO5BS<8[XV/=-
MD!GNQ/HD^:!T3"L6-: L=%9*%\$)@2 9*F-SX%ZU>1(ST7W'CXJ8,UE<,:*^
MA47M01E#MNF] "MU[?JQ*:E&FUAWIK&/1&!\?.U?>AZDM0Y.V"?X>?'GW\)_
M+2]>GH?5:M/*[+5F2=,149 "68IFZ\3*4L#Q@!&9#$:T.80'$#GQD*)&.%D>
M1VE]X_&&L;?A*VYG[$F,(LL8089,49 .E+-C0,A:>E=B,IC;O$@:2.BTN&P&
MF-V!>;#V.@#G)TQ?%LOSY><_7U"&=9_%[<S&K(.P48(N=:NDR21 17]DH56R
M/$AL=&[O1%ZW0#P<(,O6VNH @A38K"_F\;(J[,/\\Y=K/A*+5@244)C1]96
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M@@M"0^:%2T<)+%G.+HBB+[R%)OJGNTC:E:)>1C2-4S!JHH?.<;4UP<PMDY$
M8$.N+4,Y0<@ADQM&G:/6A<1V-&1-645J@X$! -M#(9U#[&8OQM8M%\\L=R8
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M+96XP_GGQ<M+(G&1_GQ0&#<Y%,;,-)UJ:).HV]49..<2N"2LT,$;9=NL46[
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MZE=A;61WVX4@6F/JGB9R(5P$<$$B>,V#42D;CWS*XV1?QJ8MPO6%XOU.HJ-
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M@3%2&-E]!CX@P^CO]KI?BSD,+!-/V#^L)7(K@:<N\J_K)AQU$"YK2,&DNG:
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M -WI-&WM+9X[+]1RXBZJ9,$Q69<#,@]!.P]>IBR\CLSP4YN%]2R>.#XGBSP
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MM]=_,UZ<D=%2YA%"340"A\!B!I,=*UX+H7F;(6J[T3=ML6E2"-V=M3J^/CM
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M[Q(_VVM*&U.0,7+00=5$0!N(*2K(B3-F>4#T;>HXCU'4"88.T/8/ ;2'Z#N
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MX__^7_\?4$L! A0#%     @ "(A44_X$6"(Y"    BL   X
M ( !     &5X+3,Q,7$S,C$N:'1M4$L! A0#%     @ "(A44\)NVM1&"
M"RL   X              ( !90@  &5X+3,Q,G$S,C$N:'1M4$L! A0#%
M  @ "(A44ZAX-:;4!   7A0   X              ( !UQ   &5X+3,R,7$S
M,C$N:'1M4$L! A0#%     @ "(A44R18%HK;!   ?!0   X
M ( !UQ4  &5X+3,R,G$S,C$N:'1M4$L! A0#%     @ "(A44Y0/%;5E!@
MH!L  !X              ( !WAH  &5X:&EB:70S,2UA<F-E<G1I9FEC871E
M;V9I+FAT;5!+ 0(4 Q0    (  B(5%,=TJ3BNGX" !./'@ 1
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2      L "P#& @  @($$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
